date generated: 2024-04-01
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
x | |
---|---|
GPAT3 | -5.346166 |
RUBCNL | -4.711645 |
ARRDC3 | -4.544456 |
AP001160.1 | 4.141425 |
AC239799.2 | 4.108418 |
CEP152 | 3.951021 |
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 10461 |
num_genes_in_profile | 13897 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 10868 |
num_profile_genes_not_in_sets | 3029 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used:
GMT file of genesets: c5.go.v2023.2.Hs.symbols.gmtGene sets metrics | |
---|---|
num_genesets | 10461 |
num_genesets_excluded | 4679 |
num_genesets_included | 5782 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
GOBP REGULATION OF MAST CELL CHEMOTAXIS | 5 | 1.44e-03 | -0.823 | 7.76e-02 |
GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 3.57e-03 | -0.752 | 1.25e-01 |
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 6 | 1.67e-03 | -0.741 | 8.32e-02 |
GOCC TORC1 COMPLEX | 6 | 1.73e-03 | 0.738 | 8.48e-02 |
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 3.70e-15 | -0.737 | 7.81e-12 |
GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 5 | 5.41e-03 | -0.718 | 1.54e-01 |
GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 4.85e-04 | -0.712 | 4.27e-02 |
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING | 5 | 7.29e-03 | -0.693 | 1.81e-01 |
GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 8.13e-03 | -0.684 | 1.89e-01 |
GOBP LIPID DROPLET DISASSEMBLY | 5 | 8.28e-03 | -0.682 | 1.90e-01 |
GOCC SEC61 TRANSLOCON COMPLEX | 5 | 8.53e-03 | -0.679 | 1.92e-01 |
GOCC TRANSLOCON COMPLEX | 6 | 4.11e-03 | -0.677 | 1.36e-01 |
GOBP FAT PAD DEVELOPMENT | 7 | 2.36e-03 | -0.664 | 1.05e-01 |
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 1.62e-17 | -0.664 | 4.58e-14 |
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 6 | 6.12e-03 | -0.646 | 1.65e-01 |
GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 7.91e-04 | 0.646 | 5.57e-02 |
GOMF SNRNP BINDING | 9 | 8.16e-04 | -0.644 | 5.65e-02 |
GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 7 | 3.19e-03 | 0.644 | 1.18e-01 |
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 3.36e-03 | -0.640 | 1.21e-01 |
GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 6 | 6.75e-03 | -0.639 | 1.76e-01 |
GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.35e-02 | -0.638 | 2.52e-01 |
GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 6 | 7.31e-03 | -0.632 | 1.81e-01 |
GOMF INSULIN BINDING | 5 | 1.60e-02 | 0.622 | 2.70e-01 |
GOBP SENSORY PERCEPTION OF BITTER TASTE | 6 | 8.43e-03 | 0.621 | 1.91e-01 |
GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 8.43e-03 | 0.621 | 1.91e-01 |
GOMF U1 SNRNP BINDING | 6 | 8.52e-03 | -0.620 | 1.92e-01 |
GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 8.64e-03 | -0.619 | 1.94e-01 |
GOBP PROTEIN POLYUFMYLATION | 5 | 1.66e-02 | -0.618 | 2.74e-01 |
GOBP CYCLIC NUCLEOTIDE TRANSPORT | 8 | 2.52e-03 | 0.617 | 1.07e-01 |
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 5 | 1.70e-02 | 0.616 | 2.76e-01 |
GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 8 | 2.86e-03 | -0.609 | 1.10e-01 |
GOCC POLYSOMAL RIBOSOME | 29 | 1.45e-08 | -0.608 | 1.02e-05 |
GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 6 | 9.92e-03 | 0.608 | 2.08e-01 |
GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 5 | 1.89e-02 | -0.606 | 2.89e-01 |
GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 1.94e-02 | 0.604 | 2.92e-01 |
GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 5 | 2.02e-02 | 0.600 | 2.96e-01 |
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 1.12e-02 | 0.598 | 2.23e-01 |
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 6.16e-03 | -0.598 | 1.66e-01 |
GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 2.07e-02 | 0.598 | 2.98e-01 |
GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 10 | 1.09e-03 | -0.597 | 6.75e-02 |
GOMF WNT RECEPTOR ACTIVITY | 6 | 1.14e-02 | 0.597 | 2.26e-01 |
GOBP PYRUVATE TRANSPORT | 5 | 2.21e-02 | -0.591 | 3.05e-01 |
GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT | 5 | 2.30e-02 | 0.587 | 3.10e-01 |
GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION | 5 | 2.30e-02 | 0.587 | 3.10e-01 |
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 10 | 1.31e-03 | -0.587 | 7.32e-02 |
GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 5 | 2.33e-02 | -0.586 | 3.12e-01 |
GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 7.69e-04 | -0.586 | 5.53e-02 |
GOBP MITOCHONDRIAL DNA REPLICATION | 13 | 2.55e-04 | 0.586 | 2.77e-02 |
GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 5 | 2.40e-02 | 0.583 | 3.16e-01 |
GOMF POLY ADP D RIBOSE BINDING | 6 | 1.40e-02 | 0.579 | 2.59e-01 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
GOBP REGULATION OF MAST CELL CHEMOTAXIS | 5 | 1.44e-03 | -8.23e-01 | 7.76e-02 |
GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 3.57e-03 | -7.52e-01 | 1.25e-01 |
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 6 | 1.67e-03 | -7.41e-01 | 8.32e-02 |
GOCC TORC1 COMPLEX | 6 | 1.73e-03 | 7.38e-01 | 8.48e-02 |
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 3.70e-15 | -7.37e-01 | 7.81e-12 |
GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 5 | 5.41e-03 | -7.18e-01 | 1.54e-01 |
GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 4.85e-04 | -7.12e-01 | 4.27e-02 |
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING | 5 | 7.29e-03 | -6.93e-01 | 1.81e-01 |
GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 8.13e-03 | -6.84e-01 | 1.89e-01 |
GOBP LIPID DROPLET DISASSEMBLY | 5 | 8.28e-03 | -6.82e-01 | 1.90e-01 |
GOCC SEC61 TRANSLOCON COMPLEX | 5 | 8.53e-03 | -6.79e-01 | 1.92e-01 |
GOCC TRANSLOCON COMPLEX | 6 | 4.11e-03 | -6.77e-01 | 1.36e-01 |
GOBP FAT PAD DEVELOPMENT | 7 | 2.36e-03 | -6.64e-01 | 1.05e-01 |
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 1.62e-17 | -6.64e-01 | 4.58e-14 |
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 6 | 6.12e-03 | -6.46e-01 | 1.65e-01 |
GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 7.91e-04 | 6.46e-01 | 5.57e-02 |
GOMF SNRNP BINDING | 9 | 8.16e-04 | -6.44e-01 | 5.65e-02 |
GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 7 | 3.19e-03 | 6.44e-01 | 1.18e-01 |
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 3.36e-03 | -6.40e-01 | 1.21e-01 |
GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 6 | 6.75e-03 | -6.39e-01 | 1.76e-01 |
GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.35e-02 | -6.38e-01 | 2.52e-01 |
GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 6 | 7.31e-03 | -6.32e-01 | 1.81e-01 |
GOMF INSULIN BINDING | 5 | 1.60e-02 | 6.22e-01 | 2.70e-01 |
GOBP SENSORY PERCEPTION OF BITTER TASTE | 6 | 8.43e-03 | 6.21e-01 | 1.91e-01 |
GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 8.43e-03 | 6.21e-01 | 1.91e-01 |
GOMF U1 SNRNP BINDING | 6 | 8.52e-03 | -6.20e-01 | 1.92e-01 |
GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 8.64e-03 | -6.19e-01 | 1.94e-01 |
GOBP PROTEIN POLYUFMYLATION | 5 | 1.66e-02 | -6.18e-01 | 2.74e-01 |
GOBP CYCLIC NUCLEOTIDE TRANSPORT | 8 | 2.52e-03 | 6.17e-01 | 1.07e-01 |
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 5 | 1.70e-02 | 6.16e-01 | 2.76e-01 |
GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 8 | 2.86e-03 | -6.09e-01 | 1.10e-01 |
GOCC POLYSOMAL RIBOSOME | 29 | 1.45e-08 | -6.08e-01 | 1.02e-05 |
GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 6 | 9.92e-03 | 6.08e-01 | 2.08e-01 |
GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 5 | 1.89e-02 | -6.06e-01 | 2.89e-01 |
GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 1.94e-02 | 6.04e-01 | 2.92e-01 |
GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 5 | 2.02e-02 | 6.00e-01 | 2.96e-01 |
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 1.12e-02 | 5.98e-01 | 2.23e-01 |
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 6.16e-03 | -5.98e-01 | 1.66e-01 |
GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 2.07e-02 | 5.98e-01 | 2.98e-01 |
GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 10 | 1.09e-03 | -5.97e-01 | 6.75e-02 |
GOMF WNT RECEPTOR ACTIVITY | 6 | 1.14e-02 | 5.97e-01 | 2.26e-01 |
GOBP PYRUVATE TRANSPORT | 5 | 2.21e-02 | -5.91e-01 | 3.05e-01 |
GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT | 5 | 2.30e-02 | 5.87e-01 | 3.10e-01 |
GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION | 5 | 2.30e-02 | 5.87e-01 | 3.10e-01 |
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 10 | 1.31e-03 | -5.87e-01 | 7.32e-02 |
GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 5 | 2.33e-02 | -5.86e-01 | 3.12e-01 |
GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 7.69e-04 | -5.86e-01 | 5.53e-02 |
GOBP MITOCHONDRIAL DNA REPLICATION | 13 | 2.55e-04 | 5.86e-01 | 2.77e-02 |
GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 5 | 2.40e-02 | 5.83e-01 | 3.16e-01 |
GOMF POLY ADP D RIBOSE BINDING | 6 | 1.40e-02 | 5.79e-01 | 2.59e-01 |
GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 14 | 1.81e-04 | -5.78e-01 | 2.24e-02 |
GOMF EPHRIN RECEPTOR ACTIVITY | 5 | 2.53e-02 | 5.77e-01 | 3.26e-01 |
GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY | 5 | 2.53e-02 | 5.77e-01 | 3.26e-01 |
GOBP SEQUESTERING OF METAL ION | 8 | 4.78e-03 | -5.76e-01 | 1.43e-01 |
GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 6 | 1.46e-02 | 5.76e-01 | 2.62e-01 |
GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 2.61e-02 | -5.74e-01 | 3.30e-01 |
GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 9 | 2.97e-03 | -5.72e-01 | 1.12e-01 |
GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 1.53e-02 | 5.72e-01 | 2.63e-01 |
GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 10 | 1.79e-03 | -5.70e-01 | 8.70e-02 |
GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 2.76e-02 | -5.69e-01 | 3.38e-01 |
GOCC CHROMAFFIN GRANULE | 9 | 3.34e-03 | -5.65e-01 | 1.21e-01 |
GOBP CHONDROCYTE HYPERTROPHY | 5 | 2.91e-02 | -5.63e-01 | 3.44e-01 |
GOMF SELENIUM BINDING | 5 | 2.92e-02 | -5.63e-01 | 3.44e-01 |
GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 7 | 9.89e-03 | 5.63e-01 | 2.08e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 6 | 1.71e-02 | -5.62e-01 | 2.77e-01 |
GOBP DEDIFFERENTIATION | 5 | 3.04e-02 | -5.59e-01 | 3.48e-01 |
GOCC CYTOSOLIC RIBOSOME | 109 | 7.17e-24 | -5.58e-01 | 6.06e-20 |
GOMF PRE MRNA 3 SPLICE SITE BINDING | 5 | 3.15e-02 | -5.55e-01 | 3.53e-01 |
GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 3.26e-02 | 5.52e-01 | 3.57e-01 |
GOBP ORNITHINE METABOLIC PROCESS | 6 | 1.95e-02 | -5.50e-01 | 2.92e-01 |
GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS | 5 | 3.33e-02 | 5.50e-01 | 3.61e-01 |
GOBP N ACYLETHANOLAMINE METABOLIC PROCESS | 5 | 3.33e-02 | 5.50e-01 | 3.61e-01 |
GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.00e-02 | -5.48e-01 | 2.95e-01 |
GOBP PEPTIDE MODIFICATION | 5 | 3.41e-02 | 5.47e-01 | 3.63e-01 |
GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 3.44e-02 | 5.46e-01 | 3.64e-01 |
GOBP RESPONSE TO ZINC ION STARVATION | 6 | 2.07e-02 | 5.45e-01 | 2.98e-01 |
GOCC CELL POLE | 5 | 3.62e-02 | -5.41e-01 | 3.73e-01 |
GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 1.34e-02 | 5.40e-01 | 2.51e-01 |
GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 2.22e-02 | -5.39e-01 | 3.05e-01 |
GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 1.36e-02 | 5.39e-01 | 2.54e-01 |
GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 6 | 2.29e-02 | -5.36e-01 | 3.10e-01 |
GOCC GOLGI TRANS CISTERNA | 9 | 5.38e-03 | -5.36e-01 | 1.54e-01 |
GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 5 | 3.82e-02 | 5.35e-01 | 3.80e-01 |
GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 5 | 3.82e-02 | 5.35e-01 | 3.80e-01 |
GOCC SODIUM CHANNEL COMPLEX | 5 | 3.84e-02 | -5.35e-01 | 3.80e-01 |
GOCC RESPIRATORY CHAIN COMPLEX IV | 19 | 5.55e-05 | -5.34e-01 | 9.01e-03 |
GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 5 | 3.87e-02 | 5.34e-01 | 3.81e-01 |
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 1.46e-02 | -5.33e-01 | 2.62e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 5 | 3.92e-02 | 5.33e-01 | 3.82e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 3.92e-02 | 5.33e-01 | 3.82e-01 |
GOCC MPP7 DLG1 LIN7 COMPLEX | 5 | 3.93e-02 | 5.32e-01 | 3.82e-01 |
GOBP MAST CELL CHEMOTAXIS | 6 | 2.43e-02 | -5.31e-01 | 3.19e-01 |
GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION | 5 | 4.04e-02 | -5.29e-01 | 3.83e-01 |
GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 4.07e-02 | 5.29e-01 | 3.83e-01 |
GOCC GOLGI TRANSPORT COMPLEX | 9 | 6.25e-03 | 5.26e-01 | 1.66e-01 |
GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 4.16e-02 | 5.26e-01 | 3.86e-01 |
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 5 | 4.17e-02 | -5.26e-01 | 3.87e-01 |
GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 15 | 4.32e-04 | -5.25e-01 | 3.97e-02 |
GOBP PROTEIN UFMYLATION | 6 | 2.65e-02 | -5.23e-01 | 3.33e-01 |
GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 11 | 2.68e-03 | 5.23e-01 | 1.07e-01 |
GOBP REGULATION OF NK T CELL DIFFERENTIATION | 6 | 2.68e-02 | 5.22e-01 | 3.34e-01 |
GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 1.68e-02 | 5.22e-01 | 2.75e-01 |
GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 2.72e-02 | -5.21e-01 | 3.36e-01 |
GOBP GUANINE NUCLEOTIDE TRANSPORT | 8 | 1.10e-02 | 5.19e-01 | 2.22e-01 |
GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 11 | 2.91e-03 | -5.18e-01 | 1.11e-01 |
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 4.48e-02 | -5.18e-01 | 4.00e-01 |
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 4.48e-02 | -5.18e-01 | 4.00e-01 |
GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 1.77e-02 | -5.18e-01 | 2.81e-01 |
GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 4.55e-02 | -5.17e-01 | 4.00e-01 |
GOCC LAMELLAR BODY | 6 | 2.91e-02 | -5.14e-01 | 3.44e-01 |
GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 6 | 2.92e-02 | -5.14e-01 | 3.44e-01 |
GOCC CALCINEURIN COMPLEX | 5 | 4.66e-02 | 5.14e-01 | 4.05e-01 |
GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY | 5 | 4.77e-02 | -5.11e-01 | 4.12e-01 |
GOCC U2AF COMPLEX | 5 | 4.78e-02 | -5.11e-01 | 4.12e-01 |
GOBP B CELL CHEMOTAXIS | 5 | 4.78e-02 | 5.11e-01 | 4.12e-01 |
GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 5 | 4.78e-02 | 5.11e-01 | 4.12e-01 |
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 6 | 3.04e-02 | -5.10e-01 | 3.48e-01 |
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 6 | 3.04e-02 | -5.10e-01 | 3.48e-01 |
GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 7 | 1.94e-02 | -5.10e-01 | 2.92e-01 |
GOBP CYCLOOXYGENASE PATHWAY | 8 | 1.26e-02 | 5.09e-01 | 2.43e-01 |
GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 7 | 1.97e-02 | 5.09e-01 | 2.93e-01 |
GOBP PROXIMAL DISTAL PATTERN FORMATION | 5 | 4.94e-02 | -5.08e-01 | 4.14e-01 |
GOBP CELLULAR RESPONSE TO NICOTINE | 5 | 4.97e-02 | -5.07e-01 | 4.14e-01 |
GOCC CHROMAFFIN GRANULE MEMBRANE | 7 | 2.03e-02 | -5.06e-01 | 2.97e-01 |
GOMF GPI ANCHOR BINDING | 5 | 5.02e-02 | 5.06e-01 | 4.15e-01 |
GOBP ARGININE CATABOLIC PROCESS | 6 | 3.23e-02 | -5.05e-01 | 3.56e-01 |
GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 9 | 8.75e-03 | 5.05e-01 | 1.96e-01 |
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 3.80e-03 | -5.04e-01 | 1.30e-01 |
GOCC ENDOCYTIC VESICLE LUMEN | 15 | 7.32e-04 | -5.04e-01 | 5.47e-02 |
GOBP LEUKOCYTE AGGREGATION | 10 | 5.91e-03 | -5.03e-01 | 1.62e-01 |
GOBP OXALATE TRANSPORT | 6 | 3.33e-02 | -5.02e-01 | 3.61e-01 |
GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB | 6 | 3.35e-02 | 5.01e-01 | 3.61e-01 |
GOBP REGULATION OF T CELL EXTRAVASATION | 5 | 5.26e-02 | 5.00e-01 | 4.19e-01 |
GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 8 | 1.43e-02 | -5.00e-01 | 2.60e-01 |
GOBP SEQUESTERING OF IRON ION | 5 | 5.30e-02 | -5.00e-01 | 4.19e-01 |
GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.22e-02 | -4.99e-01 | 3.05e-01 |
GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 5.45e-02 | -4.97e-01 | 4.23e-01 |
GOBP OXYGEN TRANSPORT | 5 | 5.46e-02 | -4.96e-01 | 4.23e-01 |
GOBP HEPARIN METABOLIC PROCESS | 13 | 1.96e-03 | 4.96e-01 | 9.08e-02 |
GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.52e-02 | 4.96e-01 | 2.62e-01 |
GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 2.33e-02 | 4.95e-01 | 3.12e-01 |
GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.33e-02 | -4.95e-01 | 3.12e-01 |
GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 9 | 1.03e-02 | -4.94e-01 | 2.13e-01 |
GOBP RESPONSE TO UV A | 7 | 2.36e-02 | -4.94e-01 | 3.14e-01 |
GOBP FEMALE GENITALIA DEVELOPMENT | 7 | 2.41e-02 | 4.92e-01 | 3.17e-01 |
GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 5 | 5.73e-02 | -4.91e-01 | 4.29e-01 |
GOBP SENSORY PERCEPTION OF TASTE | 11 | 4.84e-03 | 4.91e-01 | 1.43e-01 |
GOCC CATION TRANSPORTING ATPASE COMPLEX | 6 | 3.82e-02 | -4.89e-01 | 3.80e-01 |
GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 1.70e-02 | 4.88e-01 | 2.76e-01 |
GOBP AXONAL FASCICULATION | 10 | 7.66e-03 | 4.87e-01 | 1.83e-01 |
GOBP METANEPHRIC TUBULE MORPHOGENESIS | 5 | 6.03e-02 | 4.85e-01 | 4.38e-01 |
GOBP LEUCINE CATABOLIC PROCESS | 5 | 6.04e-02 | 4.85e-01 | 4.38e-01 |
GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 3.99e-02 | -4.84e-01 | 3.83e-01 |
GOMF POLY G BINDING | 8 | 1.77e-02 | -4.84e-01 | 2.81e-01 |
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 8 | 1.77e-02 | 4.84e-01 | 2.81e-01 |
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 6 | 4.01e-02 | -4.84e-01 | 3.83e-01 |
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 5 | 6.10e-02 | 4.84e-01 | 4.40e-01 |
GOBP MALE GENITALIA DEVELOPMENT | 8 | 1.79e-02 | 4.84e-01 | 2.82e-01 |
GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 6 | 4.03e-02 | -4.83e-01 | 3.83e-01 |
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 7 | 2.69e-02 | -4.83e-01 | 3.34e-01 |
GOMF MALATE DEHYDROGENASE ACTIVITY | 5 | 6.17e-02 | 4.83e-01 | 4.43e-01 |
GOBP CELLULAR RESPONSE TO UV A | 6 | 4.08e-02 | -4.82e-01 | 3.83e-01 |
GOBP HORMONE CATABOLIC PROCESS | 5 | 6.21e-02 | 4.82e-01 | 4.44e-01 |
GOBP POSITIVE REGULATION OF MITOPHAGY | 6 | 4.12e-02 | -4.81e-01 | 3.85e-01 |
GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 13 | 2.66e-03 | 4.81e-01 | 1.07e-01 |
GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 7 | 2.76e-02 | 4.81e-01 | 3.38e-01 |
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 13 | 2.71e-03 | -4.80e-01 | 1.08e-01 |
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 9 | 1.26e-02 | 4.80e-01 | 2.43e-01 |
GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 7 | 2.80e-02 | -4.80e-01 | 3.38e-01 |
GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 1.89e-02 | 4.79e-01 | 2.89e-01 |
GOCC AXON INITIAL SEGMENT | 7 | 2.83e-02 | -4.79e-01 | 3.41e-01 |
GOBP MITOCHONDRIAL DNA REPAIR | 5 | 6.41e-02 | 4.78e-01 | 4.53e-01 |
GOBP GLUTAMINE TRANSPORT | 7 | 2.85e-02 | 4.78e-01 | 3.41e-01 |
GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.85e-02 | 4.78e-01 | 3.41e-01 |
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 8 | 2.01e-02 | -4.75e-01 | 2.95e-01 |
GOBP RESPONSE TO TYPE III INTERFERON | 7 | 2.96e-02 | -4.75e-01 | 3.47e-01 |
GOMF GLUTAMATE RECEPTOR ACTIVITY | 5 | 6.65e-02 | -4.74e-01 | 4.59e-01 |
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 8 | 2.04e-02 | -4.74e-01 | 2.97e-01 |
GOCC DYNACTIN COMPLEX | 8 | 2.05e-02 | -4.73e-01 | 2.97e-01 |
GOMF 7S RNA BINDING | 7 | 3.03e-02 | -4.73e-01 | 3.48e-01 |
GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 6 | 4.49e-02 | -4.73e-01 | 4.00e-01 |
GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 3.03e-02 | -4.73e-01 | 3.48e-01 |
GOBP PYRIMIDINE DIMER REPAIR | 9 | 1.41e-02 | 4.72e-01 | 2.60e-01 |
GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 4.54e-02 | -4.72e-01 | 4.00e-01 |
GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 5 | 6.81e-02 | 4.71e-01 | 4.65e-01 |
GOBP AMINOPHOSPHOLIPID TRANSPORT | 7 | 3.12e-02 | 4.70e-01 | 3.53e-01 |
GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 7 | 3.15e-02 | 4.70e-01 | 3.53e-01 |
GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 6 | 4.64e-02 | -4.69e-01 | 4.04e-01 |
GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 13 | 3.42e-03 | -4.69e-01 | 1.22e-01 |
GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 5 | 7.06e-02 | -4.67e-01 | 4.73e-01 |
GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 11 | 7.39e-03 | -4.66e-01 | 1.82e-01 |
GOBP CYTOPLASMIC TRANSLATION | 145 | 3.26e-22 | -4.66e-01 | 1.38e-18 |
GOCC DNA REPLICATION PREINITIATION COMPLEX | 7 | 3.28e-02 | 4.66e-01 | 3.58e-01 |
GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 4.86e-02 | -4.65e-01 | 4.13e-01 |
GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 6 | 4.88e-02 | -4.65e-01 | 4.14e-01 |
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 14 | 2.64e-03 | -4.64e-01 | 1.07e-01 |
GOCC CMG COMPLEX | 6 | 4.90e-02 | 4.64e-01 | 4.14e-01 |
GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 5 | 7.38e-02 | -4.62e-01 | 4.85e-01 |
GOBP UV DAMAGE EXCISION REPAIR | 12 | 5.64e-03 | 4.61e-01 | 1.58e-01 |
GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 7 | 3.47e-02 | 4.61e-01 | 3.65e-01 |
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 6 | 5.18e-02 | 4.59e-01 | 4.19e-01 |
GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 18 | 7.60e-04 | -4.58e-01 | 5.53e-02 |
GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 6 | 5.20e-02 | 4.58e-01 | 4.19e-01 |
GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 7.76e-02 | -4.56e-01 | 4.97e-01 |
GOBP REGULATION OF ICOSANOID SECRETION | 11 | 8.87e-03 | -4.56e-01 | 1.96e-01 |
GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 5.34e-02 | -4.55e-01 | 4.21e-01 |
GOBP VAGINA DEVELOPMENT | 5 | 7.83e-02 | 4.55e-01 | 4.99e-01 |
GOBP HEPARIN BIOSYNTHETIC PROCESS | 9 | 1.83e-02 | 4.54e-01 | 2.86e-01 |
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 3.80e-02 | 4.53e-01 | 3.80e-01 |
GOBP B CELL LINEAGE COMMITMENT | 5 | 7.97e-02 | 4.53e-01 | 5.04e-01 |
GOBP REGULATION OF PROSTAGLANDIN SECRETION | 9 | 1.88e-02 | -4.52e-01 | 2.89e-01 |
GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 7 | 3.86e-02 | 4.52e-01 | 3.81e-01 |
GOBP REGULATION OF CELLULAR PH REDUCTION | 5 | 8.05e-02 | -4.51e-01 | 5.07e-01 |
GOCC MICROVILLUS MEMBRANE | 15 | 2.50e-03 | -4.51e-01 | 1.07e-01 |
GOBP MAST CELL MIGRATION | 8 | 2.72e-02 | -4.51e-01 | 3.36e-01 |
GOBP BILE ACID SECRETION | 5 | 8.09e-02 | -4.51e-01 | 5.08e-01 |
GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 6 | 5.60e-02 | -4.51e-01 | 4.27e-01 |
GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 3.92e-02 | 4.50e-01 | 3.82e-01 |
GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 3.92e-02 | 4.50e-01 | 3.82e-01 |
GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 6 | 5.64e-02 | 4.50e-01 | 4.28e-01 |
GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 15 | 2.56e-03 | -4.50e-01 | 1.07e-01 |
GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 8.16e-02 | -4.50e-01 | 5.08e-01 |
GOBP RESPONSE TO SODIUM ARSENITE | 5 | 8.16e-02 | -4.50e-01 | 5.08e-01 |
GOBP SOMATIC STEM CELL DIVISION | 5 | 8.16e-02 | 4.50e-01 | 5.08e-01 |
GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 11 | 9.85e-03 | 4.49e-01 | 2.08e-01 |
GOMF DNA INSERTION OR DELETION BINDING | 6 | 5.71e-02 | 4.48e-01 | 4.28e-01 |
GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 7 | 4.00e-02 | -4.48e-01 | 3.83e-01 |
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 8 | 2.83e-02 | 4.48e-01 | 3.41e-01 |
GOBP POSITIVE REGULATION OF BONE RESORPTION | 11 | 1.02e-02 | -4.47e-01 | 2.13e-01 |
GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 5.78e-02 | 4.47e-01 | 4.31e-01 |
GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 8 | 2.87e-02 | -4.47e-01 | 3.41e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 5.82e-02 | -4.47e-01 | 4.33e-01 |
GOCC HOPS COMPLEX | 9 | 2.04e-02 | 4.46e-01 | 2.97e-01 |
GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 5 | 8.45e-02 | -4.46e-01 | 5.15e-01 |
GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 10 | 1.47e-02 | -4.45e-01 | 2.62e-01 |
GOBP HARD PALATE DEVELOPMENT | 5 | 8.48e-02 | 4.45e-01 | 5.16e-01 |
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 3.95e-03 | -4.45e-01 | 1.33e-01 |
GOCC RIPOPTOSOME | 6 | 5.93e-02 | -4.45e-01 | 4.35e-01 |
GOMF DNA DNA ANNEALING ACTIVITY | 5 | 8.54e-02 | 4.44e-01 | 5.17e-01 |
GOCC NUCLEAR REPLICATION FORK | 30 | 2.56e-05 | 4.44e-01 | 5.27e-03 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 8.55e-02 | -4.44e-01 | 5.17e-01 |
GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 8.56e-02 | 4.44e-01 | 5.17e-01 |
GOBP AGGRESOME ASSEMBLY | 5 | 8.60e-02 | -4.43e-01 | 5.18e-01 |
GOBP MICROTUBULE ANCHORING | 20 | 6.00e-04 | 4.43e-01 | 4.70e-02 |
GOBP MITOCHONDRIAL RNA MODIFICATION | 10 | 1.53e-02 | 4.43e-01 | 2.63e-01 |
GOCC HFE TRANSFERRIN RECEPTOR COMPLEX | 5 | 8.65e-02 | -4.43e-01 | 5.19e-01 |
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 8 | 3.02e-02 | -4.42e-01 | 3.48e-01 |
GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 3.04e-02 | -4.42e-01 | 3.48e-01 |
GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 8 | 3.07e-02 | 4.41e-01 | 3.49e-01 |
GOBP NEGATIVE REGULATION OF BEHAVIOR | 5 | 8.76e-02 | -4.41e-01 | 5.20e-01 |
GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 5 | 8.79e-02 | -4.41e-01 | 5.20e-01 |
GOMF DELTA CATENIN BINDING | 6 | 6.17e-02 | -4.41e-01 | 4.43e-01 |
GOBP HISTONE H3 K9 METHYLATION | 5 | 8.87e-02 | 4.40e-01 | 5.21e-01 |
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 8.90e-02 | 4.39e-01 | 5.21e-01 |
GOMF LONG CHAIN FATTY ACID BINDING | 10 | 1.62e-02 | -4.39e-01 | 2.72e-01 |
GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 14 | 4.45e-03 | 4.39e-01 | 1.39e-01 |
GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 5 | 8.95e-02 | -4.39e-01 | 5.22e-01 |
GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 8 | 3.21e-02 | 4.38e-01 | 3.55e-01 |
GOCC SIGNAL RECOGNITION PARTICLE | 8 | 3.23e-02 | -4.37e-01 | 3.56e-01 |
GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 1.68e-02 | -4.37e-01 | 2.75e-01 |
GOCC GID COMPLEX | 5 | 9.09e-02 | -4.37e-01 | 5.24e-01 |
GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 6 | 6.52e-02 | -4.35e-01 | 4.55e-01 |
GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.64e-02 | -4.35e-01 | 4.04e-01 |
GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 5 | 9.27e-02 | -4.34e-01 | 5.29e-01 |
GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 9.23e-03 | 4.34e-01 | 2.00e-01 |
GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 6.62e-02 | -4.33e-01 | 4.59e-01 |
GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 9.36e-02 | 4.33e-01 | 5.31e-01 |
GOBP HEPATIC STELLATE CELL ACTIVATION | 7 | 4.83e-02 | 4.31e-01 | 4.13e-01 |
GOMF UBIQUINONE BINDING | 6 | 6.76e-02 | -4.31e-01 | 4.64e-01 |
GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 11 | 1.34e-02 | -4.31e-01 | 2.51e-01 |
GOMF 5 3 DNA HELICASE ACTIVITY | 6 | 6.92e-02 | 4.28e-01 | 4.68e-01 |
GOCC PROTEASOME REGULATORY PARTICLE | 19 | 1.24e-03 | -4.28e-01 | 7.23e-02 |
GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 7 | 4.99e-02 | 4.28e-01 | 4.14e-01 |
GOBP PEPTIDYL LYSINE DEACETYLATION | 6 | 6.95e-02 | 4.28e-01 | 4.69e-01 |
GOBP AROMATIC AMINO ACID TRANSPORT | 7 | 5.03e-02 | -4.27e-01 | 4.15e-01 |
GOCC NBAF COMPLEX | 13 | 7.69e-03 | 4.27e-01 | 1.83e-01 |
GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 8 | 3.66e-02 | -4.27e-01 | 3.75e-01 |
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 9.85e-02 | -4.27e-01 | 5.45e-01 |
GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 5 | 9.95e-02 | -4.25e-01 | 5.47e-01 |
GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 12 | 1.07e-02 | -4.25e-01 | 2.20e-01 |
GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 7 | 5.13e-02 | -4.25e-01 | 4.19e-01 |
GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 3.73e-02 | 4.25e-01 | 3.77e-01 |
GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 17 | 2.43e-03 | -4.25e-01 | 1.07e-01 |
GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.01e-01 | -4.24e-01 | 5.48e-01 |
GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY | 5 | 1.01e-01 | 4.23e-01 | 5.49e-01 |
GOMF ICOSANOID BINDING | 7 | 5.26e-02 | -4.23e-01 | 4.19e-01 |
GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 2.06e-02 | 4.23e-01 | 2.98e-01 |
GOCC GROWTH CONE MEMBRANE | 5 | 1.02e-01 | -4.23e-01 | 5.50e-01 |
GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY | 5 | 1.02e-01 | 4.23e-01 | 5.50e-01 |
GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 2.82e-02 | 4.23e-01 | 3.40e-01 |
GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS | 5 | 1.03e-01 | 4.22e-01 | 5.52e-01 |
GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 10 | 2.12e-02 | -4.21e-01 | 3.01e-01 |
GOBP REGULATION OF NADP METABOLIC PROCESS | 8 | 3.96e-02 | 4.20e-01 | 3.83e-01 |
GOBP SIALYLATION | 5 | 1.04e-01 | -4.20e-01 | 5.56e-01 |
GOMF IGG BINDING | 7 | 5.44e-02 | 4.20e-01 | 4.23e-01 |
GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING | 5 | 1.05e-01 | -4.19e-01 | 5.56e-01 |
GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 5.49e-02 | 4.19e-01 | 4.24e-01 |
GOBP 7 METHYLGUANOSINE RNA CAPPING | 8 | 4.03e-02 | 4.19e-01 | 3.83e-01 |
GOBP REGULATION OF HYPERSENSITIVITY | 10 | 2.20e-02 | 4.18e-01 | 3.05e-01 |
GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 10 | 2.20e-02 | -4.18e-01 | 3.05e-01 |
GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 2.99e-02 | -4.18e-01 | 3.48e-01 |
GOMF SIGNAL RECOGNITION PARTICLE BINDING | 6 | 7.63e-02 | -4.18e-01 | 4.94e-01 |
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 7 | 5.56e-02 | 4.18e-01 | 4.26e-01 |
GOBP REGULATION OF DENDRITE EXTENSION | 16 | 3.81e-03 | -4.18e-01 | 1.30e-01 |
GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 4.08e-02 | 4.18e-01 | 3.83e-01 |
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 4.08e-02 | 4.18e-01 | 3.83e-01 |
GOBP NEGATIVE REGULATION OF RNA SPLICING | 23 | 5.33e-04 | -4.17e-01 | 4.45e-02 |
GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 7 | 5.61e-02 | -4.17e-01 | 4.27e-01 |
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 6 | 7.72e-02 | -4.17e-01 | 4.96e-01 |
GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 1.07e-01 | 4.16e-01 | 5.63e-01 |
GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 13 | 9.38e-03 | -4.16e-01 | 2.01e-01 |
GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 14 | 7.06e-03 | 4.16e-01 | 1.78e-01 |
GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 9 | 3.08e-02 | 4.16e-01 | 3.50e-01 |
GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 8 | 4.22e-02 | 4.15e-01 | 3.88e-01 |
GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 30 | 8.75e-05 | 4.14e-01 | 1.34e-02 |
GOBP GOLGI LUMEN ACIDIFICATION | 13 | 9.83e-03 | -4.14e-01 | 2.08e-01 |
GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.10e-01 | 4.13e-01 | 5.69e-01 |
GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 7 | 5.85e-02 | 4.13e-01 | 4.33e-01 |
GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 9 | 3.20e-02 | -4.13e-01 | 3.55e-01 |
GOMF NOTCH BINDING | 15 | 5.67e-03 | -4.13e-01 | 1.58e-01 |
GOMF ACID THIOL LIGASE ACTIVITY | 21 | 1.07e-03 | 4.13e-01 | 6.67e-02 |
GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 7 | 5.88e-02 | -4.12e-01 | 4.34e-01 |
GOBP MALATE METABOLIC PROCESS | 7 | 5.90e-02 | 4.12e-01 | 4.34e-01 |
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 14 | 7.60e-03 | -4.12e-01 | 1.83e-01 |
GOCC MCM COMPLEX | 7 | 5.91e-02 | 4.12e-01 | 4.35e-01 |
GOCC SORTING ENDOSOME | 5 | 1.11e-01 | 4.12e-01 | 5.71e-01 |
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 10 | 2.42e-02 | -4.12e-01 | 3.18e-01 |
GOBP MIDDLE EAR MORPHOGENESIS | 7 | 6.00e-02 | -4.11e-01 | 4.37e-01 |
GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 10 | 2.46e-02 | -4.10e-01 | 3.22e-01 |
GOMF ACID PHOSPHATASE ACTIVITY | 6 | 8.17e-02 | 4.10e-01 | 5.08e-01 |
GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 8.21e-02 | -4.10e-01 | 5.08e-01 |
GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 8.23e-02 | 4.10e-01 | 5.08e-01 |
GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 8.27e-02 | 4.09e-01 | 5.09e-01 |
GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 8 | 4.51e-02 | -4.09e-01 | 4.00e-01 |
GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 2.67e-03 | -4.09e-01 | 1.07e-01 |
GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 1.14e-01 | 4.08e-01 | 5.78e-01 |
GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 13 | 1.09e-02 | -4.08e-01 | 2.21e-01 |
GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 20 | 1.60e-03 | 4.08e-01 | 8.16e-02 |
GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 5 | 1.15e-01 | -4.08e-01 | 5.78e-01 |
GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 5 | 1.15e-01 | -4.07e-01 | 5.78e-01 |
GOCC BBAF COMPLEX | 9 | 3.48e-02 | 4.06e-01 | 3.66e-01 |
GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 2.61e-02 | 4.06e-01 | 3.30e-01 |
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 11 | 1.97e-02 | 4.06e-01 | 2.92e-01 |
GOCC NUCLEAR ENVELOPE LUMEN | 8 | 4.67e-02 | -4.06e-01 | 4.06e-01 |
GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 18 | 2.88e-03 | -4.06e-01 | 1.10e-01 |
GOBP ERROR PRONE TRANSLESION SYNTHESIS | 11 | 1.98e-02 | 4.06e-01 | 2.93e-01 |
GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 22 | 9.87e-04 | -4.06e-01 | 6.34e-02 |
GOBP PROTEIN REPAIR | 6 | 8.55e-02 | 4.05e-01 | 5.17e-01 |
GOBP MDA 5 SIGNALING PATHWAY | 10 | 2.66e-02 | 4.05e-01 | 3.33e-01 |
GOBP L SERINE TRANSPORT | 6 | 8.64e-02 | 4.04e-01 | 5.19e-01 |
GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.64e-02 | 4.04e-01 | 5.19e-01 |
GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 18 | 3.00e-03 | -4.04e-01 | 1.13e-01 |
GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 12 | 1.55e-02 | -4.04e-01 | 2.66e-01 |
GOBP WYBUTOSINE METABOLIC PROCESS | 5 | 1.18e-01 | 4.03e-01 | 5.82e-01 |
GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 6 | 8.80e-02 | 4.02e-01 | 5.20e-01 |
GOBP GROOMING BEHAVIOR | 6 | 8.81e-02 | 4.02e-01 | 5.20e-01 |
GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 15 | 7.03e-03 | -4.02e-01 | 1.78e-01 |
GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 8.82e-02 | 4.02e-01 | 5.20e-01 |
GOBP REGULATION OF FEVER GENERATION | 5 | 1.21e-01 | -4.01e-01 | 5.84e-01 |
GOCC INTEGRIN COMPLEX | 18 | 3.25e-03 | -4.01e-01 | 1.19e-01 |
GOCC U7 SNRNP | 7 | 6.64e-02 | -4.01e-01 | 4.59e-01 |
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 18 | 3.30e-03 | -4.00e-01 | 1.21e-01 |
GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 11 | 2.16e-02 | -4.00e-01 | 3.04e-01 |
GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 5 | 1.22e-01 | 4.00e-01 | 5.86e-01 |
GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 10 | 2.86e-02 | -4.00e-01 | 3.41e-01 |
GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 6 | 9.01e-02 | 4.00e-01 | 5.23e-01 |
GOCC REPLISOME | 15 | 7.52e-03 | 3.99e-01 | 1.82e-01 |
GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 9.09e-02 | -3.99e-01 | 5.24e-01 |
GOMF MRNA METHYLTRANSFERASE ACTIVITY | 13 | 1.29e-02 | 3.98e-01 | 2.47e-01 |
GOMF PROSTANOID RECEPTOR ACTIVITY | 6 | 9.12e-02 | -3.98e-01 | 5.25e-01 |
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 5.14e-02 | 3.98e-01 | 4.19e-01 |
GOCC OUTER KINETOCHORE | 11 | 2.24e-02 | 3.98e-01 | 3.06e-01 |
GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 10 | 2.95e-02 | -3.97e-01 | 3.46e-01 |
GOMF STEROL TRANSFER ACTIVITY | 12 | 1.72e-02 | -3.97e-01 | 2.77e-01 |
GOBP MESENDODERM DEVELOPMENT | 5 | 1.24e-01 | -3.97e-01 | 5.89e-01 |
GOBP PEPTIDE CROSS LINKING | 8 | 5.21e-02 | -3.97e-01 | 4.19e-01 |
GOMF LIPASE INHIBITOR ACTIVITY | 6 | 9.28e-02 | -3.96e-01 | 5.29e-01 |
GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 12 | 1.75e-02 | 3.96e-01 | 2.80e-01 |
GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 8 | 5.28e-02 | -3.95e-01 | 4.19e-01 |
GOBP HEMATOPOIETIC STEM CELL MIGRATION | 5 | 1.26e-01 | 3.95e-01 | 5.93e-01 |
GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 5 | 1.26e-01 | -3.95e-01 | 5.93e-01 |
GOBP NEGATIVE REGULATION OF SISTER CHROMATID COHESION | 5 | 1.26e-01 | -3.95e-01 | 5.93e-01 |
GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 4.81e-03 | 3.95e-01 | 1.43e-01 |
GOBP LEUCINE METABOLIC PROCESS | 7 | 7.05e-02 | 3.95e-01 | 4.73e-01 |
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 1.27e-01 | -3.94e-01 | 5.96e-01 |
GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 8 | 5.40e-02 | 3.93e-01 | 4.23e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 15 | 8.38e-03 | -3.93e-01 | 1.91e-01 |
GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 5 | 1.28e-01 | 3.93e-01 | 5.98e-01 |
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 9 | 4.15e-02 | -3.93e-01 | 3.86e-01 |
GOMF MUTSALPHA COMPLEX BINDING | 6 | 9.62e-02 | 3.92e-01 | 5.38e-01 |
GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 5 | 1.29e-01 | -3.92e-01 | 5.99e-01 |
GOCC ARP2 3 PROTEIN COMPLEX | 9 | 4.20e-02 | -3.91e-01 | 3.87e-01 |
GOMF OXO ACID LYASE ACTIVITY | 5 | 1.30e-01 | 3.91e-01 | 6.00e-01 |
GOMF MOLECULAR TAG ACTIVITY | 12 | 1.91e-02 | -3.91e-01 | 2.89e-01 |
GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 6 | 9.76e-02 | -3.91e-01 | 5.42e-01 |
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 4.27e-02 | -3.90e-01 | 3.90e-01 |
GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 9 | 4.28e-02 | 3.90e-01 | 3.90e-01 |
GOBP CHOLESTEROL STORAGE | 20 | 2.59e-03 | -3.89e-01 | 1.07e-01 |
GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 10 | 3.35e-02 | 3.88e-01 | 3.61e-01 |
GOBP AUTOPHAGIC CELL DEATH | 8 | 5.73e-02 | -3.88e-01 | 4.29e-01 |
GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 11 | 2.59e-02 | 3.88e-01 | 3.29e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 5 | 1.34e-01 | -3.87e-01 | 6.05e-01 |
GOCC SMN COMPLEX | 10 | 3.40e-02 | 3.87e-01 | 3.63e-01 |
GOBP PML BODY ORGANIZATION | 6 | 1.01e-01 | -3.87e-01 | 5.48e-01 |
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 19 | 3.52e-03 | -3.87e-01 | 1.25e-01 |
GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 9 | 4.51e-02 | -3.86e-01 | 4.00e-01 |
GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 11 | 2.68e-02 | 3.86e-01 | 3.34e-01 |
GOBP STEROID CATABOLIC PROCESS | 9 | 4.52e-02 | 3.86e-01 | 4.00e-01 |
GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 11 | 2.69e-02 | 3.85e-01 | 3.34e-01 |
GOMF RAGE RECEPTOR BINDING | 9 | 4.57e-02 | -3.85e-01 | 4.00e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 13 | 1.65e-02 | -3.84e-01 | 2.73e-01 |
GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 5 | 1.37e-01 | -3.84e-01 | 6.08e-01 |
GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 1.37e-01 | -3.84e-01 | 6.08e-01 |
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 6 | 1.04e-01 | -3.83e-01 | 5.56e-01 |
GOBP TYPE II HYPERSENSITIVITY | 5 | 1.38e-01 | 3.83e-01 | 6.08e-01 |
GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 1.04e-01 | 3.83e-01 | 5.56e-01 |
GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 6 | 1.04e-01 | 3.83e-01 | 5.56e-01 |
GOBP POSITIVE REGULATION OF VASCULOGENESIS | 6 | 1.05e-01 | -3.82e-01 | 5.56e-01 |
GOBP REGULATION OF VASCULOGENESIS | 6 | 1.05e-01 | -3.82e-01 | 5.56e-01 |
GOMF WNT PROTEIN BINDING | 13 | 1.71e-02 | 3.82e-01 | 2.77e-01 |
GOBP RESPONSE TO GLYCOPROTEIN | 8 | 6.17e-02 | 3.82e-01 | 4.43e-01 |
GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 10 | 3.69e-02 | -3.81e-01 | 3.77e-01 |
GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 4.80e-02 | 3.81e-01 | 4.12e-01 |
GOBP CELL MIGRATION IN HINDBRAIN | 10 | 3.73e-02 | 3.80e-01 | 3.77e-01 |
GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 23 | 1.61e-03 | -3.80e-01 | 8.16e-02 |
GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.18e-02 | 3.80e-01 | 5.08e-01 |
GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 1.42e-01 | -3.80e-01 | 6.14e-01 |
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 6 | 1.08e-01 | -3.79e-01 | 5.65e-01 |
GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 10 | 3.82e-02 | 3.79e-01 | 3.80e-01 |
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 8.31e-02 | -3.78e-01 | 5.10e-01 |
GOMF VIRION BINDING | 7 | 8.34e-02 | -3.78e-01 | 5.10e-01 |
GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 14 | 1.44e-02 | -3.78e-01 | 2.61e-01 |
GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 12 | 2.35e-02 | 3.78e-01 | 3.13e-01 |
GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 1.09e-01 | 3.78e-01 | 5.68e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 39 | 4.50e-05 | -3.78e-01 | 7.69e-03 |
GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 7 | 8.37e-02 | -3.78e-01 | 5.12e-01 |
GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 9 | 4.99e-02 | -3.77e-01 | 4.14e-01 |
GOMF ALPHA GLUCOSIDASE ACTIVITY | 5 | 1.44e-01 | 3.77e-01 | 6.19e-01 |
GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 8 | 6.49e-02 | -3.77e-01 | 4.55e-01 |
GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 9.10e-03 | -3.77e-01 | 1.99e-01 |
GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 5 | 1.45e-01 | 3.77e-01 | 6.20e-01 |
GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.46e-02 | 3.76e-01 | 5.15e-01 |
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 12 | 2.40e-02 | -3.76e-01 | 3.16e-01 |
GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 1.10e-01 | 3.76e-01 | 5.70e-01 |
GOBP MUCUS SECRETION | 10 | 3.98e-02 | -3.76e-01 | 3.83e-01 |
GOBP TROPHOBLAST CELL MIGRATION | 9 | 5.13e-02 | -3.75e-01 | 4.19e-01 |
GOMF PROTON CHANNEL ACTIVITY | 19 | 4.67e-03 | -3.75e-01 | 1.42e-01 |
GOBP BEHAVIORAL RESPONSE TO PAIN | 8 | 6.65e-02 | -3.75e-01 | 4.59e-01 |
GOBP ENDOSOMAL VESICLE FUSION | 12 | 2.47e-02 | 3.75e-01 | 3.22e-01 |
GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 13 | 1.95e-02 | 3.74e-01 | 2.92e-01 |
GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 1.48e-01 | 3.74e-01 | 6.24e-01 |
GOBP REGULATION OF CHROMATIN BINDING | 9 | 5.21e-02 | 3.74e-01 | 4.19e-01 |
GOBP RRNA 5 END PROCESSING | 5 | 1.48e-01 | 3.73e-01 | 6.24e-01 |
GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 9 | 5.25e-02 | -3.73e-01 | 4.19e-01 |
GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 8 | 6.80e-02 | -3.73e-01 | 4.65e-01 |
GOBP REGULATION OF KERATINOCYTE MIGRATION | 9 | 5.30e-02 | -3.72e-01 | 4.19e-01 |
GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 1.99e-03 | -3.72e-01 | 9.11e-02 |
GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 23 | 2.00e-03 | -3.72e-01 | 9.11e-02 |
GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 5.34e-02 | 3.72e-01 | 4.21e-01 |
GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 1.29e-03 | 3.72e-01 | 7.32e-02 |
GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 7 | 8.87e-02 | 3.72e-01 | 5.21e-01 |
GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 6 | 1.15e-01 | 3.71e-01 | 5.78e-01 |
GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 1.16e-01 | -3.71e-01 | 5.78e-01 |
GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 8.99e-02 | 3.70e-01 | 5.23e-01 |
GOBP PEPTIDYL LYSINE DIMETHYLATION | 10 | 4.28e-02 | 3.70e-01 | 3.90e-01 |
GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 10 | 4.31e-02 | -3.70e-01 | 3.91e-01 |
GOBP GANGLION DEVELOPMENT | 9 | 5.51e-02 | -3.69e-01 | 4.24e-01 |
GOBP MICROGLIA DIFFERENTIATION | 10 | 4.33e-02 | -3.69e-01 | 3.92e-01 |
GOBP REGULATION OF MITOCHONDRIAL FUSION | 11 | 3.40e-02 | -3.69e-01 | 3.63e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 1.06e-02 | 3.69e-01 | 2.19e-01 |
GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 2.73e-02 | 3.68e-01 | 3.36e-01 |
GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 5 | 1.55e-01 | 3.68e-01 | 6.36e-01 |
GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 11 | 3.50e-02 | 3.67e-01 | 3.68e-01 |
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 24 | 1.87e-03 | -3.67e-01 | 8.90e-02 |
GOBP SPERM DNA CONDENSATION | 6 | 1.20e-01 | -3.66e-01 | 5.83e-01 |
GOBP SPERM CAPACITATION | 10 | 4.48e-02 | -3.66e-01 | 4.00e-01 |
GOCC CORVET COMPLEX | 7 | 9.32e-02 | 3.66e-01 | 5.30e-01 |
GOBP GENITALIA DEVELOPMENT | 18 | 7.13e-03 | 3.66e-01 | 1.79e-01 |
GOBP MITOCHONDRIAL TRNA PROCESSING | 14 | 1.78e-02 | 3.66e-01 | 2.82e-01 |
GOMF PROTEIN SERINE THREONINE KINASE BINDING | 7 | 9.39e-02 | -3.66e-01 | 5.32e-01 |
GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 5 | 1.57e-01 | 3.65e-01 | 6.39e-01 |
GOBP ZINC ION IMPORT INTO ORGANELLE | 5 | 1.57e-01 | -3.65e-01 | 6.39e-01 |
GOCC CYTOCHROME COMPLEX | 30 | 5.37e-04 | -3.65e-01 | 4.45e-02 |
GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 8 | 7.37e-02 | 3.65e-01 | 4.85e-01 |
GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 5.81e-02 | -3.65e-01 | 4.33e-01 |
GOBP AMELOGENESIS | 11 | 3.62e-02 | -3.65e-01 | 3.73e-01 |
GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 1.58e-01 | 3.65e-01 | 6.39e-01 |
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 8 | 7.42e-02 | -3.64e-01 | 4.87e-01 |
GOBP MISMATCH REPAIR | 25 | 1.65e-03 | 3.64e-01 | 8.28e-02 |
GOBP MEMBRANE RAFT ASSEMBLY | 6 | 1.23e-01 | -3.63e-01 | 5.87e-01 |
GOCC DNA POLYMERASE COMPLEX | 19 | 6.11e-03 | 3.63e-01 | 1.65e-01 |
GOBP GAS TRANSPORT | 6 | 1.23e-01 | -3.63e-01 | 5.87e-01 |
GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 8 | 7.52e-02 | 3.63e-01 | 4.90e-01 |
GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 5 | 1.60e-01 | 3.63e-01 | 6.42e-01 |
GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 1.60e-01 | 3.63e-01 | 6.42e-01 |
GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 4.71e-02 | 3.63e-01 | 4.08e-01 |
GOBP ODONTOBLAST DIFFERENTIATION | 7 | 9.68e-02 | -3.62e-01 | 5.39e-01 |
GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 14 | 1.90e-02 | 3.62e-01 | 2.89e-01 |
GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 1.61e-01 | -3.62e-01 | 6.42e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 19 | 6.37e-03 | -3.62e-01 | 1.68e-01 |
GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 7 | 9.80e-02 | -3.61e-01 | 5.43e-01 |
GOMF GTPASE ACTIVATING PROTEIN BINDING | 10 | 4.80e-02 | -3.61e-01 | 4.12e-01 |
GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 18 | 8.09e-03 | -3.61e-01 | 1.89e-01 |
GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 7 | 9.86e-02 | -3.61e-01 | 5.45e-01 |
GOBP GASTRIC ACID SECRETION | 7 | 9.90e-02 | 3.60e-01 | 5.46e-01 |
GOMF OXYGEN BINDING | 8 | 7.84e-02 | -3.59e-01 | 4.99e-01 |
GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 12 | 3.16e-02 | -3.58e-01 | 3.53e-01 |
GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 7 | 1.01e-01 | -3.58e-01 | 5.49e-01 |
GOCC PRESPLICEOSOME | 16 | 1.32e-02 | -3.58e-01 | 2.49e-01 |
GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 7 | 1.01e-01 | 3.58e-01 | 5.49e-01 |
GOMF MUTLALPHA COMPLEX BINDING | 6 | 1.29e-01 | 3.58e-01 | 5.99e-01 |
GOBP COBALAMIN TRANSPORT | 5 | 1.66e-01 | -3.57e-01 | 6.49e-01 |
GOCC MON1 CCZ1 COMPLEX | 5 | 1.67e-01 | -3.57e-01 | 6.49e-01 |
GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 1.30e-01 | -3.57e-01 | 6.01e-01 |
GOCC ASTROCYTE PROJECTION | 7 | 1.02e-01 | 3.57e-01 | 5.51e-01 |
GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 19 | 7.14e-03 | -3.57e-01 | 1.79e-01 |
GOCC POLYSOME | 61 | 1.48e-06 | -3.57e-01 | 6.93e-04 |
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 14 | 2.11e-02 | -3.56e-01 | 3.01e-01 |
GOBP HYPERSENSITIVITY | 13 | 2.63e-02 | 3.56e-01 | 3.31e-01 |
GOMF CYCLOHYDROLASE ACTIVITY | 5 | 1.69e-01 | 3.55e-01 | 6.51e-01 |
GOBP RESPONSE TO SORBITOL | 5 | 1.69e-01 | -3.55e-01 | 6.52e-01 |
GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 1.69e-01 | 3.55e-01 | 6.52e-01 |
GOMF C METHYLTRANSFERASE ACTIVITY | 7 | 1.04e-01 | 3.55e-01 | 5.56e-01 |
GOBP EMBRYONIC BRAIN DEVELOPMENT | 12 | 3.34e-02 | -3.55e-01 | 3.61e-01 |
GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 1.70e-01 | -3.54e-01 | 6.52e-01 |
GOBP PROXIMAL TUBULE DEVELOPMENT | 7 | 1.05e-01 | 3.54e-01 | 5.56e-01 |
GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 11 | 4.20e-02 | -3.54e-01 | 3.87e-01 |
GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 8.30e-02 | 3.54e-01 | 5.10e-01 |
GOCC INSULIN RESPONSIVE COMPARTMENT | 6 | 1.33e-01 | -3.54e-01 | 6.05e-01 |
GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 8 | 8.31e-02 | -3.54e-01 | 5.10e-01 |
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 6 | 1.34e-01 | -3.54e-01 | 6.05e-01 |
GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 5.30e-02 | 3.53e-01 | 4.19e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 12 | 3.43e-02 | -3.53e-01 | 3.64e-01 |
GOMF RDNA BINDING | 9 | 6.70e-02 | 3.53e-01 | 4.61e-01 |
GOBP PEPTIDYL LYSINE HYDROXYLATION | 5 | 1.73e-01 | 3.52e-01 | 6.55e-01 |
GOBP MITOCHONDRIAL RNA PROCESSING | 21 | 5.26e-03 | 3.52e-01 | 1.52e-01 |
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 10 | 5.43e-02 | -3.52e-01 | 4.23e-01 |
GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 5 | 1.74e-01 | -3.51e-01 | 6.56e-01 |
GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 6 | 1.36e-01 | -3.51e-01 | 6.08e-01 |
GOBP REGULATION OF HELICASE ACTIVITY | 11 | 4.38e-02 | 3.51e-01 | 3.95e-01 |
GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 20 | 6.56e-03 | -3.51e-01 | 1.72e-01 |
GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 1.38e-01 | 3.50e-01 | 6.08e-01 |
GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 9 | 6.92e-02 | -3.50e-01 | 4.68e-01 |
GOCC BRAHMA COMPLEX | 12 | 3.60e-02 | 3.50e-01 | 3.73e-01 |
GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 8 | 8.70e-02 | 3.49e-01 | 5.19e-01 |
GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 1.76e-01 | -3.49e-01 | 6.60e-01 |
GOBP DETECTION OF BACTERIUM | 13 | 2.93e-02 | 3.49e-01 | 3.44e-01 |
GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 5 | 1.77e-01 | -3.49e-01 | 6.60e-01 |
GOBP PROTEIN HEXAMERIZATION | 8 | 8.74e-02 | 3.49e-01 | 5.20e-01 |
GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 8 | 8.75e-02 | -3.49e-01 | 5.20e-01 |
GOBP KERATINOCYTE DEVELOPMENT | 7 | 1.10e-01 | -3.49e-01 | 5.69e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 1.39e-01 | -3.49e-01 | 6.10e-01 |
GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 8.82e-02 | -3.48e-01 | 5.20e-01 |
GOBP AMINO ACID BETAINE TRANSPORT | 10 | 5.67e-02 | 3.48e-01 | 4.28e-01 |
GOBP FORELIMB MORPHOGENESIS | 15 | 1.96e-02 | -3.48e-01 | 2.92e-01 |
GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 1.78e-01 | 3.48e-01 | 6.61e-01 |
GOCC BETA CATENIN TCF COMPLEX | 12 | 3.72e-02 | -3.47e-01 | 3.77e-01 |
GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 9.91e-04 | 3.47e-01 | 6.34e-02 |
GOBP CYSTEINE METABOLIC PROCESS | 7 | 1.12e-01 | 3.47e-01 | 5.73e-01 |
GOCC FEMALE GERM CELL NUCLEUS | 9 | 7.16e-02 | -3.47e-01 | 4.76e-01 |
GOMF ACETYLCHOLINE RECEPTOR BINDING | 7 | 1.13e-01 | 3.46e-01 | 5.75e-01 |
GOMF THIOESTERASE BINDING | 9 | 7.20e-02 | -3.46e-01 | 4.77e-01 |
GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 6 | 1.42e-01 | -3.46e-01 | 6.14e-01 |
GOBP MESODERMAL CELL DIFFERENTIATION | 6 | 1.42e-01 | -3.46e-01 | 6.15e-01 |
GOCC OUTER DYNEIN ARM | 5 | 1.80e-01 | 3.46e-01 | 6.64e-01 |
GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 12 | 3.83e-02 | -3.45e-01 | 3.80e-01 |
GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 12 | 3.87e-02 | -3.45e-01 | 3.81e-01 |
GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 8 | 9.14e-02 | -3.45e-01 | 5.26e-01 |
GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 1.44e-01 | -3.45e-01 | 6.18e-01 |
GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 17 | 1.40e-02 | -3.44e-01 | 2.59e-01 |
GOBP INSULIN METABOLIC PROCESS | 8 | 9.17e-02 | -3.44e-01 | 5.26e-01 |
GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 24 | 3.57e-03 | 3.44e-01 | 1.25e-01 |
GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY | 5 | 1.84e-01 | -3.43e-01 | 6.68e-01 |
GOCC TOR COMPLEX | 11 | 4.87e-02 | 3.43e-01 | 4.14e-01 |
GOBP TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX | 5 | 1.84e-01 | 3.43e-01 | 6.69e-01 |
GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 6 | 1.46e-01 | 3.43e-01 | 6.21e-01 |
GOBP DETECTION OF TEMPERATURE STIMULUS | 9 | 7.49e-02 | 3.43e-01 | 4.89e-01 |
GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 7 | 1.16e-01 | 3.43e-01 | 5.79e-01 |
GOMF DNA DEMETHYLASE ACTIVITY | 5 | 1.87e-01 | 3.41e-01 | 6.70e-01 |
GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 1.87e-01 | 3.41e-01 | 6.70e-01 |
GOBP ESTABLISHMENT OF SERTOLI CELL BARRIER | 5 | 1.87e-01 | -3.41e-01 | 6.70e-01 |
GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 11 | 5.03e-02 | -3.41e-01 | 4.15e-01 |
GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 7 | 1.19e-01 | 3.41e-01 | 5.82e-01 |
GOMF LEUCINE BINDING | 6 | 1.49e-01 | -3.41e-01 | 6.25e-01 |
GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 7 | 1.19e-01 | 3.40e-01 | 5.82e-01 |
GOMF NUCLEOTIDASE ACTIVITY | 9 | 7.72e-02 | 3.40e-01 | 4.96e-01 |
GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 7 | 1.19e-01 | -3.40e-01 | 5.82e-01 |
GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 1.88e-01 | 3.40e-01 | 6.72e-01 |
GOMF PROFILIN BINDING | 6 | 1.50e-01 | -3.39e-01 | 6.28e-01 |
GOCC 90S PRERIBOSOME | 25 | 3.35e-03 | 3.39e-01 | 1.21e-01 |
GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 9 | 7.83e-02 | -3.39e-01 | 4.99e-01 |
GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 5 | 1.89e-01 | 3.39e-01 | 6.73e-01 |
GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 5 | 1.90e-01 | -3.39e-01 | 6.73e-01 |
GOBP REGULATION OF CHOLESTEROL STORAGE | 15 | 2.31e-02 | -3.39e-01 | 3.11e-01 |
GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 11 | 5.17e-02 | 3.39e-01 | 4.19e-01 |
GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 1.51e-01 | 3.39e-01 | 6.29e-01 |
GOBP REGULATION OF CELL CYCLE CHECKPOINT | 39 | 2.60e-04 | 3.38e-01 | 2.78e-02 |
GOBP RENAL WATER TRANSPORT | 5 | 1.91e-01 | 3.38e-01 | 6.73e-01 |
GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 7 | 1.22e-01 | 3.38e-01 | 5.86e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 7 | 1.22e-01 | 3.38e-01 | 5.86e-01 |
GOBP VIRAL RELEASE FROM HOST CELL | 24 | 4.22e-03 | -3.37e-01 | 1.37e-01 |
GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 6 | 1.53e-01 | -3.37e-01 | 6.32e-01 |
GOBP REGULATION OF COLLATERAL SPROUTING | 8 | 9.87e-02 | -3.37e-01 | 5.45e-01 |
GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 5 | 1.92e-01 | -3.37e-01 | 6.75e-01 |
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 30 | 1.42e-03 | -3.37e-01 | 7.76e-02 |
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 7 | 1.23e-01 | 3.37e-01 | 5.87e-01 |
GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 7 | 1.23e-01 | 3.37e-01 | 5.87e-01 |
GOCC SMOOTH ENDOPLASMIC RETICULUM | 19 | 1.11e-02 | -3.36e-01 | 2.23e-01 |
GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 9.95e-02 | -3.36e-01 | 5.47e-01 |
GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 7 | 1.24e-01 | 3.36e-01 | 5.87e-01 |
GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 1.54e-01 | 3.36e-01 | 6.36e-01 |
GOCC PERICENTRIOLAR MATERIAL | 20 | 9.34e-03 | 3.36e-01 | 2.01e-01 |
GOBP MITOCHONDRIAL GENOME MAINTENANCE | 27 | 2.54e-03 | 3.36e-01 | 1.07e-01 |
GOCC IGM IMMUNOGLOBULIN COMPLEX | 5 | 1.94e-01 | 3.36e-01 | 6.75e-01 |
GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 1.94e-01 | 3.36e-01 | 6.75e-01 |
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 1.00e-01 | -3.35e-01 | 5.48e-01 |
GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.94e-01 | -3.35e-01 | 6.75e-01 |
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 5 | 1.94e-01 | -3.35e-01 | 6.75e-01 |
GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 1.25e-01 | 3.35e-01 | 5.90e-01 |
GOCC LSM2 8 COMPLEX | 7 | 1.25e-01 | -3.35e-01 | 5.90e-01 |
GOBP IRIS MORPHOGENESIS | 5 | 1.95e-01 | -3.35e-01 | 6.75e-01 |
GOBP FAT CELL PROLIFERATION | 8 | 1.01e-01 | -3.35e-01 | 5.49e-01 |
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 5 | 1.95e-01 | 3.35e-01 | 6.75e-01 |
GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 11 | 5.47e-02 | -3.35e-01 | 4.23e-01 |
GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.01e-01 | -3.35e-01 | 5.49e-01 |
GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 14 | 3.03e-02 | -3.34e-01 | 3.48e-01 |
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 6 | 1.56e-01 | -3.34e-01 | 6.38e-01 |
GOBP MICROVILLUS ORGANIZATION | 20 | 9.66e-03 | -3.34e-01 | 2.06e-01 |
GOBP LABYRINTHINE LAYER MORPHOGENESIS | 11 | 5.52e-02 | -3.34e-01 | 4.24e-01 |
GOBP NOREPINEPHRINE TRANSPORT | 7 | 1.26e-01 | -3.34e-01 | 5.94e-01 |
GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 1.96e-01 | 3.34e-01 | 6.76e-01 |
GOBP ENAMEL MINERALIZATION | 9 | 8.32e-02 | -3.33e-01 | 5.10e-01 |
GOBP OUTER DYNEIN ARM ASSEMBLY | 7 | 1.27e-01 | 3.33e-01 | 5.96e-01 |
GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 13 | 3.80e-02 | 3.32e-01 | 3.80e-01 |
GOBP NEURON RECOGNITION | 22 | 6.99e-03 | 3.32e-01 | 1.78e-01 |
GOBP SURFACTANT HOMEOSTASIS | 9 | 8.45e-02 | -3.32e-01 | 5.15e-01 |
GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 6 | 1.59e-01 | 3.32e-01 | 6.41e-01 |
GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 15 | 2.61e-02 | -3.32e-01 | 3.30e-01 |
GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 156 | 9.34e-13 | -3.32e-01 | 1.32e-09 |
GOBP REGULATION OF PROTON TRANSPORT | 13 | 3.86e-02 | -3.31e-01 | 3.81e-01 |
GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 1.30e-01 | 3.31e-01 | 6.00e-01 |
GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 9 | 8.57e-02 | -3.31e-01 | 5.17e-01 |
GOCC U1 SNRNP | 19 | 1.26e-02 | -3.31e-01 | 2.43e-01 |
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 8 | 1.05e-01 | -3.31e-01 | 5.56e-01 |
GOBP NUCLEOBASE TRANSPORT | 7 | 1.30e-01 | -3.31e-01 | 6.00e-01 |
GOBP MICROVILLUS ASSEMBLY | 17 | 1.84e-02 | -3.30e-01 | 2.87e-01 |
GOBP RENAL SODIUM ION ABSORPTION | 6 | 1.61e-01 | -3.30e-01 | 6.42e-01 |
GOBP RENAL SODIUM ION TRANSPORT | 6 | 1.61e-01 | -3.30e-01 | 6.42e-01 |
GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 8 | 1.06e-01 | -3.30e-01 | 5.57e-01 |
GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 8.64e-02 | 3.30e-01 | 5.19e-01 |
GOBP OSMOSENSORY SIGNALING PATHWAY | 5 | 2.02e-01 | -3.30e-01 | 6.84e-01 |
GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 17 | 1.87e-02 | 3.29e-01 | 2.89e-01 |
GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 5 | 2.03e-01 | -3.29e-01 | 6.85e-01 |
GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 1.63e-01 | 3.29e-01 | 6.45e-01 |
GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 2.03e-01 | -3.29e-01 | 6.85e-01 |
GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 15 | 2.78e-02 | 3.28e-01 | 3.38e-01 |
GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 15 | 2.78e-02 | -3.28e-01 | 3.38e-01 |
GOBP CHONDROCYTE DEVELOPMENT | 13 | 4.08e-02 | -3.28e-01 | 3.83e-01 |
GOMF CERAMIDE BINDING | 13 | 4.09e-02 | -3.28e-01 | 3.83e-01 |
GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 7 | 1.34e-01 | -3.27e-01 | 6.05e-01 |
GOBP COCHLEA MORPHOGENESIS | 5 | 2.05e-01 | 3.27e-01 | 6.85e-01 |
GOCC LARGE RIBOSOMAL SUBUNIT | 112 | 2.33e-09 | -3.27e-01 | 2.13e-06 |
GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 2.06e-01 | -3.27e-01 | 6.87e-01 |
GOCC DENDRITIC GROWTH CONE | 7 | 1.35e-01 | 3.27e-01 | 6.05e-01 |
GOBP CENTROMERIC SISTER CHROMATID COHESION | 7 | 1.35e-01 | -3.26e-01 | 6.05e-01 |
GOMF BETA 2 MICROGLOBULIN BINDING | 8 | 1.10e-01 | 3.26e-01 | 5.69e-01 |
GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 9 | 9.05e-02 | -3.26e-01 | 5.23e-01 |
GOCC X CHROMOSOME | 7 | 1.36e-01 | 3.25e-01 | 6.08e-01 |
GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 23 | 7.01e-03 | -3.25e-01 | 1.78e-01 |
GOBP INTERSTRAND CROSS LINK REPAIR | 35 | 8.93e-04 | 3.25e-01 | 5.90e-02 |
GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 11 | 6.24e-02 | 3.24e-01 | 4.44e-01 |
GOMF C ACETYLTRANSFERASE ACTIVITY | 7 | 1.37e-01 | -3.24e-01 | 6.08e-01 |
GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 1.44e-02 | -3.24e-01 | 2.61e-01 |
GOBP NEURONAL ACTION POTENTIAL | 11 | 6.25e-02 | -3.24e-01 | 4.44e-01 |
GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 11 | 6.26e-02 | -3.24e-01 | 4.45e-01 |
GOBP FEVER GENERATION | 7 | 1.38e-01 | -3.24e-01 | 6.08e-01 |
GOBP HEART FIELD SPECIFICATION | 6 | 1.70e-01 | 3.24e-01 | 6.52e-01 |
GOMF AMIDINE LYASE ACTIVITY | 5 | 2.11e-01 | 3.23e-01 | 6.87e-01 |
GOBP BASIC AMINO ACID TRANSPORT | 13 | 4.38e-02 | -3.23e-01 | 3.95e-01 |
GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 5 | 2.12e-01 | -3.23e-01 | 6.87e-01 |
GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 2.12e-01 | -3.23e-01 | 6.87e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 5 | 2.12e-01 | -3.22e-01 | 6.87e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 5 | 2.12e-01 | -3.22e-01 | 6.87e-01 |
GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 7.81e-02 | 3.22e-01 | 4.99e-01 |
GOBP SEQUESTERING OF TRIGLYCERIDE | 13 | 4.46e-02 | -3.22e-01 | 4.00e-01 |
GOBP TRANSLATIONAL READTHROUGH | 8 | 1.15e-01 | -3.22e-01 | 5.78e-01 |
GOBP POSITIVE REGULATION OF HYPERSENSITIVITY | 6 | 1.73e-01 | 3.22e-01 | 6.55e-01 |
GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 31 | 1.95e-03 | 3.22e-01 | 9.08e-02 |
GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 22 | 9.09e-03 | -3.21e-01 | 1.99e-01 |
GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 8 | 1.16e-01 | -3.21e-01 | 5.78e-01 |
GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 2.14e-01 | 3.21e-01 | 6.89e-01 |
GOBP CORPUS CALLOSUM MORPHOGENESIS | 5 | 2.14e-01 | 3.21e-01 | 6.89e-01 |
GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 8 | 1.16e-01 | -3.21e-01 | 5.78e-01 |
GOMF ANKYRIN REPEAT BINDING | 5 | 2.14e-01 | -3.21e-01 | 6.89e-01 |
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 5.47e-02 | 3.20e-01 | 4.23e-01 |
GOCC POSTSYNAPTIC CYTOSOL | 11 | 6.60e-02 | 3.20e-01 | 4.59e-01 |
GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 5 | 2.16e-01 | -3.20e-01 | 6.91e-01 |
GOBP ADP METABOLIC PROCESS | 7 | 1.44e-01 | -3.19e-01 | 6.17e-01 |
GOBP SCHWANN CELL MIGRATION | 5 | 2.17e-01 | 3.19e-01 | 6.92e-01 |
GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 15 | 3.25e-02 | -3.19e-01 | 3.57e-01 |
GOBP HEPATOCYTE DIFFERENTIATION | 5 | 2.17e-01 | -3.19e-01 | 6.93e-01 |
GOMF MISMATCHED DNA BINDING | 13 | 4.68e-02 | 3.19e-01 | 4.06e-01 |
GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 10 | 8.13e-02 | -3.18e-01 | 5.08e-01 |
GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 23 | 8.24e-03 | 3.18e-01 | 1.90e-01 |
GOBP PEPTIDYL HISTIDINE MODIFICATION | 8 | 1.20e-01 | 3.18e-01 | 5.82e-01 |
GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY | 5 | 2.19e-01 | -3.18e-01 | 6.95e-01 |
GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 1.78e-01 | 3.18e-01 | 6.61e-01 |
GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 11 | 6.83e-02 | -3.18e-01 | 4.65e-01 |
GOBP PARAXIAL MESODERM MORPHOGENESIS | 5 | 2.19e-01 | -3.17e-01 | 6.96e-01 |
GOBP COBALT ION TRANSPORT | 6 | 1.78e-01 | -3.17e-01 | 6.61e-01 |
GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 5 | 2.19e-01 | 3.17e-01 | 6.96e-01 |
GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 10 | 8.25e-02 | 3.17e-01 | 5.08e-01 |
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 18 | 2.01e-02 | 3.17e-01 | 2.95e-01 |
GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 6 | 1.79e-01 | -3.17e-01 | 6.62e-01 |
GOBP LOCOMOTOR RHYTHM | 10 | 8.32e-02 | 3.16e-01 | 5.10e-01 |
GOBP LAMELLIPODIUM MORPHOGENESIS | 16 | 2.88e-02 | -3.16e-01 | 3.41e-01 |
GOBP PROTEIN ACTIVATION CASCADE | 7 | 1.48e-01 | -3.16e-01 | 6.24e-01 |
GOBP SPERMATID NUCLEUS DIFFERENTIATION | 14 | 4.08e-02 | -3.16e-01 | 3.83e-01 |
GOBP LEUKOTRIENE TRANSPORT | 6 | 1.80e-01 | 3.16e-01 | 6.64e-01 |
GOBP KERATINIZATION | 9 | 1.02e-01 | -3.15e-01 | 5.50e-01 |
GOBP NEURON FATE SPECIFICATION | 6 | 1.82e-01 | 3.14e-01 | 6.65e-01 |
GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 13 | 4.99e-02 | -3.14e-01 | 4.14e-01 |
GOBP ADAPTATION OF SIGNALING PATHWAY | 9 | 1.03e-01 | -3.14e-01 | 5.52e-01 |
GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 5 | 2.24e-01 | -3.14e-01 | 7.02e-01 |
GOBP REGULATION OF FERTILIZATION | 5 | 2.24e-01 | 3.14e-01 | 7.02e-01 |
GOMF KINETOCHORE BINDING | 5 | 2.25e-01 | 3.14e-01 | 7.02e-01 |
GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 5 | 2.25e-01 | 3.13e-01 | 7.02e-01 |
GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 5 | 2.25e-01 | -3.13e-01 | 7.02e-01 |
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 5 | 2.26e-01 | -3.13e-01 | 7.02e-01 |
GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 5 | 2.26e-01 | -3.13e-01 | 7.02e-01 |
GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 1.84e-01 | 3.13e-01 | 6.69e-01 |
GOMF CARBOHYDRATE KINASE ACTIVITY | 18 | 2.16e-02 | 3.13e-01 | 3.04e-01 |
GOBP MICROGLIAL CELL MIGRATION | 5 | 2.26e-01 | -3.13e-01 | 7.02e-01 |
GOBP NATURAL KILLER CELL DIFFERENTIATION | 21 | 1.32e-02 | 3.12e-01 | 2.49e-01 |
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 7 | 1.52e-01 | 3.12e-01 | 6.32e-01 |
GOCC RIBOSOMAL SUBUNIT | 180 | 5.35e-13 | -3.12e-01 | 9.03e-10 |
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 7 | 1.53e-01 | -3.12e-01 | 6.32e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 15 | 3.63e-02 | -3.12e-01 | 3.74e-01 |
GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 1.86e-01 | 3.12e-01 | 6.69e-01 |
GOBP NEGATIVE REGULATION OF LIPID STORAGE | 17 | 2.60e-02 | -3.12e-01 | 3.30e-01 |
GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 20 | 1.58e-02 | 3.12e-01 | 2.69e-01 |
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 7 | 1.53e-01 | -3.12e-01 | 6.32e-01 |
GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 8 | 1.27e-01 | -3.12e-01 | 5.95e-01 |
GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 2.27e-01 | -3.12e-01 | 7.02e-01 |
GOBP HEXOSE PHOSPHATE TRANSPORT | 5 | 2.28e-01 | 3.12e-01 | 7.02e-01 |
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 5 | 2.28e-01 | 3.12e-01 | 7.02e-01 |
GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 6 | 1.86e-01 | 3.12e-01 | 6.70e-01 |
GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 15 | 3.67e-02 | -3.12e-01 | 3.75e-01 |
GOBP VITAMIN D METABOLIC PROCESS | 9 | 1.06e-01 | -3.11e-01 | 5.57e-01 |
GOBP GOLGI TO LYSOSOME TRANSPORT | 10 | 8.82e-02 | 3.11e-01 | 5.20e-01 |
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 7 | 1.54e-01 | -3.11e-01 | 6.34e-01 |
GOBP SINGLE STRAND BREAK REPAIR | 10 | 8.83e-02 | 3.11e-01 | 5.20e-01 |
GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 8 | 1.27e-01 | 3.11e-01 | 5.96e-01 |
GOCC RESPIRASOME | 88 | 4.59e-07 | -3.11e-01 | 2.77e-04 |
GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 8 | 1.28e-01 | -3.11e-01 | 5.97e-01 |
GOBP ADP BIOSYNTHETIC PROCESS | 5 | 2.29e-01 | -3.11e-01 | 7.02e-01 |
GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 8.88e-02 | -3.11e-01 | 5.21e-01 |
GOCC IMMUNOGLOBULIN COMPLEX CIRCULATING | 5 | 2.29e-01 | 3.11e-01 | 7.02e-01 |
GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 12 | 6.24e-02 | -3.11e-01 | 4.44e-01 |
GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 5 | 2.29e-01 | 3.11e-01 | 7.02e-01 |
GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 2.29e-01 | -3.11e-01 | 7.02e-01 |
GOBP REGULATION OF FAT CELL PROLIFERATION | 6 | 1.88e-01 | -3.10e-01 | 6.72e-01 |
GOBP LEUCINE TRANSPORT | 7 | 1.55e-01 | -3.10e-01 | 6.37e-01 |
GOBP METHIONINE METABOLIC PROCESS | 13 | 5.29e-02 | 3.10e-01 | 4.19e-01 |
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 6.22e-03 | -3.10e-01 | 1.66e-01 |
GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 7 | 1.55e-01 | -3.10e-01 | 6.37e-01 |
GOBP CARNITINE TRANSMEMBRANE TRANSPORT | 5 | 2.30e-01 | 3.10e-01 | 7.03e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 8 | 1.29e-01 | 3.10e-01 | 5.99e-01 |
GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 10 | 8.99e-02 | -3.10e-01 | 5.23e-01 |
GOCC U4 SNRNP | 10 | 9.02e-02 | -3.09e-01 | 5.23e-01 |
GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 6 | 1.90e-01 | -3.09e-01 | 6.73e-01 |
GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.90e-01 | -3.09e-01 | 6.73e-01 |
GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 12 | 6.39e-02 | -3.09e-01 | 4.53e-01 |
GOBP VESICLE TETHERING TO GOLGI | 5 | 2.32e-01 | -3.09e-01 | 7.06e-01 |
GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 7.62e-02 | 3.09e-01 | 4.94e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 11 | 7.66e-02 | 3.08e-01 | 4.95e-01 |
GOCC APICOLATERAL PLASMA MEMBRANE | 5 | 2.33e-01 | -3.08e-01 | 7.07e-01 |
GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 5 | 2.33e-01 | -3.08e-01 | 7.08e-01 |
GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 2.33e-01 | -3.08e-01 | 7.08e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 15 | 3.92e-02 | 3.08e-01 | 3.82e-01 |
GOMF THIOL OXIDASE ACTIVITY | 6 | 1.92e-01 | -3.08e-01 | 6.75e-01 |
GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 5 | 2.34e-01 | 3.07e-01 | 7.08e-01 |
GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 6 | 1.92e-01 | 3.07e-01 | 6.75e-01 |
GOCC U2 SNRNP | 25 | 7.85e-03 | -3.07e-01 | 1.85e-01 |
GOCC SMALL RIBOSOMAL SUBUNIT | 72 | 6.65e-06 | -3.07e-01 | 1.81e-03 |
GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 9 | 1.11e-01 | 3.07e-01 | 5.70e-01 |
GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 15 | 3.95e-02 | -3.07e-01 | 3.83e-01 |
GOMF 3 5 DNA HELICASE ACTIVITY | 12 | 6.56e-02 | 3.07e-01 | 4.58e-01 |
GOBP REGULATION OF SREBP SIGNALING PATHWAY | 6 | 1.94e-01 | -3.07e-01 | 6.75e-01 |
GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 9 | 1.12e-01 | -3.06e-01 | 5.72e-01 |
GOCC SERINE TYPE PEPTIDASE COMPLEX | 6 | 1.94e-01 | -3.06e-01 | 6.75e-01 |
GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 5 | 2.36e-01 | -3.06e-01 | 7.10e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 18 | 2.47e-02 | 3.06e-01 | 3.22e-01 |
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 14 | 4.76e-02 | 3.06e-01 | 4.11e-01 |
GOBP GLYCINE METABOLIC PROCESS | 8 | 1.34e-01 | 3.06e-01 | 6.05e-01 |
GOBP SEX DETERMINATION | 6 | 1.95e-01 | 3.06e-01 | 6.75e-01 |
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 62 | 3.22e-05 | -3.05e-01 | 6.05e-03 |
GOBP NEUTROPHIL DEGRANULATION | 12 | 6.71e-02 | -3.05e-01 | 4.61e-01 |
GOBP PROLINE METABOLIC PROCESS | 5 | 2.37e-01 | -3.05e-01 | 7.11e-01 |
GOMF DNA DAMAGE SENSOR ACTIVITY | 17 | 2.95e-02 | 3.05e-01 | 3.46e-01 |
GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 2.38e-01 | 3.05e-01 | 7.11e-01 |
GOBP DOPAMINE BIOSYNTHETIC PROCESS | 6 | 1.96e-01 | 3.05e-01 | 6.76e-01 |
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 9 | 1.13e-01 | -3.05e-01 | 5.76e-01 |
GOBP CHORION DEVELOPMENT | 7 | 1.63e-01 | -3.05e-01 | 6.45e-01 |
GOBP PRIMARY MIRNA PROCESSING | 18 | 2.55e-02 | -3.04e-01 | 3.27e-01 |
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 5 | 2.40e-01 | -3.04e-01 | 7.13e-01 |
GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 10 | 9.65e-02 | -3.04e-01 | 5.38e-01 |
GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 29 | 4.69e-03 | -3.03e-01 | 1.42e-01 |
GOCC CATSPER COMPLEX | 6 | 1.98e-01 | -3.03e-01 | 6.79e-01 |
GOMF COBALAMIN BINDING | 7 | 1.65e-01 | -3.03e-01 | 6.47e-01 |
GOMF CARDIOLIPIN BINDING | 7 | 1.65e-01 | 3.03e-01 | 6.47e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 16 | 3.59e-02 | 3.03e-01 | 3.72e-01 |
GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 8 | 1.38e-01 | 3.03e-01 | 6.09e-01 |
GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT | 6 | 1.99e-01 | -3.03e-01 | 6.79e-01 |
GOBP LUTEOLYSIS | 5 | 2.42e-01 | 3.02e-01 | 7.14e-01 |
GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 13 | 5.93e-02 | -3.02e-01 | 4.35e-01 |
GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 5 | 2.42e-01 | 3.02e-01 | 7.14e-01 |
GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 9 | 1.17e-01 | -3.02e-01 | 5.79e-01 |
GOCC GTPASE ACTIVATOR COMPLEX | 11 | 8.30e-02 | -3.02e-01 | 5.10e-01 |
GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 8 | 1.40e-01 | -3.02e-01 | 6.12e-01 |
GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 14 | 5.08e-02 | 3.02e-01 | 4.17e-01 |
GOMF DEATH DOMAIN BINDING | 10 | 9.87e-02 | -3.02e-01 | 5.45e-01 |
GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 15 | 4.32e-02 | -3.02e-01 | 3.92e-01 |
GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 2.43e-01 | -3.02e-01 | 7.14e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 1.18e-01 | -3.01e-01 | 5.80e-01 |
GOMF MISMATCH REPAIR COMPLEX BINDING | 10 | 9.91e-02 | 3.01e-01 | 5.46e-01 |
GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 9 | 1.18e-01 | -3.01e-01 | 5.80e-01 |
GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 24 | 1.08e-02 | 3.01e-01 | 2.20e-01 |
GOMF ATP GATED ION CHANNEL ACTIVITY | 5 | 2.45e-01 | -3.00e-01 | 7.14e-01 |
GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 19 | 2.37e-02 | -3.00e-01 | 3.14e-01 |
GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 9 | 1.20e-01 | 3.00e-01 | 5.82e-01 |
GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 8 | 1.42e-01 | -2.99e-01 | 6.15e-01 |
GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 5 | 2.46e-01 | -2.99e-01 | 7.15e-01 |
GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 8 | 1.43e-01 | -2.99e-01 | 6.16e-01 |
GOBP MAINTENANCE OF CENTROSOME LOCATION | 6 | 2.04e-01 | 2.99e-01 | 6.85e-01 |
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 2.48e-01 | 2.99e-01 | 7.17e-01 |
GOMF TRNA METHYLTRANSFERASE ACTIVITY | 31 | 4.07e-03 | 2.98e-01 | 1.36e-01 |
GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 5 | 2.48e-01 | 2.98e-01 | 7.17e-01 |
GOCC SPERM MIDPIECE | 24 | 1.15e-02 | -2.98e-01 | 2.28e-01 |
GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 6 | 2.06e-01 | -2.98e-01 | 6.87e-01 |
GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 11 | 8.72e-02 | -2.98e-01 | 5.19e-01 |
GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 55 | 1.35e-04 | -2.98e-01 | 1.87e-02 |
GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 17 | 3.37e-02 | -2.98e-01 | 3.61e-01 |
GOMF L ASCORBIC ACID BINDING | 16 | 3.94e-02 | 2.97e-01 | 3.83e-01 |
GOCC PREFOLDIN COMPLEX | 7 | 1.73e-01 | -2.97e-01 | 6.56e-01 |
GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 24 | 1.17e-02 | -2.97e-01 | 2.31e-01 |
GOCC CTF18 RFC LIKE COMPLEX | 6 | 2.08e-01 | 2.97e-01 | 6.87e-01 |
GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 9 | 1.23e-01 | -2.97e-01 | 5.87e-01 |
GOCC TORC2 COMPLEX | 9 | 1.23e-01 | 2.97e-01 | 5.87e-01 |
GOBP REGULATION OF SISTER CHROMATID COHESION | 14 | 5.48e-02 | -2.97e-01 | 4.23e-01 |
GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 8 | 1.46e-01 | -2.97e-01 | 6.22e-01 |
GOBP CATECHOLAMINE SECRETION | 20 | 2.19e-02 | -2.96e-01 | 3.05e-01 |
GOCC CLATHRIN SCULPTED VESICLE | 6 | 2.09e-01 | -2.96e-01 | 6.87e-01 |
GOBP REGULATION OF FATTY ACID TRANSPORT | 19 | 2.56e-02 | -2.96e-01 | 3.27e-01 |
GOCC FILOPODIUM TIP | 14 | 5.53e-02 | 2.96e-01 | 4.24e-01 |
GOBP CGMP METABOLIC PROCESS | 5 | 2.52e-01 | 2.96e-01 | 7.20e-01 |
GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 7 | 1.75e-01 | 2.96e-01 | 6.59e-01 |
GOCC PARASPECKLES | 8 | 1.48e-01 | -2.96e-01 | 6.24e-01 |
GOBP TRANSLESION SYNTHESIS | 22 | 1.64e-02 | 2.96e-01 | 2.73e-01 |
GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 12 | 7.64e-02 | 2.95e-01 | 4.94e-01 |
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 13 | 6.52e-02 | -2.95e-01 | 4.55e-01 |
GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 8 | 1.48e-01 | -2.95e-01 | 6.24e-01 |
GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 6 | 2.10e-01 | -2.95e-01 | 6.87e-01 |
GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 8 | 1.48e-01 | -2.95e-01 | 6.24e-01 |
GOBP SYMPATHETIC GANGLION DEVELOPMENT | 6 | 2.11e-01 | -2.95e-01 | 6.87e-01 |
GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 6 | 2.11e-01 | -2.95e-01 | 6.87e-01 |
GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 22 | 1.67e-02 | -2.95e-01 | 2.74e-01 |
GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 10 | 1.07e-01 | -2.95e-01 | 5.61e-01 |
GOCC HAUS COMPLEX | 8 | 1.49e-01 | -2.94e-01 | 6.27e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 2.12e-01 | 2.94e-01 | 6.87e-01 |
GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 6 | 2.12e-01 | 2.94e-01 | 6.87e-01 |
GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 1.78e-01 | -2.94e-01 | 6.61e-01 |
GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 8 | 1.50e-01 | -2.94e-01 | 6.28e-01 |
GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 6 | 2.13e-01 | 2.94e-01 | 6.89e-01 |
GOCC PEPTIDASE INHIBITOR COMPLEX | 6 | 2.13e-01 | -2.94e-01 | 6.89e-01 |
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 5 | 2.56e-01 | 2.93e-01 | 7.23e-01 |
GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 5.44e-03 | -2.93e-01 | 1.54e-01 |
GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 22 | 1.74e-02 | 2.93e-01 | 2.79e-01 |
GOBP NK T CELL DIFFERENTIATION | 11 | 9.26e-02 | 2.93e-01 | 5.29e-01 |
GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 5.78e-02 | 2.93e-01 | 4.31e-01 |
GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 10 | 1.09e-01 | -2.93e-01 | 5.67e-01 |
GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 24 | 1.31e-02 | -2.93e-01 | 2.49e-01 |
GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 17 | 3.67e-02 | -2.93e-01 | 3.75e-01 |
GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 18 | 3.16e-02 | 2.93e-01 | 3.53e-01 |
GOCC RAGULATOR COMPLEX | 5 | 2.57e-01 | -2.92e-01 | 7.24e-01 |
GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 13 | 6.79e-02 | -2.92e-01 | 4.65e-01 |
GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 2.58e-01 | -2.92e-01 | 7.24e-01 |
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 1.81e-01 | -2.92e-01 | 6.64e-01 |
GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 11 | 9.35e-02 | -2.92e-01 | 5.31e-01 |
GOMF FILAMIN BINDING | 8 | 1.53e-01 | -2.92e-01 | 6.32e-01 |
GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 18 | 3.20e-02 | 2.92e-01 | 3.55e-01 |
GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 5 | 2.59e-01 | -2.92e-01 | 7.24e-01 |
GOBP REACTIVE GLIOSIS | 5 | 2.59e-01 | -2.92e-01 | 7.24e-01 |
GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 12 | 8.03e-02 | -2.92e-01 | 5.07e-01 |
GOBP KERATINOCYTE MIGRATION | 11 | 9.42e-02 | -2.91e-01 | 5.32e-01 |
GOBP SNARE COMPLEX ASSEMBLY | 19 | 2.79e-02 | 2.91e-01 | 3.38e-01 |
GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 1.11e-01 | 2.91e-01 | 5.72e-01 |
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 14 | 5.97e-02 | -2.91e-01 | 4.36e-01 |
GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 25 | 1.19e-02 | -2.91e-01 | 2.34e-01 |
GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 10 | 1.12e-01 | -2.91e-01 | 5.72e-01 |
GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 5 | 2.61e-01 | -2.90e-01 | 7.24e-01 |
GOCC INTEGRATOR COMPLEX | 16 | 4.47e-02 | 2.90e-01 | 4.00e-01 |
GOCC CIA COMPLEX | 5 | 2.62e-01 | 2.90e-01 | 7.24e-01 |
GOBP CHEMOSENSORY BEHAVIOR | 6 | 2.19e-01 | 2.90e-01 | 6.96e-01 |
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 5 | 2.62e-01 | 2.89e-01 | 7.24e-01 |
GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 2.62e-01 | 2.89e-01 | 7.24e-01 |
GOMF G PROTEIN ACTIVITY | 34 | 3.51e-03 | -2.89e-01 | 1.25e-01 |
GOBP GLUTAMATE CATABOLIC PROCESS | 5 | 2.63e-01 | -2.89e-01 | 7.24e-01 |
GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY | 6 | 2.20e-01 | -2.89e-01 | 6.96e-01 |
GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 51 | 3.57e-04 | -2.89e-01 | 3.39e-02 |
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 8 | 1.57e-01 | 2.89e-01 | 6.39e-01 |
GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 13 | 7.20e-02 | -2.88e-01 | 4.77e-01 |
GOBP TRNA WOBBLE BASE MODIFICATION | 18 | 3.44e-02 | 2.88e-01 | 3.64e-01 |
GOBP REGULATION OF LIGASE ACTIVITY | 9 | 1.35e-01 | 2.88e-01 | 6.05e-01 |
GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 5 | 2.65e-01 | 2.88e-01 | 7.25e-01 |
GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 15 | 5.36e-02 | -2.88e-01 | 4.21e-01 |
GOCC MICROTUBULE PLUS END | 18 | 3.45e-02 | 2.88e-01 | 3.65e-01 |
GOBP R LOOP PROCESSING | 6 | 2.22e-01 | 2.88e-01 | 7.00e-01 |
GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 5 | 2.66e-01 | -2.87e-01 | 7.25e-01 |
GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 10 | 1.16e-01 | -2.87e-01 | 5.78e-01 |
GOBP TRNA TRANSPORT | 5 | 2.66e-01 | -2.87e-01 | 7.25e-01 |
GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 9 | 1.36e-01 | 2.87e-01 | 6.07e-01 |
GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 1.89e-01 | 2.87e-01 | 6.73e-01 |
GOBP LIPID PHOSPHORYLATION | 8 | 1.60e-01 | 2.87e-01 | 6.42e-01 |
GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 8 | 1.60e-01 | 2.87e-01 | 6.42e-01 |
GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 15 | 5.45e-02 | -2.87e-01 | 4.23e-01 |
GOMF NADPH BINDING | 14 | 6.32e-02 | 2.87e-01 | 4.48e-01 |
GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 31 | 5.73e-03 | -2.87e-01 | 1.59e-01 |
GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 20 | 2.65e-02 | 2.87e-01 | 3.33e-01 |
GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 5 | 2.67e-01 | -2.87e-01 | 7.25e-01 |
GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 11 | 9.98e-02 | -2.87e-01 | 5.47e-01 |
GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 11 | 9.99e-02 | 2.87e-01 | 5.48e-01 |
GOCC COPII VESICLE COAT | 16 | 4.74e-02 | -2.86e-01 | 4.10e-01 |
GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.90e-01 | -2.86e-01 | 6.73e-01 |
GOBP SULFUR AMINO ACID METABOLIC PROCESS | 22 | 2.02e-02 | 2.86e-01 | 2.96e-01 |
GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 5 | 2.68e-01 | -2.86e-01 | 7.25e-01 |
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 7.47e-02 | 2.86e-01 | 4.88e-01 |
GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 20 | 2.71e-02 | -2.85e-01 | 3.35e-01 |
GOCC ORIGIN RECOGNITION COMPLEX | 7 | 1.91e-01 | 2.85e-01 | 6.74e-01 |
GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 16 | 4.83e-02 | 2.85e-01 | 4.13e-01 |
GOBP REGULATION OF SYNAPSE MATURATION | 10 | 1.18e-01 | 2.85e-01 | 5.82e-01 |
GOBP PIGMENT CATABOLIC PROCESS | 6 | 2.27e-01 | -2.85e-01 | 7.02e-01 |
GOBP REGULATION OF CD40 SIGNALING PATHWAY | 5 | 2.70e-01 | 2.85e-01 | 7.28e-01 |
GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 8 | 1.63e-01 | -2.85e-01 | 6.45e-01 |
GOMF OXIDIZED DNA BINDING | 10 | 1.19e-01 | 2.85e-01 | 5.82e-01 |
GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 6 | 2.28e-01 | 2.85e-01 | 7.02e-01 |
GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 10 | 1.19e-01 | 2.84e-01 | 5.82e-01 |
GOMF FIBROBLAST GROWTH FACTOR BINDING | 14 | 6.55e-02 | -2.84e-01 | 4.57e-01 |
GOBP REGULATION OF EXOSOMAL SECRETION | 17 | 4.25e-02 | -2.84e-01 | 3.90e-01 |
GOMF DNA CLAMP LOADER ACTIVITY | 8 | 1.64e-01 | 2.84e-01 | 6.47e-01 |
GOBP CENTRIOLE CENTRIOLE COHESION | 13 | 7.62e-02 | 2.84e-01 | 4.94e-01 |
GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 15 | 5.69e-02 | 2.84e-01 | 4.28e-01 |
GOMF ISOPRENOID BINDING | 9 | 1.40e-01 | -2.84e-01 | 6.13e-01 |
GOBP DENDRITE EXTENSION | 24 | 1.61e-02 | -2.84e-01 | 2.70e-01 |
GOCC T CELL RECEPTOR COMPLEX | 20 | 2.79e-02 | 2.84e-01 | 3.38e-01 |
GOBP CITRATE METABOLIC PROCESS | 5 | 2.72e-01 | 2.84e-01 | 7.29e-01 |
GOBP STRIATUM DEVELOPMENT | 14 | 6.59e-02 | 2.84e-01 | 4.59e-01 |
GOBP SUBPALLIUM DEVELOPMENT | 14 | 6.59e-02 | 2.84e-01 | 4.59e-01 |
GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 8 | 1.65e-01 | -2.84e-01 | 6.47e-01 |
GOMF CALCIUM DEPENDENT PROTEIN BINDING | 47 | 7.67e-04 | -2.84e-01 | 5.53e-02 |
GOBP GLYCOSIDE CATABOLIC PROCESS | 7 | 1.94e-01 | -2.84e-01 | 6.75e-01 |
GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 10 | 1.20e-01 | -2.84e-01 | 5.84e-01 |
GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 10 | 1.20e-01 | -2.84e-01 | 5.84e-01 |
GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 7 | 1.94e-01 | 2.83e-01 | 6.75e-01 |
GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 1.94e-01 | -2.83e-01 | 6.75e-01 |
GOBP ER OVERLOAD RESPONSE | 10 | 1.21e-01 | -2.83e-01 | 5.85e-01 |
GOBP PLASMINOGEN ACTIVATION | 12 | 8.95e-02 | -2.83e-01 | 5.22e-01 |
GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 8 | 1.66e-01 | -2.83e-01 | 6.48e-01 |
GOMF COMPLEMENT RECEPTOR ACTIVITY | 8 | 1.66e-01 | -2.83e-01 | 6.48e-01 |
GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 5 | 2.73e-01 | 2.83e-01 | 7.30e-01 |
GOMF DNA POLYMERASE BINDING | 20 | 2.86e-02 | 2.83e-01 | 3.41e-01 |
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 1.95e-01 | -2.83e-01 | 6.75e-01 |
GOCC UNIPLEX COMPLEX | 6 | 2.31e-01 | 2.83e-01 | 7.04e-01 |
GOBP REGULATION OF RESPONSE TO TUMOR CELL | 17 | 4.38e-02 | -2.83e-01 | 3.95e-01 |
GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 2.31e-01 | -2.82e-01 | 7.05e-01 |
GOMF OLIGOSACCHARIDE BINDING | 5 | 2.74e-01 | -2.82e-01 | 7.31e-01 |
GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 22 | 2.20e-02 | -2.82e-01 | 3.05e-01 |
GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 2.75e-01 | 2.82e-01 | 7.32e-01 |
GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 8 | 1.67e-01 | -2.82e-01 | 6.50e-01 |
GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 6 | 2.32e-01 | 2.82e-01 | 7.07e-01 |
GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 2.76e-01 | 2.81e-01 | 7.34e-01 |
GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 8 | 1.68e-01 | -2.81e-01 | 6.51e-01 |
GOBP MODULATION BY HOST OF VIRAL PROCESS | 39 | 2.39e-03 | -2.81e-01 | 1.06e-01 |
GOCC RIBONUCLEASE MRP COMPLEX | 10 | 1.24e-01 | 2.81e-01 | 5.89e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 11 | 1.07e-01 | 2.81e-01 | 5.63e-01 |
GOBP ASTROCYTE DEVELOPMENT | 29 | 8.98e-03 | -2.80e-01 | 1.98e-01 |
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 8 | 1.70e-01 | -2.80e-01 | 6.52e-01 |
GOBP REGULATION OF SULFUR METABOLIC PROCESS | 12 | 9.27e-02 | 2.80e-01 | 5.29e-01 |
GOCC ACROSOMAL MEMBRANE | 10 | 1.25e-01 | 2.80e-01 | 5.90e-01 |
GOBP REGULATION OF PLASMINOGEN ACTIVATION | 11 | 1.08e-01 | -2.80e-01 | 5.64e-01 |
GOCC MSL COMPLEX | 5 | 2.78e-01 | -2.80e-01 | 7.35e-01 |
GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY | 5 | 2.78e-01 | -2.80e-01 | 7.35e-01 |
GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 1.99e-01 | 2.80e-01 | 6.79e-01 |
GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 35 | 4.18e-03 | -2.80e-01 | 1.37e-01 |
GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 9 | 1.46e-01 | -2.80e-01 | 6.22e-01 |
GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 2.36e-01 | 2.80e-01 | 7.10e-01 |
GOCC TRAMP COMPLEX | 5 | 2.79e-01 | 2.79e-01 | 7.36e-01 |
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 10 | 1.26e-01 | -2.79e-01 | 5.94e-01 |
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 12 | 9.40e-02 | 2.79e-01 | 5.32e-01 |
GOMF ACTIN MONOMER BINDING | 16 | 5.33e-02 | -2.79e-01 | 4.21e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 15 | 6.14e-02 | -2.79e-01 | 4.42e-01 |
GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 6 | 2.37e-01 | 2.79e-01 | 7.11e-01 |
GOBP ADP TRANSPORT | 9 | 1.48e-01 | -2.79e-01 | 6.24e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 6 | 2.37e-01 | 2.79e-01 | 7.11e-01 |
GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 15 | 6.19e-02 | -2.79e-01 | 4.43e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 22 | 2.39e-02 | 2.78e-01 | 3.16e-01 |
GOCC MYELIN SHEATH ABAXONAL REGION | 6 | 2.38e-01 | 2.78e-01 | 7.11e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 36 | 3.88e-03 | -2.78e-01 | 1.32e-01 |
GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 5 | 2.81e-01 | -2.78e-01 | 7.38e-01 |
GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 19 | 3.58e-02 | 2.78e-01 | 3.72e-01 |
GOCC TERTIARY GRANULE LUMEN | 43 | 1.61e-03 | -2.78e-01 | 8.16e-02 |
GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 3.14e-02 | -2.78e-01 | 3.53e-01 |
GOBP TOXIN TRANSPORT | 5 | 2.82e-01 | -2.78e-01 | 7.38e-01 |
GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 8 | 1.73e-01 | -2.78e-01 | 6.56e-01 |
GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 7 | 2.03e-01 | 2.78e-01 | 6.85e-01 |
GOBP NEGATIVE REGULATION OF HEART RATE | 6 | 2.38e-01 | -2.78e-01 | 7.11e-01 |
GOCC POLAR MICROTUBULE | 5 | 2.82e-01 | 2.78e-01 | 7.38e-01 |
GOBP RESPONSE TO INTERLEUKIN 18 | 9 | 1.50e-01 | -2.77e-01 | 6.28e-01 |
GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 2.04e-01 | 2.77e-01 | 6.85e-01 |
GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 6 | 2.40e-01 | 2.77e-01 | 7.13e-01 |
GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 2.84e-01 | -2.77e-01 | 7.39e-01 |
GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 2.84e-01 | -2.77e-01 | 7.39e-01 |
GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 11 | 1.12e-01 | 2.77e-01 | 5.73e-01 |
GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 8 | 1.75e-01 | 2.77e-01 | 6.59e-01 |
GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 8 | 1.76e-01 | -2.76e-01 | 6.60e-01 |
GOBP SKELETAL MUSCLE ADAPTATION | 8 | 1.76e-01 | 2.76e-01 | 6.60e-01 |
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 12 | 9.77e-02 | -2.76e-01 | 5.42e-01 |
GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 7 | 2.06e-01 | -2.76e-01 | 6.87e-01 |
GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 2.85e-01 | 2.76e-01 | 7.41e-01 |
GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 6 | 2.42e-01 | 2.76e-01 | 7.14e-01 |
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 6 | 2.42e-01 | -2.76e-01 | 7.14e-01 |
GOBP REGULATION OF STEROID HORMONE SECRETION | 11 | 1.13e-01 | -2.76e-01 | 5.77e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 19 | 3.77e-02 | 2.75e-01 | 3.79e-01 |
GOBP SEROTONIN METABOLIC PROCESS | 5 | 2.86e-01 | 2.75e-01 | 7.43e-01 |
GOMF ALDEHYDE LYASE ACTIVITY | 6 | 2.43e-01 | -2.75e-01 | 7.14e-01 |
GOMF SUPERCOILED DNA BINDING | 6 | 2.43e-01 | -2.75e-01 | 7.14e-01 |
GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 9 | 1.53e-01 | 2.75e-01 | 6.32e-01 |
GOBP RRNA TRANSPORT | 5 | 2.87e-01 | 2.75e-01 | 7.43e-01 |
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 5 | 2.87e-01 | -2.75e-01 | 7.43e-01 |
GOMF MANNOSIDASE ACTIVITY | 14 | 7.53e-02 | 2.75e-01 | 4.90e-01 |
GOMF ENOYL COA HYDRATASE ACTIVITY | 10 | 1.33e-01 | 2.75e-01 | 6.04e-01 |
GOCC LSM1 7 PAT1 COMPLEX | 5 | 2.88e-01 | -2.74e-01 | 7.43e-01 |
GOBP STEROID HORMONE SECRETION | 13 | 8.68e-02 | -2.74e-01 | 5.19e-01 |
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 2.88e-01 | 2.74e-01 | 7.43e-01 |
GOBP NEURON REMODELING | 8 | 1.79e-01 | 2.74e-01 | 6.62e-01 |
GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 7 | 2.09e-01 | -2.74e-01 | 6.87e-01 |
GOBP COPI COATED VESICLE BUDDING | 6 | 2.45e-01 | -2.74e-01 | 7.14e-01 |
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 8 | 1.80e-01 | -2.74e-01 | 6.64e-01 |
GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 24 | 2.05e-02 | 2.73e-01 | 2.97e-01 |
GOMF SPHINGOLIPID BINDING | 18 | 4.50e-02 | -2.73e-01 | 4.00e-01 |
GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 11 | 1.17e-01 | -2.73e-01 | 5.79e-01 |
GOMF FATTY ACID LIGASE ACTIVITY | 13 | 8.85e-02 | 2.73e-01 | 5.21e-01 |
GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 6 | 2.48e-01 | -2.73e-01 | 7.17e-01 |
GOCC NADPH OXIDASE COMPLEX | 10 | 1.36e-01 | -2.73e-01 | 6.06e-01 |
GOCC SMAD PROTEIN COMPLEX | 7 | 2.12e-01 | -2.72e-01 | 6.87e-01 |
GOBP TRANSCYTOSIS | 15 | 6.78e-02 | -2.72e-01 | 4.64e-01 |
GOBP MAST CELL CYTOKINE PRODUCTION | 5 | 2.92e-01 | -2.72e-01 | 7.46e-01 |
GOBP PITUITARY GLAND DEVELOPMENT | 8 | 1.83e-01 | 2.72e-01 | 6.65e-01 |
GOBP PROTEIN PALMITOYLATION | 23 | 2.40e-02 | -2.72e-01 | 3.16e-01 |
GOBP LUNG ALVEOLUS DEVELOPMENT | 24 | 2.12e-02 | -2.72e-01 | 3.01e-01 |
GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 1.58e-01 | -2.72e-01 | 6.39e-01 |
GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 19 | 4.05e-02 | 2.72e-01 | 3.83e-01 |
GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 15 | 6.87e-02 | 2.71e-01 | 4.67e-01 |
GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 22 | 2.77e-02 | 2.71e-01 | 3.38e-01 |
GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 17 | 5.29e-02 | 2.71e-01 | 4.19e-01 |
GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 7 | 2.14e-01 | 2.71e-01 | 6.89e-01 |
GOBP MONOATOMIC ANION HOMEOSTASIS | 10 | 1.38e-01 | 2.71e-01 | 6.08e-01 |
GOBP FOLIC ACID METABOLIC PROCESS | 12 | 1.04e-01 | 2.71e-01 | 5.56e-01 |
GOCC SPINDLE POLE CENTROSOME | 10 | 1.38e-01 | -2.71e-01 | 6.09e-01 |
GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 1.60e-01 | 2.70e-01 | 6.42e-01 |
GOBP ENDOSOMAL LUMEN ACIDIFICATION | 13 | 9.16e-02 | -2.70e-01 | 5.26e-01 |
GOCC DENDRITE CYTOPLASM | 21 | 3.22e-02 | 2.70e-01 | 3.56e-01 |
GOMF DNA POLYMERASE ACTIVITY | 27 | 1.52e-02 | 2.70e-01 | 2.62e-01 |
GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 14 | 8.06e-02 | -2.70e-01 | 5.07e-01 |
GOMF PORIN ACTIVITY | 6 | 2.53e-01 | -2.70e-01 | 7.21e-01 |
GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 2.53e-01 | 2.70e-01 | 7.21e-01 |
GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 2.53e-01 | 2.70e-01 | 7.21e-01 |
GOCC ANNULATE LAMELLAE | 5 | 2.97e-01 | 2.69e-01 | 7.49e-01 |
GOBP RENAL WATER HOMEOSTASIS | 9 | 1.62e-01 | 2.69e-01 | 6.44e-01 |
GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 7 | 2.18e-01 | 2.69e-01 | 6.94e-01 |
GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 2.98e-01 | -2.69e-01 | 7.49e-01 |
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 11 | 1.23e-01 | -2.69e-01 | 5.87e-01 |
GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 2.54e-01 | 2.69e-01 | 7.22e-01 |
GOCC ENDOSOME LUMEN | 24 | 2.27e-02 | -2.69e-01 | 3.08e-01 |
GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY | 5 | 2.98e-01 | -2.69e-01 | 7.49e-01 |
GOBP REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY | 5 | 2.98e-01 | 2.69e-01 | 7.49e-01 |
GOCC F ACTIN CAPPING PROTEIN COMPLEX | 6 | 2.55e-01 | -2.68e-01 | 7.23e-01 |
GOBP GLYCOPROTEIN CATABOLIC PROCESS | 26 | 1.79e-02 | 2.68e-01 | 2.82e-01 |
GOCC SET1C COMPASS COMPLEX | 12 | 1.08e-01 | 2.68e-01 | 5.65e-01 |
GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 5 | 2.99e-01 | 2.68e-01 | 7.50e-01 |
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 8 | 1.89e-01 | 2.68e-01 | 6.73e-01 |
GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 2.20e-01 | -2.68e-01 | 6.96e-01 |
GOBP POSITIVE REGULATION OF LIPID STORAGE | 18 | 4.93e-02 | -2.68e-01 | 4.14e-01 |
GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 42 | 2.71e-03 | 2.68e-01 | 1.08e-01 |
GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 12 | 1.09e-01 | -2.67e-01 | 5.67e-01 |
GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 6 | 2.57e-01 | 2.67e-01 | 7.24e-01 |
GOBP STRESS INDUCED PREMATURE SENESCENCE | 5 | 3.01e-01 | 2.67e-01 | 7.52e-01 |
GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 7 | 2.21e-01 | 2.67e-01 | 6.98e-01 |
GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 3.01e-01 | -2.67e-01 | 7.52e-01 |
GOBP RESPONSE TO ACTINOMYCIN D | 5 | 3.01e-01 | -2.67e-01 | 7.52e-01 |
GOBP EMBRYONIC EYE MORPHOGENESIS | 11 | 1.25e-01 | -2.67e-01 | 5.91e-01 |
GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 6 | 2.58e-01 | -2.67e-01 | 7.24e-01 |
GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 10 | 1.44e-01 | -2.67e-01 | 6.19e-01 |
GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 12 | 1.10e-01 | 2.67e-01 | 5.69e-01 |
GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 3.02e-01 | -2.66e-01 | 7.53e-01 |
GOBP MITOTIC RECOMBINATION | 22 | 3.06e-02 | 2.66e-01 | 3.49e-01 |
GOBP PROSTAGLANDIN SECRETION | 11 | 1.26e-01 | -2.66e-01 | 5.94e-01 |
GOBP SIRNA PROCESSING | 8 | 1.92e-01 | 2.66e-01 | 6.75e-01 |
GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 1.45e-01 | -2.66e-01 | 6.20e-01 |
GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 7 | 2.23e-01 | 2.66e-01 | 7.01e-01 |
GOBP RESPONSE TO PEPTIDOGLYCAN | 9 | 1.67e-01 | -2.66e-01 | 6.49e-01 |
GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 15 | 7.47e-02 | -2.66e-01 | 4.88e-01 |
GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 5 | 3.03e-01 | 2.66e-01 | 7.54e-01 |
GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 11 | 1.27e-01 | 2.66e-01 | 5.96e-01 |
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 14 | 8.53e-02 | -2.66e-01 | 5.17e-01 |
GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 12 | 1.12e-01 | 2.65e-01 | 5.72e-01 |
GOBP UV PROTECTION | 9 | 1.68e-01 | 2.65e-01 | 6.51e-01 |
GOCC GLYCOGEN GRANULE | 7 | 2.25e-01 | -2.65e-01 | 7.02e-01 |
GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 19 | 4.56e-02 | -2.65e-01 | 4.00e-01 |
GOBP MYELOID DENDRITIC CELL ACTIVATION | 21 | 3.57e-02 | -2.65e-01 | 3.70e-01 |
GOMF RNA METHYLTRANSFERASE ACTIVITY | 59 | 4.38e-04 | 2.65e-01 | 3.98e-02 |
GOBP GLUCOCORTICOID SECRETION | 8 | 1.95e-01 | -2.65e-01 | 6.75e-01 |
GOCC EARLY PHAGOSOME | 10 | 1.47e-01 | -2.65e-01 | 6.24e-01 |
GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 7 | 2.26e-01 | -2.64e-01 | 7.02e-01 |
GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 11 | 1.29e-01 | -2.64e-01 | 6.00e-01 |
GOBP HAIR FOLLICLE MATURATION | 7 | 2.27e-01 | 2.64e-01 | 7.02e-01 |
GOBP REGULATION OF GLUCOCORTICOID SECRETION | 6 | 2.63e-01 | -2.64e-01 | 7.24e-01 |
GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 16 | 6.77e-02 | -2.64e-01 | 4.64e-01 |
GOBP CORONARY VASCULATURE DEVELOPMENT | 29 | 1.40e-02 | 2.64e-01 | 2.59e-01 |
GOCC ER UBIQUITIN LIGASE COMPLEX | 7 | 2.27e-01 | 2.64e-01 | 7.02e-01 |
GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 11 | 1.30e-01 | -2.64e-01 | 6.01e-01 |
GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 1.97e-01 | -2.64e-01 | 6.77e-01 |
GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 7 | 2.28e-01 | 2.63e-01 | 7.02e-01 |
GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 7 | 2.28e-01 | 2.63e-01 | 7.02e-01 |
GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY | 5 | 3.08e-01 | 2.63e-01 | 7.58e-01 |
GOCC NEURONAL DENSE CORE VESICLE | 8 | 1.98e-01 | -2.63e-01 | 6.78e-01 |
GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 5 | 3.08e-01 | 2.63e-01 | 7.58e-01 |
GOBP GDP MANNOSE METABOLIC PROCESS | 6 | 2.65e-01 | 2.63e-01 | 7.25e-01 |
GOBP EOSINOPHIL MIGRATION | 13 | 1.01e-01 | -2.63e-01 | 5.49e-01 |
GOBP SYNAPTIC VESICLE BUDDING | 7 | 2.29e-01 | -2.63e-01 | 7.02e-01 |
GOBP REGULATION OF SENSORY PERCEPTION | 5 | 3.09e-01 | -2.63e-01 | 7.58e-01 |
GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 7 | 2.29e-01 | 2.63e-01 | 7.02e-01 |
GOBP POSITIVE REGULATION OF VESICLE FUSION | 7 | 2.29e-01 | -2.62e-01 | 7.02e-01 |
GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 6 | 2.66e-01 | 2.62e-01 | 7.25e-01 |
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 10 | 1.51e-01 | 2.62e-01 | 6.29e-01 |
GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 6 | 2.66e-01 | -2.62e-01 | 7.25e-01 |
GOCC GOLGI CIS CISTERNA | 12 | 1.16e-01 | -2.62e-01 | 5.79e-01 |
GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 6 | 2.67e-01 | 2.62e-01 | 7.25e-01 |
GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 23 | 2.97e-02 | 2.62e-01 | 3.47e-01 |
GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 2.67e-01 | -2.62e-01 | 7.25e-01 |
GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 8 | 2.00e-01 | -2.62e-01 | 6.79e-01 |
GOCC PRECATALYTIC SPLICEOSOME | 52 | 1.11e-03 | -2.62e-01 | 6.76e-02 |
GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 6 | 2.67e-01 | 2.62e-01 | 7.25e-01 |
GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 13 | 1.03e-01 | 2.61e-01 | 5.52e-01 |
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 20 | 4.30e-02 | -2.61e-01 | 3.91e-01 |
GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 29 | 1.49e-02 | -2.61e-01 | 2.62e-01 |
GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 3.11e-01 | 2.61e-01 | 7.61e-01 |
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 41 | 3.80e-03 | -2.61e-01 | 1.30e-01 |
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 31 | 1.18e-02 | -2.61e-01 | 2.33e-01 |
GOBP ENDOCRINE HORMONE SECRETION | 26 | 2.12e-02 | -2.61e-01 | 3.01e-01 |
GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 6 | 2.68e-01 | -2.61e-01 | 7.25e-01 |
GOMF CARBON SULFUR LYASE ACTIVITY | 13 | 1.03e-01 | -2.61e-01 | 5.53e-01 |
GOBP NODAL SIGNALING PATHWAY | 7 | 2.32e-01 | -2.61e-01 | 7.06e-01 |
GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 16 | 7.10e-02 | -2.61e-01 | 4.74e-01 |
GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 15 | 8.05e-02 | -2.61e-01 | 5.07e-01 |
GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 16 | 7.12e-02 | -2.61e-01 | 4.75e-01 |
GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 2.69e-01 | -2.60e-01 | 7.28e-01 |
GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 8 | 2.02e-01 | -2.60e-01 | 6.84e-01 |
GOBP RESCUE OF STALLED RIBOSOME | 25 | 2.43e-02 | 2.60e-01 | 3.19e-01 |
GOCC BLEB | 9 | 1.76e-01 | -2.60e-01 | 6.60e-01 |
GOBP COMMISSURAL NEURON AXON GUIDANCE | 9 | 1.77e-01 | 2.60e-01 | 6.60e-01 |
GOCC CYTOLYTIC GRANULE | 13 | 1.04e-01 | -2.60e-01 | 5.56e-01 |
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 12 | 1.19e-01 | -2.60e-01 | 5.82e-01 |
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 7 | 2.34e-01 | 2.60e-01 | 7.08e-01 |
GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 15 | 8.13e-02 | -2.60e-01 | 5.08e-01 |
GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 6 | 2.70e-01 | 2.60e-01 | 7.28e-01 |
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 35 | 7.86e-03 | -2.60e-01 | 1.85e-01 |
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 10 | 1.55e-01 | 2.60e-01 | 6.37e-01 |
GOCC PORE COMPLEX | 18 | 5.66e-02 | -2.60e-01 | 4.28e-01 |
GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 7 | 2.35e-01 | -2.59e-01 | 7.10e-01 |
GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 1.78e-01 | 2.59e-01 | 6.61e-01 |
GOBP LEUKOTRIENE METABOLIC PROCESS | 14 | 9.30e-02 | -2.59e-01 | 5.30e-01 |
GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 18 | 5.69e-02 | 2.59e-01 | 4.28e-01 |
GOBP POSITIVE THYMIC T CELL SELECTION | 12 | 1.20e-01 | 2.59e-01 | 5.83e-01 |
GOMF CYCLASE REGULATOR ACTIVITY | 9 | 1.78e-01 | -2.59e-01 | 6.61e-01 |
GOCC MICROTUBULE MINUS END | 6 | 2.72e-01 | -2.59e-01 | 7.29e-01 |
GOBP VACUOLE FUSION | 11 | 1.37e-01 | -2.59e-01 | 6.08e-01 |
GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 10 | 1.56e-01 | 2.59e-01 | 6.39e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 2.72e-01 | -2.59e-01 | 7.29e-01 |
GOBP SKIN MORPHOGENESIS | 6 | 2.72e-01 | -2.59e-01 | 7.29e-01 |
GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 8 | 2.05e-01 | 2.59e-01 | 6.85e-01 |
GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 2.72e-01 | 2.59e-01 | 7.29e-01 |
GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 17 | 6.49e-02 | -2.59e-01 | 4.55e-01 |
GOMF SEMAPHORIN RECEPTOR ACTIVITY | 9 | 1.79e-01 | -2.58e-01 | 6.62e-01 |
GOBP ACUTE PHASE RESPONSE | 23 | 3.21e-02 | -2.58e-01 | 3.55e-01 |
GOBP TRABECULA FORMATION | 10 | 1.58e-01 | 2.58e-01 | 6.39e-01 |
GOBP GAMMA DELTA T CELL DIFFERENTIATION | 11 | 1.38e-01 | -2.58e-01 | 6.09e-01 |
GOBP ADRENAL GLAND DEVELOPMENT | 12 | 1.22e-01 | -2.58e-01 | 5.86e-01 |
GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 2.06e-01 | -2.58e-01 | 6.87e-01 |
GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 36 | 7.55e-03 | -2.57e-01 | 1.82e-01 |
GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.08e-01 | -2.57e-01 | 6.87e-01 |
GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 5 | 3.19e-01 | -2.57e-01 | 7.67e-01 |
GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 8 | 2.08e-01 | -2.57e-01 | 6.87e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 12 | 1.23e-01 | -2.57e-01 | 5.87e-01 |
GOMF DNA HELICASE ACTIVITY | 50 | 1.70e-03 | 2.57e-01 | 8.40e-02 |
GOBP REGULATION OF SPROUTING ANGIOGENESIS | 21 | 4.19e-02 | -2.57e-01 | 3.87e-01 |
GOBP HEAT GENERATION | 12 | 1.24e-01 | -2.56e-01 | 5.89e-01 |
GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 6 | 2.78e-01 | 2.56e-01 | 7.35e-01 |
GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 12 | 1.25e-01 | -2.56e-01 | 5.90e-01 |
GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 5 | 3.22e-01 | -2.56e-01 | 7.69e-01 |
GOCC WNT SIGNALOSOME | 9 | 1.84e-01 | 2.56e-01 | 6.69e-01 |
GOMF PHOSPHATE ION BINDING | 7 | 2.42e-01 | -2.56e-01 | 7.14e-01 |
GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 81 | 7.11e-05 | -2.56e-01 | 1.13e-02 |
GOBP ENDOCRINE PROCESS | 37 | 7.28e-03 | -2.55e-01 | 1.81e-01 |
GOMF GROWTH FACTOR ACTIVITY | 48 | 2.25e-03 | -2.55e-01 | 1.02e-01 |
GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 7 | 2.43e-01 | -2.55e-01 | 7.14e-01 |
GOMF CARGO ADAPTOR ACTIVITY | 18 | 6.13e-02 | 2.55e-01 | 4.42e-01 |
GOBP POSITIVE REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 7 | 2.43e-01 | -2.55e-01 | 7.14e-01 |
GOMF CYCLASE ACTIVITY | 9 | 1.86e-01 | 2.54e-01 | 6.70e-01 |
GOBP MRNA METHYLATION | 18 | 6.18e-02 | 2.54e-01 | 4.43e-01 |
GOBP FERROPTOSIS | 5 | 3.25e-01 | 2.54e-01 | 7.69e-01 |
GOBP ESTROGEN METABOLIC PROCESS | 11 | 1.44e-01 | -2.54e-01 | 6.19e-01 |
GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 40 | 5.44e-03 | -2.54e-01 | 1.54e-01 |
GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 2.44e-01 | 2.54e-01 | 7.14e-01 |
GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 73 | 1.76e-04 | -2.54e-01 | 2.24e-02 |
GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 2.44e-01 | -2.54e-01 | 7.14e-01 |
GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 13 | 1.13e-01 | -2.54e-01 | 5.76e-01 |
GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 20 | 4.96e-02 | -2.54e-01 | 4.14e-01 |
GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION | 7 | 2.45e-01 | 2.54e-01 | 7.14e-01 |
GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 8 | 2.14e-01 | -2.54e-01 | 6.89e-01 |
GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 1.65e-01 | 2.54e-01 | 6.47e-01 |
GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 13 | 1.13e-01 | 2.54e-01 | 5.77e-01 |
GOBP PROTON TRANSMEMBRANE TRANSPORT | 113 | 3.32e-06 | -2.54e-01 | 1.22e-03 |
GOMF S ACYLTRANSFERASE ACTIVITY | 24 | 3.18e-02 | -2.53e-01 | 3.54e-01 |
GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX | 5 | 3.27e-01 | -2.53e-01 | 7.70e-01 |
GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 7 | 2.46e-01 | -2.53e-01 | 7.15e-01 |
GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 1.29e-01 | -2.53e-01 | 5.99e-01 |
GOBP CELLULAR RESPONSE TO COLD | 9 | 1.89e-01 | -2.53e-01 | 6.73e-01 |
GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 3.28e-01 | -2.52e-01 | 7.71e-01 |
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 9 | 1.90e-01 | -2.52e-01 | 6.73e-01 |
GOBP DNA REPLICATION INITIATION | 27 | 2.33e-02 | 2.52e-01 | 3.12e-01 |
GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 12 | 1.30e-01 | 2.52e-01 | 6.01e-01 |
GOCC KINESIN COMPLEX | 31 | 1.52e-02 | 2.52e-01 | 2.62e-01 |
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 13 | 1.16e-01 | 2.52e-01 | 5.78e-01 |
GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 2.18e-01 | 2.51e-01 | 6.95e-01 |
GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 7 | 2.49e-01 | 2.51e-01 | 7.18e-01 |
GOMF ANTIOXIDANT ACTIVITY | 54 | 1.41e-03 | -2.51e-01 | 7.76e-02 |
GOCC GEMINI OF COILED BODIES | 12 | 1.32e-01 | 2.51e-01 | 6.03e-01 |
GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 5 | 3.31e-01 | 2.51e-01 | 7.74e-01 |
GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION | 5 | 3.31e-01 | -2.51e-01 | 7.75e-01 |
GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 17 | 7.35e-02 | -2.51e-01 | 4.83e-01 |
GOBP POST ANAL TAIL MORPHOGENESIS | 8 | 2.19e-01 | 2.51e-01 | 6.96e-01 |
GOCC NUCLEAR PORE NUCLEAR BASKET | 12 | 1.33e-01 | 2.51e-01 | 6.04e-01 |
GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY | 5 | 3.32e-01 | 2.51e-01 | 7.76e-01 |
GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 2.88e-01 | -2.51e-01 | 7.43e-01 |
GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 1.93e-01 | 2.51e-01 | 6.75e-01 |
GOBP MRNA PSEUDOURIDINE SYNTHESIS | 9 | 1.93e-01 | 2.50e-01 | 6.75e-01 |
GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 12 | 1.33e-01 | -2.50e-01 | 6.05e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 9 | 1.93e-01 | 2.50e-01 | 6.75e-01 |
GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 12 | 1.33e-01 | 2.50e-01 | 6.05e-01 |
GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE | 5 | 3.32e-01 | -2.50e-01 | 7.76e-01 |
GOCC AMPHISOME MEMBRANE | 10 | 1.71e-01 | -2.50e-01 | 6.54e-01 |
GOCC NODE OF RANVIER | 7 | 2.52e-01 | -2.50e-01 | 7.20e-01 |
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 13 | 1.19e-01 | -2.50e-01 | 5.82e-01 |
GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 10 | 1.71e-01 | -2.50e-01 | 6.54e-01 |
GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 19 | 5.94e-02 | 2.50e-01 | 4.35e-01 |
GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 6 | 2.89e-01 | 2.50e-01 | 7.44e-01 |
GOCC INTRACILIARY TRANSPORT PARTICLE B | 14 | 1.06e-01 | -2.50e-01 | 5.57e-01 |
GOBP CELLULAR RESPONSE TO CHOLESTEROL | 10 | 1.72e-01 | 2.50e-01 | 6.55e-01 |
GOBP DENDRITIC SPINE MAINTENANCE | 13 | 1.19e-01 | 2.49e-01 | 5.82e-01 |
GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 12 | 1.35e-01 | 2.49e-01 | 6.05e-01 |
GOBP SYMPATHETIC NEURON PROJECTION EXTENSION | 5 | 3.34e-01 | -2.49e-01 | 7.78e-01 |
GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 30 | 1.82e-02 | -2.49e-01 | 2.86e-01 |
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 19 | 6.01e-02 | -2.49e-01 | 4.38e-01 |
GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 5 | 3.35e-01 | 2.49e-01 | 7.78e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 5 | 3.35e-01 | -2.49e-01 | 7.78e-01 |
GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 11 | 1.53e-01 | -2.49e-01 | 6.32e-01 |
GOMF CYCLASE ACTIVATOR ACTIVITY | 6 | 2.91e-01 | -2.49e-01 | 7.46e-01 |
GOCC CHROMATOID BODY | 6 | 2.91e-01 | 2.49e-01 | 7.46e-01 |
GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 22 | 4.34e-02 | -2.49e-01 | 3.93e-01 |
GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 6 | 2.91e-01 | -2.49e-01 | 7.46e-01 |
GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 2.91e-01 | 2.49e-01 | 7.46e-01 |
GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 25 | 3.14e-02 | 2.49e-01 | 3.53e-01 |
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 15 | 9.54e-02 | -2.49e-01 | 5.37e-01 |
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 16 | 8.52e-02 | 2.49e-01 | 5.17e-01 |
GOBP NEPHRIC DUCT DEVELOPMENT | 6 | 2.92e-01 | 2.49e-01 | 7.46e-01 |
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 10 | 1.74e-01 | -2.48e-01 | 6.56e-01 |
GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 26 | 2.84e-02 | -2.48e-01 | 3.41e-01 |
GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 9 | 1.97e-01 | -2.48e-01 | 6.77e-01 |
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 6 | 2.92e-01 | -2.48e-01 | 7.46e-01 |
GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 32 | 1.52e-02 | 2.48e-01 | 2.62e-01 |
GOBP CELL ADHESION MEDIATED BY INTEGRIN | 49 | 2.67e-03 | -2.48e-01 | 1.07e-01 |
GOCC EXOCYST | 12 | 1.37e-01 | 2.48e-01 | 6.08e-01 |
GOMF TRAIL BINDING | 5 | 3.37e-01 | 2.48e-01 | 7.80e-01 |
GOBP MEIOTIC SISTER CHROMATID COHESION | 12 | 1.37e-01 | -2.48e-01 | 6.08e-01 |
GOBP ENDOCARDIUM DEVELOPMENT | 8 | 2.25e-01 | 2.48e-01 | 7.02e-01 |
GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 21 | 4.95e-02 | 2.48e-01 | 4.14e-01 |
GOBP ANATOMICAL STRUCTURE REGRESSION | 5 | 3.38e-01 | -2.48e-01 | 7.80e-01 |
GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 18 | 6.92e-02 | -2.47e-01 | 4.68e-01 |
GOMF TAP BINDING | 7 | 2.57e-01 | 2.47e-01 | 7.24e-01 |
GOCC SPERM PLASMA MEMBRANE | 5 | 3.38e-01 | -2.47e-01 | 7.80e-01 |
GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 1.99e-01 | 2.47e-01 | 6.79e-01 |
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 21 | 5.00e-02 | -2.47e-01 | 4.14e-01 |
GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 2.95e-01 | -2.47e-01 | 7.48e-01 |
GOBP MRNA MODIFICATION | 30 | 1.93e-02 | 2.47e-01 | 2.91e-01 |
GOBP RETINOL METABOLIC PROCESS | 21 | 5.03e-02 | -2.47e-01 | 4.15e-01 |
GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 24 | 3.64e-02 | -2.47e-01 | 3.74e-01 |
GOCC DENSE CORE GRANULE | 13 | 1.24e-01 | -2.47e-01 | 5.87e-01 |
GOMF PHOSPHATIDIC ACID BINDING | 16 | 8.81e-02 | 2.46e-01 | 5.20e-01 |
GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 50 | 2.61e-03 | 2.46e-01 | 1.07e-01 |
GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 3.40e-01 | -2.46e-01 | 7.81e-01 |
GOMF ACTIVIN RECEPTOR ACTIVITY | 7 | 2.59e-01 | -2.46e-01 | 7.24e-01 |
GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 7 | 2.59e-01 | -2.46e-01 | 7.24e-01 |
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 9 | 2.01e-01 | -2.46e-01 | 6.83e-01 |
GOCC REPLICATION FORK | 60 | 9.92e-04 | 2.46e-01 | 6.34e-02 |
GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 24 | 3.71e-02 | -2.46e-01 | 3.77e-01 |
GOMF DEATH RECEPTOR ACTIVITY | 10 | 1.78e-01 | -2.46e-01 | 6.61e-01 |
GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 2.98e-01 | -2.46e-01 | 7.49e-01 |
GOBP V D J RECOMBINATION | 17 | 7.98e-02 | 2.45e-01 | 5.04e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 12 | 1.41e-01 | -2.45e-01 | 6.14e-01 |
GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 9 | 2.04e-01 | -2.45e-01 | 6.85e-01 |
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 9 | 2.04e-01 | -2.45e-01 | 6.85e-01 |
GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 20 | 5.83e-02 | -2.45e-01 | 4.33e-01 |
GOBP AORTA DEVELOPMENT | 35 | 1.23e-02 | 2.44e-01 | 2.40e-01 |
GOBP PROTEIN DENEDDYLATION | 10 | 1.81e-01 | -2.44e-01 | 6.64e-01 |
GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 17 | 8.15e-02 | 2.44e-01 | 5.08e-01 |
GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 18 | 7.30e-02 | -2.44e-01 | 4.82e-01 |
GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY | 5 | 3.45e-01 | -2.44e-01 | 7.83e-01 |
GOBP SKELETAL MUSCLE CELL PROLIFERATION | 16 | 9.12e-02 | 2.44e-01 | 5.25e-01 |
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 2.64e-01 | -2.44e-01 | 7.25e-01 |
GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 10 | 1.82e-01 | -2.44e-01 | 6.65e-01 |
GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 10 | 1.82e-01 | -2.44e-01 | 6.65e-01 |
GOCC RIBOSOME | 221 | 4.72e-10 | -2.44e-01 | 4.98e-07 |
GOMF MAP KINASE SCAFFOLD ACTIVITY | 9 | 2.06e-01 | 2.44e-01 | 6.87e-01 |
GOCC AXON HILLOCK | 5 | 3.46e-01 | -2.44e-01 | 7.83e-01 |
GOMF O ACETYLTRANSFERASE ACTIVITY | 6 | 3.02e-01 | -2.43e-01 | 7.53e-01 |
GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 9 | 2.07e-01 | 2.43e-01 | 6.87e-01 |
GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 9 | 2.07e-01 | 2.43e-01 | 6.87e-01 |
GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 3.03e-01 | 2.43e-01 | 7.54e-01 |
GOCC ACTIN FILAMENT BUNDLE | 52 | 2.52e-03 | -2.42e-01 | 1.07e-01 |
GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 7 | 2.67e-01 | -2.42e-01 | 7.25e-01 |
GOBP EPITHELIAL STRUCTURE MAINTENANCE | 16 | 9.35e-02 | -2.42e-01 | 5.31e-01 |
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 10 | 1.85e-01 | -2.42e-01 | 6.69e-01 |
GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 14 | 1.17e-01 | -2.42e-01 | 5.79e-01 |
GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 2.68e-01 | -2.42e-01 | 7.25e-01 |
GOBP ERBB2 EGFR SIGNALING PATHWAY | 5 | 3.49e-01 | -2.42e-01 | 7.86e-01 |
GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 2.19e-02 | -2.42e-01 | 3.05e-01 |
GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS | 5 | 3.49e-01 | -2.42e-01 | 7.86e-01 |
GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 10 | 1.86e-01 | -2.42e-01 | 6.69e-01 |
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 38 | 9.99e-03 | 2.42e-01 | 2.09e-01 |
GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 99 | 3.34e-05 | 2.42e-01 | 6.13e-03 |
GOBP DNA PROTECTION | 5 | 3.50e-01 | 2.41e-01 | 7.86e-01 |
GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 21 | 5.58e-02 | 2.41e-01 | 4.27e-01 |
GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 17 | 8.53e-02 | 2.41e-01 | 5.17e-01 |
GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 6 | 3.07e-01 | 2.41e-01 | 7.57e-01 |
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 11 | 1.67e-01 | -2.41e-01 | 6.49e-01 |
GOBP SECRETION BY TISSUE | 19 | 6.94e-02 | -2.41e-01 | 4.69e-01 |
GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 5 | 3.51e-01 | -2.41e-01 | 7.87e-01 |
GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 16 | 9.57e-02 | -2.41e-01 | 5.38e-01 |
GOBP CENTRAL NERVOUS SYSTEM MATURATION | 5 | 3.52e-01 | 2.41e-01 | 7.87e-01 |
GOCC SUMO LIGASE COMPLEX | 13 | 1.34e-01 | -2.40e-01 | 6.05e-01 |
GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 3.09e-01 | -2.40e-01 | 7.58e-01 |
GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 15 | 1.08e-01 | -2.40e-01 | 5.65e-01 |
GOBP PANCREATIC JUICE SECRETION | 5 | 3.53e-01 | -2.40e-01 | 7.89e-01 |
GOBP FOREGUT MORPHOGENESIS | 6 | 3.09e-01 | -2.40e-01 | 7.58e-01 |
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 15 | 1.08e-01 | -2.40e-01 | 5.65e-01 |
GOBP RESPONSE TO GRAVITY | 5 | 3.53e-01 | -2.40e-01 | 7.89e-01 |
GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 8 | 2.41e-01 | -2.40e-01 | 7.13e-01 |
GOBP TRNA METHYLATION | 41 | 7.95e-03 | 2.40e-01 | 1.87e-01 |
GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 12 | 1.51e-01 | -2.40e-01 | 6.29e-01 |
GOMF T CELL RECEPTOR BINDING | 10 | 1.90e-01 | 2.40e-01 | 6.73e-01 |
GOBP ZYMOGEN ACTIVATION | 32 | 1.91e-02 | -2.39e-01 | 2.90e-01 |
GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 10 | 1.90e-01 | -2.39e-01 | 6.73e-01 |
GOBP REGULATION OF LIPID STORAGE | 40 | 8.84e-03 | -2.39e-01 | 1.96e-01 |
GOCC MHC CLASS I PROTEIN COMPLEX | 9 | 2.14e-01 | 2.39e-01 | 6.89e-01 |
GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 24 | 4.26e-02 | -2.39e-01 | 3.90e-01 |
GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 10 | 1.91e-01 | -2.39e-01 | 6.73e-01 |
GOBP EXPLORATION BEHAVIOR | 12 | 1.52e-01 | 2.39e-01 | 6.31e-01 |
GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 11 | 1.70e-01 | 2.39e-01 | 6.53e-01 |
GOBP CLEAVAGE FURROW FORMATION | 6 | 3.11e-01 | -2.39e-01 | 7.60e-01 |
GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 8 | 2.43e-01 | 2.38e-01 | 7.14e-01 |
GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION | 5 | 3.56e-01 | -2.38e-01 | 7.91e-01 |
GOBP TRNA TRANSCRIPTION | 11 | 1.71e-01 | 2.38e-01 | 6.55e-01 |
GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 2.75e-01 | 2.38e-01 | 7.33e-01 |
GOBP REGULATION OF TORC2 SIGNALING | 8 | 2.44e-01 | 2.38e-01 | 7.14e-01 |
GOCC SEMAPHORIN RECEPTOR COMPLEX | 8 | 2.44e-01 | -2.38e-01 | 7.14e-01 |
GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 3.13e-01 | -2.38e-01 | 7.62e-01 |
GOBP VASCULAR WOUND HEALING | 9 | 2.17e-01 | -2.38e-01 | 6.92e-01 |
GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 11 | 1.72e-01 | 2.38e-01 | 6.55e-01 |
GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 11 | 1.72e-01 | -2.38e-01 | 6.55e-01 |
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 23 | 4.84e-02 | -2.38e-01 | 4.13e-01 |
GOBP RESPONSE TO INACTIVITY | 5 | 3.57e-01 | 2.38e-01 | 7.91e-01 |
GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 3.57e-01 | 2.38e-01 | 7.91e-01 |
GOBP CARDIOBLAST PROLIFERATION | 5 | 3.58e-01 | -2.37e-01 | 7.91e-01 |
GOBP BEHAVIORAL RESPONSE TO ETHANOL | 5 | 3.58e-01 | 2.37e-01 | 7.91e-01 |
GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 7 | 2.78e-01 | 2.37e-01 | 7.35e-01 |
GOBP MALE MEIOTIC NUCLEAR DIVISION | 23 | 4.93e-02 | 2.37e-01 | 4.14e-01 |
GOMF CYCLOSPORIN A BINDING | 16 | 1.01e-01 | -2.37e-01 | 5.49e-01 |
GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX | 5 | 3.60e-01 | 2.37e-01 | 7.92e-01 |
GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 2.47e-01 | -2.36e-01 | 7.16e-01 |
GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 9 | 2.20e-01 | -2.36e-01 | 6.96e-01 |
GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 6 | 3.16e-01 | -2.36e-01 | 7.64e-01 |
GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 7 | 2.79e-01 | -2.36e-01 | 7.36e-01 |
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 6 | 3.16e-01 | -2.36e-01 | 7.64e-01 |
GOBP AMP BIOSYNTHETIC PROCESS | 11 | 1.75e-01 | 2.36e-01 | 6.59e-01 |
GOBP CENTRIOLE ASSEMBLY | 42 | 8.27e-03 | 2.36e-01 | 1.90e-01 |
GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 42 | 8.28e-03 | -2.36e-01 | 1.90e-01 |
GOBP NEURON PROJECTION MAINTENANCE | 7 | 2.81e-01 | 2.36e-01 | 7.37e-01 |
GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 12 | 1.58e-01 | 2.35e-01 | 6.39e-01 |
GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 1.98e-01 | -2.35e-01 | 6.79e-01 |
GOMF SUMO POLYMER BINDING | 5 | 3.63e-01 | 2.35e-01 | 7.94e-01 |
GOMF RRNA BINDING | 63 | 1.27e-03 | -2.35e-01 | 7.23e-02 |
GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 11 | 1.77e-01 | 2.35e-01 | 6.61e-01 |
GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 67 | 8.92e-04 | 2.35e-01 | 5.90e-02 |
GOBP MOTOR NEURON APOPTOTIC PROCESS | 15 | 1.15e-01 | -2.35e-01 | 5.78e-01 |
GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 28 | 3.15e-02 | -2.35e-01 | 3.53e-01 |
GOCC LEWY BODY | 7 | 2.82e-01 | -2.35e-01 | 7.38e-01 |
GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 29 | 2.87e-02 | -2.35e-01 | 3.41e-01 |
GOMF FMN BINDING | 9 | 2.23e-01 | 2.35e-01 | 7.01e-01 |
GOBP GROWTH HORMONE SECRETION | 8 | 2.51e-01 | -2.35e-01 | 7.19e-01 |
GOBP OXIDATIVE PHOSPHORYLATION | 128 | 4.82e-06 | -2.34e-01 | 1.50e-03 |
GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 9 | 2.24e-01 | -2.34e-01 | 7.02e-01 |
GOBP ECTODERM DEVELOPMENT | 13 | 1.44e-01 | -2.34e-01 | 6.17e-01 |
GOBP PERICARDIUM DEVELOPMENT | 7 | 2.83e-01 | -2.34e-01 | 7.39e-01 |
GOBP NEGATIVE REGULATION OF NEUTROPHIL MIGRATION | 5 | 3.64e-01 | 2.34e-01 | 7.95e-01 |
GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.21e-01 | -2.34e-01 | 7.68e-01 |
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 8 | 2.52e-01 | -2.34e-01 | 7.20e-01 |
GOBP CUT CATABOLIC PROCESS | 5 | 3.65e-01 | 2.34e-01 | 7.95e-01 |
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 8 | 2.52e-01 | -2.34e-01 | 7.20e-01 |
GOBP RENAL FILTRATION | 12 | 1.61e-01 | 2.34e-01 | 6.42e-01 |
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 6 | 3.21e-01 | 2.34e-01 | 7.69e-01 |
GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 12 | 1.61e-01 | -2.34e-01 | 6.42e-01 |
GOMF GDP BINDING | 57 | 2.30e-03 | -2.34e-01 | 1.03e-01 |
GOBP BASE EXCISION REPAIR | 42 | 8.85e-03 | 2.34e-01 | 1.96e-01 |
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 47 | 5.63e-03 | -2.34e-01 | 1.58e-01 |
GOCC PLATELET ALPHA GRANULE LUMEN | 40 | 1.06e-02 | -2.34e-01 | 2.19e-01 |
GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 6 | 3.22e-01 | 2.34e-01 | 7.69e-01 |
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 5 | 3.66e-01 | -2.33e-01 | 7.96e-01 |
GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 18 | 8.67e-02 | 2.33e-01 | 5.19e-01 |
GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 21 | 6.43e-02 | 2.33e-01 | 4.53e-01 |
GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 17 | 9.61e-02 | -2.33e-01 | 5.38e-01 |
GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 2.54e-01 | -2.33e-01 | 7.22e-01 |
GOMF PHOSPHATIDYLGLYCEROL BINDING | 9 | 2.26e-01 | 2.33e-01 | 7.02e-01 |
GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 2.02e-01 | -2.33e-01 | 6.84e-01 |
GOBP CARNITINE TRANSPORT | 6 | 3.23e-01 | 2.33e-01 | 7.69e-01 |
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 14 | 1.32e-01 | -2.33e-01 | 6.02e-01 |
GOMF LYSINE ACETYLATED HISTONE BINDING | 22 | 5.88e-02 | 2.33e-01 | 4.34e-01 |
GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 7 | 2.86e-01 | -2.33e-01 | 7.43e-01 |
GOBP RESPONSE TO ACIDIC PH | 12 | 1.63e-01 | -2.33e-01 | 6.45e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 14 | 1.32e-01 | -2.33e-01 | 6.03e-01 |
GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 3.24e-01 | -2.32e-01 | 7.69e-01 |
GOBP RESPONSE TO INTERLEUKIN 12 | 11 | 1.82e-01 | -2.32e-01 | 6.65e-01 |
GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 5 | 3.68e-01 | -2.32e-01 | 7.96e-01 |
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 7 | 2.87e-01 | -2.32e-01 | 7.43e-01 |
GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 3.25e-01 | -2.32e-01 | 7.69e-01 |
GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 7 | 2.88e-01 | -2.32e-01 | 7.43e-01 |
GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 24 | 4.92e-02 | -2.32e-01 | 4.14e-01 |
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 7 | 2.88e-01 | 2.32e-01 | 7.43e-01 |
GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 6 | 3.26e-01 | -2.32e-01 | 7.69e-01 |
GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 10 | 2.04e-01 | -2.32e-01 | 6.85e-01 |
GOBP RESPONSE TO POTASSIUM ION | 12 | 1.65e-01 | -2.32e-01 | 6.47e-01 |
GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 14 | 1.33e-01 | 2.32e-01 | 6.05e-01 |
GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 17 | 9.83e-02 | -2.32e-01 | 5.44e-01 |
GOBP REGULATION OF MAST CELL ACTIVATION | 33 | 2.14e-02 | -2.32e-01 | 3.02e-01 |
GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 3.27e-01 | 2.31e-01 | 7.70e-01 |
GOBP VITAMIN D BIOSYNTHETIC PROCESS | 7 | 2.90e-01 | -2.31e-01 | 7.45e-01 |
GOBP RESPONSE TO OXYGEN RADICAL | 17 | 9.93e-02 | 2.31e-01 | 5.46e-01 |
GOBP NUCLEOTIDE EXCISION REPAIR | 80 | 3.62e-04 | 2.31e-01 | 3.40e-02 |
GOCC SPERM CONNECTING PIECE | 5 | 3.72e-01 | 2.31e-01 | 7.99e-01 |
GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 89 | 1.71e-04 | -2.31e-01 | 2.24e-02 |
GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 8 | 2.59e-01 | -2.31e-01 | 7.24e-01 |
GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 8.20e-02 | 2.31e-01 | 5.08e-01 |
GOBP ASTROCYTE DIFFERENTIATION | 53 | 3.73e-03 | -2.30e-01 | 1.30e-01 |
GOBP LIPID EXPORT FROM CELL | 27 | 3.83e-02 | -2.30e-01 | 3.80e-01 |
GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 28 | 3.51e-02 | -2.30e-01 | 3.68e-01 |
GOBP NEUTROPHIL DIFFERENTIATION | 10 | 2.08e-01 | -2.30e-01 | 6.87e-01 |
GOCC ROUGH ENDOPLASMIC RETICULUM | 46 | 6.96e-03 | -2.30e-01 | 1.78e-01 |
GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 2.92e-01 | 2.30e-01 | 7.46e-01 |
GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 12 | 1.68e-01 | 2.30e-01 | 6.50e-01 |
GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 1.87e-01 | -2.30e-01 | 6.70e-01 |
GOBP ENDODERMAL CELL DIFFERENTIATION | 21 | 6.86e-02 | -2.30e-01 | 4.66e-01 |
GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 7 | 2.93e-01 | 2.30e-01 | 7.47e-01 |
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 24 | 5.16e-02 | -2.30e-01 | 4.19e-01 |
GOBP INTERLEUKIN 18 PRODUCTION | 8 | 2.61e-01 | -2.30e-01 | 7.24e-01 |
GOMF BH3 DOMAIN BINDING | 5 | 3.74e-01 | -2.30e-01 | 7.99e-01 |
GOBP DNA INTEGRATION | 6 | 3.31e-01 | 2.29e-01 | 7.74e-01 |
GOMF PHOSPHOLIPASE A1 ACTIVITY | 11 | 1.88e-01 | 2.29e-01 | 6.72e-01 |
GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 5 | 3.76e-01 | -2.29e-01 | 8.00e-01 |
GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 10 | 2.11e-01 | -2.29e-01 | 6.87e-01 |
GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 10 | 2.11e-01 | 2.28e-01 | 6.87e-01 |
GOCC NPBAF COMPLEX | 14 | 1.39e-01 | 2.28e-01 | 6.11e-01 |
GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 2.36e-01 | 2.28e-01 | 7.10e-01 |
GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 16 | 1.14e-01 | -2.28e-01 | 5.78e-01 |
GOCC EXTRINSIC COMPONENT OF ENDOSOME MEMBRANE | 5 | 3.77e-01 | -2.28e-01 | 8.01e-01 |
GOBP POSITIVE REGULATION OF HEART GROWTH | 12 | 1.72e-01 | -2.28e-01 | 6.55e-01 |
GOBP DETECTION OF OTHER ORGANISM | 16 | 1.14e-01 | 2.28e-01 | 5.78e-01 |
GOBP REGULATION OF DNA DUPLEX UNWINDING | 5 | 3.78e-01 | 2.28e-01 | 8.02e-01 |
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 10 | 2.12e-01 | -2.28e-01 | 6.87e-01 |
GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 3.78e-01 | -2.28e-01 | 8.02e-01 |
GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 7 | 2.97e-01 | 2.28e-01 | 7.49e-01 |
GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 7 | 2.97e-01 | -2.28e-01 | 7.49e-01 |
GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 14 | 1.40e-01 | -2.28e-01 | 6.13e-01 |
GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 11 | 1.91e-01 | -2.28e-01 | 6.74e-01 |
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 12 | 1.72e-01 | -2.28e-01 | 6.55e-01 |
GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 8 | 2.65e-01 | 2.28e-01 | 7.25e-01 |
GOBP AMINO ACID ACTIVATION | 24 | 5.36e-02 | 2.28e-01 | 4.21e-01 |
GOCC NADH DEHYDROGENASE COMPLEX | 47 | 7.00e-03 | -2.27e-01 | 1.78e-01 |
GOCC VESICLE TETHERING COMPLEX | 53 | 4.19e-03 | 2.27e-01 | 1.37e-01 |
GOMF HORMONE RECEPTOR BINDING | 8 | 2.65e-01 | -2.27e-01 | 7.25e-01 |
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 14 | 1.41e-01 | -2.27e-01 | 6.14e-01 |
GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 8 | 2.66e-01 | -2.27e-01 | 7.25e-01 |
GOBP CENTROMERE COMPLEX ASSEMBLY | 25 | 4.95e-02 | 2.27e-01 | 4.14e-01 |
GOMF LIPOPEPTIDE BINDING | 5 | 3.79e-01 | 2.27e-01 | 8.02e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 19 | 8.69e-02 | -2.27e-01 | 5.19e-01 |
GOCC U6 SNRNP | 8 | 2.67e-01 | -2.27e-01 | 7.25e-01 |
GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 9 | 2.39e-01 | 2.27e-01 | 7.12e-01 |
GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 3.80e-01 | 2.27e-01 | 8.02e-01 |
GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 8 | 2.67e-01 | -2.27e-01 | 7.25e-01 |
GOBP REGULATION OF RRNA PROCESSING | 16 | 1.17e-01 | 2.26e-01 | 5.79e-01 |
GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 12 | 1.75e-01 | 2.26e-01 | 6.58e-01 |
GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 6 | 3.38e-01 | 2.26e-01 | 7.80e-01 |
GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 32 | 2.69e-02 | -2.26e-01 | 3.34e-01 |
GOBP ATP BIOSYNTHETIC PROCESS | 91 | 1.97e-04 | -2.26e-01 | 2.37e-02 |
GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 11 | 1.95e-01 | 2.26e-01 | 6.75e-01 |
GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 54 | 4.11e-03 | 2.26e-01 | 1.36e-01 |
GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 6 | 3.38e-01 | -2.26e-01 | 7.80e-01 |
GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 1.95e-01 | -2.26e-01 | 6.75e-01 |
GOMF NARROW PORE CHANNEL ACTIVITY | 6 | 3.38e-01 | 2.26e-01 | 7.80e-01 |
GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 39 | 1.47e-02 | -2.26e-01 | 2.62e-01 |
GOMF RNA POLYMERASE II ACTIVITY | 11 | 1.95e-01 | -2.26e-01 | 6.75e-01 |
GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 7 | 3.01e-01 | -2.26e-01 | 7.52e-01 |
GOBP ASTRAL MICROTUBULE ORGANIZATION | 9 | 2.41e-01 | -2.26e-01 | 7.14e-01 |
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 6 | 3.39e-01 | -2.25e-01 | 7.80e-01 |
GOBP NEUROTRANSMITTER REUPTAKE | 12 | 1.76e-01 | -2.25e-01 | 6.60e-01 |
GOMF CASPASE BINDING | 9 | 2.42e-01 | -2.25e-01 | 7.14e-01 |
GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 8 | 2.70e-01 | -2.25e-01 | 7.28e-01 |
GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 8 | 2.70e-01 | 2.25e-01 | 7.28e-01 |
GOBP MAGNESIUM ION TRANSPORT | 15 | 1.31e-01 | -2.25e-01 | 6.02e-01 |
GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 64 | 1.86e-03 | -2.25e-01 | 8.88e-02 |
GOMF COMPLEMENT BINDING | 9 | 2.42e-01 | -2.25e-01 | 7.14e-01 |
GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 13 | 1.61e-01 | -2.25e-01 | 6.42e-01 |
GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 3.84e-01 | 2.25e-01 | 8.04e-01 |
GOBP DNA TEMPLATED DNA REPLICATION | 139 | 4.98e-06 | 2.25e-01 | 1.50e-03 |
GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 23 | 6.23e-02 | -2.25e-01 | 4.44e-01 |
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 3.41e-01 | -2.25e-01 | 7.81e-01 |
GOMF ELECTRON TRANSFER ACTIVITY | 100 | 1.07e-04 | -2.24e-01 | 1.53e-02 |
GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 8 | 2.72e-01 | -2.24e-01 | 7.29e-01 |
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 1.33e-01 | 2.24e-01 | 6.04e-01 |
GOBP REGULATION OF GTP BINDING | 9 | 2.44e-01 | 2.24e-01 | 7.14e-01 |
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 15 | 1.33e-01 | -2.24e-01 | 6.04e-01 |
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 9 | 2.44e-01 | -2.24e-01 | 7.14e-01 |
GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 5 | 3.85e-01 | -2.24e-01 | 8.05e-01 |
GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 20 | 8.28e-02 | -2.24e-01 | 5.10e-01 |
GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 26 | 4.81e-02 | 2.24e-01 | 4.12e-01 |
GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 1.10e-01 | 2.24e-01 | 5.69e-01 |
GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 14 | 1.47e-01 | 2.24e-01 | 6.23e-01 |
GOBP TOLL SIGNALING PATHWAY | 10 | 2.20e-01 | -2.24e-01 | 6.97e-01 |
GOCC SPLICEOSOMAL SNRNP COMPLEX | 65 | 1.82e-03 | -2.24e-01 | 8.78e-02 |
GOCC BCL 2 FAMILY PROTEIN COMPLEX | 9 | 2.45e-01 | -2.24e-01 | 7.14e-01 |
GOBP HEME TRANSPORT | 6 | 3.43e-01 | 2.24e-01 | 7.82e-01 |
GOBP IRON COORDINATION ENTITY TRANSPORT | 6 | 3.43e-01 | 2.24e-01 | 7.82e-01 |
GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.43e-01 | 2.24e-01 | 7.82e-01 |
GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 6 | 3.43e-01 | 2.24e-01 | 7.82e-01 |
GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 15 | 1.34e-01 | -2.23e-01 | 6.05e-01 |
GOBP INFLAMMATORY RESPONSE TO WOUNDING | 21 | 7.65e-02 | -2.23e-01 | 4.94e-01 |
GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 9 | 2.46e-01 | -2.23e-01 | 7.15e-01 |
GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 5 | 3.87e-01 | -2.23e-01 | 8.06e-01 |
GOBP CELL PROLIFERATION IN FOREBRAIN | 12 | 1.81e-01 | 2.23e-01 | 6.64e-01 |
GOBP COLLAGEN FIBRIL ORGANIZATION | 23 | 6.39e-02 | 2.23e-01 | 4.53e-01 |
GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 1.64e-01 | 2.23e-01 | 6.46e-01 |
GOBP POSITIVE REGULATION OF DNA BINDING | 29 | 3.76e-02 | -2.23e-01 | 3.79e-01 |
GOBP SPHINGOMYELIN CATABOLIC PROCESS | 6 | 3.44e-01 | -2.23e-01 | 7.83e-01 |
GOBP SNRNA CATABOLIC PROCESS | 5 | 3.88e-01 | 2.23e-01 | 8.06e-01 |
GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 7 | 3.07e-01 | 2.23e-01 | 7.57e-01 |
GOBP NUCLEAR BODY ORGANIZATION | 12 | 1.82e-01 | -2.23e-01 | 6.65e-01 |
GOBP TRNA MODIFICATION | 89 | 2.86e-04 | 2.23e-01 | 2.88e-02 |
GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 18 | 1.02e-01 | -2.23e-01 | 5.50e-01 |
GOBP AZOLE TRANSMEMBRANE TRANSPORT | 7 | 3.08e-01 | -2.23e-01 | 7.58e-01 |
GOBP TONGUE DEVELOPMENT | 6 | 3.45e-01 | 2.23e-01 | 7.83e-01 |
GOBP RESPONSE TO INTERLEUKIN 9 | 6 | 3.45e-01 | 2.23e-01 | 7.83e-01 |
GOMF COLLAGEN BINDING | 33 | 2.70e-02 | -2.23e-01 | 3.34e-01 |
GOBP INNER DYNEIN ARM ASSEMBLY | 6 | 3.45e-01 | 2.22e-01 | 7.83e-01 |
GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 5 | 3.89e-01 | -2.22e-01 | 8.07e-01 |
GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 6 | 3.46e-01 | 2.22e-01 | 7.83e-01 |
GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 20 | 8.53e-02 | 2.22e-01 | 5.17e-01 |
GOBP MITOCHONDRIAL TRANSCRIPTION | 18 | 1.03e-01 | 2.22e-01 | 5.52e-01 |
GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 13 | 1.65e-01 | -2.22e-01 | 6.48e-01 |
GOBP SPERMINE METABOLIC PROCESS | 5 | 3.90e-01 | -2.22e-01 | 8.08e-01 |
GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 12 | 1.83e-01 | -2.22e-01 | 6.66e-01 |
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 13 | 1.66e-01 | -2.22e-01 | 6.48e-01 |
GOBP REGULATION OF MICROVILLUS ORGANIZATION | 7 | 3.09e-01 | -2.22e-01 | 7.58e-01 |
GOBP COLLATERAL SPROUTING | 13 | 1.66e-01 | -2.22e-01 | 6.49e-01 |
GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 39 | 1.65e-02 | -2.22e-01 | 2.73e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 8 | 2.77e-01 | 2.22e-01 | 7.35e-01 |
GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 3.10e-01 | -2.22e-01 | 7.58e-01 |
GOCC PAR POLARITY COMPLEX | 6 | 3.47e-01 | 2.22e-01 | 7.85e-01 |
GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 10 | 2.25e-01 | -2.22e-01 | 7.02e-01 |
GOBP ADENINE TRANSPORT | 5 | 3.91e-01 | -2.21e-01 | 8.09e-01 |
GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 21 | 7.93e-02 | 2.21e-01 | 5.03e-01 |
GOCC ACTIVIN RECEPTOR COMPLEX | 5 | 3.92e-01 | -2.21e-01 | 8.09e-01 |
GOBP MACROPINOCYTOSIS | 9 | 2.50e-01 | -2.21e-01 | 7.19e-01 |
GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 29 | 3.93e-02 | 2.21e-01 | 3.82e-01 |
GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 6 | 3.49e-01 | 2.21e-01 | 7.86e-01 |
GOMF MHC CLASS I RECEPTOR ACTIVITY | 11 | 2.05e-01 | -2.21e-01 | 6.85e-01 |
GOBP REGULATION OF GOLGI ORGANIZATION | 15 | 1.39e-01 | 2.21e-01 | 6.10e-01 |
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 12 | 1.85e-01 | 2.21e-01 | 6.69e-01 |
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 9 | 2.52e-01 | -2.21e-01 | 7.20e-01 |
GOBP PLATELET AGGREGATION | 48 | 8.22e-03 | -2.21e-01 | 1.90e-01 |
GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 2.80e-01 | 2.21e-01 | 7.37e-01 |
GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 3.94e-01 | 2.20e-01 | 8.11e-01 |
GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 18 | 1.06e-01 | -2.20e-01 | 5.57e-01 |
GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 15 | 1.40e-01 | 2.20e-01 | 6.12e-01 |
GOBP REGULATION OF CENTRIOLE REPLICATION | 21 | 8.09e-02 | 2.20e-01 | 5.08e-01 |
GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 84 | 4.96e-04 | -2.20e-01 | 4.32e-02 |
GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 104 | 1.09e-04 | 2.20e-01 | 1.53e-02 |
GOCC KATANIN COMPLEX | 5 | 3.95e-01 | 2.20e-01 | 8.12e-01 |
GOMF SNORNA BINDING | 32 | 3.16e-02 | 2.20e-01 | 3.53e-01 |
GOMF FERROUS IRON BINDING | 20 | 8.91e-02 | 2.20e-01 | 5.21e-01 |
GOCC SWI SNF COMPLEX | 28 | 4.43e-02 | 2.20e-01 | 3.98e-01 |
GOCC PRE SNORNP COMPLEX | 7 | 3.14e-01 | 2.20e-01 | 7.64e-01 |
GOBP HINDLIMB MORPHOGENESIS | 13 | 1.71e-01 | -2.20e-01 | 6.54e-01 |
GOCC MITOTIC SPINDLE MIDZONE | 9 | 2.54e-01 | 2.19e-01 | 7.22e-01 |
GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 16 | 1.29e-01 | 2.19e-01 | 5.99e-01 |
GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 9 | 2.55e-01 | -2.19e-01 | 7.23e-01 |
GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 9 | 2.55e-01 | -2.19e-01 | 7.23e-01 |
GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 21 | 8.23e-02 | -2.19e-01 | 5.08e-01 |
GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 11 | 2.09e-01 | 2.19e-01 | 6.87e-01 |
GOBP URONIC ACID METABOLIC PROCESS | 7 | 3.16e-01 | 2.19e-01 | 7.64e-01 |
GOCC SPECTRIN | 5 | 3.97e-01 | 2.19e-01 | 8.12e-01 |
GOBP ERBB4 SIGNALING PATHWAY | 6 | 3.54e-01 | 2.19e-01 | 7.89e-01 |
GOMF ICOSANOID RECEPTOR ACTIVITY | 9 | 2.56e-01 | -2.19e-01 | 7.24e-01 |
GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 6 | 3.54e-01 | 2.19e-01 | 7.89e-01 |
GOMF HYDRO LYASE ACTIVITY | 40 | 1.69e-02 | 2.18e-01 | 2.76e-01 |
GOCC GOLGI LUMEN | 29 | 4.19e-02 | -2.18e-01 | 3.87e-01 |
GOBP SULFATE TRANSPORT | 9 | 2.57e-01 | -2.18e-01 | 7.24e-01 |
GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 5 | 3.98e-01 | -2.18e-01 | 8.13e-01 |
GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 3.55e-01 | -2.18e-01 | 7.90e-01 |
GOBP HISTONE H4 ACETYLATION | 12 | 1.91e-01 | -2.18e-01 | 6.74e-01 |
GOBP CELLULAR HYPOTONIC RESPONSE | 7 | 3.18e-01 | -2.18e-01 | 7.65e-01 |
GOBP HYPOTONIC RESPONSE | 7 | 3.18e-01 | -2.18e-01 | 7.65e-01 |
GOBP PROTEIN K11 LINKED UBIQUITINATION | 27 | 4.98e-02 | -2.18e-01 | 4.14e-01 |
GOBP INTRACELLULAR STEROL TRANSPORT | 27 | 5.00e-02 | -2.18e-01 | 4.14e-01 |
GOBP THYMIC T CELL SELECTION | 18 | 1.09e-01 | 2.18e-01 | 5.68e-01 |
GOBP LINOLEIC ACID METABOLIC PROCESS | 9 | 2.58e-01 | -2.18e-01 | 7.24e-01 |
GOBP CELL DIFFERENTIATION IN HINDBRAIN | 11 | 2.11e-01 | 2.18e-01 | 6.87e-01 |
GOMF MYOSIN V BINDING | 10 | 2.33e-01 | 2.18e-01 | 7.08e-01 |
GOCC NUCLEAR LAMINA | 11 | 2.11e-01 | 2.18e-01 | 6.87e-01 |
GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 36 | 2.39e-02 | -2.18e-01 | 3.16e-01 |
GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 8 | 2.87e-01 | 2.18e-01 | 7.43e-01 |
GOMF LAMIN BINDING | 14 | 1.59e-01 | -2.17e-01 | 6.41e-01 |
GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 12 | 1.92e-01 | 2.17e-01 | 6.75e-01 |
GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 9 | 2.59e-01 | -2.17e-01 | 7.24e-01 |
GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 5 | 4.01e-01 | -2.17e-01 | 8.15e-01 |
GOBP SIGNAL PEPTIDE PROCESSING | 13 | 1.76e-01 | -2.17e-01 | 6.60e-01 |
GOBP SPINDLE ELONGATION | 8 | 2.89e-01 | 2.17e-01 | 7.44e-01 |
GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 96 | 2.48e-04 | -2.17e-01 | 2.75e-02 |
GOMF HELICASE ACTIVITY | 134 | 1.54e-05 | 2.17e-01 | 3.50e-03 |
GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 9 | 2.61e-01 | -2.17e-01 | 7.24e-01 |
GOCC ENZYME ACTIVATOR COMPLEX | 16 | 1.34e-01 | -2.17e-01 | 6.05e-01 |
GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 41 | 1.65e-02 | 2.16e-01 | 2.73e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 26 | 5.63e-02 | -2.16e-01 | 4.28e-01 |
GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 11 | 2.14e-01 | -2.16e-01 | 6.89e-01 |
GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 12 | 1.95e-01 | 2.16e-01 | 6.75e-01 |
GOBP OTIC VESICLE DEVELOPMENT | 5 | 4.02e-01 | 2.16e-01 | 8.15e-01 |
GOBP RESPONSE TO PAIN | 12 | 1.95e-01 | -2.16e-01 | 6.75e-01 |
GOBP REGULATION OF DNA LIGATION | 6 | 3.59e-01 | 2.16e-01 | 7.92e-01 |
GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 21 | 8.65e-02 | -2.16e-01 | 5.19e-01 |
GOMF LNCRNA BINDING | 11 | 2.15e-01 | -2.16e-01 | 6.90e-01 |
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 6 | 3.60e-01 | 2.16e-01 | 7.92e-01 |
GOBP HEMOGLOBIN METABOLIC PROCESS | 10 | 2.37e-01 | -2.16e-01 | 7.11e-01 |
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 12 | 1.95e-01 | 2.16e-01 | 6.75e-01 |
GOBP COPII COATED VESICLE CARGO LOADING | 16 | 1.35e-01 | -2.16e-01 | 6.05e-01 |
GOBP REGULATION OF MITOPHAGY | 13 | 1.78e-01 | -2.16e-01 | 6.61e-01 |
GOBP NON LYTIC VIRAL RELEASE | 13 | 1.78e-01 | -2.16e-01 | 6.61e-01 |
GOBP MITRAL VALVE DEVELOPMENT | 8 | 2.91e-01 | -2.16e-01 | 7.46e-01 |
GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 8 | 2.91e-01 | -2.16e-01 | 7.46e-01 |
GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 1.63e-01 | -2.15e-01 | 6.45e-01 |
GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 3.61e-01 | 2.15e-01 | 7.92e-01 |
GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 16 | 1.36e-01 | -2.15e-01 | 6.06e-01 |
GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 14 | 1.63e-01 | -2.15e-01 | 6.45e-01 |
GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 10 | 2.38e-01 | 2.15e-01 | 7.11e-01 |
GOBP CELLULAR RESPONSE TO ATP | 13 | 1.79e-01 | -2.15e-01 | 6.62e-01 |
GOBP COPII COATED VESICLE BUDDING | 41 | 1.71e-02 | -2.15e-01 | 2.77e-01 |
GOBP REGULATION OF MEMBRANE INVAGINATION | 11 | 2.16e-01 | 2.15e-01 | 6.92e-01 |
GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 6 | 3.62e-01 | 2.15e-01 | 7.92e-01 |
GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 13 | 1.80e-01 | 2.15e-01 | 6.62e-01 |
GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 12 | 1.98e-01 | 2.15e-01 | 6.78e-01 |
GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 12 | 1.98e-01 | -2.15e-01 | 6.79e-01 |
GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 6 | 3.63e-01 | -2.15e-01 | 7.94e-01 |
GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 7 | 3.26e-01 | -2.15e-01 | 7.69e-01 |
GOBP FOCAL ADHESION ASSEMBLY | 59 | 4.39e-03 | -2.15e-01 | 1.39e-01 |
GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 23 | 7.51e-02 | -2.14e-01 | 4.89e-01 |
GOBP REGULATION OF NK T CELL PROLIFERATION | 7 | 3.26e-01 | -2.14e-01 | 7.69e-01 |
GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 8 | 2.94e-01 | 2.14e-01 | 7.48e-01 |
GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 5 | 4.06e-01 | -2.14e-01 | 8.17e-01 |
GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 20 | 9.71e-02 | -2.14e-01 | 5.40e-01 |
GOCC AMPHISOME | 12 | 1.99e-01 | -2.14e-01 | 6.79e-01 |
GOBP SNRNA TRANSCRIPTION | 17 | 1.26e-01 | 2.14e-01 | 5.94e-01 |
GOCC INO80 COMPLEX | 15 | 1.51e-01 | -2.14e-01 | 6.29e-01 |
GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 6 | 3.64e-01 | -2.14e-01 | 7.95e-01 |
GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY | 5 | 4.07e-01 | 2.14e-01 | 8.17e-01 |
GOBP RESPONSE TO HYDROXYUREA | 10 | 2.41e-01 | -2.14e-01 | 7.14e-01 |
GOBP ELASTIN METABOLIC PROCESS | 6 | 3.65e-01 | -2.14e-01 | 7.95e-01 |
GOBP LIVER MORPHOGENESIS | 14 | 1.67e-01 | -2.14e-01 | 6.49e-01 |
GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 19 | 1.07e-01 | -2.13e-01 | 5.63e-01 |
GOBP REGULATION OF HEAT GENERATION | 8 | 2.96e-01 | -2.13e-01 | 7.49e-01 |
GOMF POLYSACCHARIDE BINDING | 12 | 2.01e-01 | -2.13e-01 | 6.80e-01 |
GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 5 | 4.09e-01 | -2.13e-01 | 8.17e-01 |
GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 9 | 2.68e-01 | -2.13e-01 | 7.25e-01 |
GOBP REGULATION OF VIRAL TRANSCRIPTION | 16 | 1.40e-01 | 2.13e-01 | 6.13e-01 |
GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 14 | 1.68e-01 | 2.13e-01 | 6.50e-01 |
GOBP PARTURITION | 6 | 3.66e-01 | 2.13e-01 | 7.96e-01 |
GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 2.97e-01 | 2.13e-01 | 7.49e-01 |
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 37 | 2.52e-02 | -2.13e-01 | 3.25e-01 |
GOBP T HELPER CELL LINEAGE COMMITMENT | 18 | 1.18e-01 | -2.13e-01 | 5.82e-01 |
GOBP MITOPHAGY | 34 | 3.19e-02 | -2.13e-01 | 3.55e-01 |
GOCC TRANSCRIPTION REPRESSOR COMPLEX | 61 | 4.10e-03 | -2.13e-01 | 1.36e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 21 | 9.17e-02 | -2.13e-01 | 5.26e-01 |
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 26 | 6.07e-02 | 2.13e-01 | 4.39e-01 |
GOBP PROTEIN NEDDYLATION | 27 | 5.60e-02 | -2.13e-01 | 4.27e-01 |
GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 89 | 5.42e-04 | -2.12e-01 | 4.45e-02 |
GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 17 | 1.30e-01 | -2.12e-01 | 6.00e-01 |
GOCC INNER KINETOCHORE | 15 | 1.55e-01 | 2.12e-01 | 6.36e-01 |
GOBP RRNA TRANSCRIPTION | 32 | 3.81e-02 | 2.12e-01 | 3.80e-01 |
GOBP PROTEIN K29 LINKED UBIQUITINATION | 5 | 4.12e-01 | -2.12e-01 | 8.21e-01 |
GOBP ICOSANOID SECRETION | 18 | 1.20e-01 | -2.12e-01 | 5.82e-01 |
GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 9 | 2.71e-01 | -2.12e-01 | 7.29e-01 |
GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 13 | 1.86e-01 | -2.12e-01 | 6.70e-01 |
GOBP ENDOTHELIAL CELL CHEMOTAXIS | 15 | 1.56e-01 | -2.12e-01 | 6.38e-01 |
GOBP ENDOTHELIAL CELL ACTIVATION | 7 | 3.32e-01 | 2.12e-01 | 7.76e-01 |
GOBP VESICLE BUDDING FROM MEMBRANE | 76 | 1.44e-03 | -2.12e-01 | 7.76e-02 |
GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION | 5 | 4.13e-01 | 2.11e-01 | 8.21e-01 |
GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 8 | 3.00e-01 | 2.11e-01 | 7.52e-01 |
GOBP RESPONSE TO PROTOZOAN | 23 | 7.93e-02 | -2.11e-01 | 5.03e-01 |
GOBP DIOL BIOSYNTHETIC PROCESS | 15 | 1.56e-01 | 2.11e-01 | 6.39e-01 |
GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 28 | 5.30e-02 | -2.11e-01 | 4.19e-01 |
GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 7 | 3.33e-01 | 2.11e-01 | 7.76e-01 |
GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 13 | 1.87e-01 | -2.11e-01 | 6.70e-01 |
GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 6 | 3.70e-01 | -2.11e-01 | 7.98e-01 |
GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 9 | 2.73e-01 | -2.11e-01 | 7.29e-01 |
GOBP HYALURONAN BIOSYNTHETIC PROCESS | 8 | 3.01e-01 | -2.11e-01 | 7.52e-01 |
GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 10 | 2.48e-01 | 2.11e-01 | 7.17e-01 |
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 21 | 9.41e-02 | 2.11e-01 | 5.32e-01 |
GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 6 | 3.71e-01 | 2.11e-01 | 7.98e-01 |
GOBP LATERAL VENTRICLE DEVELOPMENT | 6 | 3.71e-01 | -2.11e-01 | 7.98e-01 |
GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 10 | 2.48e-01 | -2.11e-01 | 7.17e-01 |
GOCC CHROMOCENTER | 9 | 2.73e-01 | 2.11e-01 | 7.30e-01 |
GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 5 | 4.14e-01 | 2.11e-01 | 8.21e-01 |
GOBP POLYKETIDE METABOLIC PROCESS | 5 | 4.14e-01 | 2.11e-01 | 8.21e-01 |
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 15 | 1.58e-01 | -2.11e-01 | 6.39e-01 |
GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 25 | 6.84e-02 | -2.11e-01 | 4.66e-01 |
GOMF LIPOPROTEIN LIPASE ACTIVITY | 5 | 4.15e-01 | -2.11e-01 | 8.21e-01 |
GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 6 | 3.72e-01 | 2.10e-01 | 7.99e-01 |
GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 4.15e-01 | -2.10e-01 | 8.21e-01 |
GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 108 | 1.61e-04 | -2.10e-01 | 2.16e-02 |
GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 5 | 4.15e-01 | -2.10e-01 | 8.21e-01 |
GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 16 | 1.45e-01 | 2.10e-01 | 6.21e-01 |
GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.15e-01 | 2.10e-01 | 8.21e-01 |
GOMF MICROTUBULE MINUS END BINDING | 13 | 1.89e-01 | 2.10e-01 | 6.73e-01 |
GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY | 7 | 3.36e-01 | -2.10e-01 | 7.79e-01 |
GOBP LONG TERM SYNAPTIC DEPRESSION | 15 | 1.59e-01 | -2.10e-01 | 6.40e-01 |
GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 17 | 1.34e-01 | -2.10e-01 | 6.05e-01 |
GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 17 | 1.34e-01 | -2.10e-01 | 6.05e-01 |
GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 4.16e-01 | 2.10e-01 | 8.21e-01 |
GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 3.36e-01 | 2.10e-01 | 7.79e-01 |
GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 9 | 2.76e-01 | 2.10e-01 | 7.33e-01 |
GOBP ISG15 PROTEIN CONJUGATION | 6 | 3.73e-01 | 2.10e-01 | 7.99e-01 |
GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 3.74e-01 | 2.10e-01 | 7.99e-01 |
GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 9 | 2.76e-01 | -2.10e-01 | 7.34e-01 |
GOMF G PROTEIN ALPHA SUBUNIT BINDING | 20 | 1.05e-01 | 2.10e-01 | 5.56e-01 |
GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 143 | 1.57e-05 | -2.10e-01 | 3.50e-03 |
GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 9 | 2.77e-01 | -2.09e-01 | 7.35e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 6 | 3.75e-01 | 2.09e-01 | 8.00e-01 |
GOMF PHOSPHATIDYLCHOLINE FLIPPASE ACTIVITY | 5 | 4.18e-01 | -2.09e-01 | 8.21e-01 |
GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 20 | 1.05e-01 | 2.09e-01 | 5.56e-01 |
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 7 | 3.38e-01 | -2.09e-01 | 7.80e-01 |
GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 12 | 2.10e-01 | -2.09e-01 | 6.87e-01 |
GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 9 | 2.77e-01 | 2.09e-01 | 7.35e-01 |
GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 17 | 1.36e-01 | -2.09e-01 | 6.06e-01 |
GOCC TRAPPII PROTEIN COMPLEX | 11 | 2.30e-01 | -2.09e-01 | 7.03e-01 |
GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 9 | 2.78e-01 | -2.09e-01 | 7.35e-01 |
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 6 | 3.75e-01 | -2.09e-01 | 8.00e-01 |
GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 5 | 4.18e-01 | 2.09e-01 | 8.21e-01 |
GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 6 | 3.76e-01 | -2.09e-01 | 8.00e-01 |
GOBP CATECHOLAMINE UPTAKE | 6 | 3.76e-01 | -2.09e-01 | 8.00e-01 |
GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 5 | 4.19e-01 | 2.09e-01 | 8.22e-01 |
GOBP NEUROTROPHIN SIGNALING PATHWAY | 23 | 8.33e-02 | -2.09e-01 | 5.10e-01 |
GOBP TRACHEA DEVELOPMENT | 12 | 2.11e-01 | -2.09e-01 | 6.87e-01 |
GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 13 | 1.93e-01 | -2.09e-01 | 6.75e-01 |
GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 35 | 3.28e-02 | 2.09e-01 | 3.58e-01 |
GOBP REGULATION OF APPETITE | 8 | 3.07e-01 | -2.08e-01 | 7.57e-01 |
GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 25 | 7.13e-02 | 2.08e-01 | 4.75e-01 |
GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 25 | 7.15e-02 | -2.08e-01 | 4.76e-01 |
GOBP SNRNA TRANSPORT | 6 | 3.77e-01 | 2.08e-01 | 8.01e-01 |
GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 9 | 2.80e-01 | -2.08e-01 | 7.37e-01 |
GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 82 | 1.14e-03 | -2.08e-01 | 6.86e-02 |
GOBP INTESTINAL CHOLESTEROL ABSORPTION | 5 | 4.20e-01 | -2.08e-01 | 8.23e-01 |
GOBP LIPID DIGESTION | 5 | 4.20e-01 | -2.08e-01 | 8.23e-01 |
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 41 | 2.14e-02 | -2.08e-01 | 3.02e-01 |
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 23 | 8.46e-02 | -2.08e-01 | 5.15e-01 |
GOMF DENEDDYLASE ACTIVITY | 5 | 4.22e-01 | -2.08e-01 | 8.23e-01 |
GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 3.42e-01 | 2.08e-01 | 7.82e-01 |
GOBP PURINE RIBONUCLEOSIDE SALVAGE | 7 | 3.42e-01 | -2.07e-01 | 7.82e-01 |
GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 4.22e-01 | 2.07e-01 | 8.23e-01 |
GOCC DOPAMINERGIC SYNAPSE | 6 | 3.79e-01 | -2.07e-01 | 8.02e-01 |
GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 11 | 2.34e-01 | -2.07e-01 | 7.08e-01 |
GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 28 | 5.77e-02 | 2.07e-01 | 4.31e-01 |
GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 9 | 2.82e-01 | 2.07e-01 | 7.38e-01 |
GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 8 | 3.10e-01 | 2.07e-01 | 7.59e-01 |
GOBP REGULATION OF DNA CATABOLIC PROCESS | 9 | 2.82e-01 | 2.07e-01 | 7.38e-01 |
GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS | 5 | 4.23e-01 | 2.07e-01 | 8.23e-01 |
GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 6 | 3.80e-01 | 2.07e-01 | 8.02e-01 |
GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 4.23e-01 | -2.07e-01 | 8.23e-01 |
GOBP HISTONE H4 K16 ACETYLATION | 7 | 3.43e-01 | -2.07e-01 | 7.82e-01 |
GOBP GMP BIOSYNTHETIC PROCESS | 13 | 1.96e-01 | 2.07e-01 | 6.76e-01 |
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 33 | 3.97e-02 | -2.07e-01 | 3.83e-01 |
GOBP RRNA MODIFICATION | 30 | 4.98e-02 | 2.07e-01 | 4.14e-01 |
GOBP HYPOTHALAMUS CELL DIFFERENTIATION | 5 | 4.23e-01 | -2.07e-01 | 8.23e-01 |
GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION | 5 | 4.23e-01 | -2.07e-01 | 8.23e-01 |
GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 25 | 7.34e-02 | 2.07e-01 | 4.83e-01 |
GOBP IMMATURE B CELL DIFFERENTIATION | 9 | 2.83e-01 | -2.07e-01 | 7.39e-01 |
GOBP CELLULAR RESPONSE TO FATTY ACID | 20 | 1.09e-01 | -2.07e-01 | 5.68e-01 |
GOBP DOPAMINE METABOLIC PROCESS | 17 | 1.40e-01 | 2.07e-01 | 6.13e-01 |
GOBP MICROTUBULE SEVERING | 7 | 3.44e-01 | 2.07e-01 | 7.82e-01 |
GOBP ACTIN FILAMENT SEVERING | 14 | 1.81e-01 | -2.07e-01 | 6.64e-01 |
GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 12 | 2.16e-01 | -2.06e-01 | 6.91e-01 |
GOBP TRNA METABOLIC PROCESS | 170 | 3.66e-06 | 2.06e-01 | 1.29e-03 |
GOCC OMEGASOME | 5 | 4.25e-01 | -2.06e-01 | 8.23e-01 |
GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 3.13e-01 | 2.06e-01 | 7.62e-01 |
GOBP PROSTAGLANDIN TRANSPORT | 13 | 1.98e-01 | -2.06e-01 | 6.79e-01 |
GOMF FATTY ACID BINDING | 23 | 8.71e-02 | -2.06e-01 | 5.19e-01 |
GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 15 | 1.67e-01 | 2.06e-01 | 6.49e-01 |
GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION | 5 | 4.25e-01 | -2.06e-01 | 8.23e-01 |
GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 18 | 1.30e-01 | -2.06e-01 | 6.01e-01 |
GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 2.60e-01 | -2.06e-01 | 7.24e-01 |
GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 107 | 2.37e-04 | -2.06e-01 | 2.69e-02 |
GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 24 | 8.11e-02 | -2.06e-01 | 5.08e-01 |
GOBP CONVERGENT EXTENSION | 6 | 3.83e-01 | 2.06e-01 | 8.03e-01 |
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 28 | 5.97e-02 | -2.06e-01 | 4.36e-01 |
GOMF ALPHA CATENIN BINDING | 6 | 3.83e-01 | 2.06e-01 | 8.03e-01 |
GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 4.26e-01 | 2.05e-01 | 8.23e-01 |
GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 14 | 1.83e-01 | -2.05e-01 | 6.67e-01 |
GOMF PRE MRNA BINDING | 30 | 5.19e-02 | -2.05e-01 | 4.19e-01 |
GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 10 | 2.62e-01 | -2.05e-01 | 7.24e-01 |
GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 30 | 5.20e-02 | 2.05e-01 | 4.19e-01 |
GOBP REGULATION OF LIPID LOCALIZATION | 99 | 4.32e-04 | -2.05e-01 | 3.97e-02 |
GOBP TRACHEA MORPHOGENESIS | 7 | 3.48e-01 | -2.05e-01 | 7.86e-01 |
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 5 | 4.28e-01 | -2.05e-01 | 8.24e-01 |
GOBP POSITIVE REGULATION OF URINE VOLUME | 5 | 4.28e-01 | 2.05e-01 | 8.24e-01 |
GOMF HISTONE READER ACTIVITY | 11 | 2.39e-01 | 2.05e-01 | 7.13e-01 |
GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 6 | 3.85e-01 | -2.05e-01 | 8.04e-01 |
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 3.48e-01 | -2.05e-01 | 7.86e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 21 | 1.04e-01 | -2.05e-01 | 5.56e-01 |
GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 6 | 3.85e-01 | -2.05e-01 | 8.04e-01 |
GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 48 | 1.42e-02 | -2.05e-01 | 2.60e-01 |
GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 19 | 1.23e-01 | -2.05e-01 | 5.87e-01 |
GOBP SLEEP | 11 | 2.40e-01 | -2.05e-01 | 7.13e-01 |
GOBP BONE MARROW DEVELOPMENT | 6 | 3.86e-01 | -2.05e-01 | 8.05e-01 |
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 22 | 9.70e-02 | -2.04e-01 | 5.40e-01 |
GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 10 | 2.63e-01 | -2.04e-01 | 7.25e-01 |
GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 14 | 1.86e-01 | 2.04e-01 | 6.69e-01 |
GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 4.29e-01 | -2.04e-01 | 8.25e-01 |
GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 7 | 3.50e-01 | -2.04e-01 | 7.86e-01 |
GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 30 | 5.31e-02 | 2.04e-01 | 4.20e-01 |
GOBP CHROMATIN LOOPING | 11 | 2.41e-01 | -2.04e-01 | 7.14e-01 |
GOBP BRANCH ELONGATION OF AN EPITHELIUM | 5 | 4.30e-01 | -2.04e-01 | 8.25e-01 |
GOBP BASE EXCISION REPAIR GAP FILLING | 13 | 2.03e-01 | 2.04e-01 | 6.85e-01 |
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 32 | 4.60e-02 | 2.04e-01 | 4.02e-01 |
GOMF HYALURONIC ACID BINDING | 10 | 2.64e-01 | 2.04e-01 | 7.25e-01 |
GOMF MYOSIN II BINDING | 7 | 3.50e-01 | 2.04e-01 | 7.86e-01 |
GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 13 | 2.03e-01 | -2.04e-01 | 6.85e-01 |
GOBP REGULATION OF ENDOCYTIC RECYCLING | 13 | 2.03e-01 | -2.04e-01 | 6.85e-01 |
GOBP REGULATION OF POSITIVE CHEMOTAXIS | 12 | 2.22e-01 | -2.04e-01 | 6.99e-01 |
GOBP RETICULOPHAGY | 16 | 1.58e-01 | -2.04e-01 | 6.39e-01 |
GOBP MECHANOSENSORY BEHAVIOR | 5 | 4.30e-01 | -2.04e-01 | 8.25e-01 |
GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 11 | 2.42e-01 | 2.04e-01 | 7.14e-01 |
GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 9 | 2.90e-01 | -2.04e-01 | 7.45e-01 |
GOBP NOSE DEVELOPMENT | 5 | 4.31e-01 | 2.04e-01 | 8.25e-01 |
GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 4.31e-01 | -2.04e-01 | 8.25e-01 |
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE | 5 | 4.31e-01 | 2.04e-01 | 8.25e-01 |
GOCC VARICOSITY | 5 | 4.31e-01 | -2.04e-01 | 8.25e-01 |
GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 6 | 3.88e-01 | -2.04e-01 | 8.06e-01 |
GOBP BLEB ASSEMBLY | 8 | 3.19e-01 | -2.03e-01 | 7.67e-01 |
GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 71 | 3.06e-03 | -2.03e-01 | 1.14e-01 |
GOMF HEXOSAMINIDASE ACTIVITY | 11 | 2.43e-01 | 2.03e-01 | 7.14e-01 |
GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 11 | 2.43e-01 | 2.03e-01 | 7.14e-01 |
GOBP DERMATAN SULFATE METABOLIC PROCESS | 8 | 3.19e-01 | -2.03e-01 | 7.67e-01 |
GOMF INTERLEUKIN 1 BINDING | 6 | 3.89e-01 | 2.03e-01 | 8.07e-01 |
GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 19 | 1.25e-01 | 2.03e-01 | 5.91e-01 |
GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 8 | 3.20e-01 | 2.03e-01 | 7.68e-01 |
GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 18 | 1.36e-01 | 2.03e-01 | 6.07e-01 |
GOBP MAMMALIAN OOGENESIS STAGE | 7 | 3.52e-01 | -2.03e-01 | 7.88e-01 |
GOBP POSITIVE REGULATION OF WOUND HEALING | 32 | 4.71e-02 | -2.03e-01 | 4.08e-01 |
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 9 | 2.93e-01 | -2.02e-01 | 7.47e-01 |
GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 16 | 1.61e-01 | -2.02e-01 | 6.42e-01 |
GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 18 | 1.37e-01 | 2.02e-01 | 6.08e-01 |
GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 9 | 2.94e-01 | 2.02e-01 | 7.48e-01 |
GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS | 5 | 4.34e-01 | -2.02e-01 | 8.27e-01 |
GOBP RENAL VESICLE DEVELOPMENT | 5 | 4.34e-01 | -2.02e-01 | 8.27e-01 |
GOBP POSITIVE REGULATION OF TORC2 SIGNALING | 5 | 4.34e-01 | 2.02e-01 | 8.27e-01 |
GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 7 | 3.55e-01 | -2.02e-01 | 7.90e-01 |
GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 26 | 7.49e-02 | 2.02e-01 | 4.89e-01 |
GOCC CILIARY TRANSITION FIBER | 7 | 3.55e-01 | 2.02e-01 | 7.90e-01 |
GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 6 | 3.92e-01 | 2.02e-01 | 8.10e-01 |
GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 8 | 3.23e-01 | -2.02e-01 | 7.69e-01 |
GOCC LAMELLIPODIUM MEMBRANE | 14 | 1.92e-01 | -2.02e-01 | 6.75e-01 |
GOBP CENTROSOME DUPLICATION | 67 | 4.37e-03 | 2.02e-01 | 1.39e-01 |
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 25 | 8.13e-02 | -2.01e-01 | 5.08e-01 |
GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 3.24e-01 | 2.01e-01 | 7.69e-01 |
GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 112 | 2.36e-04 | -2.01e-01 | 2.69e-02 |
GOBP GLYCOLIPID TRANSPORT | 7 | 3.57e-01 | 2.01e-01 | 7.91e-01 |
GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 14 | 1.93e-01 | 2.01e-01 | 6.75e-01 |
GOBP REGULATION OF SODIUM ION TRANSPORT | 43 | 2.27e-02 | -2.01e-01 | 3.08e-01 |
GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 33 | 4.60e-02 | -2.01e-01 | 4.02e-01 |
GOBP NON CANONICAL WNT SIGNALING PATHWAY | 36 | 3.72e-02 | 2.01e-01 | 3.77e-01 |
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 11 | 2.49e-01 | 2.01e-01 | 7.18e-01 |
GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 9 | 2.97e-01 | -2.01e-01 | 7.49e-01 |
GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 8 | 3.26e-01 | -2.01e-01 | 7.69e-01 |
GOBP G0 TO G1 TRANSITION | 32 | 4.98e-02 | 2.00e-01 | 4.14e-01 |
GOBP TRNA PROCESSING | 126 | 1.04e-04 | 2.00e-01 | 1.53e-02 |
GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 26 | 7.70e-02 | -2.00e-01 | 4.95e-01 |
GOBP DNA LIGATION | 16 | 1.65e-01 | 2.00e-01 | 6.48e-01 |
GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 6 | 3.96e-01 | -2.00e-01 | 8.12e-01 |
GOBP PLASMA CELL DIFFERENTIATION | 6 | 3.96e-01 | -2.00e-01 | 8.12e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 11 | 2.51e-01 | 2.00e-01 | 7.19e-01 |
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 27 | 7.21e-02 | -2.00e-01 | 4.77e-01 |
GOBP ANTEROGRADE DENDRITIC TRANSPORT | 7 | 3.60e-01 | 2.00e-01 | 7.92e-01 |
GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 19 | 1.32e-01 | 2.00e-01 | 6.03e-01 |
GOBP MONOAMINE TRANSPORT | 31 | 5.45e-02 | -2.00e-01 | 4.23e-01 |
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 4.40e-01 | -1.99e-01 | 8.29e-01 |
GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 20 | 1.23e-01 | -1.99e-01 | 5.87e-01 |
GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 14 | 1.96e-01 | -1.99e-01 | 6.76e-01 |
GOBP CARBOHYDRATE PHOSPHORYLATION | 20 | 1.23e-01 | 1.99e-01 | 5.87e-01 |
GOBP PHAGOSOME ACIDIFICATION | 7 | 3.61e-01 | -1.99e-01 | 7.92e-01 |
GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 4.41e-01 | 1.99e-01 | 8.29e-01 |
GOBP DEHYDROASCORBIC ACID TRANSPORT | 5 | 4.41e-01 | -1.99e-01 | 8.29e-01 |
GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.41e-01 | -1.99e-01 | 8.29e-01 |
GOMF D GLUCOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.41e-01 | -1.99e-01 | 8.29e-01 |
GOBP ERYTHROCYTE MATURATION | 13 | 2.14e-01 | -1.99e-01 | 6.89e-01 |
GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 6 | 3.99e-01 | 1.99e-01 | 8.13e-01 |
GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 13 | 2.15e-01 | -1.99e-01 | 6.90e-01 |
GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 9.27e-02 | -1.98e-01 | 5.29e-01 |
GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 9 | 3.03e-01 | 1.98e-01 | 7.54e-01 |
GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 18 | 1.46e-01 | -1.98e-01 | 6.21e-01 |
GOBP REGULATION OF LIPID TRANSPORT | 77 | 2.66e-03 | -1.98e-01 | 1.07e-01 |
GOBP INTERMEDIATE FILAMENT ORGANIZATION | 10 | 2.78e-01 | -1.98e-01 | 7.36e-01 |
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 12 | 2.35e-01 | -1.98e-01 | 7.10e-01 |
GOMF LAMININ BINDING | 14 | 2.00e-01 | -1.98e-01 | 6.79e-01 |
GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 12 | 2.35e-01 | 1.98e-01 | 7.10e-01 |
GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 10 | 2.79e-01 | -1.98e-01 | 7.36e-01 |
GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.04e-01 | 1.98e-01 | 7.54e-01 |
GOBP CORTICOSPINAL TRACT MORPHOGENESIS | 7 | 3.65e-01 | 1.98e-01 | 7.95e-01 |
GOCC ENDONUCLEASE COMPLEX | 36 | 4.01e-02 | 1.98e-01 | 3.83e-01 |
GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 5 | 4.44e-01 | 1.98e-01 | 8.32e-01 |
GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 2.00e-01 | 1.98e-01 | 6.80e-01 |
GOBP RESPONSE TO WATER | 7 | 3.65e-01 | 1.98e-01 | 7.95e-01 |
GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 15 | 1.85e-01 | -1.98e-01 | 6.69e-01 |
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 26 | 8.13e-02 | -1.98e-01 | 5.08e-01 |
GOBP SYNAPSE MATURATION | 16 | 1.71e-01 | 1.98e-01 | 6.55e-01 |
GOCC AUTOLYSOSOME | 12 | 2.36e-01 | -1.98e-01 | 7.11e-01 |
GOBP DETOXIFICATION OF COPPER ION | 6 | 4.02e-01 | 1.97e-01 | 8.15e-01 |
GOBP CARTILAGE CONDENSATION | 6 | 4.02e-01 | 1.97e-01 | 8.15e-01 |
GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 9 | 3.05e-01 | 1.97e-01 | 7.55e-01 |
GOBP MITOTIC SPINDLE ELONGATION | 6 | 4.03e-01 | 1.97e-01 | 8.15e-01 |
GOBP ONE CARBON METABOLIC PROCESS | 24 | 9.43e-02 | 1.97e-01 | 5.33e-01 |
GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 15 | 1.86e-01 | -1.97e-01 | 6.69e-01 |
GOBP RESPONSE TO VITAMIN A | 5 | 4.45e-01 | -1.97e-01 | 8.33e-01 |
GOBP LENS FIBER CELL DIFFERENTIATION | 22 | 1.09e-01 | -1.97e-01 | 5.68e-01 |
GOBP CILIUM DISASSEMBLY | 5 | 4.45e-01 | 1.97e-01 | 8.33e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 8 | 3.34e-01 | 1.97e-01 | 7.78e-01 |
GOBP REGULATION OF FIBROBLAST MIGRATION | 30 | 6.19e-02 | -1.97e-01 | 4.43e-01 |
GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 7 | 3.67e-01 | 1.97e-01 | 7.96e-01 |
GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 56 | 1.08e-02 | -1.97e-01 | 2.20e-01 |
GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 16 | 1.73e-01 | -1.97e-01 | 6.55e-01 |
GOBP FRUCTOSE METABOLIC PROCESS | 11 | 2.58e-01 | -1.97e-01 | 7.24e-01 |
GOBP RESPONSE TO ETHER | 9 | 3.07e-01 | -1.97e-01 | 7.57e-01 |
GOBP INTRACILIARY RETROGRADE TRANSPORT | 10 | 2.81e-01 | 1.97e-01 | 7.38e-01 |
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 31 | 5.82e-02 | -1.97e-01 | 4.33e-01 |
GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 7 | 3.68e-01 | 1.97e-01 | 7.96e-01 |
GOBP PROTEIN LOCALIZATION TO ENDOSOME | 25 | 8.90e-02 | 1.97e-01 | 5.21e-01 |
GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 4.47e-01 | -1.97e-01 | 8.33e-01 |
GOMF HISTONE DEUBIQUITINASE ACTIVITY | 5 | 4.47e-01 | -1.96e-01 | 8.33e-01 |
GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 11 | 2.59e-01 | 1.96e-01 | 7.24e-01 |
GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 16 | 1.74e-01 | 1.96e-01 | 6.56e-01 |
GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 73 | 3.75e-03 | -1.96e-01 | 1.30e-01 |
GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 5 | 4.47e-01 | 1.96e-01 | 8.33e-01 |
GOBP HEART TRABECULA FORMATION | 5 | 4.47e-01 | 1.96e-01 | 8.33e-01 |
GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 21 | 1.20e-01 | -1.96e-01 | 5.82e-01 |
GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 7 | 3.69e-01 | -1.96e-01 | 7.97e-01 |
GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 11 | 2.60e-01 | 1.96e-01 | 7.24e-01 |
GOBP PRE MIRNA PROCESSING | 14 | 2.05e-01 | 1.96e-01 | 6.85e-01 |
GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 8 | 3.38e-01 | 1.96e-01 | 7.80e-01 |
GOBP PROTEIN TARGETING TO MEMBRANE | 100 | 7.32e-04 | -1.96e-01 | 5.47e-02 |
GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 4.07e-01 | -1.96e-01 | 8.17e-01 |
GOMF SULFATIDE BINDING | 5 | 4.49e-01 | -1.96e-01 | 8.34e-01 |
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 33 | 5.19e-02 | -1.96e-01 | 4.19e-01 |
GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 4.49e-01 | 1.96e-01 | 8.34e-01 |
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 41 | 3.05e-02 | -1.95e-01 | 3.48e-01 |
GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 6 | 4.08e-01 | 1.95e-01 | 8.17e-01 |
GOBP CONNECTIVE TISSUE REPLACEMENT | 10 | 2.85e-01 | -1.95e-01 | 7.41e-01 |
GOBP MYOSIN FILAMENT ORGANIZATION | 5 | 4.50e-01 | 1.95e-01 | 8.34e-01 |
GOCC CATALYTIC STEP 2 SPLICEOSOME | 88 | 1.58e-03 | -1.95e-01 | 8.16e-02 |
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 10 | 2.86e-01 | 1.95e-01 | 7.42e-01 |
GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 13 | 2.24e-01 | 1.95e-01 | 7.02e-01 |
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 9 | 3.11e-01 | 1.95e-01 | 7.60e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 8 | 3.40e-01 | 1.95e-01 | 7.81e-01 |
GOCC MEIOTIC SPINDLE | 9 | 3.12e-01 | 1.95e-01 | 7.61e-01 |
GOBP PHOSPHOLIPID EFFLUX | 5 | 4.51e-01 | -1.95e-01 | 8.36e-01 |
GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 9 | 3.13e-01 | 1.94e-01 | 7.62e-01 |
GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 5 | 4.52e-01 | 1.94e-01 | 8.36e-01 |
GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 5 | 4.52e-01 | 1.94e-01 | 8.36e-01 |
GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 1.66e-01 | -1.94e-01 | 6.49e-01 |
GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 1.67e-01 | -1.94e-01 | 6.49e-01 |
GOMF SUMO BINDING | 16 | 1.80e-01 | 1.94e-01 | 6.62e-01 |
GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 11 | 2.66e-01 | 1.94e-01 | 7.25e-01 |
GOBP NEGATIVE REGULATION OF MYELINATION | 7 | 3.75e-01 | -1.94e-01 | 8.00e-01 |
GOBP HYALURONAN CATABOLIC PROCESS | 8 | 3.43e-01 | -1.94e-01 | 7.82e-01 |
GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 7 | 3.75e-01 | 1.94e-01 | 8.00e-01 |
GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 52 | 1.58e-02 | 1.94e-01 | 2.69e-01 |
GOBP RESPONSE TO PROSTAGLANDIN E | 15 | 1.94e-01 | -1.94e-01 | 6.75e-01 |
GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 4.54e-01 | 1.94e-01 | 8.37e-01 |
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 5 | 4.54e-01 | -1.93e-01 | 8.37e-01 |
GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 5 | 4.54e-01 | -1.93e-01 | 8.37e-01 |
GOBP REGULATION OF MACROPHAGE PROLIFERATION | 5 | 4.54e-01 | 1.93e-01 | 8.37e-01 |
GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 8 | 3.44e-01 | -1.93e-01 | 7.82e-01 |
GOCC AXONAL GROWTH CONE | 20 | 1.35e-01 | 1.93e-01 | 6.05e-01 |
GOBP STEM CELL DIVISION | 20 | 1.35e-01 | 1.93e-01 | 6.05e-01 |
GOBP PUTRESCINE METABOLIC PROCESS | 6 | 4.13e-01 | -1.93e-01 | 8.21e-01 |
GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 45 | 2.51e-02 | -1.93e-01 | 3.25e-01 |
GOBP PSEUDOPODIUM ORGANIZATION | 11 | 2.68e-01 | -1.93e-01 | 7.25e-01 |
GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 4.55e-01 | -1.93e-01 | 8.38e-01 |
GOBP HOMOCYSTEINE METABOLIC PROCESS | 8 | 3.45e-01 | 1.93e-01 | 7.83e-01 |
GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 13 | 2.29e-01 | -1.93e-01 | 7.02e-01 |
GOCC MYOSIN II COMPLEX | 11 | 2.68e-01 | -1.93e-01 | 7.25e-01 |
GOMF CATALYTIC ACTIVITY ACTING ON DNA | 204 | 2.17e-06 | 1.93e-01 | 9.18e-04 |
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 7 | 3.77e-01 | -1.93e-01 | 8.01e-01 |
GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 4.14e-01 | 1.93e-01 | 8.21e-01 |
GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 13 | 2.29e-01 | 1.93e-01 | 7.02e-01 |
GOBP PEPTIDYL METHIONINE MODIFICATION | 9 | 3.17e-01 | 1.93e-01 | 7.65e-01 |
GOCC WASH COMPLEX | 9 | 3.17e-01 | 1.93e-01 | 7.65e-01 |
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 22 | 1.18e-01 | -1.92e-01 | 5.82e-01 |
GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 6 | 4.14e-01 | 1.92e-01 | 8.21e-01 |
GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 13 | 2.30e-01 | -1.92e-01 | 7.03e-01 |
GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 11 | 2.69e-01 | -1.92e-01 | 7.28e-01 |
GOMF MICROTUBULE PLUS END BINDING | 19 | 1.47e-01 | 1.92e-01 | 6.23e-01 |
GOBP LIPID STORAGE | 67 | 6.52e-03 | -1.92e-01 | 1.71e-01 |
GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 12 | 2.49e-01 | 1.92e-01 | 7.18e-01 |
GOBP TETRAHYDROFOLATE INTERCONVERSION | 8 | 3.46e-01 | 1.92e-01 | 7.84e-01 |
GOBP CARNITINE METABOLIC PROCESS | 9 | 3.18e-01 | 1.92e-01 | 7.66e-01 |
GOBP THALAMUS DEVELOPMENT | 5 | 4.57e-01 | 1.92e-01 | 8.39e-01 |
GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 5 | 4.57e-01 | 1.92e-01 | 8.39e-01 |
GOBP RESPONSE TO ATP | 18 | 1.59e-01 | -1.92e-01 | 6.40e-01 |
GOBP LIPID DROPLET FORMATION | 10 | 2.94e-01 | 1.92e-01 | 7.48e-01 |
GOBP RESPONSE TO FUNGICIDE | 6 | 4.16e-01 | 1.92e-01 | 8.21e-01 |
GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 5 | 4.58e-01 | -1.92e-01 | 8.39e-01 |
GOCC PIGMENT GRANULE | 95 | 1.25e-03 | -1.92e-01 | 7.23e-02 |
GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 10 | 2.94e-01 | 1.92e-01 | 7.48e-01 |
GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 4.58e-01 | -1.92e-01 | 8.39e-01 |
GOBP SPHINGOLIPID CATABOLIC PROCESS | 23 | 1.12e-01 | -1.92e-01 | 5.72e-01 |
GOBP CELLULAR RESPONSE TO VIRUS | 44 | 2.79e-02 | -1.92e-01 | 3.38e-01 |
GOCC CELL TRAILING EDGE | 14 | 2.15e-01 | 1.92e-01 | 6.90e-01 |
GOBP BILE ACID SIGNALING PATHWAY | 5 | 4.58e-01 | -1.92e-01 | 8.39e-01 |
GOBP HOMOTYPIC CELL CELL ADHESION | 62 | 9.17e-03 | -1.91e-01 | 2.00e-01 |
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 7 | 3.81e-01 | 1.91e-01 | 8.02e-01 |
GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 9 | 3.20e-01 | 1.91e-01 | 7.68e-01 |
GOMF OPSONIN BINDING | 9 | 3.20e-01 | -1.91e-01 | 7.68e-01 |
GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 41 | 3.41e-02 | -1.91e-01 | 3.63e-01 |
GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 5 | 4.59e-01 | 1.91e-01 | 8.40e-01 |
GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 85 | 2.33e-03 | -1.91e-01 | 1.04e-01 |
GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 2.72e-01 | 1.91e-01 | 7.29e-01 |
GOBP REGULATION OF LYSOSOME SIZE | 8 | 3.49e-01 | -1.91e-01 | 7.86e-01 |
GOCC BORC COMPLEX | 8 | 3.49e-01 | -1.91e-01 | 7.86e-01 |
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 40 | 3.67e-02 | -1.91e-01 | 3.75e-01 |
GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 11 | 2.73e-01 | 1.91e-01 | 7.30e-01 |
GOMF PRIMARY MIRNA BINDING | 10 | 2.97e-01 | -1.91e-01 | 7.49e-01 |
GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 16 | 1.87e-01 | -1.91e-01 | 6.70e-01 |
GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 124 | 2.53e-04 | 1.91e-01 | 2.77e-02 |
GOBP REGULATION OF MONOCYTE EXTRAVASATION | 5 | 4.61e-01 | 1.90e-01 | 8.40e-01 |
GOCC SIN3 TYPE COMPLEX | 22 | 1.23e-01 | 1.90e-01 | 5.87e-01 |
GOMF CIS TRANS ISOMERASE ACTIVITY | 34 | 5.53e-02 | -1.90e-01 | 4.24e-01 |
GOCC SYMMETRIC SYNAPSE | 5 | 4.62e-01 | -1.90e-01 | 8.42e-01 |
GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 35 | 5.20e-02 | 1.90e-01 | 4.19e-01 |
GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 14 | 2.19e-01 | -1.90e-01 | 6.96e-01 |
GOCC FILOPODIUM MEMBRANE | 10 | 2.99e-01 | 1.90e-01 | 7.50e-01 |
GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 21 | 1.32e-01 | 1.90e-01 | 6.04e-01 |
GOBP RRNA METHYLATION | 21 | 1.32e-01 | 1.90e-01 | 6.04e-01 |
GOBP ARGININE METABOLIC PROCESS | 11 | 2.76e-01 | -1.90e-01 | 7.34e-01 |
GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 76 | 4.29e-03 | -1.90e-01 | 1.38e-01 |
GOBP ASYMMETRIC CELL DIVISION | 13 | 2.37e-01 | 1.90e-01 | 7.11e-01 |
GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 42 | 3.38e-02 | -1.89e-01 | 3.63e-01 |
GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 9 | 3.26e-01 | -1.89e-01 | 7.69e-01 |
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 16 | 1.90e-01 | -1.89e-01 | 6.73e-01 |
GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 14 | 2.20e-01 | 1.89e-01 | 6.97e-01 |
GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 10 | 3.00e-01 | 1.89e-01 | 7.52e-01 |
GOBP RETINA LAYER FORMATION | 8 | 3.54e-01 | -1.89e-01 | 7.90e-01 |
GOMF RACEMASE AND EPIMERASE ACTIVITY | 15 | 2.05e-01 | 1.89e-01 | 6.85e-01 |
GOBP PROTEIN O LINKED MANNOSYLATION | 15 | 2.05e-01 | 1.89e-01 | 6.85e-01 |
GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 11 | 2.78e-01 | -1.89e-01 | 7.35e-01 |
GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 8 | 3.55e-01 | 1.89e-01 | 7.90e-01 |
GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 6.45e-02 | 1.89e-01 | 4.54e-01 |
GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 7 | 3.87e-01 | -1.89e-01 | 8.06e-01 |
GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 9 | 3.27e-01 | 1.89e-01 | 7.70e-01 |
GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 72 | 5.66e-03 | -1.89e-01 | 1.58e-01 |
GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 6 | 4.23e-01 | 1.89e-01 | 8.23e-01 |
GOBP ESTABLISHMENT OF TISSUE POLARITY | 40 | 3.90e-02 | 1.89e-01 | 3.82e-01 |
GOBP UREA CYCLE | 5 | 4.65e-01 | -1.89e-01 | 8.43e-01 |
GOBP UREA METABOLIC PROCESS | 5 | 4.65e-01 | -1.89e-01 | 8.43e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 3.02e-01 | -1.89e-01 | 7.53e-01 |
GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 2.58e-01 | -1.89e-01 | 7.24e-01 |
GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 25 | 1.03e-01 | -1.88e-01 | 5.53e-01 |
GOCC RNA POLYMERASE II CORE COMPLEX | 15 | 2.07e-01 | -1.88e-01 | 6.87e-01 |
GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 10 | 3.02e-01 | -1.88e-01 | 7.53e-01 |
GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 6 | 4.24e-01 | 1.88e-01 | 8.23e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 13 | 2.40e-01 | -1.88e-01 | 7.13e-01 |
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 30 | 7.45e-02 | -1.88e-01 | 4.88e-01 |
GOBP TRANSMISSION OF NERVE IMPULSE | 24 | 1.11e-01 | -1.88e-01 | 5.70e-01 |
GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 15 | 2.07e-01 | 1.88e-01 | 6.87e-01 |
GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 11 | 2.80e-01 | -1.88e-01 | 7.37e-01 |
GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 23 | 1.19e-01 | -1.88e-01 | 5.82e-01 |
GOCC ENDOLYSOSOME LUMEN | 5 | 4.67e-01 | -1.88e-01 | 8.45e-01 |
GOBP PROTEIN K27 LINKED UBIQUITINATION | 6 | 4.26e-01 | -1.88e-01 | 8.23e-01 |
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 11 | 2.81e-01 | -1.88e-01 | 7.38e-01 |
GOBP SIGNAL COMPLEX ASSEMBLY | 7 | 3.90e-01 | -1.88e-01 | 8.08e-01 |
GOBP WNT PROTEIN SECRETION | 5 | 4.67e-01 | 1.88e-01 | 8.45e-01 |
GOBP ENDODERM FORMATION | 25 | 1.04e-01 | -1.88e-01 | 5.56e-01 |
GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 4.26e-01 | -1.88e-01 | 8.23e-01 |
GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 8 | 3.58e-01 | 1.88e-01 | 7.91e-01 |
GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 14 | 2.24e-01 | -1.88e-01 | 7.02e-01 |
GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 5 | 4.68e-01 | -1.88e-01 | 8.45e-01 |
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 31 | 7.07e-02 | -1.88e-01 | 4.73e-01 |
GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 12 | 2.61e-01 | -1.88e-01 | 7.24e-01 |
GOBP MITOCHONDRIAL GENE EXPRESSION | 160 | 4.38e-05 | 1.88e-01 | 7.69e-03 |
GOBP BASE EXCISION REPAIR AP SITE FORMATION | 12 | 2.61e-01 | 1.88e-01 | 7.24e-01 |
GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 33 | 6.24e-02 | -1.88e-01 | 4.44e-01 |
GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 5 | 4.68e-01 | 1.87e-01 | 8.45e-01 |
GOBP GLUTATHIONE TRANSPORT | 6 | 4.27e-01 | 1.87e-01 | 8.24e-01 |
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 3.59e-01 | -1.87e-01 | 7.92e-01 |
GOCC MITOTIC SPINDLE POLE | 32 | 6.69e-02 | 1.87e-01 | 4.61e-01 |
GOBP LUNG SACCULE DEVELOPMENT | 5 | 4.69e-01 | -1.87e-01 | 8.45e-01 |
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 6 | 4.28e-01 | -1.87e-01 | 8.24e-01 |
GOMF LYSOPHOSPHOLIPASE ACTIVITY | 21 | 1.38e-01 | 1.87e-01 | 6.08e-01 |
GOMF CHEMOATTRACTANT ACTIVITY | 14 | 2.26e-01 | -1.87e-01 | 7.02e-01 |
GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 6 | 4.28e-01 | -1.87e-01 | 8.24e-01 |
GOBP FIBROBLAST MIGRATION | 43 | 3.43e-02 | -1.87e-01 | 3.64e-01 |
GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 6 | 4.29e-01 | -1.87e-01 | 8.25e-01 |
GOMF PROTEIN KINASE C BINDING | 39 | 4.40e-02 | -1.86e-01 | 3.97e-01 |
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 16 | 1.97e-01 | 1.86e-01 | 6.77e-01 |
GOMF U3 SNORNA BINDING | 10 | 3.08e-01 | 1.86e-01 | 7.57e-01 |
GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 5 | 4.71e-01 | 1.86e-01 | 8.46e-01 |
GOBP NUCLEOTIDE TRANSPORT | 34 | 6.04e-02 | 1.86e-01 | 4.38e-01 |
GOBP RESPONSE TO STEROL DEPLETION | 15 | 2.12e-01 | -1.86e-01 | 6.87e-01 |
GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 12 | 2.64e-01 | -1.86e-01 | 7.25e-01 |
GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 22 | 1.31e-01 | -1.86e-01 | 6.02e-01 |
GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 5 | 4.72e-01 | 1.86e-01 | 8.46e-01 |
GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 4.72e-01 | -1.86e-01 | 8.46e-01 |
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 17 | 1.85e-01 | -1.86e-01 | 6.69e-01 |
GOMF PHOSPHOLIPASE A2 ACTIVITY | 16 | 1.98e-01 | 1.86e-01 | 6.79e-01 |
GOBP IMMUNE RESPONSE TO TUMOR CELL | 21 | 1.41e-01 | -1.86e-01 | 6.14e-01 |
GOBP ASTROCYTE ACTIVATION | 17 | 1.85e-01 | -1.86e-01 | 6.69e-01 |
GOBP FOREBRAIN REGIONALIZATION | 6 | 4.31e-01 | 1.86e-01 | 8.26e-01 |
GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 2.66e-01 | 1.86e-01 | 7.25e-01 |
GOBP OOGENESIS | 53 | 1.95e-02 | 1.86e-01 | 2.92e-01 |
GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 8 | 3.64e-01 | -1.86e-01 | 7.95e-01 |
GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 10 | 3.10e-01 | 1.85e-01 | 7.59e-01 |
GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 1.99e-01 | -1.85e-01 | 6.79e-01 |
GOMF MHC CLASS II PROTEIN BINDING | 6 | 4.32e-01 | 1.85e-01 | 8.26e-01 |
GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 12 | 2.66e-01 | 1.85e-01 | 7.25e-01 |
GOBP MESENCHYMAL CELL MIGRATION | 19 | 1.62e-01 | -1.85e-01 | 6.44e-01 |
GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 3.11e-01 | -1.85e-01 | 7.59e-01 |
GOBP EXTRACELLULAR VESICLE BIOGENESIS | 22 | 1.33e-01 | -1.85e-01 | 6.04e-01 |
GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 8 | 3.65e-01 | -1.85e-01 | 7.95e-01 |
GOBP TELOMERE CAPPING | 36 | 5.52e-02 | 1.85e-01 | 4.24e-01 |
GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 13 | 2.49e-01 | -1.85e-01 | 7.18e-01 |
GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 88 | 2.80e-03 | 1.85e-01 | 1.10e-01 |
GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 7 | 3.98e-01 | -1.84e-01 | 8.13e-01 |
GOBP DORSAL VENTRAL AXIS SPECIFICATION | 5 | 4.75e-01 | -1.84e-01 | 8.47e-01 |
GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 16 | 2.02e-01 | -1.84e-01 | 6.84e-01 |
GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 5 | 4.76e-01 | 1.84e-01 | 8.47e-01 |
GOBP REGULATION OF ENDOCRINE PROCESS | 16 | 2.03e-01 | -1.84e-01 | 6.85e-01 |
GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 5 | 4.77e-01 | -1.84e-01 | 8.48e-01 |
GOBP KINETOCHORE ASSEMBLY | 16 | 2.04e-01 | 1.84e-01 | 6.85e-01 |
GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 22 | 1.36e-01 | -1.84e-01 | 6.08e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 13 | 2.52e-01 | 1.83e-01 | 7.20e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 45 | 3.34e-02 | -1.83e-01 | 3.61e-01 |
GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 40 | 4.50e-02 | -1.83e-01 | 4.00e-01 |
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 6 | 4.37e-01 | -1.83e-01 | 8.29e-01 |
GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 11 | 2.93e-01 | 1.83e-01 | 7.47e-01 |
GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 3.41e-01 | -1.83e-01 | 7.81e-01 |
GOBP SNRNA MODIFICATION | 7 | 4.02e-01 | 1.83e-01 | 8.15e-01 |
GOBP COLLAGEN CATABOLIC PROCESS | 22 | 1.37e-01 | -1.83e-01 | 6.08e-01 |
GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 13 | 2.53e-01 | 1.83e-01 | 7.22e-01 |
GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 6 | 4.38e-01 | 1.83e-01 | 8.29e-01 |
GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 6 | 4.38e-01 | 1.83e-01 | 8.29e-01 |
GOBP I KAPPAB PHOSPHORYLATION | 13 | 2.54e-01 | -1.83e-01 | 7.22e-01 |
GOMF ANAPHASE PROMOTING COMPLEX BINDING | 5 | 4.79e-01 | -1.83e-01 | 8.50e-01 |
GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 12 | 2.73e-01 | -1.83e-01 | 7.29e-01 |
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 60 | 1.44e-02 | -1.83e-01 | 2.61e-01 |
GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 4.80e-01 | 1.83e-01 | 8.50e-01 |
GOCC AXONEMAL MICROTUBULE | 13 | 2.54e-01 | 1.83e-01 | 7.22e-01 |
GOBP REGULATION OF RELAXATION OF MUSCLE | 5 | 4.80e-01 | -1.83e-01 | 8.50e-01 |
GOBP XMP METABOLIC PROCESS | 7 | 4.03e-01 | 1.82e-01 | 8.16e-01 |
GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 8 | 3.72e-01 | 1.82e-01 | 7.99e-01 |
GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY | 5 | 4.80e-01 | 1.82e-01 | 8.50e-01 |
GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 80 | 4.86e-03 | -1.82e-01 | 1.43e-01 |
GOBP REGULATION OF VASOCONSTRICTION | 25 | 1.15e-01 | -1.82e-01 | 5.78e-01 |
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 6 | 4.40e-01 | 1.82e-01 | 8.29e-01 |
GOBP EMBRYONIC CLEAVAGE | 7 | 4.04e-01 | 1.82e-01 | 8.17e-01 |
GOCC GAMMA TUBULIN COMPLEX | 16 | 2.08e-01 | 1.82e-01 | 6.87e-01 |
GOMF SMALL MOLECULE SENSOR ACTIVITY | 31 | 7.98e-02 | 1.82e-01 | 5.04e-01 |
GOCC RECYCLING ENDOSOME MEMBRANE | 80 | 5.01e-03 | -1.82e-01 | 1.45e-01 |
GOMF CCR CHEMOKINE RECEPTOR BINDING | 14 | 2.39e-01 | -1.82e-01 | 7.13e-01 |
GOBP INNER CELL MASS CELL DIFFERENTIATION | 5 | 4.82e-01 | -1.82e-01 | 8.50e-01 |
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 13 | 2.57e-01 | -1.82e-01 | 7.24e-01 |
GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 6 | 4.41e-01 | -1.82e-01 | 8.30e-01 |
GOCC MICROBODY LUMEN | 37 | 5.62e-02 | 1.82e-01 | 4.27e-01 |
GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 16 | 2.09e-01 | -1.81e-01 | 6.87e-01 |
GOBP GLYCEROL ETHER METABOLIC PROCESS | 18 | 1.83e-01 | 1.81e-01 | 6.66e-01 |
GOMF PROTEIN KINASE C ACTIVITY | 14 | 2.40e-01 | 1.81e-01 | 7.13e-01 |
GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 11 | 2.98e-01 | -1.81e-01 | 7.49e-01 |
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 11 | 2.98e-01 | -1.81e-01 | 7.49e-01 |
GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 69 | 9.26e-03 | -1.81e-01 | 2.00e-01 |
GOMF TRANSLATION ACTIVATOR ACTIVITY | 7 | 4.06e-01 | -1.81e-01 | 8.17e-01 |
GOBP NEURAL CREST FORMATION | 8 | 3.75e-01 | 1.81e-01 | 8.00e-01 |
GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 12 | 2.78e-01 | -1.81e-01 | 7.35e-01 |
GOBP VESICLE COATING | 36 | 6.04e-02 | -1.81e-01 | 4.38e-01 |
GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 9 | 3.48e-01 | 1.81e-01 | 7.86e-01 |
GOBP ISOCITRATE METABOLIC PROCESS | 6 | 4.44e-01 | 1.81e-01 | 8.32e-01 |
GOBP REGULATION OF ORGANIC ACID TRANSPORT | 45 | 3.62e-02 | -1.81e-01 | 3.73e-01 |
GOMF METHYLATION DEPENDENT PROTEIN BINDING | 73 | 7.69e-03 | 1.81e-01 | 1.83e-01 |
GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 18 | 1.85e-01 | -1.81e-01 | 6.69e-01 |
GOCC DENDRITE TERMINUS | 10 | 3.23e-01 | 1.80e-01 | 7.69e-01 |
GOMF MAP KINASE PHOSPHATASE ACTIVITY | 11 | 3.00e-01 | -1.80e-01 | 7.52e-01 |
GOBP KINETOCHORE ORGANIZATION | 20 | 1.63e-01 | 1.80e-01 | 6.45e-01 |
GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 3.24e-01 | -1.80e-01 | 7.69e-01 |
GOCC CELL SUBSTRATE JUNCTION | 345 | 1.01e-08 | -1.80e-01 | 7.73e-06 |
GOBP KETONE BODY METABOLIC PROCESS | 5 | 4.86e-01 | 1.80e-01 | 8.53e-01 |
GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 13 | 2.61e-01 | -1.80e-01 | 7.24e-01 |
GOMF LIPID PHOSPHATASE ACTIVITY | 10 | 3.24e-01 | -1.80e-01 | 7.69e-01 |
GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 8 | 3.78e-01 | -1.80e-01 | 8.02e-01 |
GOMF DAMAGED DNA BINDING | 64 | 1.29e-02 | 1.80e-01 | 2.47e-01 |
GOBP RESPONSE TO ESTRADIOL | 61 | 1.52e-02 | -1.80e-01 | 2.62e-01 |
GOBP SPERM AXONEME ASSEMBLY | 14 | 2.44e-01 | -1.80e-01 | 7.14e-01 |
GOBP REGULATION OF INTEGRIN ACTIVATION | 8 | 3.78e-01 | -1.80e-01 | 8.02e-01 |
GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 18 | 1.87e-01 | -1.80e-01 | 6.70e-01 |
GOBP INTRACELLULAR PH REDUCTION | 47 | 3.31e-02 | -1.80e-01 | 3.60e-01 |
GOBP CELLULAR RESPONSE TO POTASSIUM ION | 8 | 3.79e-01 | -1.80e-01 | 8.02e-01 |
GOMF CULLIN FAMILY PROTEIN BINDING | 24 | 1.28e-01 | -1.80e-01 | 5.97e-01 |
GOBP REGULATION OF ADIPONECTIN SECRETION | 7 | 4.11e-01 | -1.79e-01 | 8.21e-01 |
GOMF RNA STEM LOOP BINDING | 14 | 2.45e-01 | -1.79e-01 | 7.14e-01 |
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 23 | 1.37e-01 | -1.79e-01 | 6.08e-01 |
GOBP RNA 5 END PROCESSING | 22 | 1.46e-01 | 1.79e-01 | 6.21e-01 |
GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 35 | 6.65e-02 | -1.79e-01 | 4.59e-01 |
GOMF ARACHIDONATE COA LIGASE ACTIVITY | 8 | 3.80e-01 | 1.79e-01 | 8.02e-01 |
GOBP FOREBRAIN MORPHOGENESIS | 6 | 4.47e-01 | 1.79e-01 | 8.33e-01 |
GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 24 | 1.29e-01 | -1.79e-01 | 5.99e-01 |
GOBP NEUROTRANSMITTER METABOLIC PROCESS | 10 | 3.27e-01 | 1.79e-01 | 7.70e-01 |
GOBP CHEMOKINE PRODUCTION | 68 | 1.07e-02 | -1.79e-01 | 2.20e-01 |
GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 29 | 9.51e-02 | 1.79e-01 | 5.37e-01 |
GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 15 | 2.30e-01 | 1.79e-01 | 7.03e-01 |
GOBP NEUTROPHIL CLEARANCE | 6 | 4.48e-01 | 1.79e-01 | 8.33e-01 |
GOCC TERTIARY GRANULE | 136 | 3.19e-04 | -1.79e-01 | 3.10e-02 |
GOBP CELLULAR OXIDANT DETOXIFICATION | 63 | 1.41e-02 | -1.79e-01 | 2.59e-01 |
GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 10 | 3.28e-01 | -1.79e-01 | 7.70e-01 |
GOMF PEROXIREDOXIN ACTIVITY | 8 | 3.81e-01 | -1.79e-01 | 8.02e-01 |
GOBP REGULATION OF RECEPTOR BINDING | 8 | 3.82e-01 | -1.79e-01 | 8.02e-01 |
GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 5 | 4.89e-01 | -1.79e-01 | 8.55e-01 |
GOCC PRESYNAPTIC ENDOCYTIC ZONE | 6 | 4.49e-01 | -1.78e-01 | 8.34e-01 |
GOBP SPHINGOMYELIN METABOLIC PROCESS | 17 | 2.03e-01 | -1.78e-01 | 6.85e-01 |
GOCC OXIDOREDUCTASE COMPLEX | 109 | 1.32e-03 | -1.78e-01 | 7.32e-02 |
GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 6 | 4.50e-01 | -1.78e-01 | 8.34e-01 |
GOBP REGULATION OF EXIT FROM MITOSIS | 13 | 2.66e-01 | -1.78e-01 | 7.25e-01 |
GOCC MISMATCH REPAIR COMPLEX | 7 | 4.14e-01 | 1.78e-01 | 8.21e-01 |
GOBP RESPONSE TO FOOD | 18 | 1.91e-01 | -1.78e-01 | 6.74e-01 |
GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 17 | 2.04e-01 | -1.78e-01 | 6.85e-01 |
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 11 | 3.07e-01 | 1.78e-01 | 7.57e-01 |
GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 16 | 2.18e-01 | -1.78e-01 | 6.95e-01 |
GOCC MICROTUBULE END | 24 | 1.32e-01 | 1.78e-01 | 6.02e-01 |
GOBP SECRETORY GRANULE LOCALIZATION | 7 | 4.15e-01 | -1.78e-01 | 8.21e-01 |
GOBP NEGATIVE T CELL SELECTION | 10 | 3.30e-01 | 1.78e-01 | 7.74e-01 |
GOBP REGULATION OF PLATELET ACTIVATION | 29 | 9.78e-02 | -1.78e-01 | 5.42e-01 |
GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 41 | 4.92e-02 | -1.78e-01 | 4.14e-01 |
GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 4.16e-01 | -1.78e-01 | 8.21e-01 |
GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 4.52e-01 | 1.78e-01 | 8.36e-01 |
GOMF EXTRACELLULAR MATRIX BINDING | 23 | 1.41e-01 | -1.77e-01 | 6.14e-01 |
GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 45 | 3.95e-02 | -1.77e-01 | 3.83e-01 |
GOBP ARACHIDONIC ACID METABOLIC PROCESS | 27 | 1.11e-01 | 1.77e-01 | 5.70e-01 |
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 13 | 2.68e-01 | 1.77e-01 | 7.25e-01 |
GOMF CHEMOREPELLENT ACTIVITY | 11 | 3.08e-01 | -1.77e-01 | 7.58e-01 |
GOMF G QUADRUPLEX DNA BINDING | 10 | 3.32e-01 | -1.77e-01 | 7.76e-01 |
GOBP REPLICATIVE SENESCENCE | 12 | 2.88e-01 | 1.77e-01 | 7.43e-01 |
GOBP REGULATION OF NK T CELL ACTIVATION | 9 | 3.57e-01 | -1.77e-01 | 7.91e-01 |
GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 27 | 1.11e-01 | 1.77e-01 | 5.72e-01 |
GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 35 | 7.00e-02 | -1.77e-01 | 4.71e-01 |
GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 26 | 1.18e-01 | -1.77e-01 | 5.82e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 10 | 3.33e-01 | 1.77e-01 | 7.76e-01 |
GOMF FUCOSE BINDING | 5 | 4.94e-01 | 1.77e-01 | 8.56e-01 |
GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 24 | 1.34e-01 | -1.77e-01 | 6.05e-01 |
GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 35 | 7.05e-02 | 1.77e-01 | 4.73e-01 |
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 12 | 2.89e-01 | -1.77e-01 | 7.44e-01 |
GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 10 | 3.34e-01 | 1.77e-01 | 7.77e-01 |
GOMF MANNOSYLTRANSFERASE ACTIVITY | 22 | 1.52e-01 | 1.77e-01 | 6.31e-01 |
GOBP ASSOCIATIVE LEARNING | 40 | 5.35e-02 | 1.77e-01 | 4.21e-01 |
GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 18 | 1.95e-01 | -1.76e-01 | 6.75e-01 |
GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 6 | 4.54e-01 | -1.76e-01 | 8.37e-01 |
GOBP OSTEOCLAST FUSION | 5 | 4.95e-01 | 1.76e-01 | 8.56e-01 |
GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 29 | 1.00e-01 | -1.76e-01 | 5.48e-01 |
GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 19 | 1.83e-01 | 1.76e-01 | 6.67e-01 |
GOBP NOREPINEPHRINE METABOLIC PROCESS | 5 | 4.95e-01 | -1.76e-01 | 8.56e-01 |
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 21 | 1.62e-01 | 1.76e-01 | 6.44e-01 |
GOBP RIBOSOME DISASSEMBLY | 13 | 2.71e-01 | 1.76e-01 | 7.29e-01 |
GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 5 | 4.95e-01 | -1.76e-01 | 8.57e-01 |
GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 5 | 4.95e-01 | 1.76e-01 | 8.57e-01 |
GOCC RETROMER COMPLEX | 12 | 2.91e-01 | -1.76e-01 | 7.46e-01 |
GOMF DESUMOYLASE ACTIVITY | 7 | 4.20e-01 | -1.76e-01 | 8.23e-01 |
GOMF HISTONE BINDING | 211 | 1.12e-05 | 1.76e-01 | 2.70e-03 |
GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 21 | 1.63e-01 | 1.76e-01 | 6.45e-01 |
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 11 | 3.13e-01 | -1.76e-01 | 7.62e-01 |
GOCC SPLICEOSOMAL COMPLEX | 189 | 3.21e-05 | -1.76e-01 | 6.05e-03 |
GOBP NEUTROPHIL MEDIATED IMMUNITY | 27 | 1.14e-01 | -1.76e-01 | 5.78e-01 |
GOCC CENTRIOLE | 123 | 7.77e-04 | 1.76e-01 | 5.53e-02 |
GOBP VESICLE CARGO LOADING | 27 | 1.15e-01 | -1.76e-01 | 5.78e-01 |
GOBP MULTIVESICULAR BODY ORGANIZATION | 30 | 9.64e-02 | -1.75e-01 | 5.38e-01 |
GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 5 | 4.98e-01 | 1.75e-01 | 8.59e-01 |
GOBP SERTOLI CELL DEVELOPMENT | 9 | 3.63e-01 | -1.75e-01 | 7.94e-01 |
GOBP CERAMIDE TRANSPORT | 10 | 3.38e-01 | -1.75e-01 | 7.80e-01 |
GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 63 | 1.63e-02 | 1.75e-01 | 2.73e-01 |
GOBP REGULATION OF MRNA PROCESSING | 105 | 1.97e-03 | -1.75e-01 | 9.08e-02 |
GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY | 5 | 4.98e-01 | -1.75e-01 | 8.59e-01 |
GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 33 | 8.20e-02 | 1.75e-01 | 5.08e-01 |
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 8 | 3.92e-01 | -1.75e-01 | 8.09e-01 |
GOBP REGULATION OF DENDRITE MORPHOGENESIS | 44 | 4.50e-02 | 1.75e-01 | 4.00e-01 |
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 5 | 4.99e-01 | -1.75e-01 | 8.59e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 65 | 1.50e-02 | -1.75e-01 | 2.62e-01 |
GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 5 | 4.99e-01 | -1.75e-01 | 8.59e-01 |
GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 4.99e-01 | -1.75e-01 | 8.59e-01 |
GOBP REGULATION OF NEURON MIGRATION | 23 | 1.47e-01 | -1.75e-01 | 6.24e-01 |
GOBP OXALOACETATE METABOLIC PROCESS | 7 | 4.24e-01 | 1.75e-01 | 8.23e-01 |
GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 159 | 1.52e-04 | -1.74e-01 | 2.07e-02 |
GOMF FRIZZLED BINDING | 12 | 2.96e-01 | 1.74e-01 | 7.49e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 3.93e-01 | -1.74e-01 | 8.11e-01 |
GOBP RRNA PSEUDOURIDINE SYNTHESIS | 8 | 3.94e-01 | 1.74e-01 | 8.11e-01 |
GOBP AMP SALVAGE | 5 | 5.00e-01 | 1.74e-01 | 8.60e-01 |
GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 52 | 2.99e-02 | -1.74e-01 | 3.48e-01 |
GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 101 | 2.52e-03 | -1.74e-01 | 1.07e-01 |
GOMF SIALYLTRANSFERASE ACTIVITY | 14 | 2.59e-01 | -1.74e-01 | 7.24e-01 |
GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 10 | 3.41e-01 | -1.74e-01 | 7.81e-01 |
GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 4.25e-01 | -1.74e-01 | 8.23e-01 |
GOBP PROTEIN KINASE A SIGNALING | 21 | 1.68e-01 | -1.74e-01 | 6.50e-01 |
GOCC CLATHRIN ADAPTOR COMPLEX | 24 | 1.40e-01 | 1.74e-01 | 6.13e-01 |
GOBP POSITIVE REGULATION OF RECEPTOR BINDING | 5 | 5.00e-01 | -1.74e-01 | 8.60e-01 |
GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 24 | 1.40e-01 | -1.74e-01 | 6.13e-01 |
GOBP KYNURENINE METABOLIC PROCESS | 8 | 3.94e-01 | 1.74e-01 | 8.12e-01 |
GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 6 | 4.61e-01 | -1.74e-01 | 8.40e-01 |
GOBP POSITIVE REGULATION OF PINOCYTOSIS | 7 | 4.26e-01 | 1.74e-01 | 8.23e-01 |
GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 7 | 4.26e-01 | -1.74e-01 | 8.23e-01 |
GOBP NK T CELL PROLIFERATION | 9 | 3.67e-01 | -1.74e-01 | 7.96e-01 |
GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 32 | 8.92e-02 | -1.74e-01 | 5.22e-01 |
GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.67e-01 | 1.74e-01 | 7.96e-01 |
GOBP RESPONSE TO LEAD ION | 16 | 2.30e-01 | -1.74e-01 | 7.03e-01 |
GOMF METAL CLUSTER BINDING | 63 | 1.73e-02 | 1.73e-01 | 2.78e-01 |
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 10 | 3.42e-01 | -1.73e-01 | 7.82e-01 |
GOBP PROTEIN DELIPIDATION | 5 | 5.02e-01 | -1.73e-01 | 8.60e-01 |
GOBP RESPONSE TO YEAST | 7 | 4.27e-01 | -1.73e-01 | 8.24e-01 |
GOBP FOREBRAIN CELL MIGRATION | 38 | 6.47e-02 | 1.73e-01 | 4.55e-01 |
GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 9 | 3.68e-01 | 1.73e-01 | 7.96e-01 |
GOBP LUNG MORPHOGENESIS | 27 | 1.19e-01 | -1.73e-01 | 5.82e-01 |
GOBP FEEDING BEHAVIOR | 31 | 9.52e-02 | 1.73e-01 | 5.37e-01 |
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 9 | 3.69e-01 | -1.73e-01 | 7.96e-01 |
GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 16 | 2.31e-01 | 1.73e-01 | 7.05e-01 |
GOMF SULFURTRANSFERASE ACTIVITY | 9 | 3.69e-01 | -1.73e-01 | 7.96e-01 |
GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 42 | 5.24e-02 | -1.73e-01 | 4.19e-01 |
GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 66 | 1.51e-02 | -1.73e-01 | 2.62e-01 |
GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 5.03e-01 | -1.73e-01 | 8.61e-01 |
GOBP ADENOSINE METABOLIC PROCESS | 5 | 5.03e-01 | -1.73e-01 | 8.61e-01 |
GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 3.44e-01 | -1.73e-01 | 7.82e-01 |
GOBP SERINE TRANSPORT | 8 | 3.97e-01 | 1.73e-01 | 8.12e-01 |
GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.97e-01 | 1.73e-01 | 8.12e-01 |
GOBP UBIQUITIN RECYCLING | 10 | 3.44e-01 | -1.73e-01 | 7.83e-01 |
GOBP TETRAPYRROLE CATABOLIC PROCESS | 7 | 4.29e-01 | -1.73e-01 | 8.25e-01 |
GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 6 | 4.64e-01 | 1.73e-01 | 8.42e-01 |
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 4.64e-01 | 1.73e-01 | 8.43e-01 |
GOMF CYTOKINE RECEPTOR ACTIVITY | 59 | 2.21e-02 | -1.72e-01 | 3.05e-01 |
GOCC MICROVILLUS | 52 | 3.16e-02 | -1.72e-01 | 3.53e-01 |
GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 16 | 2.33e-01 | -1.72e-01 | 7.07e-01 |
GOBP PEPTIDYL ARGININE METHYLATION | 5 | 5.05e-01 | 1.72e-01 | 8.62e-01 |
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 19 | 1.95e-01 | -1.72e-01 | 6.75e-01 |
GOCC CANONICAL INFLAMMASOME COMPLEX | 15 | 2.49e-01 | 1.72e-01 | 7.18e-01 |
GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 83 | 6.86e-03 | -1.72e-01 | 1.77e-01 |
GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 9 | 3.72e-01 | -1.72e-01 | 7.99e-01 |
GOBP DOPAMINE SECRETION | 14 | 2.66e-01 | -1.72e-01 | 7.25e-01 |
GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 23 | 1.55e-01 | -1.72e-01 | 6.36e-01 |
GOBP LIPID DROPLET ORGANIZATION | 25 | 1.38e-01 | -1.71e-01 | 6.08e-01 |
GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 9 | 3.73e-01 | 1.71e-01 | 7.99e-01 |
GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 5.07e-01 | -1.71e-01 | 8.62e-01 |
GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 14 | 2.67e-01 | -1.71e-01 | 7.25e-01 |
GOBP APICAL PROTEIN LOCALIZATION | 9 | 3.74e-01 | 1.71e-01 | 7.99e-01 |
GOBP MATURATION OF 5 8S RRNA | 36 | 7.60e-02 | 1.71e-01 | 4.94e-01 |
GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 5.08e-01 | -1.71e-01 | 8.63e-01 |
GOBP STRESS FIBER ASSEMBLY | 80 | 8.37e-03 | -1.71e-01 | 1.91e-01 |
GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 5 | 5.09e-01 | -1.71e-01 | 8.63e-01 |
GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION | 5 | 5.09e-01 | -1.70e-01 | 8.63e-01 |
GOBP LEUKOCYTE MIGRATION | 254 | 3.10e-06 | -1.70e-01 | 1.20e-03 |
GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 6 | 4.70e-01 | 1.70e-01 | 8.45e-01 |
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 10 | 3.51e-01 | -1.70e-01 | 7.86e-01 |
GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 36 | 7.70e-02 | -1.70e-01 | 4.95e-01 |
GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 518 | 4.28e-11 | 1.70e-01 | 5.16e-08 |
GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 15 | 2.54e-01 | -1.70e-01 | 7.22e-01 |
GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS | 6 | 4.70e-01 | 1.70e-01 | 8.46e-01 |
GOBP LIPID GLYCOSYLATION | 6 | 4.71e-01 | -1.70e-01 | 8.46e-01 |
GOBP LUNG CELL DIFFERENTIATION | 14 | 2.71e-01 | -1.70e-01 | 7.29e-01 |
GOMF MHC CLASS I PROTEIN BINDING | 18 | 2.12e-01 | -1.70e-01 | 6.87e-01 |
GOMF SULFOTRANSFERASE ACTIVITY | 18 | 2.12e-01 | -1.70e-01 | 6.87e-01 |
GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 6 | 4.71e-01 | 1.70e-01 | 8.46e-01 |
GOBP MITOCHONDRIAL TRANSLATION | 128 | 9.28e-04 | 1.70e-01 | 6.08e-02 |
GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 89 | 5.71e-03 | -1.70e-01 | 1.59e-01 |
GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 12 | 3.09e-01 | 1.70e-01 | 7.58e-01 |
GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 12 | 3.09e-01 | 1.70e-01 | 7.58e-01 |
GOCC PROTEASOME COMPLEX | 58 | 2.57e-02 | -1.69e-01 | 3.29e-01 |
GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 9 | 3.79e-01 | -1.69e-01 | 8.02e-01 |
GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 6 | 4.73e-01 | -1.69e-01 | 8.46e-01 |
GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 10 | 3.54e-01 | 1.69e-01 | 7.89e-01 |
GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 4.38e-01 | 1.69e-01 | 8.29e-01 |
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 142 | 5.15e-04 | -1.69e-01 | 4.38e-02 |
GOBP CAMKK AMPK SIGNALING CASCADE | 5 | 5.13e-01 | 1.69e-01 | 8.66e-01 |
GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 4.39e-01 | -1.69e-01 | 8.29e-01 |
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 13 | 2.92e-01 | 1.69e-01 | 7.46e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 5 | 5.13e-01 | 1.69e-01 | 8.66e-01 |
GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 5.13e-01 | -1.69e-01 | 8.66e-01 |
GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 9 | 3.80e-01 | 1.69e-01 | 8.02e-01 |
GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 8 | 4.08e-01 | 1.69e-01 | 8.17e-01 |
GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 34 | 8.86e-02 | -1.69e-01 | 5.21e-01 |
GOMF THIAMINE PYROPHOSPHATE BINDING | 6 | 4.74e-01 | -1.69e-01 | 8.47e-01 |
GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 9 | 3.82e-01 | -1.68e-01 | 8.02e-01 |
GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 49 | 4.15e-02 | -1.68e-01 | 3.86e-01 |
GOBP LEUKOCYTE CHEMOTAXIS | 157 | 2.78e-04 | -1.68e-01 | 2.84e-02 |
GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 12 | 3.13e-01 | 1.68e-01 | 7.62e-01 |
GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 6 | 4.75e-01 | -1.68e-01 | 8.47e-01 |
GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 32 | 9.96e-02 | -1.68e-01 | 5.47e-01 |
GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 5.15e-01 | 1.68e-01 | 8.66e-01 |
GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 5 | 5.15e-01 | 1.68e-01 | 8.66e-01 |
GOMF TELOMERASE ACTIVITY | 5 | 5.15e-01 | 1.68e-01 | 8.66e-01 |
GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 7 | 4.41e-01 | 1.68e-01 | 8.30e-01 |
GOBP RESPONSE TO INTERLEUKIN 6 | 22 | 1.73e-01 | -1.68e-01 | 6.55e-01 |
GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 6 | 4.76e-01 | -1.68e-01 | 8.48e-01 |
GOCC PINOSOME | 6 | 4.77e-01 | -1.68e-01 | 8.48e-01 |
GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 11 | 3.36e-01 | -1.68e-01 | 7.79e-01 |
GOCC NUCLEAR PORE OUTER RING | 9 | 3.84e-01 | 1.68e-01 | 8.04e-01 |
GOBP NEGATIVE REGULATION OF WOUND HEALING | 28 | 1.25e-01 | -1.68e-01 | 5.90e-01 |
GOBP OLFACTORY LOBE DEVELOPMENT | 19 | 2.06e-01 | 1.68e-01 | 6.87e-01 |
GOBP TRIGLYCERIDE CATABOLIC PROCESS | 14 | 2.78e-01 | -1.68e-01 | 7.35e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR | 6 | 4.77e-01 | 1.68e-01 | 8.49e-01 |
GOBP REGULATION OF TRANSLATIONAL TERMINATION | 9 | 3.84e-01 | 1.67e-01 | 8.04e-01 |
GOBP AMINO ACID SALVAGE | 5 | 5.17e-01 | 1.67e-01 | 8.66e-01 |
GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 5.17e-01 | 1.67e-01 | 8.66e-01 |
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 22 | 1.74e-01 | 1.67e-01 | 6.57e-01 |
GOCC GOLGI MEDIAL CISTERNA | 11 | 3.36e-01 | -1.67e-01 | 7.79e-01 |
GOBP B CELL APOPTOTIC PROCESS | 22 | 1.75e-01 | -1.67e-01 | 6.59e-01 |
GOBP PEXOPHAGY | 6 | 4.78e-01 | -1.67e-01 | 8.50e-01 |
GOBP ELECTRON TRANSPORT CHAIN | 144 | 5.56e-04 | -1.67e-01 | 4.52e-02 |
GOBP REGULATION OF HISTONE ACETYLATION | 16 | 2.48e-01 | 1.67e-01 | 7.17e-01 |
GOBP RRNA BASE METHYLATION | 8 | 4.14e-01 | 1.67e-01 | 8.21e-01 |
GOBP FEMALE MEIOSIS I | 6 | 4.79e-01 | -1.67e-01 | 8.50e-01 |
GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 8 | 4.14e-01 | -1.67e-01 | 8.21e-01 |
GOBP GOLGI TO VACUOLE TRANSPORT | 18 | 2.21e-01 | 1.67e-01 | 6.98e-01 |
GOBP INOSITOL METABOLIC PROCESS | 7 | 4.45e-01 | 1.67e-01 | 8.33e-01 |
GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 4.45e-01 | 1.67e-01 | 8.33e-01 |
GOBP SULFUR COMPOUND CATABOLIC PROCESS | 28 | 1.27e-01 | 1.67e-01 | 5.96e-01 |
GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 9 | 3.87e-01 | 1.66e-01 | 8.06e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 29 | 1.21e-01 | 1.66e-01 | 5.85e-01 |
GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 4.81e-01 | 1.66e-01 | 8.50e-01 |
GOBP REGULATION OF CATION CHANNEL ACTIVITY | 50 | 4.21e-02 | -1.66e-01 | 3.87e-01 |
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 2.22e-01 | 1.66e-01 | 7.00e-01 |
GOBP ACROSOME ASSEMBLY | 12 | 3.19e-01 | -1.66e-01 | 7.67e-01 |
GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 3.88e-01 | 1.66e-01 | 8.06e-01 |
GOBP KERATINOCYTE DIFFERENTIATION | 67 | 1.88e-02 | -1.66e-01 | 2.89e-01 |
GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 6 | 4.81e-01 | -1.66e-01 | 8.50e-01 |
GOBP LEFT RIGHT AXIS SPECIFICATION | 8 | 4.16e-01 | 1.66e-01 | 8.21e-01 |
GOBP AUTOPHAGY OF MITOCHONDRION | 85 | 8.24e-03 | -1.66e-01 | 1.90e-01 |
GOBP NEGATIVE REGULATION OF AXON EXTENSION | 22 | 1.78e-01 | -1.66e-01 | 6.61e-01 |
GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 8 | 4.17e-01 | 1.66e-01 | 8.21e-01 |
GOCC TRNA METHYLTRANSFERASE COMPLEX | 7 | 4.47e-01 | 1.66e-01 | 8.33e-01 |
GOBP POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 6 | 4.82e-01 | -1.66e-01 | 8.50e-01 |
GOBP CELL FATE SPECIFICATION | 35 | 8.99e-02 | 1.66e-01 | 5.23e-01 |
GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 30 | 1.16e-01 | -1.66e-01 | 5.79e-01 |
GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 6 | 4.82e-01 | -1.66e-01 | 8.51e-01 |
GOBP NEURON PROJECTION ORGANIZATION | 54 | 3.54e-02 | 1.66e-01 | 3.70e-01 |
GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 2.24e-01 | -1.65e-01 | 7.02e-01 |
GOBP VASCULOGENESIS | 39 | 7.39e-02 | -1.65e-01 | 4.86e-01 |
GOCC SEH1 ASSOCIATED COMPLEX | 8 | 4.18e-01 | -1.65e-01 | 8.21e-01 |
GOMF NADP BINDING | 37 | 8.18e-02 | 1.65e-01 | 5.08e-01 |
GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 24 | 1.61e-01 | 1.65e-01 | 6.42e-01 |
GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 33 | 1.00e-01 | 1.65e-01 | 5.48e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 15 | 2.68e-01 | -1.65e-01 | 7.25e-01 |
GOMF INTERLEUKIN 6 RECEPTOR BINDING | 6 | 4.83e-01 | -1.65e-01 | 8.52e-01 |
GOMF DNA BINDING BENDING | 10 | 3.66e-01 | -1.65e-01 | 7.96e-01 |
GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 12 | 3.22e-01 | -1.65e-01 | 7.69e-01 |
GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 10 | 3.66e-01 | -1.65e-01 | 7.96e-01 |
GOMF ADENYLYLTRANSFERASE ACTIVITY | 25 | 1.53e-01 | 1.65e-01 | 6.32e-01 |
GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 7 | 4.50e-01 | 1.65e-01 | 8.34e-01 |
GOCC CONDENSIN COMPLEX | 7 | 4.50e-01 | 1.65e-01 | 8.34e-01 |
GOCC PRESYNAPTIC CYTOSOL | 12 | 3.22e-01 | 1.65e-01 | 7.69e-01 |
GOCC BOX C D RNP COMPLEX | 5 | 5.23e-01 | -1.65e-01 | 8.68e-01 |
GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 7 | 4.50e-01 | 1.65e-01 | 8.34e-01 |
GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 12 | 3.23e-01 | 1.65e-01 | 7.69e-01 |
GOBP ACTIN MYOSIN FILAMENT SLIDING | 5 | 5.23e-01 | -1.65e-01 | 8.68e-01 |
GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 3.04e-01 | -1.65e-01 | 7.54e-01 |
GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 8 | 4.20e-01 | 1.65e-01 | 8.22e-01 |
GOBP QUINONE METABOLIC PROCESS | 30 | 1.18e-01 | 1.65e-01 | 5.82e-01 |
GOBP REGULATION OF ATP METABOLIC PROCESS | 17 | 2.40e-01 | -1.65e-01 | 7.13e-01 |
GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 3.67e-01 | -1.65e-01 | 7.96e-01 |
GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 5 | 5.24e-01 | -1.65e-01 | 8.68e-01 |
GOBP NEUROTRANSMITTER UPTAKE | 16 | 2.54e-01 | -1.65e-01 | 7.22e-01 |
GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS | 5 | 5.24e-01 | 1.65e-01 | 8.68e-01 |
GOBP PROTEIN DEGLYCOSYLATION | 15 | 2.70e-01 | 1.64e-01 | 7.28e-01 |
GOCC GBAF COMPLEX | 13 | 3.05e-01 | 1.64e-01 | 7.55e-01 |
GOBP REGULATION OF CENTROSOME CYCLE | 47 | 5.17e-02 | 1.64e-01 | 4.19e-01 |
GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 8 | 4.22e-01 | -1.64e-01 | 8.23e-01 |
GOBP REGULATION OF TISSUE REMODELING | 44 | 5.99e-02 | -1.64e-01 | 4.37e-01 |
GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 79 | 1.18e-02 | -1.64e-01 | 2.33e-01 |
GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION | 8 | 4.22e-01 | -1.64e-01 | 8.23e-01 |
GOMF S100 PROTEIN BINDING | 11 | 3.46e-01 | -1.64e-01 | 7.84e-01 |
GOBP RESPONSE TO EPINEPHRINE | 10 | 3.69e-01 | 1.64e-01 | 7.97e-01 |
GOBP NUCLEAR PORE ORGANIZATION | 15 | 2.72e-01 | 1.64e-01 | 7.29e-01 |
GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 5.26e-01 | 1.64e-01 | 8.69e-01 |
GOBP OXIDATIVE DEMETHYLATION | 6 | 4.87e-01 | 1.64e-01 | 8.53e-01 |
GOBP CARDIOLIPIN METABOLIC PROCESS | 13 | 3.06e-01 | -1.64e-01 | 7.57e-01 |
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 48 | 4.98e-02 | -1.64e-01 | 4.14e-01 |
GOCC PERICHROMATIN FIBRILS | 5 | 5.26e-01 | 1.64e-01 | 8.69e-01 |
GOBP CELLULAR RESPONSE TO COCAINE | 5 | 5.27e-01 | -1.64e-01 | 8.69e-01 |
GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR | 5 | 5.27e-01 | 1.63e-01 | 8.69e-01 |
GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 25 | 1.57e-01 | -1.63e-01 | 6.39e-01 |
GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 9 | 3.96e-01 | -1.63e-01 | 8.12e-01 |
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 11 | 3.48e-01 | 1.63e-01 | 7.86e-01 |
GOBP AMYLOID FIBRIL FORMATION | 29 | 1.28e-01 | -1.63e-01 | 5.97e-01 |
GOBP AXONAL TRANSPORT OF MITOCHONDRION | 11 | 3.48e-01 | -1.63e-01 | 7.86e-01 |
GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 25 | 1.58e-01 | -1.63e-01 | 6.39e-01 |
GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 11 | 3.48e-01 | 1.63e-01 | 7.86e-01 |
GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 8 | 4.24e-01 | -1.63e-01 | 8.23e-01 |
GOBP POSITIVE REGULATION OF EXOCYTOSIS | 52 | 4.18e-02 | -1.63e-01 | 3.87e-01 |
GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 22 | 1.86e-01 | -1.63e-01 | 6.69e-01 |
GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 11 | 3.50e-01 | 1.63e-01 | 7.86e-01 |
GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 33 | 1.06e-01 | 1.63e-01 | 5.57e-01 |
GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 2.45e-01 | 1.63e-01 | 7.14e-01 |
GOMF HORMONE ACTIVITY | 16 | 2.60e-01 | -1.63e-01 | 7.24e-01 |
GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 25 | 1.59e-01 | -1.63e-01 | 6.41e-01 |
GOBP VENTRAL SPINAL CORD DEVELOPMENT | 16 | 2.60e-01 | 1.63e-01 | 7.24e-01 |
GOBP LIPOPROTEIN LOCALIZATION | 14 | 2.92e-01 | -1.63e-01 | 7.47e-01 |
GOCC ACTOMYOSIN | 53 | 4.08e-02 | -1.63e-01 | 3.83e-01 |
GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 21 | 1.98e-01 | 1.62e-01 | 6.78e-01 |
GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 20 | 2.09e-01 | 1.62e-01 | 6.87e-01 |
GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY | 5 | 5.30e-01 | -1.62e-01 | 8.70e-01 |
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 7 | 4.58e-01 | 1.62e-01 | 8.39e-01 |
GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 19 | 2.22e-01 | -1.62e-01 | 6.99e-01 |
GOBP ESTROUS CYCLE | 10 | 3.75e-01 | 1.62e-01 | 8.00e-01 |
GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 17 | 2.48e-01 | -1.62e-01 | 7.17e-01 |
GOCC PERICENTRIC HETEROCHROMATIN | 27 | 1.46e-01 | 1.62e-01 | 6.21e-01 |
GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 9 | 4.01e-01 | 1.62e-01 | 8.15e-01 |
GOMF AMINO ACID BINDING | 21 | 2.00e-01 | -1.62e-01 | 6.79e-01 |
GOBP FIBROBLAST APOPTOTIC PROCESS | 20 | 2.11e-01 | -1.62e-01 | 6.87e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 84 | 1.06e-02 | -1.62e-01 | 2.18e-01 |
GOBP PLATELET DEGRANULATION | 6 | 4.93e-01 | -1.62e-01 | 8.56e-01 |
GOBP MITOTIC SISTER CHROMATID SEPARATION | 44 | 6.43e-02 | 1.61e-01 | 4.53e-01 |
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 16 | 2.65e-01 | -1.61e-01 | 7.25e-01 |
GOBP SENSORY PERCEPTION OF SMELL | 14 | 2.97e-01 | 1.61e-01 | 7.49e-01 |
GOBP NEGATIVE REGULATION OF OSSIFICATION | 19 | 2.25e-01 | -1.61e-01 | 7.02e-01 |
GOBP T CELL MEDIATED CYTOTOXICITY | 44 | 6.48e-02 | 1.61e-01 | 4.55e-01 |
GOBP GDP METABOLIC PROCESS | 11 | 3.55e-01 | -1.61e-01 | 7.90e-01 |
GOBP SPERM FLAGELLUM ASSEMBLY | 17 | 2.51e-01 | -1.61e-01 | 7.19e-01 |
GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 18 | 2.38e-01 | 1.61e-01 | 7.11e-01 |
GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 9 | 4.04e-01 | -1.61e-01 | 8.16e-01 |
GOBP REGULATION OF LEUKOCYTE MIGRATION | 152 | 6.42e-04 | -1.61e-01 | 4.95e-02 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 7 | 4.62e-01 | 1.61e-01 | 8.42e-01 |
GOBP GPI ANCHOR METABOLIC PROCESS | 28 | 1.41e-01 | 1.61e-01 | 6.14e-01 |
GOBP REGULATION OF VESICLE SIZE | 18 | 2.38e-01 | -1.61e-01 | 7.11e-01 |
GOBP AXO DENDRITIC PROTEIN TRANSPORT | 6 | 4.96e-01 | -1.61e-01 | 8.57e-01 |
GOBP REGULATION OF VASCULAR WOUND HEALING | 6 | 4.96e-01 | -1.61e-01 | 8.57e-01 |
GOBP REGULATION OF DNA METHYLATION | 13 | 3.17e-01 | -1.60e-01 | 7.64e-01 |
GOBP PROTEIN HETEROOLIGOMERIZATION | 19 | 2.26e-01 | -1.60e-01 | 7.02e-01 |
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 19 | 2.26e-01 | -1.60e-01 | 7.02e-01 |
GOBP CYTOPLASM ORGANIZATION | 8 | 4.32e-01 | -1.60e-01 | 8.26e-01 |
GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 31 | 1.23e-01 | -1.60e-01 | 5.87e-01 |
GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 13 | 3.17e-01 | 1.60e-01 | 7.65e-01 |
GOBP CELL MATRIX ADHESION | 142 | 9.98e-04 | -1.60e-01 | 6.34e-02 |
GOBP MEMBRANE LIPID CATABOLIC PROCESS | 27 | 1.50e-01 | -1.60e-01 | 6.28e-01 |
GOMF FATTY ACID DERIVATIVE BINDING | 13 | 3.17e-01 | -1.60e-01 | 7.65e-01 |
GOBP ACTIN FILAMENT NETWORK FORMATION | 5 | 5.35e-01 | -1.60e-01 | 8.73e-01 |
GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 16 | 2.68e-01 | 1.60e-01 | 7.25e-01 |
GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 6 | 4.97e-01 | -1.60e-01 | 8.59e-01 |
GOCC PLATELET ALPHA GRANULE MEMBRANE | 12 | 3.37e-01 | 1.60e-01 | 7.80e-01 |
GOCC SYNAPTONEMAL STRUCTURE | 20 | 2.16e-01 | -1.60e-01 | 6.91e-01 |
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 5.36e-01 | 1.60e-01 | 8.73e-01 |
GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 9 | 4.06e-01 | -1.60e-01 | 8.17e-01 |
GOMF GDP PHOSPHATASE ACTIVITY | 7 | 4.64e-01 | 1.60e-01 | 8.42e-01 |
GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 4.34e-01 | -1.60e-01 | 8.27e-01 |
GOBP REGULATION OF CHROMOSOME SEGREGATION | 99 | 6.07e-03 | 1.60e-01 | 1.65e-01 |
GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 8 | 4.34e-01 | -1.60e-01 | 8.27e-01 |
GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 20 | 2.16e-01 | -1.60e-01 | 6.92e-01 |
GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 9 | 4.07e-01 | 1.60e-01 | 8.17e-01 |
GOBP DETECTION OF BIOTIC STIMULUS | 27 | 1.51e-01 | 1.60e-01 | 6.29e-01 |
GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 5 | 5.36e-01 | 1.60e-01 | 8.73e-01 |
GOBP REGULATION OF HEART GROWTH | 27 | 1.51e-01 | -1.60e-01 | 6.29e-01 |
GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 27 | 1.51e-01 | -1.60e-01 | 6.29e-01 |
GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 65 | 2.61e-02 | -1.60e-01 | 3.30e-01 |
GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 10 | 3.83e-01 | -1.60e-01 | 8.03e-01 |
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 23 | 1.86e-01 | -1.59e-01 | 6.69e-01 |
GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 40 | 8.12e-02 | -1.59e-01 | 5.08e-01 |
GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 11 | 3.61e-01 | 1.59e-01 | 7.92e-01 |
GOBP DITERPENOID BIOSYNTHETIC PROCESS | 5 | 5.38e-01 | 1.59e-01 | 8.73e-01 |
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 24 | 1.78e-01 | 1.59e-01 | 6.61e-01 |
GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY | 5 | 5.38e-01 | 1.59e-01 | 8.73e-01 |
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 5.38e-01 | 1.59e-01 | 8.73e-01 |
GOCC AP 1 ADAPTOR COMPLEX | 10 | 3.84e-01 | 1.59e-01 | 8.04e-01 |
GOCC IKAPPAB KINASE COMPLEX | 5 | 5.38e-01 | -1.59e-01 | 8.73e-01 |
GOBP CHROMOSOME SEPARATION | 58 | 3.67e-02 | 1.59e-01 | 3.75e-01 |
GOMF SIRNA BINDING | 10 | 3.85e-01 | -1.59e-01 | 8.04e-01 |
GOBP RNA DECAPPING | 18 | 2.44e-01 | -1.59e-01 | 7.14e-01 |
GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 21 | 2.09e-01 | 1.59e-01 | 6.87e-01 |
GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 41 | 7.95e-02 | -1.58e-01 | 5.04e-01 |
GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 9 | 4.11e-01 | 1.58e-01 | 8.21e-01 |
GOBP REGULATION OF PIGMENTATION | 10 | 3.86e-01 | -1.58e-01 | 8.05e-01 |
GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 113 | 3.73e-03 | -1.58e-01 | 1.30e-01 |
GOBP RESPONSE TO CAFFEINE | 11 | 3.64e-01 | -1.58e-01 | 7.95e-01 |
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 8 | 4.39e-01 | 1.58e-01 | 8.29e-01 |
GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 13 | 3.24e-01 | 1.58e-01 | 7.69e-01 |
GOCC INTRACILIARY TRANSPORT PARTICLE | 21 | 2.10e-01 | -1.58e-01 | 6.87e-01 |
GOBP COCHLEA DEVELOPMENT | 13 | 3.24e-01 | 1.58e-01 | 7.69e-01 |
GOBP ARACHIDONIC ACID SECRETION | 9 | 4.12e-01 | -1.58e-01 | 8.21e-01 |
GOBP MICROTUBULE DEPOLYMERIZATION | 29 | 1.41e-01 | 1.58e-01 | 6.14e-01 |
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 3.24e-01 | -1.58e-01 | 7.69e-01 |
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 22 | 2.00e-01 | -1.58e-01 | 6.80e-01 |
GOBP RESPONSE TO COLD | 29 | 1.42e-01 | -1.58e-01 | 6.14e-01 |
GOBP POSITIVE REGULATION OF OSSIFICATION | 31 | 1.29e-01 | -1.58e-01 | 5.98e-01 |
GOBP CELLULAR RESPONSE TO CAMP | 26 | 1.64e-01 | -1.58e-01 | 6.47e-01 |
GOMF FAD BINDING | 29 | 1.43e-01 | 1.57e-01 | 6.15e-01 |
GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 19 | 2.35e-01 | -1.57e-01 | 7.10e-01 |
GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 12 | 3.45e-01 | 1.57e-01 | 7.83e-01 |
GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 13 | 3.26e-01 | 1.57e-01 | 7.69e-01 |
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 27 | 1.57e-01 | -1.57e-01 | 6.39e-01 |
GOBP CORTICOSTEROID HORMONE SECRETION | 11 | 3.66e-01 | -1.57e-01 | 7.96e-01 |
GOBP RESPONSE TO TYPE II INTERFERON | 103 | 5.87e-03 | -1.57e-01 | 1.62e-01 |
GOBP LUTEINIZATION | 6 | 5.05e-01 | -1.57e-01 | 8.62e-01 |
GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 17 | 2.62e-01 | 1.57e-01 | 7.24e-01 |
GOBP STRESS GRANULE ASSEMBLY | 28 | 1.50e-01 | -1.57e-01 | 6.28e-01 |
GOBP CARDIAC MYOFIBRIL ASSEMBLY | 7 | 4.72e-01 | -1.57e-01 | 8.46e-01 |
GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 17 | 2.63e-01 | 1.57e-01 | 7.24e-01 |
GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 14 | 3.10e-01 | -1.57e-01 | 7.58e-01 |
GOBP RIBOSOME ASSEMBLY | 57 | 4.07e-02 | -1.57e-01 | 3.83e-01 |
GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 5 | 5.44e-01 | 1.57e-01 | 8.75e-01 |
GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 4.43e-01 | -1.57e-01 | 8.32e-01 |
GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 18 | 2.51e-01 | -1.56e-01 | 7.19e-01 |
GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 4.74e-01 | -1.56e-01 | 8.47e-01 |
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 110 | 4.64e-03 | -1.56e-01 | 1.42e-01 |
GOBP INDOLALKYLAMINE METABOLIC PROCESS | 10 | 3.92e-01 | 1.56e-01 | 8.09e-01 |
GOBP REGULATION OF STEROL TRANSPORT | 34 | 1.15e-01 | -1.56e-01 | 5.78e-01 |
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 13 | 3.29e-01 | 1.56e-01 | 7.73e-01 |
GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 9 | 4.17e-01 | 1.56e-01 | 8.21e-01 |
GOMF MHC CLASS IB PROTEIN BINDING | 6 | 5.08e-01 | 1.56e-01 | 8.62e-01 |
GOBP REGULATION OF FIBROBLAST PROLIFERATION | 55 | 4.54e-02 | -1.56e-01 | 4.00e-01 |
GOBP GANGLIOSIDE METABOLIC PROCESS | 22 | 2.05e-01 | -1.56e-01 | 6.85e-01 |
GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 7 | 4.75e-01 | 1.56e-01 | 8.47e-01 |
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 9 | 4.18e-01 | -1.56e-01 | 8.21e-01 |
GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 9 | 4.18e-01 | 1.56e-01 | 8.21e-01 |
GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 5 | 5.46e-01 | -1.56e-01 | 8.75e-01 |
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 49 | 5.94e-02 | -1.56e-01 | 4.35e-01 |
GOMF ENDONUCLEASE ACTIVITY | 99 | 7.49e-03 | 1.56e-01 | 1.82e-01 |
GOBP PROTEOGLYCAN CATABOLIC PROCESS | 9 | 4.19e-01 | 1.56e-01 | 8.22e-01 |
GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 12 | 3.51e-01 | 1.55e-01 | 7.87e-01 |
GOBP OPTIC NERVE DEVELOPMENT | 11 | 3.72e-01 | -1.55e-01 | 7.99e-01 |
GOBP EPITHELIAL CELL MATURATION | 12 | 3.51e-01 | -1.55e-01 | 7.87e-01 |
GOMF RIBONUCLEASE P ACTIVITY | 11 | 3.72e-01 | 1.55e-01 | 7.99e-01 |
GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 5 | 5.48e-01 | -1.55e-01 | 8.75e-01 |
GOCC SYNAPTIC CLEFT | 6 | 5.10e-01 | -1.55e-01 | 8.64e-01 |
GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 34 | 1.18e-01 | -1.55e-01 | 5.80e-01 |
GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 43 | 7.85e-02 | -1.55e-01 | 4.99e-01 |
GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 12 | 3.52e-01 | 1.55e-01 | 7.88e-01 |
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 22 | 2.08e-01 | 1.55e-01 | 6.87e-01 |
GOCC TERTIARY GRANULE MEMBRANE | 63 | 3.36e-02 | -1.55e-01 | 3.61e-01 |
GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 26 | 1.72e-01 | -1.55e-01 | 6.55e-01 |
GOBP SNRNA METABOLIC PROCESS | 53 | 5.15e-02 | 1.55e-01 | 4.19e-01 |
GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 5 | 5.49e-01 | -1.55e-01 | 8.76e-01 |
GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 4.22e-01 | 1.55e-01 | 8.23e-01 |
GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 5.49e-01 | 1.55e-01 | 8.76e-01 |
GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 14 | 3.17e-01 | 1.55e-01 | 7.64e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 40 | 9.09e-02 | -1.55e-01 | 5.24e-01 |
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 8 | 4.49e-01 | 1.55e-01 | 8.34e-01 |
GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 8 | 4.49e-01 | 1.55e-01 | 8.34e-01 |
GOCC THO COMPLEX | 6 | 5.12e-01 | 1.55e-01 | 8.66e-01 |
GOBP REGULATION OF WOUND HEALING | 62 | 3.55e-02 | -1.55e-01 | 3.70e-01 |
GOCC PLATELET ALPHA GRANULE | 56 | 4.57e-02 | -1.54e-01 | 4.00e-01 |
GOBP MAST CELL MEDIATED IMMUNITY | 47 | 6.72e-02 | -1.54e-01 | 4.61e-01 |
GOBP RESPONSE TO ALDOSTERONE | 11 | 3.75e-01 | 1.54e-01 | 8.00e-01 |
GOBP NEGATIVE REGULATION OF ANOIKIS | 13 | 3.35e-01 | -1.54e-01 | 7.79e-01 |
GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 10 | 3.98e-01 | 1.54e-01 | 8.13e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 32 | 1.31e-01 | -1.54e-01 | 6.02e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 18 | 2.57e-01 | -1.54e-01 | 7.24e-01 |
GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 6 | 5.13e-01 | -1.54e-01 | 8.66e-01 |
GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 24 | 1.91e-01 | -1.54e-01 | 6.74e-01 |
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 12 | 3.55e-01 | -1.54e-01 | 7.90e-01 |
GOMF CARBON OXYGEN LYASE ACTIVITY | 54 | 5.03e-02 | 1.54e-01 | 4.15e-01 |
GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 5 | 5.51e-01 | -1.54e-01 | 8.76e-01 |
GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL | 7 | 4.81e-01 | -1.54e-01 | 8.50e-01 |
GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 38 | 1.01e-01 | -1.54e-01 | 5.49e-01 |
GOBP RESPONSE TO PROSTAGLANDIN | 18 | 2.58e-01 | -1.54e-01 | 7.24e-01 |
GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 13 | 3.37e-01 | -1.54e-01 | 7.80e-01 |
GOBP DETOXIFICATION | 84 | 1.49e-02 | -1.54e-01 | 2.62e-01 |
GOBP RESPONSE TO FATTY ACID | 34 | 1.21e-01 | -1.54e-01 | 5.84e-01 |
GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 5.52e-01 | 1.54e-01 | 8.77e-01 |
GOBP L KYNURENINE METABOLIC PROCESS | 5 | 5.52e-01 | -1.54e-01 | 8.77e-01 |
GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 4.01e-01 | 1.54e-01 | 8.15e-01 |
GOMF RIBONUCLEASE P RNA BINDING | 10 | 4.01e-01 | 1.54e-01 | 8.15e-01 |
GOBP CELLULAR RESPONSE TO IRON ION | 7 | 4.82e-01 | 1.54e-01 | 8.50e-01 |
GOBP REGULATION OF ACTION POTENTIAL | 27 | 1.68e-01 | -1.53e-01 | 6.50e-01 |
GOBP ACTIVATED T CELL PROLIFERATION | 35 | 1.16e-01 | -1.53e-01 | 5.79e-01 |
GOBP ACID SECRETION | 21 | 2.24e-01 | 1.53e-01 | 7.02e-01 |
GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 3.78e-01 | 1.53e-01 | 8.02e-01 |
GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 2.13e-01 | 1.53e-01 | 6.89e-01 |
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 4.26e-01 | 1.53e-01 | 8.23e-01 |
GOBP NEGATIVE REGULATION OF CELL DIVISION | 9 | 4.26e-01 | 1.53e-01 | 8.23e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 48 | 6.64e-02 | -1.53e-01 | 4.59e-01 |
GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 5.16e-01 | 1.53e-01 | 8.66e-01 |
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 59 | 4.20e-02 | -1.53e-01 | 3.87e-01 |
GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 79 | 1.87e-02 | -1.53e-01 | 2.89e-01 |
GOBP CILIUM MOVEMENT | 75 | 2.20e-02 | 1.53e-01 | 3.05e-01 |
GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 15 | 3.05e-01 | 1.53e-01 | 7.55e-01 |
GOBP SYNAPTIC VESICLE RECYCLING | 59 | 4.21e-02 | -1.53e-01 | 3.87e-01 |
GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 24 | 1.95e-01 | 1.53e-01 | 6.75e-01 |
GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 42 | 8.68e-02 | 1.53e-01 | 5.19e-01 |
GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 160 | 8.74e-04 | -1.53e-01 | 5.90e-02 |
GOBP RNA MODIFICATION | 160 | 8.76e-04 | 1.53e-01 | 5.90e-02 |
GOBP MAINTENANCE OF ORGANELLE LOCATION | 11 | 3.81e-01 | 1.53e-01 | 8.02e-01 |
GOBP TRNA 5 LEADER REMOVAL | 13 | 3.41e-01 | 1.53e-01 | 7.81e-01 |
GOMF INTEGRIN BINDING | 77 | 2.07e-02 | -1.53e-01 | 2.98e-01 |
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 11 | 3.81e-01 | -1.53e-01 | 8.02e-01 |
GOCC PRP19 COMPLEX | 12 | 3.60e-01 | -1.53e-01 | 7.92e-01 |
GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 5 | 5.55e-01 | -1.53e-01 | 8.77e-01 |
GOBP REGULATION OF CALCIUM ION IMPORT | 15 | 3.06e-01 | -1.53e-01 | 7.57e-01 |
GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 5.18e-01 | 1.53e-01 | 8.67e-01 |
GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 24 | 1.96e-01 | -1.52e-01 | 6.76e-01 |
GOCC SITE OF DNA DAMAGE | 105 | 7.04e-03 | 1.52e-01 | 1.78e-01 |
GOMF FLOPPASE ACTIVITY | 14 | 3.24e-01 | 1.52e-01 | 7.69e-01 |
GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 7 | 4.85e-01 | -1.52e-01 | 8.53e-01 |
GOBP SUGAR MEDIATED SIGNALING PATHWAY | 5 | 5.55e-01 | 1.52e-01 | 8.78e-01 |
GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 10 | 4.04e-01 | -1.52e-01 | 8.17e-01 |
GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 103 | 7.66e-03 | -1.52e-01 | 1.83e-01 |
GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 5.56e-01 | -1.52e-01 | 8.78e-01 |
GOBP REGULATION OF CELL SHAPE | 98 | 9.33e-03 | -1.52e-01 | 2.01e-01 |
GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 40 | 9.61e-02 | -1.52e-01 | 5.38e-01 |
GOBP CELL CHEMOTAXIS | 194 | 2.71e-04 | -1.52e-01 | 2.84e-02 |
GOBP NUCLEOBASE METABOLIC PROCESS | 29 | 1.57e-01 | 1.52e-01 | 6.39e-01 |
GOMF ACTIVIN BINDING | 9 | 4.30e-01 | -1.52e-01 | 8.25e-01 |
GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 4.86e-01 | 1.52e-01 | 8.53e-01 |
GOBP VIRAL PROTEIN PROCESSING | 30 | 1.50e-01 | -1.52e-01 | 6.28e-01 |
GOBP RESPONSE TO HYDROGEN PEROXIDE | 87 | 1.44e-02 | -1.52e-01 | 2.61e-01 |
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 73 | 2.50e-02 | -1.52e-01 | 3.25e-01 |
GOMF CATALYTIC ACTIVITY ACTING ON RNA | 336 | 1.91e-06 | 1.52e-01 | 8.51e-04 |
GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 21 | 2.29e-01 | -1.52e-01 | 7.02e-01 |
GOBP SYNAPTIC VESICLE CLUSTERING | 6 | 5.20e-01 | -1.52e-01 | 8.68e-01 |
GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 7 | 4.87e-01 | -1.52e-01 | 8.53e-01 |
GOBP NEUTROPHIL CHEMOTAXIS | 68 | 3.07e-02 | -1.52e-01 | 3.49e-01 |
GOMF CARBONATE DEHYDRATASE ACTIVITY | 5 | 5.57e-01 | 1.52e-01 | 8.79e-01 |
GOBP HEAD MORPHOGENESIS | 22 | 2.19e-01 | -1.52e-01 | 6.96e-01 |
GOBP CELLULAR RESPONSE TO VITAMIN D | 11 | 3.84e-01 | -1.51e-01 | 8.04e-01 |
GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.21e-01 | -1.51e-01 | 8.68e-01 |
GOBP ERYTHROCYTE DEVELOPMENT | 29 | 1.58e-01 | -1.51e-01 | 6.39e-01 |
GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 14 | 3.27e-01 | 1.51e-01 | 7.70e-01 |
GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 8 | 4.58e-01 | -1.51e-01 | 8.40e-01 |
GOMF DOPAMINE RECEPTOR BINDING | 10 | 4.08e-01 | -1.51e-01 | 8.17e-01 |
GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 27 | 1.74e-01 | -1.51e-01 | 6.56e-01 |
GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 18 | 2.67e-01 | -1.51e-01 | 7.25e-01 |
GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 6 | 5.21e-01 | -1.51e-01 | 8.68e-01 |
GOBP LYSOSOMAL LUMEN ACIDIFICATION | 22 | 2.20e-01 | -1.51e-01 | 6.96e-01 |
GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 35 | 1.22e-01 | -1.51e-01 | 5.86e-01 |
GOBP HISTONE DEACETYLATION | 20 | 2.42e-01 | 1.51e-01 | 7.14e-01 |
GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 10 | 4.08e-01 | 1.51e-01 | 8.17e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 4.89e-01 | 1.51e-01 | 8.54e-01 |
GOCC AP 3 ADAPTOR COMPLEX | 8 | 4.60e-01 | 1.51e-01 | 8.40e-01 |
GOMF TAU PROTEIN KINASE ACTIVITY | 19 | 2.55e-01 | 1.51e-01 | 7.22e-01 |
GOBP XENOBIOTIC CATABOLIC PROCESS | 8 | 4.60e-01 | -1.51e-01 | 8.40e-01 |
GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 6 | 5.22e-01 | -1.51e-01 | 8.68e-01 |
GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 12 | 3.66e-01 | -1.51e-01 | 7.96e-01 |
GOCC MEIOTIC COHESIN COMPLEX | 6 | 5.22e-01 | -1.51e-01 | 8.68e-01 |
GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 16 | 2.96e-01 | 1.51e-01 | 7.49e-01 |
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 25 | 1.92e-01 | -1.51e-01 | 6.75e-01 |
GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 9 | 4.34e-01 | 1.51e-01 | 8.27e-01 |
GOBP NK T CELL ACTIVATION | 11 | 3.87e-01 | -1.51e-01 | 8.06e-01 |
GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 20 | 2.44e-01 | -1.51e-01 | 7.14e-01 |
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 16 | 2.97e-01 | -1.51e-01 | 7.49e-01 |
GOBP THYROID GLAND DEVELOPMENT | 16 | 2.98e-01 | -1.50e-01 | 7.49e-01 |
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 6 | 5.23e-01 | 1.50e-01 | 8.68e-01 |
GOBP ENDOTHELIAL CELL DEVELOPMENT | 47 | 7.46e-02 | -1.50e-01 | 4.88e-01 |
GOMF GUANYLATE KINASE ACTIVITY | 9 | 4.35e-01 | -1.50e-01 | 8.27e-01 |
GOBP REFLEX | 5 | 5.61e-01 | -1.50e-01 | 8.80e-01 |
GOBP KERATINOCYTE APOPTOTIC PROCESS | 5 | 5.61e-01 | -1.50e-01 | 8.80e-01 |
GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 144 | 1.91e-03 | -1.50e-01 | 8.96e-02 |
GOBP LIPOXYGENASE PATHWAY | 5 | 5.61e-01 | -1.50e-01 | 8.80e-01 |
GOBP PROGESTERONE METABOLIC PROCESS | 8 | 4.62e-01 | 1.50e-01 | 8.42e-01 |
GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 8 | 4.62e-01 | -1.50e-01 | 8.42e-01 |
GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 12 | 3.68e-01 | 1.50e-01 | 7.96e-01 |
GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 6 | 5.25e-01 | 1.50e-01 | 8.69e-01 |
GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 5.25e-01 | -1.50e-01 | 8.69e-01 |
GOCC ESCRT COMPLEX | 25 | 1.95e-01 | -1.50e-01 | 6.75e-01 |
GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 20 | 2.46e-01 | -1.50e-01 | 7.15e-01 |
GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 4.92e-01 | -1.50e-01 | 8.55e-01 |
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 34 | 1.31e-01 | -1.50e-01 | 6.02e-01 |
GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 8 | 4.64e-01 | -1.50e-01 | 8.42e-01 |
GOBP GAP JUNCTION ASSEMBLY | 5 | 5.62e-01 | 1.50e-01 | 8.80e-01 |
GOBP REGULATION OF RNA SPLICING | 152 | 1.48e-03 | -1.50e-01 | 7.92e-02 |
GOBP PURINE NUCLEOTIDE TRANSPORT | 28 | 1.71e-01 | 1.50e-01 | 6.54e-01 |
GOMF MRNA 5 UTR BINDING | 23 | 2.14e-01 | -1.50e-01 | 6.89e-01 |
GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 16 | 3.00e-01 | -1.50e-01 | 7.52e-01 |
GOCC MULTIVESICULAR BODY MEMBRANE | 21 | 2.35e-01 | -1.50e-01 | 7.10e-01 |
GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 10 | 4.13e-01 | 1.50e-01 | 8.21e-01 |
GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 38 | 1.11e-01 | -1.50e-01 | 5.71e-01 |
GOCC FICOLIN 1 RICH GRANULE LUMEN | 122 | 4.40e-03 | -1.50e-01 | 1.39e-01 |
GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 28 | 1.71e-01 | -1.50e-01 | 6.54e-01 |
GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 5 | 5.63e-01 | -1.49e-01 | 8.80e-01 |
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 7 | 4.94e-01 | 1.49e-01 | 8.56e-01 |
GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 22 | 2.26e-01 | -1.49e-01 | 7.02e-01 |
GOBP REGULATION OF HEART RATE | 44 | 8.69e-02 | -1.49e-01 | 5.19e-01 |
GOBP MYELOID LEUKOCYTE MIGRATION | 154 | 1.42e-03 | -1.49e-01 | 7.76e-02 |
GOBP PSEUDOURIDINE SYNTHESIS | 18 | 2.73e-01 | 1.49e-01 | 7.30e-01 |
GOMF C2H2 ZINC FINGER DOMAIN BINDING | 9 | 4.38e-01 | 1.49e-01 | 8.29e-01 |
GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 49 | 7.12e-02 | -1.49e-01 | 4.75e-01 |
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 11 | 3.92e-01 | 1.49e-01 | 8.10e-01 |
GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 19 | 2.61e-01 | -1.49e-01 | 7.24e-01 |
GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 21 | 2.37e-01 | -1.49e-01 | 7.11e-01 |
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 56 | 5.40e-02 | 1.49e-01 | 4.23e-01 |
GOBP REGULATION OF TRANSPORTER ACTIVITY | 122 | 4.59e-03 | -1.49e-01 | 1.42e-01 |
GOBP AMINE TRANSPORT | 42 | 9.55e-02 | -1.49e-01 | 5.37e-01 |
GOMF CYTOKINE ACTIVITY | 76 | 2.51e-02 | -1.49e-01 | 3.25e-01 |
GOBP PROSTANOID BIOSYNTHETIC PROCESS | 20 | 2.50e-01 | 1.49e-01 | 7.18e-01 |
GOBP REGULATION OF MUSCLE CONTRACTION | 81 | 2.09e-02 | -1.49e-01 | 2.99e-01 |
GOCC PLATELET DENSE GRANULE LUMEN | 5 | 5.65e-01 | 1.49e-01 | 8.81e-01 |
GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 5.29e-01 | 1.49e-01 | 8.69e-01 |
GOMF TAT PROTEIN BINDING | 9 | 4.41e-01 | -1.48e-01 | 8.29e-01 |
GOBP EXTRACELLULAR TRANSPORT | 25 | 1.99e-01 | 1.48e-01 | 6.79e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 15 | 3.20e-01 | 1.48e-01 | 7.68e-01 |
GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 16 | 3.04e-01 | -1.48e-01 | 7.54e-01 |
GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 4.67e-01 | 1.48e-01 | 8.45e-01 |
GOBP BODY FLUID SECRETION | 46 | 8.20e-02 | -1.48e-01 | 5.08e-01 |
GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 30 | 1.60e-01 | -1.48e-01 | 6.42e-01 |
GOBP AEROBIC RESPIRATION | 172 | 8.13e-04 | -1.48e-01 | 5.65e-02 |
GOBP REGULATION OF BONE REMODELING | 28 | 1.75e-01 | -1.48e-01 | 6.58e-01 |
GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 11 | 3.95e-01 | 1.48e-01 | 8.12e-01 |
GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 8 | 4.68e-01 | -1.48e-01 | 8.45e-01 |
GOBP DENTATE GYRUS DEVELOPMENT | 11 | 3.95e-01 | -1.48e-01 | 8.12e-01 |
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 6 | 5.30e-01 | 1.48e-01 | 8.70e-01 |
GOBP DENDRITIC SPINE MORPHOGENESIS | 33 | 1.41e-01 | 1.48e-01 | 6.14e-01 |
GOCC ESCRT I COMPLEX | 10 | 4.18e-01 | -1.48e-01 | 8.21e-01 |
GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 12 | 3.75e-01 | -1.48e-01 | 8.00e-01 |
GOMF BH DOMAIN BINDING | 7 | 4.98e-01 | -1.48e-01 | 8.59e-01 |
GOBP INTERLEUKIN 17 PRODUCTION | 30 | 1.61e-01 | -1.48e-01 | 6.42e-01 |
GOMF PRERIBOSOME BINDING | 8 | 4.69e-01 | -1.48e-01 | 8.45e-01 |
GOBP RESPONSE TO PROGESTERONE | 26 | 1.92e-01 | -1.48e-01 | 6.75e-01 |
GOBP XENOBIOTIC EXPORT FROM CELL | 8 | 4.69e-01 | -1.48e-01 | 8.45e-01 |
GOBP MANNOSE METABOLIC PROCESS | 9 | 4.42e-01 | 1.48e-01 | 8.30e-01 |
GOBP TERPENOID BIOSYNTHETIC PROCESS | 9 | 4.42e-01 | 1.48e-01 | 8.31e-01 |
GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 14 | 3.38e-01 | -1.48e-01 | 7.80e-01 |
GOBP BARBED END ACTIN FILAMENT CAPPING | 19 | 2.65e-01 | -1.48e-01 | 7.25e-01 |
GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 1.69e-01 | -1.48e-01 | 6.51e-01 |
GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 7 | 4.99e-01 | 1.48e-01 | 8.59e-01 |
GOBP POLYOL TRANSMEMBRANE TRANSPORT | 5 | 5.68e-01 | -1.47e-01 | 8.83e-01 |
GOMF RECEPTOR ANTAGONIST ACTIVITY | 5 | 5.68e-01 | -1.47e-01 | 8.83e-01 |
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 14 | 3.40e-01 | 1.47e-01 | 7.81e-01 |
GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 3.98e-01 | 1.47e-01 | 8.13e-01 |
GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 8 | 4.71e-01 | -1.47e-01 | 8.46e-01 |
GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 3.40e-01 | -1.47e-01 | 7.81e-01 |
GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 31 | 1.56e-01 | -1.47e-01 | 6.39e-01 |
GOBP CORONARY ARTERY MORPHOGENESIS | 6 | 5.33e-01 | 1.47e-01 | 8.73e-01 |
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 10 | 4.21e-01 | -1.47e-01 | 8.23e-01 |
GOBP POLYAMINE BIOSYNTHETIC PROCESS | 12 | 3.78e-01 | -1.47e-01 | 8.02e-01 |
GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 16 | 3.09e-01 | -1.47e-01 | 7.58e-01 |
GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 20 | 2.56e-01 | -1.47e-01 | 7.23e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 6 | 5.33e-01 | -1.47e-01 | 8.73e-01 |
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 128 | 4.17e-03 | -1.47e-01 | 1.37e-01 |
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 35 | 1.33e-01 | 1.47e-01 | 6.05e-01 |
GOBP ATP METABOLIC PROCESS | 117 | 6.22e-03 | -1.47e-01 | 1.66e-01 |
GOBP POSITIVE REGULATION OF ORGAN GROWTH | 18 | 2.82e-01 | -1.47e-01 | 7.38e-01 |
GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 6 | 5.34e-01 | -1.47e-01 | 8.73e-01 |
GOBP CARDIAC CONDUCTION | 40 | 1.09e-01 | -1.47e-01 | 5.67e-01 |
GOBP DETERMINATION OF ADULT LIFESPAN | 21 | 2.46e-01 | 1.46e-01 | 7.15e-01 |
GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 7 | 5.03e-01 | -1.46e-01 | 8.61e-01 |
GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 57 | 5.63e-02 | 1.46e-01 | 4.28e-01 |
GOCC BRCA1 A COMPLEX | 8 | 4.74e-01 | -1.46e-01 | 8.47e-01 |
GOCC MANCHETTE | 10 | 4.24e-01 | -1.46e-01 | 8.23e-01 |
GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 12 | 3.81e-01 | 1.46e-01 | 8.02e-01 |
GOCC STEREOCILIUM TIP | 8 | 4.74e-01 | -1.46e-01 | 8.47e-01 |
GOBP REGULATION OF TOLERANCE INDUCTION | 15 | 3.28e-01 | -1.46e-01 | 7.70e-01 |
GOBP DAMP METABOLIC PROCESS | 5 | 5.72e-01 | -1.46e-01 | 8.85e-01 |
GOCC MLL1 2 COMPLEX | 32 | 1.53e-01 | 1.46e-01 | 6.32e-01 |
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 25 | 2.07e-01 | 1.46e-01 | 6.87e-01 |
GOBP HISTIDINE METABOLIC PROCESS | 6 | 5.36e-01 | 1.46e-01 | 8.73e-01 |
GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 9 | 4.48e-01 | 1.46e-01 | 8.34e-01 |
GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 16 | 3.12e-01 | -1.46e-01 | 7.62e-01 |
GOBP MOTILE CILIUM ASSEMBLY | 31 | 1.60e-01 | -1.46e-01 | 6.42e-01 |
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 10 | 4.25e-01 | 1.46e-01 | 8.23e-01 |
GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 59 | 5.29e-02 | -1.46e-01 | 4.19e-01 |
GOCC CORNIFIED ENVELOPE | 15 | 3.29e-01 | -1.46e-01 | 7.72e-01 |
GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 9 | 4.50e-01 | 1.46e-01 | 8.34e-01 |
GOBP B CELL HOMEOSTASIS | 30 | 1.68e-01 | -1.46e-01 | 6.50e-01 |
GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 26 | 2.00e-01 | -1.45e-01 | 6.79e-01 |
GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 183 | 7.16e-04 | 1.45e-01 | 5.45e-02 |
GOBP GALACTOSE CATABOLIC PROCESS | 5 | 5.74e-01 | 1.45e-01 | 8.86e-01 |
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 12 | 3.84e-01 | -1.45e-01 | 8.04e-01 |
GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 16 | 3.15e-01 | -1.45e-01 | 7.64e-01 |
GOCC GLYCOPROTEIN COMPLEX | 11 | 4.04e-01 | 1.45e-01 | 8.17e-01 |
GOBP TRANSLATIONAL TERMINATION | 16 | 3.15e-01 | 1.45e-01 | 7.64e-01 |
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 50 | 7.60e-02 | 1.45e-01 | 4.94e-01 |
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 47 | 8.55e-02 | 1.45e-01 | 5.17e-01 |
GOBP DOPAMINE TRANSPORT | 19 | 2.74e-01 | -1.45e-01 | 7.31e-01 |
GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 13 | 3.66e-01 | 1.45e-01 | 7.96e-01 |
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 10 | 4.27e-01 | -1.45e-01 | 8.24e-01 |
GOMF RNA ENDONUCLEASE ACTIVITY | 58 | 5.64e-02 | 1.45e-01 | 4.28e-01 |
GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 8 | 4.78e-01 | 1.45e-01 | 8.49e-01 |
GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 16 | 3.16e-01 | -1.45e-01 | 7.64e-01 |
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 9 | 4.52e-01 | 1.45e-01 | 8.36e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 6 | 5.39e-01 | 1.45e-01 | 8.73e-01 |
GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 16 | 3.16e-01 | 1.45e-01 | 7.64e-01 |
GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 17 | 3.02e-01 | 1.45e-01 | 7.53e-01 |
GOCC ATAC COMPLEX | 13 | 3.67e-01 | 1.45e-01 | 7.96e-01 |
GOMF U6 SNRNA BINDING | 14 | 3.49e-01 | -1.44e-01 | 7.86e-01 |
GOCC PLATELET DENSE GRANULE MEMBRANE | 5 | 5.76e-01 | 1.44e-01 | 8.87e-01 |
GOBP MACROPHAGE DIFFERENTIATION | 47 | 8.68e-02 | -1.44e-01 | 5.19e-01 |
GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 54 | 6.65e-02 | 1.44e-01 | 4.59e-01 |
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 21 | 2.52e-01 | -1.44e-01 | 7.20e-01 |
GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.76e-01 | 1.44e-01 | 8.87e-01 |
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 14 | 3.50e-01 | 1.44e-01 | 7.86e-01 |
GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 122 | 5.96e-03 | -1.44e-01 | 1.63e-01 |
GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 15 | 3.33e-01 | 1.44e-01 | 7.76e-01 |
GOBP TRYPTOPHAN CATABOLIC PROCESS | 7 | 5.09e-01 | 1.44e-01 | 8.63e-01 |
GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 9 | 4.54e-01 | 1.44e-01 | 8.37e-01 |
GOBP ERYTHROCYTE HOMEOSTASIS | 111 | 8.77e-03 | -1.44e-01 | 1.96e-01 |
GOBP CELLULAR RESPONSE TO STEROL | 13 | 3.68e-01 | 1.44e-01 | 7.96e-01 |
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 12 | 3.87e-01 | -1.44e-01 | 8.06e-01 |
GOBP WALKING BEHAVIOR | 20 | 2.65e-01 | 1.44e-01 | 7.25e-01 |
GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY | 5 | 5.77e-01 | 1.44e-01 | 8.87e-01 |
GOBP LIPOPHAGY | 7 | 5.09e-01 | -1.44e-01 | 8.63e-01 |
GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 14 | 3.51e-01 | -1.44e-01 | 7.86e-01 |
GOBP ARTERY DEVELOPMENT | 51 | 7.56e-02 | 1.44e-01 | 4.92e-01 |
GOBP FORMATION OF PRIMARY GERM LAYER | 55 | 6.52e-02 | -1.44e-01 | 4.55e-01 |
GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 8 | 4.81e-01 | -1.44e-01 | 8.50e-01 |
GOMF PHOSPHATIDYLCHOLINE BINDING | 20 | 2.66e-01 | 1.44e-01 | 7.25e-01 |
GOBP GLIAL CELL DEVELOPMENT | 71 | 3.63e-02 | -1.44e-01 | 3.74e-01 |
GOBP BODY MORPHOGENESIS | 30 | 1.73e-01 | -1.44e-01 | 6.56e-01 |
GOCC SECONDARY LYSOSOME | 17 | 3.05e-01 | -1.44e-01 | 7.55e-01 |
GOCC AP 2 ADAPTOR COMPLEX | 9 | 4.55e-01 | 1.44e-01 | 8.38e-01 |
GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 105 | 1.10e-02 | 1.44e-01 | 2.22e-01 |
GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 13 | 3.70e-01 | -1.44e-01 | 7.98e-01 |
GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 6 | 5.42e-01 | 1.44e-01 | 8.74e-01 |
GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 29 | 1.81e-01 | -1.44e-01 | 6.64e-01 |
GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 13 | 3.70e-01 | -1.44e-01 | 7.98e-01 |
GOCC APICAL DENDRITE | 12 | 3.90e-01 | -1.43e-01 | 8.08e-01 |
GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 7 | 5.11e-01 | -1.43e-01 | 8.65e-01 |
GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 37 | 1.31e-01 | 1.43e-01 | 6.02e-01 |
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 55 | 6.61e-02 | -1.43e-01 | 4.59e-01 |
GOBP INTESTINAL ABSORPTION | 16 | 3.21e-01 | -1.43e-01 | 7.68e-01 |
GOCC BRUSH BORDER MEMBRANE | 24 | 2.25e-01 | -1.43e-01 | 7.02e-01 |
GOBP MESENCHYME MORPHOGENESIS | 24 | 2.25e-01 | -1.43e-01 | 7.02e-01 |
GOBP DNA REPLICATION | 233 | 1.75e-04 | 1.43e-01 | 2.24e-02 |
GOBP KIDNEY MESENCHYME DEVELOPMENT | 6 | 5.44e-01 | 1.43e-01 | 8.75e-01 |
GOBP T CELL LINEAGE COMMITMENT | 26 | 2.07e-01 | -1.43e-01 | 6.87e-01 |
GOBP LAMELLIPODIUM ORGANIZATION | 69 | 4.01e-02 | -1.43e-01 | 3.83e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 9 | 4.58e-01 | -1.43e-01 | 8.39e-01 |
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 14 | 3.55e-01 | -1.43e-01 | 7.90e-01 |
GOCC CHAPERONIN CONTAINING T COMPLEX | 9 | 4.58e-01 | 1.43e-01 | 8.39e-01 |
GOBP REGULATION OF PLATELET AGGREGATION | 17 | 3.08e-01 | -1.43e-01 | 7.58e-01 |
GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 5.13e-01 | 1.43e-01 | 8.66e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 40 | 1.19e-01 | -1.43e-01 | 5.82e-01 |
GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 38 | 1.28e-01 | 1.43e-01 | 5.97e-01 |
GOBP SMOOTH MUSCLE CELL PROLIFERATION | 91 | 1.88e-02 | -1.43e-01 | 2.89e-01 |
GOBP MESONEPHROS DEVELOPMENT | 42 | 1.10e-01 | -1.43e-01 | 5.69e-01 |
GOBP METANEPHROS MORPHOGENESIS | 10 | 4.35e-01 | 1.43e-01 | 8.27e-01 |
GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 5.45e-01 | -1.43e-01 | 8.75e-01 |
GOCC BRUSH BORDER | 54 | 7.02e-02 | -1.43e-01 | 4.72e-01 |
GOBP PROTEIN NITROSYLATION | 10 | 4.35e-01 | -1.43e-01 | 8.27e-01 |
GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 12 | 3.93e-01 | -1.42e-01 | 8.11e-01 |
GOMF IMMUNOGLOBULIN BINDING | 15 | 3.40e-01 | 1.42e-01 | 7.81e-01 |
GOMF STEROID DEHYDROGENASE ACTIVITY | 19 | 2.83e-01 | -1.42e-01 | 7.39e-01 |
GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 64 | 4.90e-02 | 1.42e-01 | 4.14e-01 |
GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 7 | 5.14e-01 | -1.42e-01 | 8.66e-01 |
GOCC ENDOPEPTIDASE COMPLEX | 75 | 3.33e-02 | -1.42e-01 | 3.61e-01 |
GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 19 | 2.83e-01 | -1.42e-01 | 7.39e-01 |
GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 6 | 5.46e-01 | 1.42e-01 | 8.75e-01 |
GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 22 | 2.49e-01 | 1.42e-01 | 7.18e-01 |
GOCC FICOLIN 1 RICH GRANULE | 174 | 1.26e-03 | -1.42e-01 | 7.23e-02 |
GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 20 | 2.72e-01 | 1.42e-01 | 7.29e-01 |
GOBP T HELPER 17 CELL DIFFERENTIATION | 26 | 2.10e-01 | -1.42e-01 | 6.87e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 33 | 1.58e-01 | -1.42e-01 | 6.39e-01 |
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 67 | 4.46e-02 | -1.42e-01 | 4.00e-01 |
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 23 | 2.39e-01 | -1.42e-01 | 7.12e-01 |
GOBP AUTOCRINE SIGNALING | 5 | 5.83e-01 | -1.42e-01 | 8.89e-01 |
GOMF BUBBLE DNA BINDING | 7 | 5.16e-01 | 1.42e-01 | 8.66e-01 |
GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 157 | 2.21e-03 | 1.42e-01 | 1.00e-01 |
GOCC AZUROPHIL GRANULE MEMBRANE | 52 | 7.71e-02 | -1.42e-01 | 4.96e-01 |
GOBP REGULATION OF GLUCOSE IMPORT | 38 | 1.31e-01 | -1.42e-01 | 6.02e-01 |
GOBP POSITIVE REGULATION OF ERAD PATHWAY | 13 | 3.76e-01 | -1.42e-01 | 8.01e-01 |
GOBP REGULATION OF RIG I SIGNALING PATHWAY | 18 | 2.98e-01 | 1.42e-01 | 7.49e-01 |
GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 45 | 1.00e-01 | 1.42e-01 | 5.48e-01 |
GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 43 | 1.08e-01 | -1.42e-01 | 5.65e-01 |
GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 6 | 5.48e-01 | -1.42e-01 | 8.75e-01 |
GOBP GRANULOCYTE MIGRATION | 100 | 1.45e-02 | -1.42e-01 | 2.62e-01 |
GOBP TRNA CATABOLIC PROCESS | 16 | 3.27e-01 | 1.42e-01 | 7.70e-01 |
GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 5.48e-01 | 1.42e-01 | 8.75e-01 |
GOBP RNA METHYLATION | 84 | 2.52e-02 | 1.41e-01 | 3.25e-01 |
GOBP PODOCYTE CELL MIGRATION | 5 | 5.84e-01 | -1.41e-01 | 8.89e-01 |
GOBP PLATELET ACTIVATION | 89 | 2.13e-02 | -1.41e-01 | 3.02e-01 |
GOBP HOMOLOGOUS RECOMBINATION | 42 | 1.13e-01 | 1.41e-01 | 5.76e-01 |
GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 5 | 5.84e-01 | 1.41e-01 | 8.89e-01 |
GOCC MICROFIBRIL | 6 | 5.49e-01 | 1.41e-01 | 8.76e-01 |
GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 5 | 5.84e-01 | 1.41e-01 | 8.89e-01 |
GOMF WW DOMAIN BINDING | 13 | 3.78e-01 | -1.41e-01 | 8.02e-01 |
GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 35 | 1.48e-01 | 1.41e-01 | 6.24e-01 |
GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 10 | 4.39e-01 | 1.41e-01 | 8.29e-01 |
GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 11 | 4.18e-01 | 1.41e-01 | 8.21e-01 |
GOBP GRANULOCYTE ACTIVATION | 37 | 1.38e-01 | -1.41e-01 | 6.08e-01 |
GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 62 | 5.48e-02 | 1.41e-01 | 4.23e-01 |
GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 64 | 5.11e-02 | -1.41e-01 | 4.19e-01 |
GOBP VITAMIN K METABOLIC PROCESS | 7 | 5.18e-01 | 1.41e-01 | 8.67e-01 |
GOBP EXCRETION | 6 | 5.50e-01 | -1.41e-01 | 8.76e-01 |
GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 23 | 2.42e-01 | -1.41e-01 | 7.14e-01 |
GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 14 | 3.61e-01 | 1.41e-01 | 7.92e-01 |
GOBP RRNA 3 END PROCESSING | 10 | 4.40e-01 | -1.41e-01 | 8.29e-01 |
GOBP GRANULOCYTE CHEMOTAXIS | 83 | 2.67e-02 | -1.41e-01 | 3.34e-01 |
GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 71 | 4.05e-02 | -1.41e-01 | 3.83e-01 |
GOBP DESMOSOME ORGANIZATION | 5 | 5.86e-01 | 1.41e-01 | 8.90e-01 |
GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT | 5 | 5.86e-01 | -1.41e-01 | 8.90e-01 |
GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION | 5 | 5.86e-01 | 1.41e-01 | 8.90e-01 |
GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 5.51e-01 | 1.41e-01 | 8.76e-01 |
GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 79 | 3.10e-02 | 1.41e-01 | 3.51e-01 |
GOBP PROTEIN HYDROXYLATION | 19 | 2.89e-01 | 1.40e-01 | 7.44e-01 |
GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 7 | 5.20e-01 | -1.40e-01 | 8.68e-01 |
GOCC CHROMOSOME TELOMERIC REPEAT REGION | 12 | 4.00e-01 | 1.40e-01 | 8.14e-01 |
GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.87e-01 | 1.40e-01 | 8.90e-01 |
GOBP POSITIVE REGULATION OF RNA SPLICING | 33 | 1.63e-01 | -1.40e-01 | 6.45e-01 |
GOMF I SMAD BINDING | 13 | 3.81e-01 | -1.40e-01 | 8.02e-01 |
GOCC PRESYNAPTIC MEMBRANE | 73 | 3.85e-02 | -1.40e-01 | 3.81e-01 |
GOMF TRANSLATION REGULATOR ACTIVITY | 116 | 9.23e-03 | -1.40e-01 | 2.00e-01 |
GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 94 | 1.90e-02 | -1.40e-01 | 2.89e-01 |
GOCC EXTERNAL ENCAPSULATING STRUCTURE | 181 | 1.18e-03 | -1.40e-01 | 7.01e-02 |
GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 41 | 1.21e-01 | -1.40e-01 | 5.84e-01 |
GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 5.88e-01 | -1.40e-01 | 8.91e-01 |
GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 6 | 5.53e-01 | 1.40e-01 | 8.77e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 33 | 1.64e-01 | -1.40e-01 | 6.47e-01 |
GOBP REGULATION OF POTASSIUM ION TRANSPORT | 37 | 1.41e-01 | -1.40e-01 | 6.14e-01 |
GOBP TISSUE MIGRATION | 192 | 8.53e-04 | -1.40e-01 | 5.86e-02 |
GOBP NEURAL PRECURSOR CELL PROLIFERATION | 84 | 2.68e-02 | 1.40e-01 | 3.34e-01 |
GOBP MODIFIED AMINO ACID TRANSPORT | 31 | 1.78e-01 | 1.40e-01 | 6.61e-01 |
GOBP DIGESTION | 39 | 1.31e-01 | -1.40e-01 | 6.02e-01 |
GOBP DIGESTIVE SYSTEM PROCESS | 39 | 1.31e-01 | -1.40e-01 | 6.02e-01 |
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 34 | 1.58e-01 | -1.40e-01 | 6.39e-01 |
GOBP EPIBOLY | 23 | 2.46e-01 | -1.40e-01 | 7.15e-01 |
GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 13 | 3.83e-01 | 1.40e-01 | 8.03e-01 |
GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 21 | 2.68e-01 | 1.40e-01 | 7.25e-01 |
GOMF CADHERIN BINDING | 264 | 9.81e-05 | -1.40e-01 | 1.48e-02 |
GOMF STRUCTURAL MOLECULE ACTIVITY | 367 | 4.75e-06 | -1.40e-01 | 1.50e-03 |
GOCC PICLN SM PROTEIN COMPLEX | 6 | 5.53e-01 | -1.40e-01 | 8.77e-01 |
GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 10 | 4.45e-01 | -1.40e-01 | 8.33e-01 |
GOBP BROWN FAT CELL DIFFERENTIATION | 32 | 1.72e-01 | -1.40e-01 | 6.55e-01 |
GOBP REGULATION OF PROTEIN UBIQUITINATION | 167 | 1.91e-03 | -1.40e-01 | 8.96e-02 |
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 7 | 5.23e-01 | -1.39e-01 | 8.68e-01 |
GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 102 | 1.52e-02 | -1.39e-01 | 2.62e-01 |
GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 5 | 5.90e-01 | 1.39e-01 | 8.92e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 9 | 4.69e-01 | -1.39e-01 | 8.45e-01 |
GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 9 | 4.69e-01 | 1.39e-01 | 8.45e-01 |
GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 30 | 1.87e-01 | -1.39e-01 | 6.70e-01 |
GOMF SEMAPHORIN RECEPTOR BINDING | 9 | 4.70e-01 | -1.39e-01 | 8.46e-01 |
GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 62 | 5.84e-02 | 1.39e-01 | 4.33e-01 |
GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 5.90e-01 | -1.39e-01 | 8.92e-01 |
GOBP REGULATION OF RUFFLE ASSEMBLY | 21 | 2.70e-01 | -1.39e-01 | 7.28e-01 |
GOBP INTEGRIN ACTIVATION | 13 | 3.86e-01 | -1.39e-01 | 8.05e-01 |
GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 5 | 5.91e-01 | -1.39e-01 | 8.92e-01 |
GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 1.81e-01 | -1.39e-01 | 6.64e-01 |
GOCC CORTICAL CYTOSKELETON | 64 | 5.48e-02 | -1.39e-01 | 4.23e-01 |
GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 19 | 2.95e-01 | 1.39e-01 | 7.48e-01 |
GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 11 | 4.25e-01 | -1.39e-01 | 8.23e-01 |
GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 41 | 1.24e-01 | -1.39e-01 | 5.89e-01 |
GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 30 | 1.88e-01 | 1.39e-01 | 6.73e-01 |
GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 12 | 4.05e-01 | -1.39e-01 | 8.17e-01 |
GOMF CLATHRIN HEAVY CHAIN BINDING | 9 | 4.71e-01 | -1.39e-01 | 8.46e-01 |
GOBP PEPTIDYL PROLINE HYDROXYLATION | 10 | 4.47e-01 | 1.39e-01 | 8.33e-01 |
GOMF MISFOLDED PROTEIN BINDING | 17 | 3.22e-01 | -1.39e-01 | 7.69e-01 |
GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 150 | 3.41e-03 | -1.39e-01 | 1.22e-01 |
GOBP CELLULAR RESPIRATION | 207 | 5.96e-04 | -1.39e-01 | 4.70e-02 |
GOBP GOLGI LOCALIZATION | 13 | 3.86e-01 | 1.39e-01 | 8.05e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 11 | 4.26e-01 | 1.39e-01 | 8.23e-01 |
GOBP FUCOSE METABOLIC PROCESS | 11 | 4.26e-01 | 1.39e-01 | 8.23e-01 |
GOBP NEUTROPHIL MIGRATION | 83 | 2.90e-02 | -1.39e-01 | 3.44e-01 |
GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 4.26e-01 | 1.39e-01 | 8.23e-01 |
GOMF GROWTH FACTOR BINDING | 67 | 4.98e-02 | -1.39e-01 | 4.14e-01 |
GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 27 | 2.12e-01 | 1.39e-01 | 6.87e-01 |
GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 47 | 1.00e-01 | -1.39e-01 | 5.48e-01 |
GOCC PEPTIDASE COMPLEX | 106 | 1.38e-02 | -1.39e-01 | 2.56e-01 |
GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 14 | 3.69e-01 | -1.39e-01 | 7.97e-01 |
GOBP LYMPHOCYTE MIGRATION | 77 | 3.57e-02 | -1.39e-01 | 3.70e-01 |
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 39 | 1.34e-01 | -1.39e-01 | 6.05e-01 |
GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 57 | 7.06e-02 | -1.39e-01 | 4.73e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 18 | 3.09e-01 | -1.39e-01 | 7.58e-01 |
GOBP PHAGOCYTOSIS ENGULFMENT | 37 | 1.46e-01 | 1.38e-01 | 6.21e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 30 | 1.90e-01 | -1.38e-01 | 6.73e-01 |
GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 11 | 4.28e-01 | -1.38e-01 | 8.24e-01 |
GOMF ATP HYDROLYSIS ACTIVITY | 315 | 2.67e-05 | 1.38e-01 | 5.37e-03 |
GOBP POSITIVE REGULATION OF SECRETION | 176 | 1.61e-03 | -1.38e-01 | 8.16e-02 |
GOBP ENDOCARDIAL CUSHION FORMATION | 12 | 4.08e-01 | -1.38e-01 | 8.17e-01 |
GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 4.08e-01 | -1.38e-01 | 8.17e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 9 | 4.73e-01 | 1.38e-01 | 8.47e-01 |
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 9 | 4.73e-01 | -1.38e-01 | 8.47e-01 |
GOBP INTERLEUKIN 5 PRODUCTION | 11 | 4.28e-01 | 1.38e-01 | 8.24e-01 |
GOBP INTERLEUKIN 8 PRODUCTION | 62 | 6.06e-02 | -1.38e-01 | 4.38e-01 |
GOBP REGULATION OF MIRNA TRANSCRIPTION | 47 | 1.02e-01 | -1.38e-01 | 5.50e-01 |
GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 4.09e-01 | 1.38e-01 | 8.17e-01 |
GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 5.59e-01 | 1.38e-01 | 8.79e-01 |
GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 32 | 1.77e-01 | -1.38e-01 | 6.61e-01 |
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 28 | 2.07e-01 | -1.38e-01 | 6.87e-01 |
GOBP DNA CONFORMATION CHANGE | 76 | 3.80e-02 | 1.38e-01 | 3.80e-01 |
GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 17 | 3.26e-01 | 1.38e-01 | 7.69e-01 |
GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 5.94e-01 | 1.38e-01 | 8.94e-01 |
GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 17 | 3.26e-01 | 1.38e-01 | 7.69e-01 |
GOBP REGULATION OF ANOIKIS | 17 | 3.26e-01 | -1.38e-01 | 7.69e-01 |
GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 13 | 3.90e-01 | -1.38e-01 | 8.08e-01 |
GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 13 | 3.90e-01 | 1.38e-01 | 8.08e-01 |
GOBP BRANCHING MORPHOGENESIS OF A NERVE | 6 | 5.59e-01 | -1.38e-01 | 8.79e-01 |
GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 8 | 5.00e-01 | -1.38e-01 | 8.60e-01 |
GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 19 | 2.99e-01 | -1.38e-01 | 7.51e-01 |
GOMF ACTININ BINDING | 17 | 3.26e-01 | -1.38e-01 | 7.69e-01 |
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 23 | 2.54e-01 | -1.37e-01 | 7.22e-01 |
GOBP KERATAN SULFATE METABOLIC PROCESS | 12 | 4.10e-01 | -1.37e-01 | 8.19e-01 |
GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 9 | 4.76e-01 | -1.37e-01 | 8.47e-01 |
GOBP RHYTHMIC BEHAVIOR | 26 | 2.26e-01 | 1.37e-01 | 7.02e-01 |
GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 37 | 1.49e-01 | 1.37e-01 | 6.25e-01 |
GOCC RISC LOADING COMPLEX | 8 | 5.02e-01 | 1.37e-01 | 8.60e-01 |
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 25 | 2.35e-01 | -1.37e-01 | 7.10e-01 |
GOCC GAMMA DELTA T CELL RECEPTOR COMPLEX | 6 | 5.61e-01 | 1.37e-01 | 8.80e-01 |
GOMF COPPER CHAPERONE ACTIVITY | 7 | 5.30e-01 | 1.37e-01 | 8.70e-01 |
GOBP POSITIVE REGULATION OF NEURON MIGRATION | 13 | 3.93e-01 | -1.37e-01 | 8.11e-01 |
GOBP RUFFLE ORGANIZATION | 42 | 1.25e-01 | -1.37e-01 | 5.91e-01 |
GOBP REGULATION OF HISTONE METHYLATION | 17 | 3.29e-01 | -1.37e-01 | 7.72e-01 |
GOBP METHYLGUANOSINE CAP DECAPPING | 15 | 3.59e-01 | -1.37e-01 | 7.92e-01 |
GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 5 | 5.96e-01 | -1.37e-01 | 8.96e-01 |
GOBP AMEBOIDAL TYPE CELL MIGRATION | 254 | 1.83e-04 | -1.37e-01 | 2.24e-02 |
GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 18 | 3.16e-01 | -1.37e-01 | 7.64e-01 |
GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 11 | 4.33e-01 | 1.37e-01 | 8.27e-01 |
GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 35 | 1.62e-01 | 1.37e-01 | 6.44e-01 |
GOBP HEAT ACCLIMATION | 6 | 5.62e-01 | 1.37e-01 | 8.80e-01 |
GOBP TRYPTOPHAN METABOLIC PROCESS | 9 | 4.78e-01 | 1.37e-01 | 8.49e-01 |
GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 18 | 3.16e-01 | 1.37e-01 | 7.64e-01 |
GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 18 | 3.16e-01 | 1.37e-01 | 7.64e-01 |
GOBP CHOLESTEROL EFFLUX | 32 | 1.81e-01 | -1.37e-01 | 6.65e-01 |
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 6 | 5.63e-01 | -1.37e-01 | 8.80e-01 |
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 37 | 1.51e-01 | 1.36e-01 | 6.29e-01 |
GOBP PLASMA MEMBRANE TUBULATION | 16 | 3.45e-01 | -1.36e-01 | 7.83e-01 |
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 5.63e-01 | -1.36e-01 | 8.80e-01 |
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 10 | 4.56e-01 | 1.36e-01 | 8.38e-01 |
GOMF UNMETHYLATED CPG BINDING | 9 | 4.80e-01 | -1.36e-01 | 8.50e-01 |
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 10 | 4.56e-01 | -1.36e-01 | 8.39e-01 |
GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 7 | 5.33e-01 | -1.36e-01 | 8.73e-01 |
GOBP RESPONSE TO DEXAMETHASONE | 23 | 2.59e-01 | -1.36e-01 | 7.24e-01 |
GOBP ENDODERM DEVELOPMENT | 40 | 1.37e-01 | -1.36e-01 | 6.08e-01 |
GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 16 | 3.46e-01 | -1.36e-01 | 7.84e-01 |
GOCC ZYMOGEN GRANULE | 8 | 5.06e-01 | -1.36e-01 | 8.62e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 9 | 4.80e-01 | 1.36e-01 | 8.50e-01 |
GOBP POLYAMINE TRANSPORT | 11 | 4.35e-01 | -1.36e-01 | 8.27e-01 |
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 27 | 2.22e-01 | 1.36e-01 | 6.99e-01 |
GOBP ANTIBACTERIAL HUMORAL RESPONSE | 17 | 3.32e-01 | 1.36e-01 | 7.76e-01 |
GOBP DNA REPLICATION CHECKPOINT SIGNALING | 11 | 4.36e-01 | 1.36e-01 | 8.28e-01 |
GOMF DNA REPLICATION ORIGIN BINDING | 11 | 4.36e-01 | 1.36e-01 | 8.28e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 7 | 5.34e-01 | 1.36e-01 | 8.73e-01 |
GOMF GROWTH FACTOR RECEPTOR BINDING | 71 | 4.84e-02 | -1.36e-01 | 4.13e-01 |
GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 8 | 5.07e-01 | 1.36e-01 | 8.62e-01 |
GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 28 | 2.15e-01 | 1.35e-01 | 6.90e-01 |
GOBP PROTEIN DEMETHYLATION | 12 | 4.17e-01 | -1.35e-01 | 8.21e-01 |
GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 5 | 6.00e-01 | 1.35e-01 | 8.98e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 20 | 2.95e-01 | 1.35e-01 | 7.48e-01 |
GOMF ACTIVIN RECEPTOR BINDING | 5 | 6.00e-01 | -1.35e-01 | 8.98e-01 |
GOBP FOAM CELL DIFFERENTIATION | 26 | 2.33e-01 | -1.35e-01 | 7.07e-01 |
GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 11 | 4.37e-01 | -1.35e-01 | 8.29e-01 |
GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 20 | 2.95e-01 | 1.35e-01 | 7.48e-01 |
GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 13 | 3.99e-01 | -1.35e-01 | 8.13e-01 |
GOBP VESICLE UNCOATING | 5 | 6.01e-01 | 1.35e-01 | 8.98e-01 |
GOBP MEIOTIC CHROMOSOME CONDENSATION | 5 | 6.01e-01 | 1.35e-01 | 8.98e-01 |
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 6.01e-01 | -1.35e-01 | 8.98e-01 |
GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 77 | 4.06e-02 | 1.35e-01 | 3.83e-01 |
GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 20 | 2.96e-01 | -1.35e-01 | 7.49e-01 |
GOBP NUCLEOSOME ORGANIZATION | 59 | 7.31e-02 | 1.35e-01 | 4.82e-01 |
GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 12 | 4.18e-01 | 1.35e-01 | 8.21e-01 |
GOBP REGULATION OF COMPLEMENT ACTIVATION | 12 | 4.18e-01 | 1.35e-01 | 8.21e-01 |
GOBP RESPONSE TO ORGANOPHOSPHORUS | 69 | 5.27e-02 | -1.35e-01 | 4.19e-01 |
GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 6 | 5.67e-01 | 1.35e-01 | 8.83e-01 |
GOCC ENDOPLASMIC RETICULUM LUMEN | 170 | 2.46e-03 | -1.35e-01 | 1.07e-01 |
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 14 | 3.82e-01 | -1.35e-01 | 8.03e-01 |
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 10 | 4.60e-01 | 1.35e-01 | 8.40e-01 |
GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 52 | 9.29e-02 | 1.35e-01 | 5.29e-01 |
GOCC STRIATED MUSCLE THIN FILAMENT | 9 | 4.84e-01 | -1.35e-01 | 8.52e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 15 | 3.67e-01 | -1.35e-01 | 7.96e-01 |
GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 67 | 5.68e-02 | -1.35e-01 | 4.28e-01 |
GOCC PRC1 COMPLEX | 14 | 3.83e-01 | 1.35e-01 | 8.03e-01 |
GOBP MRNA 5 SPLICE SITE RECOGNITION | 6 | 5.68e-01 | 1.35e-01 | 8.83e-01 |
GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 13 | 4.01e-01 | -1.35e-01 | 8.15e-01 |
GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 5 | 6.02e-01 | -1.35e-01 | 8.98e-01 |
GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 6 | 5.69e-01 | -1.34e-01 | 8.83e-01 |
GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 12 | 4.20e-01 | -1.34e-01 | 8.23e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 26 | 2.36e-01 | -1.34e-01 | 7.11e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 7 | 5.39e-01 | -1.34e-01 | 8.73e-01 |
GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 23 | 2.65e-01 | 1.34e-01 | 7.25e-01 |
GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 17 | 3.38e-01 | 1.34e-01 | 7.80e-01 |
GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 6 | 5.69e-01 | 1.34e-01 | 8.84e-01 |
GOBP PEPTIDYL PROLINE MODIFICATION | 29 | 2.12e-01 | -1.34e-01 | 6.87e-01 |
GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 32 | 1.90e-01 | -1.34e-01 | 6.73e-01 |
GOBP FIBROBLAST PROLIFERATION | 66 | 6.00e-02 | -1.34e-01 | 4.37e-01 |
GOBP EXIT FROM MITOSIS | 26 | 2.37e-01 | -1.34e-01 | 7.11e-01 |
GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 15 | 3.69e-01 | -1.34e-01 | 7.97e-01 |
GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 6 | 5.70e-01 | 1.34e-01 | 8.84e-01 |
GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 6.04e-01 | 1.34e-01 | 8.99e-01 |
GOCC MULTIVESICULAR BODY | 40 | 1.43e-01 | -1.34e-01 | 6.16e-01 |
GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 23 | 2.67e-01 | -1.34e-01 | 7.25e-01 |
GOBP PINOCYTOSIS | 18 | 3.26e-01 | -1.34e-01 | 7.69e-01 |
GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 6.04e-01 | 1.34e-01 | 8.99e-01 |
GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 63 | 6.66e-02 | 1.34e-01 | 4.59e-01 |
GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 8 | 5.13e-01 | -1.34e-01 | 8.66e-01 |
GOCC METHYLOSOME | 12 | 4.23e-01 | -1.34e-01 | 8.23e-01 |
GOBP POSITIVE REGULATION OF HEART RATE | 9 | 4.87e-01 | -1.34e-01 | 8.53e-01 |
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 58 | 7.86e-02 | -1.34e-01 | 4.99e-01 |
GOBP LYMPHOCYTE CHEMOTAXIS | 33 | 1.84e-01 | -1.34e-01 | 6.69e-01 |
GOCC VESICLE LUMEN | 249 | 2.95e-04 | -1.34e-01 | 2.93e-02 |
GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 5 | 6.05e-01 | -1.34e-01 | 8.99e-01 |
GOCC CHROMOSOME TELOMERIC REGION | 135 | 7.55e-03 | 1.33e-01 | 1.82e-01 |
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 7 | 5.41e-01 | -1.33e-01 | 8.74e-01 |
GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 4.44e-01 | 1.33e-01 | 8.32e-01 |
GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 6.06e-01 | -1.33e-01 | 8.99e-01 |
GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 5 | 6.06e-01 | 1.33e-01 | 8.99e-01 |
GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 12 | 4.24e-01 | -1.33e-01 | 8.23e-01 |
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 110 | 1.59e-02 | -1.33e-01 | 2.70e-01 |
GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 19 | 3.15e-01 | 1.33e-01 | 7.64e-01 |
GOMF DNA ENDONUCLEASE ACTIVITY | 33 | 1.86e-01 | 1.33e-01 | 6.69e-01 |
GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 12 | 4.25e-01 | 1.33e-01 | 8.23e-01 |
GOBP LYMPHOCYTE COSTIMULATION | 37 | 1.61e-01 | -1.33e-01 | 6.42e-01 |
GOBP STEROL BIOSYNTHETIC PROCESS | 44 | 1.27e-01 | -1.33e-01 | 5.95e-01 |
GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 6 | 5.72e-01 | -1.33e-01 | 8.85e-01 |
GOBP TRANSLATIONAL INITIATION | 111 | 1.56e-02 | -1.33e-01 | 2.66e-01 |
GOBP PONS DEVELOPMENT | 7 | 5.42e-01 | 1.33e-01 | 8.74e-01 |
GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 18 | 3.29e-01 | -1.33e-01 | 7.72e-01 |
GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 33 | 1.86e-01 | -1.33e-01 | 6.70e-01 |
GOMF PROTEASE BINDING | 99 | 2.24e-02 | -1.33e-01 | 3.06e-01 |
GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 9 | 4.90e-01 | -1.33e-01 | 8.55e-01 |
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 9 | 4.90e-01 | 1.33e-01 | 8.55e-01 |
GOMF CYTOKINE RECEPTOR BINDING | 137 | 7.37e-03 | -1.33e-01 | 1.82e-01 |
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 69 | 5.66e-02 | -1.33e-01 | 4.28e-01 |
GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 22 | 2.81e-01 | -1.33e-01 | 7.38e-01 |
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 46 | 1.20e-01 | -1.33e-01 | 5.82e-01 |
GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 5.74e-01 | 1.33e-01 | 8.86e-01 |
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 15 | 3.74e-01 | -1.33e-01 | 7.99e-01 |
GOBP OPSONIZATION | 5 | 6.08e-01 | -1.33e-01 | 9.00e-01 |
GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 6 | 5.74e-01 | -1.33e-01 | 8.86e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 39 | 1.52e-01 | -1.33e-01 | 6.32e-01 |
GOCC INO80 TYPE COMPLEX | 26 | 2.42e-01 | -1.33e-01 | 7.14e-01 |
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 9 | 4.91e-01 | -1.32e-01 | 8.55e-01 |
GOBP REGULATION OF URINE VOLUME | 8 | 5.17e-01 | -1.32e-01 | 8.66e-01 |
GOBP VACUOLAR ACIDIFICATION | 31 | 2.02e-01 | -1.32e-01 | 6.84e-01 |
GOMF R SMAD BINDING | 21 | 2.94e-01 | 1.32e-01 | 7.48e-01 |
GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 6 | 5.74e-01 | -1.32e-01 | 8.86e-01 |
GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 20 | 3.06e-01 | 1.32e-01 | 7.56e-01 |
GOBP RESPONSE TO MANGANESE ION | 15 | 3.75e-01 | -1.32e-01 | 8.00e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 27 | 2.35e-01 | -1.32e-01 | 7.10e-01 |
GOBP TRANSFERRIN TRANSPORT | 9 | 4.92e-01 | -1.32e-01 | 8.55e-01 |
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 26 | 2.44e-01 | 1.32e-01 | 7.14e-01 |
GOCC TELOMERASE HOLOENZYME COMPLEX | 20 | 3.07e-01 | 1.32e-01 | 7.57e-01 |
GOBP SMOOTH MUSCLE CELL MIGRATION | 43 | 1.34e-01 | -1.32e-01 | 6.05e-01 |
GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 33 | 1.90e-01 | 1.32e-01 | 6.73e-01 |
GOCC GATOR2 COMPLEX | 5 | 6.09e-01 | -1.32e-01 | 9.01e-01 |
GOBP ADHERENS JUNCTION ORGANIZATION | 30 | 2.11e-01 | -1.32e-01 | 6.87e-01 |
GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 15 | 3.77e-01 | -1.32e-01 | 8.01e-01 |
GOMF OXYSTEROL BINDING | 7 | 5.46e-01 | -1.32e-01 | 8.75e-01 |
GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 22 | 2.85e-01 | -1.32e-01 | 7.41e-01 |
GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 28 | 2.28e-01 | -1.32e-01 | 7.02e-01 |
GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 73 | 5.18e-02 | 1.32e-01 | 4.19e-01 |
GOBP POSTREPLICATION REPAIR | 31 | 2.05e-01 | 1.32e-01 | 6.85e-01 |
GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 32 | 1.99e-01 | 1.31e-01 | 6.79e-01 |
GOBP REGULATION OF LYMPHOCYTE MIGRATION | 51 | 1.05e-01 | -1.31e-01 | 5.56e-01 |
GOBP MRNA EXPORT FROM NUCLEUS | 63 | 7.16e-02 | 1.31e-01 | 4.76e-01 |
GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 35 | 1.79e-01 | -1.31e-01 | 6.62e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 75 | 4.97e-02 | -1.31e-01 | 4.14e-01 |
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 14 | 3.96e-01 | -1.31e-01 | 8.12e-01 |
GOBP NEUROINFLAMMATORY RESPONSE | 54 | 9.57e-02 | -1.31e-01 | 5.38e-01 |
GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 8 | 5.21e-01 | 1.31e-01 | 8.68e-01 |
GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 17 | 3.49e-01 | -1.31e-01 | 7.86e-01 |
GOCC IMMUNOLOGICAL SYNAPSE | 44 | 1.33e-01 | -1.31e-01 | 6.04e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 7 | 5.48e-01 | 1.31e-01 | 8.75e-01 |
GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 68 | 6.20e-02 | -1.31e-01 | 4.43e-01 |
GOBP DIACYLGLYCEROL METABOLIC PROCESS | 20 | 3.11e-01 | 1.31e-01 | 7.59e-01 |
GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 12 | 4.33e-01 | -1.31e-01 | 8.27e-01 |
GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 6 | 5.79e-01 | 1.31e-01 | 8.88e-01 |
GOBP TRICARBOXYLIC ACID CYCLE | 29 | 2.23e-01 | 1.31e-01 | 7.01e-01 |
GOMF CARBOXYPEPTIDASE ACTIVITY | 22 | 2.88e-01 | -1.31e-01 | 7.44e-01 |
GOBP ORGANELLE DISASSEMBLY | 128 | 1.08e-02 | -1.31e-01 | 2.20e-01 |
GOBP REGULATION OF DNA BINDING | 61 | 7.80e-02 | -1.31e-01 | 4.99e-01 |
GOBP CELL CYCLE CHECKPOINT SIGNALING | 156 | 4.97e-03 | 1.31e-01 | 1.45e-01 |
GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 10 | 4.75e-01 | 1.30e-01 | 8.47e-01 |
GOBP CAMP METABOLIC PROCESS | 12 | 4.34e-01 | 1.30e-01 | 8.27e-01 |
GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 5.23e-01 | 1.30e-01 | 8.68e-01 |
GOBP NEGATIVE REGULATION OF DNA REPLICATION | 17 | 3.52e-01 | 1.30e-01 | 7.88e-01 |
GOBP TRNA 5 END PROCESSING | 16 | 3.67e-01 | 1.30e-01 | 7.96e-01 |
GOBP U4 SNRNA 3 END PROCESSING | 8 | 5.23e-01 | -1.30e-01 | 8.68e-01 |
GOBP MIDBODY ABSCISSION | 14 | 3.99e-01 | -1.30e-01 | 8.13e-01 |
GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 15 | 3.82e-01 | -1.30e-01 | 8.03e-01 |
GOBP ETHER METABOLIC PROCESS | 20 | 3.13e-01 | 1.30e-01 | 7.62e-01 |
GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 18 | 3.39e-01 | 1.30e-01 | 7.80e-01 |
GOMF CELL ADHESION MOLECULE BINDING | 366 | 2.07e-05 | -1.30e-01 | 4.36e-03 |
GOBP DIOL METABOLIC PROCESS | 21 | 3.02e-01 | 1.30e-01 | 7.53e-01 |
GOMF HORMONE BINDING | 33 | 1.96e-01 | -1.30e-01 | 6.76e-01 |
GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 36 | 1.77e-01 | -1.30e-01 | 6.61e-01 |
GOBP RESPONSE TO LIGHT INTENSITY | 13 | 4.17e-01 | -1.30e-01 | 8.21e-01 |
GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 11 | 4.55e-01 | 1.30e-01 | 8.38e-01 |
GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 6.15e-01 | 1.30e-01 | 9.02e-01 |
GOBP REGULATION OF MIRNA METABOLIC PROCESS | 59 | 8.46e-02 | -1.30e-01 | 5.15e-01 |
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 18 | 3.40e-01 | -1.30e-01 | 7.81e-01 |
GOBP POSITIVE REGULATION OF CELL GROWTH | 97 | 2.73e-02 | -1.30e-01 | 3.36e-01 |
GOMF PROTEIN KINASE B BINDING | 9 | 5.00e-01 | -1.30e-01 | 8.60e-01 |
GOBP NEUROBLAST PROLIFERATION | 38 | 1.67e-01 | 1.30e-01 | 6.49e-01 |
GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 13 | 4.18e-01 | 1.30e-01 | 8.21e-01 |
GOBP POSITIVE REGULATION OF MRNA PROCESSING | 25 | 2.62e-01 | -1.30e-01 | 7.24e-01 |
GOBP RNA CAPPING | 36 | 1.79e-01 | 1.30e-01 | 6.61e-01 |
GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 5.01e-01 | -1.30e-01 | 8.60e-01 |
GOBP MAST CELL ACTIVATION | 57 | 9.11e-02 | -1.29e-01 | 5.25e-01 |
GOBP REGULATION OF HAIR CYCLE | 9 | 5.01e-01 | 1.29e-01 | 8.60e-01 |
GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 14 | 4.02e-01 | -1.29e-01 | 8.15e-01 |
GOMF ATP DEPENDENT ACTIVITY | 428 | 4.95e-06 | 1.29e-01 | 1.50e-03 |
GOCC MLL3 4 COMPLEX | 12 | 4.38e-01 | 1.29e-01 | 8.29e-01 |
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 11 | 4.57e-01 | -1.29e-01 | 8.39e-01 |
GOCC POSTSYNAPTIC ENDOSOME | 11 | 4.57e-01 | -1.29e-01 | 8.39e-01 |
GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 21 | 3.05e-01 | -1.29e-01 | 7.55e-01 |
GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 16 | 3.71e-01 | 1.29e-01 | 7.98e-01 |
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 27 | 2.46e-01 | -1.29e-01 | 7.15e-01 |
GOMF ARYL HYDROCARBON RECEPTOR BINDING | 6 | 5.84e-01 | 1.29e-01 | 8.89e-01 |
GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 14 | 4.04e-01 | -1.29e-01 | 8.16e-01 |
GOBP RESPONSE TO ISCHEMIA | 45 | 1.35e-01 | -1.29e-01 | 6.06e-01 |
GOBP MATURATION OF SSU RRNA | 50 | 1.15e-01 | 1.29e-01 | 5.78e-01 |
GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 5 | 6.18e-01 | -1.29e-01 | 9.02e-01 |
GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 9 | 5.04e-01 | 1.29e-01 | 8.61e-01 |
GOBP PULMONARY VALVE MORPHOGENESIS | 10 | 4.81e-01 | 1.29e-01 | 8.50e-01 |
GOBP MEMBRANE DEPOLARIZATION | 38 | 1.70e-01 | -1.29e-01 | 6.52e-01 |
GOBP MONONUCLEAR CELL MIGRATION | 136 | 9.71e-03 | -1.29e-01 | 2.07e-01 |
GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 8 | 5.29e-01 | -1.29e-01 | 8.69e-01 |
GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 23 | 2.86e-01 | -1.29e-01 | 7.42e-01 |
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 26 | 2.57e-01 | -1.29e-01 | 7.24e-01 |
GOBP RESPONSE TO GONADOTROPIN | 10 | 4.82e-01 | 1.29e-01 | 8.50e-01 |
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 7 | 5.56e-01 | -1.29e-01 | 8.78e-01 |
GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 8 | 5.29e-01 | -1.28e-01 | 8.70e-01 |
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 30 | 2.24e-01 | 1.28e-01 | 7.02e-01 |
GOBP POLYOL BIOSYNTHETIC PROCESS | 41 | 1.55e-01 | 1.28e-01 | 6.37e-01 |
GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 36 | 1.83e-01 | -1.28e-01 | 6.65e-01 |
GOMF ATPASE REGULATOR ACTIVITY | 43 | 1.45e-01 | -1.28e-01 | 6.21e-01 |
GOMF INSULIN LIKE GROWTH FACTOR BINDING | 6 | 5.86e-01 | -1.28e-01 | 8.90e-01 |
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 148 | 7.18e-03 | -1.28e-01 | 1.80e-01 |
GOBP DNA TOPOLOGICAL CHANGE | 9 | 5.05e-01 | 1.28e-01 | 8.62e-01 |
GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 14 | 4.06e-01 | -1.28e-01 | 8.17e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 6 | 5.87e-01 | 1.28e-01 | 8.90e-01 |
GOBP RESPIRATORY SYSTEM DEVELOPMENT | 111 | 1.99e-02 | -1.28e-01 | 2.94e-01 |
GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 7 | 5.57e-01 | -1.28e-01 | 8.79e-01 |
GOBP REGULATION OF CELL MATRIX ADHESION | 82 | 4.53e-02 | -1.28e-01 | 4.00e-01 |
GOMF LIGASE ACTIVITY | 119 | 1.61e-02 | 1.28e-01 | 2.70e-01 |
GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 7 | 5.58e-01 | -1.28e-01 | 8.79e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 10 | 4.84e-01 | -1.28e-01 | 8.52e-01 |
GOBP REGULATION OF BONE MINERALIZATION | 44 | 1.43e-01 | -1.28e-01 | 6.16e-01 |
GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 6 | 5.88e-01 | 1.28e-01 | 8.91e-01 |
GOBP REGULATION OF GERM CELL PROLIFERATION | 6 | 5.88e-01 | 1.28e-01 | 8.91e-01 |
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 30 | 2.27e-01 | 1.28e-01 | 7.02e-01 |
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 12 | 4.44e-01 | -1.28e-01 | 8.32e-01 |
GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 18 | 3.49e-01 | -1.28e-01 | 7.86e-01 |
GOBP ESTABLISHMENT OF SKIN BARRIER | 13 | 4.26e-01 | 1.28e-01 | 8.23e-01 |
GOBP ACETYL COA BIOSYNTHETIC PROCESS | 17 | 3.63e-01 | 1.28e-01 | 7.94e-01 |
GOMF METALLODIPEPTIDASE ACTIVITY | 5 | 6.22e-01 | -1.27e-01 | 9.03e-01 |
GOBP TAXIS | 277 | 2.74e-04 | -1.27e-01 | 2.84e-02 |
GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 5 | 6.22e-01 | -1.27e-01 | 9.03e-01 |
GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 2.61e-01 | -1.27e-01 | 7.24e-01 |
GOMF SIGNAL SEQUENCE BINDING | 39 | 1.69e-01 | -1.27e-01 | 6.52e-01 |
GOMF ATPASE ACTIVATOR ACTIVITY | 24 | 2.80e-01 | -1.27e-01 | 7.37e-01 |
GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 5 | 6.22e-01 | -1.27e-01 | 9.03e-01 |
GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 52 | 1.12e-01 | 1.27e-01 | 5.74e-01 |
GOBP REGULATION OF TELOMERE CAPPING | 23 | 2.91e-01 | 1.27e-01 | 7.46e-01 |
GOBP MIRNA CATABOLIC PROCESS | 15 | 3.93e-01 | -1.27e-01 | 8.11e-01 |
GOCC TUBULAR ENDOSOME | 5 | 6.22e-01 | 1.27e-01 | 9.03e-01 |
GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 6 | 5.89e-01 | 1.27e-01 | 8.92e-01 |
GOBP CALCIUM ION REGULATED EXOCYTOSIS | 26 | 2.62e-01 | -1.27e-01 | 7.24e-01 |
GOBP GLUCOSE CATABOLIC PROCESS | 19 | 3.38e-01 | -1.27e-01 | 7.80e-01 |
GOCC LATE ENDOSOME MEMBRANE | 143 | 8.82e-03 | -1.27e-01 | 1.96e-01 |
GOBP GLAND MORPHOGENESIS | 56 | 1.00e-01 | -1.27e-01 | 5.48e-01 |
GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 5.09e-01 | 1.27e-01 | 8.63e-01 |
GOBP INTERMEMBRANE LIPID TRANSFER | 33 | 2.07e-01 | -1.27e-01 | 6.87e-01 |
GOMF LIPID TRANSFER ACTIVITY | 33 | 2.07e-01 | -1.27e-01 | 6.87e-01 |
GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 148 | 7.80e-03 | -1.27e-01 | 1.85e-01 |
GOBP THYROID HORMONE GENERATION | 10 | 4.87e-01 | 1.27e-01 | 8.53e-01 |
GOCC SPECIFIC GRANULE LUMEN | 45 | 1.41e-01 | -1.27e-01 | 6.14e-01 |
GOBP RESPONSE TO L GLUTAMATE | 11 | 4.66e-01 | 1.27e-01 | 8.44e-01 |
GOBP RESPONSE TO COCAINE | 22 | 3.03e-01 | -1.27e-01 | 7.54e-01 |
GOCC AUTOPHAGOSOME MEMBRANE | 44 | 1.46e-01 | -1.27e-01 | 6.21e-01 |
GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 4.47e-01 | 1.27e-01 | 8.33e-01 |
GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 20 | 3.26e-01 | -1.27e-01 | 7.69e-01 |
GOBP ACTIVATION OF GTPASE ACTIVITY | 73 | 6.13e-02 | 1.27e-01 | 4.42e-01 |
GOBP DNA REPAIR | 509 | 1.15e-06 | 1.27e-01 | 6.07e-04 |
GOBP NEUTROPHIL HOMEOSTASIS | 19 | 3.39e-01 | 1.27e-01 | 7.80e-01 |
GOMF DYNEIN HEAVY CHAIN BINDING | 7 | 5.62e-01 | -1.27e-01 | 8.80e-01 |
GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 24 | 2.83e-01 | 1.27e-01 | 7.39e-01 |
GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 7 | 5.62e-01 | 1.27e-01 | 8.80e-01 |
GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 4.88e-01 | 1.27e-01 | 8.53e-01 |
GOBP NUCLEOLUS ORGANIZATION | 16 | 3.81e-01 | 1.27e-01 | 8.02e-01 |
GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.24e-01 | 1.27e-01 | 9.04e-01 |
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 86 | 4.30e-02 | -1.26e-01 | 3.91e-01 |
GOCC MITOTIC COHESIN COMPLEX | 6 | 5.92e-01 | 1.26e-01 | 8.93e-01 |
GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 25 | 2.74e-01 | -1.26e-01 | 7.31e-01 |
GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 240 | 7.78e-04 | -1.26e-01 | 5.53e-02 |
GOBP PURINE CONTAINING COMPOUND SALVAGE | 14 | 4.13e-01 | -1.26e-01 | 8.21e-01 |
GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 8 | 5.36e-01 | 1.26e-01 | 8.73e-01 |
GOMF AMINOACYL TRNA EDITING ACTIVITY | 8 | 5.36e-01 | 1.26e-01 | 8.73e-01 |
GOCC CHROMOSOMAL REGION | 322 | 1.06e-04 | 1.26e-01 | 1.53e-02 |
GOBP CMP METABOLIC PROCESS | 7 | 5.63e-01 | 1.26e-01 | 8.80e-01 |
GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 7 | 5.63e-01 | 1.26e-01 | 8.80e-01 |
GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 42 | 1.58e-01 | -1.26e-01 | 6.39e-01 |
GOCC BRISC COMPLEX | 6 | 5.93e-01 | -1.26e-01 | 8.94e-01 |
GOBP DOUBLE STRAND BREAK REPAIR | 258 | 5.18e-04 | 1.26e-01 | 4.38e-02 |
GOBP PROTEASOME ASSEMBLY | 12 | 4.50e-01 | -1.26e-01 | 8.34e-01 |
GOMF STEROL TRANSPORTER ACTIVITY | 23 | 2.96e-01 | -1.26e-01 | 7.49e-01 |
GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 6 | 5.93e-01 | -1.26e-01 | 8.94e-01 |
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 58 | 9.81e-02 | -1.26e-01 | 5.43e-01 |
GOBP AMINO ACID BIOSYNTHETIC PROCESS | 51 | 1.21e-01 | 1.26e-01 | 5.84e-01 |
GOMF MYRISTOYLTRANSFERASE ACTIVITY | 10 | 4.92e-01 | -1.26e-01 | 8.55e-01 |
GOMF CHEMOKINE BINDING | 18 | 3.56e-01 | -1.26e-01 | 7.91e-01 |
GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 123 | 1.64e-02 | -1.25e-01 | 2.73e-01 |
GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 13 | 4.34e-01 | -1.25e-01 | 8.27e-01 |
GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 132 | 1.30e-02 | -1.25e-01 | 2.48e-01 |
GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 5.95e-01 | 1.25e-01 | 8.95e-01 |
GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 6.27e-01 | -1.25e-01 | 9.05e-01 |
GOBP POSITIVE CHEMOTAXIS | 32 | 2.20e-01 | -1.25e-01 | 6.96e-01 |
GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 28 | 2.51e-01 | -1.25e-01 | 7.19e-01 |
GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 35 | 1.99e-01 | 1.25e-01 | 6.79e-01 |
GOMF ACTIN FILAMENT BINDING | 140 | 1.06e-02 | -1.25e-01 | 2.18e-01 |
GOBP REGULATION OF FAT CELL DIFFERENTIATION | 77 | 5.75e-02 | -1.25e-01 | 4.30e-01 |
GOBP STEROL TRANSPORT | 79 | 5.44e-02 | -1.25e-01 | 4.23e-01 |
GOCC MYOFILAMENT | 11 | 4.72e-01 | -1.25e-01 | 8.46e-01 |
GOMF WIDE PORE CHANNEL ACTIVITY | 11 | 4.72e-01 | -1.25e-01 | 8.46e-01 |
GOBP SUBSTANTIA NIGRA DEVELOPMENT | 33 | 2.13e-01 | -1.25e-01 | 6.89e-01 |
GOMF FLIPPASE ACTIVITY | 13 | 4.34e-01 | 1.25e-01 | 8.27e-01 |
GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 12 | 4.53e-01 | 1.25e-01 | 8.36e-01 |
GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 22 | 3.10e-01 | -1.25e-01 | 7.58e-01 |
GOBP CELLULAR RESPONSE TO ETHANOL | 10 | 4.93e-01 | -1.25e-01 | 8.56e-01 |
GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 15 | 4.02e-01 | 1.25e-01 | 8.15e-01 |
GOMF TRANSFERRIN RECEPTOR BINDING | 8 | 5.40e-01 | 1.25e-01 | 8.74e-01 |
GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 7 | 5.67e-01 | 1.25e-01 | 8.83e-01 |
GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 33 | 2.14e-01 | 1.25e-01 | 6.89e-01 |
GOBP LACTATE METABOLIC PROCESS | 12 | 4.54e-01 | -1.25e-01 | 8.37e-01 |
GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 7 | 5.67e-01 | 1.25e-01 | 8.83e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 76 | 6.02e-02 | -1.25e-01 | 4.38e-01 |
GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 5 | 6.29e-01 | -1.25e-01 | 9.05e-01 |
GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 101 | 3.04e-02 | -1.25e-01 | 3.48e-01 |
GOBP ZYMOGEN INHIBITION | 8 | 5.41e-01 | -1.25e-01 | 8.74e-01 |
GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 30 | 2.38e-01 | 1.25e-01 | 7.11e-01 |
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 17 | 3.74e-01 | 1.25e-01 | 7.99e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 31 | 2.30e-01 | -1.25e-01 | 7.04e-01 |
GOCC CYTOSOLIC REGION | 18 | 3.61e-01 | 1.25e-01 | 7.92e-01 |
GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 5 | 6.30e-01 | -1.25e-01 | 9.05e-01 |
GOBP NEGATIVE REGULATION OF AXONOGENESIS | 33 | 2.16e-01 | -1.24e-01 | 6.91e-01 |
GOBP NEURAL PLATE PATTERN SPECIFICATION | 5 | 6.30e-01 | -1.24e-01 | 9.05e-01 |
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 21 | 3.24e-01 | -1.24e-01 | 7.69e-01 |
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 64 | 8.58e-02 | -1.24e-01 | 5.17e-01 |
GOBP MEMBRANE RAFT LOCALIZATION | 8 | 5.43e-01 | 1.24e-01 | 8.75e-01 |
GOBP RESPONSE TO COPPER ION | 20 | 3.36e-01 | -1.24e-01 | 7.79e-01 |
GOMF CYTOKINE BINDING | 84 | 4.94e-02 | -1.24e-01 | 4.14e-01 |
GOCC CORTICAL ENDOPLASMIC RETICULUM | 6 | 5.98e-01 | 1.24e-01 | 8.97e-01 |
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 16 | 3.90e-01 | -1.24e-01 | 8.08e-01 |
GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 72 | 6.89e-02 | 1.24e-01 | 4.68e-01 |
GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 114 | 2.23e-02 | -1.24e-01 | 3.06e-01 |
GOCC SM LIKE PROTEIN FAMILY COMPLEX | 85 | 4.84e-02 | -1.24e-01 | 4.13e-01 |
GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 43 | 1.60e-01 | -1.24e-01 | 6.42e-01 |
GOBP HYPEROSMOTIC RESPONSE | 19 | 3.50e-01 | -1.24e-01 | 7.86e-01 |
GOBP MACROPHAGE CHEMOTAXIS | 29 | 2.48e-01 | -1.24e-01 | 7.17e-01 |
GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 15 | 4.06e-01 | 1.24e-01 | 8.17e-01 |
GOBP RELAXATION OF MUSCLE | 20 | 3.38e-01 | -1.24e-01 | 7.80e-01 |
GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 13 | 4.40e-01 | 1.24e-01 | 8.29e-01 |
GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 24 | 2.94e-01 | -1.24e-01 | 7.48e-01 |
GOBP REPLACEMENT OSSIFICATION | 13 | 4.40e-01 | 1.24e-01 | 8.29e-01 |
GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 19 | 3.51e-01 | 1.24e-01 | 7.86e-01 |
GOBP FOLIC ACID TRANSPORT | 6 | 6.00e-01 | 1.24e-01 | 8.98e-01 |
GOBP LUNG EPITHELIUM DEVELOPMENT | 22 | 3.16e-01 | -1.24e-01 | 7.64e-01 |
GOBP TOLERANCE INDUCTION | 22 | 3.16e-01 | -1.24e-01 | 7.64e-01 |
GOBP PROTEIN INSERTION INTO ER MEMBRANE | 29 | 2.50e-01 | -1.24e-01 | 7.18e-01 |
GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 7 | 5.71e-01 | 1.24e-01 | 8.85e-01 |
GOCC EMC COMPLEX | 10 | 4.99e-01 | -1.24e-01 | 8.59e-01 |
GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 9 | 5.21e-01 | 1.24e-01 | 8.68e-01 |
GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 130 | 1.52e-02 | -1.24e-01 | 2.62e-01 |
GOBP REGULATION OF RENAL SYSTEM PROCESS | 6 | 6.00e-01 | 1.23e-01 | 8.98e-01 |
GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 7 | 5.72e-01 | -1.23e-01 | 8.85e-01 |
GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 12 | 4.59e-01 | 1.23e-01 | 8.40e-01 |
GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 52 | 1.24e-01 | 1.23e-01 | 5.89e-01 |
GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 5 | 6.33e-01 | 1.23e-01 | 9.07e-01 |
GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 146 | 1.03e-02 | -1.23e-01 | 2.15e-01 |
GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 73 | 6.92e-02 | -1.23e-01 | 4.68e-01 |
GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 15 | 4.09e-01 | 1.23e-01 | 8.17e-01 |
GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 9 | 5.23e-01 | -1.23e-01 | 8.68e-01 |
GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 10 | 5.00e-01 | -1.23e-01 | 8.60e-01 |
GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 20 | 3.41e-01 | -1.23e-01 | 7.81e-01 |
GOMF HISTONE CHAPERONE ACTIVITY | 11 | 4.80e-01 | 1.23e-01 | 8.50e-01 |
GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 5 | 6.34e-01 | 1.23e-01 | 9.07e-01 |
GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 11 | 4.80e-01 | 1.23e-01 | 8.50e-01 |
GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 6.34e-01 | 1.23e-01 | 9.07e-01 |
GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 5.47e-01 | 1.23e-01 | 8.75e-01 |
GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 36 | 2.02e-01 | 1.23e-01 | 6.84e-01 |
GOBP CHROMOSOME CONDENSATION | 25 | 2.88e-01 | 1.23e-01 | 7.43e-01 |
GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 24 | 2.98e-01 | 1.23e-01 | 7.49e-01 |
GOCC NUCLEAR CHROMOSOME | 179 | 4.73e-03 | 1.23e-01 | 1.42e-01 |
GOMF MICROTUBULE MOTOR ACTIVITY | 40 | 1.80e-01 | 1.23e-01 | 6.62e-01 |
GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 11 | 4.81e-01 | -1.23e-01 | 8.50e-01 |
GOMF STEROL ESTERASE ACTIVITY | 6 | 6.03e-01 | 1.23e-01 | 8.99e-01 |
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 8 | 5.48e-01 | -1.23e-01 | 8.75e-01 |
GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 10 | 5.02e-01 | -1.23e-01 | 8.60e-01 |
GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 89 | 4.61e-02 | -1.22e-01 | 4.02e-01 |
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 25 | 2.90e-01 | -1.22e-01 | 7.45e-01 |
GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 9 | 5.25e-01 | 1.22e-01 | 8.69e-01 |
GOBP FLUID TRANSPORT | 15 | 4.12e-01 | 1.22e-01 | 8.21e-01 |
GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 48 | 1.43e-01 | -1.22e-01 | 6.16e-01 |
GOBP LENS FIBER CELL DEVELOPMENT | 8 | 5.49e-01 | -1.22e-01 | 8.76e-01 |
GOMF IMMUNE RECEPTOR ACTIVITY | 97 | 3.76e-02 | -1.22e-01 | 3.79e-01 |
GOBP OOCYTE DIFFERENTIATION | 30 | 2.47e-01 | 1.22e-01 | 7.15e-01 |
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 5 | 6.36e-01 | -1.22e-01 | 9.08e-01 |
GOMF DIACYLGLYCEROL BINDING | 9 | 5.26e-01 | 1.22e-01 | 8.69e-01 |
GOMF ADRENERGIC RECEPTOR BINDING | 11 | 4.83e-01 | -1.22e-01 | 8.52e-01 |
GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 52 | 1.28e-01 | -1.22e-01 | 5.97e-01 |
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 5.04e-01 | 1.22e-01 | 8.61e-01 |
GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 6 | 6.05e-01 | -1.22e-01 | 8.99e-01 |
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 22 | 3.22e-01 | -1.22e-01 | 7.69e-01 |
GOBP LYMPH VESSEL DEVELOPMENT | 9 | 5.27e-01 | -1.22e-01 | 8.69e-01 |
GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 38 | 1.94e-01 | 1.22e-01 | 6.75e-01 |
GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 272 | 5.67e-04 | -1.22e-01 | 4.57e-02 |
GOBP HETEROTYPIC CELL CELL ADHESION | 36 | 2.06e-01 | -1.22e-01 | 6.87e-01 |
GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 9 | 5.27e-01 | -1.22e-01 | 8.69e-01 |
GOBP SPHINGOLIPID METABOLIC PROCESS | 110 | 2.76e-02 | -1.22e-01 | 3.38e-01 |
GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 5 | 6.37e-01 | 1.22e-01 | 9.09e-01 |
GOCC SWR1 COMPLEX | 13 | 4.48e-01 | -1.22e-01 | 8.33e-01 |
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 13 | 4.48e-01 | 1.22e-01 | 8.33e-01 |
GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 26 | 2.83e-01 | 1.22e-01 | 7.39e-01 |
GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 55 | 1.19e-01 | -1.22e-01 | 5.82e-01 |
GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 107 | 3.00e-02 | 1.22e-01 | 3.48e-01 |
GOCC SUPER ELONGATION COMPLEX | 6 | 6.06e-01 | 1.22e-01 | 8.99e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 6.38e-01 | -1.22e-01 | 9.09e-01 |
GOBP CHONDROCYTE DIFFERENTIATION | 54 | 1.23e-01 | -1.22e-01 | 5.87e-01 |
GOBP NEGATIVE REGULATION OF CELL GROWTH | 113 | 2.59e-02 | -1.21e-01 | 3.29e-01 |
GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 245 | 1.10e-03 | -1.21e-01 | 6.76e-02 |
GOBP OSTEOCLAST PROLIFERATION | 5 | 6.38e-01 | 1.21e-01 | 9.09e-01 |
GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 57 | 1.13e-01 | -1.21e-01 | 5.76e-01 |
GOBP REGULATION OF MICROTUBULE NUCLEATION | 19 | 3.60e-01 | -1.21e-01 | 7.92e-01 |
GOBP ACTIN FILAMENT BASED TRANSPORT | 18 | 3.73e-01 | -1.21e-01 | 7.99e-01 |
GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 64 | 9.33e-02 | 1.21e-01 | 5.31e-01 |
GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 9 | 5.28e-01 | -1.21e-01 | 8.69e-01 |
GOBP REGULATION OF B CELL DIFFERENTIATION | 26 | 2.85e-01 | 1.21e-01 | 7.41e-01 |
GOCC DYNEIN AXONEMAL PARTICLE | 10 | 5.07e-01 | 1.21e-01 | 8.62e-01 |
GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 4.86e-01 | 1.21e-01 | 8.53e-01 |
GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 18 | 3.73e-01 | -1.21e-01 | 7.99e-01 |
GOBP VENTRICULAR SYSTEM DEVELOPMENT | 21 | 3.36e-01 | -1.21e-01 | 7.79e-01 |
GOBP DEVELOPMENTAL CELL GROWTH | 133 | 1.60e-02 | -1.21e-01 | 2.70e-01 |
GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 33 | 2.28e-01 | 1.21e-01 | 7.02e-01 |
GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 3.48e-01 | 1.21e-01 | 7.86e-01 |
GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 8 | 5.53e-01 | 1.21e-01 | 8.77e-01 |
GOBP CELLULAR RESPONSE TO UV B | 8 | 5.53e-01 | 1.21e-01 | 8.77e-01 |
GOBP EMBRYO IMPLANTATION | 31 | 2.43e-01 | -1.21e-01 | 7.14e-01 |
GOBP ADHERENS JUNCTION ASSEMBLY | 11 | 4.87e-01 | 1.21e-01 | 8.53e-01 |
GOBP T CELL CYTOKINE PRODUCTION | 31 | 2.44e-01 | -1.21e-01 | 7.14e-01 |
GOCC TRANSCRIPTION EXPORT COMPLEX | 10 | 5.07e-01 | 1.21e-01 | 8.62e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 224 | 1.85e-03 | -1.21e-01 | 8.88e-02 |
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 17 | 3.88e-01 | -1.21e-01 | 8.06e-01 |
GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 6 | 6.08e-01 | 1.21e-01 | 9.00e-01 |
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 11 | 4.87e-01 | -1.21e-01 | 8.53e-01 |
GOBP ODONTOGENESIS | 48 | 1.48e-01 | -1.21e-01 | 6.24e-01 |
GOBP CRISTAE FORMATION | 17 | 3.88e-01 | 1.21e-01 | 8.06e-01 |
GOBP MONOCARBOXYLIC ACID TRANSPORT | 82 | 5.88e-02 | -1.21e-01 | 4.34e-01 |
GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 14 | 4.34e-01 | -1.21e-01 | 8.27e-01 |
GOBP EPIDERMIS MORPHOGENESIS | 12 | 4.69e-01 | 1.21e-01 | 8.45e-01 |
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 7 | 5.80e-01 | -1.21e-01 | 8.88e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 31 | 2.45e-01 | 1.21e-01 | 7.14e-01 |
GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 8 | 5.55e-01 | -1.21e-01 | 8.77e-01 |
GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 13 | 4.51e-01 | -1.21e-01 | 8.36e-01 |
GOBP CELLULAR COMPONENT MAINTENANCE | 42 | 1.76e-01 | 1.21e-01 | 6.60e-01 |
GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 71 | 7.91e-02 | -1.21e-01 | 5.03e-01 |
GOBP RESPONSE TO CAMP | 46 | 1.57e-01 | -1.21e-01 | 6.39e-01 |
GOBP MIRNA PROCESSING | 41 | 1.82e-01 | -1.20e-01 | 6.65e-01 |
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 38 | 1.99e-01 | -1.20e-01 | 6.79e-01 |
GOBP MYELOID CELL HOMEOSTASIS | 139 | 1.44e-02 | -1.20e-01 | 2.61e-01 |
GOBP MONOCYTE CHEMOTAXIS | 36 | 2.11e-01 | -1.20e-01 | 6.87e-01 |
GOBP MYELOID CELL APOPTOTIC PROCESS | 32 | 2.39e-01 | -1.20e-01 | 7.12e-01 |
GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 2.46e-01 | 1.20e-01 | 7.15e-01 |
GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 16 | 4.05e-01 | 1.20e-01 | 8.17e-01 |
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 87 | 5.27e-02 | -1.20e-01 | 4.19e-01 |
GOBP MRNA SPLICE SITE RECOGNITION | 28 | 2.71e-01 | -1.20e-01 | 7.29e-01 |
GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 84 | 5.71e-02 | -1.20e-01 | 4.28e-01 |
GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 16 | 4.05e-01 | -1.20e-01 | 8.17e-01 |
GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 9 | 5.33e-01 | -1.20e-01 | 8.73e-01 |
GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 20 | 3.53e-01 | -1.20e-01 | 7.88e-01 |
GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 10 | 5.11e-01 | -1.20e-01 | 8.65e-01 |
GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 67 | 8.98e-02 | -1.20e-01 | 5.23e-01 |
GOCC AXOLEMMA | 10 | 5.11e-01 | 1.20e-01 | 8.65e-01 |
GOBP NEGATIVE REGULATION OF CELL ADHESION | 196 | 3.91e-03 | -1.20e-01 | 1.32e-01 |
GOBP RNA GUANINE N7 METHYLATION | 6 | 6.11e-01 | -1.20e-01 | 9.01e-01 |
GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 6 | 6.11e-01 | 1.20e-01 | 9.01e-01 |
GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 16 | 4.07e-01 | -1.20e-01 | 8.17e-01 |
GOBP ENTRY OF BACTERIUM INTO HOST CELL | 7 | 5.83e-01 | -1.20e-01 | 8.89e-01 |
GOBP POSITIVE REGULATION OF CYTOKINESIS | 28 | 2.73e-01 | 1.20e-01 | 7.30e-01 |
GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 19 | 3.67e-01 | 1.20e-01 | 7.96e-01 |
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 9 | 5.34e-01 | -1.20e-01 | 8.73e-01 |
GOBP OUTFLOW TRACT MORPHOGENESIS | 38 | 2.02e-01 | -1.20e-01 | 6.84e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 91 | 4.88e-02 | 1.20e-01 | 4.14e-01 |
GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 20 | 3.55e-01 | -1.20e-01 | 7.90e-01 |
GOBP AMIDE CATABOLIC PROCESS | 9 | 5.35e-01 | -1.20e-01 | 8.73e-01 |
GOBP TRANSCRIPTION BY RNA POLYMERASE III | 58 | 1.16e-01 | 1.20e-01 | 5.78e-01 |
GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 5.84e-01 | 1.20e-01 | 8.89e-01 |
GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 6 | 6.12e-01 | -1.20e-01 | 9.01e-01 |
GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 5 | 6.44e-01 | -1.19e-01 | 9.10e-01 |
GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 3.80e-01 | -1.19e-01 | 8.02e-01 |
GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 8 | 5.59e-01 | 1.19e-01 | 8.79e-01 |
GOBP MRNA POLYADENYLATION | 23 | 3.22e-01 | 1.19e-01 | 7.69e-01 |
GOBP MITOCHONDRION MORPHOGENESIS | 20 | 3.56e-01 | -1.19e-01 | 7.91e-01 |
GOBP REGULATION OF RECEPTOR RECYCLING | 19 | 3.68e-01 | -1.19e-01 | 7.96e-01 |
GOBP IRON ION TRANSPORT | 36 | 2.17e-01 | -1.19e-01 | 6.92e-01 |
GOCC FIBRILLAR CENTER | 127 | 2.08e-02 | 1.19e-01 | 2.98e-01 |
GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 5.15e-01 | 1.19e-01 | 8.66e-01 |
GOMF DYSTROGLYCAN BINDING | 7 | 5.86e-01 | 1.19e-01 | 8.90e-01 |
GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 4.95e-01 | 1.19e-01 | 8.56e-01 |
GOBP RESPONSE TO THYROID HORMONE | 20 | 3.57e-01 | 1.19e-01 | 7.91e-01 |
GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 18 | 3.83e-01 | -1.19e-01 | 8.03e-01 |
GOBP DENDRITIC TRANSPORT | 10 | 5.15e-01 | 1.19e-01 | 8.66e-01 |
GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 9 | 5.37e-01 | -1.19e-01 | 8.73e-01 |
GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 52 | 1.39e-01 | -1.19e-01 | 6.09e-01 |
GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 39 | 1.99e-01 | -1.19e-01 | 6.79e-01 |
GOBP DNA DEALKYLATION | 30 | 2.60e-01 | 1.19e-01 | 7.24e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 93 | 4.80e-02 | 1.19e-01 | 4.12e-01 |
GOBP CELL SUBSTRATE ADHESION | 212 | 2.96e-03 | -1.19e-01 | 1.12e-01 |
GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 5 | 6.46e-01 | -1.19e-01 | 9.11e-01 |
GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 26 | 2.95e-01 | -1.19e-01 | 7.48e-01 |
GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 6 | 6.15e-01 | -1.19e-01 | 9.02e-01 |
GOBP CHROMOSOME ORGANIZATION | 475 | 1.06e-05 | 1.19e-01 | 2.65e-03 |
GOBP WOUND HEALING | 249 | 1.31e-03 | -1.19e-01 | 7.32e-02 |
GOBP REGULATION OF PEPTIDASE ACTIVITY | 207 | 3.34e-03 | -1.19e-01 | 1.21e-01 |
GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 6 | 6.15e-01 | 1.19e-01 | 9.02e-01 |
GOCC CIS GOLGI NETWORK | 50 | 1.47e-01 | -1.19e-01 | 6.24e-01 |
GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 268 | 8.86e-04 | -1.18e-01 | 5.90e-02 |
GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 8 | 5.62e-01 | -1.18e-01 | 8.80e-01 |
GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 6 | 6.16e-01 | -1.18e-01 | 9.02e-01 |
GOMF CYCLIC NUCLEOTIDE BINDING | 20 | 3.60e-01 | 1.18e-01 | 7.92e-01 |
GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 11 | 4.97e-01 | -1.18e-01 | 8.59e-01 |
GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 8 | 5.63e-01 | -1.18e-01 | 8.80e-01 |
GOMF CHOLESTEROL BINDING | 35 | 2.27e-01 | -1.18e-01 | 7.02e-01 |
GOCC COMMITMENT COMPLEX | 5 | 6.48e-01 | -1.18e-01 | 9.12e-01 |
GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 33 | 2.41e-01 | -1.18e-01 | 7.14e-01 |
GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 15 | 4.29e-01 | -1.18e-01 | 8.25e-01 |
GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 6 | 6.17e-01 | -1.18e-01 | 9.02e-01 |
GOBP REGULATION OF LYSOSOMAL LUMEN PH | 27 | 2.89e-01 | -1.18e-01 | 7.44e-01 |
GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 38 | 2.09e-01 | -1.18e-01 | 6.87e-01 |
GOBP REGULATION OF CELL SUBSTRATE ADHESION | 134 | 1.87e-02 | -1.18e-01 | 2.89e-01 |
GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 6 | 6.17e-01 | 1.18e-01 | 9.02e-01 |
GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 15 | 4.30e-01 | -1.18e-01 | 8.25e-01 |
GOBP LYMPH VESSEL MORPHOGENESIS | 7 | 5.90e-01 | -1.18e-01 | 8.92e-01 |
GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 9 | 5.41e-01 | -1.18e-01 | 8.74e-01 |
GOCC RIBONUCLEASE P COMPLEX | 13 | 4.63e-01 | 1.18e-01 | 8.42e-01 |
GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 9 | 5.41e-01 | -1.18e-01 | 8.74e-01 |
GOBP AMINE CATABOLIC PROCESS | 11 | 5.00e-01 | -1.18e-01 | 8.60e-01 |
GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 10 | 5.20e-01 | 1.18e-01 | 8.68e-01 |
GOBP RESPONSE TO CHEMOKINE | 51 | 1.47e-01 | -1.18e-01 | 6.23e-01 |
GOCC RIBONUCLEOPROTEIN COMPLEX | 671 | 2.67e-07 | -1.18e-01 | 1.74e-04 |
GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 9 | 5.42e-01 | -1.17e-01 | 8.74e-01 |
GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 14 | 4.47e-01 | 1.17e-01 | 8.33e-01 |
GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 2.92e-01 | -1.17e-01 | 7.46e-01 |
GOBP STORE OPERATED CALCIUM ENTRY | 14 | 4.48e-01 | 1.17e-01 | 8.33e-01 |
GOBP REGULATION OF CELL MORPHOGENESIS | 176 | 7.43e-03 | -1.17e-01 | 1.82e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 102 | 4.11e-02 | -1.17e-01 | 3.85e-01 |
GOBP GALACTOSE METABOLIC PROCESS | 8 | 5.66e-01 | 1.17e-01 | 8.82e-01 |
GOMF PENTOSYLTRANSFERASE ACTIVITY | 46 | 1.70e-01 | 1.17e-01 | 6.52e-01 |
GOBP POSITIVE REGULATION OF GLIOGENESIS | 39 | 2.06e-01 | -1.17e-01 | 6.87e-01 |
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 34 | 2.38e-01 | -1.17e-01 | 7.11e-01 |
GOBP RESPONSE TO LITHIUM ION | 7 | 5.92e-01 | -1.17e-01 | 8.93e-01 |
GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 9 | 5.44e-01 | 1.17e-01 | 8.75e-01 |
GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 10 | 5.22e-01 | -1.17e-01 | 8.68e-01 |
GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 88 | 5.83e-02 | -1.17e-01 | 4.33e-01 |
GOBP PROTEIN LOCALIZATION TO AXON | 5 | 6.51e-01 | 1.17e-01 | 9.14e-01 |
GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 6 | 6.20e-01 | -1.17e-01 | 9.03e-01 |
GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 8 | 5.67e-01 | 1.17e-01 | 8.83e-01 |
GOBP RRNA CATABOLIC PROCESS | 19 | 3.78e-01 | 1.17e-01 | 8.02e-01 |
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 201 | 4.44e-03 | -1.17e-01 | 1.39e-01 |
GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 9 | 5.44e-01 | -1.17e-01 | 8.75e-01 |
GOBP EPITHELIAL CELL DEVELOPMENT | 128 | 2.29e-02 | -1.17e-01 | 3.10e-01 |
GOBP POLYAMINE METABOLIC PROCESS | 15 | 4.34e-01 | -1.17e-01 | 8.27e-01 |
GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 16 | 4.19e-01 | -1.17e-01 | 8.22e-01 |
GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 47 | 1.67e-01 | 1.17e-01 | 6.49e-01 |
GOBP REGULATION OF DEPHOSPHORYLATION | 90 | 5.61e-02 | -1.17e-01 | 4.27e-01 |
GOMF INTERLEUKIN 1 RECEPTOR BINDING | 10 | 5.23e-01 | 1.17e-01 | 8.68e-01 |
GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 9 | 5.45e-01 | 1.17e-01 | 8.75e-01 |
GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 25 | 3.13e-01 | -1.17e-01 | 7.62e-01 |
GOBP ACTIN FILAMENT BASED MOVEMENT | 71 | 9.00e-02 | -1.16e-01 | 5.23e-01 |
GOBP CAMERA TYPE EYE MORPHOGENESIS | 59 | 1.22e-01 | -1.16e-01 | 5.86e-01 |
GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 6.22e-01 | 1.16e-01 | 9.03e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 23 | 3.34e-01 | -1.16e-01 | 7.78e-01 |
GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 11 | 5.04e-01 | 1.16e-01 | 8.62e-01 |
GOMF MONOCARBOXYLIC ACID BINDING | 36 | 2.28e-01 | -1.16e-01 | 7.02e-01 |
GOCC GTPASE COMPLEX | 29 | 2.79e-01 | -1.16e-01 | 7.36e-01 |
GOBP SISTER CHROMATID SEGREGATION | 183 | 6.89e-03 | 1.16e-01 | 1.77e-01 |
GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 27 | 2.97e-01 | -1.16e-01 | 7.49e-01 |
GOBP CELLULAR RESPONSE TO CADMIUM ION | 24 | 3.25e-01 | 1.16e-01 | 7.69e-01 |
GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 5.95e-01 | 1.16e-01 | 8.95e-01 |
GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 6 | 6.23e-01 | -1.16e-01 | 9.04e-01 |
GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 5.06e-01 | 1.16e-01 | 8.62e-01 |
GOBP SALIVARY GLAND DEVELOPMENT | 12 | 4.87e-01 | -1.16e-01 | 8.53e-01 |
GOBP CELL FATE DETERMINATION | 15 | 4.37e-01 | 1.16e-01 | 8.29e-01 |
GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 94 | 5.27e-02 | 1.16e-01 | 4.19e-01 |
GOBP P BODY ASSEMBLY | 21 | 3.59e-01 | -1.16e-01 | 7.92e-01 |
GOBP REGULATION OF CHOLESTEROL EFFLUX | 24 | 3.27e-01 | -1.16e-01 | 7.70e-01 |
GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 63 | 1.13e-01 | -1.16e-01 | 5.76e-01 |
GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 66 | 1.05e-01 | 1.16e-01 | 5.56e-01 |
GOBP REGULATION OF NEUROBLAST PROLIFERATION | 22 | 3.48e-01 | 1.16e-01 | 7.86e-01 |
GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 6.55e-01 | 1.16e-01 | 9.15e-01 |
GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 6.55e-01 | 1.16e-01 | 9.15e-01 |
GOMF ADENYLATE CYCLASE BINDING | 6 | 6.24e-01 | -1.15e-01 | 9.04e-01 |
GOMF FIBRONECTIN BINDING | 17 | 4.10e-01 | -1.15e-01 | 8.19e-01 |
GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 5.07e-01 | -1.15e-01 | 8.62e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 6.24e-01 | 1.15e-01 | 9.04e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 6.24e-01 | 1.15e-01 | 9.04e-01 |
GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 6 | 6.25e-01 | 1.15e-01 | 9.04e-01 |
GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 6.55e-01 | 1.15e-01 | 9.15e-01 |
GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 31 | 2.67e-01 | 1.15e-01 | 7.25e-01 |
GOBP REGULATION OF PROTEIN SUMOYLATION | 20 | 3.72e-01 | 1.15e-01 | 7.99e-01 |
GOBP IRON IMPORT INTO CELL | 7 | 5.98e-01 | -1.15e-01 | 8.96e-01 |
GOMF PROTEIN TYROSINE KINASE ACTIVITY | 91 | 5.78e-02 | 1.15e-01 | 4.31e-01 |
GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 6.56e-01 | -1.15e-01 | 9.15e-01 |
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 39 | 2.14e-01 | -1.15e-01 | 6.89e-01 |
GOMF NEUROTROPHIN RECEPTOR BINDING | 7 | 5.98e-01 | -1.15e-01 | 8.96e-01 |
GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 16 | 4.26e-01 | -1.15e-01 | 8.23e-01 |
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 10 | 5.29e-01 | -1.15e-01 | 8.70e-01 |
GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 63 | 1.15e-01 | 1.15e-01 | 5.78e-01 |
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 53 | 1.48e-01 | -1.15e-01 | 6.24e-01 |
GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 12 | 4.91e-01 | -1.15e-01 | 8.55e-01 |
GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 8 | 5.74e-01 | 1.15e-01 | 8.86e-01 |
GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 17 | 4.13e-01 | -1.15e-01 | 8.21e-01 |
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 8 | 5.74e-01 | 1.15e-01 | 8.86e-01 |
GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 46 | 1.79e-01 | 1.15e-01 | 6.62e-01 |
GOBP RESPONSE TO TOXIC SUBSTANCE | 141 | 1.91e-02 | -1.15e-01 | 2.89e-01 |
GOCC SARCOPLASMIC RETICULUM | 40 | 2.10e-01 | -1.15e-01 | 6.87e-01 |
GOBP DETECTION OF STIMULUS | 103 | 4.49e-02 | 1.15e-01 | 4.00e-01 |
GOBP OSTEOBLAST DEVELOPMENT | 7 | 6.00e-01 | -1.14e-01 | 8.98e-01 |
GOMF PEPTIDE ANTIGEN BINDING | 30 | 2.79e-01 | 1.14e-01 | 7.36e-01 |
GOBP MYELOID CELL DEVELOPMENT | 63 | 1.17e-01 | -1.14e-01 | 5.79e-01 |
GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 5 | 6.58e-01 | -1.14e-01 | 9.17e-01 |
GOBP REGULATION OF BLOOD CIRCULATION | 107 | 4.14e-02 | -1.14e-01 | 3.86e-01 |
GOBP URETER DEVELOPMENT | 5 | 6.58e-01 | 1.14e-01 | 9.17e-01 |
GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 10 | 5.32e-01 | -1.14e-01 | 8.72e-01 |
GOMF PROTEIN TRANSPORTER ACTIVITY | 34 | 2.50e-01 | -1.14e-01 | 7.18e-01 |
GOBP INTERLEUKIN 6 PRODUCTION | 114 | 3.55e-02 | -1.14e-01 | 3.70e-01 |
GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 129 | 2.55e-02 | 1.14e-01 | 3.27e-01 |
GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 11 | 5.12e-01 | -1.14e-01 | 8.66e-01 |
GOBP VACUOLAR LOCALIZATION | 74 | 9.02e-02 | -1.14e-01 | 5.23e-01 |
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 2.37e-01 | 1.14e-01 | 7.11e-01 |
GOBP CELLULAR RESPONSE TO CAFFEINE | 7 | 6.02e-01 | -1.14e-01 | 8.98e-01 |
GOBP REGULATION OF MYOBLAST PROLIFERATION | 6 | 6.29e-01 | -1.14e-01 | 9.05e-01 |
GOBP METAPHASE CHROMOSOME ALIGNMENT | 78 | 8.22e-02 | 1.14e-01 | 5.08e-01 |
GOCC PHOTORECEPTOR DISC MEMBRANE | 7 | 6.02e-01 | 1.14e-01 | 8.98e-01 |
GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 12 | 4.95e-01 | 1.14e-01 | 8.56e-01 |
GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 3.45e-01 | 1.14e-01 | 7.83e-01 |
GOBP RESPONSE TO INTERLEUKIN 3 | 7 | 6.02e-01 | 1.14e-01 | 8.98e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 12 | 4.95e-01 | 1.14e-01 | 8.57e-01 |
GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 6 | 6.30e-01 | -1.14e-01 | 9.05e-01 |
GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 10 | 5.34e-01 | -1.14e-01 | 8.73e-01 |
GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 11 | 5.14e-01 | 1.14e-01 | 8.66e-01 |
GOBP REGULATION OF TRANSLATIONAL INITIATION | 75 | 8.93e-02 | -1.14e-01 | 5.22e-01 |
GOMF SUMO TRANSFERASE ACTIVITY | 23 | 3.46e-01 | 1.14e-01 | 7.84e-01 |
GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 184 | 8.06e-03 | -1.14e-01 | 1.89e-01 |
GOBP RESPONSE TO TUMOR CELL | 34 | 2.52e-01 | -1.13e-01 | 7.21e-01 |
GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 125 | 2.88e-02 | 1.13e-01 | 3.41e-01 |
GOBP CELLULAR RESPONSE TO ETHER | 6 | 6.31e-01 | -1.13e-01 | 9.05e-01 |
GOBP PREPULSE INHIBITION | 6 | 6.31e-01 | 1.13e-01 | 9.05e-01 |
GOMF NAD BINDING | 47 | 1.79e-01 | 1.13e-01 | 6.62e-01 |
GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 5.35e-01 | 1.13e-01 | 8.73e-01 |
GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 18 | 4.06e-01 | -1.13e-01 | 8.17e-01 |
GOBP PENTOSE METABOLIC PROCESS | 9 | 5.57e-01 | -1.13e-01 | 8.78e-01 |
GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 8 | 5.80e-01 | -1.13e-01 | 8.88e-01 |
GOBP ENDOTHELIAL CELL MIGRATION | 138 | 2.21e-02 | -1.13e-01 | 3.05e-01 |
GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 50 | 1.67e-01 | -1.13e-01 | 6.49e-01 |
GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 7 | 6.05e-01 | 1.13e-01 | 8.99e-01 |
GOCC PHAGOCYTIC CUP | 24 | 3.38e-01 | -1.13e-01 | 7.80e-01 |
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 82 | 7.75e-02 | -1.13e-01 | 4.97e-01 |
GOCC UNCONVENTIONAL MYOSIN COMPLEX | 8 | 5.80e-01 | 1.13e-01 | 8.88e-01 |
GOBP PROTEIN K6 LINKED UBIQUITINATION | 10 | 5.37e-01 | -1.13e-01 | 8.73e-01 |
GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 11 | 5.17e-01 | 1.13e-01 | 8.67e-01 |
GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 14 | 4.65e-01 | -1.13e-01 | 8.43e-01 |
GOBP CENTROSOME SEPARATION | 13 | 4.82e-01 | -1.13e-01 | 8.50e-01 |
GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 11 | 5.17e-01 | -1.13e-01 | 8.67e-01 |
GOBP CIRCADIAN SLEEP WAKE CYCLE | 10 | 5.37e-01 | -1.13e-01 | 8.73e-01 |
GOBP REGULATION OF RECEPTOR CLUSTERING | 9 | 5.58e-01 | 1.13e-01 | 8.79e-01 |
GOBP CELLULAR RESPONSE TO X RAY | 8 | 5.81e-01 | -1.13e-01 | 8.89e-01 |
GOBP DNA BIOSYNTHETIC PROCESS | 154 | 1.60e-02 | 1.13e-01 | 2.70e-01 |
GOBP GERM CELL PROLIFERATION | 7 | 6.06e-01 | 1.13e-01 | 8.99e-01 |
GOCC CHROMOSOME CENTROMERIC REGION | 200 | 6.18e-03 | 1.13e-01 | 1.66e-01 |
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 34 | 2.57e-01 | -1.12e-01 | 7.24e-01 |
GOBP GLUCOSE IMPORT | 49 | 1.74e-01 | -1.12e-01 | 6.56e-01 |
GOMF ABC TYPE TRANSPORTER ACTIVITY | 30 | 2.87e-01 | 1.12e-01 | 7.43e-01 |
GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 10 | 5.39e-01 | -1.12e-01 | 8.73e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 10 | 5.39e-01 | -1.12e-01 | 8.73e-01 |
GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 4.68e-01 | -1.12e-01 | 8.45e-01 |
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 8 | 5.83e-01 | -1.12e-01 | 8.89e-01 |
GOBP INTRACELLULAR LIPID TRANSPORT | 40 | 2.20e-01 | -1.12e-01 | 6.96e-01 |
GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 57 | 1.44e-01 | 1.12e-01 | 6.17e-01 |
GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 5 | 6.64e-01 | 1.12e-01 | 9.20e-01 |
GOBP REGULATION OF CILIUM ASSEMBLY | 77 | 8.95e-02 | 1.12e-01 | 5.22e-01 |
GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 3.23e-01 | 1.12e-01 | 7.69e-01 |
GOCC CILIARY BASE | 27 | 3.14e-01 | 1.12e-01 | 7.63e-01 |
GOMF HISTONE ACETYLTRANSFERASE BINDING | 19 | 3.98e-01 | 1.12e-01 | 8.13e-01 |
GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 9 | 5.61e-01 | 1.12e-01 | 8.80e-01 |
GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 4.68e-01 | 1.12e-01 | 8.45e-01 |
GOMF CHEMOKINE ACTIVITY | 21 | 3.75e-01 | -1.12e-01 | 8.00e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 11 | 5.21e-01 | 1.12e-01 | 8.68e-01 |
GOBP TRIGLYCERIDE METABOLIC PROCESS | 61 | 1.31e-01 | -1.12e-01 | 6.02e-01 |
GOCC ENDOPLASMIC RETICULUM EXIT SITE | 25 | 3.33e-01 | -1.12e-01 | 7.76e-01 |
GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 5.62e-01 | -1.12e-01 | 8.80e-01 |
GOBP NAD METABOLIC PROCESS | 32 | 2.74e-01 | 1.12e-01 | 7.31e-01 |
GOBP REGULATION OF BLOOD PRESSURE | 78 | 8.83e-02 | -1.12e-01 | 5.20e-01 |
GOBP POSITIVE REGULATION OF LOCOMOTION | 362 | 2.79e-04 | -1.12e-01 | 2.84e-02 |
GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 13 | 4.86e-01 | -1.12e-01 | 8.53e-01 |
GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 6.66e-01 | 1.12e-01 | 9.21e-01 |
GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 11 | 5.22e-01 | 1.12e-01 | 8.68e-01 |
GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 7 | 6.09e-01 | -1.12e-01 | 9.01e-01 |
GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 47 | 1.86e-01 | 1.12e-01 | 6.70e-01 |
GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 7 | 6.09e-01 | 1.12e-01 | 9.01e-01 |
GOBP NEGATIVE REGULATION OF CELL KILLING | 24 | 3.45e-01 | 1.12e-01 | 7.83e-01 |
GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 244 | 2.79e-03 | -1.11e-01 | 1.10e-01 |
GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 6.36e-01 | -1.11e-01 | 9.08e-01 |
GOBP MEMBRANE PROTEIN PROTEOLYSIS | 43 | 2.06e-01 | -1.11e-01 | 6.87e-01 |
GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 9 | 5.63e-01 | 1.11e-01 | 8.80e-01 |
GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 19 | 4.01e-01 | -1.11e-01 | 8.15e-01 |
GOMF U4 SNRNA BINDING | 6 | 6.37e-01 | 1.11e-01 | 9.08e-01 |
GOBP RESPONSE TO TYPE I INTERFERON | 62 | 1.30e-01 | 1.11e-01 | 6.00e-01 |
GOBP FAT CELL DIFFERENTIATION | 148 | 1.96e-02 | -1.11e-01 | 2.92e-01 |
GOMF RNA POLYMERASE ACTIVITY | 30 | 2.91e-01 | 1.11e-01 | 7.46e-01 |
GOBP AMINO SUGAR CATABOLIC PROCESS | 10 | 5.42e-01 | 1.11e-01 | 8.74e-01 |
GOBP LACTATION | 26 | 3.26e-01 | -1.11e-01 | 7.69e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 15 | 4.56e-01 | 1.11e-01 | 8.38e-01 |
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 40 | 2.24e-01 | -1.11e-01 | 7.02e-01 |
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 11 | 5.23e-01 | 1.11e-01 | 8.68e-01 |
GOBP DIET INDUCED THERMOGENESIS | 7 | 6.11e-01 | -1.11e-01 | 9.01e-01 |
GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 46 | 1.93e-01 | -1.11e-01 | 6.75e-01 |
GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 88 | 7.21e-02 | -1.11e-01 | 4.77e-01 |
GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 43 | 2.08e-01 | 1.11e-01 | 6.87e-01 |
GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 25 | 3.37e-01 | -1.11e-01 | 7.80e-01 |
GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 33 | 2.70e-01 | 1.11e-01 | 7.28e-01 |
GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 22 | 3.68e-01 | 1.11e-01 | 7.96e-01 |
GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 9 | 5.65e-01 | 1.11e-01 | 8.81e-01 |
GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 50 | 1.75e-01 | 1.11e-01 | 6.59e-01 |
GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 29 | 3.02e-01 | -1.11e-01 | 7.53e-01 |
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 23 | 3.58e-01 | 1.11e-01 | 7.91e-01 |
GOBP POSITIVE REGULATION OF COAGULATION | 17 | 4.29e-01 | -1.11e-01 | 8.25e-01 |
GOBP SNORNA LOCALIZATION | 6 | 6.38e-01 | -1.11e-01 | 9.09e-01 |
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 23 | 3.58e-01 | 1.11e-01 | 7.91e-01 |
GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 55 | 1.56e-01 | -1.11e-01 | 6.38e-01 |
GOBP REGULATION OF GLIAL CELL PROLIFERATION | 28 | 3.11e-01 | -1.11e-01 | 7.60e-01 |
GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 14 | 4.73e-01 | -1.11e-01 | 8.47e-01 |
GOBP INTERLEUKIN 4 PRODUCTION | 27 | 3.20e-01 | -1.11e-01 | 7.68e-01 |
GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 32 | 2.80e-01 | 1.10e-01 | 7.37e-01 |
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 35 | 2.58e-01 | -1.10e-01 | 7.24e-01 |
GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 6.69e-01 | 1.10e-01 | 9.23e-01 |
GOBP REGULATION OF HEART CONTRACTION | 83 | 8.25e-02 | -1.10e-01 | 5.08e-01 |
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 13 | 4.91e-01 | 1.10e-01 | 8.55e-01 |
GOMF PHOSPHATIDYLSERINE BINDING | 32 | 2.80e-01 | 1.10e-01 | 7.37e-01 |
GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 22 | 3.71e-01 | 1.10e-01 | 7.98e-01 |
GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 104 | 5.23e-02 | -1.10e-01 | 4.19e-01 |
GOBP NEGATIVE REGULATION OF FIBRINOLYSIS | 5 | 6.69e-01 | -1.10e-01 | 9.23e-01 |
GOMF BIOTIN BINDING | 5 | 6.70e-01 | 1.10e-01 | 9.23e-01 |
GOCC MYELIN SHEATH | 31 | 2.89e-01 | -1.10e-01 | 7.44e-01 |
GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 17 | 4.32e-01 | 1.10e-01 | 8.26e-01 |
GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 5.27e-01 | -1.10e-01 | 8.69e-01 |
GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 6 | 6.41e-01 | 1.10e-01 | 9.10e-01 |
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 11 | 5.28e-01 | 1.10e-01 | 8.69e-01 |
GOBP RNA SECONDARY STRUCTURE UNWINDING | 9 | 5.68e-01 | 1.10e-01 | 8.83e-01 |
GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 18 | 4.19e-01 | -1.10e-01 | 8.22e-01 |
GOCC CELL SURFACE | 472 | 4.75e-05 | -1.10e-01 | 7.88e-03 |
GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 13 | 4.93e-01 | -1.10e-01 | 8.55e-01 |
GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 23 | 3.62e-01 | 1.10e-01 | 7.93e-01 |
GOBP GLIAL CELL PROLIFERATION | 38 | 2.41e-01 | -1.10e-01 | 7.14e-01 |
GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 14 | 4.77e-01 | -1.10e-01 | 8.48e-01 |
GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 16 | 4.47e-01 | 1.10e-01 | 8.33e-01 |
GOBP MUSCLE CELL MIGRATION | 51 | 1.75e-01 | -1.10e-01 | 6.59e-01 |
GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 26 | 3.33e-01 | -1.10e-01 | 7.76e-01 |
GOBP POSITIVE REGULATION OF CELL MATURATION | 5 | 6.71e-01 | -1.10e-01 | 9.23e-01 |
GOBP PROTEIN CONTAINING COMPLEX REMODELING | 14 | 4.78e-01 | 1.10e-01 | 8.49e-01 |
GOBP METANEPHROS DEVELOPMENT | 37 | 2.49e-01 | -1.10e-01 | 7.18e-01 |
GOBP DUMP METABOLIC PROCESS | 6 | 6.42e-01 | 1.10e-01 | 9.10e-01 |
GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 20 | 3.96e-01 | -1.10e-01 | 8.12e-01 |
GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 20 | 3.97e-01 | 1.10e-01 | 8.12e-01 |
GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 6.72e-01 | -1.10e-01 | 9.23e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 7 | 6.16e-01 | 1.09e-01 | 9.02e-01 |
GOMF DIOXYGENASE ACTIVITY | 72 | 1.09e-01 | 1.09e-01 | 5.67e-01 |
GOCC DENDRITIC SHAFT | 24 | 3.54e-01 | 1.09e-01 | 7.89e-01 |
GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 10 | 5.49e-01 | 1.09e-01 | 8.76e-01 |
GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 139 | 2.64e-02 | -1.09e-01 | 3.32e-01 |
GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 38 | 2.44e-01 | 1.09e-01 | 7.14e-01 |
GOMF NITRIC OXIDE SYNTHASE BINDING | 6 | 6.43e-01 | -1.09e-01 | 9.10e-01 |
GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 116 | 4.25e-02 | 1.09e-01 | 3.90e-01 |
GOBP CARDIAC MUSCLE CONTRACTION | 67 | 1.23e-01 | -1.09e-01 | 5.87e-01 |
GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 133 | 3.00e-02 | -1.09e-01 | 3.48e-01 |
GOBP MITOTIC SISTER CHROMATID SEGREGATION | 149 | 2.17e-02 | 1.09e-01 | 3.05e-01 |
GOMF SINGLE STRANDED DNA BINDING | 106 | 5.26e-02 | 1.09e-01 | 4.19e-01 |
GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 7 | 6.17e-01 | -1.09e-01 | 9.02e-01 |
GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 8 | 5.93e-01 | 1.09e-01 | 8.94e-01 |
GOCC ANCHORING JUNCTION | 587 | 7.53e-06 | -1.09e-01 | 1.99e-03 |
GOCC SECRETORY GRANULE | 602 | 5.84e-06 | -1.09e-01 | 1.64e-03 |
GOBP PROSTATE GLAND MORPHOGENESIS | 8 | 5.94e-01 | 1.09e-01 | 8.94e-01 |
GOCC TETRASPANIN ENRICHED MICRODOMAIN | 7 | 6.18e-01 | -1.09e-01 | 9.02e-01 |
GOBP RESPONSE TO CATECHOLAMINE | 41 | 2.28e-01 | 1.09e-01 | 7.02e-01 |
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 33 | 2.80e-01 | -1.09e-01 | 7.37e-01 |
GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 4.81e-01 | -1.09e-01 | 8.50e-01 |
GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 6.74e-01 | -1.09e-01 | 9.24e-01 |
GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 5.52e-01 | 1.09e-01 | 8.77e-01 |
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 14 | 4.82e-01 | 1.09e-01 | 8.50e-01 |
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 101 | 5.96e-02 | -1.09e-01 | 4.36e-01 |
GOBP NEURAL NUCLEUS DEVELOPMENT | 43 | 2.18e-01 | -1.09e-01 | 6.95e-01 |
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 6.45e-01 | 1.09e-01 | 9.10e-01 |
GOMF ALKALI METAL ION BINDING | 10 | 5.52e-01 | 1.09e-01 | 8.77e-01 |
GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 84 | 8.60e-02 | -1.08e-01 | 5.18e-01 |
GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE | 5 | 6.75e-01 | -1.08e-01 | 9.24e-01 |
GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 15 | 4.68e-01 | 1.08e-01 | 8.45e-01 |
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 20 | 4.02e-01 | 1.08e-01 | 8.15e-01 |
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 105 | 5.56e-02 | -1.08e-01 | 4.26e-01 |
GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 29 | 3.13e-01 | 1.08e-01 | 7.62e-01 |
GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 8 | 5.96e-01 | -1.08e-01 | 8.96e-01 |
GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 7 | 6.20e-01 | 1.08e-01 | 9.03e-01 |
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 74 | 1.08e-01 | -1.08e-01 | 5.65e-01 |
GOBP REGULATION OF EXTENT OF CELL GROWTH | 58 | 1.55e-01 | -1.08e-01 | 6.36e-01 |
GOBP ENDOCYTIC RECYCLING | 71 | 1.16e-01 | -1.08e-01 | 5.78e-01 |
GOBP SNRNA PROCESSING | 26 | 3.40e-01 | 1.08e-01 | 7.81e-01 |
GOBP CELLULAR RESPONSE TO VITAMIN | 15 | 4.69e-01 | -1.08e-01 | 8.45e-01 |
GOBP RNA SPLICING | 403 | 2.15e-04 | -1.08e-01 | 2.56e-02 |
GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 55 | 1.66e-01 | -1.08e-01 | 6.49e-01 |
GOCC COP9 SIGNALOSOME | 17 | 4.42e-01 | -1.08e-01 | 8.30e-01 |
GOBP ACTIN FILAMENT DEPOLYMERIZATION | 40 | 2.38e-01 | -1.08e-01 | 7.11e-01 |
GOBP ETHANOL METABOLIC PROCESS | 8 | 5.98e-01 | 1.08e-01 | 8.96e-01 |
GOBP NUCLEAR CHROMOSOME SEGREGATION | 234 | 4.64e-03 | 1.08e-01 | 1.42e-01 |
GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 9 | 5.76e-01 | 1.08e-01 | 8.87e-01 |
GOBP REGULATION OF BEHAVIOR | 33 | 2.85e-01 | 1.08e-01 | 7.41e-01 |
GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 27 | 3.33e-01 | -1.08e-01 | 7.76e-01 |
GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 58 | 1.57e-01 | -1.08e-01 | 6.39e-01 |
GOBP RESPONSE TO AMPHETAMINE | 15 | 4.71e-01 | 1.08e-01 | 8.46e-01 |
GOBP CALCIUM ION IMPORT | 24 | 3.62e-01 | -1.08e-01 | 7.93e-01 |
GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 12 | 5.19e-01 | -1.08e-01 | 8.67e-01 |
GOBP CRANIAL NERVE DEVELOPMENT | 29 | 3.16e-01 | -1.08e-01 | 7.64e-01 |
GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 51 | 1.84e-01 | -1.07e-01 | 6.69e-01 |
GOBP FACE MORPHOGENESIS | 18 | 4.30e-01 | -1.07e-01 | 8.25e-01 |
GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 10 | 5.57e-01 | -1.07e-01 | 8.78e-01 |
GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 12 | 5.20e-01 | 1.07e-01 | 8.68e-01 |
GOBP MUSCLE CELL APOPTOTIC PROCESS | 48 | 1.98e-01 | -1.07e-01 | 6.79e-01 |
GOBP RESPONSE TO NITRIC OXIDE | 13 | 5.03e-01 | -1.07e-01 | 8.61e-01 |
GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 5 | 6.78e-01 | -1.07e-01 | 9.24e-01 |
GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.78e-01 | -1.07e-01 | 9.24e-01 |
GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 11 | 5.38e-01 | -1.07e-01 | 8.73e-01 |
GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 185 | 1.20e-02 | -1.07e-01 | 2.35e-01 |
GOBP METANEPHRIC NEPHRON DEVELOPMENT | 13 | 5.03e-01 | 1.07e-01 | 8.61e-01 |
GOBP CARDIAC CHAMBER DEVELOPMENT | 83 | 9.15e-02 | 1.07e-01 | 5.26e-01 |
GOBP HISTONE H3 ACETYLATION | 6 | 6.49e-01 | -1.07e-01 | 9.13e-01 |
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 136 | 3.12e-02 | -1.07e-01 | 3.53e-01 |
GOMF STEROL BINDING | 44 | 2.19e-01 | -1.07e-01 | 6.96e-01 |
GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 9 | 5.78e-01 | 1.07e-01 | 8.87e-01 |
GOCC SMC5 SMC6 COMPLEX | 9 | 5.78e-01 | -1.07e-01 | 8.87e-01 |
GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 13 | 5.04e-01 | 1.07e-01 | 8.62e-01 |
GOMF PROTEIN PHOSPHATASE 1 BINDING | 18 | 4.32e-01 | 1.07e-01 | 8.26e-01 |
GOBP GLYCOLYTIC PROCESS | 67 | 1.30e-01 | -1.07e-01 | 6.01e-01 |
GOCC LYSOSOMAL LUMEN | 68 | 1.28e-01 | -1.07e-01 | 5.97e-01 |
GOBP PANCREAS DEVELOPMENT | 37 | 2.61e-01 | -1.07e-01 | 7.24e-01 |
GOCC MUSCLE MYOSIN COMPLEX | 5 | 6.79e-01 | -1.07e-01 | 9.24e-01 |
GOBP ACTION POTENTIAL | 61 | 1.49e-01 | -1.07e-01 | 6.27e-01 |
GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 9 | 5.79e-01 | 1.07e-01 | 8.88e-01 |
GOCC PHOTORECEPTOR OUTER SEGMENT | 46 | 2.11e-01 | 1.07e-01 | 6.87e-01 |
GOBP CELLULAR RESPONSE TO AMYLOID BETA | 29 | 3.20e-01 | 1.07e-01 | 7.68e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 5 | 6.80e-01 | -1.07e-01 | 9.24e-01 |
GOCC CELL CELL CONTACT ZONE | 45 | 2.16e-01 | -1.07e-01 | 6.92e-01 |
GOBP MITOCHONDRION DISTRIBUTION | 13 | 5.06e-01 | 1.07e-01 | 8.62e-01 |
GOBP ICOSANOID TRANSPORT | 25 | 3.57e-01 | -1.06e-01 | 7.91e-01 |
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 56 | 1.68e-01 | -1.06e-01 | 6.51e-01 |
GOBP CARDIAC VENTRICLE DEVELOPMENT | 64 | 1.41e-01 | 1.06e-01 | 6.14e-01 |
GOBP FACE DEVELOPMENT | 32 | 2.98e-01 | -1.06e-01 | 7.49e-01 |
GOBP POSITIVE REGULATION OF TRANSPORT | 564 | 1.80e-05 | -1.06e-01 | 3.90e-03 |
GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 22 | 3.88e-01 | -1.06e-01 | 8.06e-01 |
GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 11 | 5.41e-01 | 1.06e-01 | 8.74e-01 |
GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 14 | 4.91e-01 | 1.06e-01 | 8.55e-01 |
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 10 | 5.61e-01 | -1.06e-01 | 8.80e-01 |
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 12 | 5.24e-01 | 1.06e-01 | 8.69e-01 |
GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 6 | 6.53e-01 | -1.06e-01 | 9.15e-01 |
GOMF HISTONE H3K4ME H3K4ME2 H3K4ME3 DEMETHYLASE ACTIVITY | 5 | 6.81e-01 | 1.06e-01 | 9.25e-01 |
GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 13 | 5.08e-01 | -1.06e-01 | 8.62e-01 |
GOBP MEMBRANE HYPERPOLARIZATION | 6 | 6.53e-01 | -1.06e-01 | 9.15e-01 |
GOBP REGULATION OF NEUTROPHIL ACTIVATION | 11 | 5.43e-01 | -1.06e-01 | 8.74e-01 |
GOBP PHOTORECEPTOR CELL MAINTENANCE | 21 | 4.00e-01 | 1.06e-01 | 8.15e-01 |
GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 16 | 4.63e-01 | -1.06e-01 | 8.42e-01 |
GOBP TYPE B PANCREATIC CELL PROLIFERATION | 15 | 4.78e-01 | 1.06e-01 | 8.49e-01 |
GOBP PLASMA MEMBRANE REPAIR | 23 | 3.80e-01 | -1.06e-01 | 8.02e-01 |
GOBP OLIGODENDROCYTE DEVELOPMENT | 25 | 3.60e-01 | -1.06e-01 | 7.92e-01 |
GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 11 | 5.44e-01 | 1.06e-01 | 8.75e-01 |
GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 6 | 6.54e-01 | -1.06e-01 | 9.15e-01 |
GOBP RESPONSE TO PARATHYROID HORMONE | 6 | 6.54e-01 | -1.06e-01 | 9.15e-01 |
GOBP LOCOMOTION | 737 | 1.34e-06 | -1.06e-01 | 6.66e-04 |
GOBP REGULATION OF ERBB SIGNALING PATHWAY | 51 | 1.93e-01 | -1.06e-01 | 6.75e-01 |
GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 92 | 8.06e-02 | 1.06e-01 | 5.07e-01 |
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 18 | 4.39e-01 | -1.05e-01 | 8.29e-01 |
GOMF PROTEIN ANTIGEN BINDING | 7 | 6.29e-01 | -1.05e-01 | 9.05e-01 |
GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 6.83e-01 | -1.05e-01 | 9.25e-01 |
GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 6 | 6.55e-01 | -1.05e-01 | 9.15e-01 |
GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 8 | 6.06e-01 | -1.05e-01 | 8.99e-01 |
GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 63 | 1.49e-01 | 1.05e-01 | 6.25e-01 |
GOBP REGULATION OF EXOCYTOSIS | 121 | 4.57e-02 | -1.05e-01 | 4.00e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 6.06e-01 | -1.05e-01 | 8.99e-01 |
GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 94 | 7.84e-02 | 1.05e-01 | 4.99e-01 |
GOMF GAMMA TUBULIN BINDING | 30 | 3.19e-01 | 1.05e-01 | 7.67e-01 |
GOBP STRIATED MUSCLE ADAPTATION | 20 | 4.16e-01 | 1.05e-01 | 8.21e-01 |
GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 8 | 6.07e-01 | 1.05e-01 | 8.99e-01 |
GOCC KINETOCHORE MICROTUBULE | 18 | 4.40e-01 | -1.05e-01 | 8.29e-01 |
GOBP T CELL MIGRATION | 55 | 1.78e-01 | -1.05e-01 | 6.61e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 98 | 7.26e-02 | -1.05e-01 | 4.79e-01 |
GOBP ER NUCLEUS SIGNALING PATHWAY | 41 | 2.45e-01 | -1.05e-01 | 7.14e-01 |
GOBP DENDRITE ARBORIZATION | 5 | 6.84e-01 | -1.05e-01 | 9.25e-01 |
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 6.84e-01 | -1.05e-01 | 9.25e-01 |
GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 10 | 5.65e-01 | 1.05e-01 | 8.82e-01 |
GOBP WATER TRANSPORT | 10 | 5.66e-01 | 1.05e-01 | 8.82e-01 |
GOBP STEROL HOMEOSTASIS | 46 | 2.18e-01 | -1.05e-01 | 6.95e-01 |
GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 8 | 6.07e-01 | -1.05e-01 | 9.00e-01 |
GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 80 | 1.05e-01 | -1.05e-01 | 5.56e-01 |
GOBP ENDOCRINE PANCREAS DEVELOPMENT | 22 | 3.95e-01 | -1.05e-01 | 8.12e-01 |
GOBP TIGHT JUNCTION ORGANIZATION | 39 | 2.57e-01 | 1.05e-01 | 7.24e-01 |
GOCC CHROMATIN SILENCING COMPLEX | 12 | 5.30e-01 | 1.05e-01 | 8.70e-01 |
GOBP CORPUS CALLOSUM DEVELOPMENT | 20 | 4.17e-01 | 1.05e-01 | 8.21e-01 |
GOBP OVULATION CYCLE | 35 | 2.84e-01 | 1.05e-01 | 7.39e-01 |
GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 7 | 6.31e-01 | -1.05e-01 | 9.06e-01 |
GOBP EOSINOPHIL MEDIATED IMMUNITY | 9 | 5.87e-01 | -1.05e-01 | 8.90e-01 |
GOMF DNA N GLYCOSYLASE ACTIVITY | 14 | 4.98e-01 | 1.05e-01 | 8.59e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 10 | 5.67e-01 | 1.05e-01 | 8.83e-01 |
GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 5 | 6.86e-01 | -1.04e-01 | 9.25e-01 |
GOBP NCRNA METABOLIC PROCESS | 528 | 4.55e-05 | 1.04e-01 | 7.69e-03 |
GOBP ROOF OF MOUTH DEVELOPMENT | 46 | 2.21e-01 | -1.04e-01 | 6.98e-01 |
GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 7 | 6.33e-01 | -1.04e-01 | 9.07e-01 |
GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 43 | 2.37e-01 | -1.04e-01 | 7.11e-01 |
GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 7 | 6.33e-01 | -1.04e-01 | 9.07e-01 |
GOBP NON MOTILE CILIUM ASSEMBLY | 53 | 1.90e-01 | 1.04e-01 | 6.73e-01 |
GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 29 | 3.32e-01 | -1.04e-01 | 7.76e-01 |
GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 82 | 1.04e-01 | 1.04e-01 | 5.56e-01 |
GOBP PROTEIN TRIMERIZATION | 11 | 5.50e-01 | 1.04e-01 | 8.76e-01 |
GOCC MHC PROTEIN COMPLEX | 23 | 3.88e-01 | 1.04e-01 | 8.06e-01 |
GOCC ORGANELLAR RIBOSOME | 89 | 9.03e-02 | 1.04e-01 | 5.23e-01 |
GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 5 | 6.87e-01 | 1.04e-01 | 9.25e-01 |
GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 8 | 6.11e-01 | -1.04e-01 | 9.01e-01 |
GOCC SPECIFIC GRANULE | 131 | 4.03e-02 | -1.04e-01 | 3.83e-01 |
GOMF S METHYLTRANSFERASE ACTIVITY | 6 | 6.59e-01 | 1.04e-01 | 9.17e-01 |
GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 42 | 2.44e-01 | 1.04e-01 | 7.14e-01 |
GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 8 | 6.11e-01 | -1.04e-01 | 9.01e-01 |
GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 65 | 1.48e-01 | -1.04e-01 | 6.24e-01 |
GOBP POSITIVE REGULATION OF GROWTH | 139 | 3.48e-02 | -1.04e-01 | 3.66e-01 |
GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 6.60e-01 | -1.04e-01 | 9.17e-01 |
GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 24 | 3.79e-01 | -1.04e-01 | 8.02e-01 |
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 36 | 2.81e-01 | -1.04e-01 | 7.38e-01 |
GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 9 | 5.90e-01 | -1.04e-01 | 8.92e-01 |
GOBP APICAL JUNCTION ASSEMBLY | 39 | 2.62e-01 | 1.04e-01 | 7.24e-01 |
GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 4.00e-01 | -1.04e-01 | 8.14e-01 |
GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 12 | 5.34e-01 | -1.04e-01 | 8.73e-01 |
GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 43 | 2.40e-01 | 1.04e-01 | 7.13e-01 |
GOBP REGULATION OF CELL GROWTH | 256 | 4.44e-03 | -1.04e-01 | 1.39e-01 |
GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 36 | 2.82e-01 | 1.04e-01 | 7.39e-01 |
GOBP ACTIN FILAMENT ORGANIZATION | 312 | 1.74e-03 | -1.04e-01 | 8.48e-02 |
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 59 | 1.69e-01 | -1.04e-01 | 6.52e-01 |
GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 114 | 5.67e-02 | -1.03e-01 | 4.28e-01 |
GOMF ADENYL NUCLEOTIDE BINDING | 1210 | 2.52e-09 | 1.03e-01 | 2.13e-06 |
GOBP SELECTIVE AUTOPHAGY | 87 | 9.57e-02 | -1.03e-01 | 5.38e-01 |
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 26 | 3.61e-01 | 1.03e-01 | 7.92e-01 |
GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 393 | 4.64e-04 | -1.03e-01 | 4.13e-02 |
GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 45 | 2.30e-01 | 1.03e-01 | 7.04e-01 |
GOMF HSP90 PROTEIN BINDING | 30 | 3.27e-01 | -1.03e-01 | 7.70e-01 |
GOMF CENTROMERIC DNA BINDING | 5 | 6.89e-01 | 1.03e-01 | 9.25e-01 |
GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 5.72e-01 | -1.03e-01 | 8.85e-01 |
GOBP REGULATION OF DNA REPLICATION | 100 | 7.46e-02 | 1.03e-01 | 4.88e-01 |
GOCC NUCLEAR INCLUSION BODY | 12 | 5.36e-01 | 1.03e-01 | 8.73e-01 |
GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 4.89e-01 | -1.03e-01 | 8.54e-01 |
GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 12 | 5.36e-01 | -1.03e-01 | 8.73e-01 |
GOBP RNA STABILIZATION | 53 | 1.94e-01 | -1.03e-01 | 6.75e-01 |
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 11 | 5.54e-01 | -1.03e-01 | 8.77e-01 |
GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 54 | 1.90e-01 | -1.03e-01 | 6.73e-01 |
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 14 | 5.05e-01 | -1.03e-01 | 8.62e-01 |
GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 6.90e-01 | 1.03e-01 | 9.25e-01 |
GOBP NEURON PROJECTION EXTENSION | 105 | 6.87e-02 | -1.03e-01 | 4.67e-01 |
GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 5 | 6.90e-01 | 1.03e-01 | 9.25e-01 |
GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 7 | 6.37e-01 | -1.03e-01 | 9.09e-01 |
GOMF TELOMERIC DNA BINDING | 37 | 2.79e-01 | 1.03e-01 | 7.36e-01 |
GOCC GOLGI CISTERNA | 80 | 1.12e-01 | -1.03e-01 | 5.73e-01 |
GOBP PROTEIN DEPALMITOYLATION | 8 | 6.14e-01 | 1.03e-01 | 9.02e-01 |
GOCC CCR4 NOT COMPLEX | 14 | 5.05e-01 | 1.03e-01 | 8.62e-01 |
GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 167 | 2.22e-02 | 1.03e-01 | 3.05e-01 |
GOCC ACTIN FILAMENT | 71 | 1.35e-01 | -1.03e-01 | 6.05e-01 |
GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME | 5 | 6.91e-01 | -1.03e-01 | 9.25e-01 |
GOBP RESPONSE TO FORSKOLIN | 6 | 6.63e-01 | -1.03e-01 | 9.20e-01 |
GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 6 | 6.63e-01 | -1.03e-01 | 9.20e-01 |
GOMF PROTEIN PHOSPHATASE 2A BINDING | 23 | 3.94e-01 | -1.03e-01 | 8.11e-01 |
GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 36 | 2.87e-01 | 1.03e-01 | 7.43e-01 |
GOMF DYNACTIN BINDING | 10 | 5.74e-01 | 1.03e-01 | 8.86e-01 |
GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 6 | 6.63e-01 | 1.03e-01 | 9.20e-01 |
GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 35 | 2.94e-01 | -1.03e-01 | 7.48e-01 |
GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 22 | 4.06e-01 | 1.02e-01 | 8.17e-01 |
GOBP MYELOID LEUKOCYTE ACTIVATION | 177 | 1.90e-02 | -1.02e-01 | 2.89e-01 |
GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.16e-01 | 1.02e-01 | 9.02e-01 |
GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 6.39e-01 | -1.02e-01 | 9.09e-01 |
GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 57 | 1.82e-01 | -1.02e-01 | 6.65e-01 |
GOCC MYOSIN FILAMENT | 8 | 6.16e-01 | 1.02e-01 | 9.02e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 53 | 1.98e-01 | -1.02e-01 | 6.79e-01 |
GOBP NUCLEAR MEMBRANE ORGANIZATION | 40 | 2.64e-01 | -1.02e-01 | 7.25e-01 |
GOCC RNAI EFFECTOR COMPLEX | 21 | 4.18e-01 | -1.02e-01 | 8.21e-01 |
GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 37 | 2.82e-01 | 1.02e-01 | 7.39e-01 |
GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 89 | 9.65e-02 | -1.02e-01 | 5.38e-01 |
GOBP REGULATION OF AMINE METABOLIC PROCESS | 18 | 4.54e-01 | 1.02e-01 | 8.37e-01 |
GOBP NATURAL KILLER CELL PROLIFERATION | 12 | 5.41e-01 | -1.02e-01 | 8.74e-01 |
GOBP UREA TRANSPORT | 5 | 6.93e-01 | 1.02e-01 | 9.27e-01 |
GOBP PROTEIN LOCALIZATION TO CHROMATIN | 34 | 3.04e-01 | 1.02e-01 | 7.54e-01 |
GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 89 | 9.69e-02 | -1.02e-01 | 5.39e-01 |
GOBP WHITE FAT CELL DIFFERENTIATION | 9 | 5.97e-01 | -1.02e-01 | 8.96e-01 |
GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 5.77e-01 | -1.02e-01 | 8.87e-01 |
GOBP RRNA METABOLIC PROCESS | 243 | 6.44e-03 | 1.02e-01 | 1.69e-01 |
GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 6.18e-01 | 1.02e-01 | 9.02e-01 |
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 18 | 4.55e-01 | 1.02e-01 | 8.38e-01 |
GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 8 | 6.18e-01 | 1.02e-01 | 9.02e-01 |
GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 91 | 9.40e-02 | -1.02e-01 | 5.32e-01 |
GOBP ORGANELLE INHERITANCE | 14 | 5.11e-01 | 1.02e-01 | 8.64e-01 |
GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 90 | 9.62e-02 | -1.02e-01 | 5.38e-01 |
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 51 | 2.10e-01 | -1.02e-01 | 6.87e-01 |
GOBP MITOCHONDRION LOCALIZATION | 37 | 2.85e-01 | -1.02e-01 | 7.42e-01 |
GOBP RESPONSE TO OXYGEN LEVELS | 213 | 1.09e-02 | -1.01e-01 | 2.21e-01 |
GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 41 | 2.61e-01 | -1.01e-01 | 7.24e-01 |
GOBP REGULATION OF MITOCHONDRIAL FISSION | 25 | 3.80e-01 | -1.01e-01 | 8.02e-01 |
GOBP PHOTOTRANSDUCTION | 18 | 4.57e-01 | 1.01e-01 | 8.39e-01 |
GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 6.67e-01 | 1.01e-01 | 9.22e-01 |
GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 11 | 5.61e-01 | 1.01e-01 | 8.80e-01 |
GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 10 | 5.79e-01 | 1.01e-01 | 8.88e-01 |
GOCC GAMMA TUBULIN RING COMPLEX | 7 | 6.43e-01 | 1.01e-01 | 9.10e-01 |
GOCC CLATHRIN COAT | 41 | 2.62e-01 | 1.01e-01 | 7.24e-01 |
GOCC MITOTIC SPINDLE | 148 | 3.40e-02 | 1.01e-01 | 3.63e-01 |
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 19 | 4.45e-01 | 1.01e-01 | 8.33e-01 |
GOBP CENTRIOLE ELONGATION | 8 | 6.20e-01 | 1.01e-01 | 9.03e-01 |
GOBP GLYCOLIPID CATABOLIC PROCESS | 12 | 5.44e-01 | -1.01e-01 | 8.75e-01 |
GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 33 | 3.15e-01 | -1.01e-01 | 7.64e-01 |
GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 8 | 6.21e-01 | 1.01e-01 | 9.03e-01 |
GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 8 | 6.21e-01 | 1.01e-01 | 9.03e-01 |
GOBP AXIS SPECIFICATION | 37 | 2.88e-01 | 1.01e-01 | 7.43e-01 |
GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 14 | 5.13e-01 | -1.01e-01 | 8.66e-01 |
GOMF CHROMATIN BINDING | 438 | 3.12e-04 | 1.01e-01 | 3.07e-02 |
GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 13 | 5.28e-01 | 1.01e-01 | 8.69e-01 |
GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 5 | 6.96e-01 | -1.01e-01 | 9.29e-01 |
GOMF MRNA BINDING | 264 | 4.87e-03 | -1.01e-01 | 1.43e-01 |
GOBP VITAMIN BIOSYNTHETIC PROCESS | 16 | 4.84e-01 | 1.01e-01 | 8.52e-01 |
GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 6.44e-01 | 1.01e-01 | 9.10e-01 |
GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 12 | 5.45e-01 | -1.01e-01 | 8.75e-01 |
GOCC LIPID DROPLET | 81 | 1.17e-01 | -1.01e-01 | 5.79e-01 |
GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 71 | 1.42e-01 | 1.01e-01 | 6.14e-01 |
GOBP MYOBLAST DIFFERENTIATION | 71 | 1.42e-01 | -1.01e-01 | 6.14e-01 |
GOBP GLUCAN BIOSYNTHETIC PROCESS | 30 | 3.39e-01 | -1.01e-01 | 7.80e-01 |
GOMF JUN KINASE BINDING | 10 | 5.81e-01 | -1.01e-01 | 8.88e-01 |
GOMF PROTEIN SEQUESTERING ACTIVITY | 21 | 4.24e-01 | -1.01e-01 | 8.23e-01 |
GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 18 | 4.59e-01 | -1.01e-01 | 8.40e-01 |
GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 9 | 6.01e-01 | -1.01e-01 | 8.98e-01 |
GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 36 | 2.96e-01 | -1.01e-01 | 7.49e-01 |
GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 35 | 3.02e-01 | 1.01e-01 | 7.53e-01 |
GOBP REGULATION OF BMP SIGNALING PATHWAY | 45 | 2.43e-01 | -1.01e-01 | 7.14e-01 |
GOBP FATTY ACID ALPHA OXIDATION | 5 | 6.97e-01 | -1.01e-01 | 9.29e-01 |
GOBP AMINO SUGAR METABOLIC PROCESS | 28 | 3.57e-01 | 1.01e-01 | 7.91e-01 |
GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 37 | 2.90e-01 | 1.01e-01 | 7.45e-01 |
GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 17 | 4.73e-01 | -1.01e-01 | 8.46e-01 |
GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 11 | 5.64e-01 | -1.01e-01 | 8.80e-01 |
GOBP REGULATION OF GLUTAMATE SECRETION | 12 | 5.47e-01 | 1.01e-01 | 8.75e-01 |
GOBP MITOTIC DNA REPLICATION | 12 | 5.47e-01 | 1.00e-01 | 8.75e-01 |
GOBP VASCULAR TRANSPORT | 48 | 2.29e-01 | 1.00e-01 | 7.02e-01 |
GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 28 | 3.58e-01 | -1.00e-01 | 7.91e-01 |
GOBP SPERMATID DIFFERENTIATION | 88 | 1.04e-01 | -1.00e-01 | 5.56e-01 |
GOBP REGULATION OF MYOBLAST FUSION | 15 | 5.01e-01 | -1.00e-01 | 8.60e-01 |
GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 18 | 4.62e-01 | 1.00e-01 | 8.42e-01 |
GOCC MALE GERM CELL NUCLEUS | 36 | 2.98e-01 | 1.00e-01 | 7.49e-01 |
GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 151 | 3.40e-02 | 1.00e-01 | 3.63e-01 |
GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 5 | 6.98e-01 | -1.00e-01 | 9.29e-01 |
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 6.03e-01 | 1.00e-01 | 8.98e-01 |
GOBP ENDOSOME ORGANIZATION | 86 | 1.09e-01 | -1.00e-01 | 5.67e-01 |
GOBP MUSCLE CONTRACTION | 163 | 2.77e-02 | -1.00e-01 | 3.38e-01 |
GOBP RESPONSE TO LECTIN | 21 | 4.27e-01 | -1.00e-01 | 8.24e-01 |
GOBP PIGMENT GRANULE LOCALIZATION | 18 | 4.62e-01 | 1.00e-01 | 8.42e-01 |
GOCC MIB COMPLEX | 13 | 5.32e-01 | 1.00e-01 | 8.73e-01 |
GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 10 | 5.84e-01 | -1.00e-01 | 8.89e-01 |
GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 36 | 2.99e-01 | 1.00e-01 | 7.50e-01 |
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 13 | 5.33e-01 | 1.00e-01 | 8.73e-01 |
GOMF LEUCINE ZIPPER DOMAIN BINDING | 9 | 6.04e-01 | -9.99e-02 | 8.99e-01 |
GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 6 | 6.72e-01 | 9.99e-02 | 9.23e-01 |
GOBP MESENCHYMAL CELL PROLIFERATION | 13 | 5.33e-01 | -9.99e-02 | 8.73e-01 |
GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 18 | 4.63e-01 | -9.99e-02 | 8.42e-01 |
GOCC COPI COATED VESICLE | 24 | 3.97e-01 | -9.99e-02 | 8.12e-01 |
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 7 | 6.47e-01 | -9.99e-02 | 9.12e-01 |
GOBP RESPONSE TO NERVE GROWTH FACTOR | 32 | 3.28e-01 | -9.99e-02 | 7.71e-01 |
GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 14 | 5.18e-01 | -9.98e-02 | 8.67e-01 |
GOBP ADHESION OF SYMBIONT TO HOST | 7 | 6.48e-01 | 9.98e-02 | 9.12e-01 |
GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 6.25e-01 | 9.98e-02 | 9.05e-01 |
GOBP NCRNA PROCESSING | 391 | 7.62e-04 | 9.97e-02 | 5.53e-02 |
GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 41 | 2.70e-01 | -9.97e-02 | 7.28e-01 |
GOBP MOLTING CYCLE | 50 | 2.23e-01 | 9.96e-02 | 7.01e-01 |
GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 250 | 6.86e-03 | 9.96e-02 | 1.77e-01 |
GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 7 | 6.48e-01 | -9.96e-02 | 9.13e-01 |
GOMF PRE MIRNA BINDING | 8 | 6.26e-01 | 9.96e-02 | 9.05e-01 |
GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 28 | 3.62e-01 | -9.95e-02 | 7.94e-01 |
GOBP REGULATION OF P38MAPK CASCADE | 33 | 3.23e-01 | 9.95e-02 | 7.69e-01 |
GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 3.99e-01 | -9.95e-02 | 8.13e-01 |
GOBP POSITIVE REGULATION OF BEHAVIOR | 9 | 6.06e-01 | 9.94e-02 | 8.99e-01 |
GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 5 | 7.00e-01 | 9.94e-02 | 9.29e-01 |
GOBP PROTEIN IMPORT | 5 | 7.00e-01 | 9.94e-02 | 9.29e-01 |
GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 11 | 5.68e-01 | -9.93e-02 | 8.83e-01 |
GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 6 | 6.74e-01 | 9.93e-02 | 9.24e-01 |
GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 34 | 3.17e-01 | 9.93e-02 | 7.64e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 5.87e-01 | -9.93e-02 | 8.90e-01 |
GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 429 | 4.53e-04 | -9.93e-02 | 4.08e-02 |
GOBP CHROMOSOME LOCALIZATION | 91 | 1.02e-01 | 9.93e-02 | 5.50e-01 |
GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 26 | 3.81e-01 | -9.92e-02 | 8.02e-01 |
GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 5 | 7.01e-01 | 9.90e-02 | 9.29e-01 |
GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 12 | 5.53e-01 | 9.90e-02 | 8.77e-01 |
GOMF CYTOSKELETAL ANCHOR ACTIVITY | 19 | 4.55e-01 | 9.90e-02 | 8.38e-01 |
GOMF 7SK SNRNA BINDING | 8 | 6.28e-01 | 9.90e-02 | 9.05e-01 |
GOBP LIPID IMPORT INTO CELL | 14 | 5.22e-01 | 9.89e-02 | 8.68e-01 |
GOMF DNA TOPOISOMERASE ACTIVITY | 6 | 6.75e-01 | 9.89e-02 | 9.24e-01 |
GOBP HEART VALVE FORMATION | 5 | 7.02e-01 | -9.89e-02 | 9.29e-01 |
GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 119 | 6.32e-02 | -9.88e-02 | 4.48e-01 |
GOBP INNER CELL MASS CELL PROLIFERATION | 12 | 5.54e-01 | 9.87e-02 | 8.77e-01 |
GOMF O METHYLTRANSFERASE ACTIVITY | 22 | 4.23e-01 | 9.87e-02 | 8.23e-01 |
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 8 | 6.29e-01 | 9.87e-02 | 9.05e-01 |
GOCC ER MEMBRANE INSERTION COMPLEX | 13 | 5.38e-01 | -9.87e-02 | 8.73e-01 |
GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 28 | 3.67e-01 | -9.86e-02 | 7.96e-01 |
GOCC KINOCILIUM | 5 | 7.03e-01 | -9.86e-02 | 9.29e-01 |
GOCC SPECIFIC GRANULE MEMBRANE | 80 | 1.28e-01 | -9.86e-02 | 5.97e-01 |
GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 6 | 6.76e-01 | 9.85e-02 | 9.24e-01 |
GOBP BONE RESORPTION | 43 | 2.64e-01 | -9.85e-02 | 7.25e-01 |
GOCC ORGANELLE MEMBRANE CONTACT SITE | 43 | 2.65e-01 | -9.84e-02 | 7.25e-01 |
GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 19 | 4.58e-01 | -9.84e-02 | 8.39e-01 |
GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 34 | 3.21e-01 | 9.84e-02 | 7.68e-01 |
GOBP RESPONSE TO PH | 17 | 4.83e-01 | -9.84e-02 | 8.51e-01 |
GOMF C ACYLTRANSFERASE ACTIVITY | 13 | 5.39e-01 | 9.84e-02 | 8.73e-01 |
GOBP DETECTION OF LIGHT STIMULUS | 26 | 3.86e-01 | 9.84e-02 | 8.05e-01 |
GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 24 | 4.05e-01 | 9.83e-02 | 8.17e-01 |
GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 103 | 8.51e-02 | -9.83e-02 | 5.17e-01 |
GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 49 | 2.34e-01 | 9.83e-02 | 7.09e-01 |
GOBP NEGATIVE REGULATION OF DNA REPAIR | 32 | 3.36e-01 | 9.83e-02 | 7.79e-01 |
GOBP SUCKLING BEHAVIOR | 7 | 6.53e-01 | 9.82e-02 | 9.15e-01 |
GOMF NUCLEAR RECEPTOR ACTIVITY | 35 | 3.15e-01 | -9.82e-02 | 7.64e-01 |
GOBP RESPONSE TO LIPID | 560 | 8.01e-05 | -9.82e-02 | 1.25e-02 |
GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 8 | 6.31e-01 | 9.82e-02 | 9.05e-01 |
GOBP REGULATION OF MEMBRANE PERMEABILITY | 58 | 1.96e-01 | -9.82e-02 | 6.76e-01 |
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 18 | 4.71e-01 | -9.81e-02 | 8.46e-01 |
GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 63 | 1.79e-01 | -9.81e-02 | 6.61e-01 |
GOBP POSITIVE REGULATION OF TISSUE REMODELING | 8 | 6.31e-01 | -9.80e-02 | 9.06e-01 |
GOBP REGULATION OF LOCOMOTION | 633 | 2.99e-05 | -9.80e-02 | 5.88e-03 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 42 | 2.72e-01 | -9.79e-02 | 7.29e-01 |
GOCC SECRETORY VESICLE | 695 | 1.32e-05 | -9.79e-02 | 3.10e-03 |
GOBP NEURAL PLATE DEVELOPMENT | 6 | 6.78e-01 | 9.79e-02 | 9.24e-01 |
GOBP REGULATION OF CHROMATIN ORGANIZATION | 45 | 2.56e-01 | 9.78e-02 | 7.24e-01 |
GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 6 | 6.78e-01 | -9.78e-02 | 9.24e-01 |
GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 36 | 3.10e-01 | -9.78e-02 | 7.59e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 61 | 1.87e-01 | -9.77e-02 | 6.70e-01 |
GOBP MITOTIC SISTER CHROMATID COHESION | 23 | 4.17e-01 | 9.77e-02 | 8.21e-01 |
GOBP HISTONE H3 K4 METHYLATION | 18 | 4.73e-01 | -9.77e-02 | 8.46e-01 |
GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 28 | 3.71e-01 | -9.77e-02 | 7.98e-01 |
GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 7.05e-01 | 9.77e-02 | 9.31e-01 |
GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 25 | 3.98e-01 | -9.77e-02 | 8.13e-01 |
GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 13 | 5.43e-01 | -9.76e-02 | 8.74e-01 |
GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 29 | 3.64e-01 | 9.75e-02 | 7.95e-01 |
GOMF POTASSIUM ION LEAK CHANNEL ACTIVITY | 5 | 7.06e-01 | 9.74e-02 | 9.31e-01 |
GOBP RUFFLE ASSEMBLY | 31 | 3.48e-01 | -9.74e-02 | 7.86e-01 |
GOBP MELANOCYTE DIFFERENTIATION | 11 | 5.76e-01 | -9.74e-02 | 8.87e-01 |
GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 15 | 5.14e-01 | -9.73e-02 | 8.66e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 6.56e-01 | -9.73e-02 | 9.15e-01 |
GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 30 | 3.57e-01 | -9.73e-02 | 7.91e-01 |
GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 69 | 1.63e-01 | -9.73e-02 | 6.45e-01 |
GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 15 | 5.14e-01 | -9.72e-02 | 8.66e-01 |
GOBP DENDRITIC CELL DIFFERENTIATION | 36 | 3.13e-01 | -9.72e-02 | 7.62e-01 |
GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 40 | 2.88e-01 | 9.72e-02 | 7.43e-01 |
GOBP SOMITOGENESIS | 27 | 3.82e-01 | -9.72e-02 | 8.03e-01 |
GOBP RESPONSE TO WOUNDING | 321 | 2.87e-03 | -9.72e-02 | 1.10e-01 |
GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 331 | 2.48e-03 | -9.72e-02 | 1.07e-01 |
GOBP LEUKOCYTE TETHERING OR ROLLING | 20 | 4.52e-01 | -9.71e-02 | 8.36e-01 |
GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 55 | 2.13e-01 | 9.71e-02 | 6.89e-01 |
GOBP REGULATION OF DEVELOPMENTAL GROWTH | 172 | 2.83e-02 | -9.71e-02 | 3.41e-01 |
GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 45 | 2.60e-01 | 9.71e-02 | 7.24e-01 |
GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 5.44e-01 | 9.71e-02 | 8.75e-01 |
GOBP O GLYCAN PROCESSING | 30 | 3.58e-01 | -9.70e-02 | 7.91e-01 |
GOBP OSTEOBLAST DIFFERENTIATION | 128 | 5.86e-02 | -9.69e-02 | 4.34e-01 |
GOBP AXON EXTENSION | 72 | 1.55e-01 | -9.69e-02 | 6.37e-01 |
GOBP PEPTIDYL CYSTEINE MODIFICATION | 31 | 3.51e-01 | -9.69e-02 | 7.86e-01 |
GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 90 | 1.13e-01 | -9.69e-02 | 5.75e-01 |
GOBP PHOTOPERIODISM | 21 | 4.42e-01 | 9.69e-02 | 8.31e-01 |
GOBP CELLULAR RESPONSE TO LIPID | 393 | 1.04e-03 | -9.68e-02 | 6.58e-02 |
GOBP RESPONSE TO AMINE | 24 | 4.12e-01 | 9.68e-02 | 8.21e-01 |
GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 30 | 3.59e-01 | 9.68e-02 | 7.92e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 11 | 5.78e-01 | -9.68e-02 | 8.87e-01 |
GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 27 | 3.84e-01 | 9.68e-02 | 8.04e-01 |
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 153 | 3.93e-02 | -9.67e-02 | 3.82e-01 |
GOBP COENZYME A METABOLIC PROCESS | 19 | 4.66e-01 | 9.67e-02 | 8.44e-01 |
GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 55 | 2.15e-01 | 9.67e-02 | 6.90e-01 |
GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 26 | 3.94e-01 | -9.66e-02 | 8.11e-01 |
GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 17 | 4.91e-01 | 9.66e-02 | 8.55e-01 |
GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 23 | 4.23e-01 | 9.66e-02 | 8.23e-01 |
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 8 | 6.36e-01 | 9.66e-02 | 9.08e-01 |
GOBP DNA RECOMBINATION | 261 | 7.45e-03 | 9.65e-02 | 1.82e-01 |
GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 23 | 4.23e-01 | -9.65e-02 | 8.23e-01 |
GOBP ETHANOL CATABOLIC PROCESS | 5 | 7.09e-01 | 9.65e-02 | 9.31e-01 |
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 61 | 1.93e-01 | -9.65e-02 | 6.75e-01 |
GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 11 | 5.80e-01 | -9.65e-02 | 8.88e-01 |
GOCC EKC KEOPS COMPLEX | 5 | 7.09e-01 | 9.65e-02 | 9.31e-01 |
GOBP 3 UTR MEDIATED MRNA STABILIZATION | 17 | 4.92e-01 | -9.64e-02 | 8.55e-01 |
GOBP FAS SIGNALING PATHWAY | 6 | 6.83e-01 | -9.63e-02 | 9.25e-01 |
GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 57 | 2.09e-01 | 9.63e-02 | 6.87e-01 |
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 7.09e-01 | -9.63e-02 | 9.31e-01 |
GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 155 | 3.90e-02 | -9.63e-02 | 3.82e-01 |
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 67 | 1.73e-01 | -9.62e-02 | 6.56e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 23 | 4.25e-01 | -9.62e-02 | 8.23e-01 |
GOBP RESPONSE TO FRUCTOSE | 5 | 7.10e-01 | -9.62e-02 | 9.31e-01 |
GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 25 | 4.05e-01 | -9.61e-02 | 8.17e-01 |
GOBP POSITIVE REGULATION OF TRANSLATION | 123 | 6.60e-02 | -9.61e-02 | 4.59e-01 |
GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 8 | 6.38e-01 | 9.61e-02 | 9.09e-01 |
GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 7.10e-01 | 9.61e-02 | 9.31e-01 |
GOBP NEGATIVE CHEMOTAXIS | 24 | 4.15e-01 | -9.61e-02 | 8.21e-01 |
GOBP FEMALE SEX DIFFERENTIATION | 58 | 2.06e-01 | 9.60e-02 | 6.87e-01 |
GOCC SCHMIDT LANTERMAN INCISURE | 5 | 7.10e-01 | -9.60e-02 | 9.31e-01 |
GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 11 | 5.82e-01 | 9.60e-02 | 8.89e-01 |
GOBP AORTA MORPHOGENESIS | 16 | 5.07e-01 | -9.59e-02 | 8.62e-01 |
GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 8 | 6.39e-01 | 9.59e-02 | 9.09e-01 |
GOBP MEMBRANE BIOGENESIS | 45 | 2.66e-01 | -9.59e-02 | 7.25e-01 |
GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 6.18e-01 | 9.59e-02 | 9.02e-01 |
GOMF DNA NUCLEASE ACTIVITY | 51 | 2.37e-01 | 9.59e-02 | 7.11e-01 |
GOCC SCAR COMPLEX | 11 | 5.82e-01 | 9.58e-02 | 8.89e-01 |
GOBP BEHAVIORAL RESPONSE TO COCAINE | 6 | 6.84e-01 | 9.58e-02 | 9.25e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 65 | 1.82e-01 | -9.58e-02 | 6.65e-01 |
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 6.85e-01 | -9.58e-02 | 9.25e-01 |
GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 12 | 5.66e-01 | -9.58e-02 | 8.82e-01 |
GOBP MITOTIC CYTOKINETIC PROCESS | 22 | 4.37e-01 | -9.58e-02 | 8.29e-01 |
GOBP COLLECTING DUCT DEVELOPMENT | 6 | 6.85e-01 | 9.57e-02 | 9.25e-01 |
GOBP CHOLESTEROL IMPORT | 6 | 6.85e-01 | -9.57e-02 | 9.25e-01 |
GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 24 | 4.17e-01 | -9.57e-02 | 8.21e-01 |
GOBP RISC COMPLEX ASSEMBLY | 10 | 6.01e-01 | 9.56e-02 | 8.98e-01 |
GOBP VIRAL TRANSLATION | 20 | 4.59e-01 | -9.56e-02 | 8.40e-01 |
GOBP ENDOCRINE SYSTEM DEVELOPMENT | 58 | 2.08e-01 | -9.56e-02 | 6.87e-01 |
GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 4.71e-01 | 9.56e-02 | 8.46e-01 |
GOMF SPECTRIN BINDING | 16 | 5.09e-01 | -9.55e-02 | 8.63e-01 |
GOBP IMP BIOSYNTHETIC PROCESS | 10 | 6.01e-01 | 9.54e-02 | 8.98e-01 |
GOBP PROTEIN AUTOPROCESSING | 15 | 5.22e-01 | 9.54e-02 | 8.68e-01 |
GOBP CELL RECOGNITION | 76 | 1.51e-01 | 9.54e-02 | 6.29e-01 |
GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 20 | 4.60e-01 | 9.54e-02 | 8.40e-01 |
GOBP HORMONE BIOSYNTHETIC PROCESS | 30 | 3.66e-01 | -9.54e-02 | 7.96e-01 |
GOBP FACIAL NERVE MORPHOGENESIS | 8 | 6.41e-01 | -9.53e-02 | 9.10e-01 |
GOBP CELL GROWTH | 306 | 4.30e-03 | -9.53e-02 | 1.38e-01 |
GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 11 | 5.84e-01 | -9.52e-02 | 8.89e-01 |
GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 336 | 2.82e-03 | -9.52e-02 | 1.10e-01 |
GOBP PIGMENT BIOSYNTHETIC PROCESS | 39 | 3.04e-01 | 9.52e-02 | 7.54e-01 |
GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 8 | 6.41e-01 | -9.51e-02 | 9.10e-01 |
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 151 | 4.41e-02 | -9.51e-02 | 3.97e-01 |
GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 9 | 6.21e-01 | -9.51e-02 | 9.03e-01 |
GOBP RECOMBINATIONAL REPAIR | 155 | 4.16e-02 | 9.50e-02 | 3.86e-01 |
GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 17 | 4.98e-01 | -9.50e-02 | 8.59e-01 |
GOBP MATING BEHAVIOR | 13 | 5.53e-01 | 9.50e-02 | 8.77e-01 |
GOMF JUN KINASE KINASE KINASE ACTIVITY | 10 | 6.03e-01 | 9.49e-02 | 8.99e-01 |
GOBP POSITIVE REGULATION OF T CELL MIGRATION | 29 | 3.76e-01 | -9.49e-02 | 8.01e-01 |
GOBP T HELPER 2 CELL DIFFERENTIATION | 17 | 4.98e-01 | -9.49e-02 | 8.59e-01 |
GOMF GTPASE ACTIVITY | 237 | 1.22e-02 | -9.48e-02 | 2.37e-01 |
GOBP SNO S RNA PROCESSING | 12 | 5.70e-01 | -9.48e-02 | 8.84e-01 |
GOCC FLOTILLIN COMPLEX | 7 | 6.64e-01 | -9.47e-02 | 9.20e-01 |
GOBP PROTEIN STABILIZATION | 169 | 3.41e-02 | -9.47e-02 | 3.63e-01 |
GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 18 | 4.87e-01 | 9.47e-02 | 8.53e-01 |
GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 7 | 6.65e-01 | -9.46e-02 | 9.21e-01 |
GOBP CELLULAR RESPONSE TO KETONE | 66 | 1.84e-01 | -9.46e-02 | 6.69e-01 |
GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 229 | 1.40e-02 | -9.45e-02 | 2.59e-01 |
GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 65 | 1.88e-01 | -9.45e-02 | 6.72e-01 |
GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 14 | 5.41e-01 | 9.44e-02 | 8.74e-01 |
GOCC GAMMA SECRETASE COMPLEX | 7 | 6.65e-01 | -9.44e-02 | 9.21e-01 |
GOBP NEURAL CREST CELL DIFFERENTIATION | 42 | 2.90e-01 | -9.44e-02 | 7.45e-01 |
GOBP REGULATION OF HORMONE METABOLIC PROCESS | 24 | 4.24e-01 | 9.43e-02 | 8.23e-01 |
GOBP N GLYCAN PROCESSING | 14 | 5.41e-01 | -9.43e-02 | 8.74e-01 |
GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 14 | 5.41e-01 | -9.43e-02 | 8.74e-01 |
GOMF VOLTAGE GATED CHANNEL ACTIVITY | 66 | 1.86e-01 | -9.43e-02 | 6.69e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 248 | 1.09e-02 | -9.41e-02 | 2.21e-01 |
GOMF LIPID KINASE ACTIVITY | 34 | 3.42e-01 | 9.41e-02 | 7.82e-01 |
GOMF DYNEIN COMPLEX BINDING | 19 | 4.78e-01 | -9.41e-02 | 8.49e-01 |
GOBP DNA METABOLIC PROCESS | 826 | 5.53e-06 | 9.41e-02 | 1.61e-03 |
GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 20 | 4.66e-01 | 9.41e-02 | 8.44e-01 |
GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT | 5 | 7.16e-01 | 9.41e-02 | 9.32e-01 |
GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 37 | 3.22e-01 | -9.41e-02 | 7.69e-01 |
GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 80 | 1.46e-01 | -9.41e-02 | 6.22e-01 |
GOBP CORTICAL CYTOSKELETON ORGANIZATION | 41 | 2.98e-01 | -9.40e-02 | 7.49e-01 |
GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 14 | 5.43e-01 | -9.40e-02 | 8.74e-01 |
GOBP HEART GROWTH | 41 | 2.98e-01 | -9.40e-02 | 7.49e-01 |
GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 6 | 6.90e-01 | 9.39e-02 | 9.25e-01 |
GOBP MONOATOMIC CATION TRANSPORT | 535 | 2.24e-04 | -9.39e-02 | 2.62e-02 |
GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 9 | 6.26e-01 | 9.39e-02 | 9.05e-01 |
GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 6.90e-01 | 9.39e-02 | 9.25e-01 |
GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 27 | 3.98e-01 | -9.39e-02 | 8.13e-01 |
GOBP NEGATIVE REGULATION OF GROWTH | 143 | 5.30e-02 | -9.39e-02 | 4.19e-01 |
GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 12 | 5.73e-01 | 9.39e-02 | 8.86e-01 |
GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 45 | 2.76e-01 | -9.39e-02 | 7.34e-01 |
GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 6 | 6.91e-01 | -9.38e-02 | 9.25e-01 |
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 166 | 3.74e-02 | -9.38e-02 | 3.78e-01 |
GOBP COBALAMIN METABOLIC PROCESS | 7 | 6.67e-01 | -9.38e-02 | 9.22e-01 |
GOCC MEMBRANE PROTEIN COMPLEX | 795 | 8.63e-06 | -9.38e-02 | 2.21e-03 |
GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY | 5 | 7.17e-01 | 9.37e-02 | 9.33e-01 |
GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 8 | 6.47e-01 | -9.36e-02 | 9.11e-01 |
GOCC PRESYNAPTIC ACTIVE ZONE | 38 | 3.18e-01 | -9.36e-02 | 7.66e-01 |
GOBP CD40 SIGNALING PATHWAY | 13 | 5.59e-01 | -9.36e-02 | 8.79e-01 |
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 21 | 4.58e-01 | -9.36e-02 | 8.39e-01 |
GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 11 | 5.91e-01 | -9.35e-02 | 8.93e-01 |
GOBP CARDIAC MUSCLE CELL PROLIFERATION | 23 | 4.38e-01 | -9.35e-02 | 8.29e-01 |
GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 54 | 2.35e-01 | -9.34e-02 | 7.10e-01 |
GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 23 | 4.38e-01 | -9.34e-02 | 8.29e-01 |
GOBP TELOMERE MAINTENANCE | 143 | 5.44e-02 | 9.34e-02 | 4.23e-01 |
GOCC COPI COATED VESICLE MEMBRANE | 18 | 4.93e-01 | -9.33e-02 | 8.56e-01 |
GOMF GTPASE INHIBITOR ACTIVITY | 11 | 5.92e-01 | -9.33e-02 | 8.93e-01 |
GOBP GASTRULATION | 100 | 1.08e-01 | -9.31e-02 | 5.65e-01 |
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 33 | 3.55e-01 | -9.31e-02 | 7.90e-01 |
GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 18 | 4.94e-01 | 9.31e-02 | 8.56e-01 |
GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 8 | 6.49e-01 | -9.30e-02 | 9.13e-01 |
GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 218 | 1.83e-02 | -9.30e-02 | 2.86e-01 |
GOMF PROTEIN LIPID COMPLEX BINDING | 17 | 5.07e-01 | 9.29e-02 | 8.62e-01 |
GOBP TELOMERE ORGANIZATION | 148 | 5.16e-02 | 9.29e-02 | 4.19e-01 |
GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 27 | 4.04e-01 | 9.28e-02 | 8.16e-01 |
GOBP INTERLEUKIN 1 PRODUCTION | 84 | 1.42e-01 | -9.28e-02 | 6.14e-01 |
GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 282 | 7.54e-03 | -9.28e-02 | 1.82e-01 |
GOBP EYE MORPHOGENESIS | 69 | 1.83e-01 | -9.28e-02 | 6.66e-01 |
GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 21 | 4.62e-01 | 9.28e-02 | 8.42e-01 |
GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 10 | 6.12e-01 | -9.27e-02 | 9.01e-01 |
GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 20 | 4.73e-01 | -9.27e-02 | 8.46e-01 |
GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 10 | 6.12e-01 | -9.27e-02 | 9.01e-01 |
GOBP REGULATION OF GROWTH | 357 | 2.75e-03 | -9.27e-02 | 1.08e-01 |
GOBP LATE NUCLEOPHAGY | 7 | 6.71e-01 | -9.27e-02 | 9.23e-01 |
GOBP DETECTION OF VISIBLE LIGHT | 19 | 4.84e-01 | 9.27e-02 | 8.52e-01 |
GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 28 | 3.96e-01 | -9.27e-02 | 8.12e-01 |
GOBP PROTEIN POLYGLUTAMYLATION | 7 | 6.71e-01 | 9.26e-02 | 9.23e-01 |
GOCC SITE OF DOUBLE STRAND BREAK | 80 | 1.53e-01 | 9.26e-02 | 6.32e-01 |
GOBP EMBRYONIC PLACENTA DEVELOPMENT | 57 | 2.27e-01 | -9.26e-02 | 7.02e-01 |
GOBP REGULATION OF VASCULATURE DEVELOPMENT | 158 | 4.50e-02 | -9.26e-02 | 4.00e-01 |
GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 136 | 6.28e-02 | -9.26e-02 | 4.46e-01 |
GOBP GLUTAMATE SECRETION | 16 | 5.22e-01 | 9.26e-02 | 8.68e-01 |
GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 10 | 6.13e-01 | -9.25e-02 | 9.01e-01 |
GOBP DE NOVO PROTEIN FOLDING | 37 | 3.30e-01 | -9.25e-02 | 7.74e-01 |
GOCC RNA POLYMERASE COMPLEX | 95 | 1.20e-01 | 9.25e-02 | 5.82e-01 |
GOCC SIDE OF MEMBRANE | 424 | 1.17e-03 | -9.24e-02 | 7.00e-02 |
GOMF OMEGA PEPTIDASE ACTIVITY | 8 | 6.51e-01 | 9.24e-02 | 9.14e-01 |
GOBP ACUTE INFLAMMATORY RESPONSE | 63 | 2.05e-01 | -9.24e-02 | 6.85e-01 |
GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 6.31e-01 | -9.23e-02 | 9.06e-01 |
GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 120 | 8.11e-02 | -9.23e-02 | 5.08e-01 |
GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 10 | 6.13e-01 | 9.23e-02 | 9.01e-01 |
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 26 | 4.16e-01 | 9.23e-02 | 8.21e-01 |
GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 9 | 6.32e-01 | 9.22e-02 | 9.06e-01 |
GOCC FLEMMING BODY | 29 | 3.90e-01 | 9.22e-02 | 8.08e-01 |
GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 5.65e-01 | 9.21e-02 | 8.82e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 51 | 2.55e-01 | -9.21e-02 | 7.23e-01 |
GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 19 | 4.87e-01 | 9.21e-02 | 8.53e-01 |
GOBP SPECIFICATION OF SYMMETRY | 68 | 1.89e-01 | 9.21e-02 | 6.73e-01 |
GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 8 | 6.52e-01 | -9.21e-02 | 9.15e-01 |
GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 132 | 6.82e-02 | -9.21e-02 | 4.65e-01 |
GOBP ERBB SIGNALING PATHWAY | 85 | 1.43e-01 | -9.21e-02 | 6.16e-01 |
GOBP PARAXIAL MESODERM DEVELOPMENT | 8 | 6.52e-01 | -9.20e-02 | 9.15e-01 |
GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 7 | 6.73e-01 | 9.20e-02 | 9.24e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 9 | 6.33e-01 | -9.19e-02 | 9.07e-01 |
GOBP G1 TO G0 TRANSITION | 12 | 5.82e-01 | 9.19e-02 | 8.89e-01 |
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 16 | 5.25e-01 | -9.18e-02 | 8.69e-01 |
GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 247 | 1.32e-02 | -9.18e-02 | 2.50e-01 |
GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 8 | 6.53e-01 | -9.17e-02 | 9.15e-01 |
GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 63 | 2.09e-01 | 9.17e-02 | 6.87e-01 |
GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.75e-01 | 9.16e-02 | 9.24e-01 |
GOBP VESICLE FUSION TO PLASMA MEMBRANE | 12 | 5.83e-01 | -9.16e-02 | 8.89e-01 |
GOMF LIM DOMAIN BINDING | 5 | 7.23e-01 | -9.16e-02 | 9.36e-01 |
GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 21 | 4.68e-01 | 9.15e-02 | 8.45e-01 |
GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 37 | 3.36e-01 | -9.15e-02 | 7.79e-01 |
GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 6.17e-01 | 9.15e-02 | 9.02e-01 |
GOCC CDC73 PAF1 COMPLEX | 6 | 6.98e-01 | -9.14e-02 | 9.29e-01 |
GOMF TOLL LIKE RECEPTOR BINDING | 12 | 5.84e-01 | 9.14e-02 | 8.89e-01 |
GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 241 | 1.49e-02 | -9.13e-02 | 2.62e-01 |
GOBP LAMELLIPODIUM ASSEMBLY | 53 | 2.51e-01 | -9.13e-02 | 7.19e-01 |
GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 5.54e-01 | 9.13e-02 | 8.77e-01 |
GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 9 | 6.36e-01 | 9.12e-02 | 9.08e-01 |
GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 6.55e-01 | -9.12e-02 | 9.15e-01 |
GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 11 | 6.01e-01 | -9.12e-02 | 8.98e-01 |
GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 6.55e-01 | -9.12e-02 | 9.15e-01 |
GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 7.24e-01 | 9.12e-02 | 9.36e-01 |
GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 39 | 3.25e-01 | 9.11e-02 | 7.69e-01 |
GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 5.41e-01 | -9.11e-02 | 8.74e-01 |
GOCC CIS GOLGI NETWORK MEMBRANE | 6 | 6.99e-01 | -9.11e-02 | 9.29e-01 |
GOBP CHROMOSOME SEGREGATION | 334 | 4.41e-03 | 9.10e-02 | 1.39e-01 |
GOBP NEUTROPHIL EXTRAVASATION | 10 | 6.18e-01 | 9.10e-02 | 9.02e-01 |
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 7 | 6.77e-01 | -9.09e-02 | 9.24e-01 |
GOMF NUCLEOSOME BINDING | 52 | 2.57e-01 | 9.09e-02 | 7.24e-01 |
GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 10 | 6.19e-01 | -9.09e-02 | 9.02e-01 |
GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 9 | 6.37e-01 | -9.09e-02 | 9.08e-01 |
GOBP PROTEIN DNA COMPLEX ASSEMBLY | 139 | 6.48e-02 | 9.09e-02 | 4.55e-01 |
GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 52 | 2.59e-01 | -9.06e-02 | 7.24e-01 |
GOBP CILIUM ORGANIZATION | 281 | 9.22e-03 | 9.06e-02 | 2.00e-01 |
GOBP PYRUVATE METABOLIC PROCESS | 90 | 1.38e-01 | -9.05e-02 | 6.09e-01 |
GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 6 | 7.01e-01 | 9.04e-02 | 9.29e-01 |
GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 6 | 7.01e-01 | 9.04e-02 | 9.29e-01 |
GOBP STEROID BIOSYNTHETIC PROCESS | 102 | 1.15e-01 | -9.04e-02 | 5.78e-01 |
GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 20 | 4.84e-01 | -9.04e-02 | 8.52e-01 |
GOCC PHAGOCYTIC VESICLE | 128 | 7.80e-02 | -9.04e-02 | 4.99e-01 |
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 103 | 1.14e-01 | -9.03e-02 | 5.78e-01 |
GOBP RESPONSE TO GROWTH HORMONE | 25 | 4.35e-01 | -9.03e-02 | 8.27e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 9 | 6.39e-01 | -9.03e-02 | 9.09e-01 |
GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 9 | 6.39e-01 | 9.03e-02 | 9.09e-01 |
GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 189 | 3.27e-02 | 9.03e-02 | 3.58e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 6.79e-01 | 9.03e-02 | 9.24e-01 |
GOBP SPERMIDINE METABOLIC PROCESS | 8 | 6.58e-01 | 9.03e-02 | 9.17e-01 |
GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 5.88e-01 | 9.03e-02 | 8.91e-01 |
GOMF CHEMOKINE RECEPTOR BINDING | 28 | 4.09e-01 | -9.02e-02 | 8.17e-01 |
GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 51 | 2.66e-01 | 9.02e-02 | 7.25e-01 |
GOMF STEROID BINDING | 60 | 2.28e-01 | -9.01e-02 | 7.02e-01 |
GOBP HEMOSTASIS | 142 | 6.43e-02 | -9.01e-02 | 4.53e-01 |
GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 115 | 9.57e-02 | -9.01e-02 | 5.38e-01 |
GOCC PLATELET DENSE TUBULAR NETWORK | 8 | 6.59e-01 | -9.01e-02 | 9.17e-01 |
GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS | 5 | 7.27e-01 | 9.00e-02 | 9.37e-01 |
GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 76 | 1.76e-01 | 9.00e-02 | 6.59e-01 |
GOBP ANOIKIS | 26 | 4.27e-01 | -9.00e-02 | 8.24e-01 |
GOBP VALINE METABOLIC PROCESS | 7 | 6.80e-01 | -9.00e-02 | 9.24e-01 |
GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 282 | 9.61e-03 | -8.99e-02 | 2.06e-01 |
GOBP DETECTION OF CALCIUM ION | 8 | 6.60e-01 | -8.99e-02 | 9.17e-01 |
GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 33 | 3.72e-01 | -8.99e-02 | 7.99e-01 |
GOBP NEGATIVE REGULATION OF ATP METABOLIC PROCESS | 5 | 7.28e-01 | 8.99e-02 | 9.37e-01 |
GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 55 | 2.49e-01 | -8.99e-02 | 7.18e-01 |
GOBP TYPE 2 IMMUNE RESPONSE | 34 | 3.65e-01 | -8.98e-02 | 7.95e-01 |
GOBP MYOTUBE CELL DEVELOPMENT | 20 | 4.87e-01 | 8.98e-02 | 8.53e-01 |
GOBP PROTEIN TARGETING | 281 | 9.90e-03 | -8.97e-02 | 2.08e-01 |
GOBP ONE CARBON COMPOUND TRANSPORT | 28 | 4.12e-01 | -8.97e-02 | 8.21e-01 |
GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 36 | 3.52e-01 | -8.96e-02 | 7.88e-01 |
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 9 | 6.42e-01 | -8.96e-02 | 9.10e-01 |
GOBP LONG TERM MEMORY | 17 | 5.22e-01 | 8.96e-02 | 8.68e-01 |
GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 44 | 3.04e-01 | -8.96e-02 | 7.54e-01 |
GOBP GLIAL CELL ACTIVATION | 39 | 3.33e-01 | -8.96e-02 | 7.77e-01 |
GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 38 | 3.40e-01 | 8.95e-02 | 7.81e-01 |
GOBP SPROUTING ANGIOGENESIS | 70 | 1.96e-01 | -8.95e-02 | 6.76e-01 |
GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 102 | 1.19e-01 | 8.94e-02 | 5.82e-01 |
GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 60 | 2.31e-01 | 8.94e-02 | 7.05e-01 |
GOBP VISUAL BEHAVIOR | 29 | 4.05e-01 | 8.94e-02 | 8.17e-01 |
GOMF NUCLEOSIDE BINDING | 7 | 6.82e-01 | -8.94e-02 | 9.25e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 100 | 1.23e-01 | -8.93e-02 | 5.87e-01 |
GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 169 | 4.56e-02 | -8.93e-02 | 4.00e-01 |
GOMF 5S RRNA BINDING | 9 | 6.43e-01 | -8.92e-02 | 9.10e-01 |
GOBP NEURON NEURON SYNAPTIC TRANSMISSION | 5 | 7.30e-01 | -8.91e-02 | 9.38e-01 |
GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 40 | 3.30e-01 | 8.91e-02 | 7.73e-01 |
GOBP POSITIVE REGULATION OF RNA BINDING | 6 | 7.06e-01 | -8.91e-02 | 9.31e-01 |
GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 9 | 6.44e-01 | 8.91e-02 | 9.10e-01 |
GOBP DNA DAMAGE RESPONSE | 746 | 4.22e-05 | 8.90e-02 | 7.58e-03 |
GOBP REGULATION OF AXON GUIDANCE | 7 | 6.84e-01 | 8.89e-02 | 9.25e-01 |
GOBP REGULATION OF SYSTEM PROCESS | 247 | 1.66e-02 | -8.88e-02 | 2.73e-01 |
GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 44 | 3.09e-01 | -8.88e-02 | 7.58e-01 |
GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 7 | 6.85e-01 | 8.87e-02 | 9.25e-01 |
GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 7 | 6.85e-01 | -8.87e-02 | 9.25e-01 |
GOBP CELLULAR RESPONSE TO DSRNA | 17 | 5.28e-01 | 8.85e-02 | 8.69e-01 |
GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 23 | 4.63e-01 | 8.85e-02 | 8.42e-01 |
GOBP MUSCLE CELL PROLIFERATION | 125 | 8.82e-02 | -8.84e-02 | 5.20e-01 |
GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 72 | 1.95e-01 | -8.84e-02 | 6.75e-01 |
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 11 | 6.12e-01 | 8.83e-02 | 9.01e-01 |
GOBP TRACHEA FORMATION | 6 | 7.08e-01 | -8.83e-02 | 9.31e-01 |
GOBP ENDOTHELIAL CELL PROLIFERATION | 84 | 1.62e-01 | -8.83e-02 | 6.44e-01 |
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 7.32e-01 | -8.83e-02 | 9.39e-01 |
GOBP DEFENSE RESPONSE TO TUMOR CELL | 11 | 6.12e-01 | -8.83e-02 | 9.01e-01 |
GOBP REGULATION OF ORGANELLE ASSEMBLY | 202 | 3.10e-02 | 8.83e-02 | 3.51e-01 |
GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 19 | 5.06e-01 | 8.82e-02 | 8.62e-01 |
GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 6.13e-01 | -8.82e-02 | 9.01e-01 |
GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 31 | 3.96e-01 | 8.81e-02 | 8.12e-01 |
GOBP CELLULAR RESPONSE TO MANGANESE ION | 8 | 6.66e-01 | -8.81e-02 | 9.21e-01 |
GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 158 | 5.70e-02 | -8.79e-02 | 4.28e-01 |
GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 26 | 4.38e-01 | 8.79e-02 | 8.29e-01 |
GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 17 | 5.31e-01 | 8.79e-02 | 8.71e-01 |
GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 5 | 7.34e-01 | -8.78e-02 | 9.39e-01 |
GOBP RESPIRATORY SYSTEM PROCESS | 21 | 4.86e-01 | -8.78e-02 | 8.53e-01 |
GOBP DENDRITE MORPHOGENESIS | 84 | 1.65e-01 | 8.78e-02 | 6.47e-01 |
GOBP NEGATIVE REGULATION OF CELL CYCLE | 281 | 1.17e-02 | 8.77e-02 | 2.31e-01 |
GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 7.10e-01 | 8.77e-02 | 9.31e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 5 | 7.34e-01 | -8.77e-02 | 9.39e-01 |
GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 15 | 5.57e-01 | 8.77e-02 | 8.78e-01 |
GOMF COA HYDROLASE ACTIVITY | 15 | 5.57e-01 | 8.77e-02 | 8.78e-01 |
GOMF GAMMA CATENIN BINDING | 6 | 7.10e-01 | -8.77e-02 | 9.31e-01 |
GOBP REGULATION OF RESPONSE TO WOUNDING | 86 | 1.61e-01 | -8.76e-02 | 6.42e-01 |
GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 12 | 5.99e-01 | -8.76e-02 | 8.97e-01 |
GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 6 | 7.10e-01 | -8.76e-02 | 9.31e-01 |
GOBP THYMUS DEVELOPMENT | 33 | 3.84e-01 | 8.76e-02 | 8.04e-01 |
GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 26 | 4.40e-01 | 8.76e-02 | 8.29e-01 |
GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 98 | 1.35e-01 | 8.75e-02 | 6.05e-01 |
GOCC MRNA EDITING COMPLEX | 13 | 5.85e-01 | 8.75e-02 | 8.89e-01 |
GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 11 | 6.16e-01 | -8.74e-02 | 9.02e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 6.00e-01 | -8.74e-02 | 8.98e-01 |
GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 202 | 3.27e-02 | -8.74e-02 | 3.58e-01 |
GOMF DOUBLE STRANDED RNA BINDING | 65 | 2.23e-01 | 8.74e-02 | 7.02e-01 |
GOBP FOREBRAIN NEURON DEVELOPMENT | 14 | 5.71e-01 | -8.74e-02 | 8.85e-01 |
GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 144 | 7.10e-02 | -8.73e-02 | 4.74e-01 |
GOMF P53 BINDING | 55 | 2.63e-01 | 8.73e-02 | 7.24e-01 |
GOBP BOX C D SNORNP ASSEMBLY | 8 | 6.69e-01 | -8.73e-02 | 9.23e-01 |
GOBP CARDIAC MUSCLE CELL CONTRACTION | 33 | 3.86e-01 | -8.73e-02 | 8.05e-01 |
GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 7 | 6.89e-01 | -8.73e-02 | 9.25e-01 |
GOBP T CELL PROLIFERATION | 165 | 5.36e-02 | -8.73e-02 | 4.21e-01 |
GOBP L ALANINE TRANSPORT | 5 | 7.36e-01 | 8.72e-02 | 9.39e-01 |
GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.36e-01 | 8.72e-02 | 9.39e-01 |
GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 27 | 4.33e-01 | -8.72e-02 | 8.27e-01 |
GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 8 | 6.70e-01 | 8.71e-02 | 9.23e-01 |
GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 20 | 5.00e-01 | -8.71e-02 | 8.60e-01 |
GOBP DIAPEDESIS | 6 | 7.12e-01 | 8.71e-02 | 9.31e-01 |
GOBP VENTRICULAR SEPTUM DEVELOPMENT | 43 | 3.24e-01 | 8.70e-02 | 7.69e-01 |
GOBP REGULATION OF LIPOPHAGY | 5 | 7.36e-01 | -8.70e-02 | 9.39e-01 |
GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 65 | 2.26e-01 | -8.69e-02 | 7.02e-01 |
GOBP SEGMENT SPECIFICATION | 6 | 7.12e-01 | 8.69e-02 | 9.32e-01 |
GOMF ADP BINDING | 32 | 3.95e-01 | -8.69e-02 | 8.12e-01 |
GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 7 | 6.91e-01 | -8.69e-02 | 9.25e-01 |
GOCC P BODY | 86 | 1.64e-01 | -8.69e-02 | 6.47e-01 |
GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 5 | 7.37e-01 | 8.68e-02 | 9.39e-01 |
GOBP MALE SEX DIFFERENTIATION | 90 | 1.55e-01 | 8.68e-02 | 6.37e-01 |
GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 6 | 7.13e-01 | 8.68e-02 | 9.32e-01 |
GOBP REGULATION OF GLIAL CELL MIGRATION | 15 | 5.61e-01 | -8.68e-02 | 8.80e-01 |
GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 34 | 3.81e-01 | -8.68e-02 | 8.02e-01 |
GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 17 | 5.36e-01 | 8.68e-02 | 8.73e-01 |
GOBP MONOCYTE EXTRAVASATION | 8 | 6.71e-01 | 8.68e-02 | 9.23e-01 |
GOCC EXCITATORY SYNAPSE | 24 | 4.62e-01 | 8.68e-02 | 8.42e-01 |
GOBP SEROTONIN TRANSPORT | 8 | 6.71e-01 | -8.67e-02 | 9.23e-01 |
GOMF PROTEIN SELF ASSOCIATION | 52 | 2.80e-01 | -8.67e-02 | 7.37e-01 |
GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 38 | 3.55e-01 | 8.67e-02 | 7.90e-01 |
GOBP CHONDROCYTE PROLIFERATION | 11 | 6.19e-01 | -8.67e-02 | 9.02e-01 |
GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 127 | 9.27e-02 | -8.65e-02 | 5.29e-01 |
GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 18 | 5.25e-01 | 8.65e-02 | 8.69e-01 |
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 41 | 3.38e-01 | -8.65e-02 | 7.80e-01 |
GOBP MUSCLE ORGAN MORPHOGENESIS | 30 | 4.12e-01 | 8.65e-02 | 8.21e-01 |
GOMF SCAVENGER RECEPTOR ACTIVITY | 16 | 5.49e-01 | 8.65e-02 | 8.76e-01 |
GOBP MOTOR NEURON MIGRATION | 5 | 7.38e-01 | 8.65e-02 | 9.40e-01 |
GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 35 | 3.77e-01 | 8.64e-02 | 8.01e-01 |
GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 9 | 6.54e-01 | -8.64e-02 | 9.15e-01 |
GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 85 | 1.69e-01 | 8.64e-02 | 6.52e-01 |
GOBP MAINTENANCE OF LOCATION | 239 | 2.19e-02 | -8.63e-02 | 3.05e-01 |
GOBP CGMP MEDIATED SIGNALING | 8 | 6.73e-01 | 8.63e-02 | 9.24e-01 |
GOBP MYOFIBROBLAST DIFFERENTIATION | 8 | 6.73e-01 | -8.63e-02 | 9.24e-01 |
GOMF PHOSPHOLIPASE BINDING | 18 | 5.26e-01 | -8.63e-02 | 8.69e-01 |
GOBP CELL CYCLE DNA REPLICATION | 37 | 3.64e-01 | 8.62e-02 | 7.95e-01 |
GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 36 | 3.71e-01 | 8.62e-02 | 7.98e-01 |
GOBP DTMP METABOLIC PROCESS | 5 | 7.39e-01 | 8.62e-02 | 9.40e-01 |
GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 23 | 4.75e-01 | -8.61e-02 | 8.47e-01 |
GOBP NEGATIVE REGULATION OF COAGULATION | 19 | 5.16e-01 | -8.61e-02 | 8.66e-01 |
GOBP DEVELOPMENTAL PIGMENTATION | 29 | 4.23e-01 | -8.60e-02 | 8.23e-01 |
GOCC IGA IMMUNOGLOBULIN COMPLEX | 5 | 7.39e-01 | 8.60e-02 | 9.40e-01 |
GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 30 | 4.15e-01 | 8.60e-02 | 8.21e-01 |
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 33 | 3.93e-01 | -8.60e-02 | 8.10e-01 |
GOBP CELL VOLUME HOMEOSTASIS | 23 | 4.75e-01 | 8.60e-02 | 8.47e-01 |
GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL | 5 | 7.39e-01 | -8.60e-02 | 9.40e-01 |
GOBP REELIN MEDIATED SIGNALING PATHWAY | 5 | 7.39e-01 | 8.59e-02 | 9.40e-01 |
GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 9 | 6.55e-01 | -8.59e-02 | 9.15e-01 |
GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 89 | 1.62e-01 | -8.59e-02 | 6.43e-01 |
GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 6 | 7.16e-01 | 8.59e-02 | 9.32e-01 |
GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 24 | 4.66e-01 | 8.59e-02 | 8.44e-01 |
GOBP REGULATION OF METAL ION TRANSPORT | 199 | 3.72e-02 | -8.59e-02 | 3.77e-01 |
GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 8 | 6.74e-01 | 8.59e-02 | 9.24e-01 |
GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 34 | 3.86e-01 | -8.59e-02 | 8.05e-01 |
GOBP REGULATION OF DENDRITE DEVELOPMENT | 62 | 2.43e-01 | 8.58e-02 | 7.14e-01 |
GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 20 | 5.07e-01 | -8.58e-02 | 8.62e-01 |
GOBP GROWTH | 549 | 6.44e-04 | -8.58e-02 | 4.95e-02 |
GOBP REGULATION OF AXON EXTENSION | 52 | 2.85e-01 | -8.58e-02 | 7.41e-01 |
GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 8 | 6.75e-01 | 8.58e-02 | 9.24e-01 |
GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 8 | 6.75e-01 | -8.57e-02 | 9.24e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 33 | 3.95e-01 | -8.57e-02 | 8.12e-01 |
GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 7.40e-01 | -8.57e-02 | 9.40e-01 |
GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 5.79e-01 | -8.57e-02 | 8.88e-01 |
GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 77 | 1.94e-01 | 8.56e-02 | 6.75e-01 |
GOBP REGULATION OF SECRETION | 347 | 6.37e-03 | -8.56e-02 | 1.68e-01 |
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 11 | 6.23e-01 | -8.56e-02 | 9.04e-01 |
GOBP MRNA PROCESSING | 426 | 2.59e-03 | -8.56e-02 | 1.07e-01 |
GOBP PROTEIN PROCESSING | 149 | 7.19e-02 | -8.56e-02 | 4.77e-01 |
GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 41 | 3.43e-01 | -8.56e-02 | 7.82e-01 |
GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 57 | 2.64e-01 | -8.55e-02 | 7.25e-01 |
GOBP RESPONSE TO VITAMIN | 45 | 3.21e-01 | -8.55e-02 | 7.69e-01 |
GOMF PALMITOYLTRANSFERASE ACTIVITY | 27 | 4.42e-01 | -8.55e-02 | 8.30e-01 |
GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 7.41e-01 | -8.55e-02 | 9.40e-01 |
GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 17 | 5.42e-01 | -8.54e-02 | 8.74e-01 |
GOCC PLATELET DENSE GRANULE | 11 | 6.24e-01 | 8.54e-02 | 9.04e-01 |
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 10 | 6.40e-01 | 8.54e-02 | 9.10e-01 |
GOCC CELL PROJECTION MEMBRANE | 199 | 3.84e-02 | -8.54e-02 | 3.80e-01 |
GOBP FEMALE GAMETE GENERATION | 82 | 1.82e-01 | 8.53e-02 | 6.65e-01 |
GOBP RESPONSE TO FLUID SHEAR STRESS | 25 | 4.60e-01 | -8.53e-02 | 8.40e-01 |
GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 7 | 6.96e-01 | -8.53e-02 | 9.29e-01 |
GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 58 | 2.62e-01 | -8.53e-02 | 7.24e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 67 | 2.28e-01 | -8.52e-02 | 7.02e-01 |
GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 5 | 7.42e-01 | -8.51e-02 | 9.40e-01 |
GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 9 | 6.58e-01 | -8.51e-02 | 9.17e-01 |
GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 10 | 6.41e-01 | 8.51e-02 | 9.10e-01 |
GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 508 | 1.11e-03 | -8.51e-02 | 6.76e-02 |
GOBP STRIATED MUSCLE CONTRACTION | 88 | 1.68e-01 | -8.51e-02 | 6.51e-01 |
GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 7 | 6.97e-01 | -8.50e-02 | 9.29e-01 |
GOCC SCF UBIQUITIN LIGASE COMPLEX | 52 | 2.89e-01 | 8.50e-02 | 7.44e-01 |
GOMF DNA SECONDARY STRUCTURE BINDING | 31 | 4.13e-01 | 8.50e-02 | 8.21e-01 |
GOBP REGULATION OF CELLULAR SENESCENCE | 34 | 3.92e-01 | -8.49e-02 | 8.09e-01 |
GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 13 | 5.96e-01 | 8.49e-02 | 8.96e-01 |
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 11 | 6.26e-01 | -8.48e-02 | 9.05e-01 |
GOBP POSITIVE REGULATION OF AUTOPHAGY | 125 | 1.02e-01 | -8.48e-02 | 5.50e-01 |
GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 13 | 5.97e-01 | -8.47e-02 | 8.96e-01 |
GOBP RNA DESTABILIZATION | 96 | 1.52e-01 | 8.47e-02 | 6.32e-01 |
GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 168 | 5.90e-02 | 8.46e-02 | 4.34e-01 |
GOMF VITAMIN B6 BINDING | 31 | 4.15e-01 | 8.46e-02 | 8.21e-01 |
GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 10 | 6.43e-01 | 8.46e-02 | 9.10e-01 |
GOBP NEURONAL ION CHANNEL CLUSTERING | 5 | 7.43e-01 | 8.45e-02 | 9.41e-01 |
GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 17 | 5.47e-01 | -8.45e-02 | 8.75e-01 |
GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 5 | 7.44e-01 | 8.45e-02 | 9.41e-01 |
GOBP INTERMEDIATE FILAMENT BASED PROCESS | 25 | 4.65e-01 | -8.44e-02 | 8.43e-01 |
GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 49 | 3.07e-01 | -8.44e-02 | 7.57e-01 |
GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 260 | 1.95e-02 | -8.44e-02 | 2.92e-01 |
GOBP DEVELOPMENTAL GROWTH | 375 | 5.24e-03 | -8.44e-02 | 1.52e-01 |
GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 282 | 1.52e-02 | -8.43e-02 | 2.62e-01 |
GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 664 | 2.39e-04 | -8.43e-02 | 2.69e-02 |
GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 7 | 6.99e-01 | 8.43e-02 | 9.29e-01 |
GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 30 | 4.24e-01 | 8.43e-02 | 8.23e-01 |
GOBP NEURON FATE COMMITMENT | 16 | 5.59e-01 | 8.43e-02 | 8.79e-01 |
GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 28 | 4.40e-01 | 8.43e-02 | 8.29e-01 |
GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 7 | 6.99e-01 | 8.43e-02 | 9.29e-01 |
GOBP INTERFERON ALPHA PRODUCTION | 23 | 4.84e-01 | 8.43e-02 | 8.52e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 37 | 3.75e-01 | -8.42e-02 | 8.00e-01 |
GOBP PHOSPHOLIPID HOMEOSTASIS | 8 | 6.80e-01 | 8.42e-02 | 9.24e-01 |
GOBP PROTEIN AUTOUBIQUITINATION | 55 | 2.80e-01 | 8.42e-02 | 7.37e-01 |
GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 11 | 6.29e-01 | 8.42e-02 | 9.05e-01 |
GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 19 | 5.25e-01 | 8.42e-02 | 8.69e-01 |
GOBP RESPONSE TO INTERLEUKIN 15 | 12 | 6.14e-01 | 8.41e-02 | 9.01e-01 |
GOBP CELLULAR RESPONSE TO NUTRIENT | 30 | 4.26e-01 | -8.41e-02 | 8.23e-01 |
GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 56 | 2.77e-01 | 8.41e-02 | 7.35e-01 |
GOBP UBIQUINONE METABOLIC PROCESS | 19 | 5.26e-01 | 8.40e-02 | 8.69e-01 |
GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 18 | 5.37e-01 | -8.40e-02 | 8.73e-01 |
GOMF POTASSIUM ION BINDING | 7 | 7.01e-01 | 8.39e-02 | 9.29e-01 |
GOMF MONOOXYGENASE ACTIVITY | 30 | 4.27e-01 | 8.39e-02 | 8.24e-01 |
GOBP MONOCYTE ACTIVATION | 9 | 6.63e-01 | 8.39e-02 | 9.20e-01 |
GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 5 | 7.45e-01 | -8.38e-02 | 9.42e-01 |
GOBP DNA STRAND ELONGATION | 35 | 3.91e-01 | 8.38e-02 | 8.09e-01 |
GOBP SULFUR AMINO ACID TRANSPORT | 9 | 6.64e-01 | -8.37e-02 | 9.20e-01 |
GOMF ANTIGEN BINDING | 61 | 2.59e-01 | 8.37e-02 | 7.24e-01 |
GOBP GLIAL CELL DIFFERENTIATION | 138 | 9.03e-02 | -8.37e-02 | 5.23e-01 |
GOCC OUTER MEMBRANE | 203 | 4.04e-02 | -8.37e-02 | 3.83e-01 |
GOBP RNA EXPORT FROM NUCLEUS | 82 | 1.91e-01 | 8.36e-02 | 6.74e-01 |
GOCC HOST CELLULAR COMPONENT | 7 | 7.02e-01 | 8.36e-02 | 9.29e-01 |
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 7.46e-01 | -8.35e-02 | 9.42e-01 |
GOBP AMINO ACID METABOLIC PROCESS | 173 | 5.87e-02 | 8.35e-02 | 4.34e-01 |
GOBP POTASSIUM ION TRANSPORT | 88 | 1.77e-01 | -8.34e-02 | 6.60e-01 |
GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 5 | 7.47e-01 | -8.34e-02 | 9.42e-01 |
GOCC COLLAGEN TRIMER | 21 | 5.09e-01 | -8.33e-02 | 8.63e-01 |
GOBP REGULATION OF RESPONSE TO FOOD | 7 | 7.03e-01 | 8.33e-02 | 9.29e-01 |
GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 16 | 5.64e-01 | 8.33e-02 | 8.81e-01 |
GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 36 | 3.87e-01 | -8.33e-02 | 8.06e-01 |
GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 6.49e-01 | -8.33e-02 | 9.13e-01 |
GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 17 | 5.52e-01 | 8.32e-02 | 8.77e-01 |
GOBP PHAGOSOME MATURATION | 26 | 4.63e-01 | -8.32e-02 | 8.42e-01 |
GOBP REGULATION OF CHROMOSOME ORGANIZATION | 210 | 3.83e-02 | 8.32e-02 | 3.80e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 15 | 5.77e-01 | 8.31e-02 | 8.87e-01 |
GOBP MYELIN ASSEMBLY | 13 | 6.04e-01 | 8.31e-02 | 8.99e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 9 | 6.66e-01 | -8.31e-02 | 9.21e-01 |
GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 12 | 6.18e-01 | -8.31e-02 | 9.02e-01 |
GOCC HETEROCHROMATIN | 63 | 2.56e-01 | 8.28e-02 | 7.23e-01 |
GOMF UNFOLDED PROTEIN BINDING | 91 | 1.73e-01 | -8.28e-02 | 6.55e-01 |
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 98 | 1.57e-01 | -8.28e-02 | 6.39e-01 |
GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 30 | 4.33e-01 | -8.27e-02 | 8.27e-01 |
GOBP INNER EAR MORPHOGENESIS | 33 | 4.11e-01 | 8.26e-02 | 8.21e-01 |
GOBP MITOCHONDRIAL FUSION | 32 | 4.19e-01 | -8.26e-02 | 8.22e-01 |
GOMF POLY PURINE TRACT BINDING | 26 | 4.66e-01 | -8.26e-02 | 8.44e-01 |
GOMF NUCLEASE ACTIVITY | 174 | 6.08e-02 | 8.26e-02 | 4.39e-01 |
GOBP LIPOPROTEIN CATABOLIC PROCESS | 12 | 6.21e-01 | 8.25e-02 | 9.03e-01 |
GOBP REGULATION OF CHEMOTAXIS | 143 | 8.95e-02 | -8.24e-02 | 5.22e-01 |
GOMF LRR DOMAIN BINDING | 14 | 5.94e-01 | 8.24e-02 | 8.94e-01 |
GOBP LIVER REGENERATION | 18 | 5.45e-01 | -8.24e-02 | 8.75e-01 |
GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 8 | 6.87e-01 | -8.24e-02 | 9.25e-01 |
GOCC NURD COMPLEX | 15 | 5.81e-01 | -8.24e-02 | 8.88e-01 |
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 192 | 4.96e-02 | -8.24e-02 | 4.14e-01 |
GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 24 | 4.85e-01 | 8.24e-02 | 8.53e-01 |
GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 11 | 6.36e-01 | -8.23e-02 | 9.08e-01 |
GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 12 | 6.22e-01 | 8.23e-02 | 9.03e-01 |
GOBP LIPID LOCALIZATION | 283 | 1.77e-02 | -8.23e-02 | 2.81e-01 |
GOBP LABYRINTHINE LAYER DEVELOPMENT | 28 | 4.51e-01 | -8.22e-02 | 8.36e-01 |
GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 7.50e-01 | 8.22e-02 | 9.42e-01 |
GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 119 | 1.22e-01 | -8.22e-02 | 5.86e-01 |
GOBP EXPORT ACROSS PLASMA MEMBRANE | 35 | 4.00e-01 | -8.22e-02 | 8.15e-01 |
GOBP MEIOSIS I CELL CYCLE PROCESS | 72 | 2.28e-01 | 8.22e-02 | 7.02e-01 |
GOCC AZUROPHIL GRANULE | 134 | 1.01e-01 | -8.22e-02 | 5.49e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION | 5 | 7.51e-01 | 8.21e-02 | 9.42e-01 |
GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 5 | 7.51e-01 | -8.21e-02 | 9.42e-01 |
GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 6 | 7.28e-01 | 8.20e-02 | 9.37e-01 |
GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 6 | 7.28e-01 | 8.20e-02 | 9.37e-01 |
GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 9 | 6.70e-01 | 8.20e-02 | 9.23e-01 |
GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 10 | 6.53e-01 | -8.20e-02 | 9.15e-01 |
GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 19 | 5.36e-01 | -8.20e-02 | 8.73e-01 |
GOBP CANNABINOID SIGNALING PATHWAY | 6 | 7.28e-01 | -8.20e-02 | 9.37e-01 |
GOBP HEART TRABECULA MORPHOGENESIS | 16 | 5.70e-01 | 8.20e-02 | 8.84e-01 |
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 18 | 5.47e-01 | 8.20e-02 | 8.75e-01 |
GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 7 | 7.07e-01 | -8.20e-02 | 9.31e-01 |
GOCC PARANODE REGION OF AXON | 5 | 7.51e-01 | -8.19e-02 | 9.42e-01 |
GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 81 | 2.03e-01 | -8.19e-02 | 6.85e-01 |
GOBP VESICLE ORGANIZATION | 288 | 1.72e-02 | -8.19e-02 | 2.77e-01 |
GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 136 | 9.98e-02 | 8.19e-02 | 5.47e-01 |
GOBP REGULATION OF RESPIRATORY BURST | 14 | 5.96e-01 | 8.18e-02 | 8.96e-01 |
GOBP SULFUR COMPOUND METABOLIC PROCESS | 214 | 3.97e-02 | 8.18e-02 | 3.83e-01 |
GOBP MACROPHAGE CYTOKINE PRODUCTION | 29 | 4.46e-01 | 8.18e-02 | 8.33e-01 |
GOMF RNA NUCLEASE ACTIVITY | 106 | 1.46e-01 | 8.18e-02 | 6.22e-01 |
GOBP THYROID HORMONE METABOLIC PROCESS | 12 | 6.24e-01 | 8.17e-02 | 9.04e-01 |
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 7 | 7.08e-01 | 8.17e-02 | 9.31e-01 |
GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 81 | 2.04e-01 | -8.17e-02 | 6.85e-01 |
GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 8 | 6.89e-01 | -8.17e-02 | 9.25e-01 |
GOMF ADENYLATE KINASE ACTIVITY | 7 | 7.08e-01 | -8.17e-02 | 9.31e-01 |
GOBP STEM CELL DEVELOPMENT | 40 | 3.72e-01 | -8.16e-02 | 7.99e-01 |
GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 46 | 3.39e-01 | 8.16e-02 | 7.80e-01 |
GOBP MATURE B CELL DIFFERENTIATION | 29 | 4.47e-01 | 8.16e-02 | 8.33e-01 |
GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 11 | 6.40e-01 | -8.16e-02 | 9.09e-01 |
GOCC SECRETORY GRANULE MEMBRANE | 238 | 3.07e-02 | -8.16e-02 | 3.49e-01 |
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 25 | 4.80e-01 | 8.16e-02 | 8.50e-01 |
GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 23 | 4.98e-01 | -8.16e-02 | 8.59e-01 |
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 20 | 5.28e-01 | 8.15e-02 | 8.69e-01 |
GOBP MUSCLE SYSTEM PROCESS | 215 | 4.00e-02 | -8.15e-02 | 3.83e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 37 | 3.91e-01 | 8.15e-02 | 8.09e-01 |
GOMF GLUCOSYLTRANSFERASE ACTIVITY | 15 | 5.85e-01 | 8.15e-02 | 8.89e-01 |
GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 29 | 4.48e-01 | -8.15e-02 | 8.33e-01 |
GOBP TOOTH MINERALIZATION | 13 | 6.11e-01 | -8.15e-02 | 9.01e-01 |
GOMF DEATH RECEPTOR BINDING | 15 | 5.85e-01 | -8.14e-02 | 8.89e-01 |
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 98 | 1.64e-01 | -8.14e-02 | 6.47e-01 |
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 12 | 6.26e-01 | -8.14e-02 | 9.05e-01 |
GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 63 | 2.64e-01 | -8.14e-02 | 7.25e-01 |
GOBP FATTY ACID TRANSPORT | 57 | 2.88e-01 | -8.14e-02 | 7.44e-01 |
GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 26 | 4.73e-01 | -8.13e-02 | 8.46e-01 |
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 18 | 5.50e-01 | -8.13e-02 | 8.76e-01 |
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 25 | 4.82e-01 | 8.13e-02 | 8.50e-01 |
GOCC HISTONE METHYLTRANSFERASE COMPLEX | 59 | 2.81e-01 | 8.13e-02 | 7.37e-01 |
GOBP BASEMENT MEMBRANE ASSEMBLY | 5 | 7.53e-01 | 8.12e-02 | 9.42e-01 |
GOBP REGULATION OF CELLULAR COMPONENT SIZE | 241 | 3.04e-02 | -8.12e-02 | 3.48e-01 |
GOBP CELL ADHESION MOLECULE PRODUCTION | 8 | 6.91e-01 | 8.12e-02 | 9.25e-01 |
GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 20 | 5.30e-01 | 8.12e-02 | 8.70e-01 |
GOBP KETONE BIOSYNTHETIC PROCESS | 31 | 4.34e-01 | 8.12e-02 | 8.27e-01 |
GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 7.10e-01 | 8.11e-02 | 9.31e-01 |
GOBP REGULATION OF STEM CELL PROLIFERATION | 34 | 4.13e-01 | -8.11e-02 | 8.21e-01 |
GOBP REGULATION OF BODY FLUID LEVELS | 206 | 4.56e-02 | -8.10e-02 | 4.00e-01 |
GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 8 | 6.92e-01 | 8.10e-02 | 9.26e-01 |
GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 17 | 5.63e-01 | -8.09e-02 | 8.80e-01 |
GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 11 | 6.42e-01 | 8.09e-02 | 9.10e-01 |
GOMF STAT FAMILY PROTEIN BINDING | 8 | 6.92e-01 | 8.09e-02 | 9.26e-01 |
GOBP ETHER BIOSYNTHETIC PROCESS | 11 | 6.42e-01 | 8.09e-02 | 9.10e-01 |
GOBP PLACENTA DEVELOPMENT | 97 | 1.69e-01 | -8.08e-02 | 6.52e-01 |
GOBP SPERM MOTILITY | 48 | 3.33e-01 | 8.08e-02 | 7.76e-01 |
GOBP RESPONSE TO INTERLEUKIN 2 | 9 | 6.75e-01 | -8.07e-02 | 9.24e-01 |
GOMF CUPROUS ION BINDING | 6 | 7.32e-01 | -8.07e-02 | 9.39e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 10 | 6.59e-01 | -8.07e-02 | 9.17e-01 |
GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 27 | 4.68e-01 | -8.07e-02 | 8.45e-01 |
GOBP DEFINITIVE HEMOPOIESIS | 11 | 6.43e-01 | 8.07e-02 | 9.10e-01 |
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 8 | 6.93e-01 | 8.06e-02 | 9.27e-01 |
GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 7.55e-01 | -8.06e-02 | 9.43e-01 |
GOBP CLATHRIN COATED VESICLE CARGO LOADING | 6 | 7.32e-01 | 8.06e-02 | 9.39e-01 |
GOBP PIGMENT ACCUMULATION | 10 | 6.59e-01 | 8.06e-02 | 9.17e-01 |
GOBP PIGMENT GRANULE MATURATION | 10 | 6.59e-01 | 8.06e-02 | 9.17e-01 |
GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 12 | 6.29e-01 | -8.06e-02 | 9.05e-01 |
GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 136 | 1.05e-01 | 8.06e-02 | 5.56e-01 |
GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 16 | 5.77e-01 | -8.06e-02 | 8.87e-01 |
GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 43 | 3.61e-01 | 8.05e-02 | 7.92e-01 |
GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 15 | 5.89e-01 | -8.05e-02 | 8.92e-01 |
GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 16 | 5.77e-01 | 8.05e-02 | 8.87e-01 |
GOBP RESPONSE TO ETHANOL | 66 | 2.59e-01 | 8.05e-02 | 7.24e-01 |
GOMF METALLOPEPTIDASE ACTIVITY | 99 | 1.67e-01 | -8.04e-02 | 6.49e-01 |
GOBP GTP METABOLIC PROCESS | 21 | 5.24e-01 | -8.04e-02 | 8.68e-01 |
GOBP TRANSITION METAL ION TRANSPORT | 64 | 2.66e-01 | -8.04e-02 | 7.25e-01 |
GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 5 | 7.56e-01 | -8.04e-02 | 9.44e-01 |
GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 5 | 7.56e-01 | 8.04e-02 | 9.44e-01 |
GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 334 | 1.20e-02 | 8.03e-02 | 2.35e-01 |
GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 112 | 1.43e-01 | 8.02e-02 | 6.16e-01 |
GOBP MRNA TRANSPORT | 113 | 1.42e-01 | 8.02e-02 | 6.14e-01 |
GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 7.13e-01 | 8.02e-02 | 9.32e-01 |
GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 10 | 6.61e-01 | 8.02e-02 | 9.18e-01 |
GOMF FUCOSYLTRANSFERASE ACTIVITY | 7 | 7.14e-01 | -8.01e-02 | 9.32e-01 |
GOMF RETROMER COMPLEX BINDING | 9 | 6.77e-01 | 8.01e-02 | 9.24e-01 |
GOBP REGULATION OF ENDOSOME SIZE | 13 | 6.17e-01 | -8.01e-02 | 9.02e-01 |
GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 13 | 6.17e-01 | -8.00e-02 | 9.02e-01 |
GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 704 | 3.39e-04 | 8.00e-02 | 3.25e-02 |
GOMF G QUADRUPLEX RNA BINDING | 6 | 7.34e-01 | -8.00e-02 | 9.39e-01 |
GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 229 | 3.76e-02 | 8.00e-02 | 3.79e-01 |
GOBP PHOTORECEPTOR CELL DEVELOPMENT | 25 | 4.89e-01 | 8.00e-02 | 8.54e-01 |
GOMF PROTEIN PHOSPHATASE 2B BINDING | 5 | 7.57e-01 | -8.00e-02 | 9.44e-01 |
GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 43 | 3.65e-01 | -8.00e-02 | 7.95e-01 |
GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 19 | 5.47e-01 | -7.99e-02 | 8.75e-01 |
GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX | 5 | 7.57e-01 | -7.99e-02 | 9.44e-01 |
GOCC FILAMENTOUS ACTIN | 15 | 5.93e-01 | -7.98e-02 | 8.93e-01 |
GOBP CEREBRAL CORTEX CELL MIGRATION | 31 | 4.42e-01 | 7.98e-02 | 8.30e-01 |
GOCC TRANSPORTER COMPLEX | 201 | 5.18e-02 | -7.98e-02 | 4.19e-01 |
GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 7 | 7.15e-01 | -7.98e-02 | 9.32e-01 |
GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 13 | 6.19e-01 | -7.97e-02 | 9.02e-01 |
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 24 | 4.99e-01 | 7.97e-02 | 8.59e-01 |
GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 25 | 4.90e-01 | -7.97e-02 | 8.55e-01 |
GOBP INTERFERON BETA PRODUCTION | 52 | 3.21e-01 | 7.97e-02 | 7.68e-01 |
GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 16 | 5.81e-01 | -7.97e-02 | 8.89e-01 |
GOCC CHROMOSOME | 1256 | 3.12e-06 | 7.96e-02 | 1.20e-03 |
GOBP RESPONSE TO VITAMIN D | 19 | 5.48e-01 | -7.96e-02 | 8.75e-01 |
GOCC PHOTORECEPTOR INNER SEGMENT | 31 | 4.43e-01 | -7.96e-02 | 8.32e-01 |
GOCC CYTOPLASMIC SIDE OF MEMBRANE | 156 | 8.71e-02 | -7.95e-02 | 5.19e-01 |
GOBP POLYSACCHARIDE CATABOLIC PROCESS | 15 | 5.94e-01 | 7.95e-02 | 8.94e-01 |
GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 25 | 4.92e-01 | -7.95e-02 | 8.55e-01 |
GOBP SUPEROXIDE ANION GENERATION | 26 | 4.83e-01 | -7.95e-02 | 8.52e-01 |
GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 6 | 7.36e-01 | 7.94e-02 | 9.39e-01 |
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 22 | 5.20e-01 | -7.93e-02 | 8.68e-01 |
GOBP RIG I SIGNALING PATHWAY | 24 | 5.02e-01 | 7.93e-02 | 8.60e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 7.37e-01 | 7.93e-02 | 9.39e-01 |
GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 12 | 6.35e-01 | -7.92e-02 | 9.08e-01 |
GOCC ENDOSOME MEMBRANE | 437 | 4.79e-03 | -7.92e-02 | 1.43e-01 |
GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 9 | 6.81e-01 | 7.91e-02 | 9.25e-01 |
GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 19 | 5.51e-01 | -7.90e-02 | 8.76e-01 |
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 6.36e-01 | 7.90e-02 | 9.08e-01 |
GOBP PEPTIDYL ARGININE MODIFICATION | 8 | 6.99e-01 | -7.89e-02 | 9.29e-01 |
GOBP REGULATION OF INFLAMMATORY RESPONSE | 250 | 3.23e-02 | -7.89e-02 | 3.56e-01 |
GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 32 | 4.40e-01 | 7.88e-02 | 8.29e-01 |
GOBP CAMP CATABOLIC PROCESS | 7 | 7.18e-01 | -7.88e-02 | 9.34e-01 |
GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 192 | 6.06e-02 | 7.87e-02 | 4.39e-01 |
GOBP DIENCEPHALON DEVELOPMENT | 23 | 5.14e-01 | 7.87e-02 | 8.66e-01 |
GOBP DECIDUALIZATION | 16 | 5.86e-01 | 7.87e-02 | 8.90e-01 |
GOMF PEPTIDASE REGULATOR ACTIVITY | 105 | 1.64e-01 | -7.87e-02 | 6.47e-01 |
GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 32 | 4.42e-01 | 7.86e-02 | 8.30e-01 |
GOMF SODIUM CHANNEL ACTIVITY | 9 | 6.83e-01 | -7.86e-02 | 9.25e-01 |
GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 8 | 7.00e-01 | 7.86e-02 | 9.29e-01 |
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 7.19e-01 | -7.86e-02 | 9.34e-01 |
GOCC MITOCHONDRIAL MATRIX | 423 | 5.87e-03 | 7.85e-02 | 1.62e-01 |
GOBP PROTEIN ACYLATION | 116 | 1.45e-01 | -7.85e-02 | 6.19e-01 |
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 118 | 1.41e-01 | 7.85e-02 | 6.14e-01 |
GOBP MAMMARY GLAND DEVELOPMENT | 74 | 2.44e-01 | -7.84e-02 | 7.14e-01 |
GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 6 | 7.40e-01 | -7.84e-02 | 9.40e-01 |
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 17 | 5.76e-01 | -7.83e-02 | 8.87e-01 |
GOBP BLOOD VESSEL MORPHOGENESIS | 335 | 1.42e-02 | -7.83e-02 | 2.60e-01 |
GOBP GLUCAN METABOLIC PROCESS | 54 | 3.20e-01 | -7.83e-02 | 7.68e-01 |
GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 5.45e-01 | -7.82e-02 | 8.75e-01 |
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 69 | 2.62e-01 | 7.82e-02 | 7.24e-01 |
GOBP RESPONSE TO LEUCINE | 13 | 6.26e-01 | -7.82e-02 | 9.05e-01 |
GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 36 | 4.18e-01 | 7.81e-02 | 8.21e-01 |
GOBP OVULATION CYCLE PROCESS | 23 | 5.17e-01 | 7.81e-02 | 8.66e-01 |
GOBP EPITHELIAL TUBE FORMATION | 81 | 2.25e-01 | 7.81e-02 | 7.02e-01 |
GOBP MANNOSYLATION | 19 | 5.56e-01 | 7.81e-02 | 8.78e-01 |
GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 6 | 7.40e-01 | -7.81e-02 | 9.40e-01 |
GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 12 | 6.40e-01 | -7.81e-02 | 9.09e-01 |
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 40 | 3.94e-01 | -7.80e-02 | 8.11e-01 |
GOMF ORGANIC ACID BINDING | 100 | 1.78e-01 | -7.80e-02 | 6.61e-01 |
GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 6.86e-01 | 7.79e-02 | 9.25e-01 |
GOMF N METHYLTRANSFERASE ACTIVITY | 82 | 2.23e-01 | 7.79e-02 | 7.01e-01 |
GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 18 | 5.67e-01 | -7.79e-02 | 8.83e-01 |
GOBP IRON SULFUR CLUSTER ASSEMBLY | 29 | 4.68e-01 | 7.78e-02 | 8.45e-01 |
GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 160 | 9.04e-02 | -7.77e-02 | 5.23e-01 |
GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 7.63e-01 | 7.77e-02 | 9.45e-01 |
GOBP APOPTOTIC SIGNALING PATHWAY | 460 | 4.53e-03 | -7.77e-02 | 1.41e-01 |
GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 44 | 3.73e-01 | -7.77e-02 | 7.99e-01 |
GOMF PURINE NUCLEOTIDE BINDING | 1461 | 1.14e-06 | 7.77e-02 | 6.07e-04 |
GOBP POSTSYNAPSE ORGANIZATION | 114 | 1.53e-01 | 7.77e-02 | 6.32e-01 |
GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 118 | 1.46e-01 | -7.77e-02 | 6.21e-01 |
GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 9 | 6.87e-01 | -7.77e-02 | 9.25e-01 |
GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 9 | 6.87e-01 | -7.77e-02 | 9.25e-01 |
GOBP GLYCOSIDE METABOLIC PROCESS | 12 | 6.41e-01 | -7.76e-02 | 9.10e-01 |
GOBP MYOTUBE DIFFERENTIATION | 65 | 2.79e-01 | 7.76e-02 | 7.37e-01 |
GOMF HISTONE H3 KINASE ACTIVITY | 10 | 6.71e-01 | 7.76e-02 | 9.23e-01 |
GOBP CORONARY VASCULATURE MORPHOGENESIS | 11 | 6.56e-01 | 7.76e-02 | 9.15e-01 |
GOMF CHANNEL REGULATOR ACTIVITY | 67 | 2.73e-01 | -7.75e-02 | 7.29e-01 |
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 21 | 5.39e-01 | -7.75e-02 | 8.73e-01 |
GOBP NERVE DEVELOPMENT | 44 | 3.74e-01 | -7.75e-02 | 7.99e-01 |
GOBP RELAXATION OF CARDIAC MUSCLE | 12 | 6.42e-01 | 7.75e-02 | 9.10e-01 |
GOCC MICROBODY | 113 | 1.56e-01 | 7.75e-02 | 6.37e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 19 | 5.59e-01 | 7.74e-02 | 8.79e-01 |
GOBP MICROTUBULE NUCLEATION | 43 | 3.80e-01 | 7.74e-02 | 8.02e-01 |
GOBP ACTIN MEDIATED CELL CONTRACTION | 47 | 3.59e-01 | -7.74e-02 | 7.92e-01 |
GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 584 | 1.53e-03 | -7.73e-02 | 8.10e-02 |
GOBP ENGULFMENT OF APOPTOTIC CELL | 7 | 7.23e-01 | 7.73e-02 | 9.36e-01 |
GOBP MACROPHAGE ACTIVATION | 76 | 2.45e-01 | -7.73e-02 | 7.14e-01 |
GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 7.43e-01 | -7.72e-02 | 9.41e-01 |
GOCC LAMELLIPODIUM | 154 | 9.90e-02 | -7.72e-02 | 5.46e-01 |
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 22 | 5.31e-01 | -7.72e-02 | 8.71e-01 |
GOBP SEX DIFFERENTIATION | 139 | 1.17e-01 | 7.71e-02 | 5.80e-01 |
GOBP CELLULAR RESPONSE TO ZINC ION | 11 | 6.58e-01 | 7.71e-02 | 9.17e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 7 | 7.24e-01 | 7.70e-02 | 9.36e-01 |
GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 8 | 7.06e-01 | 7.70e-02 | 9.31e-01 |
GOBP REGULATION OF ACTIN FILAMENT LENGTH | 107 | 1.69e-01 | -7.70e-02 | 6.52e-01 |
GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 11 | 6.58e-01 | 7.70e-02 | 9.17e-01 |
GOBP CARDIAC ATRIUM MORPHOGENESIS | 10 | 6.73e-01 | -7.70e-02 | 9.24e-01 |
GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 7.66e-01 | -7.69e-02 | 9.45e-01 |
GOMF KINASE INHIBITOR ACTIVITY | 59 | 3.07e-01 | -7.69e-02 | 7.57e-01 |
GOBP CAMP MEDIATED SIGNALING | 23 | 5.24e-01 | -7.68e-02 | 8.68e-01 |
GOBP DNA CATABOLIC PROCESS | 22 | 5.33e-01 | 7.68e-02 | 8.73e-01 |
GOBP REGULATION OF VIRAL GENOME REPLICATION | 72 | 2.60e-01 | 7.68e-02 | 7.24e-01 |
GOBP UTERUS DEVELOPMENT | 9 | 6.90e-01 | -7.68e-02 | 9.25e-01 |
GOBP ALDITOL CATABOLIC PROCESS | 6 | 7.45e-01 | -7.68e-02 | 9.42e-01 |
GOBP LOCALIZATION WITHIN MEMBRANE | 511 | 3.17e-03 | -7.68e-02 | 1.17e-01 |
GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 7 | 7.25e-01 | -7.68e-02 | 9.37e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 31 | 4.60e-01 | 7.67e-02 | 8.40e-01 |
GOBP REGULATION OF DNA REPAIR | 191 | 6.81e-02 | 7.67e-02 | 4.65e-01 |
GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 42 | 3.90e-01 | -7.67e-02 | 8.08e-01 |
GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 7 | 7.25e-01 | 7.67e-02 | 9.37e-01 |
GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 6.75e-01 | 7.67e-02 | 9.24e-01 |
GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 14 | 6.20e-01 | 7.66e-02 | 9.03e-01 |
GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 14 | 6.20e-01 | -7.66e-02 | 9.03e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 5 | 7.67e-01 | 7.66e-02 | 9.45e-01 |
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 9 | 6.91e-01 | -7.66e-02 | 9.25e-01 |
GOBP MEIOTIC CELL CYCLE | 163 | 9.24e-02 | 7.66e-02 | 5.29e-01 |
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 110 | 1.66e-01 | -7.65e-02 | 6.49e-01 |
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 9 | 6.91e-01 | 7.65e-02 | 9.25e-01 |
GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 21 | 5.44e-01 | -7.65e-02 | 8.75e-01 |
GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC SPECIALIZATION MEMBRANE | 5 | 7.67e-01 | 7.64e-02 | 9.45e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 21 | 5.45e-01 | -7.64e-02 | 8.75e-01 |
GOBP HEART PROCESS | 112 | 1.63e-01 | -7.64e-02 | 6.45e-01 |
GOBP TISSUE HOMEOSTASIS | 155 | 1.02e-01 | -7.64e-02 | 5.50e-01 |
GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 20 | 5.55e-01 | 7.63e-02 | 8.77e-01 |
GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 14 | 6.21e-01 | 7.62e-02 | 9.03e-01 |
GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 16 | 5.98e-01 | -7.62e-02 | 8.96e-01 |
GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 23 | 5.27e-01 | 7.62e-02 | 8.69e-01 |
GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 5 | 7.68e-01 | -7.61e-02 | 9.45e-01 |
GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 77 | 2.49e-01 | -7.61e-02 | 7.18e-01 |
GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 9 | 6.93e-01 | 7.61e-02 | 9.27e-01 |
GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 37 | 4.24e-01 | -7.60e-02 | 8.23e-01 |
GOBP INCLUSION BODY ASSEMBLY | 18 | 5.77e-01 | -7.60e-02 | 8.87e-01 |
GOCC TERMINAL BOUTON | 21 | 5.47e-01 | 7.60e-02 | 8.75e-01 |
GOCC MICROBODY MEMBRANE | 56 | 3.26e-01 | 7.59e-02 | 7.69e-01 |
GOCC CORTICAL ACTIN CYTOSKELETON | 47 | 3.68e-01 | -7.59e-02 | 7.96e-01 |
GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 9 | 6.93e-01 | -7.59e-02 | 9.27e-01 |
GOBP CHROMATIN REMODELING | 476 | 4.80e-03 | 7.59e-02 | 1.43e-01 |
GOBP REGULATION OF STEM CELL DIVISION | 7 | 7.28e-01 | -7.59e-02 | 9.37e-01 |
GOMF SNRNA BINDING | 45 | 3.79e-01 | -7.59e-02 | 8.02e-01 |
GOCC NON MOTILE CILIUM | 84 | 2.30e-01 | 7.59e-02 | 7.03e-01 |
GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 12 | 6.49e-01 | -7.59e-02 | 9.13e-01 |
GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 52 | 3.45e-01 | -7.58e-02 | 7.83e-01 |
GOCC PHAGOCYTIC VESICLE MEMBRANE | 70 | 2.73e-01 | -7.58e-02 | 7.30e-01 |
GOBP ESTABLISHMENT OF CELL POLARITY | 117 | 1.57e-01 | 7.58e-02 | 6.39e-01 |
GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 13 | 6.36e-01 | 7.57e-02 | 9.08e-01 |
GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 6.50e-01 | 7.57e-02 | 9.14e-01 |
GOMF REGULATORY RNA BINDING | 41 | 4.02e-01 | -7.57e-02 | 8.15e-01 |
GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 14 | 6.24e-01 | -7.57e-02 | 9.04e-01 |
GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 15 | 6.12e-01 | -7.56e-02 | 9.01e-01 |
GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 8 | 7.11e-01 | -7.56e-02 | 9.31e-01 |
GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 7.29e-01 | -7.56e-02 | 9.37e-01 |
GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 11 | 6.64e-01 | 7.56e-02 | 9.20e-01 |
GOBP REGULATION OF XENOPHAGY | 8 | 7.11e-01 | 7.55e-02 | 9.31e-01 |
GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 7.12e-01 | 7.55e-02 | 9.31e-01 |
GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 129 | 1.39e-01 | -7.55e-02 | 6.12e-01 |
GOBP MEMBRANE LIPID METABOLIC PROCESS | 147 | 1.15e-01 | -7.54e-02 | 5.78e-01 |
GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 7.49e-01 | -7.54e-02 | 9.42e-01 |
GOBP REGULATION OF SPINDLE ORGANIZATION | 39 | 4.15e-01 | 7.54e-02 | 8.21e-01 |
GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 80 | 2.44e-01 | -7.54e-02 | 7.14e-01 |
GOCC INTERCALATED DISC | 29 | 4.82e-01 | -7.54e-02 | 8.51e-01 |
GOBP PHAGOLYSOSOME ASSEMBLY | 15 | 6.14e-01 | 7.53e-02 | 9.01e-01 |
GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 18 | 5.80e-01 | -7.53e-02 | 8.88e-01 |
GOMF FK506 BINDING | 7 | 7.30e-01 | 7.53e-02 | 9.38e-01 |
GOMF MACROLIDE BINDING | 7 | 7.30e-01 | 7.53e-02 | 9.38e-01 |
GOBP DENDRITE DEVELOPMENT | 147 | 1.16e-01 | 7.53e-02 | 5.78e-01 |
GOBP PROTEOGLYCAN METABOLIC PROCESS | 53 | 3.44e-01 | 7.52e-02 | 7.82e-01 |
GOBP REGULATION OF CELLULAR RESPIRATION | 35 | 4.41e-01 | -7.52e-02 | 8.30e-01 |
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 50 | 3.58e-01 | -7.52e-02 | 7.91e-01 |
GOMF PH DOMAIN BINDING | 8 | 7.13e-01 | 7.52e-02 | 9.32e-01 |
GOMF MYOSIN BINDING | 41 | 4.05e-01 | 7.52e-02 | 8.17e-01 |
GOBP ANIMAL ORGAN FORMATION | 24 | 5.24e-01 | -7.51e-02 | 8.68e-01 |
GOCC ACTIN CYTOSKELETON | 324 | 2.08e-02 | -7.50e-02 | 2.98e-01 |
GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 166 | 9.62e-02 | -7.50e-02 | 5.38e-01 |
GOBP FATTY ACID CATABOLIC PROCESS | 84 | 2.35e-01 | 7.50e-02 | 7.10e-01 |
GOBP PROTEIN RNA COMPLEX ORGANIZATION | 194 | 7.25e-02 | -7.50e-02 | 4.79e-01 |
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 24 | 5.25e-01 | 7.50e-02 | 8.69e-01 |
GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 56 | 3.32e-01 | -7.50e-02 | 7.76e-01 |
GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 41 | 4.07e-01 | 7.50e-02 | 8.17e-01 |
GOBP UTP BIOSYNTHETIC PROCESS | 8 | 7.14e-01 | 7.49e-02 | 9.32e-01 |
GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 150 | 1.14e-01 | 7.49e-02 | 5.78e-01 |
GOMF GLYCOSYLTRANSFERASE ACTIVITY | 180 | 8.44e-02 | 7.47e-02 | 5.15e-01 |
GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 10 | 6.82e-01 | -7.47e-02 | 9.25e-01 |
GOBP PEPTIDYL LYSINE ACETYLATION | 59 | 3.21e-01 | -7.47e-02 | 7.69e-01 |
GOBP MONOATOMIC ION TRANSPORT | 628 | 1.54e-03 | -7.46e-02 | 8.10e-02 |
GOBP SMOOTHENED SIGNALING PATHWAY | 85 | 2.35e-01 | 7.46e-02 | 7.10e-01 |
GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 73 | 2.71e-01 | -7.46e-02 | 7.29e-01 |
GOBP TAURINE TRANSPORT | 6 | 7.52e-01 | 7.46e-02 | 9.42e-01 |
GOBP CELL JUNCTION MAINTENANCE | 26 | 5.11e-01 | 7.46e-02 | 8.64e-01 |
GOBP REGULATORY T CELL DIFFERENTIATION | 30 | 4.80e-01 | 7.46e-02 | 8.50e-01 |
GOBP STEROL METABOLIC PROCESS | 91 | 2.20e-01 | -7.45e-02 | 6.96e-01 |
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 17 | 5.95e-01 | -7.45e-02 | 8.95e-01 |
GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 7.52e-01 | 7.45e-02 | 9.42e-01 |
GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 22 | 5.45e-01 | 7.45e-02 | 8.75e-01 |
GOBP RETINA HOMEOSTASIS | 38 | 4.27e-01 | 7.45e-02 | 8.24e-01 |
GOBP PODOSOME ASSEMBLY | 17 | 5.95e-01 | -7.45e-02 | 8.95e-01 |
GOBP REGULATION OF KIDNEY DEVELOPMENT | 11 | 6.69e-01 | -7.45e-02 | 9.23e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 66 | 2.96e-01 | -7.44e-02 | 7.49e-01 |
GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 64 | 3.04e-01 | -7.44e-02 | 7.54e-01 |
GOBP HEXOSE CATABOLIC PROCESS | 30 | 4.81e-01 | -7.44e-02 | 8.50e-01 |
GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 85 | 2.36e-01 | -7.44e-02 | 7.11e-01 |
GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 23 | 5.37e-01 | 7.44e-02 | 8.73e-01 |
GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 55 | 3.41e-01 | 7.43e-02 | 7.81e-01 |
GOBP REGULATION OF PHOSPHATASE ACTIVITY | 51 | 3.59e-01 | -7.43e-02 | 7.92e-01 |
GOBP INTERLEUKIN 13 PRODUCTION | 14 | 6.30e-01 | -7.43e-02 | 9.05e-01 |
GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 28 | 4.97e-01 | 7.42e-02 | 8.58e-01 |
GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 5 | 7.74e-01 | 7.42e-02 | 9.47e-01 |
GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 266 | 3.81e-02 | -7.41e-02 | 3.80e-01 |
GOBP LEUKOCYTE CELL CELL ADHESION | 312 | 2.50e-02 | -7.41e-02 | 3.25e-01 |
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 79 | 2.56e-01 | -7.41e-02 | 7.23e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 99 | 2.04e-01 | -7.40e-02 | 6.85e-01 |
GOBP LOCOMOTORY BEHAVIOR | 101 | 2.00e-01 | 7.39e-02 | 6.79e-01 |
GOCC RECYCLING ENDOSOME | 149 | 1.20e-01 | -7.39e-02 | 5.83e-01 |
GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 32 | 4.70e-01 | -7.39e-02 | 8.45e-01 |
GOBP POSITIVE REGULATION OF DNA REPLICATION | 29 | 4.91e-01 | 7.38e-02 | 8.55e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 9 | 7.02e-01 | -7.38e-02 | 9.29e-01 |
GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 25 | 5.23e-01 | 7.38e-02 | 8.68e-01 |
GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 17 | 5.99e-01 | -7.38e-02 | 8.97e-01 |
GOBP SPERM EGG RECOGNITION | 21 | 5.59e-01 | 7.37e-02 | 8.79e-01 |
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 7 | 7.36e-01 | 7.36e-02 | 9.39e-01 |
GOBP AXONAL TRANSPORT | 49 | 3.73e-01 | -7.36e-02 | 7.99e-01 |
GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 7 | 7.36e-01 | -7.36e-02 | 9.39e-01 |
GOCC NUCLEOSOME | 34 | 4.58e-01 | -7.36e-02 | 8.39e-01 |
GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 7 | 7.36e-01 | 7.35e-02 | 9.39e-01 |
GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 6 | 7.55e-01 | -7.35e-02 | 9.43e-01 |
GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 50 | 3.69e-01 | -7.35e-02 | 7.96e-01 |
GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 75 | 2.71e-01 | -7.35e-02 | 7.29e-01 |
GOMF MOLECULAR CARRIER ACTIVITY | 81 | 2.53e-01 | 7.35e-02 | 7.22e-01 |
GOBP METHYLATION | 229 | 5.61e-02 | 7.35e-02 | 4.27e-01 |
GOBP GASTRULATION WITH MOUTH FORMING SECOND | 16 | 6.11e-01 | -7.35e-02 | 9.01e-01 |
GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 13 | 6.47e-01 | 7.35e-02 | 9.11e-01 |
GOMF GLUTAMATE RECEPTOR BINDING | 26 | 5.18e-01 | -7.33e-02 | 8.67e-01 |
GOBP RESPONSE TO BACTERIUM | 399 | 1.25e-02 | -7.32e-02 | 2.42e-01 |
GOCC SARCOPLASMIC RETICULUM MEMBRANE | 24 | 5.35e-01 | -7.32e-02 | 8.73e-01 |
GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 229 | 5.71e-02 | 7.32e-02 | 4.28e-01 |
GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 53 | 3.57e-01 | -7.32e-02 | 7.91e-01 |
GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 47 | 3.86e-01 | 7.32e-02 | 8.05e-01 |
GOBP REGULATION OF PH | 73 | 2.81e-01 | -7.31e-02 | 7.37e-01 |
GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 14 | 6.36e-01 | -7.31e-02 | 9.08e-01 |
GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 282 | 3.55e-02 | -7.30e-02 | 3.70e-01 |
GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 8 | 7.21e-01 | 7.30e-02 | 9.36e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 83 | 2.51e-01 | -7.29e-02 | 7.20e-01 |
GOMF QUATERNARY AMMONIUM GROUP BINDING | 28 | 5.04e-01 | 7.29e-02 | 8.62e-01 |
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 7.21e-01 | -7.29e-02 | 9.36e-01 |
GOBP REGULATION OF CELL ADHESION | 532 | 4.29e-03 | -7.29e-02 | 1.38e-01 |
GOBP L GLUTAMATE IMPORT | 26 | 5.20e-01 | -7.29e-02 | 8.68e-01 |
GOBP BASEMENT MEMBRANE ORGANIZATION | 20 | 5.73e-01 | -7.29e-02 | 8.86e-01 |
GOMF RNA CAP BINDING | 19 | 5.83e-01 | 7.28e-02 | 8.89e-01 |
GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 28 | 5.05e-01 | 7.28e-02 | 8.62e-01 |
GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 30 | 4.90e-01 | -7.28e-02 | 8.55e-01 |
GOBP EPITHELIAL CELL DIFFERENTIATION | 342 | 2.14e-02 | -7.28e-02 | 3.02e-01 |
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 6.76e-01 | 7.27e-02 | 9.24e-01 |
GOCC CONDENSED CHROMOSOME | 223 | 6.23e-02 | 7.27e-02 | 4.44e-01 |
GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 17 | 6.04e-01 | 7.26e-02 | 8.99e-01 |
GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 126 | 1.60e-01 | -7.26e-02 | 6.42e-01 |
GOMF RECEPTOR TYROSINE KINASE BINDING | 57 | 3.43e-01 | 7.26e-02 | 7.82e-01 |
GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 15 | 6.27e-01 | 7.26e-02 | 9.05e-01 |
GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 72 | 2.88e-01 | -7.25e-02 | 7.43e-01 |
GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 73 | 2.84e-01 | -7.25e-02 | 7.41e-01 |
GOCC ACTIN BASED CELL PROJECTION | 137 | 1.44e-01 | -7.25e-02 | 6.17e-01 |
GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 70 | 2.95e-01 | -7.25e-02 | 7.48e-01 |
GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 264 | 4.33e-02 | -7.25e-02 | 3.92e-01 |
GOBP REGULATION OF PODOSOME ASSEMBLY | 11 | 6.77e-01 | -7.25e-02 | 9.24e-01 |
GOMF POLY A BINDING | 20 | 5.75e-01 | 7.25e-02 | 8.86e-01 |
GOBP MULTIVESICULAR BODY SORTING PATHWAY | 44 | 4.06e-01 | -7.25e-02 | 8.17e-01 |
GOMF DEACETYLASE ACTIVITY | 33 | 4.72e-01 | 7.24e-02 | 8.46e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 26 | 5.23e-01 | -7.24e-02 | 8.68e-01 |
GOMF HEPARIN BINDING | 64 | 3.17e-01 | -7.24e-02 | 7.65e-01 |
GOMF CORECEPTOR ACTIVITY | 30 | 4.93e-01 | -7.24e-02 | 8.55e-01 |
GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 49 | 3.81e-01 | -7.23e-02 | 8.02e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 40 | 4.29e-01 | -7.23e-02 | 8.25e-01 |
GOBP REGULATION OF CELL CYCLE PROCESS | 532 | 4.60e-03 | 7.23e-02 | 1.42e-01 |
GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 7.59e-01 | -7.23e-02 | 9.45e-01 |
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 16 | 6.17e-01 | -7.23e-02 | 9.02e-01 |
GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 6 | 7.59e-01 | 7.23e-02 | 9.45e-01 |
GOCC MICROTUBULE ASSOCIATED COMPLEX | 101 | 2.10e-01 | 7.23e-02 | 6.87e-01 |
GOCC SMN SM PROTEIN COMPLEX | 17 | 6.06e-01 | 7.22e-02 | 8.99e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 44 | 4.08e-01 | 7.22e-02 | 8.17e-01 |
GOBP REGULATION OF CILIUM MOVEMENT | 14 | 6.40e-01 | 7.22e-02 | 9.10e-01 |
GOMF ARP2 3 COMPLEX BINDING | 12 | 6.65e-01 | -7.22e-02 | 9.21e-01 |
GOMF PRENYLTRANSFERASE ACTIVITY | 17 | 6.07e-01 | -7.21e-02 | 8.99e-01 |
GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 88 | 2.43e-01 | -7.21e-02 | 7.14e-01 |
GOBP POLYOL METABOLIC PROCESS | 72 | 2.91e-01 | 7.21e-02 | 7.46e-01 |
GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 37 | 4.48e-01 | -7.20e-02 | 8.34e-01 |
GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 26 | 5.25e-01 | 7.20e-02 | 8.69e-01 |
GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 28 | 5.10e-01 | 7.20e-02 | 8.64e-01 |
GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 72 | 2.92e-01 | -7.19e-02 | 7.46e-01 |
GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 10 | 6.94e-01 | -7.19e-02 | 9.27e-01 |
GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 86 | 2.50e-01 | 7.18e-02 | 7.18e-01 |
GOBP HOMEOSTASIS OF NUMBER OF CELLS | 240 | 5.68e-02 | -7.16e-02 | 4.28e-01 |
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 9 | 7.10e-01 | 7.15e-02 | 9.31e-01 |
GOCC COMPACT MYELIN | 7 | 7.43e-01 | -7.15e-02 | 9.41e-01 |
GOCC ORGANELLE ENVELOPE LUMEN | 77 | 2.79e-01 | 7.15e-02 | 7.36e-01 |
GOBP CELL CELL ADHESION | 542 | 4.73e-03 | -7.15e-02 | 1.42e-01 |
GOBP REGULATION OF SYNAPSE ASSEMBLY | 53 | 3.69e-01 | 7.15e-02 | 7.96e-01 |
GOBP RECEPTOR INTERNALIZATION | 83 | 2.61e-01 | -7.14e-02 | 7.24e-01 |
GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 12 | 6.68e-01 | 7.14e-02 | 9.23e-01 |
GOMF GTPASE ACTIVATOR ACTIVITY | 217 | 7.07e-02 | 7.14e-02 | 4.73e-01 |
GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 76 | 2.83e-01 | -7.13e-02 | 7.39e-01 |
GOCC AXON CYTOPLASM | 47 | 3.98e-01 | -7.13e-02 | 8.13e-01 |
GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 7.83e-01 | -7.13e-02 | 9.51e-01 |
GOBP REGULATION OF NEURON PROJECTION REGENERATION | 18 | 6.01e-01 | 7.13e-02 | 8.98e-01 |
GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 10 | 6.96e-01 | 7.13e-02 | 9.29e-01 |
GOBP NEGATIVE REGULATION OF LOCOMOTION | 209 | 7.67e-02 | -7.12e-02 | 4.95e-01 |
GOBP VESICLE LOCALIZATION | 174 | 1.06e-01 | -7.12e-02 | 5.57e-01 |
GOCC CELL BODY MEMBRANE | 11 | 6.83e-01 | -7.12e-02 | 9.25e-01 |
GOBP INTERLEUKIN 10 PRODUCTION | 48 | 3.94e-01 | -7.12e-02 | 8.11e-01 |
GOBP DETECTION OF CELL DENSITY | 6 | 7.63e-01 | -7.12e-02 | 9.45e-01 |
GOBP PEPTIDE BIOSYNTHETIC PROCESS | 629 | 2.53e-03 | -7.12e-02 | 1.07e-01 |
GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 36 | 4.61e-01 | -7.11e-02 | 8.40e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 16 | 6.23e-01 | -7.11e-02 | 9.04e-01 |
GOBP CELL ADHESION | 846 | 5.18e-04 | -7.11e-02 | 4.38e-02 |
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 8 | 7.28e-01 | -7.10e-02 | 9.37e-01 |
GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 19 | 5.92e-01 | 7.10e-02 | 8.93e-01 |
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 28 | 5.16e-01 | -7.09e-02 | 8.66e-01 |
GOBP MEIOTIC CYTOKINESIS | 6 | 7.64e-01 | -7.09e-02 | 9.45e-01 |
GOCC BETA CATENIN DESTRUCTION COMPLEX | 10 | 6.98e-01 | 7.09e-02 | 9.29e-01 |
GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 41 | 4.33e-01 | 7.09e-02 | 8.27e-01 |
GOMF E BOX BINDING | 25 | 5.40e-01 | -7.09e-02 | 8.74e-01 |
GOBP NUCLEOSIDE SALVAGE | 10 | 6.98e-01 | -7.08e-02 | 9.29e-01 |
GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 17 | 6.13e-01 | 7.08e-02 | 9.01e-01 |
GOBP SECRETORY GRANULE ORGANIZATION | 43 | 4.22e-01 | -7.08e-02 | 8.23e-01 |
GOBP PROTEIN N LINKED GLYCOSYLATION | 56 | 3.60e-01 | -7.08e-02 | 7.92e-01 |
GOBP VIRION ASSEMBLY | 31 | 4.96e-01 | -7.08e-02 | 8.57e-01 |
GOCC CD40 RECEPTOR COMPLEX | 11 | 6.85e-01 | 7.07e-02 | 9.25e-01 |
GOBP MYELIN MAINTENANCE | 12 | 6.71e-01 | -7.07e-02 | 9.23e-01 |
GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 8 | 7.29e-01 | -7.07e-02 | 9.37e-01 |
GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 171 | 1.12e-01 | 7.07e-02 | 5.72e-01 |
GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 130 | 1.65e-01 | -7.07e-02 | 6.47e-01 |
GOBP SEQUESTERING OF ACTIN MONOMERS | 6 | 7.64e-01 | -7.06e-02 | 9.45e-01 |
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 6.85e-01 | -7.06e-02 | 9.25e-01 |
GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 20 | 5.85e-01 | 7.06e-02 | 8.89e-01 |
GOBP RESPONSE TO ZINC ION | 25 | 5.41e-01 | 7.06e-02 | 8.74e-01 |
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 5.76e-01 | -7.06e-02 | 8.87e-01 |
GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 41 | 4.35e-01 | -7.05e-02 | 8.27e-01 |
GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION | 5 | 7.85e-01 | -7.05e-02 | 9.52e-01 |
GOMF PHOSPHOTYROSINE RESIDUE BINDING | 41 | 4.35e-01 | -7.05e-02 | 8.27e-01 |
GOMF UBIQUITIN BINDING | 96 | 2.33e-01 | -7.05e-02 | 7.08e-01 |
GOBP NEURAL TUBE FORMATION | 74 | 2.95e-01 | 7.05e-02 | 7.48e-01 |
GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 22 | 5.67e-01 | -7.05e-02 | 8.83e-01 |
GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 7.00e-01 | 7.04e-02 | 9.29e-01 |
GOBP REGULATION OF CELL SIZE | 115 | 1.93e-01 | -7.04e-02 | 6.75e-01 |
GOBP SUCCINYL COA METABOLIC PROCESS | 9 | 7.15e-01 | 7.04e-02 | 9.32e-01 |
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 17 | 6.16e-01 | 7.04e-02 | 9.02e-01 |
GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 8 | 7.30e-01 | -7.03e-02 | 9.38e-01 |
GOMF TRANSCRIPTION COREPRESSOR BINDING | 45 | 4.15e-01 | -7.03e-02 | 8.21e-01 |
GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 14 | 6.49e-01 | -7.02e-02 | 9.13e-01 |
GOMF 14 3 3 PROTEIN BINDING | 29 | 5.13e-01 | 7.02e-02 | 8.66e-01 |
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 25 | 5.44e-01 | -7.02e-02 | 8.75e-01 |
GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 191 | 9.54e-02 | -7.02e-02 | 5.37e-01 |
GOBP FOREBRAIN DEVELOPMENT | 216 | 7.64e-02 | 7.02e-02 | 4.94e-01 |
GOBP APPENDAGE MORPHOGENESIS | 69 | 3.14e-01 | -7.01e-02 | 7.64e-01 |
GOBP EPITHELIAL CELL PROLIFERATION | 233 | 6.62e-02 | -7.01e-02 | 4.59e-01 |
GOBP COPPER ION HOMEOSTASIS | 16 | 6.28e-01 | -7.01e-02 | 9.05e-01 |
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 6.74e-01 | -7.01e-02 | 9.24e-01 |
GOBP PROTEIN O LINKED GLYCOSYLATION | 66 | 3.25e-01 | 7.01e-02 | 7.69e-01 |
GOCC ENDOCYTIC VESICLE | 263 | 5.14e-02 | -7.00e-02 | 4.19e-01 |
GOBP AMIDE BIOSYNTHETIC PROCESS | 722 | 1.51e-03 | -7.00e-02 | 8.01e-02 |
GOCC NUCLEAR INNER MEMBRANE | 43 | 4.27e-01 | -7.00e-02 | 8.24e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 9 | 7.16e-01 | -7.00e-02 | 9.32e-01 |
GOBP NEURAL TUBE DEVELOPMENT | 106 | 2.14e-01 | 7.00e-02 | 6.89e-01 |
GOBP REGULATION OF CELL CELL ADHESION | 347 | 2.58e-02 | -7.00e-02 | 3.29e-01 |
GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 65 | 3.30e-01 | -6.99e-02 | 7.73e-01 |
GOCC CYTOPLASMIC MICROTUBULE | 60 | 3.49e-01 | -6.99e-02 | 7.86e-01 |
GOBP RESPONSE TO INTERLEUKIN 4 | 31 | 5.01e-01 | -6.99e-02 | 8.60e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 31 | 5.01e-01 | 6.99e-02 | 8.60e-01 |
GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 25 | 5.45e-01 | 6.99e-02 | 8.75e-01 |
GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 36 | 4.68e-01 | -6.99e-02 | 8.45e-01 |
GOBP DIGESTIVE SYSTEM DEVELOPMENT | 55 | 3.71e-01 | 6.98e-02 | 7.98e-01 |
GOBP SODIUM ION TRANSPORT | 99 | 2.31e-01 | -6.98e-02 | 7.04e-01 |
GOBP NUCLEOPHAGY | 17 | 6.18e-01 | 6.98e-02 | 9.02e-01 |
GOBP LAYER FORMATION IN CEREBRAL CORTEX | 8 | 7.32e-01 | -6.98e-02 | 9.39e-01 |
GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 13 | 6.63e-01 | -6.98e-02 | 9.20e-01 |
GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 6 | 7.67e-01 | -6.98e-02 | 9.45e-01 |
GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 32 | 4.95e-01 | 6.97e-02 | 8.56e-01 |
GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 16 | 6.29e-01 | 6.97e-02 | 9.05e-01 |
GOBP RENAL ABSORPTION | 15 | 6.40e-01 | 6.97e-02 | 9.10e-01 |
GOCC COATED VESICLE MEMBRANE | 158 | 1.31e-01 | -6.97e-02 | 6.02e-01 |
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 24 | 5.55e-01 | 6.97e-02 | 8.77e-01 |
GOBP REGULATION OF CELL MATURATION | 10 | 7.03e-01 | -6.96e-02 | 9.29e-01 |
GOBP ADIPOSE TISSUE DEVELOPMENT | 45 | 4.19e-01 | -6.96e-02 | 8.22e-01 |
GOCC M BAND | 11 | 6.89e-01 | -6.96e-02 | 9.25e-01 |
GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 389 | 1.91e-02 | -6.96e-02 | 2.89e-01 |
GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 62 | 3.44e-01 | -6.96e-02 | 7.82e-01 |
GOBP MEMBRANE FISSION | 40 | 4.47e-01 | -6.95e-02 | 8.33e-01 |
GOBP BILE ACID BIOSYNTHETIC PROCESS | 18 | 6.10e-01 | 6.94e-02 | 9.01e-01 |
GOBP CARDIAC SEPTUM DEVELOPMENT | 62 | 3.45e-01 | 6.94e-02 | 7.83e-01 |
GOBP RESPONSE TO LIPOTEICHOIC ACID | 8 | 7.34e-01 | 6.93e-02 | 9.39e-01 |
GOBP POSITIVE REGULATION OF PROTEOLYSIS | 268 | 5.17e-02 | -6.93e-02 | 4.19e-01 |
GOBP DENDRITIC SPINE DEVELOPMENT | 63 | 3.42e-01 | 6.93e-02 | 7.82e-01 |
GOBP REGULATION OF PROTEOLYSIS | 442 | 1.31e-02 | -6.93e-02 | 2.49e-01 |
GOMF SULFUR COMPOUND BINDING | 131 | 1.72e-01 | -6.92e-02 | 6.55e-01 |
GOBP ANIMAL ORGAN MATURATION | 15 | 6.43e-01 | -6.92e-02 | 9.10e-01 |
GOBP REGULATION OF CALCIUM ION TRANSPORT | 134 | 1.68e-01 | -6.91e-02 | 6.50e-01 |
GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT | 6 | 7.69e-01 | -6.91e-02 | 9.46e-01 |
GOBP POSITIVE REGULATION OF HORMONE SECRETION | 71 | 3.15e-01 | -6.91e-02 | 7.64e-01 |
GOBP CELLULAR EXTRAVASATION | 49 | 4.03e-01 | -6.91e-02 | 8.16e-01 |
GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 6 | 7.70e-01 | 6.91e-02 | 9.46e-01 |
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 7 | 7.52e-01 | -6.90e-02 | 9.42e-01 |
GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 6.22e-01 | 6.90e-02 | 9.04e-01 |
GOBP REGULATION OF MYELINATION | 30 | 5.14e-01 | -6.89e-02 | 8.66e-01 |
GOBP REGULATION OF GLYCOLYTIC PROCESS | 39 | 4.57e-01 | -6.89e-02 | 8.39e-01 |
GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 9 | 7.21e-01 | -6.89e-02 | 9.36e-01 |
GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 22 | 5.76e-01 | 6.89e-02 | 8.87e-01 |
GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 130 | 1.76e-01 | -6.89e-02 | 6.60e-01 |
GOBP REGULATION OF LIPID KINASE ACTIVITY | 25 | 5.51e-01 | 6.89e-02 | 8.76e-01 |
GOBP POLYSACCHARIDE METABOLIC PROCESS | 67 | 3.31e-01 | -6.88e-02 | 7.74e-01 |
GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 18 | 6.13e-01 | -6.88e-02 | 9.01e-01 |
GOBP SINGLE FERTILIZATION | 56 | 3.74e-01 | 6.88e-02 | 7.99e-01 |
GOMF TRIGLYCERIDE LIPASE ACTIVITY | 13 | 6.68e-01 | -6.87e-02 | 9.23e-01 |
GOBP DIGESTIVE TRACT MORPHOGENESIS | 14 | 6.56e-01 | -6.87e-02 | 9.16e-01 |
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 11 | 6.93e-01 | -6.87e-02 | 9.27e-01 |
GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 8 | 7.37e-01 | 6.87e-02 | 9.39e-01 |
GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 9 | 7.21e-01 | -6.86e-02 | 9.36e-01 |
GOBP RENAL SYSTEM PROCESS | 50 | 4.02e-01 | 6.86e-02 | 8.15e-01 |
GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 158 | 1.38e-01 | -6.86e-02 | 6.08e-01 |
GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 91 | 2.59e-01 | 6.85e-02 | 7.24e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 55 | 3.80e-01 | 6.85e-02 | 8.02e-01 |
GOBP REGULATION OF NCRNA TRANSCRIPTION | 65 | 3.41e-01 | -6.84e-02 | 7.81e-01 |
GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 7.08e-01 | 6.84e-02 | 9.31e-01 |
GOBP PROTEIN TARGETING TO MITOCHONDRION | 97 | 2.45e-01 | -6.84e-02 | 7.14e-01 |
GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 7 | 7.54e-01 | 6.84e-02 | 9.43e-01 |
GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 10 | 7.09e-01 | -6.83e-02 | 9.31e-01 |
GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 6.26e-01 | -6.83e-02 | 9.05e-01 |
GOBP NUCLEAR RNA SURVEILLANCE | 14 | 6.59e-01 | -6.82e-02 | 9.17e-01 |
GOBP POSITIVE REGULATION OF CHEMOTAXIS | 94 | 2.54e-01 | -6.82e-02 | 7.22e-01 |
GOMF TRANSCRIPTION COACTIVATOR BINDING | 34 | 4.92e-01 | -6.82e-02 | 8.55e-01 |
GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 222 | 8.12e-02 | -6.81e-02 | 5.08e-01 |
GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 49 | 4.10e-01 | -6.81e-02 | 8.19e-01 |
GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 7.92e-01 | -6.81e-02 | 9.54e-01 |
GOBP RESPONSE TO INORGANIC SUBSTANCE | 335 | 3.31e-02 | -6.80e-02 | 3.60e-01 |
GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 55 | 3.83e-01 | -6.80e-02 | 8.03e-01 |
GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 15 | 6.48e-01 | 6.80e-02 | 9.13e-01 |
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 52 | 3.97e-01 | -6.79e-02 | 8.12e-01 |
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 7.73e-01 | 6.79e-02 | 9.47e-01 |
GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 28 | 5.34e-01 | -6.79e-02 | 8.73e-01 |
GOBP REGULATION OF OSSIFICATION | 66 | 3.41e-01 | -6.78e-02 | 7.81e-01 |
GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 60 | 3.64e-01 | -6.78e-02 | 7.95e-01 |
GOBP RESPONSE TO KETONE | 118 | 2.04e-01 | -6.78e-02 | 6.85e-01 |
GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 9 | 7.25e-01 | -6.78e-02 | 9.37e-01 |
GOBP SPLEEN DEVELOPMENT | 26 | 5.50e-01 | -6.78e-02 | 8.76e-01 |
GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 8 | 7.40e-01 | 6.78e-02 | 9.40e-01 |
GOBP MACROMOLECULE METHYLATION | 177 | 1.21e-01 | 6.77e-02 | 5.84e-01 |
GOBP NUCLEAR MEMBRANE REASSEMBLY | 24 | 5.66e-01 | -6.77e-02 | 8.82e-01 |
GOBP SECRETION | 554 | 6.82e-03 | -6.77e-02 | 1.77e-01 |
GOBP MYELOID CELL DIFFERENTIATION | 314 | 4.01e-02 | -6.76e-02 | 3.83e-01 |
GOBP REGULATION OF HORMONE SECRETION | 132 | 1.81e-01 | -6.76e-02 | 6.64e-01 |
GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 20 | 6.01e-01 | 6.75e-02 | 8.98e-01 |
GOMF PROTEIN FOLDING CHAPERONE BINDING | 99 | 2.46e-01 | -6.75e-02 | 7.15e-01 |
GOBP COPULATION | 5 | 7.94e-01 | -6.75e-02 | 9.54e-01 |
GOBP MESODERM MORPHOGENESIS | 31 | 5.16e-01 | -6.75e-02 | 8.66e-01 |
GOBP REGULATION OF RNA BINDING | 8 | 7.41e-01 | -6.74e-02 | 9.40e-01 |
GOBP LONG TERM SYNAPTIC POTENTIATION | 46 | 4.29e-01 | -6.74e-02 | 8.25e-01 |
GOBP AMYLOID BETA METABOLIC PROCESS | 41 | 4.55e-01 | 6.74e-02 | 8.38e-01 |
GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 361 | 2.86e-02 | -6.74e-02 | 3.41e-01 |
GOBP TISSUE REMODELING | 97 | 2.52e-01 | -6.74e-02 | 7.20e-01 |
GOBP RESPONSE TO MINERALOCORTICOID | 17 | 6.31e-01 | 6.74e-02 | 9.05e-01 |
GOCC GOLGI STACK | 105 | 2.34e-01 | -6.73e-02 | 7.08e-01 |
GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 36 | 4.85e-01 | -6.73e-02 | 8.53e-01 |
GOBP BLASTOCYST GROWTH | 17 | 6.31e-01 | 6.73e-02 | 9.05e-01 |
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 242 | 7.22e-02 | -6.73e-02 | 4.78e-01 |
GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 67 | 3.41e-01 | -6.73e-02 | 7.81e-01 |
GOBP REGULATION OF VACUOLE ORGANIZATION | 51 | 4.06e-01 | 6.73e-02 | 8.17e-01 |
GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 9 | 7.27e-01 | -6.72e-02 | 9.37e-01 |
GOBP HEPATOCYTE APOPTOTIC PROCESS | 16 | 6.42e-01 | -6.72e-02 | 9.10e-01 |
GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 42 | 4.51e-01 | -6.72e-02 | 8.36e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 159 | 1.44e-01 | -6.72e-02 | 6.19e-01 |
GOBP EXPORT FROM CELL | 528 | 8.71e-03 | -6.72e-02 | 1.95e-01 |
GOBP MEIOTIC CELL CYCLE PROCESS | 116 | 2.12e-01 | 6.72e-02 | 6.87e-01 |
GOBP CALCIUM ION TRANSPORT | 229 | 8.07e-02 | -6.72e-02 | 5.08e-01 |
GOBP SYNAPTIC VESICLE PRIMING | 13 | 6.75e-01 | -6.72e-02 | 9.24e-01 |
GOBP GOLGI ORGANIZATION | 125 | 1.95e-01 | 6.72e-02 | 6.75e-01 |
GOBP RESPONSE TO SODIUM PHOSPHATE | 5 | 7.95e-01 | 6.71e-02 | 9.54e-01 |
GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 20 | 6.04e-01 | 6.71e-02 | 8.99e-01 |
GOBP STRIATED MUSCLE CELL DEVELOPMENT | 32 | 5.11e-01 | -6.71e-02 | 8.65e-01 |
GOCC LEADING EDGE MEMBRANE | 118 | 2.10e-01 | -6.70e-02 | 6.87e-01 |
GOBP GOLGI VESICLE BUDDING | 10 | 7.14e-01 | -6.70e-02 | 9.32e-01 |
GOBP POSITIVE REGULATION OF SIGNALING | 1133 | 1.82e-04 | -6.70e-02 | 2.24e-02 |
GOBP MITOTIC SPINDLE ORGANIZATION | 109 | 2.28e-01 | 6.69e-02 | 7.02e-01 |
GOBP POLYOL CATABOLIC PROCESS | 8 | 7.43e-01 | -6.69e-02 | 9.41e-01 |
GOBP CEREBELLAR CORTEX FORMATION | 16 | 6.44e-01 | 6.68e-02 | 9.10e-01 |
GOBP RESPONSE TO INTERLEUKIN 17 | 13 | 6.77e-01 | -6.68e-02 | 9.24e-01 |
GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 21 | 5.96e-01 | -6.68e-02 | 8.96e-01 |
GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 58 | 3.79e-01 | -6.68e-02 | 8.02e-01 |
GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 171 | 1.33e-01 | 6.68e-02 | 6.04e-01 |
GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 30 | 5.27e-01 | -6.68e-02 | 8.69e-01 |
GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 12 | 6.89e-01 | -6.67e-02 | 9.25e-01 |
GOBP CELLULAR RESPONSE TO ALKALOID | 25 | 5.64e-01 | -6.67e-02 | 8.80e-01 |
GOBP EAR DEVELOPMENT | 86 | 2.86e-01 | -6.67e-02 | 7.42e-01 |
GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 96 | 2.60e-01 | 6.67e-02 | 7.24e-01 |
GOCC NSL COMPLEX | 11 | 7.02e-01 | -6.67e-02 | 9.29e-01 |
GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 6 | 7.77e-01 | -6.66e-02 | 9.49e-01 |
GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 59 | 3.77e-01 | 6.66e-02 | 8.01e-01 |
GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 15 | 6.56e-01 | -6.65e-02 | 9.15e-01 |
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 21 | 5.98e-01 | 6.65e-02 | 8.96e-01 |
GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 7.61e-01 | -6.65e-02 | 9.45e-01 |
GOBP CELL JUNCTION DISASSEMBLY | 19 | 6.16e-01 | 6.65e-02 | 9.02e-01 |
GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 218 | 9.19e-02 | -6.64e-02 | 5.27e-01 |
GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 13 | 6.78e-01 | -6.64e-02 | 9.24e-01 |
GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 31 | 5.22e-01 | 6.64e-02 | 8.68e-01 |
GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 6 | 7.78e-01 | -6.63e-02 | 9.49e-01 |
GOBP REGULATION OF PINOCYTOSIS | 9 | 7.30e-01 | 6.63e-02 | 9.38e-01 |
GOMF PROTEIN TYROSINE KINASE BINDING | 81 | 3.03e-01 | 6.63e-02 | 7.53e-01 |
GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 30 | 5.30e-01 | 6.63e-02 | 8.70e-01 |
GOBP CLATHRIN COAT ASSEMBLY | 13 | 6.79e-01 | 6.63e-02 | 9.24e-01 |
GOMF FERRIC IRON BINDING | 5 | 7.98e-01 | -6.62e-02 | 9.54e-01 |
GOBP HORMONE METABOLIC PROCESS | 99 | 2.56e-01 | -6.62e-02 | 7.23e-01 |
GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 8 | 7.46e-01 | 6.61e-02 | 9.42e-01 |
GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 29 | 5.38e-01 | -6.61e-02 | 8.73e-01 |
GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 97 | 2.62e-01 | -6.60e-02 | 7.24e-01 |
GOMF CO SMAD BINDING | 8 | 7.47e-01 | -6.60e-02 | 9.42e-01 |
GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 33 | 5.12e-01 | -6.59e-02 | 8.66e-01 |
GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 89 | 2.83e-01 | 6.59e-02 | 7.39e-01 |
GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 51 | 4.16e-01 | 6.59e-02 | 8.21e-01 |
GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 19 | 6.19e-01 | 6.59e-02 | 9.02e-01 |
GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 32 | 5.19e-01 | -6.59e-02 | 8.67e-01 |
GOBP HIPPOCAMPUS DEVELOPMENT | 55 | 3.99e-01 | 6.58e-02 | 8.13e-01 |
GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 77 | 3.18e-01 | -6.58e-02 | 7.66e-01 |
GOBP RESPONSE TO DSRNA | 33 | 5.13e-01 | 6.58e-02 | 8.66e-01 |
GOBP REGULATION OF PROTEIN SECRETION | 159 | 1.53e-01 | -6.58e-02 | 6.32e-01 |
GOCC POLE PLASM | 13 | 6.81e-01 | -6.58e-02 | 9.25e-01 |
GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 35 | 5.01e-01 | -6.58e-02 | 8.60e-01 |
GOBP MATURATION OF LSU RRNA | 28 | 5.47e-01 | -6.57e-02 | 8.75e-01 |
GOBP INTRACELLULAR TRANSPORT OF VIRUS | 8 | 7.48e-01 | -6.57e-02 | 9.42e-01 |
GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 83 | 3.01e-01 | 6.57e-02 | 7.52e-01 |
GOBP REGULATION OF MUSCLE HYPERTROPHY | 36 | 4.96e-01 | -6.57e-02 | 8.57e-01 |
GOBP DETECTION OF ABIOTIC STIMULUS | 57 | 3.92e-01 | 6.56e-02 | 8.09e-01 |
GOCC TRANSPORT VESICLE MEMBRANE | 147 | 1.70e-01 | -6.56e-02 | 6.53e-01 |
GOMF TITIN BINDING | 8 | 7.48e-01 | -6.56e-02 | 9.42e-01 |
GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 195 | 1.15e-01 | -6.56e-02 | 5.78e-01 |
GOMF PEPTIDE RECEPTOR ACTIVITY | 31 | 5.28e-01 | 6.55e-02 | 8.69e-01 |
GOBP REGULATION OF MACROAUTOPHAGY | 138 | 1.85e-01 | -6.55e-02 | 6.69e-01 |
GOBP PROTEIN DNA COMPLEX ORGANIZATION | 664 | 4.33e-03 | 6.55e-02 | 1.39e-01 |
GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 13 | 6.83e-01 | 6.54e-02 | 9.25e-01 |
GOMF LYASE ACTIVITY | 134 | 1.92e-01 | 6.54e-02 | 6.75e-01 |
GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 9 | 7.34e-01 | -6.53e-02 | 9.39e-01 |
GOCC MULTI PASS TRANSLOCON COMPLEX | 9 | 7.34e-01 | -6.53e-02 | 9.39e-01 |
GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 124 | 2.10e-01 | 6.53e-02 | 6.87e-01 |
GOBP REGULATION OF PROTEIN POLYMERIZATION | 144 | 1.77e-01 | -6.53e-02 | 6.61e-01 |
GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 7.49e-01 | -6.53e-02 | 9.42e-01 |
GOBP RESPONSE TO CYTOKINE | 634 | 5.41e-03 | -6.53e-02 | 1.54e-01 |
GOMF MHC PROTEIN BINDING | 28 | 5.50e-01 | -6.52e-02 | 8.76e-01 |
GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 7.65e-01 | -6.51e-02 | 9.45e-01 |
GOBP GOLGI DISASSEMBLY | 6 | 7.82e-01 | -6.51e-02 | 9.51e-01 |
GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 14 | 6.73e-01 | -6.51e-02 | 9.24e-01 |
GOBP NADP METABOLIC PROCESS | 35 | 5.05e-01 | 6.51e-02 | 8.62e-01 |
GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 8 | 7.50e-01 | 6.51e-02 | 9.42e-01 |
GOMF TRNA BINDING | 66 | 3.61e-01 | 6.50e-02 | 7.92e-01 |
GOCC TRANS GOLGI NETWORK MEMBRANE | 85 | 3.01e-01 | 6.50e-02 | 7.52e-01 |
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 36 | 5.00e-01 | -6.50e-02 | 8.60e-01 |
GOMF CXCR CHEMOKINE RECEPTOR BINDING | 9 | 7.36e-01 | 6.49e-02 | 9.39e-01 |
GOCC VACUOLAR LUMEN | 132 | 1.99e-01 | -6.49e-02 | 6.79e-01 |
GOBP OSTEOBLAST PROLIFERATION | 16 | 6.53e-01 | -6.49e-02 | 9.15e-01 |
GOBP ESTABLISHMENT OF RNA LOCALIZATION | 143 | 1.82e-01 | 6.48e-02 | 6.65e-01 |
GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 10 | 7.23e-01 | -6.48e-02 | 9.36e-01 |
GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 59 | 3.90e-01 | 6.48e-02 | 8.08e-01 |
GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 6 | 7.83e-01 | -6.48e-02 | 9.52e-01 |
GOBP CYTOSOLIC TRANSPORT | 158 | 1.61e-01 | 6.48e-02 | 6.42e-01 |
GOMF HISTONE MODIFYING ACTIVITY | 178 | 1.37e-01 | 6.48e-02 | 6.08e-01 |
GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 7 | 7.67e-01 | -6.47e-02 | 9.45e-01 |
GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 5.33e-01 | -6.47e-02 | 8.73e-01 |
GOBP SMOOTH MUSCLE CONTRACTION | 49 | 4.34e-01 | -6.47e-02 | 8.27e-01 |
GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 13 | 6.86e-01 | -6.47e-02 | 9.25e-01 |
GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 47 | 4.43e-01 | -6.47e-02 | 8.32e-01 |
GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 13 | 6.87e-01 | -6.47e-02 | 9.25e-01 |
GOBP EPITHELIAL CELL CELL ADHESION | 9 | 7.37e-01 | 6.46e-02 | 9.39e-01 |
GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 7.84e-01 | 6.46e-02 | 9.52e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 128 | 2.08e-01 | -6.46e-02 | 6.87e-01 |
GOMF PROTEIN KINASE A BINDING | 39 | 4.86e-01 | 6.46e-02 | 8.53e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 21 | 6.09e-01 | 6.46e-02 | 9.00e-01 |
GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 12 | 6.99e-01 | -6.45e-02 | 9.29e-01 |
GOMF TETRAPYRROLE BINDING | 66 | 3.65e-01 | -6.45e-02 | 7.95e-01 |
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 303 | 5.43e-02 | -6.45e-02 | 4.23e-01 |
GOBP TEMPERATURE HOMEOSTASIS | 124 | 2.16e-01 | -6.45e-02 | 6.91e-01 |
GOBP TRANSLOCATION OF MOLECULES INTO HOST | 8 | 7.52e-01 | 6.45e-02 | 9.42e-01 |
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 28 | 5.55e-01 | -6.45e-02 | 8.78e-01 |
GOBP RESPONSE TO TESTOSTERONE | 25 | 5.77e-01 | 6.44e-02 | 8.87e-01 |
GOBP CELL AGGREGATION | 7 | 7.68e-01 | 6.44e-02 | 9.45e-01 |
GOBP ENTRY INTO HOST | 115 | 2.33e-01 | -6.44e-02 | 7.08e-01 |
GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 7.68e-01 | -6.44e-02 | 9.45e-01 |
GOBP BIOMINERAL TISSUE DEVELOPMENT | 87 | 3.00e-01 | -6.44e-02 | 7.51e-01 |
GOBP CELLULAR SENESCENCE | 79 | 3.23e-01 | -6.44e-02 | 7.69e-01 |
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 5 | 8.03e-01 | 6.44e-02 | 9.55e-01 |
GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 11 | 7.12e-01 | -6.44e-02 | 9.31e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 18 | 6.37e-01 | -6.44e-02 | 9.08e-01 |
GOBP RESPONSE TO MUSCLE STRETCH | 17 | 6.46e-01 | -6.43e-02 | 9.11e-01 |
GOMF COPPER ION BINDING | 34 | 5.16e-01 | -6.43e-02 | 8.66e-01 |
GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 38 | 4.93e-01 | 6.43e-02 | 8.56e-01 |
GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 8 | 7.53e-01 | -6.43e-02 | 9.42e-01 |
GOCC PLASMA MEMBRANE RAFT | 65 | 3.71e-01 | 6.43e-02 | 7.98e-01 |
GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 7.53e-01 | 6.42e-02 | 9.42e-01 |
GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 78 | 3.27e-01 | 6.42e-02 | 7.70e-01 |
GOBP REGULATION OF LYSOSOME ORGANIZATION | 10 | 7.25e-01 | 6.42e-02 | 9.37e-01 |
GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 29 | 5.50e-01 | 6.41e-02 | 8.76e-01 |
GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 18 | 6.38e-01 | 6.41e-02 | 9.09e-01 |
GOBP GLIOGENESIS | 197 | 1.22e-01 | -6.41e-02 | 5.86e-01 |
GOBP REGULATION OF TRANSPORT | 1039 | 5.82e-04 | -6.40e-02 | 4.64e-02 |
GOBP SKIN EPIDERMIS DEVELOPMENT | 56 | 4.08e-01 | 6.40e-02 | 8.17e-01 |
GOCC GOLGI CISTERNA MEMBRANE | 60 | 3.92e-01 | -6.39e-02 | 8.09e-01 |
GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 7 | 7.70e-01 | -6.39e-02 | 9.46e-01 |
GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 7.70e-01 | -6.39e-02 | 9.46e-01 |
GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 6.79e-01 | 6.39e-02 | 9.24e-01 |
GOMF SCAFFOLD PROTEIN BINDING | 41 | 4.79e-01 | -6.39e-02 | 8.50e-01 |
GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 78 | 3.30e-01 | 6.39e-02 | 7.73e-01 |
GOBP RESPONSE TO DOPAMINE | 31 | 5.38e-01 | 6.39e-02 | 8.73e-01 |
GOMF MHC CLASS II RECEPTOR ACTIVITY | 9 | 7.40e-01 | 6.39e-02 | 9.40e-01 |
GOMF EXOGENOUS PROTEIN BINDING | 56 | 4.08e-01 | -6.39e-02 | 8.17e-01 |
GOBP OSSIFICATION | 230 | 9.61e-02 | -6.39e-02 | 5.38e-01 |
GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 523 | 1.31e-02 | -6.39e-02 | 2.49e-01 |
GOBP PEPTIDE METABOLIC PROCESS | 716 | 3.94e-03 | -6.39e-02 | 1.33e-01 |
GOBP ENERGY RESERVE METABOLIC PROCESS | 56 | 4.09e-01 | -6.38e-02 | 8.17e-01 |
GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 104 | 2.62e-01 | -6.38e-02 | 7.24e-01 |
GOBP ADAPTIVE THERMOGENESIS | 114 | 2.40e-01 | -6.38e-02 | 7.13e-01 |
GOBP REGULATION OF MITOTIC RECOMBINATION | 6 | 7.87e-01 | 6.38e-02 | 9.53e-01 |
GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 259 | 7.84e-02 | -6.37e-02 | 4.99e-01 |
GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 13 | 6.91e-01 | 6.37e-02 | 9.25e-01 |
GOMF PROTEIN PHOSPHATASE BINDING | 116 | 2.37e-01 | -6.37e-02 | 7.11e-01 |
GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 19 | 6.31e-01 | -6.37e-02 | 9.05e-01 |
GOBP EPIDERMAL CELL DIFFERENTIATION | 97 | 2.79e-01 | -6.37e-02 | 7.36e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 122 | 2.26e-01 | -6.36e-02 | 7.02e-01 |
GOBP PROTEIN TETRAMERIZATION | 66 | 3.72e-01 | 6.36e-02 | 7.99e-01 |
GOCC SEX CHROMOSOME | 24 | 5.90e-01 | 6.36e-02 | 8.92e-01 |
GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 15 | 6.70e-01 | -6.36e-02 | 9.23e-01 |
GOBP INFLAMMATORY RESPONSE | 551 | 1.13e-02 | -6.36e-02 | 2.25e-01 |
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 6.91e-01 | 6.36e-02 | 9.26e-01 |
GOCC ATPASE COMPLEX | 131 | 2.10e-01 | -6.36e-02 | 6.87e-01 |
GOCC NUCLEAR STRESS GRANULE | 6 | 7.88e-01 | -6.35e-02 | 9.53e-01 |
GOMF NADPLUS BINDING | 16 | 6.60e-01 | 6.35e-02 | 9.17e-01 |
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 40 | 4.87e-01 | 6.35e-02 | 8.53e-01 |
GOBP NOTCH SIGNALING PATHWAY | 103 | 2.66e-01 | -6.35e-02 | 7.25e-01 |
GOBP LIPOSACCHARIDE METABOLIC PROCESS | 77 | 3.36e-01 | -6.35e-02 | 7.79e-01 |
GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 8 | 7.56e-01 | -6.35e-02 | 9.44e-01 |
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 9 | 7.42e-01 | 6.35e-02 | 9.40e-01 |
GOBP CHRONIC INFLAMMATORY RESPONSE | 12 | 7.04e-01 | -6.34e-02 | 9.30e-01 |
GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 70 | 3.60e-01 | 6.34e-02 | 7.92e-01 |
GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 30 | 5.48e-01 | -6.34e-02 | 8.75e-01 |
GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 7.88e-01 | -6.33e-02 | 9.53e-01 |
GOMF U2 SNRNA BINDING | 6 | 7.88e-01 | 6.33e-02 | 9.53e-01 |
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 19 | 6.33e-01 | -6.33e-02 | 9.07e-01 |
GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 38 | 5.00e-01 | 6.33e-02 | 8.60e-01 |
GOBP PROSTANOID METABOLIC PROCESS | 30 | 5.49e-01 | 6.33e-02 | 8.75e-01 |
GOBP AMINOGLYCAN CATABOLIC PROCESS | 17 | 6.52e-01 | -6.33e-02 | 9.14e-01 |
GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 14 | 6.82e-01 | 6.33e-02 | 9.25e-01 |
GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 31 | 5.43e-01 | 6.32e-02 | 8.74e-01 |
GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 18 | 6.43e-01 | 6.32e-02 | 9.10e-01 |
GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 18 | 6.43e-01 | -6.32e-02 | 9.10e-01 |
GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 5 | 8.07e-01 | -6.32e-02 | 9.56e-01 |
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 21 | 6.16e-01 | -6.32e-02 | 9.02e-01 |
GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 932 | 1.26e-03 | -6.31e-02 | 7.23e-02 |
GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 16 | 6.62e-01 | -6.31e-02 | 9.19e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 49 | 4.45e-01 | -6.31e-02 | 8.33e-01 |
GOBP EXCITATORY SYNAPSE ASSEMBLY | 17 | 6.53e-01 | -6.30e-02 | 9.15e-01 |
GOBP MULTICELLULAR ORGANISM GROWTH | 100 | 2.77e-01 | -6.30e-02 | 7.35e-01 |
GOMF POLY PYRIMIDINE TRACT BINDING | 23 | 6.02e-01 | -6.29e-02 | 8.98e-01 |
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 12 | 7.06e-01 | -6.29e-02 | 9.31e-01 |
GOBP CONNECTIVE TISSUE DEVELOPMENT | 142 | 1.96e-01 | -6.29e-02 | 6.76e-01 |
GOBP PROTEIN OXIDATION | 7 | 7.74e-01 | 6.28e-02 | 9.47e-01 |
GOMF GATED CHANNEL ACTIVITY | 105 | 2.67e-01 | -6.28e-02 | 7.25e-01 |
GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 170 | 1.59e-01 | -6.28e-02 | 6.40e-01 |
GOBP SEQUESTERING OF CALCIUM ION | 83 | 3.24e-01 | -6.27e-02 | 7.69e-01 |
GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 15 | 6.74e-01 | 6.27e-02 | 9.24e-01 |
GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 7.90e-01 | 6.27e-02 | 9.54e-01 |
GOBP REGULATION OF MAP KINASE ACTIVITY | 97 | 2.87e-01 | -6.27e-02 | 7.43e-01 |
GOMF ACTIN BINDING | 284 | 7.06e-02 | -6.26e-02 | 4.73e-01 |
GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 27 | 5.74e-01 | -6.26e-02 | 8.86e-01 |
GOMF EPHRIN RECEPTOR BINDING | 21 | 6.20e-01 | -6.26e-02 | 9.03e-01 |
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 25 | 5.88e-01 | -6.26e-02 | 8.91e-01 |
GOCC CONTRACTILE FIBER | 132 | 2.15e-01 | -6.26e-02 | 6.90e-01 |
GOBP MELANIN METABOLIC PROCESS | 14 | 6.85e-01 | -6.25e-02 | 9.25e-01 |
GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 28 | 5.67e-01 | 6.25e-02 | 8.83e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 324 | 5.46e-02 | -6.24e-02 | 4.23e-01 |
GOCC EUCHROMATIN | 41 | 4.90e-01 | 6.24e-02 | 8.55e-01 |
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 24 | 5.97e-01 | 6.23e-02 | 8.96e-01 |
GOCC RECEPTOR COMPLEX | 209 | 1.21e-01 | -6.23e-02 | 5.86e-01 |
GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 515 | 1.62e-02 | -6.23e-02 | 2.72e-01 |
GOCC MALE PRONUCLEUS | 6 | 7.92e-01 | 6.23e-02 | 9.54e-01 |
GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 274 | 7.72e-02 | -6.23e-02 | 4.96e-01 |
GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 6 | 7.92e-01 | -6.22e-02 | 9.54e-01 |
GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 8.10e-01 | -6.22e-02 | 9.57e-01 |
GOCC SPINDLE POLE | 145 | 1.97e-01 | 6.21e-02 | 6.78e-01 |
GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 7.34e-01 | -6.21e-02 | 9.39e-01 |
GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 107 | 2.68e-01 | 6.21e-02 | 7.25e-01 |
GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 28 | 5.70e-01 | -6.21e-02 | 8.84e-01 |
GOMF GLUTATHIONE BINDING | 6 | 7.92e-01 | 6.21e-02 | 9.54e-01 |
GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 15 | 6.77e-01 | -6.20e-02 | 9.24e-01 |
GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 21 | 6.23e-01 | -6.20e-02 | 9.04e-01 |
GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 7.62e-01 | 6.20e-02 | 9.45e-01 |
GOBP VESICLE TARGETING | 60 | 4.07e-01 | -6.19e-02 | 8.17e-01 |
GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 7.93e-01 | -6.19e-02 | 9.54e-01 |
GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 317 | 5.93e-02 | -6.19e-02 | 4.35e-01 |
GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 14 | 6.89e-01 | -6.18e-02 | 9.25e-01 |
GOMF ESTROGEN RESPONSE ELEMENT BINDING | 8 | 7.62e-01 | -6.18e-02 | 9.45e-01 |
GOBP AUTOPHAGOSOME LYSOSOME FUSION | 9 | 7.49e-01 | -6.17e-02 | 9.42e-01 |
GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 246 | 9.68e-02 | 6.17e-02 | 5.39e-01 |
GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 12 | 7.11e-01 | -6.17e-02 | 9.31e-01 |
GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 10 | 7.36e-01 | -6.17e-02 | 9.39e-01 |
GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 34 | 5.34e-01 | 6.16e-02 | 8.73e-01 |
GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 15 | 6.80e-01 | -6.16e-02 | 9.24e-01 |
GOBP CERAMIDE BIOSYNTHETIC PROCESS | 46 | 4.70e-01 | -6.16e-02 | 8.46e-01 |
GOCC LATERAL PLASMA MEMBRANE | 36 | 5.23e-01 | -6.16e-02 | 8.68e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 67 | 3.85e-01 | 6.15e-02 | 8.04e-01 |
GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 98 | 2.94e-01 | 6.14e-02 | 7.48e-01 |
GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 190 | 1.45e-01 | -6.14e-02 | 6.21e-01 |
GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 169 | 1.70e-01 | -6.14e-02 | 6.52e-01 |
GOMF CERAMIDE 1 PHOSPHATE BINDING | 5 | 8.12e-01 | -6.14e-02 | 9.57e-01 |
GOMF ANNEALING ACTIVITY | 8 | 7.64e-01 | 6.13e-02 | 9.45e-01 |
GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 11 | 7.25e-01 | -6.13e-02 | 9.37e-01 |
GOCC NLRP3 INFLAMMASOME COMPLEX | 8 | 7.64e-01 | -6.13e-02 | 9.45e-01 |
GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 19 | 6.44e-01 | -6.13e-02 | 9.10e-01 |
GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 7.51e-01 | 6.12e-02 | 9.42e-01 |
GOBP REGULATORY NCRNA PROCESSING | 61 | 4.09e-01 | -6.12e-02 | 8.17e-01 |
GOBP NUCLEAR TRANSPORT | 285 | 7.68e-02 | 6.12e-02 | 4.95e-01 |
GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 169 | 1.71e-01 | 6.11e-02 | 6.55e-01 |
GOBP PIRNA PROCESSING | 6 | 7.96e-01 | 6.11e-02 | 9.54e-01 |
GOBP MACROPHAGE MIGRATION | 41 | 4.99e-01 | -6.11e-02 | 8.59e-01 |
GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 33 | 5.45e-01 | 6.10e-02 | 8.75e-01 |
GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 7.65e-01 | 6.10e-02 | 9.45e-01 |
GOCC PROTEIN KINASE COMPLEX | 120 | 2.49e-01 | 6.10e-02 | 7.18e-01 |
GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 7.96e-01 | 6.10e-02 | 9.54e-01 |
GOMF APOLIPOPROTEIN BINDING | 9 | 7.52e-01 | -6.09e-02 | 9.42e-01 |
GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 8.14e-01 | -6.09e-02 | 9.58e-01 |
GOCC FEMALE PRONUCLEUS | 8 | 7.66e-01 | 6.08e-02 | 9.45e-01 |
GOBP RETINOIC ACID METABOLIC PROCESS | 8 | 7.66e-01 | 6.08e-02 | 9.45e-01 |
GOBP REGULATION OF ENDOCYTOSIS | 204 | 1.35e-01 | -6.08e-02 | 6.06e-01 |
GOCC EXON EXON JUNCTION COMPLEX | 11 | 7.27e-01 | -6.08e-02 | 9.37e-01 |
GOBP ACROSOME REACTION | 12 | 7.16e-01 | 6.07e-02 | 9.32e-01 |
GOBP PROTEIN HOMOTETRAMERIZATION | 43 | 4.91e-01 | 6.07e-02 | 8.55e-01 |
GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 14 | 6.94e-01 | -6.07e-02 | 9.28e-01 |
GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 21 | 6.31e-01 | 6.06e-02 | 9.05e-01 |
GOBP REGULATION OF CAMP MEDIATED SIGNALING | 12 | 7.16e-01 | -6.06e-02 | 9.32e-01 |
GOBP MACROAUTOPHAGY | 298 | 7.30e-02 | -6.06e-02 | 4.82e-01 |
GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION | 5 | 8.14e-01 | -6.06e-02 | 9.58e-01 |
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 547 | 1.61e-02 | -6.06e-02 | 2.71e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 10 | 7.40e-01 | 6.06e-02 | 9.40e-01 |
GOBP RESPONSE TO AMYLOID BETA | 31 | 5.60e-01 | 6.05e-02 | 8.80e-01 |
GOCC SHELTERIN COMPLEX | 6 | 7.97e-01 | 6.05e-02 | 9.54e-01 |
GOBP REGULATION OF FEEDING BEHAVIOR | 11 | 7.28e-01 | 6.05e-02 | 9.37e-01 |
GOBP RESPONSE TO INTERLEUKIN 7 | 14 | 6.95e-01 | -6.05e-02 | 9.28e-01 |
GOBP CELL MOTILITY | 980 | 1.58e-03 | -6.04e-02 | 8.16e-02 |
GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 6 | 7.98e-01 | -6.04e-02 | 9.54e-01 |
GOBP CELLULAR RESPONSE TO LEUCINE | 11 | 7.29e-01 | -6.04e-02 | 9.37e-01 |
GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 158 | 1.91e-01 | 6.04e-02 | 6.74e-01 |
GOBP MACROMOLECULE DEPALMITOYLATION | 10 | 7.41e-01 | 6.03e-02 | 9.40e-01 |
GOMF PALMITOYL HYDROLASE ACTIVITY | 10 | 7.41e-01 | 6.03e-02 | 9.40e-01 |
GOBP REGULATION OF CYTOKINESIS | 66 | 3.97e-01 | 6.03e-02 | 8.12e-01 |
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 62 | 4.12e-01 | 6.03e-02 | 8.21e-01 |
GOMF POLY A RNA POLYMERASE ACTIVITY | 9 | 7.54e-01 | -6.03e-02 | 9.43e-01 |
GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 25 | 6.02e-01 | 6.03e-02 | 8.98e-01 |
GOCC CHITOSOME | 11 | 7.29e-01 | -6.03e-02 | 9.38e-01 |
GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 7 | 7.82e-01 | -6.03e-02 | 9.51e-01 |
GOBP POSTSYNAPSE ASSEMBLY | 17 | 6.67e-01 | -6.03e-02 | 9.22e-01 |
GOMF 3 5 EXONUCLEASE ACTIVITY | 51 | 4.57e-01 | 6.02e-02 | 8.39e-01 |
GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 14 | 6.97e-01 | -6.02e-02 | 9.29e-01 |
GOMF HISTONE METHYLTRANSFERASE BINDING | 14 | 6.97e-01 | -6.02e-02 | 9.29e-01 |
GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 54 | 4.45e-01 | -6.01e-02 | 8.33e-01 |
GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 18 | 6.59e-01 | 6.01e-02 | 9.17e-01 |
GOCC SARCOPLASM | 52 | 4.53e-01 | -6.01e-02 | 8.37e-01 |
GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 49 | 4.67e-01 | -6.01e-02 | 8.45e-01 |
GOBP REGULATION OF DNA METABOLIC PROCESS | 425 | 3.46e-02 | 6.01e-02 | 3.65e-01 |
GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 132 | 2.34e-01 | -6.01e-02 | 7.08e-01 |
GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 20 | 6.42e-01 | -6.01e-02 | 9.10e-01 |
GOBP REGULATION OF ACTIN NUCLEATION | 30 | 5.69e-01 | 6.01e-02 | 8.84e-01 |
GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 6 | 7.99e-01 | -6.00e-02 | 9.54e-01 |
GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 25 | 6.04e-01 | 6.00e-02 | 8.99e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 7 | 7.84e-01 | 5.99e-02 | 9.52e-01 |
GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 30 | 5.71e-01 | 5.99e-02 | 8.84e-01 |
GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 66 | 4.01e-01 | 5.99e-02 | 8.15e-01 |
GOBP NEGATIVE REGULATION OF GLIOGENESIS | 22 | 6.27e-01 | 5.98e-02 | 9.05e-01 |
GOBP TORC2 SIGNALING | 15 | 6.88e-01 | 5.98e-02 | 9.25e-01 |
GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 175 | 1.73e-01 | 5.98e-02 | 6.56e-01 |
GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 7.20e-01 | -5.98e-02 | 9.35e-01 |
GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 7 | 7.84e-01 | 5.98e-02 | 9.52e-01 |
GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 27 | 5.91e-01 | -5.97e-02 | 8.93e-01 |
GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 123 | 2.53e-01 | -5.97e-02 | 7.22e-01 |
GOBP RESPONSE TO INSULIN | 189 | 1.58e-01 | 5.97e-02 | 6.39e-01 |
GOBP PRENYLATION | 10 | 7.44e-01 | -5.96e-02 | 9.41e-01 |
GOBP MESENCHYMAL CELL DIFFERENTIATION | 132 | 2.38e-01 | -5.96e-02 | 7.11e-01 |
GOBP GOLGI RIBBON FORMATION | 9 | 7.57e-01 | 5.96e-02 | 9.44e-01 |
GOMF PROTEIN SERINE KINASE ACTIVITY | 285 | 8.46e-02 | 5.96e-02 | 5.15e-01 |
GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 363 | 5.24e-02 | -5.96e-02 | 4.19e-01 |
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 80 | 3.58e-01 | -5.95e-02 | 7.91e-01 |
GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 27 | 5.93e-01 | -5.95e-02 | 8.93e-01 |
GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 37 | 5.32e-01 | 5.94e-02 | 8.72e-01 |
GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 30 | 5.73e-01 | -5.94e-02 | 8.86e-01 |
GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 17 | 6.72e-01 | -5.94e-02 | 9.23e-01 |
GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 7.45e-01 | 5.94e-02 | 9.42e-01 |
GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 5 | 8.18e-01 | -5.93e-02 | 9.58e-01 |
GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 14 | 7.01e-01 | 5.93e-02 | 9.29e-01 |
GOBP POSITIVE REGULATION OF INSULIN SECRETION | 48 | 4.78e-01 | -5.93e-02 | 8.49e-01 |
GOBP REGULATION OF JNK CASCADE | 100 | 3.07e-01 | 5.92e-02 | 7.57e-01 |
GOCC CILIARY TRANSITION ZONE | 49 | 4.74e-01 | 5.92e-02 | 8.47e-01 |
GOMF MODIFIED AMINO ACID BINDING | 43 | 5.02e-01 | 5.92e-02 | 8.60e-01 |
GOBP REGULATION OF HORMONE LEVELS | 255 | 1.05e-01 | -5.91e-02 | 5.56e-01 |
GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 8.19e-01 | -5.91e-02 | 9.58e-01 |
GOBP HORMONE TRANSPORT | 166 | 1.90e-01 | -5.91e-02 | 6.73e-01 |
GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 15 | 6.92e-01 | -5.91e-02 | 9.26e-01 |
GOBP GLUCOSE METABOLIC PROCESS | 137 | 2.33e-01 | -5.91e-02 | 7.08e-01 |
GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 30 | 5.76e-01 | 5.90e-02 | 8.87e-01 |
GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 60 | 4.29e-01 | -5.90e-02 | 8.25e-01 |
GOBP SNRNA 3 END PROCESSING | 21 | 6.40e-01 | 5.90e-02 | 9.10e-01 |
GOBP POSITIVE REGULATION OF GENE EXPRESSION | 788 | 5.33e-03 | -5.90e-02 | 1.53e-01 |
GOBP REGULATION OF PROGRAMMED CELL DEATH | 1026 | 1.66e-03 | -5.89e-02 | 8.28e-02 |
GOBP NEURON MATURATION | 24 | 6.18e-01 | 5.89e-02 | 9.02e-01 |
GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 9 | 7.60e-01 | -5.89e-02 | 9.45e-01 |
GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION | 5 | 8.20e-01 | -5.89e-02 | 9.58e-01 |
GOBP POSITIVE REGULATION OF CELL ADHESION | 338 | 6.42e-02 | -5.88e-02 | 4.53e-01 |
GOBP RESPONSE TO REDOX STATE | 10 | 7.47e-01 | -5.88e-02 | 9.42e-01 |
GOBP PEROXISOMAL TRANSPORT | 22 | 6.33e-01 | 5.88e-02 | 9.07e-01 |
GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 8 | 7.73e-01 | 5.88e-02 | 9.47e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 172 | 1.85e-01 | -5.88e-02 | 6.69e-01 |
GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 31 | 5.72e-01 | -5.87e-02 | 8.85e-01 |
GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 7 | 7.88e-01 | 5.87e-02 | 9.53e-01 |
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 56 | 4.48e-01 | -5.87e-02 | 8.33e-01 |
GOBP REGULATION OF HISTONE MODIFICATION | 34 | 5.54e-01 | 5.87e-02 | 8.77e-01 |
GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 24 | 6.19e-01 | -5.87e-02 | 9.02e-01 |
GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 260 | 1.05e-01 | 5.86e-02 | 5.56e-01 |
GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 8 | 7.74e-01 | 5.86e-02 | 9.47e-01 |
GOCC A BAND | 16 | 6.85e-01 | 5.86e-02 | 9.25e-01 |
GOBP RESPONSE TO IONIZING RADIATION | 117 | 2.75e-01 | 5.85e-02 | 7.32e-01 |
GOCC LATERAL PART OF CELL | 5 | 8.21e-01 | -5.85e-02 | 9.58e-01 |
GOBP KILLING BY HOST OF SYMBIONT CELLS | 11 | 7.37e-01 | -5.85e-02 | 9.39e-01 |
GOMF TUBULIN BINDING | 275 | 9.62e-02 | 5.85e-02 | 5.38e-01 |
GOCC COATED VESICLE | 243 | 1.18e-01 | -5.85e-02 | 5.80e-01 |
GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 7.37e-01 | -5.85e-02 | 9.39e-01 |
GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 108 | 2.95e-01 | -5.84e-02 | 7.48e-01 |
GOCC PROTEIN DNA COMPLEX | 830 | 4.72e-03 | 5.84e-02 | 1.42e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 5 | 8.21e-01 | 5.84e-02 | 9.58e-01 |
GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 8.05e-01 | -5.83e-02 | 9.55e-01 |
GOBP ORGAN GROWTH | 83 | 3.59e-01 | -5.83e-02 | 7.92e-01 |
GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 10 | 7.50e-01 | 5.83e-02 | 9.42e-01 |
GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 11 | 7.38e-01 | 5.82e-02 | 9.40e-01 |
GOCC SYNAPSE | 826 | 4.97e-03 | -5.82e-02 | 1.45e-01 |
GOBP TRABECULA MORPHOGENESIS | 24 | 6.22e-01 | 5.82e-02 | 9.03e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 10 | 7.50e-01 | 5.81e-02 | 9.42e-01 |
GOCC ORGANELLE INNER MEMBRANE | 468 | 3.22e-02 | -5.81e-02 | 3.56e-01 |
GOBP PHOSPHOLIPID CATABOLIC PROCESS | 38 | 5.36e-01 | 5.81e-02 | 8.73e-01 |
GOBP FATTY ACID BETA OXIDATION | 64 | 4.22e-01 | 5.81e-02 | 8.23e-01 |
GOBP EAR MORPHOGENESIS | 42 | 5.15e-01 | 5.81e-02 | 8.66e-01 |
GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 98 | 3.21e-01 | -5.81e-02 | 7.68e-01 |
GOBP ACYLGLYCEROL HOMEOSTASIS | 17 | 6.79e-01 | -5.80e-02 | 9.24e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 535 | 2.26e-02 | 5.80e-02 | 3.08e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 23 | 6.30e-01 | 5.80e-02 | 9.05e-01 |
GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 7.76e-01 | 5.80e-02 | 9.48e-01 |
GOBP VIRAL GENE EXPRESSION | 93 | 3.34e-01 | -5.80e-02 | 7.78e-01 |
GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 217 | 1.42e-01 | -5.80e-02 | 6.15e-01 |
GOBP SKIN DEVELOPMENT | 130 | 2.55e-01 | -5.80e-02 | 7.22e-01 |
GOBP PATTERN SPECIFICATION PROCESS | 190 | 1.69e-01 | 5.80e-02 | 6.52e-01 |
GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 47 | 4.92e-01 | 5.79e-02 | 8.55e-01 |
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1140 | 1.19e-03 | -5.79e-02 | 7.01e-02 |
GOCC PODOSOME | 25 | 6.17e-01 | -5.78e-02 | 9.02e-01 |
GOBP PIGMENT GRANULE ORGANIZATION | 32 | 5.71e-01 | 5.78e-02 | 8.85e-01 |
GOBP ADULT LOCOMOTORY BEHAVIOR | 44 | 5.07e-01 | 5.78e-02 | 8.62e-01 |
GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 25 | 6.17e-01 | -5.78e-02 | 9.02e-01 |
GOMF PHOSPHATIDYLINOSITOL BINDING | 210 | 1.50e-01 | 5.78e-02 | 6.28e-01 |
GOBP REGULATION OF T CIRCLE FORMATION | 5 | 8.23e-01 | 5.77e-02 | 9.58e-01 |
GOBP CALCINEURIN MEDIATED SIGNALING | 31 | 5.78e-01 | 5.77e-02 | 8.87e-01 |
GOBP SECOND MESSENGER MEDIATED SIGNALING | 158 | 2.12e-01 | -5.77e-02 | 6.87e-01 |
GOBP AMMONIUM ION METABOLIC PROCESS | 9 | 7.64e-01 | -5.77e-02 | 9.45e-01 |
GOBP REGULATION OF HYDROLASE ACTIVITY | 520 | 2.54e-02 | -5.77e-02 | 3.27e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 10 | 7.52e-01 | 5.77e-02 | 9.42e-01 |
GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 10 | 7.52e-01 | -5.76e-02 | 9.42e-01 |
GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 36 | 5.50e-01 | 5.76e-02 | 8.76e-01 |
GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 57 | 4.52e-01 | -5.76e-02 | 8.36e-01 |
GOBP MANGANESE ION TRANSPORT | 8 | 7.78e-01 | -5.76e-02 | 9.49e-01 |
GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 26 | 6.11e-01 | -5.76e-02 | 9.01e-01 |
GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 7.92e-01 | 5.76e-02 | 9.54e-01 |
GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 5 | 8.24e-01 | -5.76e-02 | 9.58e-01 |
GOBP CARDIOBLAST DIFFERENTIATION | 9 | 7.65e-01 | 5.75e-02 | 9.45e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 66 | 4.20e-01 | -5.75e-02 | 8.22e-01 |
GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 7.92e-01 | 5.75e-02 | 9.54e-01 |
GOBP ENERGY HOMEOSTASIS | 45 | 5.05e-01 | -5.75e-02 | 8.62e-01 |
GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 148 | 2.29e-01 | -5.74e-02 | 7.02e-01 |
GOCC PHOTORECEPTOR RIBBON SYNAPSE | 7 | 7.93e-01 | -5.74e-02 | 9.54e-01 |
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 78 | 3.81e-01 | -5.74e-02 | 8.02e-01 |
GOCC CENTRIOLAR SATELLITE | 91 | 3.45e-01 | 5.74e-02 | 7.83e-01 |
GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 133 | 2.54e-01 | 5.74e-02 | 7.22e-01 |
GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 57 | 4.54e-01 | -5.74e-02 | 8.37e-01 |
GOBP MITOCHONDRIAL TRANSPORT | 166 | 2.03e-01 | -5.74e-02 | 6.85e-01 |
GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 108 | 3.04e-01 | -5.73e-02 | 7.54e-01 |
GOCC DNA REPAIR COMPLEX | 22 | 6.42e-01 | 5.73e-02 | 9.10e-01 |
GOBP CELL CELL JUNCTION ASSEMBLY | 74 | 3.94e-01 | 5.73e-02 | 8.12e-01 |
GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 42 | 5.21e-01 | -5.73e-02 | 8.68e-01 |
GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 5 | 8.25e-01 | 5.73e-02 | 9.58e-01 |
GOBP DELAMINATION | 5 | 8.25e-01 | 5.73e-02 | 9.58e-01 |
GOBP ISOLEUCINE METABOLIC PROCESS | 7 | 7.93e-01 | -5.72e-02 | 9.54e-01 |
GOBP MAMMARY GLAND INVOLUTION | 5 | 8.25e-01 | 5.72e-02 | 9.58e-01 |
GOCC RSC TYPE COMPLEX | 14 | 7.11e-01 | 5.72e-02 | 9.31e-01 |
GOMF TRANSCRIPTION COREGULATOR BINDING | 94 | 3.39e-01 | -5.72e-02 | 7.80e-01 |
GOBP MICROTUBULE BASED MOVEMENT | 237 | 1.31e-01 | 5.71e-02 | 6.02e-01 |
GOBP NEGATIVE REGULATION OF BONE REMODELING | 9 | 7.67e-01 | -5.71e-02 | 9.45e-01 |
GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 5 | 8.25e-01 | 5.71e-02 | 9.58e-01 |
GOCC CLATHRIN COATED PIT | 62 | 4.38e-01 | -5.71e-02 | 8.29e-01 |
GOBP KIDNEY EPITHELIUM DEVELOPMENT | 64 | 4.30e-01 | -5.70e-02 | 8.25e-01 |
GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 89 | 3.54e-01 | 5.70e-02 | 7.89e-01 |
GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 501 | 3.02e-02 | -5.70e-02 | 3.48e-01 |
GOBP NEUTRAL LIPID CATABOLIC PROCESS | 21 | 6.52e-01 | -5.69e-02 | 9.14e-01 |
GOBP RESPONSE TO ACTIVITY | 41 | 5.29e-01 | 5.69e-02 | 8.69e-01 |
GOMF HEXOSYLTRANSFERASE ACTIVITY | 120 | 2.83e-01 | 5.69e-02 | 7.39e-01 |
GOBP SULFATION | 9 | 7.68e-01 | 5.69e-02 | 9.45e-01 |
GOBP ACIDIC AMINO ACID TRANSPORT | 38 | 5.45e-01 | -5.68e-02 | 8.75e-01 |
GOMF GLUCOSIDASE ACTIVITY | 9 | 7.68e-01 | 5.68e-02 | 9.45e-01 |
GOBP ATRIAL SEPTUM MORPHOGENESIS | 6 | 8.10e-01 | -5.68e-02 | 9.57e-01 |
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 5 | 8.26e-01 | -5.68e-02 | 9.58e-01 |
GOBP BONE GROWTH | 13 | 7.23e-01 | -5.67e-02 | 9.36e-01 |
GOBP B CELL MEDIATED IMMUNITY | 104 | 3.18e-01 | 5.67e-02 | 7.66e-01 |
GOBP REGULATION OF IRON ION TRANSPORT | 5 | 8.26e-01 | 5.67e-02 | 9.58e-01 |
GOBP NUCLEAR MIGRATION | 23 | 6.38e-01 | 5.67e-02 | 9.09e-01 |
GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 14 | 7.14e-01 | -5.67e-02 | 9.32e-01 |
GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 182 | 1.89e-01 | -5.66e-02 | 6.73e-01 |
GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 12 | 7.34e-01 | -5.66e-02 | 9.39e-01 |
GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 70 | 4.14e-01 | 5.66e-02 | 8.21e-01 |
GOBP ALANINE TRANSPORT | 9 | 7.69e-01 | 5.66e-02 | 9.46e-01 |
GOBP RESPONSE TO MISFOLDED PROTEIN | 24 | 6.32e-01 | 5.66e-02 | 9.06e-01 |
GOBP MITOCHONDRION ORGANIZATION | 478 | 3.53e-02 | -5.66e-02 | 3.70e-01 |
GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 49 | 4.94e-01 | -5.65e-02 | 8.56e-01 |
GOBP CELL MATURATION | 93 | 3.48e-01 | -5.64e-02 | 7.86e-01 |
GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 121 | 2.85e-01 | 5.64e-02 | 7.41e-01 |
GOMF PROTEIN CARRIER CHAPERONE | 33 | 5.76e-01 | -5.63e-02 | 8.87e-01 |
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 8.11e-01 | 5.62e-02 | 9.57e-01 |
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 6 | 8.11e-01 | 5.62e-02 | 9.57e-01 |
GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 20 | 6.64e-01 | -5.62e-02 | 9.20e-01 |
GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 65 | 4.34e-01 | -5.62e-02 | 8.27e-01 |
GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 57 | 4.64e-01 | 5.62e-02 | 8.42e-01 |
GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 30 | 5.95e-01 | 5.62e-02 | 8.95e-01 |
GOMF ACYL COA BINDING | 16 | 6.98e-01 | -5.61e-02 | 9.29e-01 |
GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 9 | 7.71e-01 | 5.61e-02 | 9.46e-01 |
GOMF PEPTIDOGLYCAN BINDING | 9 | 7.71e-01 | 5.61e-02 | 9.46e-01 |
GOMF TRANSLATION INITIATION FACTOR BINDING | 28 | 6.08e-01 | -5.60e-02 | 9.00e-01 |
GOBP CELL CYCLE PROCESS | 956 | 3.78e-03 | 5.60e-02 | 1.30e-01 |
GOBP POSITIVE REGULATION OF CELL CYCLE | 216 | 1.57e-01 | 5.60e-02 | 6.39e-01 |
GOBP REGULATION OF VASCULAR PERMEABILITY | 25 | 6.28e-01 | -5.60e-02 | 9.05e-01 |
GOMF RNA EXONUCLEASE ACTIVITY | 43 | 5.26e-01 | -5.60e-02 | 8.69e-01 |
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 6 | 8.12e-01 | -5.59e-02 | 9.57e-01 |
GOBP RESPONSE TO GAMMA RADIATION | 42 | 5.31e-01 | 5.59e-02 | 8.72e-01 |
GOMF GLYCOSAMINOGLYCAN BINDING | 94 | 3.50e-01 | -5.59e-02 | 7.86e-01 |
GOMF AMINOPEPTIDASE ACTIVITY | 31 | 5.91e-01 | 5.58e-02 | 8.93e-01 |
GOBP AMINO ACID BETAINE METABOLIC PROCESS | 11 | 7.49e-01 | 5.58e-02 | 9.42e-01 |
GOBP HAIR CELL DIFFERENTIATION | 24 | 6.36e-01 | 5.58e-02 | 9.08e-01 |
GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 61 | 4.52e-01 | -5.58e-02 | 8.36e-01 |
GOBP REGULATION OF MUCUS SECRETION | 5 | 8.29e-01 | -5.57e-02 | 9.59e-01 |
GOBP MICROTUBULE BASED PROCESS | 632 | 1.77e-02 | 5.57e-02 | 2.81e-01 |
GOBP MEGAKARYOCYTE DIFFERENTIATION | 37 | 5.58e-01 | -5.57e-02 | 8.79e-01 |
GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 113 | 3.07e-01 | -5.57e-02 | 7.57e-01 |
GOBP PEROXISOME ORGANIZATION | 32 | 5.86e-01 | 5.57e-02 | 8.90e-01 |
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 457 | 4.26e-02 | 5.57e-02 | 3.90e-01 |
GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 81 | 3.87e-01 | -5.57e-02 | 8.06e-01 |
GOBP DEFENSE RESPONSE TO FUNGUS | 27 | 6.17e-01 | -5.57e-02 | 9.02e-01 |
GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 9 | 7.73e-01 | -5.56e-02 | 9.47e-01 |
GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 25 | 6.31e-01 | 5.56e-02 | 9.05e-01 |
GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 7.99e-01 | -5.55e-02 | 9.54e-01 |
GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 11 | 7.50e-01 | 5.55e-02 | 9.42e-01 |
GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 16 | 7.01e-01 | -5.55e-02 | 9.29e-01 |
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 99 | 3.41e-01 | -5.55e-02 | 7.81e-01 |
GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 10 | 7.61e-01 | -5.55e-02 | 9.45e-01 |
GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 19 | 6.76e-01 | -5.55e-02 | 9.24e-01 |
GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 75 | 4.07e-01 | -5.55e-02 | 8.17e-01 |
GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 41 | 5.39e-01 | -5.55e-02 | 8.73e-01 |
GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 18 | 6.84e-01 | 5.54e-02 | 9.25e-01 |
GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 204 | 1.74e-01 | 5.54e-02 | 6.56e-01 |
GOCC XY BODY | 11 | 7.51e-01 | -5.54e-02 | 9.42e-01 |
GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 42 | 5.35e-01 | 5.53e-02 | 8.73e-01 |
GOBP GLYCEROLIPID METABOLIC PROCESS | 276 | 1.15e-01 | 5.53e-02 | 5.78e-01 |
GOMF LIGAND GATED CHANNEL ACTIVITY | 39 | 5.51e-01 | -5.52e-02 | 8.76e-01 |
GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 10 | 7.62e-01 | -5.52e-02 | 9.45e-01 |
GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 18 | 6.85e-01 | -5.52e-02 | 9.25e-01 |
GOBP POSITIVE REGULATION OF DNA REPAIR | 115 | 3.07e-01 | 5.52e-02 | 7.57e-01 |
GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 110 | 3.18e-01 | -5.52e-02 | 7.66e-01 |
GOBP LEARNING | 73 | 4.16e-01 | 5.52e-02 | 8.21e-01 |
GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 7 | 8.01e-01 | -5.51e-02 | 9.55e-01 |
GOBP EMBRYONIC DIGIT MORPHOGENESIS | 28 | 6.14e-01 | -5.51e-02 | 9.01e-01 |
GOCC VESICLE MEMBRANE | 885 | 5.99e-03 | -5.51e-02 | 1.63e-01 |
GOBP EXECUTION PHASE OF APOPTOSIS | 52 | 4.93e-01 | 5.50e-02 | 8.56e-01 |
GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 11 | 7.52e-01 | 5.50e-02 | 9.42e-01 |
GOBP REGULATION OF GONAD DEVELOPMENT | 5 | 8.32e-01 | -5.49e-02 | 9.60e-01 |
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 16 | 7.04e-01 | -5.49e-02 | 9.30e-01 |
GOBP DENDRITIC CELL CHEMOTAXIS | 20 | 6.71e-01 | 5.49e-02 | 9.23e-01 |
GOMF NEUREXIN FAMILY PROTEIN BINDING | 7 | 8.01e-01 | 5.49e-02 | 9.55e-01 |
GOBP GLUCOCORTICOID METABOLIC PROCESS | 9 | 7.76e-01 | -5.49e-02 | 9.48e-01 |
GOMF PROTEASOME BINDING | 15 | 7.13e-01 | -5.48e-02 | 9.32e-01 |
GOCC SAGA TYPE COMPLEX | 36 | 5.69e-01 | 5.48e-02 | 8.84e-01 |
GOBP SODIUM ION HOMEOSTASIS | 14 | 7.23e-01 | -5.48e-02 | 9.36e-01 |
GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 11 | 7.53e-01 | 5.47e-02 | 9.42e-01 |
GOMF TRANSPORTER ACTIVITY | 650 | 1.83e-02 | -5.47e-02 | 2.86e-01 |
GOMF LBD DOMAIN BINDING | 5 | 8.32e-01 | -5.47e-02 | 9.60e-01 |
GOBP CELLULAR RESPONSE TO SALT | 113 | 3.16e-01 | -5.46e-02 | 7.64e-01 |
GOBP MACROMOLECULE DEACYLATION | 60 | 4.65e-01 | 5.46e-02 | 8.43e-01 |
GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 44 | 5.31e-01 | -5.46e-02 | 8.71e-01 |
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 14 | 7.24e-01 | -5.46e-02 | 9.36e-01 |
GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 8.17e-01 | -5.46e-02 | 9.58e-01 |
GOBP NCRNA CATABOLIC PROCESS | 49 | 5.10e-01 | 5.45e-02 | 8.63e-01 |
GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 8 | 7.90e-01 | 5.45e-02 | 9.54e-01 |
GOMF IRON ION BINDING | 71 | 4.28e-01 | 5.45e-02 | 8.24e-01 |
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 40 | 5.51e-01 | -5.45e-02 | 8.76e-01 |
GOBP ORGANIC ACID METABOLIC PROCESS | 608 | 2.30e-02 | 5.45e-02 | 3.10e-01 |
GOBP MAINTENANCE OF LOCATION IN CELL | 158 | 2.39e-01 | -5.45e-02 | 7.12e-01 |
GOCC ISWI TYPE COMPLEX | 12 | 7.44e-01 | 5.44e-02 | 9.41e-01 |
GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 49 | 5.10e-01 | -5.44e-02 | 8.64e-01 |
GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 23 | 6.52e-01 | 5.44e-02 | 9.14e-01 |
GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 58 | 4.74e-01 | -5.44e-02 | 8.47e-01 |
GOMF GTPASE BINDING | 265 | 1.29e-01 | 5.44e-02 | 5.99e-01 |
GOBP DENDRITIC CELL APOPTOTIC PROCESS | 9 | 7.78e-01 | 5.43e-02 | 9.49e-01 |
GOBP FACIAL NERVE STRUCTURAL ORGANIZATION | 7 | 8.03e-01 | -5.43e-02 | 9.55e-01 |
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 29 | 6.13e-01 | -5.42e-02 | 9.01e-01 |
GOBP NUCLEUS ORGANIZATION | 118 | 3.10e-01 | -5.42e-02 | 7.58e-01 |
GOBP TELOMERIC D LOOP DISASSEMBLY | 6 | 8.18e-01 | -5.42e-02 | 9.58e-01 |
GOCC GABA ERGIC SYNAPSE | 23 | 6.53e-01 | -5.42e-02 | 9.15e-01 |
GOBP MELANOSOME ASSEMBLY | 18 | 6.91e-01 | 5.42e-02 | 9.25e-01 |
GOCC SYNAPTIC MEMBRANE | 165 | 2.31e-01 | -5.42e-02 | 7.05e-01 |
GOBP POSITIVE REGULATION OF NEUROGENESIS | 138 | 2.73e-01 | -5.42e-02 | 7.30e-01 |
GOMF TPR DOMAIN BINDING | 7 | 8.04e-01 | 5.41e-02 | 9.55e-01 |
GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 6 | 8.18e-01 | -5.41e-02 | 9.58e-01 |
GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 6 | 8.19e-01 | 5.41e-02 | 9.58e-01 |
GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 34 | 5.86e-01 | 5.40e-02 | 8.90e-01 |
GOBP NUCLEOSIDE METABOLIC PROCESS | 43 | 5.40e-01 | -5.40e-02 | 8.74e-01 |
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 6 | 8.19e-01 | 5.39e-02 | 9.58e-01 |
GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 6 | 8.19e-01 | -5.39e-02 | 9.58e-01 |
GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 7.92e-01 | 5.39e-02 | 9.54e-01 |
GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 8 | 7.92e-01 | 5.39e-02 | 9.54e-01 |
GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 69 | 4.40e-01 | -5.39e-02 | 8.29e-01 |
GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 38 | 5.66e-01 | -5.39e-02 | 8.82e-01 |
GOBP REGULATION OF AMYLOID BETA CLEARANCE | 12 | 7.47e-01 | -5.38e-02 | 9.42e-01 |
GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 389 | 6.99e-02 | -5.38e-02 | 4.71e-01 |
GOBP INTERLEUKIN 12 PRODUCTION | 51 | 5.06e-01 | -5.38e-02 | 8.62e-01 |
GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 8 | 7.92e-01 | 5.38e-02 | 9.54e-01 |
GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 79 | 4.09e-01 | -5.38e-02 | 8.17e-01 |
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 18 | 6.93e-01 | -5.38e-02 | 9.27e-01 |
GOMF INSULIN RECEPTOR BINDING | 16 | 7.10e-01 | 5.38e-02 | 9.31e-01 |
GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 20 | 6.78e-01 | 5.37e-02 | 9.24e-01 |
GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 5 | 8.35e-01 | 5.37e-02 | 9.61e-01 |
GOCC MITOCHONDRIAL ENVELOPE | 675 | 1.84e-02 | -5.37e-02 | 2.87e-01 |
GOBP CELLULAR RESPONSE TO PH | 11 | 7.58e-01 | 5.37e-02 | 9.44e-01 |
GOBP TRANSPORT OF VIRUS | 17 | 7.02e-01 | 5.36e-02 | 9.29e-01 |
GOBP SELF PROTEOLYSIS | 8 | 7.93e-01 | 5.36e-02 | 9.54e-01 |
GOBP REGULATION OF PROTEIN STABILITY | 261 | 1.37e-01 | -5.36e-02 | 6.08e-01 |
GOBP MITOTIC CHROMOSOME CONDENSATION | 16 | 7.10e-01 | 5.36e-02 | 9.31e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 55 | 4.92e-01 | -5.36e-02 | 8.55e-01 |
GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 7.28e-01 | -5.36e-02 | 9.37e-01 |
GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 19 | 6.86e-01 | 5.36e-02 | 9.25e-01 |
GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 26 | 6.37e-01 | -5.35e-02 | 9.08e-01 |
GOBP INTERLEUKIN 23 PRODUCTION | 7 | 8.06e-01 | -5.35e-02 | 9.56e-01 |
GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 7.49e-01 | 5.35e-02 | 9.42e-01 |
GOBP PROTEIN DEACETYLATION | 50 | 5.14e-01 | 5.34e-02 | 8.66e-01 |
GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 9 | 7.82e-01 | -5.34e-02 | 9.51e-01 |
GOBP BONE REMODELING | 50 | 5.14e-01 | -5.34e-02 | 8.66e-01 |
GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 40 | 5.59e-01 | -5.34e-02 | 8.79e-01 |
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 344 | 9.04e-02 | -5.34e-02 | 5.23e-01 |
GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 10 | 7.70e-01 | -5.34e-02 | 9.46e-01 |
GOCC MRNA CAP BINDING COMPLEX | 11 | 7.60e-01 | 5.33e-02 | 9.45e-01 |
GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 9 | 7.82e-01 | -5.33e-02 | 9.51e-01 |
GOBP FIBROBLAST ACTIVATION | 12 | 7.49e-01 | 5.33e-02 | 9.42e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 7.04e-01 | 5.33e-02 | 9.30e-01 |
GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 8 | 7.94e-01 | 5.32e-02 | 9.54e-01 |
GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 34 | 5.92e-01 | 5.32e-02 | 8.93e-01 |
GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 9 | 7.82e-01 | -5.32e-02 | 9.51e-01 |
GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 301 | 1.14e-01 | -5.32e-02 | 5.78e-01 |
GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 12 | 7.51e-01 | 5.30e-02 | 9.42e-01 |
GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 71 | 4.41e-01 | -5.30e-02 | 8.29e-01 |
GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 20 | 6.82e-01 | 5.30e-02 | 9.25e-01 |
GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 36 | 5.83e-01 | 5.29e-02 | 8.89e-01 |
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 64 | 4.64e-01 | 5.29e-02 | 8.43e-01 |
GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 12 | 7.51e-01 | 5.29e-02 | 9.42e-01 |
GOCC MITOCHONDRIAL CRISTA | 6 | 8.23e-01 | 5.29e-02 | 9.58e-01 |
GOMF METALLOEXOPEPTIDASE ACTIVITY | 35 | 5.88e-01 | -5.29e-02 | 8.91e-01 |
GOBP REGULATION OF VESICLE FUSION | 15 | 7.23e-01 | -5.29e-02 | 9.36e-01 |
GOBP PORE COMPLEX ASSEMBLY | 20 | 6.83e-01 | 5.28e-02 | 9.25e-01 |
GOBP TUBE MORPHOGENESIS | 473 | 5.05e-02 | -5.28e-02 | 4.16e-01 |
GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 23 | 6.61e-01 | -5.28e-02 | 9.18e-01 |
GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 50 | 5.19e-01 | 5.28e-02 | 8.67e-01 |
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 66 | 4.59e-01 | -5.27e-02 | 8.40e-01 |
GOBP PROTEOLYSIS | 1140 | 3.14e-03 | -5.27e-02 | 1.17e-01 |
GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 8 | 7.96e-01 | 5.27e-02 | 9.54e-01 |
GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 101 | 3.61e-01 | -5.26e-02 | 7.92e-01 |
GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 157 | 2.56e-01 | -5.26e-02 | 7.24e-01 |
GOBP GLUTAMINE METABOLIC PROCESS | 17 | 7.08e-01 | 5.26e-02 | 9.31e-01 |
GOCC AUTOPHAGOSOME | 101 | 3.62e-01 | -5.26e-02 | 7.93e-01 |
GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 355 | 9.07e-02 | -5.25e-02 | 5.24e-01 |
GOCC APICAL JUNCTION COMPLEX | 80 | 4.17e-01 | -5.25e-02 | 8.21e-01 |
GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 136 | 2.92e-01 | -5.25e-02 | 7.46e-01 |
GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 34 | 5.97e-01 | 5.24e-02 | 8.96e-01 |
GOBP ALPHA AMINO ACID METABOLIC PROCESS | 123 | 3.16e-01 | 5.24e-02 | 7.64e-01 |
GOMF DEMETHYLASE ACTIVITY | 34 | 5.97e-01 | 5.24e-02 | 8.96e-01 |
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 8.39e-01 | -5.24e-02 | 9.63e-01 |
GOBP LEUKOCYTE PROLIFERATION | 247 | 1.58e-01 | -5.24e-02 | 6.39e-01 |
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 378 | 8.22e-02 | -5.23e-02 | 5.08e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 148 | 2.73e-01 | -5.23e-02 | 7.29e-01 |
GOBP PIGMENT CELL DIFFERENTIATION | 22 | 6.71e-01 | -5.23e-02 | 9.23e-01 |
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 16 | 7.17e-01 | -5.23e-02 | 9.33e-01 |
GOBP CYTIDINE TO URIDINE EDITING | 7 | 8.11e-01 | -5.23e-02 | 9.57e-01 |
GOBP REGULATION OF AEROBIC RESPIRATION | 25 | 6.51e-01 | -5.23e-02 | 9.14e-01 |
GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 130 | 3.04e-01 | 5.23e-02 | 7.55e-01 |
GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 47 | 5.36e-01 | -5.22e-02 | 8.73e-01 |
GOBP POSITIVE REGULATION OF JNK CASCADE | 65 | 4.67e-01 | 5.22e-02 | 8.45e-01 |
GOBP SENSORY ORGAN MORPHOGENESIS | 107 | 3.52e-01 | -5.22e-02 | 7.87e-01 |
GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 39 | 5.73e-01 | 5.21e-02 | 8.86e-01 |
GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 21 | 6.79e-01 | 5.21e-02 | 9.24e-01 |
GOBP MALE MEIOSIS I | 11 | 7.65e-01 | 5.21e-02 | 9.45e-01 |
GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 277 | 1.37e-01 | -5.21e-02 | 6.08e-01 |
GOBP PROTEIN MATURATION | 388 | 7.98e-02 | -5.21e-02 | 5.04e-01 |
GOBP RESPONSE TO MECHANICAL STIMULUS | 129 | 3.08e-01 | -5.20e-02 | 7.58e-01 |
GOBP SCHWANN CELL DIFFERENTIATION | 24 | 6.60e-01 | 5.19e-02 | 9.17e-01 |
GOMF LIPOPOLYSACCHARIDE BINDING | 20 | 6.88e-01 | -5.19e-02 | 9.25e-01 |
GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 90 | 3.96e-01 | 5.19e-02 | 8.12e-01 |
GOMF MAGNESIUM ION BINDING | 177 | 2.35e-01 | 5.19e-02 | 7.10e-01 |
GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 173 | 2.40e-01 | -5.19e-02 | 7.13e-01 |
GOBP TUBE FORMATION | 88 | 4.01e-01 | 5.19e-02 | 8.15e-01 |
GOBP MECHANORECEPTOR DIFFERENTIATION | 33 | 6.07e-01 | -5.18e-02 | 8.99e-01 |
GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 33 | 6.07e-01 | -5.18e-02 | 8.99e-01 |
GOBP REGULATION OF MEMBRANE POTENTIAL | 198 | 2.10e-01 | -5.18e-02 | 6.87e-01 |
GOBP MACROPHAGE APOPTOTIC PROCESS | 12 | 7.56e-01 | -5.17e-02 | 9.44e-01 |
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 7.57e-01 | 5.17e-02 | 9.44e-01 |
GOCC MAIN AXON | 34 | 6.02e-01 | -5.17e-02 | 8.98e-01 |
GOBP PRIMITIVE HEMOPOIESIS | 6 | 8.27e-01 | 5.17e-02 | 9.58e-01 |
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 140 | 2.92e-01 | 5.16e-02 | 7.47e-01 |
GOBP L AMINO ACID TRANSPORT | 53 | 5.16e-01 | -5.16e-02 | 8.66e-01 |
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 6 | 8.27e-01 | 5.16e-02 | 9.58e-01 |
GOBP CERAMIDE METABOLIC PROCESS | 73 | 4.46e-01 | -5.16e-02 | 8.33e-01 |
GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 16 | 7.21e-01 | -5.16e-02 | 9.36e-01 |
GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 18 | 7.05e-01 | -5.16e-02 | 9.30e-01 |
GOMF SIGNALING RECEPTOR BINDING | 733 | 1.86e-02 | -5.16e-02 | 2.89e-01 |
GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 500 | 4.99e-02 | -5.16e-02 | 4.14e-01 |
GOCC CLATHRIN COAT OF COATED PIT | 16 | 7.21e-01 | 5.16e-02 | 9.36e-01 |
GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 19 | 6.97e-01 | -5.15e-02 | 9.29e-01 |
GOMF METALLOAMINOPEPTIDASE ACTIVITY | 19 | 6.97e-01 | 5.15e-02 | 9.29e-01 |
GOBP NEGATIVE REGULATION OF SECRETION | 91 | 3.96e-01 | -5.15e-02 | 8.12e-01 |
GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 299 | 1.28e-01 | -5.14e-02 | 5.97e-01 |
GOCC MICROTUBULE | 318 | 1.17e-01 | 5.14e-02 | 5.79e-01 |
GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 104 | 3.66e-01 | 5.14e-02 | 7.96e-01 |
GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING | 5 | 8.42e-01 | 5.14e-02 | 9.64e-01 |
GOBP LIMBIC SYSTEM DEVELOPMENT | 64 | 4.78e-01 | 5.13e-02 | 8.49e-01 |
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 34 | 6.05e-01 | -5.13e-02 | 8.99e-01 |
GOBP DEFENSE RESPONSE TO SYMBIONT | 258 | 1.58e-01 | 5.13e-02 | 6.39e-01 |
GOBP REGULATION OF ISOMERASE ACTIVITY | 8 | 8.02e-01 | -5.13e-02 | 9.55e-01 |
GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 9 | 7.90e-01 | -5.13e-02 | 9.54e-01 |
GOBP REGULATION OF AMINO ACID TRANSPORT | 25 | 6.58e-01 | -5.12e-02 | 9.17e-01 |
GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 38 | 5.85e-01 | 5.12e-02 | 8.89e-01 |
GOBP MESENCHYME DEVELOPMENT | 155 | 2.72e-01 | -5.12e-02 | 7.29e-01 |
GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 8 | 8.02e-01 | -5.12e-02 | 9.55e-01 |
GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 7 | 8.15e-01 | 5.12e-02 | 9.58e-01 |
GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 56 | 5.08e-01 | -5.11e-02 | 8.63e-01 |
GOCC AZUROPHIL GRANULE LUMEN | 77 | 4.38e-01 | -5.11e-02 | 8.29e-01 |
GOBP REGULATION OF ORGAN GROWTH | 44 | 5.58e-01 | -5.11e-02 | 8.79e-01 |
GOBP POLYPRENOL METABOLIC PROCESS | 22 | 6.79e-01 | 5.10e-02 | 9.24e-01 |
GOBP PLASMA MEMBRANE ORGANIZATION | 96 | 3.88e-01 | -5.10e-02 | 8.06e-01 |
GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 42 | 5.67e-01 | -5.10e-02 | 8.83e-01 |
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 14 | 7.41e-01 | 5.10e-02 | 9.40e-01 |
GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 37 | 5.92e-01 | -5.10e-02 | 8.93e-01 |
GOCC ENDOSOME | 777 | 1.69e-02 | -5.09e-02 | 2.76e-01 |
GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 15 | 7.33e-01 | 5.09e-02 | 9.39e-01 |
GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 5.34e-01 | -5.09e-02 | 8.73e-01 |
GOBP EOSINOPHIL ACTIVATION | 9 | 7.91e-01 | -5.09e-02 | 9.54e-01 |
GOMF PHOSPHATASE ACTIVITY | 190 | 2.27e-01 | 5.09e-02 | 7.02e-01 |
GOBP TRNA 3 END PROCESSING | 7 | 8.16e-01 | 5.09e-02 | 9.58e-01 |
GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 10 | 7.81e-01 | -5.09e-02 | 9.51e-01 |
GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 14 | 7.42e-01 | 5.08e-02 | 9.40e-01 |
GOBP TRANSCRIPTION BY RNA POLYMERASE I | 61 | 4.93e-01 | 5.08e-02 | 8.55e-01 |
GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 11 | 7.71e-01 | 5.08e-02 | 9.46e-01 |
GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 67 | 4.73e-01 | -5.08e-02 | 8.46e-01 |
GOBP RELAXATION OF SMOOTH MUSCLE | 7 | 8.16e-01 | 5.08e-02 | 9.58e-01 |
GOBP RESPONSE TO CORTICOSTEROID | 75 | 4.48e-01 | -5.07e-02 | 8.33e-01 |
GOCC PROTEASOME CORE COMPLEX | 18 | 7.09e-01 | -5.07e-02 | 9.31e-01 |
GOBP SECONDARY PALATE DEVELOPMENT | 13 | 7.51e-01 | 5.07e-02 | 9.42e-01 |
GOBP NEGATIVE REGULATION OF CELL SIZE | 7 | 8.16e-01 | 5.07e-02 | 9.58e-01 |
GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 498 | 5.42e-02 | -5.07e-02 | 4.23e-01 |
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 19 | 7.02e-01 | 5.07e-02 | 9.29e-01 |
GOCC NUCLEOID | 42 | 5.70e-01 | 5.06e-02 | 8.84e-01 |
GOBP TRANSMEMBRANE TRANSPORT | 817 | 1.51e-02 | -5.06e-02 | 2.62e-01 |
GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 8 | 8.04e-01 | 5.06e-02 | 9.55e-01 |
GOBP CALCIUM MEDIATED SIGNALING | 123 | 3.34e-01 | -5.05e-02 | 7.78e-01 |
GOBP INSULIN SECRETION | 112 | 3.57e-01 | -5.05e-02 | 7.91e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 55 | 5.17e-01 | 5.05e-02 | 8.67e-01 |
GOBP PYRAMIDAL NEURON DIFFERENTIATION | 9 | 7.93e-01 | -5.05e-02 | 9.54e-01 |
GOBP REGULATION OF B CELL PROLIFERATION | 51 | 5.33e-01 | -5.05e-02 | 8.73e-01 |
GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 127 | 3.27e-01 | 5.04e-02 | 7.70e-01 |
GOBP SYNAPTIC TRANSMISSION GABAERGIC | 20 | 6.96e-01 | -5.04e-02 | 9.29e-01 |
GOBP REGULATION OF PEPTIDE TRANSPORT | 108 | 3.66e-01 | -5.04e-02 | 7.96e-01 |
GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 8 | 8.05e-01 | -5.04e-02 | 9.55e-01 |
GOBP APOPTOTIC PROCESS | 1325 | 2.50e-03 | -5.04e-02 | 1.07e-01 |
GOBP RESPONSE TO DIETARY EXCESS | 16 | 7.27e-01 | -5.04e-02 | 9.37e-01 |
GOBP REGULATION OF PROTEIN MATURATION | 46 | 5.55e-01 | -5.04e-02 | 8.77e-01 |
GOMF HSP70 PROTEIN BINDING | 40 | 5.82e-01 | -5.04e-02 | 8.89e-01 |
GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 146 | 2.95e-01 | -5.03e-02 | 7.48e-01 |
GOBP ENDOTHELIUM DEVELOPMENT | 85 | 4.23e-01 | -5.03e-02 | 8.23e-01 |
GOMF MANGANESE ION BINDING | 55 | 5.19e-01 | -5.03e-02 | 8.67e-01 |
GOCC DENDRITE MEMBRANE | 12 | 7.63e-01 | -5.03e-02 | 9.45e-01 |
GOBP SNO S RNA METABOLIC PROCESS | 15 | 7.36e-01 | -5.03e-02 | 9.39e-01 |
GOMF PHOSPHOLIPID BINDING | 332 | 1.17e-01 | 5.03e-02 | 5.79e-01 |
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 35 | 6.07e-01 | -5.03e-02 | 8.99e-01 |
GOCC SPINDLE MIDZONE | 28 | 6.45e-01 | -5.03e-02 | 9.10e-01 |
GOBP VESICLE DOCKING | 49 | 5.43e-01 | 5.02e-02 | 8.75e-01 |
GOBP ENSHEATHMENT OF NEURONS | 88 | 4.16e-01 | -5.02e-02 | 8.21e-01 |
GOBP REGULATION OF MACROPHAGE ACTIVATION | 38 | 5.93e-01 | -5.01e-02 | 8.94e-01 |
GOCC TRANSPORT VESICLE | 279 | 1.51e-01 | -5.01e-02 | 6.30e-01 |
GOBP RESPONSE TO X RAY | 24 | 6.71e-01 | -5.01e-02 | 9.23e-01 |
GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 18 | 7.13e-01 | -5.00e-02 | 9.32e-01 |
GOBP ORGANIC CATION TRANSPORT | 30 | 6.36e-01 | 5.00e-02 | 9.08e-01 |
GOBP RNA LOCALIZATION | 179 | 2.50e-01 | 5.00e-02 | 7.18e-01 |
GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 24 | 6.72e-01 | -5.00e-02 | 9.24e-01 |
GOMF N ACYLTRANSFERASE ACTIVITY | 68 | 4.77e-01 | -4.99e-02 | 8.48e-01 |
GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 175 | 2.55e-01 | -4.99e-02 | 7.23e-01 |
GOBP MONOSACCHARIDE METABOLIC PROCESS | 193 | 2.33e-01 | -4.99e-02 | 7.08e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 23 | 6.79e-01 | -4.99e-02 | 9.24e-01 |
GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 23 | 6.79e-01 | 4.99e-02 | 9.24e-01 |
GOBP NEGATIVE REGULATION OF TRANSPORT | 257 | 1.70e-01 | -4.99e-02 | 6.52e-01 |
GOBP REGULATION OF PROTEIN TARGETING | 66 | 4.84e-01 | -4.99e-02 | 8.52e-01 |
GOBP EMBRYONIC ORGAN MORPHOGENESIS | 111 | 3.65e-01 | 4.99e-02 | 7.95e-01 |
GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 6 | 8.33e-01 | 4.99e-02 | 9.60e-01 |
GOMF KINASE ACTIVITY | 560 | 4.56e-02 | 4.98e-02 | 4.00e-01 |
GOBP RESPONSE TO GLUCAGON | 9 | 7.96e-01 | -4.98e-02 | 9.54e-01 |
GOBP DETECTION OF MECHANICAL STIMULUS | 22 | 6.86e-01 | -4.98e-02 | 9.25e-01 |
GOBP RESPONSE TO METAL ION | 214 | 2.11e-01 | -4.98e-02 | 6.87e-01 |
GOBP ACTIN FILAMENT BASED PROCESS | 511 | 5.59e-02 | -4.98e-02 | 4.27e-01 |
GOBP TUBE DEVELOPMENT | 595 | 3.99e-02 | -4.97e-02 | 3.83e-01 |
GOBP ADHESION OF SYMBIONT TO HOST CELL | 5 | 8.47e-01 | 4.97e-02 | 9.67e-01 |
GOMF HISTONE DEACETYLASE BINDING | 91 | 4.14e-01 | 4.97e-02 | 8.21e-01 |
GOBP PROTEIN GERANYLGERANYLATION | 7 | 8.20e-01 | 4.97e-02 | 9.58e-01 |
GOBP REGULATION OF FATTY ACID BETA OXIDATION | 16 | 7.31e-01 | -4.97e-02 | 9.38e-01 |
GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 8.20e-01 | 4.96e-02 | 9.58e-01 |
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 6 | 8.33e-01 | -4.96e-02 | 9.60e-01 |
GOBP RHYTHMIC PROCESS | 187 | 2.44e-01 | 4.96e-02 | 7.14e-01 |
GOBP CELL CYCLE | 1336 | 2.88e-03 | 4.95e-02 | 1.10e-01 |
GOBP C4 DICARBOXYLATE TRANSPORT | 17 | 7.24e-01 | 4.95e-02 | 9.36e-01 |
GOCC PSEUDOPODIUM | 12 | 7.67e-01 | -4.95e-02 | 9.45e-01 |
GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 8 | 8.09e-01 | 4.94e-02 | 9.57e-01 |
GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 793 | 1.92e-02 | 4.94e-02 | 2.90e-01 |
GOBP IMP METABOLIC PROCESS | 13 | 7.58e-01 | 4.94e-02 | 9.44e-01 |
GOBP FATTY ACID ELONGATION | 9 | 7.97e-01 | -4.94e-02 | 9.54e-01 |
GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 9 | 7.97e-01 | -4.94e-02 | 9.54e-01 |
GOBP CELLULAR DEFENSE RESPONSE | 42 | 5.80e-01 | -4.94e-02 | 8.88e-01 |
GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 67 | 4.85e-01 | -4.94e-02 | 8.53e-01 |
GOBP RESPONSE TO LEPTIN | 11 | 7.77e-01 | -4.94e-02 | 9.49e-01 |
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 79 | 4.49e-01 | 4.94e-02 | 8.34e-01 |
GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 7 | 8.21e-01 | -4.94e-02 | 9.58e-01 |
GOBP SCHWANN CELL PROLIFERATION | 7 | 8.21e-01 | -4.94e-02 | 9.58e-01 |
GOCC NUCLEOLUS | 869 | 1.47e-02 | 4.94e-02 | 2.62e-01 |
GOBP MEMBRANE INVAGINATION | 52 | 5.38e-01 | 4.94e-02 | 8.73e-01 |
GOBP HOMEOSTATIC PROCESS | 1047 | 7.82e-03 | -4.93e-02 | 1.85e-01 |
GOBP CELLULAR HYPEROSMOTIC RESPONSE | 14 | 7.49e-01 | -4.93e-02 | 9.42e-01 |
GOBP REGULATION OF GLIOGENESIS | 57 | 5.20e-01 | -4.93e-02 | 8.68e-01 |
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 5 | 8.49e-01 | -4.93e-02 | 9.67e-01 |
GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 16 | 7.33e-01 | -4.93e-02 | 9.39e-01 |
GOBP STARTLE RESPONSE | 10 | 7.87e-01 | -4.93e-02 | 9.53e-01 |
GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 7 | 8.21e-01 | 4.93e-02 | 9.58e-01 |
GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 153 | 2.94e-01 | 4.92e-02 | 7.48e-01 |
GOBP PLASMA MEMBRANE FUSION | 6 | 8.35e-01 | -4.92e-02 | 9.61e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 15 | 7.42e-01 | -4.92e-02 | 9.40e-01 |
GOBP REGULATION OF T CELL CHEMOTAXIS | 12 | 7.68e-01 | 4.92e-02 | 9.45e-01 |
GOBP POSITIVE REGULATION OF AXONOGENESIS | 49 | 5.52e-01 | -4.92e-02 | 8.77e-01 |
GOBP NEURON APOPTOTIC PROCESS | 171 | 2.69e-01 | -4.91e-02 | 7.27e-01 |
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 50 | 5.48e-01 | -4.91e-02 | 8.75e-01 |
GOMF AMIDE BINDING | 243 | 1.89e-01 | -4.91e-02 | 6.73e-01 |
GOMF ANKYRIN BINDING | 8 | 8.10e-01 | -4.91e-02 | 9.57e-01 |
GOCC POSTSYNAPTIC DENSITY MEMBRANE | 36 | 6.11e-01 | 4.91e-02 | 9.01e-01 |
GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 59 | 5.15e-01 | 4.91e-02 | 8.66e-01 |
GOBP REGULATION OF AUTOPHAGY | 298 | 1.47e-01 | -4.91e-02 | 6.23e-01 |
GOCC PRERIBOSOME | 103 | 3.90e-01 | 4.91e-02 | 8.08e-01 |
GOBP ASTROCYTE CELL MIGRATION | 8 | 8.10e-01 | 4.90e-02 | 9.57e-01 |
GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 8.50e-01 | 4.90e-02 | 9.68e-01 |
GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 36 | 6.11e-01 | -4.90e-02 | 9.01e-01 |
GOBP NEURON PROJECTION ARBORIZATION | 21 | 6.98e-01 | -4.90e-02 | 9.29e-01 |
GOCC METHYLTRANSFERASE COMPLEX | 89 | 4.25e-01 | 4.89e-02 | 8.23e-01 |
GOBP SKELETAL SYSTEM DEVELOPMENT | 244 | 1.89e-01 | -4.89e-02 | 6.73e-01 |
GOBP VIRAL PROCESS | 350 | 1.18e-01 | -4.89e-02 | 5.80e-01 |
GOBP THYMOCYTE MIGRATION | 6 | 8.36e-01 | -4.89e-02 | 9.61e-01 |
GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 139 | 3.21e-01 | -4.89e-02 | 7.68e-01 |
GOBP NEUROMUSCULAR PROCESS | 74 | 4.68e-01 | 4.88e-02 | 8.45e-01 |
GOBP HYALURONAN METABOLIC PROCESS | 16 | 7.35e-01 | -4.88e-02 | 9.39e-01 |
GOCC NEURON SPINE | 102 | 3.96e-01 | 4.88e-02 | 8.12e-01 |
GOMF PEPTIDASE ACTIVATOR ACTIVITY | 42 | 5.85e-01 | -4.87e-02 | 8.89e-01 |
GOBP HISTONE UBIQUITINATION | 9 | 8.00e-01 | -4.87e-02 | 9.55e-01 |
GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 34 | 6.23e-01 | -4.87e-02 | 9.04e-01 |
GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 8 | 8.12e-01 | 4.87e-02 | 9.57e-01 |
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 765 | 2.35e-02 | -4.86e-02 | 3.13e-01 |
GOBP ORGANIC ACID TRANSPORT | 179 | 2.63e-01 | -4.86e-02 | 7.24e-01 |
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 134 | 3.33e-01 | 4.86e-02 | 7.76e-01 |
GOBP AMIDE METABOLIC PROCESS | 920 | 1.37e-02 | -4.85e-02 | 2.56e-01 |
GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 28 | 6.57e-01 | 4.85e-02 | 9.16e-01 |
GOBP REGULATION OF INSULIN SECRETION | 93 | 4.19e-01 | -4.85e-02 | 8.22e-01 |
GOBP REVERSE CHOLESTEROL TRANSPORT | 10 | 7.91e-01 | -4.85e-02 | 9.54e-01 |
GOBP SIGNAL RELEASE | 258 | 1.81e-01 | -4.85e-02 | 6.65e-01 |
GOBP PROTEIN TARGETING TO LYSOSOME | 30 | 6.46e-01 | -4.85e-02 | 9.11e-01 |
GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 73 | 4.75e-01 | -4.84e-02 | 8.47e-01 |
GOBP LIPID HOMEOSTASIS | 91 | 4.25e-01 | -4.84e-02 | 8.23e-01 |
GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 23 | 6.88e-01 | 4.84e-02 | 9.25e-01 |
GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 35 | 6.20e-01 | -4.84e-02 | 9.03e-01 |
GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 8.37e-01 | 4.84e-02 | 9.63e-01 |
GOBP APPENDAGE DEVELOPMENT | 89 | 4.31e-01 | -4.84e-02 | 8.25e-01 |
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 101 | 4.02e-01 | -4.84e-02 | 8.15e-01 |
GOBP MAMMARY GLAND MORPHOGENESIS | 22 | 6.95e-01 | -4.84e-02 | 9.28e-01 |
GOBP VITAMIN METABOLIC PROCESS | 68 | 4.91e-01 | 4.83e-02 | 8.55e-01 |
GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 9 | 8.02e-01 | -4.82e-02 | 9.55e-01 |
GOBP REGULATION OF MICROTUBULE BASED PROCESS | 185 | 2.60e-01 | 4.82e-02 | 7.24e-01 |
GOCC AGGRESOME | 26 | 6.71e-01 | -4.82e-02 | 9.23e-01 |
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 15 | 7.47e-01 | -4.81e-02 | 9.42e-01 |
GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 23 | 6.90e-01 | 4.81e-02 | 9.25e-01 |
GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 21 | 7.03e-01 | 4.81e-02 | 9.29e-01 |
GOBP XENOPHAGY | 13 | 7.64e-01 | 4.81e-02 | 9.45e-01 |
GOCC I BAND | 76 | 4.69e-01 | -4.81e-02 | 8.45e-01 |
GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 909 | 1.52e-02 | -4.81e-02 | 2.62e-01 |
GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 8 | 8.14e-01 | 4.81e-02 | 9.58e-01 |
GOCC PERIKARYON | 70 | 4.87e-01 | -4.80e-02 | 8.53e-01 |
GOBP RESPONSE TO INTERLEUKIN 1 | 85 | 4.45e-01 | -4.80e-02 | 8.33e-01 |
GOBP POSITIVE REGULATION OF HEAT GENERATION | 6 | 8.39e-01 | 4.79e-02 | 9.63e-01 |
GOBP POTASSIUM ION HOMEOSTASIS | 16 | 7.40e-01 | -4.79e-02 | 9.40e-01 |
GOBP IMPORT INTO NUCLEUS | 136 | 3.36e-01 | 4.79e-02 | 7.79e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 384 | 1.09e-01 | -4.78e-02 | 5.68e-01 |
GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 9 | 8.04e-01 | -4.78e-02 | 9.55e-01 |
GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 35 | 6.25e-01 | -4.78e-02 | 9.04e-01 |
GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 8.53e-01 | -4.78e-02 | 9.68e-01 |
GOBP RESPONSE TO CORTICOSTERONE | 5 | 8.53e-01 | 4.78e-02 | 9.68e-01 |
GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 212 | 2.32e-01 | -4.78e-02 | 7.06e-01 |
GOBP REGULATION OF CELL CYCLE | 808 | 2.24e-02 | 4.78e-02 | 3.06e-01 |
GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 43 | 5.88e-01 | 4.78e-02 | 8.91e-01 |
GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 8.53e-01 | -4.78e-02 | 9.68e-01 |
GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 5 | 8.53e-01 | 4.78e-02 | 9.68e-01 |
GOBP VASCULATURE DEVELOPMENT | 411 | 9.88e-02 | -4.77e-02 | 5.45e-01 |
GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 85 | 4.48e-01 | 4.77e-02 | 8.33e-01 |
GOCC CELL CORTEX | 206 | 2.39e-01 | -4.77e-02 | 7.13e-01 |
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 36 | 6.21e-01 | 4.77e-02 | 9.03e-01 |
GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 45 | 5.80e-01 | -4.77e-02 | 8.88e-01 |
GOCC INTRACILIARY TRANSPORT PARTICLE A | 8 | 8.15e-01 | 4.77e-02 | 9.58e-01 |
GOCC ANAPHASE PROMOTING COMPLEX | 17 | 7.34e-01 | -4.77e-02 | 9.39e-01 |
GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 120 | 3.69e-01 | 4.76e-02 | 7.96e-01 |
GOCC CYTOPLASMIC STRESS GRANULE | 77 | 4.71e-01 | -4.76e-02 | 8.46e-01 |
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 35 | 6.27e-01 | -4.75e-02 | 9.05e-01 |
GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 10 | 7.95e-01 | -4.75e-02 | 9.54e-01 |
GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 13 | 7.67e-01 | -4.75e-02 | 9.45e-01 |
GOBP RESPONSE TO INDOLE 3 METHANOL | 5 | 8.54e-01 | -4.75e-02 | 9.68e-01 |
GOCC SMALL SUBUNIT PROCESSOME | 70 | 4.92e-01 | -4.75e-02 | 8.55e-01 |
GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 136 | 3.40e-01 | -4.75e-02 | 7.81e-01 |
GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 104 | 4.03e-01 | 4.75e-02 | 8.16e-01 |
GOBP B CELL DIFFERENTIATION | 105 | 4.01e-01 | 4.75e-02 | 8.15e-01 |
GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 21 | 7.07e-01 | -4.74e-02 | 9.31e-01 |
GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 22 | 7.00e-01 | -4.74e-02 | 9.29e-01 |
GOBP MRNA TRANSCRIPTION | 48 | 5.70e-01 | 4.74e-02 | 8.84e-01 |
GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 6 | 8.41e-01 | 4.74e-02 | 9.64e-01 |
GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 24 | 6.88e-01 | 4.73e-02 | 9.25e-01 |
GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 201 | 2.49e-01 | 4.73e-02 | 7.18e-01 |
GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 19 | 7.21e-01 | -4.73e-02 | 9.36e-01 |
GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 184 | 2.70e-01 | -4.73e-02 | 7.28e-01 |
GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 10 | 7.96e-01 | 4.72e-02 | 9.54e-01 |
GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 855 | 2.05e-02 | -4.72e-02 | 2.97e-01 |
GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 195 | 2.57e-01 | 4.72e-02 | 7.24e-01 |
GOBP B CELL PROLIFERATION | 66 | 5.08e-01 | -4.72e-02 | 8.62e-01 |
GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 24 | 6.89e-01 | -4.72e-02 | 9.25e-01 |
GOBP TELOMERIC LOOP DISASSEMBLY | 8 | 8.17e-01 | 4.72e-02 | 9.58e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 53 | 5.53e-01 | -4.72e-02 | 8.77e-01 |
GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 10 | 7.96e-01 | -4.71e-02 | 9.54e-01 |
GOMF PROTEIN KINASE ACTIVITY | 426 | 9.71e-02 | 4.71e-02 | 5.40e-01 |
GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 83 | 4.59e-01 | 4.71e-02 | 8.40e-01 |
GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 6 | 8.42e-01 | -4.71e-02 | 9.64e-01 |
GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 516 | 6.90e-02 | -4.71e-02 | 4.68e-01 |
GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 8 | 8.18e-01 | -4.71e-02 | 9.58e-01 |
GOBP CERAMIDE CATABOLIC PROCESS | 13 | 7.69e-01 | -4.71e-02 | 9.46e-01 |
GOBP CARBOHYDRATE MEDIATED SIGNALING | 7 | 8.30e-01 | -4.70e-02 | 9.59e-01 |
GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS | 5 | 8.56e-01 | -4.70e-02 | 9.68e-01 |
GOBP SEMI LUNAR VALVE DEVELOPMENT | 22 | 7.03e-01 | -4.70e-02 | 9.29e-01 |
GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 17 | 7.37e-01 | -4.70e-02 | 9.40e-01 |
GOBP RESPONSE TO ELECTRICAL STIMULUS | 26 | 6.79e-01 | 4.69e-02 | 9.24e-01 |
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 79 | 4.71e-01 | -4.69e-02 | 8.46e-01 |
GOCC GAP JUNCTION | 5 | 8.56e-01 | -4.69e-02 | 9.68e-01 |
GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 15 | 7.53e-01 | -4.69e-02 | 9.42e-01 |
GOMF UBIQUITIN LIKE PROTEIN BINDING | 114 | 3.88e-01 | -4.68e-02 | 8.06e-01 |
GOBP EXTRACELLULAR MATRIX ASSEMBLY | 18 | 7.31e-01 | 4.68e-02 | 9.38e-01 |
GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 174 | 2.88e-01 | -4.68e-02 | 7.43e-01 |
GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 10 | 7.98e-01 | 4.68e-02 | 9.54e-01 |
GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 15 | 7.54e-01 | -4.68e-02 | 9.43e-01 |
GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 136 | 3.47e-01 | -4.68e-02 | 7.85e-01 |
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 7 | 8.30e-01 | 4.68e-02 | 9.59e-01 |
GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 7 | 8.30e-01 | 4.67e-02 | 9.59e-01 |
GOBP VIRAL LIFE CYCLE | 251 | 2.04e-01 | -4.67e-02 | 6.85e-01 |
GOBP REGULATION OF MITOTIC CYTOKINESIS | 6 | 8.43e-01 | -4.67e-02 | 9.64e-01 |
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 18 | 7.32e-01 | -4.66e-02 | 9.39e-01 |
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 9 | 8.09e-01 | 4.66e-02 | 9.57e-01 |
GOCC ADHERENS JUNCTION | 119 | 3.81e-01 | -4.66e-02 | 8.02e-01 |
GOBP RESPONSE TO NUTRIENT | 87 | 4.53e-01 | -4.66e-02 | 8.37e-01 |
GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 142 | 3.39e-01 | -4.66e-02 | 7.80e-01 |
GOBP CARDIAC SEPTUM MORPHOGENESIS | 37 | 6.24e-01 | -4.66e-02 | 9.04e-01 |
GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 11 | 7.89e-01 | 4.65e-02 | 9.54e-01 |
GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 5 | 8.57e-01 | 4.65e-02 | 9.68e-01 |
GOBP REGULATION OF COAGULATION | 33 | 6.44e-01 | -4.65e-02 | 9.10e-01 |
GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 45 | 5.90e-01 | -4.65e-02 | 8.92e-01 |
GOBP ACETYL COA METABOLIC PROCESS | 27 | 6.76e-01 | 4.65e-02 | 9.24e-01 |
GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 18 | 7.33e-01 | -4.64e-02 | 9.39e-01 |
GOBP HEART VALVE MORPHOGENESIS | 31 | 6.55e-01 | -4.64e-02 | 9.15e-01 |
GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 134 | 3.55e-01 | 4.63e-02 | 7.90e-01 |
GOMF CYTOSKELETAL MOTOR ACTIVITY | 65 | 5.19e-01 | 4.63e-02 | 8.67e-01 |
GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 8.21e-01 | 4.63e-02 | 9.58e-01 |
GOBP KIDNEY MORPHOGENESIS | 40 | 6.13e-01 | 4.63e-02 | 9.01e-01 |
GOBP PROSTATE GLAND DEVELOPMENT | 23 | 7.01e-01 | -4.63e-02 | 9.29e-01 |
GOBP ADULT BEHAVIOR | 71 | 5.01e-01 | 4.62e-02 | 8.60e-01 |
GOBP SPHINGOID METABOLIC PROCESS | 16 | 7.49e-01 | 4.62e-02 | 9.42e-01 |
GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 17 | 7.42e-01 | -4.61e-02 | 9.40e-01 |
GOBP ANTEROGRADE AXONAL TRANSPORT | 37 | 6.28e-01 | -4.61e-02 | 9.05e-01 |
GOMF PROLINE RICH REGION BINDING | 14 | 7.65e-01 | 4.61e-02 | 9.45e-01 |
GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 8.58e-01 | -4.61e-02 | 9.68e-01 |
GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 14 | 7.66e-01 | -4.60e-02 | 9.45e-01 |
GOBP HINDBRAIN MORPHOGENESIS | 28 | 6.74e-01 | 4.60e-02 | 9.24e-01 |
GOBP RETINAL METABOLIC PROCESS | 9 | 8.11e-01 | -4.60e-02 | 9.57e-01 |
GOMF SH2 DOMAIN BINDING | 35 | 6.38e-01 | -4.60e-02 | 9.09e-01 |
GOBP PROTEIN K48 LINKED UBIQUITINATION | 59 | 5.42e-01 | -4.60e-02 | 8.74e-01 |
GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 8 | 8.22e-01 | -4.59e-02 | 9.58e-01 |
GOCC LUMENAL SIDE OF MEMBRANE | 33 | 6.48e-01 | -4.59e-02 | 9.13e-01 |
GOMF TBP CLASS PROTEIN BINDING | 23 | 7.03e-01 | -4.59e-02 | 9.30e-01 |
GOBP PROTEIN FOLDING | 175 | 2.96e-01 | -4.59e-02 | 7.49e-01 |
GOMF GROWTH HORMONE RECEPTOR BINDING | 5 | 8.59e-01 | 4.58e-02 | 9.68e-01 |
GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 20 | 7.23e-01 | -4.58e-02 | 9.36e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 76 | 4.90e-01 | -4.58e-02 | 8.55e-01 |
GOMF GABA RECEPTOR BINDING | 10 | 8.02e-01 | -4.58e-02 | 9.55e-01 |
GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 49 | 5.80e-01 | -4.58e-02 | 8.88e-01 |
GOMF HISTONE KINASE ACTIVITY | 16 | 7.51e-01 | 4.57e-02 | 9.42e-01 |
GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 34 | 6.45e-01 | 4.57e-02 | 9.10e-01 |
GOBP RETINAL GANGLION CELL AXON GUIDANCE | 12 | 7.84e-01 | 4.57e-02 | 9.52e-01 |
GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 60 | 5.41e-01 | -4.57e-02 | 8.74e-01 |
GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 13 | 7.75e-01 | -4.57e-02 | 9.48e-01 |
GOBP DNA DEAMINATION | 11 | 7.93e-01 | -4.57e-02 | 9.54e-01 |
GOBP UTP METABOLIC PROCESS | 10 | 8.03e-01 | 4.57e-02 | 9.55e-01 |
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 44 | 6.01e-01 | -4.56e-02 | 8.98e-01 |
GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 16 | 7.52e-01 | 4.55e-02 | 9.42e-01 |
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 8.13e-01 | -4.55e-02 | 9.57e-01 |
GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 111 | 4.08e-01 | 4.55e-02 | 8.17e-01 |
GOCC NUCLEAR PORE | 86 | 4.66e-01 | 4.55e-02 | 8.44e-01 |
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 22 | 7.12e-01 | 4.55e-02 | 9.32e-01 |
GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 33 | 6.51e-01 | -4.55e-02 | 9.14e-01 |
GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 13 | 7.77e-01 | -4.54e-02 | 9.49e-01 |
GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 127 | 3.78e-01 | -4.54e-02 | 8.02e-01 |
GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 7 | 8.35e-01 | -4.54e-02 | 9.61e-01 |
GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 42 | 6.11e-01 | -4.53e-02 | 9.01e-01 |
GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 29 | 6.73e-01 | 4.53e-02 | 9.24e-01 |
GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 626 | 5.49e-02 | -4.53e-02 | 4.24e-01 |
GOBP REGULATION OF GLUCONEOGENESIS | 38 | 6.29e-01 | -4.53e-02 | 9.05e-01 |
GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 16 | 7.54e-01 | -4.53e-02 | 9.43e-01 |
GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 29 | 6.73e-01 | 4.53e-02 | 9.24e-01 |
GOCC 9PLUS2 MOTILE CILIUM | 79 | 4.87e-01 | -4.53e-02 | 8.53e-01 |
GOBP EXOCYTOSIS | 232 | 2.37e-01 | -4.52e-02 | 7.11e-01 |
GOCC PRESYNAPSE | 311 | 1.72e-01 | -4.52e-02 | 6.55e-01 |
GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 14 | 7.70e-01 | 4.52e-02 | 9.46e-01 |
GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 42 | 6.12e-01 | -4.52e-02 | 9.01e-01 |
GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION | 5 | 8.61e-01 | 4.52e-02 | 9.69e-01 |
GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 49 | 5.84e-01 | 4.52e-02 | 8.89e-01 |
GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 184 | 2.92e-01 | 4.52e-02 | 7.46e-01 |
GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 14 | 7.70e-01 | 4.52e-02 | 9.46e-01 |
GOBP PROTEIN INSERTION INTO MEMBRANE | 68 | 5.20e-01 | -4.51e-02 | 8.68e-01 |
GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 42 | 6.13e-01 | 4.51e-02 | 9.01e-01 |
GOBP PEPTIDYL THREONINE MODIFICATION | 85 | 4.73e-01 | 4.51e-02 | 8.46e-01 |
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 100 | 4.37e-01 | 4.51e-02 | 8.29e-01 |
GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 76 | 4.97e-01 | -4.51e-02 | 8.59e-01 |
GOBP STRIATED MUSCLE CELL PROLIFERATION | 39 | 6.27e-01 | 4.51e-02 | 9.05e-01 |
GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 45 | 6.01e-01 | 4.51e-02 | 8.98e-01 |
GOCC LATE ENDOSOME | 245 | 2.26e-01 | -4.50e-02 | 7.02e-01 |
GOBP CELL JUNCTION ASSEMBLY | 217 | 2.54e-01 | -4.50e-02 | 7.22e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 280 | 1.97e-01 | -4.50e-02 | 6.76e-01 |
GOBP RESPONSE TO CARBOHYDRATE | 135 | 3.67e-01 | -4.50e-02 | 7.96e-01 |
GOCC BASOLATERAL PLASMA MEMBRANE | 139 | 3.61e-01 | -4.50e-02 | 7.92e-01 |
GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 8.26e-01 | -4.50e-02 | 9.58e-01 |
GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 8 | 8.26e-01 | 4.49e-02 | 9.58e-01 |
GOCC VESICLE COAT | 57 | 5.58e-01 | -4.49e-02 | 8.79e-01 |
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 8.62e-01 | 4.49e-02 | 9.69e-01 |
GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 8.62e-01 | 4.49e-02 | 9.69e-01 |
GOBP REGULATION OF GLOMERULAR FILTRATION | 5 | 8.62e-01 | 4.49e-02 | 9.69e-01 |
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME | 5 | 8.62e-01 | 4.49e-02 | 9.69e-01 |
GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 5 | 8.62e-01 | 4.49e-02 | 9.69e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 352 | 1.50e-01 | -4.49e-02 | 6.28e-01 |
GOCC VACUOLE | 678 | 4.85e-02 | -4.49e-02 | 4.13e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 97 | 4.46e-01 | 4.49e-02 | 8.33e-01 |
GOBP DEFENSE RESPONSE TO BACTERIUM | 146 | 3.51e-01 | -4.48e-02 | 7.86e-01 |
GOMF FOUR WAY JUNCTION DNA BINDING | 17 | 7.49e-01 | -4.48e-02 | 9.42e-01 |
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 780 | 3.54e-02 | -4.48e-02 | 3.70e-01 |
GOBP MOLTING CYCLE PROCESS | 43 | 6.12e-01 | 4.47e-02 | 9.01e-01 |
GOBP CELLULAR PIGMENTATION | 50 | 5.85e-01 | 4.47e-02 | 8.89e-01 |
GOCC RIBONUCLEOPROTEIN GRANULE | 216 | 2.59e-01 | -4.47e-02 | 7.24e-01 |
GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 17 | 7.50e-01 | 4.46e-02 | 9.42e-01 |
GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION | 5 | 8.63e-01 | -4.46e-02 | 9.69e-01 |
GOCC ORGANELLE SUBCOMPARTMENT | 1080 | 1.48e-02 | -4.46e-02 | 2.62e-01 |
GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 22 | 7.17e-01 | 4.46e-02 | 9.33e-01 |
GOBP ARTERY MORPHOGENESIS | 30 | 6.73e-01 | 4.46e-02 | 9.24e-01 |
GOBP FATTY ACID METABOLIC PROCESS | 248 | 2.29e-01 | 4.45e-02 | 7.02e-01 |
GOMF RIBOSOME BINDING | 103 | 4.36e-01 | -4.45e-02 | 8.28e-01 |
GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 154 | 3.42e-01 | -4.45e-02 | 7.82e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 115 | 4.11e-01 | -4.44e-02 | 8.21e-01 |
GOMF MONOSACCHARIDE BINDING | 57 | 5.62e-01 | 4.44e-02 | 8.80e-01 |
GOMF ENZYME INHIBITOR ACTIVITY | 209 | 2.70e-01 | -4.44e-02 | 7.28e-01 |
GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 14 | 7.74e-01 | -4.44e-02 | 9.47e-01 |
GOBP REGULATION OF NEUTROPHIL MIGRATION | 36 | 6.45e-01 | -4.44e-02 | 9.10e-01 |
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 15 | 7.66e-01 | 4.43e-02 | 9.45e-01 |
GOCC CELL LEADING EDGE | 312 | 1.80e-01 | -4.43e-02 | 6.64e-01 |
GOMF ATPASE BINDING | 57 | 5.63e-01 | -4.43e-02 | 8.80e-01 |
GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 6.91e-01 | 4.43e-02 | 9.25e-01 |
GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 378 | 1.42e-01 | -4.43e-02 | 6.14e-01 |
GOBP REGULATION OF ISOTYPE SWITCHING | 34 | 6.55e-01 | -4.43e-02 | 9.15e-01 |
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 89 | 4.71e-01 | -4.42e-02 | 8.46e-01 |
GOBP PROTEIN KINASE C SIGNALING | 21 | 7.26e-01 | -4.42e-02 | 9.37e-01 |
GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 12 | 7.91e-01 | 4.41e-02 | 9.54e-01 |
GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 72 | 5.18e-01 | 4.41e-02 | 8.67e-01 |
GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 22 | 7.20e-01 | -4.41e-02 | 9.35e-01 |
GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 75 | 5.09e-01 | -4.41e-02 | 8.63e-01 |
GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 20 | 7.33e-01 | -4.41e-02 | 9.39e-01 |
GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 10 | 8.09e-01 | -4.41e-02 | 9.57e-01 |
GOCC GOLGI ASSOCIATED VESICLE | 77 | 5.04e-01 | -4.41e-02 | 8.62e-01 |
GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE | 5 | 8.65e-01 | -4.41e-02 | 9.70e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 11 | 8.00e-01 | -4.40e-02 | 9.55e-01 |
GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 24 | 7.09e-01 | 4.40e-02 | 9.31e-01 |
GOBP SPINDLE LOCALIZATION | 44 | 6.14e-01 | -4.40e-02 | 9.01e-01 |
GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 6 | 8.52e-01 | 4.40e-02 | 9.68e-01 |
GOCC DENDRITIC SPINE MEMBRANE | 6 | 8.52e-01 | -4.40e-02 | 9.68e-01 |
GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 15 | 7.68e-01 | -4.40e-02 | 9.45e-01 |
GOMF MAP KINASE ACTIVITY | 12 | 7.92e-01 | -4.39e-02 | 9.54e-01 |
GOBP REGULATION OF TRANSLATIONAL FIDELITY | 13 | 7.84e-01 | 4.39e-02 | 9.52e-01 |
GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 21 | 7.28e-01 | -4.39e-02 | 9.37e-01 |
GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 30 | 6.78e-01 | 4.38e-02 | 9.24e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 596 | 6.98e-02 | 4.38e-02 | 4.71e-01 |
GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 28 | 6.88e-01 | 4.38e-02 | 9.25e-01 |
GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT | 7 | 8.41e-01 | -4.38e-02 | 9.64e-01 |
GOBP CIRCADIAN RHYTHM | 136 | 3.79e-01 | 4.38e-02 | 8.02e-01 |
GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 8.66e-01 | 4.37e-02 | 9.70e-01 |
GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 98 | 4.55e-01 | -4.37e-02 | 8.38e-01 |
GOBP B CELL RECEPTOR SIGNALING PATHWAY | 56 | 5.72e-01 | 4.37e-02 | 8.85e-01 |
GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 117 | 4.16e-01 | 4.36e-02 | 8.21e-01 |
GOBP TELENCEPHALON DEVELOPMENT | 159 | 3.44e-01 | 4.36e-02 | 7.82e-01 |
GOMF PEPTIDE BINDING | 187 | 3.05e-01 | -4.36e-02 | 7.55e-01 |
GOCC POSTSYNAPTIC MEMBRANE | 100 | 4.52e-01 | -4.36e-02 | 8.36e-01 |
GOBP BLASTOCYST DEVELOPMENT | 86 | 4.85e-01 | 4.36e-02 | 8.53e-01 |
GOBP REGULATION OF CARTILAGE DEVELOPMENT | 29 | 6.85e-01 | 4.35e-02 | 9.25e-01 |
GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 53 | 5.84e-01 | 4.35e-02 | 8.89e-01 |
GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 12 | 7.94e-01 | -4.35e-02 | 9.54e-01 |
GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 33 | 6.66e-01 | 4.34e-02 | 9.21e-01 |
GOBP FERTILIZATION | 76 | 5.14e-01 | 4.34e-02 | 8.66e-01 |
GOBP REGULATION OF TUBE SIZE | 63 | 5.52e-01 | 4.34e-02 | 8.77e-01 |
GOBP RESPONSE TO ACID CHEMICAL | 88 | 4.83e-01 | -4.33e-02 | 8.51e-01 |
GOBP MIRNA METABOLIC PROCESS | 75 | 5.18e-01 | -4.32e-02 | 8.67e-01 |
GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 52 | 5.91e-01 | 4.32e-02 | 8.92e-01 |
GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 10 | 8.13e-01 | 4.32e-02 | 9.57e-01 |
GOMF CARBOHYDRATE BINDING | 156 | 3.53e-01 | 4.31e-02 | 7.89e-01 |
GOMF S ADENOSYL L METHIONINE BINDING | 16 | 7.65e-01 | -4.31e-02 | 9.45e-01 |
GOBP GLAND DEVELOPMENT | 231 | 2.60e-01 | -4.31e-02 | 7.24e-01 |
GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 31 | 6.78e-01 | 4.31e-02 | 9.24e-01 |
GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 90 | 4.81e-01 | 4.30e-02 | 8.50e-01 |
GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 8 | 8.33e-01 | 4.30e-02 | 9.60e-01 |
GOBP RADIAL GLIAL CELL DIFFERENTIATION | 8 | 8.33e-01 | -4.30e-02 | 9.60e-01 |
GOBP METENCEPHALON DEVELOPMENT | 66 | 5.47e-01 | 4.29e-02 | 8.75e-01 |
GOBP VASODILATION | 23 | 7.22e-01 | 4.29e-02 | 9.36e-01 |
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 13 | 7.89e-01 | 4.29e-02 | 9.54e-01 |
GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 9 | 8.24e-01 | 4.29e-02 | 9.58e-01 |
GOMF DISORDERED DOMAIN SPECIFIC BINDING | 22 | 7.28e-01 | -4.28e-02 | 9.37e-01 |
GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 7.28e-01 | 4.28e-02 | 9.37e-01 |
GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 8 | 8.34e-01 | -4.28e-02 | 9.61e-01 |
GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 240 | 2.55e-01 | -4.28e-02 | 7.23e-01 |
GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 6.57e-01 | -4.28e-02 | 9.16e-01 |
GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 8.56e-01 | 4.28e-02 | 9.68e-01 |
GOBP CRD MEDIATED MRNA STABILIZATION | 10 | 8.15e-01 | -4.27e-02 | 9.58e-01 |
GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 8 | 8.34e-01 | -4.27e-02 | 9.61e-01 |
GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 39 | 6.45e-01 | -4.27e-02 | 9.10e-01 |
GOBP NEURON PROJECTION REGENERATION | 33 | 6.71e-01 | 4.27e-02 | 9.23e-01 |
GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 15 | 7.75e-01 | 4.27e-02 | 9.48e-01 |
GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 108 | 4.45e-01 | 4.26e-02 | 8.33e-01 |
GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 7.18e-01 | -4.26e-02 | 9.33e-01 |
GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 6 | 8.57e-01 | -4.26e-02 | 9.68e-01 |
GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 58 | 5.75e-01 | -4.26e-02 | 8.87e-01 |
GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 16 | 7.68e-01 | 4.25e-02 | 9.45e-01 |
GOCC FILOPODIUM | 72 | 5.33e-01 | -4.25e-02 | 8.73e-01 |
GOCC TRAPP COMPLEX | 15 | 7.76e-01 | -4.25e-02 | 9.48e-01 |
GOBP REGULATION OF CILIUM BEAT FREQUENCY | 9 | 8.25e-01 | 4.25e-02 | 9.58e-01 |
GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 16 | 7.69e-01 | -4.23e-02 | 9.46e-01 |
GOMF SNAP RECEPTOR ACTIVITY | 34 | 6.70e-01 | -4.23e-02 | 9.23e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 25 | 7.14e-01 | 4.23e-02 | 9.32e-01 |
GOMF C C CHEMOKINE BINDING | 12 | 8.00e-01 | -4.23e-02 | 9.55e-01 |
GOBP ENDOTHELIAL CELL MORPHOGENESIS | 5 | 8.70e-01 | -4.23e-02 | 9.72e-01 |
GOMF RNA POLYMERASE I ACTIVITY | 9 | 8.27e-01 | -4.22e-02 | 9.58e-01 |
GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY | 5 | 8.70e-01 | -4.22e-02 | 9.72e-01 |
GOBP NEURON MIGRATION | 94 | 4.81e-01 | 4.21e-02 | 8.50e-01 |
GOBP MONOSACCHARIDE CATABOLIC PROCESS | 37 | 6.58e-01 | -4.21e-02 | 9.17e-01 |
GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 11 | 8.09e-01 | -4.20e-02 | 9.57e-01 |
GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 6 | 8.59e-01 | 4.20e-02 | 9.68e-01 |
GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 38 | 6.54e-01 | 4.20e-02 | 9.15e-01 |
GOBP REGULATION OF PHAGOCYTOSIS | 73 | 5.36e-01 | -4.19e-02 | 8.73e-01 |
GOBP KERATINOCYTE PROLIFERATION | 26 | 7.12e-01 | 4.19e-02 | 9.31e-01 |
GOBP LEUKOCYTE DEGRANULATION | 66 | 5.57e-01 | -4.19e-02 | 8.78e-01 |
GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 11 | 8.10e-01 | 4.19e-02 | 9.57e-01 |
GOBP STEROID METABOLIC PROCESS | 165 | 3.55e-01 | -4.18e-02 | 7.90e-01 |
GOMF OXIDOREDUCTASE ACTIVITY | 492 | 1.15e-01 | -4.18e-02 | 5.78e-01 |
GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 13 | 7.94e-01 | 4.18e-02 | 9.54e-01 |
GOBP SYNAPTIC MEMBRANE ADHESION | 9 | 8.28e-01 | -4.18e-02 | 9.59e-01 |
GOBP ALDEHYDE CATABOLIC PROCESS | 10 | 8.19e-01 | 4.17e-02 | 9.58e-01 |
GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 23 | 7.29e-01 | 4.17e-02 | 9.37e-01 |
GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 12 | 8.03e-01 | -4.17e-02 | 9.55e-01 |
GOBP FATTY ACYL COA METABOLIC PROCESS | 28 | 7.03e-01 | -4.16e-02 | 9.29e-01 |
GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 31 | 6.89e-01 | -4.16e-02 | 9.25e-01 |
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 8.72e-01 | -4.16e-02 | 9.73e-01 |
GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 28 | 7.03e-01 | 4.16e-02 | 9.30e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 31 | 6.89e-01 | 4.15e-02 | 9.25e-01 |
GOBP GLUTAMATE METABOLIC PROCESS | 18 | 7.61e-01 | -4.15e-02 | 9.45e-01 |
GOBP MEGAKARYOCYTE DEVELOPMENT | 15 | 7.81e-01 | -4.15e-02 | 9.51e-01 |
GOBP SERTOLI CELL DIFFERENTIATION | 11 | 8.12e-01 | -4.14e-02 | 9.57e-01 |
GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 7.55e-01 | -4.14e-02 | 9.43e-01 |
GOBP REGULATION OF B CELL ACTIVATION | 108 | 4.58e-01 | -4.14e-02 | 8.40e-01 |
GOBP REGULATION OF CELLULAR LOCALIZATION | 692 | 6.66e-02 | -4.13e-02 | 4.59e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 17 | 7.68e-01 | 4.13e-02 | 9.45e-01 |
GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 36 | 6.68e-01 | 4.13e-02 | 9.23e-01 |
GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 16 | 7.75e-01 | 4.13e-02 | 9.48e-01 |
GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 6 | 8.61e-01 | 4.12e-02 | 9.69e-01 |
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 10 | 8.21e-01 | -4.12e-02 | 9.58e-01 |
GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 7 | 8.50e-01 | 4.12e-02 | 9.68e-01 |
GOBP BONE MINERALIZATION | 67 | 5.61e-01 | -4.11e-02 | 8.80e-01 |
GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 15 | 7.83e-01 | -4.11e-02 | 9.51e-01 |
GOBP POSITIVE REGULATION OF MYELINATION | 10 | 8.22e-01 | -4.11e-02 | 9.58e-01 |
GOBP MONOCYTE DIFFERENTIATION | 27 | 7.11e-01 | -4.11e-02 | 9.31e-01 |
GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 17 | 7.69e-01 | 4.11e-02 | 9.46e-01 |
GOMF MICROTUBULE BINDING | 195 | 3.24e-01 | 4.11e-02 | 7.69e-01 |
GOMF CGMP BINDING | 8 | 8.41e-01 | -4.10e-02 | 9.64e-01 |
GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 20 | 7.52e-01 | 4.09e-02 | 9.42e-01 |
GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 10 | 8.23e-01 | 4.09e-02 | 9.58e-01 |
GOBP TERPENOID METABOLIC PROCESS | 41 | 6.51e-01 | -4.09e-02 | 9.14e-01 |
GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 30 | 6.98e-01 | -4.09e-02 | 9.29e-01 |
GOCC PERINUCLEAR REGION OF CYTOPLASM | 516 | 1.15e-01 | -4.09e-02 | 5.78e-01 |
GOBP ENDOCYTOSIS | 508 | 1.17e-01 | -4.09e-02 | 5.80e-01 |
GOBP T CELL TOLERANCE INDUCTION | 12 | 8.06e-01 | -4.09e-02 | 9.56e-01 |
GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 20 | 7.52e-01 | -4.08e-02 | 9.42e-01 |
GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 77 | 5.36e-01 | 4.08e-02 | 8.73e-01 |
GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 16 | 7.77e-01 | 4.08e-02 | 9.49e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 658 | 7.69e-02 | -4.08e-02 | 4.95e-01 |
GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 12 | 8.07e-01 | 4.08e-02 | 9.56e-01 |
GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 17 | 7.71e-01 | -4.08e-02 | 9.46e-01 |
GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 35 | 6.77e-01 | -4.07e-02 | 9.24e-01 |
GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 93 | 4.98e-01 | -4.07e-02 | 8.59e-01 |
GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 137 | 4.12e-01 | 4.07e-02 | 8.21e-01 |
GOBP CELLULAR COMPONENT DISASSEMBLY | 384 | 1.74e-01 | -4.07e-02 | 6.56e-01 |
GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 140 | 4.07e-01 | -4.07e-02 | 8.17e-01 |
GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 74 | 5.46e-01 | -4.06e-02 | 8.75e-01 |
GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 8.52e-01 | -4.06e-02 | 9.68e-01 |
GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 24 | 7.31e-01 | -4.06e-02 | 9.38e-01 |
GOBP INTESTINAL LIPID ABSORPTION | 7 | 8.53e-01 | -4.06e-02 | 9.68e-01 |
GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 344 | 1.98e-01 | -4.05e-02 | 6.79e-01 |
GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 8 | 8.43e-01 | -4.05e-02 | 9.64e-01 |
GOBP DNA MODIFICATION | 82 | 5.27e-01 | 4.05e-02 | 8.69e-01 |
GOBP CELLULAR RESPONSE TO STRESS | 1525 | 9.83e-03 | 4.05e-02 | 2.08e-01 |
GOBP DETOXIFICATION OF INORGANIC COMPOUND | 11 | 8.16e-01 | 4.04e-02 | 9.58e-01 |
GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 737 | 6.44e-02 | -4.04e-02 | 4.53e-01 |
GOMF U1 SNRNA BINDING | 8 | 8.43e-01 | -4.04e-02 | 9.64e-01 |
GOBP REGULATION OF TRANSLATION AT SYNAPSE | 5 | 8.76e-01 | -4.04e-02 | 9.75e-01 |
GOBP SYNCYTIUM FORMATION | 36 | 6.75e-01 | 4.04e-02 | 9.24e-01 |
GOBP REGULATION OF GASTRULATION | 8 | 8.43e-01 | -4.04e-02 | 9.64e-01 |
GOBP PROTEIN DEPHOSPHORYLATION | 164 | 3.74e-01 | -4.03e-02 | 7.99e-01 |
GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 275 | 2.52e-01 | -4.03e-02 | 7.20e-01 |
GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1100 | 2.64e-02 | -4.03e-02 | 3.32e-01 |
GOBP REGULATION OF ERAD PATHWAY | 19 | 7.61e-01 | 4.03e-02 | 9.45e-01 |
GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 13 | 8.02e-01 | 4.01e-02 | 9.55e-01 |
GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 46 | 6.38e-01 | 4.01e-02 | 9.09e-01 |
GOMF SMAD BINDING | 58 | 5.98e-01 | -4.01e-02 | 8.96e-01 |
GOBP INTRACELLULAR PROTEIN TRANSPORT | 731 | 6.79e-02 | -4.01e-02 | 4.65e-01 |
GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 5 | 8.77e-01 | 4.01e-02 | 9.75e-01 |
GOBP DOSAGE COMPENSATION | 28 | 7.14e-01 | -4.00e-02 | 9.32e-01 |
GOCC T TUBULE | 25 | 7.30e-01 | -3.99e-02 | 9.38e-01 |
GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 28 | 7.15e-01 | -3.99e-02 | 9.32e-01 |
GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 14 | 7.96e-01 | 3.98e-02 | 9.54e-01 |
GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 14 | 7.96e-01 | -3.98e-02 | 9.54e-01 |
GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 28 | 7.15e-01 | -3.98e-02 | 9.32e-01 |
GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 57 | 6.03e-01 | -3.98e-02 | 8.99e-01 |
GOBP HEART FORMATION | 13 | 8.04e-01 | -3.98e-02 | 9.55e-01 |
GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 19 | 7.64e-01 | 3.98e-02 | 9.45e-01 |
GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 119 | 4.54e-01 | -3.98e-02 | 8.37e-01 |
GOBP PEPTIDE TRANSPORT | 142 | 4.14e-01 | -3.98e-02 | 8.21e-01 |
GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 7 | 8.56e-01 | -3.97e-02 | 9.68e-01 |
GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 62 | 5.89e-01 | -3.97e-02 | 8.92e-01 |
GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 91 | 5.14e-01 | 3.96e-02 | 8.66e-01 |
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 14 | 7.98e-01 | 3.96e-02 | 9.54e-01 |
GOCC BLOOD MICROPARTICLE | 52 | 6.22e-01 | -3.96e-02 | 9.03e-01 |
GOBP ORGANIC ANION TRANSPORT | 229 | 3.04e-01 | -3.96e-02 | 7.54e-01 |
GOMF ZINC ION BINDING | 564 | 1.11e-01 | 3.95e-02 | 5.72e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 75 | 5.55e-01 | -3.95e-02 | 8.77e-01 |
GOMF CARBOXY LYASE ACTIVITY | 24 | 7.38e-01 | 3.95e-02 | 9.40e-01 |
GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 8.67e-01 | -3.94e-02 | 9.71e-01 |
GOMF THIOLESTER HYDROLASE ACTIVITY | 29 | 7.14e-01 | 3.94e-02 | 9.32e-01 |
GOMF G PROTEIN BETA SUBUNIT BINDING | 11 | 8.21e-01 | -3.93e-02 | 9.58e-01 |
GOMF PDZ DOMAIN BINDING | 51 | 6.27e-01 | 3.93e-02 | 9.05e-01 |
GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 17 | 7.79e-01 | -3.93e-02 | 9.50e-01 |
GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 73 | 5.62e-01 | 3.93e-02 | 8.80e-01 |
GOCC CORE MEDIATOR COMPLEX | 26 | 7.29e-01 | 3.93e-02 | 9.37e-01 |
GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.79e-01 | 3.93e-02 | 9.75e-01 |
GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 11 | 8.22e-01 | -3.93e-02 | 9.58e-01 |
GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 52 | 6.25e-01 | 3.93e-02 | 9.04e-01 |
GOCC CLATHRIN VESICLE COAT | 29 | 7.15e-01 | 3.93e-02 | 9.32e-01 |
GOBP PHAGOCYTOSIS RECOGNITION | 11 | 8.22e-01 | -3.92e-02 | 9.58e-01 |
GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 75 | 5.58e-01 | 3.92e-02 | 8.79e-01 |
GOBP POSITIVE REGULATION OF CELL DIVISION | 48 | 6.39e-01 | -3.92e-02 | 9.09e-01 |
GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT | 5 | 8.79e-01 | -3.92e-02 | 9.75e-01 |
GOCC PRONUCLEUS | 11 | 8.22e-01 | 3.91e-02 | 9.58e-01 |
GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 8.58e-01 | 3.91e-02 | 9.68e-01 |
GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 16 | 7.87e-01 | -3.91e-02 | 9.53e-01 |
GOCC PLASMA MEMBRANE REGION | 672 | 8.71e-02 | -3.91e-02 | 5.19e-01 |
GOCC CAVEOLA | 49 | 6.37e-01 | 3.90e-02 | 9.08e-01 |
GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 76 | 5.57e-01 | 3.90e-02 | 8.78e-01 |
GOBP RESPONSE TO UV C | 12 | 8.15e-01 | -3.90e-02 | 9.58e-01 |
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 68 | 5.79e-01 | 3.90e-02 | 8.88e-01 |
GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 97 | 5.08e-01 | -3.90e-02 | 8.62e-01 |
GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 21 | 7.57e-01 | -3.90e-02 | 9.44e-01 |
GOBP BLOOD VESSEL MATURATION | 6 | 8.69e-01 | 3.90e-02 | 9.71e-01 |
GOBP REGULATION OF PROTEIN ACETYLATION | 32 | 7.03e-01 | 3.90e-02 | 9.29e-01 |
GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 20 | 7.63e-01 | 3.89e-02 | 9.45e-01 |
GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 441 | 1.64e-01 | -3.89e-02 | 6.47e-01 |
GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 6 | 8.69e-01 | -3.89e-02 | 9.71e-01 |
GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 8.01e-01 | -3.88e-02 | 9.55e-01 |
GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 7 | 8.59e-01 | -3.88e-02 | 9.68e-01 |
GOBP PEPTIDYL TYROSINE MODIFICATION | 177 | 3.74e-01 | -3.88e-02 | 7.99e-01 |
GOBP RETINAL ROD CELL DIFFERENTIATION | 7 | 8.59e-01 | 3.88e-02 | 9.68e-01 |
GOCC CILIARY PLASM | 70 | 5.75e-01 | 3.88e-02 | 8.86e-01 |
GOBP MONOATOMIC ION HOMEOSTASIS | 359 | 2.09e-01 | -3.88e-02 | 6.87e-01 |
GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 7 | 8.59e-01 | 3.88e-02 | 9.68e-01 |
GOBP CELLULAR RESPONSE TO COPPER ION | 13 | 8.09e-01 | 3.88e-02 | 9.57e-01 |
GOBP 2FE 2S CLUSTER ASSEMBLY | 11 | 8.24e-01 | 3.88e-02 | 9.58e-01 |
GOBP C21 STEROID HORMONE METABOLIC PROCESS | 14 | 8.02e-01 | 3.88e-02 | 9.55e-01 |
GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 121 | 4.63e-01 | -3.87e-02 | 8.42e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 53 | 6.26e-01 | -3.87e-02 | 9.05e-01 |
GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 19 | 7.70e-01 | 3.87e-02 | 9.46e-01 |
GOCC ENDOCYTIC VESICLE MEMBRANE | 145 | 4.22e-01 | -3.87e-02 | 8.23e-01 |
GOBP HORMONE MEDIATED SIGNALING PATHWAY | 128 | 4.51e-01 | -3.87e-02 | 8.35e-01 |
GOBP AMINE METABOLIC PROCESS | 63 | 5.96e-01 | 3.86e-02 | 8.96e-01 |
GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 23 | 7.48e-01 | -3.86e-02 | 9.42e-01 |
GOMF MYOSIN PHOSPHATASE ACTIVITY | 60 | 6.06e-01 | -3.85e-02 | 8.99e-01 |
GOCC SAGA COMPLEX | 23 | 7.49e-01 | 3.85e-02 | 9.42e-01 |
GOBP RESPONSE TO ENDOGENOUS STIMULUS | 1015 | 4.08e-02 | -3.85e-02 | 3.83e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 522 | 1.35e-01 | 3.85e-02 | 6.06e-01 |
GOBP OLIGODENDROCYTE DIFFERENTIATION | 53 | 6.29e-01 | -3.84e-02 | 9.05e-01 |
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 14 | 8.04e-01 | -3.84e-02 | 9.55e-01 |
GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 9 | 8.42e-01 | -3.84e-02 | 9.64e-01 |
GOBP EMBRYONIC ORGAN DEVELOPMENT | 213 | 3.36e-01 | -3.84e-02 | 7.79e-01 |
GOBP LIPOPROTEIN METABOLIC PROCESS | 99 | 5.10e-01 | 3.84e-02 | 8.64e-01 |
GOBP RESPONSE TO STEROL | 21 | 7.61e-01 | 3.84e-02 | 9.45e-01 |
GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 12 | 8.18e-01 | -3.84e-02 | 9.58e-01 |
GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 17 | 7.84e-01 | -3.83e-02 | 9.52e-01 |
GOBP CHEMICAL HOMEOSTASIS | 587 | 1.16e-01 | -3.83e-02 | 5.78e-01 |
GOMF ALCOHOL BINDING | 51 | 6.36e-01 | -3.83e-02 | 9.08e-01 |
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 491 | 1.49e-01 | -3.83e-02 | 6.26e-01 |
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 6 | 8.71e-01 | 3.83e-02 | 9.73e-01 |
GOBP CEREBELLAR CORTEX DEVELOPMENT | 31 | 7.12e-01 | 3.83e-02 | 9.32e-01 |
GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 277 | 2.75e-01 | -3.83e-02 | 7.32e-01 |
GOBP IMPORT INTO CELL | 601 | 1.12e-01 | -3.83e-02 | 5.73e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 39 | 6.79e-01 | -3.83e-02 | 9.24e-01 |
GOBP ANTIMICROBIAL HUMORAL RESPONSE | 40 | 6.76e-01 | -3.82e-02 | 9.24e-01 |
GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1343 | 2.12e-02 | -3.82e-02 | 3.01e-01 |
GOBP RECEPTOR CLUSTERING | 35 | 6.96e-01 | 3.82e-02 | 9.29e-01 |
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 20 | 7.68e-01 | -3.81e-02 | 9.45e-01 |
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 8.52e-01 | 3.81e-02 | 9.68e-01 |
GOBP BONE CELL DEVELOPMENT | 14 | 8.05e-01 | 3.81e-02 | 9.55e-01 |
GOBP SENSORY ORGAN DEVELOPMENT | 254 | 2.98e-01 | -3.81e-02 | 7.49e-01 |
GOBP CELL CELL JUNCTION MAINTENANCE | 9 | 8.43e-01 | -3.81e-02 | 9.64e-01 |
GOBP CELL CYCLE PHASE TRANSITION | 428 | 1.79e-01 | 3.81e-02 | 6.62e-01 |
GOBP NEURAL TUBE PATTERNING | 23 | 7.52e-01 | 3.81e-02 | 9.42e-01 |
GOCC GOLGI MEMBRANE | 499 | 1.48e-01 | -3.80e-02 | 6.24e-01 |
GOCC RNA CAP BINDING COMPLEX | 19 | 7.74e-01 | -3.80e-02 | 9.47e-01 |
GOBP AMIDE TRANSPORT | 195 | 3.61e-01 | -3.80e-02 | 7.92e-01 |
GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 252 | 3.01e-01 | 3.80e-02 | 7.52e-01 |
GOBP RESPONSE TO STARVATION | 165 | 4.01e-01 | 3.80e-02 | 8.15e-01 |
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 42 | 6.71e-01 | 3.80e-02 | 9.23e-01 |
GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 8.53e-01 | 3.79e-02 | 9.68e-01 |
GOBP DEMETHYLATION | 38 | 6.86e-01 | 3.79e-02 | 9.25e-01 |
GOBP VACUOLAR TRANSPORT | 142 | 4.36e-01 | -3.79e-02 | 8.28e-01 |
GOMF CAMP BINDING | 13 | 8.13e-01 | 3.79e-02 | 9.57e-01 |
GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 25 | 7.43e-01 | -3.78e-02 | 9.41e-01 |
GOMF ARRESTIN FAMILY PROTEIN BINDING | 5 | 8.84e-01 | 3.78e-02 | 9.76e-01 |
GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 45 | 6.61e-01 | 3.78e-02 | 9.18e-01 |
GOBP PHOSPHOLIPID TRANSLOCATION | 34 | 7.03e-01 | 3.78e-02 | 9.29e-01 |
GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 14 | 8.07e-01 | -3.78e-02 | 9.56e-01 |
GOBP CELLULAR RESPONSE TO HEAT | 54 | 6.31e-01 | 3.78e-02 | 9.06e-01 |
GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 135 | 4.50e-01 | -3.77e-02 | 8.34e-01 |
GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 5 | 8.84e-01 | -3.76e-02 | 9.76e-01 |
GOMF N ACETYLTRANSFERASE ACTIVITY | 56 | 6.27e-01 | -3.76e-02 | 9.05e-01 |
GOBP HETEROCHROMATIN ORGANIZATION | 80 | 5.61e-01 | 3.76e-02 | 8.80e-01 |
GOBP RESPONSE TO AMINO ACID STARVATION | 51 | 6.42e-01 | 3.76e-02 | 9.10e-01 |
GOMF STEROID HYDROXYLASE ACTIVITY | 5 | 8.84e-01 | -3.76e-02 | 9.76e-01 |
GOCC GERM CELL NUCLEUS | 45 | 6.63e-01 | 3.76e-02 | 9.20e-01 |
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 7 | 8.63e-01 | -3.76e-02 | 9.69e-01 |
GOBP PROTEIN DESTABILIZATION | 43 | 6.71e-01 | -3.75e-02 | 9.23e-01 |
GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 143 | 4.40e-01 | -3.75e-02 | 8.29e-01 |
GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 26 | 7.41e-01 | -3.74e-02 | 9.40e-01 |
GOBP RESPONSE TO HEAT | 76 | 5.73e-01 | 3.74e-02 | 8.86e-01 |
GOBP OVARIAN FOLLICLE DEVELOPMENT | 29 | 7.27e-01 | 3.74e-02 | 9.37e-01 |
GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 62 | 6.11e-01 | -3.74e-02 | 9.01e-01 |
GOMF TELOMERASE RNA BINDING | 21 | 7.67e-01 | 3.74e-02 | 9.45e-01 |
GOMF CHANNEL INHIBITOR ACTIVITY | 23 | 7.57e-01 | -3.74e-02 | 9.44e-01 |
GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 29 | 7.28e-01 | 3.73e-02 | 9.37e-01 |
GOBP MUSCLE CELL DEVELOPMENT | 96 | 5.28e-01 | 3.73e-02 | 8.69e-01 |
GOBP HINDBRAIN DEVELOPMENT | 87 | 5.48e-01 | 3.73e-02 | 8.75e-01 |
GOBP VIRAL BUDDING | 23 | 7.57e-01 | -3.73e-02 | 9.44e-01 |
GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 21 | 7.67e-01 | 3.73e-02 | 9.45e-01 |
GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 9 | 8.46e-01 | -3.73e-02 | 9.66e-01 |
GOBP REGULATION OF JUN KINASE ACTIVITY | 32 | 7.15e-01 | 3.73e-02 | 9.32e-01 |
GOBP CELLULAR LIPID CATABOLIC PROCESS | 159 | 4.19e-01 | 3.72e-02 | 8.22e-01 |
GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 119 | 4.84e-01 | -3.72e-02 | 8.52e-01 |
GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 5 | 8.86e-01 | 3.72e-02 | 9.76e-01 |
GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 28 | 7.34e-01 | -3.72e-02 | 9.39e-01 |
GOBP REGULATION OF T CELL MIGRATION | 37 | 6.97e-01 | -3.71e-02 | 9.29e-01 |
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 42 | 6.78e-01 | 3.71e-02 | 9.24e-01 |
GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 16 | 7.98e-01 | -3.70e-02 | 9.54e-01 |
GOBP CARTILAGE DEVELOPMENT | 89 | 5.47e-01 | -3.70e-02 | 8.75e-01 |
GOBP RECEPTOR RECYCLING | 37 | 6.97e-01 | -3.70e-02 | 9.29e-01 |
GOBP THIAMINE TRANSPORT | 5 | 8.86e-01 | -3.70e-02 | 9.76e-01 |
GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 13 | 8.17e-01 | -3.70e-02 | 9.58e-01 |
GOBP T CELL CHEMOTAXIS | 19 | 7.80e-01 | -3.70e-02 | 9.51e-01 |
GOBP PRO B CELL DIFFERENTIATION | 11 | 8.32e-01 | -3.70e-02 | 9.60e-01 |
GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 26 | 7.44e-01 | -3.70e-02 | 9.41e-01 |
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 63 | 6.12e-01 | 3.70e-02 | 9.01e-01 |
GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 450 | 1.82e-01 | -3.69e-02 | 6.65e-01 |
GOCC 9PLUS0 NON MOTILE CILIUM | 68 | 5.99e-01 | 3.69e-02 | 8.97e-01 |
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 9 | 8.48e-01 | -3.69e-02 | 9.67e-01 |
GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 13 | 8.18e-01 | 3.69e-02 | 9.58e-01 |
GOBP NUCLEUS LOCALIZATION | 29 | 7.32e-01 | 3.68e-02 | 9.39e-01 |
GOBP LIPID OXIDATION | 85 | 5.58e-01 | 3.68e-02 | 8.79e-01 |
GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 42 | 6.80e-01 | -3.68e-02 | 9.24e-01 |
GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 53 | 6.43e-01 | 3.68e-02 | 9.10e-01 |
GOBP REGULATION OF CHROMOSOME CONDENSATION | 10 | 8.40e-01 | 3.68e-02 | 9.64e-01 |
GOMF PHOSPHATASE BINDING | 155 | 4.30e-01 | -3.68e-02 | 8.25e-01 |
GOBP REGULATION OF CELL FATE SPECIFICATION | 14 | 8.12e-01 | 3.68e-02 | 9.57e-01 |
GOBP GAMETE GENERATION | 398 | 2.11e-01 | 3.67e-02 | 6.87e-01 |
GOMF MAP KINASE KINASE ACTIVITY | 14 | 8.12e-01 | 3.67e-02 | 9.57e-01 |
GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 127 | 4.76e-01 | 3.67e-02 | 8.47e-01 |
GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 7.88e-01 | -3.67e-02 | 9.53e-01 |
GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 8.76e-01 | 3.67e-02 | 9.75e-01 |
GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 8.41e-01 | 3.66e-02 | 9.64e-01 |
GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 75 | 5.84e-01 | -3.66e-02 | 8.89e-01 |
GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 7 | 8.67e-01 | 3.65e-02 | 9.71e-01 |
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 9 | 8.50e-01 | 3.65e-02 | 9.68e-01 |
GOBP CYTOCHROME COMPLEX ASSEMBLY | 37 | 7.01e-01 | -3.65e-02 | 9.29e-01 |
GOMF GTP DEPENDENT PROTEIN BINDING | 19 | 7.83e-01 | 3.65e-02 | 9.51e-01 |
GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 76 | 5.83e-01 | -3.65e-02 | 8.89e-01 |
GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 18 | 7.89e-01 | 3.64e-02 | 9.54e-01 |
GOBP ALPHA BETA T CELL PROLIFERATION | 42 | 6.84e-01 | -3.64e-02 | 9.25e-01 |
GOBP REGULATION OF LIPASE ACTIVITY | 42 | 6.84e-01 | -3.63e-02 | 9.25e-01 |
GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 16 | 8.01e-01 | -3.63e-02 | 9.55e-01 |
GOCC SPINDLE | 346 | 2.48e-01 | 3.63e-02 | 7.17e-01 |
GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 73 | 5.92e-01 | 3.63e-02 | 8.93e-01 |
GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 11 | 8.35e-01 | 3.63e-02 | 9.61e-01 |
GOBP REGULATION OF PROTEIN DEACETYLATION | 28 | 7.40e-01 | -3.63e-02 | 9.40e-01 |
GOMF SYMPORTER ACTIVITY | 65 | 6.13e-01 | 3.63e-02 | 9.01e-01 |
GOBP VASOCONSTRICTION | 32 | 7.23e-01 | -3.63e-02 | 9.36e-01 |
GOMF SH3 DOMAIN BINDING | 88 | 5.57e-01 | 3.63e-02 | 8.79e-01 |
GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 8 | 8.59e-01 | 3.63e-02 | 9.68e-01 |
GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 5 | 8.88e-01 | -3.63e-02 | 9.77e-01 |
GOBP RETINAL ROD CELL DEVELOPMENT | 5 | 8.88e-01 | -3.63e-02 | 9.77e-01 |
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 13 | 8.21e-01 | 3.62e-02 | 9.58e-01 |
GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 34 | 7.15e-01 | 3.62e-02 | 9.32e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 8 | 8.59e-01 | 3.62e-02 | 9.68e-01 |
GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 19 | 7.85e-01 | 3.62e-02 | 9.52e-01 |
GOCC RNA POLYMERASE I COMPLEX | 10 | 8.43e-01 | -3.62e-02 | 9.64e-01 |
GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 8.43e-01 | 3.62e-02 | 9.64e-01 |
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 176 | 4.09e-01 | -3.62e-02 | 8.17e-01 |
GOCC CENTROSOME | 525 | 1.59e-01 | 3.62e-02 | 6.41e-01 |
GOMF TUMOR NECROSIS FACTOR BINDING | 6 | 8.78e-01 | 3.61e-02 | 9.75e-01 |
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 11 | 8.36e-01 | -3.61e-02 | 9.61e-01 |
GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 12 | 8.29e-01 | -3.61e-02 | 9.59e-01 |
GOBP IMMUNOLOGICAL MEMORY PROCESS | 14 | 8.15e-01 | -3.61e-02 | 9.58e-01 |
GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 41 | 6.90e-01 | -3.60e-02 | 9.25e-01 |
GOCC CILIUM | 400 | 2.19e-01 | 3.60e-02 | 6.96e-01 |
GOMF PEPTIDASE ACTIVITY | 330 | 2.63e-01 | -3.60e-02 | 7.24e-01 |
GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 27 | 7.46e-01 | 3.60e-02 | 9.42e-01 |
GOMF ALPHA TUBULIN BINDING | 32 | 7.25e-01 | -3.60e-02 | 9.37e-01 |
GOBP RESPONSE TO NITROSATIVE STRESS | 9 | 8.52e-01 | 3.60e-02 | 9.68e-01 |
GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 797 | 8.79e-02 | -3.60e-02 | 5.20e-01 |
GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 6 | 8.79e-01 | -3.59e-02 | 9.75e-01 |
GOBP CARBOHYDRATE CATABOLIC PROCESS | 121 | 4.96e-01 | -3.59e-02 | 8.57e-01 |
GOCC TRANSFERASE COMPLEX | 736 | 1.02e-01 | 3.58e-02 | 5.50e-01 |
GOCC RUFFLE MEMBRANE | 79 | 5.83e-01 | -3.57e-02 | 8.89e-01 |
GOBP INTRACELLULAR TRANSPORT | 1310 | 3.31e-02 | -3.57e-02 | 3.60e-01 |
GOBP NUCLEAR ENVELOPE ORGANIZATION | 50 | 6.62e-01 | -3.57e-02 | 9.19e-01 |
GOBP REGULATION OF REPRODUCTIVE PROCESS | 94 | 5.50e-01 | -3.57e-02 | 8.76e-01 |
GOBP MITOTIC NUCLEAR DIVISION | 211 | 3.73e-01 | 3.57e-02 | 7.99e-01 |
GOMF GALACTOSYLTRANSFERASE ACTIVITY | 19 | 7.88e-01 | 3.56e-02 | 9.53e-01 |
GOMF TORC2 COMPLEX BINDING | 5 | 8.90e-01 | -3.56e-02 | 9.77e-01 |
GOBP RESPIRATORY BURST | 30 | 7.36e-01 | -3.56e-02 | 9.39e-01 |
GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 6 | 8.80e-01 | -3.56e-02 | 9.76e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 36 | 7.13e-01 | -3.55e-02 | 9.32e-01 |
GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 108 | 5.25e-01 | -3.55e-02 | 8.69e-01 |
GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 8 | 8.62e-01 | -3.55e-02 | 9.69e-01 |
GOBP NCRNA TRANSCRIPTION | 102 | 5.37e-01 | 3.54e-02 | 8.73e-01 |
GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 27 | 7.50e-01 | -3.54e-02 | 9.42e-01 |
GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 17 | 8.00e-01 | -3.54e-02 | 9.55e-01 |
GOCC CELL CELL JUNCTION | 283 | 3.07e-01 | -3.54e-02 | 7.57e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 54 | 6.53e-01 | -3.54e-02 | 9.15e-01 |
GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 13 | 8.26e-01 | -3.53e-02 | 9.58e-01 |
GOBP REGULATION OF INTRACELLULAR TRANSPORT | 266 | 3.25e-01 | -3.52e-02 | 7.69e-01 |
GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 13 | 8.26e-01 | 3.52e-02 | 9.58e-01 |
GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 140 | 4.74e-01 | 3.51e-02 | 8.47e-01 |
GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 9 | 8.55e-01 | 3.51e-02 | 9.68e-01 |
GOMF SEQUENCE SPECIFIC MRNA BINDING | 7 | 8.72e-01 | -3.51e-02 | 9.73e-01 |
GOBP RESPONSE TO VITAMIN E | 5 | 8.92e-01 | 3.51e-02 | 9.78e-01 |
GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1237 | 4.15e-02 | -3.51e-02 | 3.86e-01 |
GOBP BONE MATURATION | 13 | 8.27e-01 | -3.51e-02 | 9.58e-01 |
GOBP MAINTENANCE OF LENS TRANSPARENCY | 6 | 8.82e-01 | 3.51e-02 | 9.76e-01 |
GOBP TETRAPYRROLE METABOLIC PROCESS | 44 | 6.88e-01 | 3.50e-02 | 9.25e-01 |
GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 52 | 6.62e-01 | -3.50e-02 | 9.19e-01 |
GOBP REGULATION OF HEMOPOIESIS | 308 | 2.93e-01 | 3.50e-02 | 7.48e-01 |
GOCC RIBBON SYNAPSE | 9 | 8.56e-01 | 3.50e-02 | 9.68e-01 |
GOMF LIPASE ACTIVATOR ACTIVITY | 14 | 8.21e-01 | 3.49e-02 | 9.58e-01 |
GOBP BIOGENIC AMINE METABOLIC PROCESS | 55 | 6.55e-01 | 3.48e-02 | 9.15e-01 |
GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 11 | 8.41e-01 | -3.48e-02 | 9.64e-01 |
GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 60 | 6.42e-01 | -3.47e-02 | 9.10e-01 |
GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 54 | 6.59e-01 | 3.47e-02 | 9.17e-01 |
GOMF SERINE HYDROLASE ACTIVITY | 73 | 6.09e-01 | -3.47e-02 | 9.00e-01 |
GOCC NUCLEAR SPECK | 364 | 2.58e-01 | -3.47e-02 | 7.24e-01 |
GOBP REGULATION OF SPINDLE ASSEMBLY | 28 | 7.51e-01 | 3.47e-02 | 9.42e-01 |
GOBP NUCLEAR EXPORT | 153 | 4.60e-01 | 3.47e-02 | 8.40e-01 |
GOBP NADPH REGENERATION | 19 | 7.94e-01 | 3.47e-02 | 9.54e-01 |
GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 25 | 7.64e-01 | -3.47e-02 | 9.45e-01 |
GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 248 | 3.49e-01 | 3.47e-02 | 7.86e-01 |
GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 66 | 6.27e-01 | -3.46e-02 | 9.05e-01 |
GOCC CLEAVAGE FURROW | 44 | 6.92e-01 | -3.45e-02 | 9.26e-01 |
GOCC POTASSIUM CHANNEL COMPLEX | 29 | 7.48e-01 | -3.45e-02 | 9.42e-01 |
GOBP RESPONSE TO GROWTH FACTOR | 414 | 2.31e-01 | -3.45e-02 | 7.05e-01 |
GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 17 | 8.06e-01 | -3.45e-02 | 9.56e-01 |
GOMF BETA CATENIN BINDING | 58 | 6.50e-01 | 3.45e-02 | 9.14e-01 |
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 48 | 6.80e-01 | -3.44e-02 | 9.24e-01 |
GOBP ALCOHOL CATABOLIC PROCESS | 19 | 7.95e-01 | 3.44e-02 | 9.54e-01 |
GOBP SEXUAL REPRODUCTION | 547 | 1.73e-01 | 3.43e-02 | 6.56e-01 |
GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 6.33e-01 | 3.43e-02 | 9.07e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 8.67e-01 | -3.43e-02 | 9.71e-01 |
GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 18 | 8.02e-01 | -3.42e-02 | 9.55e-01 |
GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 20 | 7.91e-01 | -3.42e-02 | 9.54e-01 |
GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 20 | 7.91e-01 | -3.42e-02 | 9.54e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 50 | 6.76e-01 | 3.41e-02 | 9.24e-01 |
GOBP T HELPER 1 CELL DIFFERENTIATION | 20 | 7.92e-01 | 3.41e-02 | 9.54e-01 |
GOBP PROTEIN EXPORT FROM NUCLEUS | 56 | 6.59e-01 | 3.41e-02 | 9.17e-01 |
GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 22 | 7.82e-01 | -3.41e-02 | 9.51e-01 |
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 38 | 7.16e-01 | -3.41e-02 | 9.32e-01 |
GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 102 | 5.53e-01 | -3.41e-02 | 8.77e-01 |
GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 15 | 8.19e-01 | 3.40e-02 | 9.58e-01 |
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 202 | 4.06e-01 | -3.40e-02 | 8.17e-01 |
GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 15 | 8.20e-01 | 3.40e-02 | 9.58e-01 |
GOMF PRE MRNA INTRONIC BINDING | 9 | 8.60e-01 | 3.40e-02 | 9.68e-01 |
GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 11 | 8.45e-01 | 3.40e-02 | 9.66e-01 |
GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 14 | 8.26e-01 | -3.40e-02 | 9.58e-01 |
GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 6 | 8.86e-01 | 3.39e-02 | 9.76e-01 |
GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 8.86e-01 | -3.39e-02 | 9.76e-01 |
GOBP CELLULAR RESPONSE TO STARVATION | 143 | 4.85e-01 | 3.39e-02 | 8.53e-01 |
GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 8 | 8.68e-01 | 3.39e-02 | 9.71e-01 |
GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 8.77e-01 | -3.39e-02 | 9.75e-01 |
GOBP CELL FATE COMMITMENT | 112 | 5.37e-01 | 3.38e-02 | 8.73e-01 |
GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 8.86e-01 | -3.38e-02 | 9.76e-01 |
GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 9 | 8.61e-01 | 3.38e-02 | 9.69e-01 |
GOCC SPERM PRINCIPAL PIECE | 18 | 8.04e-01 | -3.38e-02 | 9.55e-01 |
GOBP CELLULAR RESPONSE TO INTERFERON BETA | 20 | 7.94e-01 | 3.37e-02 | 9.54e-01 |
GOCC NURF COMPLEX | 6 | 8.86e-01 | -3.37e-02 | 9.76e-01 |
GOBP CELLULAR RESPONSE TO SALT STRESS | 10 | 8.54e-01 | 3.37e-02 | 9.68e-01 |
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 36 | 7.27e-01 | -3.37e-02 | 9.37e-01 |
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 7 | 8.77e-01 | -3.37e-02 | 9.75e-01 |
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 7 | 8.77e-01 | -3.37e-02 | 9.75e-01 |
GOBP REGULATION OF TRANSFERASE ACTIVITY | 483 | 2.09e-01 | 3.36e-02 | 6.87e-01 |
GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.87e-01 | 3.35e-02 | 9.76e-01 |
GOBP CYTOKINETIC PROCESS | 36 | 7.28e-01 | -3.35e-02 | 9.37e-01 |
GOCC MHC CLASS II PROTEIN COMPLEX | 15 | 8.22e-01 | -3.35e-02 | 9.58e-01 |
GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 12 | 8.41e-01 | -3.35e-02 | 9.64e-01 |
GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 69 | 6.31e-01 | -3.35e-02 | 9.05e-01 |
GOMF METALLOENDOPEPTIDASE ACTIVITY | 51 | 6.79e-01 | -3.35e-02 | 9.24e-01 |
GOBP BEHAVIOR | 310 | 3.13e-01 | 3.34e-02 | 7.62e-01 |
GOBP POSITIVE REGULATION OF CELL KILLING | 58 | 6.60e-01 | -3.34e-02 | 9.17e-01 |
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 62 | 6.49e-01 | 3.34e-02 | 9.13e-01 |
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 48 | 6.89e-01 | -3.34e-02 | 9.25e-01 |
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 20 | 7.96e-01 | -3.34e-02 | 9.54e-01 |
GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 71 | 6.27e-01 | -3.34e-02 | 9.05e-01 |
GOBP LIPID CATABOLIC PROCESS | 212 | 4.04e-01 | 3.34e-02 | 8.16e-01 |
GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 22 | 7.87e-01 | 3.34e-02 | 9.53e-01 |
GOBP ACTIN NUCLEATION | 43 | 7.05e-01 | -3.33e-02 | 9.31e-01 |
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 90 | 5.86e-01 | 3.33e-02 | 8.90e-01 |
GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 53 | 6.76e-01 | -3.33e-02 | 9.24e-01 |
GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 73 | 6.24e-01 | 3.32e-02 | 9.04e-01 |
GOBP HYPOTHALAMUS DEVELOPMENT | 11 | 8.49e-01 | -3.32e-02 | 9.67e-01 |
GOBP TELOMERASE RNA LOCALIZATION | 19 | 8.02e-01 | -3.32e-02 | 9.55e-01 |
GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 9 | 8.63e-01 | -3.32e-02 | 9.69e-01 |
GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 32 | 7.46e-01 | 3.32e-02 | 9.42e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 219 | 4.00e-01 | -3.31e-02 | 8.15e-01 |
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 6 | 8.88e-01 | -3.31e-02 | 9.77e-01 |
GOMF MAP KINASE KINASE KINASE ACTIVITY | 22 | 7.88e-01 | 3.31e-02 | 9.53e-01 |
GOBP BRANCHIOMOTOR NEURON AXON GUIDANCE | 5 | 8.98e-01 | -3.31e-02 | 9.80e-01 |
GOBP REGULATION OF KINASE ACTIVITY | 395 | 2.63e-01 | 3.30e-02 | 7.24e-01 |
GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 111 | 5.48e-01 | -3.30e-02 | 8.75e-01 |
GOBP POSITIVE REGULATION OF TOR SIGNALING | 61 | 6.56e-01 | -3.30e-02 | 9.15e-01 |
GOCC EARLY ENDOSOME | 319 | 3.13e-01 | 3.30e-02 | 7.62e-01 |
GOBP COPPER ION IMPORT | 5 | 8.98e-01 | 3.30e-02 | 9.80e-01 |
GOBP PHOSPHOLIPID METABOLIC PROCESS | 280 | 3.45e-01 | 3.29e-02 | 7.83e-01 |
GOBP REPRODUCTION | 756 | 1.28e-01 | 3.29e-02 | 5.97e-01 |
GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 384 | 2.72e-01 | 3.28e-02 | 7.29e-01 |
GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 91 | 5.89e-01 | -3.28e-02 | 8.91e-01 |
GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 58 | 6.66e-01 | 3.28e-02 | 9.21e-01 |
GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 26 | 7.72e-01 | 3.28e-02 | 9.46e-01 |
GOBP PHAGOCYTOSIS | 181 | 4.48e-01 | -3.28e-02 | 8.33e-01 |
GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 108 | 5.56e-01 | -3.28e-02 | 8.78e-01 |
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 9 | 8.65e-01 | -3.28e-02 | 9.70e-01 |
GOMF ARYLSULFATASE ACTIVITY | 9 | 8.65e-01 | -3.28e-02 | 9.70e-01 |
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 45 | 7.04e-01 | -3.28e-02 | 9.30e-01 |
GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 15 | 8.26e-01 | -3.27e-02 | 9.58e-01 |
GOBP LIPID MODIFICATION | 138 | 5.08e-01 | 3.27e-02 | 8.62e-01 |
GOBP INORGANIC ANION TRANSPORT | 74 | 6.27e-01 | 3.27e-02 | 9.05e-01 |
GOBP REGULATION OF LIPID METABOLIC PROCESS | 205 | 4.22e-01 | -3.27e-02 | 8.23e-01 |
GOBP NUCLEAR PORE LOCALIZATION | 5 | 8.99e-01 | -3.27e-02 | 9.80e-01 |
GOBP CELLULAR RESPONSE TO PEPTIDE | 244 | 3.81e-01 | 3.26e-02 | 8.02e-01 |
GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 7.74e-01 | -3.26e-02 | 9.47e-01 |
GOBP MRNA METABOLIC PROCESS | 638 | 1.64e-01 | -3.26e-02 | 6.46e-01 |
GOCC EXTRINSIC COMPONENT OF MEMBRANE | 139 | 5.08e-01 | -3.26e-02 | 8.63e-01 |
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 13 | 8.39e-01 | 3.25e-02 | 9.63e-01 |
GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 13 | 8.39e-01 | -3.25e-02 | 9.63e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 489 | 2.22e-01 | -3.25e-02 | 6.99e-01 |
GOBP MYOBLAST FUSION | 27 | 7.70e-01 | 3.25e-02 | 9.46e-01 |
GOBP POSITIVE REGULATION OF HEMOPOIESIS | 154 | 4.88e-01 | 3.25e-02 | 8.53e-01 |
GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 12 | 8.46e-01 | 3.24e-02 | 9.66e-01 |
GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 40 | 7.23e-01 | -3.24e-02 | 9.36e-01 |
GOBP SKELETAL MUSCLE CONTRACTION | 19 | 8.07e-01 | 3.24e-02 | 9.56e-01 |
GOCC MONOATOMIC ION CHANNEL COMPLEX | 100 | 5.76e-01 | 3.24e-02 | 8.87e-01 |
GOBP MATERNAL PLACENTA DEVELOPMENT | 22 | 7.93e-01 | 3.24e-02 | 9.54e-01 |
GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 12 | 8.46e-01 | -3.23e-02 | 9.66e-01 |
GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 20 | 8.02e-01 | 3.23e-02 | 9.55e-01 |
GOBP THIOESTER METABOLIC PROCESS | 68 | 6.45e-01 | 3.23e-02 | 9.10e-01 |
GOBP REGULATION OF CYCLASE ACTIVITY | 22 | 7.93e-01 | -3.23e-02 | 9.54e-01 |
GOBP CELL DIFFERENTIATION IN SPINAL CORD | 15 | 8.29e-01 | 3.23e-02 | 9.59e-01 |
GOCC ENVELOPE | 1049 | 8.17e-02 | -3.23e-02 | 5.08e-01 |
GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 42 | 7.18e-01 | -3.23e-02 | 9.33e-01 |
GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 26 | 7.76e-01 | 3.22e-02 | 9.48e-01 |
GOBP RESPONSE TO ANGIOTENSIN | 24 | 7.85e-01 | -3.22e-02 | 9.52e-01 |
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 20 | 8.03e-01 | -3.22e-02 | 9.55e-01 |
GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 56 | 6.78e-01 | 3.22e-02 | 9.24e-01 |
GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 49 | 6.97e-01 | 3.22e-02 | 9.29e-01 |
GOCC SEPTIN CYTOSKELETON | 11 | 8.54e-01 | -3.21e-02 | 9.68e-01 |
GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 48 | 7.01e-01 | 3.21e-02 | 9.29e-01 |
GOBP RESPONSE TO STEROID HORMONE | 200 | 4.36e-01 | -3.21e-02 | 8.28e-01 |
GOBP DEVELOPMENTAL INDUCTION | 9 | 8.68e-01 | 3.20e-02 | 9.71e-01 |
GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 515 | 2.17e-01 | -3.20e-02 | 6.94e-01 |
GOCC MICROTUBULE CYTOSKELETON | 1028 | 8.79e-02 | 3.19e-02 | 5.20e-01 |
GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 52 | 6.91e-01 | -3.19e-02 | 9.25e-01 |
GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 18 | 8.15e-01 | 3.19e-02 | 9.58e-01 |
GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 25 | 7.82e-01 | 3.19e-02 | 9.51e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 22 | 7.96e-01 | -3.19e-02 | 9.54e-01 |
GOBP INORGANIC ION HOMEOSTASIS | 297 | 3.47e-01 | -3.18e-02 | 7.85e-01 |
GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 21 | 8.01e-01 | 3.18e-02 | 9.55e-01 |
GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 320 | 3.31e-01 | -3.18e-02 | 7.74e-01 |
GOBP REGULATION OF NUCLEASE ACTIVITY | 21 | 8.01e-01 | 3.18e-02 | 9.55e-01 |
GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 42 | 7.22e-01 | -3.17e-02 | 9.36e-01 |
GOBP CYTIDINE METABOLIC PROCESS | 8 | 8.77e-01 | -3.17e-02 | 9.75e-01 |
GOMF CYTIDINE DEAMINASE ACTIVITY | 8 | 8.77e-01 | -3.17e-02 | 9.75e-01 |
GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 54 | 6.87e-01 | -3.17e-02 | 9.25e-01 |
GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 16 | 8.26e-01 | -3.17e-02 | 9.58e-01 |
GOBP PROTEIN LOCALIZATION TO NUCLEUS | 258 | 3.82e-01 | 3.17e-02 | 8.03e-01 |
GOBP REGULATION OF MRNA METABOLIC PROCESS | 244 | 3.96e-01 | -3.17e-02 | 8.12e-01 |
GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 9.02e-01 | 3.17e-02 | 9.81e-01 |
GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 244 | 3.96e-01 | 3.17e-02 | 8.12e-01 |
GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 444 | 2.56e-01 | -3.16e-02 | 7.23e-01 |
GOCC DYNEIN COMPLEX | 30 | 7.65e-01 | 3.16e-02 | 9.45e-01 |
GOBP BLOOD VESSEL REMODELING | 22 | 7.98e-01 | -3.16e-02 | 9.54e-01 |
GOBP RETINAL CONE CELL DIFFERENTIATION | 5 | 9.03e-01 | 3.16e-02 | 9.81e-01 |
GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 13 | 8.44e-01 | -3.15e-02 | 9.64e-01 |
GOCC NEURON PROJECTION TERMINUS | 62 | 6.68e-01 | 3.15e-02 | 9.23e-01 |
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1020 | 9.34e-02 | -3.15e-02 | 5.31e-01 |
GOCC UBIQUITIN LIGASE COMPLEX | 273 | 3.72e-01 | 3.15e-02 | 7.99e-01 |
GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 8.77e-01 | 3.15e-02 | 9.75e-01 |
GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 7 | 8.85e-01 | -3.15e-02 | 9.76e-01 |
GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 6 | 8.94e-01 | 3.15e-02 | 9.78e-01 |
GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 6 | 8.94e-01 | -3.15e-02 | 9.78e-01 |
GOBP VIRAL TRANSCRIPTION | 45 | 7.15e-01 | 3.15e-02 | 9.32e-01 |
GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 108 | 5.73e-01 | -3.14e-02 | 8.86e-01 |
GOBP NEGATIVE REGULATION OF MAPK CASCADE | 107 | 5.76e-01 | 3.14e-02 | 8.87e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 57 | 6.82e-01 | -3.14e-02 | 9.25e-01 |
GOBP GLYCOSYLATION | 161 | 4.94e-01 | 3.13e-02 | 8.56e-01 |
GOBP FATTY ACID HOMEOSTASIS | 9 | 8.71e-01 | -3.13e-02 | 9.73e-01 |
GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 21 | 8.04e-01 | -3.13e-02 | 9.55e-01 |
GOBP SCHWANN CELL DEVELOPMENT | 18 | 8.18e-01 | 3.13e-02 | 9.58e-01 |
GOBP AUTOPHAGOSOME MATURATION | 59 | 6.78e-01 | -3.13e-02 | 9.24e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 55 | 6.89e-01 | 3.12e-02 | 9.25e-01 |
GOBP ENDODERMAL CELL FATE COMMITMENT | 7 | 8.86e-01 | -3.12e-02 | 9.76e-01 |
GOBP VESICLE CYTOSKELETAL TRAFFICKING | 55 | 6.89e-01 | -3.12e-02 | 9.25e-01 |
GOBP REGULATION OF NEUROGENESIS | 210 | 4.38e-01 | -3.12e-02 | 8.29e-01 |
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.95e-01 | -3.11e-02 | 9.79e-01 |
GOCC CEREBELLAR CLIMBING FIBER TO PURKINJE CELL SYNAPSE | 5 | 9.04e-01 | 3.11e-02 | 9.82e-01 |
GOBP T CELL RECEPTOR SIGNALING PATHWAY | 122 | 5.54e-01 | 3.11e-02 | 8.77e-01 |
GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 8 | 8.79e-01 | -3.11e-02 | 9.75e-01 |
GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 9 | 8.72e-01 | -3.11e-02 | 9.73e-01 |
GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 54 | 6.93e-01 | -3.11e-02 | 9.27e-01 |
GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 10 | 8.65e-01 | 3.11e-02 | 9.70e-01 |
GOBP EXOCRINE SYSTEM DEVELOPMENT | 16 | 8.30e-01 | -3.10e-02 | 9.59e-01 |
GOBP NEGATIVE REGULATION OF JNK CASCADE | 28 | 7.76e-01 | -3.10e-02 | 9.48e-01 |
GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 8.79e-01 | -3.10e-02 | 9.75e-01 |
GOBP ALPHA BETA T CELL DIFFERENTIATION | 107 | 5.81e-01 | -3.09e-02 | 8.88e-01 |
GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 52 | 7.00e-01 | -3.09e-02 | 9.29e-01 |
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 8.53e-01 | 3.09e-02 | 9.68e-01 |
GOCC MICROTUBULE ORGANIZING CENTER | 667 | 1.78e-01 | 3.09e-02 | 6.61e-01 |
GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 226 | 4.25e-01 | -3.09e-02 | 8.23e-01 |
GOBP SYNAPTIC VESICLE TRANSPORT | 34 | 7.56e-01 | 3.08e-02 | 9.44e-01 |
GOBP REGULATION OF FIBRINOLYSIS | 6 | 8.96e-01 | -3.08e-02 | 9.79e-01 |
GOBP PROTEIN K63 LINKED UBIQUITINATION | 53 | 6.99e-01 | -3.07e-02 | 9.29e-01 |
GOMF SIGNALING ADAPTOR ACTIVITY | 81 | 6.33e-01 | 3.07e-02 | 9.07e-01 |
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 353 | 3.24e-01 | -3.07e-02 | 7.69e-01 |
GOBP TISSUE REGENERATION | 39 | 7.40e-01 | -3.07e-02 | 9.40e-01 |
GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 28 | 7.79e-01 | -3.06e-02 | 9.50e-01 |
GOBP MULTICELLULAR ORGANISM REPRODUCTION | 464 | 2.62e-01 | 3.06e-02 | 7.24e-01 |
GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 21 | 8.08e-01 | 3.06e-02 | 9.57e-01 |
GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 42 | 7.32e-01 | 3.06e-02 | 9.39e-01 |
GOBP RESPONSE TO FUNGUS | 37 | 7.48e-01 | -3.06e-02 | 9.42e-01 |
GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 164 | 5.01e-01 | 3.05e-02 | 8.60e-01 |
GOMF NUCLEAR RECEPTOR BINDING | 117 | 5.69e-01 | -3.05e-02 | 8.84e-01 |
GOBP RESPONSE TO COBALT ION | 10 | 8.67e-01 | 3.05e-02 | 9.71e-01 |
GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 16 | 8.33e-01 | 3.05e-02 | 9.60e-01 |
GOBP CALCIUM ION HOMEOSTASIS | 177 | 4.86e-01 | -3.05e-02 | 8.53e-01 |
GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 18 | 8.23e-01 | -3.04e-02 | 9.58e-01 |
GOBP CELL MORPHOGENESIS | 550 | 2.26e-01 | -3.04e-02 | 7.02e-01 |
GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 304 | 3.64e-01 | 3.04e-02 | 7.95e-01 |
GOBP CIRCULATORY SYSTEM DEVELOPMENT | 624 | 1.99e-01 | -3.04e-02 | 6.79e-01 |
GOBP FC RECEPTOR SIGNALING PATHWAY | 51 | 7.08e-01 | 3.04e-02 | 9.31e-01 |
GOBP RETROGRADE AXONAL TRANSPORT | 13 | 8.50e-01 | -3.04e-02 | 9.68e-01 |
GOBP AXON GUIDANCE | 98 | 6.04e-01 | 3.03e-02 | 8.99e-01 |
GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 13 | 8.50e-01 | 3.03e-02 | 9.68e-01 |
GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 62 | 6.80e-01 | 3.03e-02 | 9.24e-01 |
GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 164 | 5.04e-01 | -3.03e-02 | 8.62e-01 |
GOBP RECEPTOR CATABOLIC PROCESS | 24 | 7.98e-01 | -3.03e-02 | 9.54e-01 |
GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 8.34e-01 | -3.02e-02 | 9.61e-01 |
GOCC VACUOLAR MEMBRANE | 409 | 2.97e-01 | -3.02e-02 | 7.49e-01 |
GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 154 | 5.18e-01 | 3.02e-02 | 8.67e-01 |
GOMF METHYL CPG BINDING | 20 | 8.15e-01 | 3.02e-02 | 9.58e-01 |
GOBP SKELETAL MUSCLE TISSUE REGENERATION | 23 | 8.02e-01 | -3.02e-02 | 9.55e-01 |
GOBP REGULATION OF MRNA CATABOLIC PROCESS | 156 | 5.16e-01 | 3.02e-02 | 8.66e-01 |
GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 32 | 7.68e-01 | 3.01e-02 | 9.45e-01 |
GOMF ANGIOTENSIN RECEPTOR BINDING | 6 | 8.98e-01 | -3.01e-02 | 9.80e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 47 | 7.22e-01 | -3.00e-02 | 9.36e-01 |
GOBP RESPONSE TO MURAMYL DIPEPTIDE | 19 | 8.21e-01 | -3.00e-02 | 9.58e-01 |
GOMF PROTEIN DEMETHYLASE ACTIVITY | 27 | 7.87e-01 | 3.00e-02 | 9.53e-01 |
GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.99e-01 | 2.99e-02 | 9.80e-01 |
GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 8.91e-01 | -2.99e-02 | 9.77e-01 |
GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 11 | 8.64e-01 | -2.98e-02 | 9.70e-01 |
GOBP HUMORAL IMMUNE RESPONSE | 103 | 6.02e-01 | -2.97e-02 | 8.98e-01 |
GOBP RESPONSE TO CORTISOL | 5 | 9.08e-01 | -2.97e-02 | 9.82e-01 |
GOBP MALONYL COA METABOLIC PROCESS | 6 | 9.00e-01 | 2.97e-02 | 9.80e-01 |
GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 13 | 8.53e-01 | 2.97e-02 | 9.68e-01 |
GOBP GTP BIOSYNTHETIC PROCESS | 9 | 8.78e-01 | 2.96e-02 | 9.75e-01 |
GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 233 | 4.38e-01 | -2.96e-02 | 8.29e-01 |
GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 46 | 7.29e-01 | 2.96e-02 | 9.37e-01 |
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 151 | 5.32e-01 | -2.95e-02 | 8.72e-01 |
GOBP MALE GAMETE GENERATION | 300 | 3.81e-01 | 2.95e-02 | 8.02e-01 |
GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 79 | 6.50e-01 | 2.95e-02 | 9.14e-01 |
GOBP OTOLITH DEVELOPMENT | 6 | 9.00e-01 | -2.95e-02 | 9.80e-01 |
GOMF VINCULIN BINDING | 9 | 8.78e-01 | -2.95e-02 | 9.75e-01 |
GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 21 | 8.15e-01 | 2.95e-02 | 9.58e-01 |
GOBP PROLINE TRANSPORT | 6 | 9.01e-01 | 2.94e-02 | 9.80e-01 |
GOMF O ACYLTRANSFERASE ACTIVITY | 39 | 7.51e-01 | 2.94e-02 | 9.42e-01 |
GOBP AXONEME ASSEMBLY | 35 | 7.63e-01 | -2.94e-02 | 9.45e-01 |
GOBP ORGANIC ACID CATABOLIC PROCESS | 173 | 5.05e-01 | 2.94e-02 | 8.62e-01 |
GOBP ORGANELLE FISSION | 337 | 3.56e-01 | 2.94e-02 | 7.90e-01 |
GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 5 | 9.09e-01 | 2.94e-02 | 9.82e-01 |
GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 621 | 2.16e-01 | -2.93e-02 | 6.91e-01 |
GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 21 | 8.16e-01 | -2.93e-02 | 9.58e-01 |
GOBP RESPONSE TO SALT | 203 | 4.74e-01 | -2.92e-02 | 8.47e-01 |
GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 8 | 8.86e-01 | 2.92e-02 | 9.76e-01 |
GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 68 | 6.77e-01 | 2.92e-02 | 9.24e-01 |
GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 79 | 6.54e-01 | -2.92e-02 | 9.15e-01 |
GOBP PEPTIDE CATABOLIC PROCESS | 16 | 8.40e-01 | 2.92e-02 | 9.64e-01 |
GOCC POLYMERIC CYTOSKELETAL FIBER | 418 | 3.10e-01 | 2.91e-02 | 7.58e-01 |
GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 165 | 5.19e-01 | 2.91e-02 | 8.68e-01 |
GOBP CELLULAR RESPONSE TO UV | 72 | 6.70e-01 | 2.91e-02 | 9.23e-01 |
GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 8.56e-01 | 2.90e-02 | 9.68e-01 |
GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 31 | 7.80e-01 | -2.90e-02 | 9.50e-01 |
GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 8 | 8.87e-01 | 2.90e-02 | 9.76e-01 |
GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 11 | 8.68e-01 | -2.90e-02 | 9.71e-01 |
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 65 | 6.87e-01 | -2.89e-02 | 9.25e-01 |
GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 194 | 4.89e-01 | -2.89e-02 | 8.54e-01 |
GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 11 | 8.68e-01 | 2.89e-02 | 9.71e-01 |
GOBP CRANIAL NERVE MORPHOGENESIS | 14 | 8.52e-01 | -2.89e-02 | 9.68e-01 |
GOBP CELL KILLING | 139 | 5.58e-01 | -2.89e-02 | 8.79e-01 |
GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 8 | 8.88e-01 | 2.89e-02 | 9.76e-01 |
GOMF QUINONE BINDING | 13 | 8.57e-01 | -2.88e-02 | 9.68e-01 |
GOBP IRON ION TRANSMEMBRANE TRANSPORT | 18 | 8.33e-01 | -2.88e-02 | 9.60e-01 |
GOBP INTRACILIARY TRANSPORT | 34 | 7.72e-01 | 2.87e-02 | 9.46e-01 |
GOBP RESPONSE TO HYPEROXIA | 13 | 8.58e-01 | -2.87e-02 | 9.68e-01 |
GOBP AMINOGLYCAN METABOLIC PROCESS | 72 | 6.75e-01 | 2.86e-02 | 9.24e-01 |
GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 13 | 8.58e-01 | 2.86e-02 | 9.68e-01 |
GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 22 | 8.17e-01 | -2.86e-02 | 9.58e-01 |
GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 137 | 5.65e-01 | -2.85e-02 | 8.81e-01 |
GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 121 | 5.88e-01 | 2.85e-02 | 8.91e-01 |
GOBP DEFENSE RESPONSE | 1146 | 1.09e-01 | -2.85e-02 | 5.67e-01 |
GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 5 | 9.12e-01 | 2.85e-02 | 9.82e-01 |
GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 7 | 8.96e-01 | -2.85e-02 | 9.79e-01 |
GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 105 | 6.15e-01 | -2.85e-02 | 9.02e-01 |
GOBP ADAPTIVE IMMUNE RESPONSE | 359 | 3.56e-01 | 2.85e-02 | 7.91e-01 |
GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 23 | 8.13e-01 | -2.84e-02 | 9.58e-01 |
GOBP PROTEIN AUTOPHOSPHORYLATION | 150 | 5.49e-01 | -2.84e-02 | 8.75e-01 |
GOBP GRANULOCYTE DIFFERENTIATION | 31 | 7.84e-01 | -2.84e-02 | 9.52e-01 |
GOBP CELLULAR RESPONSE TO ACIDIC PH | 7 | 8.96e-01 | -2.84e-02 | 9.79e-01 |
GOCC LATERAL ELEMENT | 10 | 8.76e-01 | 2.84e-02 | 9.75e-01 |
GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 84 | 6.54e-01 | -2.83e-02 | 9.15e-01 |
GOBP CARDIAC ATRIUM DEVELOPMENT | 14 | 8.55e-01 | 2.83e-02 | 9.68e-01 |
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 655 | 2.21e-01 | -2.83e-02 | 6.98e-01 |
GOBP RESPONSE TO INTERFERON BETA | 27 | 7.99e-01 | 2.83e-02 | 9.55e-01 |
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 29 | 7.92e-01 | -2.82e-02 | 9.54e-01 |
GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 53 | 7.22e-01 | -2.82e-02 | 9.36e-01 |
GOBP GLYCEROLIPID CATABOLIC PROCESS | 41 | 7.55e-01 | 2.82e-02 | 9.43e-01 |
GOBP MEMBRANE ORGANIZATION | 614 | 2.37e-01 | -2.82e-02 | 7.11e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 7 | 8.97e-01 | 2.81e-02 | 9.79e-01 |
GOMF PHOSPHOPROTEIN BINDING | 79 | 6.66e-01 | 2.81e-02 | 9.21e-01 |
GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 124 | 5.89e-01 | -2.81e-02 | 8.92e-01 |
GOMF POTASSIUM CHANNEL ACTIVITY | 34 | 7.77e-01 | -2.81e-02 | 9.49e-01 |
GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 63 | 7.00e-01 | -2.81e-02 | 9.29e-01 |
GOBP CELL PROJECTION ASSEMBLY | 421 | 3.26e-01 | 2.81e-02 | 7.69e-01 |
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 91 | 6.44e-01 | -2.81e-02 | 9.10e-01 |
GOBP PHOSPHATE ION TRANSPORT | 15 | 8.51e-01 | -2.81e-02 | 9.68e-01 |
GOMF RNA POLYMERASE BINDING | 55 | 7.19e-01 | -2.81e-02 | 9.34e-01 |
GOBP T CELL APOPTOTIC PROCESS | 46 | 7.43e-01 | 2.80e-02 | 9.41e-01 |
GOBP DNA METHYLATION | 38 | 7.65e-01 | -2.80e-02 | 9.45e-01 |
GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 701 | 2.12e-01 | -2.80e-02 | 6.87e-01 |
GOMF GLUCOSE BINDING | 9 | 8.85e-01 | -2.80e-02 | 9.76e-01 |
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 45 | 7.46e-01 | 2.79e-02 | 9.42e-01 |
GOBP REGULATION OF MACROPHAGE MIGRATION | 31 | 7.88e-01 | -2.79e-02 | 9.53e-01 |
GOBP CYTOKINE PRODUCTION | 573 | 2.58e-01 | -2.79e-02 | 7.24e-01 |
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 173 | 5.28e-01 | 2.79e-02 | 8.69e-01 |
GOMF ACETYLTRANSFERASE ACTIVITY | 80 | 6.67e-01 | -2.78e-02 | 9.22e-01 |
GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 25 | 8.10e-01 | -2.78e-02 | 9.57e-01 |
GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 20 | 8.29e-01 | -2.78e-02 | 9.59e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 98 | 6.34e-01 | -2.78e-02 | 9.07e-01 |
GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 113 | 6.10e-01 | -2.78e-02 | 9.01e-01 |
GOBP SMALL MOLECULE METABOLIC PROCESS | 1245 | 1.05e-01 | 2.78e-02 | 5.56e-01 |
GOCC LAMIN FILAMENT | 5 | 9.14e-01 | 2.78e-02 | 9.83e-01 |
GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 8.73e-01 | -2.78e-02 | 9.74e-01 |
GOBP HYPEROSMOTIC SALINITY RESPONSE | 7 | 8.99e-01 | 2.78e-02 | 9.80e-01 |
GOCC MICOS COMPLEX | 8 | 8.92e-01 | 2.77e-02 | 9.78e-01 |
GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 43 | 7.54e-01 | -2.77e-02 | 9.43e-01 |
GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 21 | 8.26e-01 | 2.77e-02 | 9.58e-01 |
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 11 | 8.74e-01 | 2.77e-02 | 9.74e-01 |
GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 14 | 8.58e-01 | 2.77e-02 | 9.68e-01 |
GOCC PHOTORECEPTOR CONNECTING CILIUM | 24 | 8.15e-01 | 2.77e-02 | 9.58e-01 |
GOBP RESPONSE TO ALCOHOL | 149 | 5.61e-01 | 2.77e-02 | 8.80e-01 |
GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 19 | 8.35e-01 | -2.77e-02 | 9.61e-01 |
GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 16 | 8.48e-01 | 2.76e-02 | 9.67e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 13 | 8.63e-01 | -2.76e-02 | 9.69e-01 |
GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 534 | 2.79e-01 | -2.76e-02 | 7.36e-01 |
GOBP HEART MORPHOGENESIS | 125 | 5.95e-01 | 2.76e-02 | 8.95e-01 |
GOBP CARDIAC VENTRICLE MORPHOGENESIS | 30 | 7.94e-01 | -2.76e-02 | 9.54e-01 |
GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 32 | 7.88e-01 | -2.75e-02 | 9.53e-01 |
GOBP MAINTENANCE OF CELL POLARITY | 14 | 8.59e-01 | 2.75e-02 | 9.68e-01 |
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 7 | 9.00e-01 | -2.75e-02 | 9.80e-01 |
GOBP GLUTATHIONE METABOLIC PROCESS | 28 | 8.02e-01 | -2.74e-02 | 9.55e-01 |
GOBP TELOMERE LOCALIZATION | 7 | 9.00e-01 | -2.74e-02 | 9.80e-01 |
GOCC ACROSOMAL VESICLE | 62 | 7.09e-01 | -2.74e-02 | 9.31e-01 |
GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 24 | 8.16e-01 | -2.74e-02 | 9.58e-01 |
GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 347 | 3.83e-01 | -2.74e-02 | 8.03e-01 |
GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 9 | 8.87e-01 | 2.74e-02 | 9.76e-01 |
GOMF ENZYME ACTIVATOR ACTIVITY | 445 | 3.25e-01 | 2.74e-02 | 7.69e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 9 | 8.87e-01 | 2.73e-02 | 9.76e-01 |
GOBP MITOCHONDRIAL DEPOLARIZATION | 16 | 8.50e-01 | 2.73e-02 | 9.68e-01 |
GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 245 | 4.64e-01 | 2.73e-02 | 8.42e-01 |
GOBP MUSCLE CELL DIFFERENTIATION | 213 | 4.94e-01 | 2.73e-02 | 8.56e-01 |
GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 11 | 8.76e-01 | -2.73e-02 | 9.75e-01 |
GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 741 | 2.11e-01 | -2.73e-02 | 6.87e-01 |
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 43 | 7.58e-01 | -2.72e-02 | 9.44e-01 |
GOBP CEREBELLAR CORTEX MORPHOGENESIS | 21 | 8.30e-01 | 2.71e-02 | 9.59e-01 |
GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 9.16e-01 | 2.71e-02 | 9.84e-01 |
GOMF D1 DOPAMINE RECEPTOR BINDING | 5 | 9.16e-01 | -2.71e-02 | 9.84e-01 |
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 9.09e-01 | 2.71e-02 | 9.82e-01 |
GOCC EXORIBONUCLEASE COMPLEX | 19 | 8.38e-01 | -2.70e-02 | 9.63e-01 |
GOMF EXOPEPTIDASE ACTIVITY | 63 | 7.11e-01 | 2.70e-02 | 9.31e-01 |
GOBP REGULATION OF PROTEIN FOLDING | 8 | 8.95e-01 | 2.69e-02 | 9.79e-01 |
GOBP VOCALIZATION BEHAVIOR | 5 | 9.17e-01 | 2.69e-02 | 9.84e-01 |
GOMF MOLECULAR TRANSDUCER ACTIVITY | 515 | 2.99e-01 | -2.69e-02 | 7.50e-01 |
GOBP CELL REDOX HOMEOSTASIS | 34 | 7.86e-01 | 2.69e-02 | 9.53e-01 |
GOBP BONE TRABECULA MORPHOGENESIS | 6 | 9.09e-01 | -2.69e-02 | 9.82e-01 |
GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 773 | 2.09e-01 | -2.69e-02 | 6.87e-01 |
GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 34 | 7.86e-01 | 2.69e-02 | 9.53e-01 |
GOMF CYCLIN BINDING | 27 | 8.09e-01 | 2.68e-02 | 9.57e-01 |
GOBP CARBOHYDRATE HOMEOSTASIS | 142 | 5.82e-01 | -2.68e-02 | 8.89e-01 |
GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 491 | 3.12e-01 | 2.68e-02 | 7.62e-01 |
GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 62 | 7.15e-01 | 2.68e-02 | 9.32e-01 |
GOCC MMXD COMPLEX | 5 | 9.17e-01 | -2.68e-02 | 9.84e-01 |
GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 30 | 8.00e-01 | 2.67e-02 | 9.55e-01 |
GOBP GLOMERULUS DEVELOPMENT | 31 | 7.97e-01 | -2.67e-02 | 9.54e-01 |
GOBP RIBOSOME BIOGENESIS | 307 | 4.24e-01 | 2.67e-02 | 8.23e-01 |
GOBP REGULATION OF MICROTUBULE BINDING | 6 | 9.10e-01 | -2.66e-02 | 9.82e-01 |
GOBP FIBRINOLYSIS | 9 | 8.90e-01 | -2.66e-02 | 9.77e-01 |
GOCC INCLUSION BODY | 55 | 7.33e-01 | -2.66e-02 | 9.39e-01 |
GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 17 | 8.50e-01 | -2.65e-02 | 9.68e-01 |
GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 176 | 5.45e-01 | 2.65e-02 | 8.75e-01 |
GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 94 | 6.58e-01 | 2.65e-02 | 9.17e-01 |
GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 267 | 4.59e-01 | -2.64e-02 | 8.40e-01 |
GOBP BRAIN MORPHOGENESIS | 22 | 8.31e-01 | -2.64e-02 | 9.59e-01 |
GOBP SULFUR COMPOUND TRANSPORT | 36 | 7.85e-01 | -2.63e-02 | 9.52e-01 |
GOBP REGULATION OF CELL FATE COMMITMENT | 20 | 8.39e-01 | 2.63e-02 | 9.63e-01 |
GOBP SUPEROXIDE METABOLIC PROCESS | 43 | 7.65e-01 | 2.63e-02 | 9.45e-01 |
GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 28 | 8.10e-01 | 2.63e-02 | 9.57e-01 |
GOBP MUSCLE ADAPTATION | 57 | 7.31e-01 | -2.63e-02 | 9.39e-01 |
GOBP NEURON CELLULAR HOMEOSTASIS | 41 | 7.71e-01 | -2.63e-02 | 9.46e-01 |
GOBP PROTEIN MONOUBIQUITINATION | 39 | 7.77e-01 | -2.62e-02 | 9.49e-01 |
GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 5 | 9.19e-01 | 2.62e-02 | 9.84e-01 |
GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 55 | 7.37e-01 | -2.62e-02 | 9.39e-01 |
GOBP NEUROPEPTIDE SIGNALING PATHWAY | 20 | 8.39e-01 | 2.62e-02 | 9.63e-01 |
GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 129 | 6.08e-01 | -2.62e-02 | 9.00e-01 |
GOBP RESPONSE TO PEPTIDE HORMONE | 272 | 4.59e-01 | 2.62e-02 | 8.40e-01 |
GOMF KINESIN BINDING | 34 | 7.92e-01 | 2.62e-02 | 9.54e-01 |
GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 41 | 7.72e-01 | -2.61e-02 | 9.46e-01 |
GOBP REGULATION OF RECEPTOR INTERNALIZATION | 41 | 7.72e-01 | -2.61e-02 | 9.46e-01 |
GOMF TRANSITION METAL ION BINDING | 708 | 2.41e-01 | 2.61e-02 | 7.14e-01 |
GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 28 | 8.11e-01 | 2.61e-02 | 9.57e-01 |
GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 21 | 8.36e-01 | 2.61e-02 | 9.61e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 49 | 7.53e-01 | 2.60e-02 | 9.42e-01 |
GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 59 | 7.30e-01 | 2.60e-02 | 9.38e-01 |
GOBP LYMPHOCYTE HOMEOSTASIS | 63 | 7.21e-01 | -2.60e-02 | 9.36e-01 |
GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 11 | 8.82e-01 | 2.60e-02 | 9.76e-01 |
GOBP CELLULAR LIPID METABOLIC PROCESS | 654 | 2.62e-01 | 2.59e-02 | 7.24e-01 |
GOBP RESPONSE TO NICOTINE | 23 | 8.30e-01 | -2.59e-02 | 9.59e-01 |
GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 11 | 8.82e-01 | -2.59e-02 | 9.76e-01 |
GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 22 | 8.33e-01 | 2.59e-02 | 9.60e-01 |
GOBP TISSUE MORPHOGENESIS | 316 | 4.32e-01 | 2.58e-02 | 8.26e-01 |
GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 5 | 9.20e-01 | 2.58e-02 | 9.84e-01 |
GOBP RESPONSE TO RETINOIC ACID | 52 | 7.48e-01 | 2.58e-02 | 9.42e-01 |
GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 70 | 7.09e-01 | -2.58e-02 | 9.31e-01 |
GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 70 | 7.09e-01 | -2.58e-02 | 9.31e-01 |
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 44 | 7.67e-01 | -2.58e-02 | 9.45e-01 |
GOMF CARBON CARBON LYASE ACTIVITY | 37 | 7.87e-01 | 2.57e-02 | 9.53e-01 |
GOBP GANGLIOSIDE CATABOLIC PROCESS | 6 | 9.13e-01 | 2.57e-02 | 9.82e-01 |
GOMF ACID AMINO ACID LIGASE ACTIVITY | 15 | 8.63e-01 | 2.57e-02 | 9.69e-01 |
GOBP AORTIC VALVE MORPHOGENESIS | 17 | 8.55e-01 | -2.57e-02 | 9.68e-01 |
GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 11 | 8.83e-01 | -2.57e-02 | 9.76e-01 |
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 8.83e-01 | -2.56e-02 | 9.76e-01 |
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 11 | 8.83e-01 | 2.56e-02 | 9.76e-01 |
GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 134 | 6.09e-01 | -2.56e-02 | 9.01e-01 |
GOBP RESPONSE TO ALKALOID | 56 | 7.41e-01 | -2.56e-02 | 9.40e-01 |
GOBP STEM CELL DIFFERENTIATION | 131 | 6.14e-01 | -2.56e-02 | 9.01e-01 |
GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 43 | 7.72e-01 | 2.56e-02 | 9.46e-01 |
GOBP REGULATION OF TELOMERASE ACTIVITY | 41 | 7.77e-01 | 2.56e-02 | 9.49e-01 |
GOMF DEAMINASE ACTIVITY | 23 | 8.32e-01 | 2.56e-02 | 9.60e-01 |
GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 9.07e-01 | -2.55e-02 | 9.82e-01 |
GOBP OOCYTE MATURATION | 17 | 8.55e-01 | 2.55e-02 | 9.68e-01 |
GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 21 | 8.40e-01 | -2.54e-02 | 9.64e-01 |
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 83 | 6.89e-01 | -2.54e-02 | 9.25e-01 |
GOBP REGULATION OF CATABOLIC PROCESS | 814 | 2.23e-01 | -2.54e-02 | 7.01e-01 |
GOBP DISACCHARIDE METABOLIC PROCESS | 7 | 9.07e-01 | -2.54e-02 | 9.82e-01 |
GOBP RNA SURVEILLANCE | 17 | 8.56e-01 | -2.54e-02 | 9.68e-01 |
GOCC CELL DIVISION SITE | 58 | 7.39e-01 | -2.54e-02 | 9.40e-01 |
GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 40 | 7.82e-01 | 2.54e-02 | 9.51e-01 |
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 39 | 7.84e-01 | -2.53e-02 | 9.52e-01 |
GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 19 | 8.49e-01 | 2.53e-02 | 9.67e-01 |
GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 6 | 9.14e-01 | -2.53e-02 | 9.83e-01 |
GOMF AMP BINDING | 12 | 8.79e-01 | -2.53e-02 | 9.75e-01 |
GOBP MITOTIC SPINDLE ASSEMBLY | 58 | 7.39e-01 | -2.53e-02 | 9.40e-01 |
GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 71 | 7.13e-01 | 2.53e-02 | 9.32e-01 |
GOBP RESPONSE TO CALCIUM ION | 81 | 6.95e-01 | -2.53e-02 | 9.28e-01 |
GOMF TROPOMYOSIN BINDING | 9 | 8.96e-01 | -2.52e-02 | 9.79e-01 |
GOBP CELLULAR KETONE METABOLIC PROCESS | 134 | 6.14e-01 | 2.52e-02 | 9.02e-01 |
GOBP MONONUCLEAR CELL DIFFERENTIATION | 371 | 4.07e-01 | 2.52e-02 | 8.17e-01 |
GOBP SYNAPSE ORGANIZATION | 239 | 5.04e-01 | 2.52e-02 | 8.61e-01 |
GOCC DESMOSOME | 12 | 8.80e-01 | -2.51e-02 | 9.76e-01 |
GOBP NEUTROPHIL APOPTOTIC PROCESS | 8 | 9.02e-01 | -2.51e-02 | 9.81e-01 |
GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 8 | 9.02e-01 | -2.51e-02 | 9.81e-01 |
GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 19 | 8.50e-01 | -2.51e-02 | 9.68e-01 |
GOCC DENDRITIC TREE | 337 | 4.32e-01 | 2.50e-02 | 8.26e-01 |
GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 15 | 8.67e-01 | -2.50e-02 | 9.71e-01 |
GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 52 | 7.55e-01 | -2.50e-02 | 9.43e-01 |
GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 35 | 7.98e-01 | -2.50e-02 | 9.54e-01 |
GOBP PROTEIN METHYLATION | 66 | 7.26e-01 | 2.50e-02 | 9.37e-01 |
GOMF PHOSPHATASE REGULATOR ACTIVITY | 76 | 7.07e-01 | -2.50e-02 | 9.31e-01 |
GOBP CELL CYCLE G1 S PHASE TRANSITION | 200 | 5.44e-01 | -2.50e-02 | 8.75e-01 |
GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 32 | 8.07e-01 | 2.50e-02 | 9.56e-01 |
GOMF CD4 RECEPTOR BINDING | 7 | 9.09e-01 | -2.50e-02 | 9.82e-01 |
GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 8.67e-01 | 2.50e-02 | 9.71e-01 |
GOBP RESPONSE TO RADIATION | 300 | 4.59e-01 | 2.49e-02 | 8.40e-01 |
GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 345 | 4.29e-01 | 2.49e-02 | 8.25e-01 |
GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 32 | 8.08e-01 | -2.49e-02 | 9.56e-01 |
GOCC POSTSYNAPSE | 363 | 4.18e-01 | -2.49e-02 | 8.21e-01 |
GOBP MAINTENANCE OF CELL NUMBER | 138 | 6.15e-01 | -2.49e-02 | 9.02e-01 |
GOBP T CELL SELECTION | 45 | 7.73e-01 | 2.49e-02 | 9.47e-01 |
GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 86 | 6.91e-01 | 2.48e-02 | 9.25e-01 |
GOBP ECTODERMAL PLACODE DEVELOPMENT | 6 | 9.16e-01 | 2.48e-02 | 9.84e-01 |
GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 24 | 8.33e-01 | 2.48e-02 | 9.60e-01 |
GOBP PHOSPHOLIPID TRANSPORT | 65 | 7.30e-01 | 2.48e-02 | 9.38e-01 |
GOBP COGNITION | 158 | 5.92e-01 | 2.48e-02 | 8.93e-01 |
GOBP BRADYKININ CATABOLIC PROCESS | 5 | 9.24e-01 | -2.48e-02 | 9.84e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 5 | 9.24e-01 | -2.48e-02 | 9.84e-01 |
GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 8 | 9.04e-01 | 2.47e-02 | 9.81e-01 |
GOBP COENZYME A BIOSYNTHETIC PROCESS | 11 | 8.87e-01 | 2.47e-02 | 9.76e-01 |
GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 7 | 9.10e-01 | -2.47e-02 | 9.82e-01 |
GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 6 | 9.17e-01 | -2.47e-02 | 9.84e-01 |
GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 33 | 8.06e-01 | 2.47e-02 | 9.56e-01 |
GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1191 | 1.59e-01 | -2.46e-02 | 6.41e-01 |
GOCC CELL CORTEX REGION | 21 | 8.45e-01 | -2.46e-02 | 9.66e-01 |
GOBP RESPONSE TO INTERFERON ALPHA | 18 | 8.57e-01 | 2.46e-02 | 9.68e-01 |
GOCC APICAL PART OF CELL | 218 | 5.34e-01 | -2.45e-02 | 8.73e-01 |
GOBP PROTEIN LOCALIZATION TO SYNAPSE | 41 | 7.86e-01 | 2.45e-02 | 9.53e-01 |
GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 335 | 4.43e-01 | 2.45e-02 | 8.32e-01 |
GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 77 | 7.11e-01 | -2.45e-02 | 9.31e-01 |
GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 270 | 4.91e-01 | -2.44e-02 | 8.55e-01 |
GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 5 | 9.25e-01 | -2.44e-02 | 9.84e-01 |
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 30 | 8.17e-01 | 2.44e-02 | 9.58e-01 |
GOBP POSITIVE REGULATION OF MAPK CASCADE | 270 | 4.93e-01 | -2.44e-02 | 8.55e-01 |
GOBP EMBRYONIC AXIS SPECIFICATION | 13 | 8.79e-01 | 2.43e-02 | 9.75e-01 |
GOBP KETONE CATABOLIC PROCESS | 9 | 8.99e-01 | -2.43e-02 | 9.80e-01 |
GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 28 | 8.24e-01 | -2.43e-02 | 9.58e-01 |
GOMF ARMADILLO REPEAT DOMAIN BINDING | 8 | 9.05e-01 | 2.43e-02 | 9.82e-01 |
GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 149 | 6.09e-01 | 2.43e-02 | 9.01e-01 |
GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 237 | 5.21e-01 | -2.43e-02 | 8.68e-01 |
GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 8.94e-01 | -2.43e-02 | 9.79e-01 |
GOMF TRANSMEMBRANE TRANSPORTER BINDING | 79 | 7.09e-01 | -2.43e-02 | 9.31e-01 |
GOBP FUCOSYLATION | 11 | 8.89e-01 | 2.43e-02 | 9.77e-01 |
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 9.00e-01 | 2.42e-02 | 9.80e-01 |
GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 312 | 4.64e-01 | -2.42e-02 | 8.42e-01 |
GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 234 | 5.25e-01 | -2.42e-02 | 8.69e-01 |
GOBP T CELL HOMEOSTASIS | 37 | 7.99e-01 | 2.42e-02 | 9.54e-01 |
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 362 | 4.32e-01 | -2.42e-02 | 8.26e-01 |
GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 232 | 5.27e-01 | -2.42e-02 | 8.69e-01 |
GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 19 | 8.55e-01 | -2.42e-02 | 9.68e-01 |
GOBP RESPONSE TO IRON II ION | 5 | 9.25e-01 | 2.42e-02 | 9.84e-01 |
GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 221 | 5.37e-01 | 2.42e-02 | 8.73e-01 |
GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 9.12e-01 | 2.41e-02 | 9.82e-01 |
GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 6 | 9.18e-01 | 2.41e-02 | 9.84e-01 |
GOBP SPINAL CORD DEVELOPMENT | 40 | 7.92e-01 | 2.41e-02 | 9.54e-01 |
GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 14 | 8.76e-01 | -2.41e-02 | 9.75e-01 |
GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 10 | 8.95e-01 | -2.40e-02 | 9.79e-01 |
GOMF ALPHA ACTININ BINDING | 13 | 8.81e-01 | -2.40e-02 | 9.76e-01 |
GOBP VACUOLE ORGANIZATION | 196 | 5.64e-01 | -2.40e-02 | 8.80e-01 |
GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 77 | 7.16e-01 | 2.40e-02 | 9.32e-01 |
GOBP LIPID BIOSYNTHETIC PROCESS | 480 | 3.72e-01 | 2.40e-02 | 7.99e-01 |
GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 20 | 8.53e-01 | 2.39e-02 | 9.68e-01 |
GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 7 | 9.13e-01 | -2.39e-02 | 9.82e-01 |
GOMF EXONUCLEASE ACTIVITY | 74 | 7.22e-01 | -2.39e-02 | 9.36e-01 |
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 73 | 7.24e-01 | 2.39e-02 | 9.36e-01 |
GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 22 | 8.46e-01 | 2.39e-02 | 9.66e-01 |
GOBP SENSORY PERCEPTION | 207 | 5.55e-01 | 2.39e-02 | 8.77e-01 |
GOBP MYOBLAST MIGRATION | 7 | 9.13e-01 | -2.39e-02 | 9.82e-01 |
GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 8.82e-01 | -2.39e-02 | 9.76e-01 |
GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 30 | 8.21e-01 | -2.39e-02 | 9.58e-01 |
GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 19 | 8.57e-01 | -2.38e-02 | 9.68e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1315 | 1.55e-01 | -2.38e-02 | 6.36e-01 |
GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 11 | 8.91e-01 | 2.38e-02 | 9.77e-01 |
GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 47 | 7.78e-01 | 2.38e-02 | 9.49e-01 |
GOMF ANTIPORTER ACTIVITY | 89 | 6.99e-01 | -2.38e-02 | 9.29e-01 |
GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 41 | 7.93e-01 | -2.37e-02 | 9.54e-01 |
GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.02e-01 | 2.37e-02 | 9.81e-01 |
GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 8 | 9.08e-01 | -2.37e-02 | 9.82e-01 |
GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 225 | 5.42e-01 | -2.37e-02 | 8.74e-01 |
GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 20 | 8.55e-01 | -2.37e-02 | 9.68e-01 |
GOBP CELLULAR COMPONENT MORPHOGENESIS | 424 | 4.06e-01 | -2.37e-02 | 8.17e-01 |
GOBP L SERINE METABOLIC PROCESS | 8 | 9.08e-01 | 2.37e-02 | 9.82e-01 |
GOBP NERVOUS SYSTEM PROCESS | 466 | 3.84e-01 | 2.37e-02 | 8.04e-01 |
GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 42 | 7.91e-01 | -2.36e-02 | 9.54e-01 |
GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 28 | 8.29e-01 | -2.36e-02 | 9.59e-01 |
GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 20 | 8.55e-01 | 2.36e-02 | 9.68e-01 |
GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 8 | 9.08e-01 | -2.35e-02 | 9.82e-01 |
GOMF CARBON NITROGEN LYASE ACTIVITY | 10 | 8.97e-01 | 2.35e-02 | 9.79e-01 |
GOMF SEQUENCE SPECIFIC DNA BINDING | 1004 | 2.15e-01 | 2.35e-02 | 6.90e-01 |
GOBP RESPONSE TO SALT STRESS | 16 | 8.71e-01 | -2.34e-02 | 9.73e-01 |
GOBP MESODERM DEVELOPMENT | 56 | 7.62e-01 | -2.34e-02 | 9.45e-01 |
GOBP REGULATION OF FILOPODIUM ASSEMBLY | 38 | 8.03e-01 | -2.34e-02 | 9.55e-01 |
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 6 | 9.21e-01 | 2.33e-02 | 9.84e-01 |
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 92 | 7.00e-01 | 2.33e-02 | 9.29e-01 |
GOBP ERBB2 SIGNALING PATHWAY | 11 | 8.94e-01 | -2.33e-02 | 9.78e-01 |
GOBP IMMUNOGLOBULIN PRODUCTION | 87 | 7.08e-01 | 2.32e-02 | 9.31e-01 |
GOCC CONDENSED NUCLEAR CHROMOSOME | 52 | 7.72e-01 | -2.32e-02 | 9.46e-01 |
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 87 | 7.09e-01 | -2.32e-02 | 9.31e-01 |
GOBP IMMUNE SYSTEM DEVELOPMENT | 148 | 6.27e-01 | 2.32e-02 | 9.05e-01 |
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 9 | 9.04e-01 | -2.32e-02 | 9.82e-01 |
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 646 | 3.19e-01 | -2.32e-02 | 7.67e-01 |
GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 196 | 5.77e-01 | -2.32e-02 | 8.87e-01 |
GOBP REGULATION OF AXONOGENESIS | 87 | 7.09e-01 | -2.32e-02 | 9.31e-01 |
GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 273 | 5.12e-01 | 2.31e-02 | 8.66e-01 |
GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 13 | 8.85e-01 | -2.31e-02 | 9.76e-01 |
GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 452 | 4.02e-01 | -2.31e-02 | 8.15e-01 |
GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 6 | 9.22e-01 | -2.31e-02 | 9.84e-01 |
GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.22e-01 | -2.31e-02 | 9.84e-01 |
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 167 | 6.07e-01 | -2.31e-02 | 9.00e-01 |
GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 21 | 8.55e-01 | 2.31e-02 | 9.68e-01 |
GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 8.77e-01 | -2.31e-02 | 9.75e-01 |
GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 166 | 6.09e-01 | 2.31e-02 | 9.01e-01 |
GOBP DICARBOXYLIC ACID TRANSPORT | 57 | 7.64e-01 | -2.31e-02 | 9.45e-01 |
GOBP REGULATION OF TELOMERE MAINTENANCE | 98 | 6.94e-01 | 2.31e-02 | 9.27e-01 |
GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 18 | 8.66e-01 | -2.30e-02 | 9.70e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 9.22e-01 | -2.30e-02 | 9.84e-01 |
GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 409 | 4.28e-01 | -2.30e-02 | 8.24e-01 |
GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 28 | 8.33e-01 | 2.30e-02 | 9.60e-01 |
GOBP NEUROBLAST DIVISION | 9 | 9.05e-01 | -2.29e-02 | 9.82e-01 |
GOBP CELL PART MORPHOGENESIS | 375 | 4.50e-01 | -2.28e-02 | 8.34e-01 |
GOBP PROGRAMMED NECROTIC CELL DEATH | 42 | 7.98e-01 | -2.28e-02 | 9.54e-01 |
GOBP MICROTUBULE BASED TRANSPORT | 154 | 6.27e-01 | 2.28e-02 | 9.05e-01 |
GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 15 | 8.79e-01 | 2.27e-02 | 9.75e-01 |
GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 49 | 7.84e-01 | -2.27e-02 | 9.52e-01 |
GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 43 | 7.97e-01 | -2.27e-02 | 9.54e-01 |
GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 173 | 6.08e-01 | 2.26e-02 | 9.00e-01 |
GOBP DNA DOUBLE STRAND BREAK PROCESSING | 17 | 8.72e-01 | 2.26e-02 | 9.73e-01 |
GOBP MIDBRAIN DEVELOPMENT | 53 | 7.76e-01 | -2.26e-02 | 9.48e-01 |
GOMF MOLECULAR ADAPTOR ACTIVITY | 475 | 4.02e-01 | 2.26e-02 | 8.15e-01 |
GOBP PROTEIN CATABOLIC PROCESS | 808 | 2.83e-01 | -2.25e-02 | 7.39e-01 |
GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 58 | 7.67e-01 | -2.25e-02 | 9.45e-01 |
GOBP VESICLE FUSION WITH GOLGI APPARATUS | 8 | 9.12e-01 | 2.25e-02 | 9.82e-01 |
GOBP RNA 3 END PROCESSING | 88 | 7.16e-01 | 2.24e-02 | 9.32e-01 |
GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 11 | 8.98e-01 | -2.24e-02 | 9.80e-01 |
GOBP CDP CHOLINE PATHWAY | 5 | 9.31e-01 | 2.24e-02 | 9.85e-01 |
GOCC CAJAL BODY | 57 | 7.70e-01 | -2.24e-02 | 9.46e-01 |
GOCC BLOC COMPLEX | 14 | 8.85e-01 | -2.24e-02 | 9.76e-01 |
GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 38 | 8.12e-01 | 2.24e-02 | 9.57e-01 |
GOBP SYNAPSE PRUNING | 9 | 9.08e-01 | 2.23e-02 | 9.82e-01 |
GOBP PROTEIN POLYMERIZATION | 209 | 5.80e-01 | -2.23e-02 | 8.88e-01 |
GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 420 | 4.36e-01 | -2.23e-02 | 8.28e-01 |
GOBP AMYLOID BETA CLEARANCE | 29 | 8.36e-01 | 2.23e-02 | 9.61e-01 |
GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 21 | 8.60e-01 | -2.23e-02 | 9.68e-01 |
GOBP EPITHELIUM DEVELOPMENT | 616 | 3.52e-01 | -2.22e-02 | 7.87e-01 |
GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 30 | 8.34e-01 | 2.21e-02 | 9.61e-01 |
GOBP BLASTODERM SEGMENTATION | 7 | 9.19e-01 | -2.21e-02 | 9.84e-01 |
GOBP BONE DEVELOPMENT | 109 | 6.90e-01 | -2.21e-02 | 9.25e-01 |
GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 16 | 8.78e-01 | -2.21e-02 | 9.75e-01 |
GOBP SPINDLE ASSEMBLY | 113 | 6.86e-01 | -2.21e-02 | 9.25e-01 |
GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 145 | 6.48e-01 | -2.20e-02 | 9.12e-01 |
GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 8 | 9.14e-01 | 2.20e-02 | 9.83e-01 |
GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 12 | 8.95e-01 | 2.20e-02 | 9.79e-01 |
GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 102 | 7.02e-01 | 2.20e-02 | 9.29e-01 |
GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 9 | 9.09e-01 | 2.20e-02 | 9.82e-01 |
GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 801 | 2.97e-01 | -2.19e-02 | 7.49e-01 |
GOBP INTRACELLULAR MRNA LOCALIZATION | 12 | 8.95e-01 | 2.19e-02 | 9.79e-01 |
GOBP BICARBONATE TRANSPORT | 19 | 8.69e-01 | -2.19e-02 | 9.71e-01 |
GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 160 | 6.34e-01 | 2.19e-02 | 9.07e-01 |
GOCC IGG IMMUNOGLOBULIN COMPLEX | 6 | 9.26e-01 | -2.18e-02 | 9.84e-01 |
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 6 | 9.26e-01 | 2.18e-02 | 9.84e-01 |
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 464 | 4.25e-01 | 2.17e-02 | 8.23e-01 |
GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 138 | 6.60e-01 | 2.17e-02 | 9.17e-01 |
GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 9.10e-01 | 2.17e-02 | 9.82e-01 |
GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 147 | 6.51e-01 | -2.17e-02 | 9.14e-01 |
GOBP PROTEIN TARGETING TO VACUOLE | 43 | 8.06e-01 | -2.17e-02 | 9.56e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 46 | 8.00e-01 | 2.16e-02 | 9.55e-01 |
GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 22 | 8.61e-01 | -2.16e-02 | 9.69e-01 |
GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 17 | 8.78e-01 | 2.16e-02 | 9.75e-01 |
GOBP DNA CYTOSINE DEAMINATION | 7 | 9.21e-01 | 2.15e-02 | 9.84e-01 |
GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 83 | 7.35e-01 | -2.15e-02 | 9.39e-01 |
GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 42 | 8.09e-01 | 2.15e-02 | 9.57e-01 |
GOCC STEREOCILIUM BUNDLE | 32 | 8.33e-01 | -2.15e-02 | 9.60e-01 |
GOBP MITOCHONDRIAL FISSION | 35 | 8.26e-01 | -2.15e-02 | 9.58e-01 |
GOBP CELLULAR HOMEOSTASIS | 498 | 4.15e-01 | -2.15e-02 | 8.21e-01 |
GOBP SCARNA LOCALIZATION TO CAJAL BODY | 5 | 9.34e-01 | -2.15e-02 | 9.86e-01 |
GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 401 | 4.64e-01 | -2.14e-02 | 8.42e-01 |
GOBP OVULATION | 7 | 9.22e-01 | 2.14e-02 | 9.84e-01 |
GOBP PIGMENT METABOLIC PROCESS | 48 | 7.97e-01 | 2.14e-02 | 9.54e-01 |
GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 68 | 7.60e-01 | -2.14e-02 | 9.45e-01 |
GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 10 | 9.07e-01 | 2.14e-02 | 9.82e-01 |
GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 43 | 8.08e-01 | 2.14e-02 | 9.57e-01 |
GOBP NECROPTOTIC SIGNALING PATHWAY | 6 | 9.28e-01 | -2.14e-02 | 9.85e-01 |
GOCC MEMBRANE MICRODOMAIN | 182 | 6.20e-01 | -2.13e-02 | 9.03e-01 |
GOBP MRNA 3 END PROCESSING | 47 | 8.00e-01 | 2.13e-02 | 9.55e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 816 | 3.07e-01 | -2.13e-02 | 7.57e-01 |
GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 41 | 8.14e-01 | -2.13e-02 | 9.58e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 47 | 8.01e-01 | 2.13e-02 | 9.55e-01 |
GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 57 | 7.82e-01 | 2.12e-02 | 9.51e-01 |
GOBP REGULATION OF MEIOTIC CELL CYCLE | 35 | 8.28e-01 | -2.12e-02 | 9.59e-01 |
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 26 | 8.52e-01 | 2.12e-02 | 9.68e-01 |
GOBP DENDRITE SELF AVOIDANCE | 5 | 9.35e-01 | 2.12e-02 | 9.86e-01 |
GOCC HISTONE DEACETYLASE COMPLEX | 76 | 7.50e-01 | -2.12e-02 | 9.42e-01 |
GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 53 | 7.90e-01 | -2.11e-02 | 9.54e-01 |
GOCC GOLGI APPARATUS SUBCOMPARTMENT | 291 | 5.37e-01 | -2.11e-02 | 8.73e-01 |
GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 9.13e-01 | 2.11e-02 | 9.82e-01 |
GOBP REGULATION OF DEFENSE RESPONSE | 561 | 3.97e-01 | -2.11e-02 | 8.12e-01 |
GOBP NATURAL KILLER CELL ACTIVATION | 68 | 7.64e-01 | 2.11e-02 | 9.45e-01 |
GOBP AMINO ACID TRANSPORT | 82 | 7.42e-01 | 2.11e-02 | 9.40e-01 |
GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 73 | 7.56e-01 | 2.10e-02 | 9.44e-01 |
GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 8 | 9.18e-01 | 2.10e-02 | 9.84e-01 |
GOBP PEROXISOME FISSION | 7 | 9.23e-01 | -2.10e-02 | 9.84e-01 |
GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 10 | 9.09e-01 | -2.10e-02 | 9.82e-01 |
GOBP REGULATION OF NEURON DIFFERENTIATION | 84 | 7.40e-01 | -2.09e-02 | 9.40e-01 |
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 38 | 8.23e-01 | -2.09e-02 | 9.58e-01 |
GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 38 | 8.23e-01 | 2.09e-02 | 9.58e-01 |
GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 9.18e-01 | -2.09e-02 | 9.84e-01 |
GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 242 | 5.77e-01 | -2.09e-02 | 8.87e-01 |
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 60 | 7.80e-01 | -2.09e-02 | 9.50e-01 |
GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 23 | 8.63e-01 | 2.09e-02 | 9.69e-01 |
GOBP CARBOHYDRATE TRANSPORT | 97 | 7.23e-01 | 2.08e-02 | 9.36e-01 |
GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 9.24e-01 | -2.08e-02 | 9.84e-01 |
GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 6 | 9.30e-01 | 2.08e-02 | 9.85e-01 |
GOBP LIPID METABOLIC PROCESS | 868 | 3.04e-01 | 2.08e-02 | 7.54e-01 |
GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 198 | 6.15e-01 | 2.08e-02 | 9.02e-01 |
GOBP VIRAL RNA GENOME REPLICATION | 26 | 8.55e-01 | 2.08e-02 | 9.68e-01 |
GOCC CLATHRIN COATED VESICLE MEMBRANE | 97 | 7.24e-01 | -2.08e-02 | 9.36e-01 |
GOBP VESICLE MEDIATED TRANSPORT | 1137 | 2.45e-01 | -2.08e-02 | 7.14e-01 |
GOCC CILIARY MEMBRANE | 36 | 8.30e-01 | -2.06e-02 | 9.59e-01 |
GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 7 | 9.25e-01 | 2.06e-02 | 9.84e-01 |
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 18 | 8.80e-01 | 2.06e-02 | 9.75e-01 |
GOCC CELL BODY | 304 | 5.38e-01 | -2.06e-02 | 8.73e-01 |
GOMF SODIUM CHANNEL INHIBITOR ACTIVITY | 5 | 9.36e-01 | -2.06e-02 | 9.86e-01 |
GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 60 | 7.83e-01 | -2.06e-02 | 9.51e-01 |
GOBP PLATELET DENSE GRANULE ORGANIZATION | 23 | 8.64e-01 | 2.06e-02 | 9.70e-01 |
GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 15 | 8.90e-01 | -2.06e-02 | 9.77e-01 |
GOBP NEUTRAL LIPID METABOLIC PROCESS | 82 | 7.48e-01 | -2.06e-02 | 9.42e-01 |
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 17 | 8.83e-01 | 2.06e-02 | 9.76e-01 |
GOBP RESPONSE TO TEMPERATURE STIMULUS | 112 | 7.07e-01 | 2.06e-02 | 9.31e-01 |
GOBP VIRAL GENOME REPLICATION | 111 | 7.09e-01 | -2.05e-02 | 9.31e-01 |
GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 22 | 8.68e-01 | 2.05e-02 | 9.71e-01 |
GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 8 | 9.20e-01 | 2.05e-02 | 9.84e-01 |
GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 93 | 7.33e-01 | 2.05e-02 | 9.39e-01 |
GOBP REGULATION OF CELL ACTIVATION | 490 | 4.40e-01 | -2.05e-02 | 8.29e-01 |
GOMF TAU PROTEIN BINDING | 36 | 8.32e-01 | 2.05e-02 | 9.60e-01 |
GOCC PHAGOLYSOSOME | 5 | 9.37e-01 | 2.05e-02 | 9.86e-01 |
GOBP MONOATOMIC ANION TRANSPORT | 79 | 7.54e-01 | 2.04e-02 | 9.43e-01 |
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 7 | 9.26e-01 | 2.04e-02 | 9.84e-01 |
GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 19 | 8.78e-01 | -2.04e-02 | 9.75e-01 |
GOBP AMP METABOLIC PROCESS | 17 | 8.85e-01 | 2.03e-02 | 9.76e-01 |
GOBP FOREBRAIN GENERATION OF NEURONS | 24 | 8.63e-01 | 2.03e-02 | 9.69e-01 |
GOBP MOTOR NEURON AXON GUIDANCE | 18 | 8.82e-01 | 2.03e-02 | 9.76e-01 |
GOBP MITOCHONDRIAL PROTEIN PROCESSING | 12 | 9.03e-01 | 2.03e-02 | 9.81e-01 |
GOCC NUCLEAR OUTER MEMBRANE | 21 | 8.72e-01 | -2.03e-02 | 9.73e-01 |
GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 402 | 4.88e-01 | 2.03e-02 | 8.53e-01 |
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 5 | 9.38e-01 | -2.02e-02 | 9.86e-01 |
GOMF PEPTIDE HORMONE BINDING | 16 | 8.89e-01 | 2.02e-02 | 9.77e-01 |
GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 9.26e-01 | 2.02e-02 | 9.84e-01 |
GOBP RECEPTOR METABOLIC PROCESS | 60 | 7.87e-01 | -2.02e-02 | 9.53e-01 |
GOCC MITOCHONDRION | 1366 | 2.20e-01 | 2.02e-02 | 6.96e-01 |
GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 5 | 9.38e-01 | -2.02e-02 | 9.87e-01 |
GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 11 | 9.08e-01 | 2.02e-02 | 9.82e-01 |
GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 38 | 8.30e-01 | -2.02e-02 | 9.59e-01 |
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 26 | 8.59e-01 | -2.02e-02 | 9.68e-01 |
GOCC CATENIN COMPLEX | 10 | 9.12e-01 | -2.02e-02 | 9.82e-01 |
GOBP HEART VALVE DEVELOPMENT | 39 | 8.28e-01 | -2.01e-02 | 9.59e-01 |
GOBP EPITHELIAL TUBE MORPHOGENESIS | 178 | 6.44e-01 | 2.01e-02 | 9.10e-01 |
GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 13 | 9.00e-01 | -2.01e-02 | 9.80e-01 |
GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 48 | 8.10e-01 | 2.01e-02 | 9.57e-01 |
GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 115 | 7.10e-01 | -2.01e-02 | 9.31e-01 |
GOBP LEUKOCYTE MEDIATED IMMUNITY | 307 | 5.47e-01 | -2.01e-02 | 8.75e-01 |
GOBP NEUTRAL AMINO ACID TRANSPORT | 32 | 8.44e-01 | 2.01e-02 | 9.65e-01 |
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 9 | 9.17e-01 | -2.00e-02 | 9.84e-01 |
GOBP ALDITOL METABOLIC PROCESS | 15 | 8.93e-01 | 2.00e-02 | 9.78e-01 |
GOBP LYMPHOCYTE ANERGY | 6 | 9.32e-01 | 2.00e-02 | 9.85e-01 |
GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 467 | 4.61e-01 | 2.00e-02 | 8.42e-01 |
GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 8 | 9.22e-01 | -2.00e-02 | 9.84e-01 |
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 13 | 9.01e-01 | 1.99e-02 | 9.81e-01 |
GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 12 | 9.05e-01 | -1.99e-02 | 9.82e-01 |
GOBP HISTONE MRNA METABOLIC PROCESS | 23 | 8.69e-01 | -1.99e-02 | 9.71e-01 |
GOBP CELLULAR RESPONSE TO RETINOIC ACID | 27 | 8.59e-01 | -1.98e-02 | 9.68e-01 |
GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 9 | 9.18e-01 | -1.98e-02 | 9.84e-01 |
GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 230 | 6.06e-01 | -1.98e-02 | 8.99e-01 |
GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 51 | 8.07e-01 | 1.98e-02 | 9.56e-01 |
GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 10 | 9.14e-01 | 1.98e-02 | 9.82e-01 |
GOMF PHOSPHOLIPASE C ACTIVITY | 18 | 8.85e-01 | -1.98e-02 | 9.76e-01 |
GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 116 | 7.14e-01 | -1.97e-02 | 9.32e-01 |
GOBP ENDOSOMAL TRANSPORT | 212 | 6.23e-01 | -1.96e-02 | 9.04e-01 |
GOBP NADH METABOLIC PROCESS | 8 | 9.24e-01 | 1.96e-02 | 9.84e-01 |
GOCC COSTAMERE | 11 | 9.11e-01 | -1.96e-02 | 9.82e-01 |
GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 58 | 7.97e-01 | 1.96e-02 | 9.54e-01 |
GOBP FATTY ACYL COA CATABOLIC PROCESS | 6 | 9.34e-01 | 1.96e-02 | 9.86e-01 |
GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 5 | 9.40e-01 | 1.96e-02 | 9.87e-01 |
GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 79 | 7.64e-01 | -1.96e-02 | 9.45e-01 |
GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 83 | 7.59e-01 | 1.95e-02 | 9.45e-01 |
GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 40 | 8.31e-01 | 1.95e-02 | 9.60e-01 |
GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 8.96e-01 | -1.95e-02 | 9.79e-01 |
GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 7 | 9.29e-01 | -1.95e-02 | 9.85e-01 |
GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 8 | 9.24e-01 | 1.94e-02 | 9.84e-01 |
GOMF ENDOPEPTIDASE ACTIVITY | 193 | 6.43e-01 | -1.94e-02 | 9.10e-01 |
GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1036 | 2.98e-01 | -1.94e-02 | 7.49e-01 |
GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 81 | 7.63e-01 | -1.94e-02 | 9.45e-01 |
GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 32 | 8.50e-01 | -1.94e-02 | 9.68e-01 |
GOBP MAGNESIUM ION HOMEOSTASIS | 5 | 9.40e-01 | 1.94e-02 | 9.87e-01 |
GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 99 | 7.40e-01 | -1.93e-02 | 9.40e-01 |
GOBP REGULATION OF FATTY ACID OXIDATION | 23 | 8.73e-01 | 1.93e-02 | 9.73e-01 |
GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 11 | 9.12e-01 | 1.93e-02 | 9.82e-01 |
GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 46 | 8.21e-01 | -1.93e-02 | 9.58e-01 |
GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 24 | 8.70e-01 | 1.93e-02 | 9.72e-01 |
GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 8.94e-01 | -1.93e-02 | 9.78e-01 |
GOCC SUPRAMOLECULAR COMPLEX | 836 | 3.50e-01 | 1.93e-02 | 7.86e-01 |
GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 31 | 8.53e-01 | 1.92e-02 | 9.68e-01 |
GOBP GENOMIC IMPRINTING | 11 | 9.12e-01 | 1.92e-02 | 9.82e-01 |
GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 7 | 9.30e-01 | 1.92e-02 | 9.85e-01 |
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 20 | 8.82e-01 | 1.92e-02 | 9.76e-01 |
GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 388 | 5.19e-01 | -1.92e-02 | 8.67e-01 |
GOBP RESPONSE TO LIGHT STIMULUS | 214 | 6.30e-01 | 1.91e-02 | 9.05e-01 |
GOCC SYNAPTIC VESICLE MEMBRANE | 64 | 7.92e-01 | -1.91e-02 | 9.54e-01 |
GOBP CELLULAR CATABOLIC PROCESS | 1182 | 2.77e-01 | -1.91e-02 | 7.35e-01 |
GOBP LYMPHOCYTE APOPTOTIC PROCESS | 65 | 7.90e-01 | -1.91e-02 | 9.54e-01 |
GOMF MIRNA BINDING | 32 | 8.52e-01 | -1.91e-02 | 9.68e-01 |
GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 57 | 8.04e-01 | -1.90e-02 | 9.55e-01 |
GOBP CELLULAR RESPONSE TO RADIATION | 133 | 7.06e-01 | 1.90e-02 | 9.31e-01 |
GOBP PROTEIN ACETYLATION | 85 | 7.63e-01 | -1.89e-02 | 9.45e-01 |
GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1072 | 3.03e-01 | 1.89e-02 | 7.53e-01 |
GOBP DENDRITIC CELL MIGRATION | 27 | 8.65e-01 | -1.89e-02 | 9.70e-01 |
GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 54 | 8.11e-01 | -1.88e-02 | 9.57e-01 |
GOBP MAINTENANCE OF PROTEIN LOCATION | 73 | 7.81e-01 | 1.88e-02 | 9.51e-01 |
GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 6 | 9.36e-01 | 1.88e-02 | 9.86e-01 |
GOBP LYSOSOMAL MICROAUTOPHAGY | 11 | 9.14e-01 | -1.88e-02 | 9.83e-01 |
GOCC CILIARY TIP | 34 | 8.50e-01 | 1.88e-02 | 9.68e-01 |
GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 50 | 8.19e-01 | -1.88e-02 | 9.58e-01 |
GOBP MEIOTIC TELOMERE CLUSTERING | 6 | 9.37e-01 | 1.87e-02 | 9.86e-01 |
GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 10 | 9.18e-01 | 1.87e-02 | 9.84e-01 |
GOCC NEURON TO NEURON SYNAPSE | 206 | 6.44e-01 | -1.87e-02 | 9.10e-01 |
GOCC CYTOPLASMIC DYNEIN COMPLEX | 16 | 8.97e-01 | 1.87e-02 | 9.79e-01 |
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 32 | 8.55e-01 | 1.87e-02 | 9.68e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 16 | 8.97e-01 | 1.87e-02 | 9.79e-01 |
GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 40 | 8.38e-01 | 1.87e-02 | 9.63e-01 |
GOCC BASAL PART OF CELL | 165 | 6.80e-01 | -1.87e-02 | 9.24e-01 |
GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 12 | 9.11e-01 | -1.87e-02 | 9.82e-01 |
GOMF METALLOCHAPERONE ACTIVITY | 12 | 9.11e-01 | 1.86e-02 | 9.82e-01 |
GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 7 | 9.32e-01 | -1.86e-02 | 9.85e-01 |
GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 9.11e-01 | 1.85e-02 | 9.82e-01 |
GOBP SECONDARY METABOLIC PROCESS | 24 | 8.75e-01 | -1.85e-02 | 9.75e-01 |
GOBP LYTIC VACUOLE ORGANIZATION | 89 | 7.63e-01 | -1.85e-02 | 9.45e-01 |
GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 9 | 9.24e-01 | 1.85e-02 | 9.84e-01 |
GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 9.33e-01 | 1.85e-02 | 9.85e-01 |
GOMF NF KAPPAB BINDING | 28 | 8.66e-01 | -1.84e-02 | 9.70e-01 |
GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 13 | 9.09e-01 | -1.84e-02 | 9.82e-01 |
GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 37 | 8.47e-01 | 1.84e-02 | 9.66e-01 |
GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 23 | 8.79e-01 | -1.84e-02 | 9.75e-01 |
GOMF RNA POLYMERASE III ACTIVITY | 10 | 9.20e-01 | 1.83e-02 | 9.84e-01 |
GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 16 | 8.99e-01 | -1.83e-02 | 9.80e-01 |
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 47 | 8.28e-01 | -1.83e-02 | 9.59e-01 |
GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 11 | 9.16e-01 | 1.83e-02 | 9.84e-01 |
GOBP LEUKOCYTE DIFFERENTIATION | 467 | 5.01e-01 | 1.83e-02 | 8.60e-01 |
GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 13 | 9.09e-01 | 1.82e-02 | 9.82e-01 |
GOMF MHC CLASS I PROTEIN COMPLEX BINDING | 7 | 9.33e-01 | 1.82e-02 | 9.86e-01 |
GOBP AXIS ELONGATION | 9 | 9.25e-01 | 1.82e-02 | 9.84e-01 |
GOMF CHROMATIN DNA BINDING | 81 | 7.78e-01 | 1.82e-02 | 9.49e-01 |
GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 6 | 9.39e-01 | 1.82e-02 | 9.87e-01 |
GOMF SUMO LIGASE ACTIVITY | 13 | 9.10e-01 | 1.82e-02 | 9.82e-01 |
GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 91 | 7.65e-01 | 1.81e-02 | 9.45e-01 |
GOBP CIRCULATORY SYSTEM PROCESS | 288 | 5.98e-01 | -1.81e-02 | 8.96e-01 |
GOBP TYPE II INTERFERON PRODUCTION | 85 | 7.74e-01 | -1.80e-02 | 9.47e-01 |
GOBP COLLAGEN METABOLIC PROCESS | 49 | 8.27e-01 | -1.80e-02 | 9.58e-01 |
GOBP CARDIOCYTE DIFFERENTIATION | 80 | 7.81e-01 | -1.80e-02 | 9.51e-01 |
GOBP HISTONE METHYLATION | 33 | 8.58e-01 | -1.80e-02 | 9.68e-01 |
GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 54 | 8.19e-01 | -1.80e-02 | 9.58e-01 |
GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 33 | 8.58e-01 | 1.80e-02 | 9.68e-01 |
GOBP MEMBRANE FUSION | 127 | 7.27e-01 | 1.80e-02 | 9.37e-01 |
GOBP RESPONSE TO MONOSACCHARIDE | 117 | 7.38e-01 | -1.79e-02 | 9.40e-01 |
GOBP P38MAPK CASCADE | 42 | 8.41e-01 | 1.79e-02 | 9.64e-01 |
GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 9.39e-01 | -1.79e-02 | 9.87e-01 |
GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 58 | 8.14e-01 | 1.79e-02 | 9.58e-01 |
GOBP SENSORY SYSTEM DEVELOPMENT | 188 | 6.73e-01 | -1.79e-02 | 9.24e-01 |
GOMF LIPID TRANSPORTER ACTIVITY | 98 | 7.60e-01 | 1.78e-02 | 9.45e-01 |
GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 199 | 6.66e-01 | 1.78e-02 | 9.21e-01 |
GOBP FATTY ACID BIOSYNTHETIC PROCESS | 95 | 7.65e-01 | 1.78e-02 | 9.45e-01 |
GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 7 | 9.35e-01 | 1.78e-02 | 9.86e-01 |
GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 724 | 4.21e-01 | 1.77e-02 | 8.23e-01 |
GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 9.45e-01 | 1.77e-02 | 9.88e-01 |
GOBP CELL CELL SIGNALING | 855 | 3.85e-01 | -1.77e-02 | 8.04e-01 |
GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 36 | 8.55e-01 | 1.76e-02 | 9.68e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION | 91 | 7.72e-01 | -1.76e-02 | 9.46e-01 |
GOCC NUCLEAR BODY | 717 | 4.26e-01 | 1.76e-02 | 8.23e-01 |
GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 6 | 9.40e-01 | -1.76e-02 | 9.87e-01 |
GOBP PHOSPHORYLATION | 1087 | 3.34e-01 | 1.76e-02 | 7.78e-01 |
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 15 | 9.06e-01 | -1.76e-02 | 9.82e-01 |
GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 536 | 4.89e-01 | -1.76e-02 | 8.55e-01 |
GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 74 | 7.94e-01 | -1.76e-02 | 9.54e-01 |
GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 23 | 8.84e-01 | -1.76e-02 | 9.76e-01 |
GOBP HIPPO SIGNALING | 28 | 8.72e-01 | -1.76e-02 | 9.73e-01 |
GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 160 | 7.02e-01 | 1.76e-02 | 9.29e-01 |
GOBP ANDROGEN METABOLIC PROCESS | 14 | 9.09e-01 | -1.76e-02 | 9.82e-01 |
GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 168 | 6.95e-01 | -1.76e-02 | 9.28e-01 |
GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 5 | 9.46e-01 | 1.75e-02 | 9.89e-01 |
GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 60 | 8.15e-01 | -1.75e-02 | 9.58e-01 |
GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 93 | 7.71e-01 | -1.75e-02 | 9.46e-01 |
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 28 | 8.73e-01 | -1.74e-02 | 9.74e-01 |
GOMF AMINOACYLTRANSFERASE ACTIVITY | 370 | 5.68e-01 | 1.74e-02 | 8.83e-01 |
GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 31 | 8.67e-01 | -1.74e-02 | 9.71e-01 |
GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 10 | 9.24e-01 | 1.74e-02 | 9.84e-01 |
GOMF PROTEOGLYCAN BINDING | 17 | 9.02e-01 | -1.73e-02 | 9.81e-01 |
GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 16 | 9.05e-01 | -1.72e-02 | 9.82e-01 |
GOBP REGULATION OF MITOTIC CELL CYCLE | 373 | 5.70e-01 | 1.72e-02 | 8.84e-01 |
GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 9 | 9.29e-01 | 1.72e-02 | 9.85e-01 |
GOCC MOTILE CILIUM | 124 | 7.41e-01 | -1.72e-02 | 9.40e-01 |
GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 303 | 6.08e-01 | -1.72e-02 | 9.00e-01 |
GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 86 | 7.83e-01 | 1.72e-02 | 9.51e-01 |
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 77 | 7.94e-01 | 1.72e-02 | 9.54e-01 |
GOBP MORPHOGENESIS OF AN EPITHELIUM | 265 | 6.31e-01 | 1.72e-02 | 9.06e-01 |
GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 6 | 9.42e-01 | -1.72e-02 | 9.87e-01 |
GOMF MOLECULAR SEQUESTERING ACTIVITY | 31 | 8.69e-01 | 1.71e-02 | 9.71e-01 |
GOBP REGULATION OF VIRAL PROCESS | 130 | 7.37e-01 | 1.71e-02 | 9.39e-01 |
GOBP PROTEIN LOCALIZATION TO VACUOLE | 75 | 7.99e-01 | -1.71e-02 | 9.54e-01 |
GOMF SINGLE STRANDED RNA BINDING | 69 | 8.07e-01 | -1.70e-02 | 9.56e-01 |
GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 42 | 8.49e-01 | -1.70e-02 | 9.68e-01 |
GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 11 | 9.23e-01 | 1.69e-02 | 9.84e-01 |
GOCC ENDOLYSOSOME MEMBRANE | 15 | 9.10e-01 | 1.69e-02 | 9.82e-01 |
GOBP PLATELET MORPHOGENESIS | 20 | 8.96e-01 | -1.69e-02 | 9.79e-01 |
GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 9.38e-01 | -1.69e-02 | 9.87e-01 |
GOBP CELL ACTIVATION | 820 | 4.17e-01 | -1.69e-02 | 8.21e-01 |
GOBP T CELL DIFFERENTIATION IN THYMUS | 68 | 8.10e-01 | 1.68e-02 | 9.57e-01 |
GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 38 | 8.58e-01 | 1.68e-02 | 9.68e-01 |
GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 8 | 9.34e-01 | -1.68e-02 | 9.86e-01 |
GOCC MEDIATOR COMPLEX | 37 | 8.60e-01 | 1.68e-02 | 9.68e-01 |
GOBP CHAPERONE MEDIATED AUTOPHAGY | 13 | 9.16e-01 | -1.68e-02 | 9.84e-01 |
GOBP INNATE IMMUNE RESPONSE | 659 | 4.67e-01 | -1.68e-02 | 8.45e-01 |
GOBP RESPONSE TO OSMOTIC STRESS | 61 | 8.21e-01 | 1.68e-02 | 9.58e-01 |
GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 23 | 8.90e-01 | -1.67e-02 | 9.77e-01 |
GOBP GLIAL CELL APOPTOTIC PROCESS | 15 | 9.11e-01 | 1.67e-02 | 9.82e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 15 | 9.11e-01 | 1.67e-02 | 9.82e-01 |
GOMF SYNTAXIN BINDING | 45 | 8.47e-01 | -1.66e-02 | 9.66e-01 |
GOBP SEBACEOUS GLAND DEVELOPMENT | 5 | 9.49e-01 | -1.66e-02 | 9.90e-01 |
GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 261 | 6.47e-01 | 1.65e-02 | 9.12e-01 |
GOBP CELLULAR RESPONSE TO ALDEHYDE | 9 | 9.32e-01 | -1.65e-02 | 9.85e-01 |
GOBP MYOBLAST PROLIFERATION | 12 | 9.21e-01 | -1.65e-02 | 9.84e-01 |
GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 86 | 7.92e-01 | -1.65e-02 | 9.54e-01 |
GOBP PROTEIN TARGETING TO PEROXISOME | 18 | 9.04e-01 | -1.65e-02 | 9.82e-01 |
GOMF KINASE BINDING | 575 | 5.03e-01 | -1.65e-02 | 8.61e-01 |
GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 77 | 8.03e-01 | 1.65e-02 | 9.55e-01 |
GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 59 | 8.28e-01 | -1.63e-02 | 9.59e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 56 | 8.33e-01 | 1.63e-02 | 9.60e-01 |
GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 9.22e-01 | -1.63e-02 | 9.84e-01 |
GOMF DEUBIQUITINASE ACTIVITY | 85 | 7.95e-01 | 1.63e-02 | 9.54e-01 |
GOBP COMPLEMENT ACTIVATION | 27 | 8.84e-01 | -1.63e-02 | 9.76e-01 |
GOMF MYOSIN HEAVY CHAIN BINDING | 7 | 9.41e-01 | -1.63e-02 | 9.87e-01 |
GOCC RNA POLYMERASE III COMPLEX | 17 | 9.08e-01 | -1.62e-02 | 9.82e-01 |
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 9.50e-01 | -1.62e-02 | 9.90e-01 |
GOMF NUCLEOSOMAL DNA BINDING | 23 | 8.93e-01 | 1.62e-02 | 9.78e-01 |
GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 378 | 5.91e-01 | 1.62e-02 | 8.93e-01 |
GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 35 | 8.69e-01 | -1.62e-02 | 9.71e-01 |
GOBP REGULATION OF T CELL ACTIVATION | 295 | 6.35e-01 | -1.61e-02 | 9.08e-01 |
GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 26 | 8.87e-01 | -1.61e-02 | 9.76e-01 |
GOBP REGULATION OF LIPID CATABOLIC PROCESS | 38 | 8.64e-01 | 1.61e-02 | 9.69e-01 |
GOBP PROTEIN HETEROTETRAMERIZATION | 12 | 9.23e-01 | 1.61e-02 | 9.84e-01 |
GOBP NUCLEAR MIGRATION ALONG MICROTUBULE | 5 | 9.50e-01 | 1.61e-02 | 9.90e-01 |
GOBP IMPORT ACROSS PLASMA MEMBRANE | 95 | 7.87e-01 | -1.60e-02 | 9.53e-01 |
GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 25 | 8.90e-01 | -1.60e-02 | 9.77e-01 |
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 282 | 6.45e-01 | -1.60e-02 | 9.10e-01 |
GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 343 | 6.13e-01 | -1.60e-02 | 9.01e-01 |
GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 47 | 8.50e-01 | 1.59e-02 | 9.68e-01 |
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 16 | 9.12e-01 | -1.59e-02 | 9.82e-01 |
GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 13 | 9.21e-01 | -1.59e-02 | 9.84e-01 |
GOMF PROTEIN DOMAIN SPECIFIC BINDING | 483 | 5.53e-01 | -1.59e-02 | 8.77e-01 |
GOBP SYNAPSE ASSEMBLY | 81 | 8.06e-01 | -1.58e-02 | 9.56e-01 |
GOBP MITOTIC CELL CYCLE PROCESS | 596 | 5.14e-01 | 1.58e-02 | 8.66e-01 |
GOBP NOTCH RECEPTOR PROCESSING | 9 | 9.35e-01 | -1.58e-02 | 9.86e-01 |
GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 83 | 8.04e-01 | 1.57e-02 | 9.55e-01 |
GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 10 | 9.31e-01 | 1.57e-02 | 9.85e-01 |
GOBP ANATOMICAL STRUCTURE MATURATION | 127 | 7.61e-01 | -1.57e-02 | 9.45e-01 |
GOBP JNK CASCADE | 127 | 7.62e-01 | 1.56e-02 | 9.45e-01 |
GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 9.43e-01 | -1.56e-02 | 9.87e-01 |
GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 9.06e-01 | 1.56e-02 | 9.82e-01 |
GOMF DEAD H BOX RNA HELICASE BINDING | 7 | 9.43e-01 | 1.56e-02 | 9.87e-01 |
GOBP VESICLE TETHERING | 32 | 8.80e-01 | 1.55e-02 | 9.75e-01 |
GOCC CILIARY ROOTLET | 10 | 9.33e-01 | -1.55e-02 | 9.85e-01 |
GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 484 | 5.63e-01 | -1.54e-02 | 8.80e-01 |
GOBP PYRAMIDAL NEURON DEVELOPMENT | 8 | 9.40e-01 | -1.54e-02 | 9.87e-01 |
GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 48 | 8.54e-01 | 1.54e-02 | 9.68e-01 |
GOBP T CELL DIFFERENTIATION | 255 | 6.73e-01 | 1.54e-02 | 9.24e-01 |
GOMF GUANYL NUCLEOTIDE BINDING | 285 | 6.56e-01 | -1.54e-02 | 9.15e-01 |
GOBP TYROSINE METABOLIC PROCESS | 6 | 9.48e-01 | -1.54e-02 | 9.89e-01 |
GOBP CORNIFIED ENVELOPE ASSEMBLY | 5 | 9.53e-01 | 1.54e-02 | 9.91e-01 |
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 27 | 8.91e-01 | 1.53e-02 | 9.77e-01 |
GOBP ORGANELLE LOCALIZATION | 478 | 5.70e-01 | -1.53e-02 | 8.84e-01 |
GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 7 | 9.44e-01 | 1.53e-02 | 9.88e-01 |
GOBP NEPHRON MORPHOGENESIS | 29 | 8.87e-01 | 1.52e-02 | 9.76e-01 |
GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 31 | 8.83e-01 | -1.52e-02 | 9.76e-01 |
GOBP NEPHRON EPITHELIUM DEVELOPMENT | 48 | 8.56e-01 | -1.52e-02 | 9.68e-01 |
GOBP AXO DENDRITIC TRANSPORT | 59 | 8.40e-01 | -1.52e-02 | 9.64e-01 |
GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 9 | 9.37e-01 | -1.52e-02 | 9.86e-01 |
GOBP MUSCLE STRUCTURE DEVELOPMENT | 372 | 6.18e-01 | -1.51e-02 | 9.02e-01 |
GOCC BBSOME | 7 | 9.45e-01 | -1.51e-02 | 9.88e-01 |
GOBP MRNA CATABOLIC PROCESS | 209 | 7.07e-01 | 1.51e-02 | 9.31e-01 |
GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 48 | 8.56e-01 | -1.51e-02 | 9.68e-01 |
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 11 | 9.31e-01 | -1.51e-02 | 9.85e-01 |
GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 23 | 9.00e-01 | -1.51e-02 | 9.80e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 79 | 8.17e-01 | -1.50e-02 | 9.58e-01 |
GOBP SPINDLE MIDZONE ASSEMBLY | 8 | 9.41e-01 | 1.50e-02 | 9.87e-01 |
GOBP CARBOHYDRATE METABOLIC PROCESS | 400 | 6.08e-01 | -1.50e-02 | 9.00e-01 |
GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 265 | 6.75e-01 | 1.50e-02 | 9.24e-01 |
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 21 | 9.05e-01 | 1.50e-02 | 9.82e-01 |
GOCC CYTOPLASMIC REGION | 156 | 7.47e-01 | 1.50e-02 | 9.42e-01 |
GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 21 | 9.05e-01 | 1.50e-02 | 9.82e-01 |
GOBP ENDOCANNABINOID SIGNALING PATHWAY | 5 | 9.54e-01 | -1.50e-02 | 9.92e-01 |
GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 41 | 8.68e-01 | 1.50e-02 | 9.71e-01 |
GOBP REGULATION OF WNT SIGNALING PATHWAY | 197 | 7.19e-01 | -1.49e-02 | 9.34e-01 |
GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 34 | 8.81e-01 | -1.49e-02 | 9.76e-01 |
GOBP DEPHOSPHORYLATION | 232 | 6.98e-01 | -1.49e-02 | 9.29e-01 |
GOBP ERAD PATHWAY | 95 | 8.03e-01 | 1.48e-02 | 9.55e-01 |
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 6 | 9.50e-01 | 1.48e-02 | 9.90e-01 |
GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 289 | 6.67e-01 | -1.48e-02 | 9.22e-01 |
GOMF DNA EXONUCLEASE ACTIVITY | 20 | 9.09e-01 | 1.48e-02 | 9.82e-01 |
GOBP IMMATURE T CELL PROLIFERATION | 8 | 9.43e-01 | -1.47e-02 | 9.87e-01 |
GOMF DIPEPTIDASE ACTIVITY | 11 | 9.33e-01 | -1.47e-02 | 9.85e-01 |
GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 5 | 9.55e-01 | -1.47e-02 | 9.92e-01 |
GOBP NEUROTRANSMITTER SECRETION | 79 | 8.22e-01 | 1.47e-02 | 9.58e-01 |
GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 64 | 8.39e-01 | -1.47e-02 | 9.63e-01 |
GOBP DORSAL VENTRAL PATTERN FORMATION | 34 | 8.83e-01 | 1.46e-02 | 9.76e-01 |
GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 19 | 9.12e-01 | -1.46e-02 | 9.82e-01 |
GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 61 | 8.43e-01 | -1.46e-02 | 9.64e-01 |
GOCC INTERCELLULAR BRIDGE | 56 | 8.50e-01 | -1.46e-02 | 9.68e-01 |
GOBP RESPONSE TO HORMONE | 528 | 5.69e-01 | -1.46e-02 | 8.84e-01 |
GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 89 | 8.12e-01 | -1.46e-02 | 9.57e-01 |
GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 8.51e-01 | 1.45e-02 | 9.68e-01 |
GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 9 | 9.40e-01 | -1.45e-02 | 9.87e-01 |
GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 18 | 9.15e-01 | 1.45e-02 | 9.83e-01 |
GOBP CHLORIDE TRANSPORT | 48 | 8.62e-01 | 1.45e-02 | 9.69e-01 |
GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 9 | 9.40e-01 | -1.45e-02 | 9.87e-01 |
GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 24 | 9.02e-01 | -1.45e-02 | 9.81e-01 |
GOCC BLOC 1 COMPLEX | 9 | 9.40e-01 | -1.45e-02 | 9.87e-01 |
GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 81 | 8.22e-01 | 1.45e-02 | 9.58e-01 |
GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 133 | 7.74e-01 | -1.45e-02 | 9.47e-01 |
GOBP POSITIVE REGULATION OF AXON EXTENSION | 24 | 9.03e-01 | -1.44e-02 | 9.81e-01 |
GOBP RESPONSE TO HYDROPEROXIDE | 13 | 9.28e-01 | 1.44e-02 | 9.85e-01 |
GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 27 | 8.97e-01 | -1.44e-02 | 9.79e-01 |
GOCC RNA POLYMERASE II HOLOENZYME | 69 | 8.37e-01 | 1.44e-02 | 9.62e-01 |
GOBP RESPONSE TO UV | 124 | 7.83e-01 | 1.44e-02 | 9.51e-01 |
GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 24 | 9.03e-01 | -1.44e-02 | 9.81e-01 |
GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 10 | 9.37e-01 | -1.43e-02 | 9.86e-01 |
GOMF SNARE BINDING | 75 | 8.30e-01 | -1.43e-02 | 9.59e-01 |
GOMF AMYLOID BETA BINDING | 57 | 8.52e-01 | -1.43e-02 | 9.68e-01 |
GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE | 6 | 9.52e-01 | 1.43e-02 | 9.91e-01 |
GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 202 | 7.27e-01 | -1.43e-02 | 9.37e-01 |
GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 55 | 8.54e-01 | 1.43e-02 | 9.68e-01 |
GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 393 | 6.28e-01 | 1.43e-02 | 9.05e-01 |
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 9.16e-01 | 1.43e-02 | 9.84e-01 |
GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 15 | 9.24e-01 | 1.42e-02 | 9.84e-01 |
GOCC MYOSIN COMPLEX | 31 | 8.91e-01 | -1.42e-02 | 9.77e-01 |
GOBP HISTAMINE SECRETION | 11 | 9.35e-01 | 1.42e-02 | 9.86e-01 |
GOBP HISTAMINE TRANSPORT | 11 | 9.35e-01 | 1.42e-02 | 9.86e-01 |
GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 22 | 9.08e-01 | -1.42e-02 | 9.82e-01 |
GOBP REGULATION OF CIRCADIAN RHYTHM | 84 | 8.23e-01 | 1.41e-02 | 9.58e-01 |
GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 243 | 7.06e-01 | 1.41e-02 | 9.31e-01 |
GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 896 | 4.80e-01 | -1.41e-02 | 8.50e-01 |
GOCC SUPRAMOLECULAR POLYMER | 540 | 5.78e-01 | 1.41e-02 | 8.87e-01 |
GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 23 | 9.07e-01 | -1.40e-02 | 9.82e-01 |
GOCC NEURON PROJECTION | 711 | 5.28e-01 | 1.40e-02 | 8.69e-01 |
GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 21 | 9.12e-01 | -1.40e-02 | 9.82e-01 |
GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 14 | 9.28e-01 | -1.39e-02 | 9.85e-01 |
GOBP GOLGI VESICLE TRANSPORT | 265 | 6.98e-01 | 1.39e-02 | 9.29e-01 |
GOBP EMBRYONIC MORPHOGENESIS | 287 | 6.86e-01 | -1.39e-02 | 9.25e-01 |
GOBP RESPONSE TO ABIOTIC STIMULUS | 724 | 5.28e-01 | -1.39e-02 | 8.69e-01 |
GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 22 | 9.10e-01 | 1.39e-02 | 9.82e-01 |
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 7 | 9.49e-01 | -1.39e-02 | 9.90e-01 |
GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.58e-01 | 1.38e-02 | 9.92e-01 |
GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 16 | 9.24e-01 | -1.38e-02 | 9.84e-01 |
GOBP T CELL EXTRAVASATION | 12 | 9.34e-01 | 1.37e-02 | 9.86e-01 |
GOBP T CELL MEDIATED IMMUNITY | 101 | 8.12e-01 | -1.37e-02 | 9.57e-01 |
GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 32 | 8.93e-01 | 1.37e-02 | 9.78e-01 |
GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 6 | 9.54e-01 | -1.37e-02 | 9.92e-01 |
GOCC NEUROMUSCULAR JUNCTION | 47 | 8.72e-01 | -1.36e-02 | 9.73e-01 |
GOBP STEM CELL PROLIFERATION | 54 | 8.63e-01 | -1.36e-02 | 9.69e-01 |
GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 796 | 5.19e-01 | -1.36e-02 | 8.67e-01 |
GOCC NUCLEAR ENVELOPE | 397 | 6.45e-01 | 1.36e-02 | 9.10e-01 |
GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 691 | 5.47e-01 | 1.36e-02 | 8.75e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 76 | 8.38e-01 | -1.35e-02 | 9.63e-01 |
GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 16 | 9.26e-01 | 1.35e-02 | 9.84e-01 |
GOBP NEUROGENESIS | 956 | 4.86e-01 | -1.35e-02 | 8.53e-01 |
GOMF MUSCLE ALPHA ACTININ BINDING | 8 | 9.47e-01 | 1.35e-02 | 9.89e-01 |
GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 640 | 5.64e-01 | -1.35e-02 | 8.81e-01 |
GOBP THYMOCYTE APOPTOTIC PROCESS | 14 | 9.30e-01 | 1.35e-02 | 9.85e-01 |
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 34 | 8.92e-01 | 1.34e-02 | 9.78e-01 |
GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 93 | 8.23e-01 | -1.34e-02 | 9.58e-01 |
GOBP ATP TRANSPORT | 13 | 9.33e-01 | -1.34e-02 | 9.86e-01 |
GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 564 | 5.89e-01 | -1.34e-02 | 8.91e-01 |
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 8 | 9.48e-01 | 1.34e-02 | 9.89e-01 |
GOMF CLATHRIN BINDING | 47 | 8.74e-01 | 1.34e-02 | 9.74e-01 |
GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 806 | 5.23e-01 | 1.34e-02 | 8.68e-01 |
GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 265 | 7.09e-01 | -1.34e-02 | 9.31e-01 |
GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY | 5 | 9.59e-01 | -1.34e-02 | 9.92e-01 |
GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 20 | 9.18e-01 | 1.34e-02 | 9.84e-01 |
GOBP REGULATION OF CELL DEVELOPMENT | 534 | 6.01e-01 | 1.33e-02 | 8.98e-01 |
GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 9.55e-01 | -1.33e-02 | 9.92e-01 |
GOBP MEMBRANE DISASSEMBLY | 10 | 9.42e-01 | 1.33e-02 | 9.87e-01 |
GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 17 | 9.24e-01 | 1.33e-02 | 9.84e-01 |
GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 9.37e-01 | -1.33e-02 | 9.86e-01 |
GOBP PEPTIDYL AMINO ACID MODIFICATION | 677 | 5.61e-01 | -1.32e-02 | 8.80e-01 |
GOBP DISTAL TUBULE DEVELOPMENT | 6 | 9.55e-01 | -1.32e-02 | 9.92e-01 |
GOMF CYTOSKELETAL PROTEIN BINDING | 672 | 5.64e-01 | -1.32e-02 | 8.81e-01 |
GOMF ADENOSINE DEAMINASE ACTIVITY | 9 | 9.46e-01 | 1.31e-02 | 9.88e-01 |
GOBP SPINDLE ORGANIZATION | 170 | 7.68e-01 | 1.31e-02 | 9.45e-01 |
GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 34 | 8.95e-01 | -1.31e-02 | 9.79e-01 |
GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 20 | 9.19e-01 | 1.31e-02 | 9.84e-01 |
GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 21 | 9.17e-01 | -1.31e-02 | 9.84e-01 |
GOBP TRANSEPITHELIAL TRANSPORT | 15 | 9.30e-01 | 1.31e-02 | 9.85e-01 |
GOBP CELL DIVISION | 477 | 6.27e-01 | 1.31e-02 | 9.05e-01 |
GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 18 | 9.24e-01 | 1.31e-02 | 9.84e-01 |
GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 42 | 8.84e-01 | 1.30e-02 | 9.76e-01 |
GOBP ORGANELLE FUSION | 131 | 7.97e-01 | -1.30e-02 | 9.54e-01 |
GOBP POSITIVE REGULATION OF BINDING | 95 | 8.27e-01 | -1.30e-02 | 9.58e-01 |
GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 215 | 7.43e-01 | -1.30e-02 | 9.41e-01 |
GOMF FOLIC ACID BINDING | 8 | 9.49e-01 | 1.29e-02 | 9.90e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 42 | 8.85e-01 | 1.29e-02 | 9.76e-01 |
GOCC GOLGI APPARATUS | 1139 | 4.70e-01 | -1.29e-02 | 8.46e-01 |
GOBP NATURAL KILLER CELL DEGRANULATION | 11 | 9.41e-01 | -1.29e-02 | 9.87e-01 |
GOCC AXONEMAL DYNEIN COMPLEX | 9 | 9.47e-01 | 1.29e-02 | 9.89e-01 |
GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 98 | 8.26e-01 | -1.28e-02 | 9.58e-01 |
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 671 | 5.74e-01 | -1.28e-02 | 8.86e-01 |
GOBP REGULATION OF PROTEIN BINDING | 106 | 8.20e-01 | 1.28e-02 | 9.58e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 51 | 8.75e-01 | -1.28e-02 | 9.75e-01 |
GOBP REGULATION OF PHOSPHORYLATION | 673 | 5.77e-01 | -1.27e-02 | 8.87e-01 |
GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 63 | 8.62e-01 | 1.27e-02 | 9.69e-01 |
GOBP REGULATION OF STEROID METABOLIC PROCESS | 55 | 8.71e-01 | -1.27e-02 | 9.73e-01 |
GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 216 | 7.49e-01 | 1.27e-02 | 9.42e-01 |
GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 18 | 9.26e-01 | -1.27e-02 | 9.84e-01 |
GOBP LYMPH NODE DEVELOPMENT | 12 | 9.40e-01 | 1.26e-02 | 9.87e-01 |
GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 374 | 6.77e-01 | -1.26e-02 | 9.24e-01 |
GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 6 | 9.57e-01 | -1.26e-02 | 9.92e-01 |
GOBP SEGMENTATION | 41 | 8.89e-01 | -1.26e-02 | 9.77e-01 |
GOBP DUMP CATABOLIC PROCESS | 5 | 9.61e-01 | 1.26e-02 | 9.93e-01 |
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 15 | 9.33e-01 | -1.26e-02 | 9.85e-01 |
GOMF CELL ADHESION MEDIATOR ACTIVITY | 27 | 9.10e-01 | -1.26e-02 | 9.82e-01 |
GOBP MUSCLE ATROPHY | 5 | 9.61e-01 | 1.25e-02 | 9.93e-01 |
GOBP COLLAGEN BIOSYNTHETIC PROCESS | 19 | 9.25e-01 | 1.25e-02 | 9.84e-01 |
GOBP PROTEIN LOCALIZATION TO ORGANELLE | 778 | 5.58e-01 | 1.25e-02 | 8.79e-01 |
GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 7 | 9.55e-01 | -1.24e-02 | 9.92e-01 |
GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 44 | 8.87e-01 | 1.24e-02 | 9.76e-01 |
GOMF BHLH TRANSCRIPTION FACTOR BINDING | 19 | 9.26e-01 | 1.24e-02 | 9.84e-01 |
GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 7 | 9.55e-01 | -1.23e-02 | 9.92e-01 |
GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 47 | 8.84e-01 | 1.23e-02 | 9.76e-01 |
GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 19 | 9.26e-01 | -1.22e-02 | 9.84e-01 |
GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 215 | 7.58e-01 | 1.22e-02 | 9.44e-01 |
GOCC GRANULAR COMPONENT | 6 | 9.59e-01 | -1.22e-02 | 9.92e-01 |
GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 14 | 9.37e-01 | 1.22e-02 | 9.86e-01 |
GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 277 | 7.27e-01 | 1.22e-02 | 9.37e-01 |
GOCC NUCLEAR PERIPHERY | 132 | 8.09e-01 | 1.22e-02 | 9.57e-01 |
GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 22 | 9.21e-01 | 1.22e-02 | 9.84e-01 |
GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 9.37e-01 | -1.22e-02 | 9.86e-01 |
GOCC JUXTAPARANODE REGION OF AXON | 8 | 9.52e-01 | -1.22e-02 | 9.91e-01 |
GOCC ACETYLTRANSFERASE COMPLEX | 92 | 8.40e-01 | -1.22e-02 | 9.64e-01 |
GOBP PRESYNAPSE ORGANIZATION | 21 | 9.23e-01 | 1.22e-02 | 9.84e-01 |
GOBP REGULATION OF HIPPO SIGNALING | 19 | 9.27e-01 | 1.21e-02 | 9.84e-01 |
GOBP OSTEOCLAST DIFFERENTIATION | 75 | 8.56e-01 | 1.21e-02 | 9.68e-01 |
GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 12 | 9.42e-01 | -1.21e-02 | 9.87e-01 |
GOBP EATING BEHAVIOR | 11 | 9.45e-01 | 1.21e-02 | 9.88e-01 |
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 213 | 7.62e-01 | -1.21e-02 | 9.45e-01 |
GOBP HEAD DEVELOPMENT | 435 | 6.68e-01 | 1.21e-02 | 9.23e-01 |
GOMF CALMODULIN BINDING | 121 | 8.19e-01 | -1.20e-02 | 9.58e-01 |
GOMF SYNTAXIN 1 BINDING | 12 | 9.42e-01 | -1.20e-02 | 9.87e-01 |
GOBP MUSCLE TISSUE DEVELOPMENT | 205 | 7.67e-01 | -1.20e-02 | 9.45e-01 |
GOCC U5 SNRNP | 19 | 9.28e-01 | -1.20e-02 | 9.85e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 10 | 9.48e-01 | -1.20e-02 | 9.89e-01 |
GOBP AXON DEVELOPMENT | 258 | 7.41e-01 | 1.20e-02 | 9.40e-01 |
GOBP EMBRYONIC HEMOPOIESIS | 15 | 9.36e-01 | -1.20e-02 | 9.86e-01 |
GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 11 | 9.45e-01 | -1.20e-02 | 9.88e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 9.63e-01 | 1.19e-02 | 9.94e-01 |
GOBP PHAGOSOME LYSOSOME FUSION | 11 | 9.46e-01 | 1.19e-02 | 9.88e-01 |
GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 55 | 8.79e-01 | -1.19e-02 | 9.75e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 13 | 9.41e-01 | -1.19e-02 | 9.87e-01 |
GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 364 | 6.99e-01 | -1.19e-02 | 9.29e-01 |
GOMF VITAMIN BINDING | 85 | 8.50e-01 | 1.18e-02 | 9.68e-01 |
GOBP LEUKOCYTE APOPTOTIC PROCESS | 97 | 8.41e-01 | -1.18e-02 | 9.64e-01 |
GOMF GLYCOLIPID BINDING | 18 | 9.31e-01 | 1.18e-02 | 9.85e-01 |
GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 9.64e-01 | 1.18e-02 | 9.94e-01 |
GOCC CHLORIDE CHANNEL COMPLEX | 14 | 9.39e-01 | -1.18e-02 | 9.87e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 12 | 9.44e-01 | 1.18e-02 | 9.88e-01 |
GOBP RNA CATABOLIC PROCESS | 258 | 7.47e-01 | 1.17e-02 | 9.42e-01 |
GOBP EPITHELIAL CELL FATE COMMITMENT | 6 | 9.61e-01 | -1.17e-02 | 9.93e-01 |
GOBP EMBRYONIC BODY MORPHOGENESIS | 7 | 9.57e-01 | -1.16e-02 | 9.92e-01 |
GOBP PROTEIN DESUMOYLATION | 8 | 9.55e-01 | -1.16e-02 | 9.92e-01 |
GOBP TOR SIGNALING | 143 | 8.12e-01 | 1.16e-02 | 9.57e-01 |
GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 52 | 8.86e-01 | -1.15e-02 | 9.76e-01 |
GOCC EXOCYTIC VESICLE | 134 | 8.18e-01 | -1.15e-02 | 9.58e-01 |
GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 6 | 9.61e-01 | -1.15e-02 | 9.93e-01 |
GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 9 | 9.52e-01 | 1.15e-02 | 9.91e-01 |
GOBP ALCOHOL BIOSYNTHETIC PROCESS | 90 | 8.51e-01 | -1.15e-02 | 9.68e-01 |
GOBP BONE MORPHOGENESIS | 39 | 9.01e-01 | 1.15e-02 | 9.81e-01 |
GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 58 | 8.80e-01 | 1.15e-02 | 9.76e-01 |
GOBP ACTIVATION OF IMMUNE RESPONSE | 417 | 6.90e-01 | -1.15e-02 | 9.25e-01 |
GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 827 | 5.80e-01 | -1.14e-02 | 8.88e-01 |
GOBP CARDIAC CHAMBER MORPHOGENESIS | 56 | 8.82e-01 | 1.14e-02 | 9.76e-01 |
GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 47 | 8.92e-01 | 1.14e-02 | 9.78e-01 |
GOBP REGULATION OF CELL DIVISION | 112 | 8.35e-01 | -1.14e-02 | 9.61e-01 |
GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 80 | 8.60e-01 | -1.14e-02 | 9.68e-01 |
GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 11 | 9.48e-01 | 1.14e-02 | 9.89e-01 |
GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 10 | 9.50e-01 | -1.13e-02 | 9.90e-01 |
GOBP UROGENITAL SYSTEM DEVELOPMENT | 31 | 9.13e-01 | 1.13e-02 | 9.82e-01 |
GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 9.53e-01 | -1.13e-02 | 9.92e-01 |
GOBP REGULATION OF GERMINAL CENTER FORMATION | 7 | 9.59e-01 | 1.13e-02 | 9.92e-01 |
GOBP REGULATION OF CELLULAR EXTRAVASATION | 26 | 9.20e-01 | -1.13e-02 | 9.84e-01 |
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 18 | 9.34e-01 | -1.13e-02 | 9.86e-01 |
GOBP GERM CELL DEVELOPMENT | 167 | 8.01e-01 | 1.13e-02 | 9.55e-01 |
GOBP EMBRYONIC PATTERN SPECIFICATION | 27 | 9.19e-01 | 1.13e-02 | 9.84e-01 |
GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 9.59e-01 | -1.13e-02 | 9.92e-01 |
GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 235 | 7.67e-01 | 1.13e-02 | 9.45e-01 |
GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 18 | 9.34e-01 | -1.12e-02 | 9.86e-01 |
GOCC EARLY ENDOSOME MEMBRANE | 143 | 8.17e-01 | -1.12e-02 | 9.58e-01 |
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 22 | 9.27e-01 | -1.12e-02 | 9.85e-01 |
GOCC TRAPPIII PROTEIN COMPLEX | 12 | 9.46e-01 | -1.12e-02 | 9.89e-01 |
GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 50 | 8.91e-01 | -1.12e-02 | 9.77e-01 |
GOBP ORGAN INDUCTION | 6 | 9.62e-01 | -1.12e-02 | 9.93e-01 |
GOMF G PROTEIN COUPLED RECEPTOR BINDING | 124 | 8.30e-01 | -1.12e-02 | 9.59e-01 |
GOBP PEPTIDYL LYSINE METHYLATION | 44 | 8.98e-01 | 1.11e-02 | 9.80e-01 |
GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 179 | 7.99e-01 | -1.11e-02 | 9.54e-01 |
GOMF PALMITOYL COA HYDROLASE ACTIVITY | 11 | 9.49e-01 | 1.11e-02 | 9.90e-01 |
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 6 | 9.63e-01 | -1.11e-02 | 9.94e-01 |
GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 26 | 9.22e-01 | -1.10e-02 | 9.84e-01 |
GOBP TRANS SYNAPTIC SIGNALING BY LIPID | 5 | 9.66e-01 | -1.10e-02 | 9.94e-01 |
GOBP SYNAPTIC VESICLE EXOCYTOSIS | 53 | 8.90e-01 | 1.10e-02 | 9.77e-01 |
GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 122 | 8.34e-01 | -1.10e-02 | 9.61e-01 |
GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 129 | 8.30e-01 | -1.09e-02 | 9.59e-01 |
GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 15 | 9.42e-01 | -1.09e-02 | 9.87e-01 |
GOBP AMINE BIOSYNTHETIC PROCESS | 21 | 9.31e-01 | 1.09e-02 | 9.85e-01 |
GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 22 | 9.29e-01 | -1.09e-02 | 9.85e-01 |
GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 9.55e-01 | -1.09e-02 | 9.92e-01 |
GOBP GLYCOPROTEIN METABOLIC PROCESS | 247 | 7.69e-01 | 1.09e-02 | 9.46e-01 |
GOBP TYPE I INTERFERON PRODUCTION | 106 | 8.47e-01 | 1.08e-02 | 9.67e-01 |
GOBP SKELETAL SYSTEM MORPHOGENESIS | 97 | 8.54e-01 | -1.08e-02 | 9.68e-01 |
GOCC NEURON PROJECTION MEMBRANE | 26 | 9.24e-01 | -1.08e-02 | 9.84e-01 |
GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 15 | 9.42e-01 | -1.08e-02 | 9.87e-01 |
GOBP FOREBRAIN NEURON DIFFERENTIATION | 19 | 9.35e-01 | -1.08e-02 | 9.86e-01 |
GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 6 | 9.64e-01 | 1.08e-02 | 9.94e-01 |
GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 7 | 9.61e-01 | 1.07e-02 | 9.93e-01 |
GOBP CEREBRAL CORTEX DEVELOPMENT | 81 | 8.68e-01 | -1.07e-02 | 9.71e-01 |
GOBP MOTOR BEHAVIOR | 16 | 9.41e-01 | -1.06e-02 | 9.87e-01 |
GOBP TRNA SURVEILLANCE | 8 | 9.59e-01 | 1.06e-02 | 9.92e-01 |
GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1069 | 5.64e-01 | -1.06e-02 | 8.80e-01 |
GOBP NECROPTOTIC PROCESS | 34 | 9.15e-01 | -1.06e-02 | 9.83e-01 |
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 120 | 8.41e-01 | 1.06e-02 | 9.64e-01 |
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 69 | 8.80e-01 | 1.06e-02 | 9.75e-01 |
GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 30 | 9.20e-01 | -1.06e-02 | 9.84e-01 |
GOBP ORGANELLE MEMBRANE FUSION | 97 | 8.58e-01 | 1.05e-02 | 9.68e-01 |
GOMF ACETYLCHOLINE RECEPTOR ACTIVITY | 5 | 9.68e-01 | -1.05e-02 | 9.95e-01 |
GOBP REGULATION OF DNA DEMETHYLATION | 8 | 9.59e-01 | 1.05e-02 | 9.93e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 36 | 9.13e-01 | -1.05e-02 | 9.82e-01 |
GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 15 | 9.44e-01 | 1.05e-02 | 9.88e-01 |
GOCC ENDOLYSOSOME | 23 | 9.31e-01 | -1.04e-02 | 9.85e-01 |
GOMF MHC CLASS IB RECEPTOR ACTIVITY | 6 | 9.65e-01 | 1.04e-02 | 9.94e-01 |
GOBP MITOTIC CELL CYCLE | 700 | 6.42e-01 | 1.04e-02 | 9.10e-01 |
GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 9.65e-01 | 1.04e-02 | 9.94e-01 |
GOCC ZONULA ADHERENS | 7 | 9.62e-01 | 1.04e-02 | 9.93e-01 |
GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 44 | 9.05e-01 | -1.04e-02 | 9.82e-01 |
GOBP REGULATION OF MUSCLE ADAPTATION | 46 | 9.04e-01 | 1.03e-02 | 9.81e-01 |
GOBP REGULATION OF STEM CELL DIFFERENTIATION | 55 | 8.95e-01 | -1.03e-02 | 9.79e-01 |
GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 424 | 7.17e-01 | 1.03e-02 | 9.33e-01 |
GOMF LIPID BINDING | 532 | 6.87e-01 | -1.03e-02 | 9.25e-01 |
GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 44 | 9.06e-01 | 1.03e-02 | 9.82e-01 |
GOBP ORGANELLE ASSEMBLY | 736 | 6.40e-01 | 1.02e-02 | 9.10e-01 |
GOBP SYNAPTIC VESICLE MATURATION | 21 | 9.36e-01 | -1.02e-02 | 9.86e-01 |
GOBP MUSCLE HYPERTROPHY | 52 | 8.99e-01 | -1.02e-02 | 9.80e-01 |
GOBP REPRODUCTIVE BEHAVIOR | 16 | 9.44e-01 | 1.01e-02 | 9.88e-01 |
GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 26 | 9.29e-01 | -1.01e-02 | 9.85e-01 |
GOCC POSTSYNAPTIC SPECIALIZATION | 190 | 8.11e-01 | -1.01e-02 | 9.57e-01 |
GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 50 | 9.02e-01 | -1.01e-02 | 9.81e-01 |
GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 788 | 6.34e-01 | 1.01e-02 | 9.07e-01 |
GOBP POSITIVE T CELL SELECTION | 35 | 9.18e-01 | -1.01e-02 | 9.84e-01 |
GOBP CELL CELL RECOGNITION | 36 | 9.17e-01 | -1.01e-02 | 9.84e-01 |
GOBP T CELL ACTIVATION | 446 | 7.18e-01 | -1.01e-02 | 9.33e-01 |
GOBP INNERVATION | 12 | 9.52e-01 | 1.00e-02 | 9.91e-01 |
GOBP SYNAPTIC SIGNALING | 372 | 7.41e-01 | 1.00e-02 | 9.40e-01 |
GOBP RESPONSE TO MAGNESIUM ION | 12 | 9.52e-01 | 1.00e-02 | 9.91e-01 |
GOCC BRCA1 C COMPLEX | 6 | 9.66e-01 | -1.00e-02 | 9.94e-01 |
GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 5 | 9.69e-01 | -9.99e-03 | 9.95e-01 |
GOBP RESPONSE TO PEPTIDE | 330 | 7.56e-01 | 9.98e-03 | 9.44e-01 |
GOMF PROTEIN FOLDING CHAPERONE | 48 | 9.05e-01 | 9.96e-03 | 9.82e-01 |
GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 11 | 9.55e-01 | -9.91e-03 | 9.92e-01 |
GOCC CKM COMPLEX | 5 | 9.69e-01 | -9.90e-03 | 9.95e-01 |
GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 445 | 7.22e-01 | 9.88e-03 | 9.36e-01 |
GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 350 | 7.52e-01 | 9.87e-03 | 9.42e-01 |
GOCC CATALYTIC COMPLEX | 1468 | 5.36e-01 | -9.86e-03 | 8.73e-01 |
GOBP TRANSPORT ALONG MICROTUBULE | 133 | 8.46e-01 | 9.78e-03 | 9.66e-01 |
GOBP POSITIVE REGULATION OF CELL SIZE | 8 | 9.62e-01 | -9.76e-03 | 9.93e-01 |
GOMF MHC PROTEIN COMPLEX BINDING | 33 | 9.23e-01 | -9.74e-03 | 9.84e-01 |
GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 238 | 7.97e-01 | -9.73e-03 | 9.54e-01 |
GOBP AMINO ACID CATABOLIC PROCESS | 69 | 8.89e-01 | -9.70e-03 | 9.77e-01 |
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 46 | 9.10e-01 | 9.66e-03 | 9.82e-01 |
GOBP HETEROCYCLE CATABOLIC PROCESS | 385 | 7.47e-01 | 9.62e-03 | 9.42e-01 |
GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 10 | 9.58e-01 | 9.61e-03 | 9.92e-01 |
GOCC SARCOLEMMA | 72 | 8.88e-01 | -9.58e-03 | 9.77e-01 |
GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 9.70e-01 | -9.56e-03 | 9.95e-01 |
GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 351 | 7.60e-01 | -9.56e-03 | 9.45e-01 |
GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 37 | 9.20e-01 | -9.56e-03 | 9.84e-01 |
GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 49 | 9.09e-01 | 9.48e-03 | 9.82e-01 |
GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 9.05e-01 | -9.48e-03 | 9.82e-01 |
GOBP ISOPRENOID METABOLIC PROCESS | 73 | 8.89e-01 | -9.48e-03 | 9.77e-01 |
GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 32 | 9.26e-01 | -9.45e-03 | 9.84e-01 |
GOBP MEIOTIC SPINDLE ORGANIZATION | 16 | 9.48e-01 | -9.45e-03 | 9.89e-01 |
GOBP MACROMOLECULE CATABOLIC PROCESS | 1108 | 6.04e-01 | -9.37e-03 | 8.99e-01 |
GOBP REGULATION OF BINDING | 192 | 8.24e-01 | -9.35e-03 | 9.58e-01 |
GOBP NEGATIVE REGULATION OF BINDING | 85 | 8.82e-01 | 9.34e-03 | 9.76e-01 |
GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 97 | 8.75e-01 | 9.29e-03 | 9.75e-01 |
GOMF MICROFILAMENT MOTOR ACTIVITY | 22 | 9.40e-01 | 9.25e-03 | 9.87e-01 |
GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 31 | 9.29e-01 | -9.22e-03 | 9.85e-01 |
GOBP REGULATION OF RIBOSOME BIOGENESIS | 9 | 9.62e-01 | -9.22e-03 | 9.93e-01 |
GOMF MRNA 3 UTR BINDING | 82 | 8.86e-01 | -9.18e-03 | 9.76e-01 |
GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 5 | 9.72e-01 | 9.16e-03 | 9.95e-01 |
GOBP MICROTUBULE BUNDLE FORMATION | 54 | 9.08e-01 | -9.14e-03 | 9.82e-01 |
GOBP MEMBRANE RAFT ORGANIZATION | 20 | 9.44e-01 | 9.12e-03 | 9.88e-01 |
GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 72 | 8.94e-01 | -9.09e-03 | 9.78e-01 |
GOBP AGGREPHAGY | 8 | 9.65e-01 | -9.07e-03 | 9.94e-01 |
GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 6 | 9.69e-01 | 9.07e-03 | 9.95e-01 |
GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 96 | 8.78e-01 | -9.04e-03 | 9.75e-01 |
GOCC SITE OF POLARIZED GROWTH | 126 | 8.61e-01 | 9.04e-03 | 9.69e-01 |
GOBP REGULATION OF ANIMAL ORGAN FORMATION | 7 | 9.67e-01 | 9.03e-03 | 9.95e-01 |
GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 148 | 8.50e-01 | -9.03e-03 | 9.68e-01 |
GOBP NEURON CELL CELL ADHESION | 6 | 9.70e-01 | 9.00e-03 | 9.95e-01 |
GOBP GAMMA DELTA T CELL ACTIVATION | 22 | 9.42e-01 | 8.97e-03 | 9.87e-01 |
GOMF ACYLTRANSFERASE ACTIVITY | 540 | 7.24e-01 | 8.97e-03 | 9.36e-01 |
GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 402 | 7.60e-01 | 8.93e-03 | 9.45e-01 |
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 24 | 9.40e-01 | 8.91e-03 | 9.87e-01 |
GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.70e-01 | -8.88e-03 | 9.95e-01 |
GOBP RESPONSE TO AXON INJURY | 44 | 9.19e-01 | 8.83e-03 | 9.84e-01 |
GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 297 | 7.95e-01 | -8.82e-03 | 9.54e-01 |
GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 6 | 9.70e-01 | -8.81e-03 | 9.95e-01 |
GOBP REGULATION OF CELL DIFFERENTIATION | 930 | 6.54e-01 | -8.80e-03 | 9.15e-01 |
GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 44 | 9.21e-01 | -8.66e-03 | 9.84e-01 |
GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 33 | 9.32e-01 | -8.62e-03 | 9.85e-01 |
GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 95 | 8.85e-01 | -8.61e-03 | 9.76e-01 |
GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 102 | 8.81e-01 | -8.58e-03 | 9.76e-01 |
GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 15 | 9.54e-01 | -8.54e-03 | 9.92e-01 |
GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 28 | 9.38e-01 | -8.46e-03 | 9.87e-01 |
GOBP NEUROTRANSMITTER TRANSPORT | 99 | 8.85e-01 | -8.44e-03 | 9.76e-01 |
GOCC MKS COMPLEX | 10 | 9.63e-01 | 8.44e-03 | 9.94e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 5 | 9.74e-01 | 8.41e-03 | 9.95e-01 |
GOBP PROTEIN LOCALIZATION TO CILIUM | 50 | 9.18e-01 | 8.38e-03 | 9.84e-01 |
GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 867 | 6.80e-01 | -8.36e-03 | 9.24e-01 |
GOCC PHOSPHATASE COMPLEX | 47 | 9.21e-01 | 8.36e-03 | 9.84e-01 |
GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 8 | 9.67e-01 | 8.35e-03 | 9.95e-01 |
GOBP PALLIUM DEVELOPMENT | 115 | 8.77e-01 | -8.35e-03 | 9.75e-01 |
GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 22 | 9.46e-01 | 8.30e-03 | 9.89e-01 |
GOBP RESPONSE TO NITROGEN COMPOUND | 720 | 7.07e-01 | -8.29e-03 | 9.31e-01 |
GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 160 | 8.58e-01 | -8.22e-03 | 9.68e-01 |
GOMF RNA POLYMERASE CORE ENZYME BINDING | 40 | 9.29e-01 | -8.17e-03 | 9.85e-01 |
GOBP MEMORY | 52 | 9.19e-01 | -8.16e-03 | 9.84e-01 |
GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 115 | 8.80e-01 | -8.14e-03 | 9.76e-01 |
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 38 | 9.31e-01 | 8.13e-03 | 9.85e-01 |
GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 22 | 9.47e-01 | 8.12e-03 | 9.89e-01 |
GOBP SYNAPTIC VESICLE LOCALIZATION | 38 | 9.31e-01 | 8.12e-03 | 9.85e-01 |
GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 7 | 9.70e-01 | -8.08e-03 | 9.95e-01 |
GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 8 | 9.68e-01 | 8.06e-03 | 9.95e-01 |
GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 29 | 9.40e-01 | 8.02e-03 | 9.87e-01 |
GOCC TRANS GOLGI NETWORK | 208 | 8.43e-01 | 8.00e-03 | 9.64e-01 |
GOBP ANIMAL ORGAN REGENERATION | 38 | 9.32e-01 | 7.98e-03 | 9.85e-01 |
GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 401 | 7.87e-01 | -7.92e-03 | 9.53e-01 |
GOBP NEURAL RETINA DEVELOPMENT | 32 | 9.38e-01 | -7.91e-03 | 9.87e-01 |
GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 9.76e-01 | 7.89e-03 | 9.96e-01 |
GOBP CANONICAL WNT SIGNALING PATHWAY | 178 | 8.56e-01 | 7.89e-03 | 9.68e-01 |
GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 639 | 7.38e-01 | -7.83e-03 | 9.40e-01 |
GOBP CELL CELL JUNCTION ORGANIZATION | 109 | 8.88e-01 | -7.83e-03 | 9.77e-01 |
GOBP CELL CYCLE G2 M PHASE TRANSITION | 119 | 8.83e-01 | -7.82e-03 | 9.76e-01 |
GOBP MICROTUBULE POLYMERIZATION | 79 | 9.05e-01 | 7.81e-03 | 9.82e-01 |
GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 73 | 9.08e-01 | -7.79e-03 | 9.82e-01 |
GOCC PROTEIN LIPID COMPLEX | 19 | 9.53e-01 | -7.76e-03 | 9.92e-01 |
GOBP GERMINAL CENTER FORMATION | 12 | 9.63e-01 | -7.75e-03 | 9.94e-01 |
GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 32 | 9.40e-01 | -7.75e-03 | 9.87e-01 |
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 9 | 9.68e-01 | -7.71e-03 | 9.95e-01 |
GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 8 | 9.70e-01 | -7.69e-03 | 9.95e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 57 | 9.20e-01 | -7.68e-03 | 9.84e-01 |
GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 7 | 9.72e-01 | 7.61e-03 | 9.95e-01 |
GOBP PROTEIN RETENTION IN ER LUMEN | 7 | 9.72e-01 | -7.61e-03 | 9.95e-01 |
GOBP MAPK CASCADE | 470 | 7.79e-01 | -7.59e-03 | 9.50e-01 |
GOBP RESPONSE TO IMMOBILIZATION STRESS | 13 | 9.62e-01 | -7.59e-03 | 9.93e-01 |
GOBP LYMPHOCYTE MEDIATED IMMUNITY | 234 | 8.42e-01 | -7.59e-03 | 9.64e-01 |
GOBP RESPONSE TO OXIDATIVE STRESS | 302 | 8.22e-01 | -7.56e-03 | 9.58e-01 |
GOBP MACROPHAGE PROLIFERATION | 7 | 9.73e-01 | -7.49e-03 | 9.95e-01 |
GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 9.75e-01 | 7.49e-03 | 9.95e-01 |
GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 9.77e-01 | 7.46e-03 | 9.96e-01 |
GOMF CTPASE ACTIVITY | 5 | 9.77e-01 | -7.46e-03 | 9.96e-01 |
GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 12 | 9.64e-01 | 7.45e-03 | 9.94e-01 |
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 8 | 9.71e-01 | 7.45e-03 | 9.95e-01 |
GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 7 | 9.73e-01 | 7.45e-03 | 9.95e-01 |
GOBP ANIMAL ORGAN MORPHOGENESIS | 476 | 7.83e-01 | -7.41e-03 | 9.51e-01 |
GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 15 | 9.61e-01 | 7.37e-03 | 9.93e-01 |
GOBP POST EMBRYONIC DEVELOPMENT | 68 | 9.16e-01 | 7.36e-03 | 9.84e-01 |
GOBP RESPONSE TO ESTROGEN | 38 | 9.38e-01 | -7.30e-03 | 9.87e-01 |
GOBP EMBRYO DEVELOPMENT | 633 | 7.56e-01 | -7.29e-03 | 9.44e-01 |
GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 263 | 8.40e-01 | -7.28e-03 | 9.63e-01 |
GOBP RENAL SYSTEM DEVELOPMENT | 162 | 8.74e-01 | -7.22e-03 | 9.74e-01 |
GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 12 | 9.66e-01 | -7.19e-03 | 9.94e-01 |
GOMF CALCIUM ION BINDING | 308 | 8.30e-01 | -7.16e-03 | 9.59e-01 |
GOMF PROTEIN CONTAINING COMPLEX BINDING | 1254 | 6.76e-01 | -7.15e-03 | 9.24e-01 |
GOBP GENERATION OF NEURONS | 815 | 7.32e-01 | 7.14e-03 | 9.39e-01 |
GOBP HISTONE MODIFICATION | 105 | 9.00e-01 | 7.14e-03 | 9.80e-01 |
GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 5 | 9.78e-01 | -7.14e-03 | 9.97e-01 |
GOBP PROTEIN POLYUBIQUITINATION | 191 | 8.65e-01 | -7.14e-03 | 9.70e-01 |
GOBP BILE ACID METABOLIC PROCESS | 24 | 9.52e-01 | 7.14e-03 | 9.91e-01 |
GOBP APOPTOTIC DNA FRAGMENTATION | 13 | 9.65e-01 | 7.12e-03 | 9.94e-01 |
GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 275 | 8.42e-01 | -7.02e-03 | 9.64e-01 |
GOBP PEPTIDYL SERINE MODIFICATION | 219 | 8.58e-01 | 7.02e-03 | 9.68e-01 |
GOMF 5 3 EXONUCLEASE ACTIVITY | 17 | 9.60e-01 | 7.01e-03 | 9.93e-01 |
GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 41 | 9.39e-01 | -6.92e-03 | 9.87e-01 |
GOCC CATION CHANNEL COMPLEX | 68 | 9.22e-01 | 6.92e-03 | 9.84e-01 |
GOBP RESPONSE TO XENOBIOTIC STIMULUS | 219 | 8.60e-01 | 6.92e-03 | 9.68e-01 |
GOCC TRANSCRIPTION REGULATOR COMPLEX | 361 | 8.22e-01 | 6.91e-03 | 9.58e-01 |
GOMF MRNA 3 UTR AU RICH REGION BINDING | 23 | 9.54e-01 | -6.90e-03 | 9.92e-01 |
GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 63 | 9.25e-01 | -6.88e-03 | 9.84e-01 |
GOBP NUCLEOTIDE SALVAGE | 16 | 9.62e-01 | -6.83e-03 | 9.93e-01 |
GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 7 | 9.75e-01 | 6.81e-03 | 9.95e-01 |
GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 151 | 8.85e-01 | -6.80e-03 | 9.76e-01 |
GOBP TUBULIN DEACETYLATION | 19 | 9.59e-01 | -6.74e-03 | 9.93e-01 |
GOBP CELL JUNCTION ORGANIZATION | 391 | 8.20e-01 | -6.73e-03 | 9.58e-01 |
GOCC RUFFLE | 146 | 8.89e-01 | -6.69e-03 | 9.77e-01 |
GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 22 | 9.57e-01 | 6.67e-03 | 9.92e-01 |
GOBP REGENERATION | 105 | 9.06e-01 | 6.66e-03 | 9.82e-01 |
GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 180 | 8.78e-01 | -6.64e-03 | 9.75e-01 |
GOCC CALCIUM CHANNEL COMPLEX | 36 | 9.46e-01 | 6.58e-03 | 9.88e-01 |
GOBP REGULATION OF PROTEIN GLYCOSYLATION | 10 | 9.71e-01 | -6.57e-03 | 9.95e-01 |
GOMF LIPASE ACTIVITY | 78 | 9.20e-01 | 6.54e-03 | 9.84e-01 |
GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 875 | 7.46e-01 | -6.54e-03 | 9.42e-01 |
GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 9 | 9.73e-01 | -6.50e-03 | 9.95e-01 |
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 16 | 9.64e-01 | -6.47e-03 | 9.94e-01 |
GOBP NEPHRON DEVELOPMENT | 66 | 9.28e-01 | -6.47e-03 | 9.85e-01 |
GOMF MANNOSE BINDING | 17 | 9.63e-01 | -6.45e-03 | 9.94e-01 |
GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 9.72e-01 | 6.44e-03 | 9.95e-01 |
GOCC COHESIN COMPLEX | 9 | 9.74e-01 | -6.38e-03 | 9.95e-01 |
GOCC PHAGOPHORE ASSEMBLY SITE | 33 | 9.49e-01 | -6.38e-03 | 9.90e-01 |
GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 11 | 9.71e-01 | 6.36e-03 | 9.95e-01 |
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 25 | 9.56e-01 | 6.33e-03 | 9.92e-01 |
GOBP VITAMIN TRANSPORT | 26 | 9.56e-01 | 6.31e-03 | 9.92e-01 |
GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 32 | 9.51e-01 | -6.30e-03 | 9.91e-01 |
GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 108 | 9.10e-01 | 6.29e-03 | 9.82e-01 |
GOCC CCR4 NOT CORE COMPLEX | 6 | 9.79e-01 | -6.29e-03 | 9.97e-01 |
GOBP AUTOPHAGY OF PEROXISOME | 10 | 9.73e-01 | 6.28e-03 | 9.95e-01 |
GOBP RESPONSE TO AUDITORY STIMULUS | 12 | 9.70e-01 | -6.27e-03 | 9.95e-01 |
GOBP REGULATION OF CELL KILLING | 84 | 9.21e-01 | 6.25e-03 | 9.84e-01 |
GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 152 | 8.95e-01 | -6.24e-03 | 9.79e-01 |
GOBP MEMBRANE REPOLARIZATION | 17 | 9.64e-01 | 6.24e-03 | 9.94e-01 |
GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 9.79e-01 | -6.17e-03 | 9.97e-01 |
GOBP REGULATION OF ORGANELLE ORGANIZATION | 904 | 7.58e-01 | -6.12e-03 | 9.44e-01 |
GOBP CELLULAR RESPONSE TO ALCOHOL | 61 | 9.34e-01 | 6.11e-03 | 9.86e-01 |
GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 557 | 8.07e-01 | 6.09e-03 | 9.56e-01 |
GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 6 | 9.79e-01 | 6.07e-03 | 9.97e-01 |
GOBP PROTEIN LOCALIZATION TO LYSOSOME | 50 | 9.41e-01 | 6.05e-03 | 9.87e-01 |
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 9.77e-01 | 6.01e-03 | 9.96e-01 |
GOBP SOMITE DEVELOPMENT | 35 | 9.51e-01 | 5.98e-03 | 9.91e-01 |
GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1090 | 7.44e-01 | -5.95e-03 | 9.41e-01 |
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 5 | 9.82e-01 | -5.93e-03 | 9.97e-01 |
GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 448 | 8.31e-01 | -5.93e-03 | 9.59e-01 |
GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 6 | 9.80e-01 | 5.86e-03 | 9.97e-01 |
GOBP REGULATION OF NUCLEAR DIVISION | 86 | 9.25e-01 | -5.84e-03 | 9.84e-01 |
GOCC MIDBODY | 179 | 8.93e-01 | -5.83e-03 | 9.78e-01 |
GOCC IMMUNOGLOBULIN COMPLEX | 13 | 9.71e-01 | -5.82e-03 | 9.95e-01 |
GOCC SOMATODENDRITIC COMPARTMENT | 451 | 8.33e-01 | 5.82e-03 | 9.60e-01 |
GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 9.82e-01 | -5.82e-03 | 9.98e-01 |
GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 49 | 9.44e-01 | -5.81e-03 | 9.88e-01 |
GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 9.79e-01 | 5.80e-03 | 9.97e-01 |
GOBP RESPONSE TO MUSCLE ACTIVITY | 12 | 9.72e-01 | -5.79e-03 | 9.95e-01 |
GOBP REGULATION OF AMIDE METABOLIC PROCESS | 405 | 8.44e-01 | 5.74e-03 | 9.64e-01 |
GOBP FEAR RESPONSE | 19 | 9.66e-01 | -5.68e-03 | 9.94e-01 |
GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION | 8 | 9.78e-01 | -5.67e-03 | 9.97e-01 |
GOBP REGULATION OF CATALYTIC ACTIVITY | 1015 | 7.64e-01 | -5.65e-03 | 9.45e-01 |
GOMF SPHINGOLIPID TRANSFER ACTIVITY | 5 | 9.83e-01 | 5.64e-03 | 9.98e-01 |
GOCC BASEMENT MEMBRANE | 30 | 9.58e-01 | -5.62e-03 | 9.92e-01 |
GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 35 | 9.55e-01 | 5.57e-03 | 9.92e-01 |
GOBP RESPONSE TO SELENIUM ION | 5 | 9.83e-01 | 5.56e-03 | 9.98e-01 |
GOBP BILE ACID AND BILE SALT TRANSPORT | 12 | 9.74e-01 | 5.53e-03 | 9.95e-01 |
GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 439 | 8.44e-01 | -5.51e-03 | 9.64e-01 |
GOBP RESPONSE TO BMP | 74 | 9.35e-01 | -5.50e-03 | 9.86e-01 |
GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 14 | 9.72e-01 | -5.49e-03 | 9.95e-01 |
GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 8 | 9.79e-01 | -5.49e-03 | 9.97e-01 |
GOBP CELLULAR RESPONSE TO CALCIUM ION | 48 | 9.48e-01 | -5.47e-03 | 9.89e-01 |
GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 17 | 9.69e-01 | 5.47e-03 | 9.95e-01 |
GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 150 | 9.08e-01 | -5.46e-03 | 9.82e-01 |
GOBP SENSORY PERCEPTION OF PAIN | 34 | 9.56e-01 | -5.46e-03 | 9.92e-01 |
GOBP MEIOTIC SPINDLE ASSEMBLY | 10 | 9.76e-01 | 5.44e-03 | 9.96e-01 |
GOBP ENDOSOME TO LYSOSOME TRANSPORT | 60 | 9.42e-01 | -5.42e-03 | 9.87e-01 |
GOBP IMMUNE EFFECTOR PROCESS | 466 | 8.42e-01 | -5.42e-03 | 9.64e-01 |
GOBP SMALL MOLECULE CATABOLIC PROCESS | 253 | 8.82e-01 | -5.42e-03 | 9.76e-01 |
GOBP SISTER CHROMATID COHESION | 45 | 9.50e-01 | -5.38e-03 | 9.90e-01 |
GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 27 | 9.62e-01 | -5.37e-03 | 9.93e-01 |
GOCC PML BODY | 100 | 9.27e-01 | -5.32e-03 | 9.84e-01 |
GOBP LEUKOCYTE HOMEOSTASIS | 90 | 9.31e-01 | -5.30e-03 | 9.85e-01 |
GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 310 | 8.73e-01 | 5.29e-03 | 9.74e-01 |
GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 39 | 9.54e-01 | 5.29e-03 | 9.92e-01 |
GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 96 | 9.29e-01 | -5.27e-03 | 9.85e-01 |
GOCC GLIAL CELL PROJECTION | 19 | 9.68e-01 | 5.25e-03 | 9.95e-01 |
GOCC B WICH COMPLEX | 7 | 9.81e-01 | -5.22e-03 | 9.97e-01 |
GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 33 | 9.59e-01 | 5.21e-03 | 9.92e-01 |
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 10 | 9.77e-01 | 5.20e-03 | 9.97e-01 |
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 17 | 9.70e-01 | 5.20e-03 | 9.95e-01 |
GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 9.84e-01 | -5.15e-03 | 9.98e-01 |
GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 72 | 9.40e-01 | 5.15e-03 | 9.87e-01 |
GOCC GLUTAMATERGIC SYNAPSE | 236 | 8.92e-01 | 5.12e-03 | 9.78e-01 |
GOMF TRANSLATION REPRESSOR ACTIVITY | 24 | 9.65e-01 | -5.11e-03 | 9.94e-01 |
GOMF BETA TUBULIN BINDING | 33 | 9.60e-01 | 5.09e-03 | 9.93e-01 |
GOBP HEMOPOIESIS | 696 | 8.22e-01 | 5.05e-03 | 9.58e-01 |
GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1282 | 7.67e-01 | 5.02e-03 | 9.45e-01 |
GOBP NEGATIVE REGULATION OF DNA BINDING | 25 | 9.65e-01 | -5.00e-03 | 9.94e-01 |
GOBP IN UTERO EMBRYONIC DEVELOPMENT | 273 | 8.88e-01 | -4.99e-03 | 9.76e-01 |
GOBP AUTOPHAGOSOME ORGANIZATION | 106 | 9.29e-01 | 4.99e-03 | 9.85e-01 |
GOCC MEMBRANE COAT | 86 | 9.36e-01 | 4.98e-03 | 9.86e-01 |
GOMF CARGO RECEPTOR ACTIVITY | 43 | 9.55e-01 | -4.95e-03 | 9.92e-01 |
GOBP STABILIZATION OF MEMBRANE POTENTIAL | 6 | 9.83e-01 | 4.94e-03 | 9.98e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 121 | 9.26e-01 | -4.87e-03 | 9.84e-01 |
GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 107 | 9.31e-01 | 4.86e-03 | 9.85e-01 |
GOBP TORC1 SIGNALING | 91 | 9.37e-01 | -4.79e-03 | 9.86e-01 |
GOBP ERK1 AND ERK2 CASCADE | 178 | 9.12e-01 | -4.79e-03 | 9.82e-01 |
GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 25 | 9.67e-01 | 4.77e-03 | 9.95e-01 |
GOBP NEURON DEVELOPMENT | 647 | 8.39e-01 | -4.73e-03 | 9.63e-01 |
GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 5 | 9.85e-01 | -4.72e-03 | 9.98e-01 |
GOCC SNARE COMPLEX | 39 | 9.60e-01 | 4.67e-03 | 9.93e-01 |
GOBP RESPONSE TO HYDROSTATIC PRESSURE | 5 | 9.86e-01 | 4.66e-03 | 9.98e-01 |
GOBP XENOBIOTIC METABOLIC PROCESS | 48 | 9.56e-01 | -4.65e-03 | 9.92e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 33 | 9.63e-01 | -4.65e-03 | 9.94e-01 |
GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 24 | 9.69e-01 | 4.61e-03 | 9.95e-01 |
GOBP G QUADRUPLEX DNA UNWINDING | 7 | 9.83e-01 | -4.53e-03 | 9.98e-01 |
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 9.85e-01 | -4.51e-03 | 9.98e-01 |
GOBP POSITIVE REGULATION OF PROTEIN BINDING | 47 | 9.57e-01 | 4.50e-03 | 9.92e-01 |
GOBP DEVELOPMENTAL MATURATION | 171 | 9.19e-01 | 4.49e-03 | 9.84e-01 |
GOBP CELL PROJECTION ORGANIZATION | 969 | 8.15e-01 | 4.49e-03 | 9.58e-01 |
GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 20 | 9.72e-01 | 4.48e-03 | 9.95e-01 |
GOBP RESPONSE TO VIRUS | 328 | 8.90e-01 | 4.48e-03 | 9.77e-01 |
GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 9 | 9.82e-01 | -4.46e-03 | 9.97e-01 |
GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 32 | 9.65e-01 | -4.45e-03 | 9.94e-01 |
GOBP REGULATION OF GTPASE ACTIVITY | 210 | 9.12e-01 | 4.45e-03 | 9.82e-01 |
GOBP REGULATION OF TRANSLATIONAL ELONGATION | 11 | 9.80e-01 | 4.43e-03 | 9.97e-01 |
GOMF ENZYME REGULATOR ACTIVITY | 898 | 8.24e-01 | 4.42e-03 | 9.58e-01 |
GOBP CARDIAC CELL DEVELOPMENT | 46 | 9.59e-01 | -4.42e-03 | 9.92e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 28 | 9.68e-01 | -4.35e-03 | 9.95e-01 |
GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 14 | 9.78e-01 | -4.34e-03 | 9.97e-01 |
GOBP CELL CELL SIGNALING BY WNT | 271 | 9.03e-01 | -4.32e-03 | 9.81e-01 |
GOCC DISTAL AXON | 167 | 9.24e-01 | 4.30e-03 | 9.84e-01 |
GOBP ALCOHOL METABOLIC PROCESS | 226 | 9.12e-01 | 4.30e-03 | 9.82e-01 |
GOBP PEPTIDYL LYSINE MODIFICATION | 183 | 9.21e-01 | -4.27e-03 | 9.84e-01 |
GOMF FLAP ENDONUCLEASE ACTIVITY | 5 | 9.87e-01 | -4.23e-03 | 9.98e-01 |
GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 196 | 9.19e-01 | -4.21e-03 | 9.84e-01 |
GOBP GMP METABOLIC PROCESS | 25 | 9.71e-01 | -4.19e-03 | 9.95e-01 |
GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 6 | 9.86e-01 | -4.15e-03 | 9.98e-01 |
GOBP BLASTOCYST FORMATION | 33 | 9.67e-01 | -4.14e-03 | 9.95e-01 |
GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 18 | 9.76e-01 | 4.13e-03 | 9.96e-01 |
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 6 | 9.86e-01 | -4.13e-03 | 9.98e-01 |
GOBP PROTEIN SUMOYLATION | 60 | 9.56e-01 | 4.11e-03 | 9.92e-01 |
GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 11 | 9.81e-01 | -4.09e-03 | 9.97e-01 |
GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 368 | 8.95e-01 | -4.04e-03 | 9.79e-01 |
GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 14 | 9.79e-01 | -4.00e-03 | 9.97e-01 |
GOBP POSITIVE REGULATION OF CELL ACTIVATION | 310 | 9.04e-01 | -3.99e-03 | 9.82e-01 |
GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 488 | 8.81e-01 | 3.98e-03 | 9.76e-01 |
GOBP ICOSANOID BIOSYNTHETIC PROCESS | 33 | 9.69e-01 | -3.86e-03 | 9.95e-01 |
GOMF TRANSCRIPTION FACTOR BINDING | 467 | 8.89e-01 | -3.80e-03 | 9.77e-01 |
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 25 | 9.74e-01 | 3.75e-03 | 9.95e-01 |
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 16 | 9.79e-01 | -3.74e-03 | 9.97e-01 |
GOBP HEART DEVELOPMENT | 327 | 9.09e-01 | 3.70e-03 | 9.82e-01 |
GOCC AXON | 368 | 9.04e-01 | 3.69e-03 | 9.82e-01 |
GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 24 | 9.75e-01 | -3.68e-03 | 9.95e-01 |
GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 25 | 9.75e-01 | -3.67e-03 | 9.95e-01 |
GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 8 | 9.86e-01 | 3.67e-03 | 9.98e-01 |
GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 163 | 9.36e-01 | 3.67e-03 | 9.86e-01 |
GOBP THIOESTER BIOSYNTHETIC PROCESS | 36 | 9.70e-01 | -3.66e-03 | 9.95e-01 |
GOCC ESC E Z COMPLEX | 9 | 9.85e-01 | -3.63e-03 | 9.98e-01 |
GOBP REGULATION OF INNATE IMMUNE RESPONSE | 342 | 9.10e-01 | 3.57e-03 | 9.82e-01 |
GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 38 | 9.70e-01 | -3.57e-03 | 9.95e-01 |
GOBP COPPER ION TRANSPORT | 13 | 9.82e-01 | 3.56e-03 | 9.98e-01 |
GOBP APOPTOTIC CELL CLEARANCE | 30 | 9.73e-01 | -3.55e-03 | 9.95e-01 |
GOBP SARCOMERE ORGANIZATION | 18 | 9.79e-01 | -3.55e-03 | 9.97e-01 |
GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 16 | 9.81e-01 | -3.51e-03 | 9.97e-01 |
GOBP PROTEIN DEPOLYMERIZATION | 76 | 9.58e-01 | -3.48e-03 | 9.92e-01 |
GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 7 | 9.87e-01 | 3.48e-03 | 9.98e-01 |
GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 8 | 9.87e-01 | -3.44e-03 | 9.98e-01 |
GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 11 | 9.84e-01 | 3.40e-03 | 9.98e-01 |
GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 13 | 9.83e-01 | 3.38e-03 | 9.98e-01 |
GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 50 | 9.67e-01 | -3.37e-03 | 9.95e-01 |
GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 8 | 9.87e-01 | 3.35e-03 | 9.98e-01 |
GOBP REGULATION OF SYNAPTIC PLASTICITY | 102 | 9.54e-01 | 3.34e-03 | 9.92e-01 |
GOMF SIALIC ACID BINDING | 10 | 9.85e-01 | -3.34e-03 | 9.98e-01 |
GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 8 | 9.87e-01 | 3.31e-03 | 9.98e-01 |
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 41 | 9.71e-01 | 3.29e-03 | 9.95e-01 |
GOBP PIGMENTATION | 75 | 9.61e-01 | 3.29e-03 | 9.93e-01 |
GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 5 | 9.90e-01 | -3.28e-03 | 9.98e-01 |
GOCC COPI VESICLE COAT | 13 | 9.84e-01 | 3.28e-03 | 9.98e-01 |
GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 98 | 9.55e-01 | 3.27e-03 | 9.92e-01 |
GOBP ATRIAL SEPTUM DEVELOPMENT | 9 | 9.87e-01 | -3.23e-03 | 9.98e-01 |
GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 369 | 9.16e-01 | -3.21e-03 | 9.84e-01 |
GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 144 | 9.48e-01 | 3.18e-03 | 9.89e-01 |
GOBP PROTEIN PHOSPHORYLATION | 889 | 8.75e-01 | -3.16e-03 | 9.75e-01 |
GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 21 | 9.80e-01 | -3.15e-03 | 9.97e-01 |
GOBP PYROPTOSIS | 30 | 9.76e-01 | 3.15e-03 | 9.96e-01 |
GOBP LYMPHOCYTE ACTIVATION | 625 | 8.95e-01 | 3.11e-03 | 9.79e-01 |
GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 204 | 9.40e-01 | -3.08e-03 | 9.87e-01 |
GOBP MEMBRANE DOCKING | 74 | 9.64e-01 | -3.06e-03 | 9.94e-01 |
GOBP PROTEIN COMPLEX OLIGOMERIZATION | 171 | 9.45e-01 | 3.06e-03 | 9.88e-01 |
GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 49 | 9.70e-01 | -3.06e-03 | 9.95e-01 |
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 65 | 9.66e-01 | 3.05e-03 | 9.94e-01 |
GOBP REGULATION OF IMMUNE RESPONSE | 691 | 8.93e-01 | 3.03e-03 | 9.78e-01 |
GOBP REGULATED EXOCYTOSIS | 142 | 9.51e-01 | -2.99e-03 | 9.91e-01 |
GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 127 | 9.54e-01 | -2.99e-03 | 9.92e-01 |
GOCC CONTRACTILE RING | 9 | 9.88e-01 | -2.94e-03 | 9.98e-01 |
GOBP RESPONSE TO ANTIBIOTIC | 30 | 9.78e-01 | -2.93e-03 | 9.97e-01 |
GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 400 | 9.21e-01 | -2.91e-03 | 9.84e-01 |
GOBP RESPONSE TO UV B | 15 | 9.84e-01 | -2.91e-03 | 9.98e-01 |
GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 13 | 9.86e-01 | 2.90e-03 | 9.98e-01 |
GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 36 | 9.76e-01 | 2.90e-03 | 9.96e-01 |
GOBP REGULATION OF DNA RECOMBINATION | 113 | 9.58e-01 | 2.89e-03 | 9.92e-01 |
GOBP PULMONARY VALVE DEVELOPMENT | 14 | 9.85e-01 | 2.88e-03 | 9.98e-01 |
GOBP MUSCLE ORGAN DEVELOPMENT | 175 | 9.48e-01 | 2.88e-03 | 9.89e-01 |
GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 287 | 9.34e-01 | -2.87e-03 | 9.86e-01 |
GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 49 | 9.73e-01 | -2.84e-03 | 9.95e-01 |
GOBP NATURAL KILLER CELL CHEMOTAXIS | 8 | 9.89e-01 | 2.83e-03 | 9.98e-01 |
GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 27 | 9.80e-01 | 2.80e-03 | 9.97e-01 |
GOBP METANEPHRIC GLOMERULUS DEVELOPMENT | 5 | 9.91e-01 | -2.79e-03 | 9.98e-01 |
GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 14 | 9.86e-01 | 2.74e-03 | 9.98e-01 |
GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 7 | 9.90e-01 | 2.69e-03 | 9.98e-01 |
GOBP EPITHELIAL CELL MORPHOGENESIS | 18 | 9.84e-01 | 2.66e-03 | 9.98e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 119 | 9.61e-01 | -2.62e-03 | 9.93e-01 |
GOBP INTERLEUKIN 2 PRODUCTION | 55 | 9.74e-01 | 2.58e-03 | 9.95e-01 |
GOBP MITOTIC CYTOKINESIS | 74 | 9.70e-01 | 2.56e-03 | 9.95e-01 |
GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 9.91e-01 | 2.51e-03 | 9.98e-01 |
GOCC TIGHT JUNCTION | 67 | 9.72e-01 | 2.51e-03 | 9.95e-01 |
GOBP RESPONSE TO ACETYLCHOLINE | 18 | 9.85e-01 | 2.49e-03 | 9.98e-01 |
GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 150 | 9.58e-01 | -2.49e-03 | 9.92e-01 |
GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 23 | 9.84e-01 | -2.46e-03 | 9.98e-01 |
GOBP RESPONSE TO CADMIUM ION | 41 | 9.78e-01 | 2.44e-03 | 9.97e-01 |
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 50 | 9.77e-01 | -2.38e-03 | 9.96e-01 |
GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 8 | 9.91e-01 | -2.30e-03 | 9.98e-01 |
GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 13 | 9.89e-01 | -2.27e-03 | 9.98e-01 |
GOCC SPINDLE MICROTUBULE | 68 | 9.74e-01 | 2.27e-03 | 9.95e-01 |
GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 15 | 9.88e-01 | -2.27e-03 | 9.98e-01 |
GOBP RENAL TUBULE DEVELOPMENT | 41 | 9.80e-01 | 2.26e-03 | 9.97e-01 |
GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 565 | 9.29e-01 | -2.22e-03 | 9.85e-01 |
GOBP REGULATION OF LYASE ACTIVITY | 24 | 9.85e-01 | -2.20e-03 | 9.98e-01 |
GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 69 | 9.75e-01 | 2.18e-03 | 9.95e-01 |
GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 9.91e-01 | -2.18e-03 | 9.98e-01 |
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 23 | 9.86e-01 | 2.16e-03 | 9.98e-01 |
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 5 | 9.93e-01 | -2.16e-03 | 9.99e-01 |
GOBP L ASCORBIC ACID METABOLIC PROCESS | 8 | 9.92e-01 | -2.12e-03 | 9.98e-01 |
GOBP B CELL ACTIVATION | 210 | 9.58e-01 | -2.12e-03 | 9.92e-01 |
GOMF HEAT SHOCK PROTEIN BINDING | 100 | 9.71e-01 | -2.11e-03 | 9.95e-01 |
GOBP REGULATION OF CARDIAC CONDUCTION | 10 | 9.91e-01 | -2.10e-03 | 9.98e-01 |
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 27 | 9.85e-01 | 2.07e-03 | 9.98e-01 |
GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 5 | 9.94e-01 | 2.04e-03 | 9.99e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 38 | 9.83e-01 | 2.04e-03 | 9.98e-01 |
GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 15 | 9.89e-01 | -1.98e-03 | 9.98e-01 |
GOCC NEURON PROJECTION CYTOPLASM | 65 | 9.78e-01 | 1.97e-03 | 9.97e-01 |
GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 9.94e-01 | -1.96e-03 | 9.99e-01 |
GOBP MEIOTIC CHROMOSOME SEGREGATION | 50 | 9.81e-01 | -1.95e-03 | 9.97e-01 |
GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 10 | 9.92e-01 | -1.94e-03 | 9.98e-01 |
GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 21 | 9.88e-01 | -1.94e-03 | 9.98e-01 |
GOBP EPIDERMIS DEVELOPMENT | 157 | 9.67e-01 | -1.93e-03 | 9.95e-01 |
GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 26 | 9.87e-01 | 1.89e-03 | 9.98e-01 |
GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 164 | 9.67e-01 | -1.86e-03 | 9.95e-01 |
GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 100 | 9.74e-01 | 1.86e-03 | 9.95e-01 |
GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 271 | 9.58e-01 | 1.85e-03 | 9.92e-01 |
GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 746 | 9.33e-01 | 1.82e-03 | 9.86e-01 |
GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 50 | 9.82e-01 | 1.81e-03 | 9.98e-01 |
GOBP RNA PROCESSING | 850 | 9.31e-01 | 1.78e-03 | 9.85e-01 |
GOBP GLIAL CELL MIGRATION | 42 | 9.84e-01 | 1.78e-03 | 9.98e-01 |
GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 30 | 9.87e-01 | 1.77e-03 | 9.98e-01 |
GOCC PCG PROTEIN COMPLEX | 32 | 9.86e-01 | -1.76e-03 | 9.98e-01 |
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 273 | 9.60e-01 | 1.76e-03 | 9.93e-01 |
GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 69 | 9.80e-01 | -1.75e-03 | 9.97e-01 |
GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 10 | 9.92e-01 | -1.74e-03 | 9.99e-01 |
GOMF KINASE REGULATOR ACTIVITY | 190 | 9.69e-01 | 1.65e-03 | 9.95e-01 |
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 9 | 9.93e-01 | -1.63e-03 | 9.99e-01 |
GOBP PROTEIN REFOLDING | 21 | 9.90e-01 | 1.61e-03 | 9.98e-01 |
GOMF ISOMERASE ACTIVITY | 133 | 9.75e-01 | -1.61e-03 | 9.95e-01 |
GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 13 | 9.92e-01 | -1.61e-03 | 9.98e-01 |
GOBP XENOBIOTIC TRANSPORT | 25 | 9.89e-01 | 1.57e-03 | 9.98e-01 |
GOBP ACTIN CROSSLINK FORMATION | 10 | 9.93e-01 | 1.54e-03 | 9.99e-01 |
GOBP LYSOSOMAL TRANSPORT | 111 | 9.79e-01 | -1.47e-03 | 9.97e-01 |
GOBP TRANSPOSITION | 18 | 9.92e-01 | 1.43e-03 | 9.98e-01 |
GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 36 | 9.88e-01 | 1.41e-03 | 9.98e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 15 | 9.93e-01 | -1.36e-03 | 9.99e-01 |
GOCC ASTER | 8 | 9.95e-01 | 1.35e-03 | 9.99e-01 |
GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 9.94e-01 | -1.34e-03 | 9.99e-01 |
GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 402 | 9.64e-01 | -1.33e-03 | 9.94e-01 |
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 134 | 9.79e-01 | 1.31e-03 | 9.97e-01 |
GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 11 | 9.94e-01 | 1.30e-03 | 9.99e-01 |
GOMF PHOSPHATASE INHIBITOR ACTIVITY | 26 | 9.91e-01 | 1.29e-03 | 9.98e-01 |
GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 48 | 9.88e-01 | 1.29e-03 | 9.98e-01 |
GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 20 | 9.92e-01 | 1.28e-03 | 9.98e-01 |
GOBP NEGATIVE REGULATION OF AUTOPHAGY | 77 | 9.85e-01 | 1.28e-03 | 9.98e-01 |
GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 102 | 9.82e-01 | 1.27e-03 | 9.98e-01 |
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 85 | 9.84e-01 | -1.27e-03 | 9.98e-01 |
GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 25 | 9.91e-01 | -1.25e-03 | 9.98e-01 |
GOCC CLATHRIN COATED VESICLE | 155 | 9.80e-01 | 1.19e-03 | 9.97e-01 |
GOBP RESPONSE TO IRON ION | 22 | 9.92e-01 | -1.18e-03 | 9.99e-01 |
GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 8 | 9.95e-01 | -1.17e-03 | 9.99e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1096 | 9.51e-01 | 1.12e-03 | 9.91e-01 |
GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 15 | 9.94e-01 | 1.11e-03 | 9.99e-01 |
GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 10 | 9.95e-01 | 1.11e-03 | 9.99e-01 |
GOBP ALPHA BETA T CELL ACTIVATION | 158 | 9.81e-01 | 1.11e-03 | 9.97e-01 |
GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 14 | 9.94e-01 | -1.10e-03 | 9.99e-01 |
GOBP POSITIVE REGULATION OF VIRAL PROCESS | 57 | 9.89e-01 | 1.07e-03 | 9.98e-01 |
GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 21 | 9.93e-01 | -1.06e-03 | 9.99e-01 |
GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 34 | 9.91e-01 | 1.06e-03 | 9.98e-01 |
GOBP TRANSLATIONAL ELONGATION | 61 | 9.89e-01 | -1.05e-03 | 9.98e-01 |
GOBP NEGATIVE REGULATION OF TOR SIGNALING | 62 | 9.89e-01 | 1.02e-03 | 9.98e-01 |
GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 23 | 9.93e-01 | -1.02e-03 | 9.99e-01 |
GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 35 | 9.92e-01 | 1.02e-03 | 9.98e-01 |
GOBP PEPTIDYL LYSINE TRIMETHYLATION | 9 | 9.96e-01 | 1.01e-03 | 9.99e-01 |
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 6 | 9.97e-01 | 1.01e-03 | 9.99e-01 |
GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 15 | 9.95e-01 | -8.93e-04 | 9.99e-01 |
GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 48 | 9.92e-01 | -8.39e-04 | 9.98e-01 |
GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 9 | 9.97e-01 | 7.68e-04 | 9.99e-01 |
GOCC CILIARY BASAL BODY | 122 | 9.89e-01 | 7.47e-04 | 9.98e-01 |
GOBP REGULATION OF MEMBRANE REPOLARIZATION | 13 | 9.96e-01 | -7.09e-04 | 9.99e-01 |
GOMF ACYLGLYCEROL LIPASE ACTIVITY | 11 | 9.97e-01 | -6.81e-04 | 9.99e-01 |
GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 127 | 9.90e-01 | -6.59e-04 | 9.98e-01 |
GOBP CYTOSKELETON ORGANIZATION | 971 | 9.75e-01 | -6.02e-04 | 9.95e-01 |
GOBP INTEGRATED STRESS RESPONSE SIGNALING | 38 | 9.95e-01 | -6.00e-04 | 9.99e-01 |
GOBP REGULATION OF RESPONSE TO STRESS | 1061 | 9.75e-01 | 5.77e-04 | 9.95e-01 |
GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 24 | 9.96e-01 | -5.41e-04 | 9.99e-01 |
GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 201 | 9.90e-01 | 5.04e-04 | 9.98e-01 |
GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY | 5 | 9.98e-01 | 4.89e-04 | 1.00e+00 |
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 350 | 9.88e-01 | -4.89e-04 | 9.98e-01 |
GOBP TELENCEPHALON GLIAL CELL MIGRATION | 19 | 9.97e-01 | -4.70e-04 | 9.99e-01 |
GOBP DEPYRIMIDINATION | 8 | 9.98e-01 | 4.68e-04 | 1.00e+00 |
GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 20 | 9.97e-01 | 4.54e-04 | 9.99e-01 |
GOBP ICOSANOID METABOLIC PROCESS | 60 | 9.95e-01 | 4.24e-04 | 9.99e-01 |
GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 56 | 9.96e-01 | -4.18e-04 | 9.99e-01 |
GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 172 | 9.93e-01 | 4.08e-04 | 9.99e-01 |
GOBP EXOCYTIC PROCESS | 60 | 9.96e-01 | -4.05e-04 | 9.99e-01 |
GOBP FILOPODIUM ASSEMBLY | 51 | 9.96e-01 | 3.82e-04 | 9.99e-01 |
GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 9.99e-01 | 3.74e-04 | 1.00e+00 |
GOMF PROTEIN DIMERIZATION ACTIVITY | 659 | 9.89e-01 | 3.14e-04 | 9.98e-01 |
GOCC NUCLEAR MEMBRANE | 252 | 9.93e-01 | 3.12e-04 | 9.99e-01 |
GOBP NEGATIVE REGULATION OF SIGNALING | 904 | 9.88e-01 | -3.09e-04 | 9.98e-01 |
GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 18 | 9.98e-01 | -3.04e-04 | 1.00e+00 |
GOBP ZINC ION TRANSPORT | 18 | 9.98e-01 | 2.88e-04 | 1.00e+00 |
GOBP LONG CHAIN FATTY ACID TRANSPORT | 36 | 9.98e-01 | -2.85e-04 | 1.00e+00 |
GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 436 | 9.94e-01 | 2.05e-04 | 9.99e-01 |
GOBP PROTEIN HOMOOLIGOMERIZATION | 125 | 9.97e-01 | -2.01e-04 | 9.99e-01 |
GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 9 | 9.99e-01 | -1.76e-04 | 1.00e+00 |
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 91 | 9.98e-01 | 1.48e-04 | 1.00e+00 |
GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1224 | 9.94e-01 | 1.40e-04 | 9.99e-01 |
GOBP CYTOKINESIS | 145 | 9.98e-01 | 1.19e-04 | 1.00e+00 |
GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 12 | 9.99e-01 | 1.08e-04 | 1.00e+00 |
GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 191 | 9.98e-01 | -1.06e-04 | 1.00e+00 |
GOCC CALYX OF HELD | 11 | 1.00e+00 | 1.05e-04 | 1.00e+00 |
GOMF PHOSPHOLIPASE ACTIVITY | 63 | 9.99e-01 | 9.18e-05 | 1.00e+00 |
GOCC CASPASE COMPLEX | 9 | 1.00e+00 | -8.00e-05 | 1.00e+00 |
GOCC PALMITOYLTRANSFERASE COMPLEX | 8 | 1.00e+00 | 7.20e-05 | 1.00e+00 |
GOMF CARD DOMAIN BINDING | 13 | 1.00e+00 | -3.32e-05 | 1.00e+00 |
GOMF KINASE ACTIVATOR ACTIVITY | 94 | 1.00e+00 | -2.31e-05 | 1.00e+00 |
GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 262 | 1.00e+00 | 1.74e-05 | 1.00e+00 |
GOBP REGULATION OF MAST CELL CHEMOTAXIS
Top enriched genes
GOCC SIGNAL PEPTIDASE COMPLEX
Top enriched genes
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
Top enriched genes
GOCC TORC1 COMPLEX
Top enriched genes
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT
Top enriched genes
GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION
Top enriched genes
GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY
Top enriched genes
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING
Top enriched genes
GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY
Top enriched genes
GOBP LIPID DROPLET DISASSEMBLY
Top enriched genes
GOCC SEC61 TRANSLOCON COMPLEX
Top enriched genes
GOCC TRANSLOCON COMPLEX
Top enriched genes
GOBP FAT PAD DEVELOPMENT
Top enriched genes
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT
Top enriched genes
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING
Top enriched genes
GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI
Top enriched genes
GOMF SNRNP BINDING
Top enriched genes
GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE
Top enriched genes
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION
Top enriched genes
GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING
Top enriched genes
GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY
Top enriched genes
GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS
Top enriched genes
GOMF INSULIN BINDING
Top enriched genes
GOBP SENSORY PERCEPTION OF BITTER TASTE
Top enriched genes
GOCC PROCENTRIOLE REPLICATION COMPLEX
Top enriched genes
GOMF U1 SNRNP BINDING
Top enriched genes
GOBP MRNA 3 SPLICE SITE RECOGNITION
Top enriched genes
GOBP PROTEIN POLYUFMYLATION
Top enriched genes
GOBP CYCLIC NUCLEOTIDE TRANSPORT
Top enriched genes
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN
Top enriched genes
GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE
Top enriched genes
GOCC POLYSOMAL RIBOSOME
Top enriched genes
GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY
Top enriched genes
GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION
Top enriched genes
GOCC CCAAT BINDING FACTOR COMPLEX
Top enriched genes
GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE
Top enriched genes
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE
Top enriched genes
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION
Top enriched genes
GOMF DIPHOSPHOTRANSFERASE ACTIVITY
Top enriched genes
GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY
Top enriched genes
GOMF WNT RECEPTOR ACTIVITY
Top enriched genes
GOBP PYRUVATE TRANSPORT
Top enriched genes
GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT
Top enriched genes
GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION
Top enriched genes
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS
Top enriched genes
GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION
Top enriched genes
GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM
Top enriched genes
GOBP MITOCHONDRIAL DNA REPLICATION
Top enriched genes
GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION
Top enriched genes
GOMF POLY ADP D RIBOSE BINDING
Top enriched genes
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.3.3 (2024-02-29)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.3.4 GGally_2.2.1
## [3] ggplot2_3.5.0 reshape2_1.4.4
## [5] gtools_3.9.5 tibble_3.2.1
## [7] dplyr_1.1.4 echarts4r_0.4.5
## [9] gplots_3.1.3.1 kableExtra_1.4.0
## [11] limma_3.58.1 mitch_1.15.0
## [13] DESeq2_1.42.0 muscat_1.16.0
## [15] beeswarm_0.4.0 stringi_1.8.3
## [17] SingleCellExperiment_1.24.0 SummarizedExperiment_1.32.0
## [19] Biobase_2.62.0 GenomicRanges_1.54.1
## [21] GenomeInfoDb_1.38.6 IRanges_2.36.0
## [23] S4Vectors_0.40.2 BiocGenerics_0.48.1
## [25] MatrixGenerics_1.14.0 matrixStats_1.2.0
## [27] hdf5r_1.3.9 Seurat_5.0.1
## [29] SeuratObject_5.0.1 sp_2.1-3
## [31] plyr_1.8.9
##
## loaded via a namespace (and not attached):
## [1] spatstat.sparse_3.0-3 bitops_1.0-7
## [3] httr_1.4.7 RColorBrewer_1.1-3
## [5] doParallel_1.0.17 numDeriv_2016.8-1.1
## [7] backports_1.4.1 tools_4.3.3
## [9] sctransform_0.4.1 utf8_1.2.4
## [11] R6_2.5.1 lazyeval_0.2.2
## [13] uwot_0.1.16 mgcv_1.9-1
## [15] GetoptLong_1.0.5 withr_3.0.0
## [17] prettyunits_1.2.0 gridExtra_2.3
## [19] progressr_0.14.0 cli_3.6.2
## [21] spatstat.explore_3.2-6 fastDummies_1.7.3
## [23] labeling_0.4.3 sass_0.4.8
## [25] mvtnorm_1.2-4 spatstat.data_3.0-4
## [27] blme_1.0-5 ggridges_0.5.6
## [29] pbapply_1.7-2 systemfonts_1.0.5
## [31] svglite_2.1.3 scater_1.30.1
## [33] parallelly_1.37.0 rstudioapi_0.15.0
## [35] generics_0.1.3 shape_1.4.6
## [37] ica_1.0-3 spatstat.random_3.2-2
## [39] Matrix_1.6-5 ggbeeswarm_0.7.2
## [41] fansi_1.0.6 abind_1.4-5
## [43] lifecycle_1.0.4 yaml_2.3.8
## [45] edgeR_4.0.15 SparseArray_1.2.4
## [47] Rtsne_0.17 grid_4.3.3
## [49] promises_1.2.1 crayon_1.5.2
## [51] miniUI_0.1.1.1 lattice_0.22-5
## [53] beachmat_2.18.1 cowplot_1.1.3
## [55] pillar_1.9.0 knitr_1.45
## [57] ComplexHeatmap_2.18.0 rjson_0.2.21
## [59] boot_1.3-28.1 corpcor_1.6.10
## [61] future.apply_1.11.1 codetools_0.2-19
## [63] leiden_0.4.3.1 glue_1.7.0
## [65] data.table_1.15.2 vctrs_0.6.5
## [67] png_0.1-8 spam_2.10-0
## [69] Rdpack_2.6 gtable_0.3.4
## [71] cachem_1.0.8 xfun_0.42
## [73] rbibutils_2.2.16 S4Arrays_1.2.0
## [75] mime_0.12 survival_3.5-8
## [77] iterators_1.0.14 statmod_1.5.0
## [79] ellipsis_0.3.2 fitdistrplus_1.1-11
## [81] ROCR_1.0-11 nlme_3.1-164
## [83] pbkrtest_0.5.2 bit64_4.0.5
## [85] EnvStats_2.8.1 progress_1.2.3
## [87] RcppAnnoy_0.0.22 bslib_0.6.1
## [89] TMB_1.9.10 irlba_2.3.5.1
## [91] vipor_0.4.7 KernSmooth_2.23-22
## [93] colorspace_2.1-0 ggrastr_1.0.2
## [95] tidyselect_1.2.0 bit_4.0.5
## [97] compiler_4.3.3 BiocNeighbors_1.20.2
## [99] xml2_1.3.6 DelayedArray_0.28.0
## [101] plotly_4.10.4 scales_1.3.0
## [103] caTools_1.18.2 remaCor_0.0.18
## [105] lmtest_0.9-40 stringr_1.5.1
## [107] digest_0.6.34 goftest_1.2-3
## [109] spatstat.utils_3.0-4 minqa_1.2.6
## [111] variancePartition_1.32.5 rmarkdown_2.25
## [113] aod_1.3.3 XVector_0.42.0
## [115] RhpcBLASctl_0.23-42 htmltools_0.5.7
## [117] pkgconfig_2.0.3 lme4_1.1-35.1
## [119] sparseMatrixStats_1.14.0 highr_0.10
## [121] fastmap_1.1.1 rlang_1.1.3
## [123] GlobalOptions_0.1.2 htmlwidgets_1.6.4
## [125] shiny_1.8.0 DelayedMatrixStats_1.24.0
## [127] farver_2.1.1 jquerylib_0.1.4
## [129] zoo_1.8-12 jsonlite_1.8.8
## [131] BiocParallel_1.36.0 BiocSingular_1.18.0
## [133] RCurl_1.98-1.14 magrittr_2.0.3
## [135] scuttle_1.12.0 GenomeInfoDbData_1.2.11
## [137] dotCall64_1.1-1 patchwork_1.2.0
## [139] munsell_0.5.0 Rcpp_1.0.12
## [141] viridis_0.6.5 reticulate_1.35.0
## [143] zlibbioc_1.48.0 MASS_7.3-60.0.1
## [145] ggstats_0.5.1 listenv_0.9.1
## [147] ggrepel_0.9.5 deldir_2.0-2
## [149] splines_4.3.3 tensor_1.5
## [151] hms_1.1.3 circlize_0.4.15
## [153] locfit_1.5-9.8 igraph_2.0.2
## [155] spatstat.geom_3.2-8 RcppHNSW_0.6.0
## [157] ScaledMatrix_1.10.0 evaluate_0.23
## [159] nloptr_2.0.3 foreach_1.5.2
## [161] httpuv_1.6.14 RANN_2.6.1
## [163] tidyr_1.3.1 purrr_1.0.2
## [165] polyclip_1.10-6 future_1.33.1
## [167] clue_0.3-65 scattermore_1.2
## [169] rsvd_1.0.5 broom_1.0.5
## [171] xtable_1.8-4 fANCOVA_0.6-1
## [173] RSpectra_0.16-1 later_1.3.2
## [175] viridisLite_0.4.2 lmerTest_3.1-3
## [177] glmmTMB_1.1.9 cluster_2.1.6
## [179] globals_0.16.2
END of report